PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Catto, G; Pringle, AJ; Ribeiro, B; Johnson, J				Catto, Graeme; Pringle, Adam James; Ribeiro, Bernard; Johnson, James			Will we be getting good doctors and safer patients?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Gen Med Council, London, England; Royal Coll Surgeons England, London WC2A 3PN, England; British Med Assoc, London, England; Patient Concern, London, England	Royal College of Surgeons of England	Catto, G (corresponding author), Gen Med Council, London, England.								0	4	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 3	2007	334	7591					450	451		10.1136/bmj.39136.510949.AD	http://dx.doi.org/10.1136/bmj.39136.510949.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144NB	17332578	Green Published			2022-12-28	WOS:000244802000028
J	Greenberg, DL				Greenberg, Daniel L.			Comment on "Detecting awareness in the vegetative state"	SCIENCE			English	Editorial Material									Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Greenberg, DL (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	dlgreenberg@mednet.ucla.edu	Husain, Masud/C-2074-2008	Husain, Masud/0000-0002-6850-9255; Nachev, Parashkev/0000-0002-2718-4423	Medical Research Council [MC_U105559847] Funding Source: Medline; Wellcome Trust [061140, 073735] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197	1	46	47	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816								10.1126/science.1135284	http://dx.doi.org/10.1126/science.1135284			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332395				2022-12-28	WOS:000244564700027
J	Hutchings, J; Gardner, F; Bywater, T; Daley, D; Whitaker, C; Jones, K; Eames, C; Edwards, RT				Hutchings, Judy; Gardner, Frances; Bywater, Tracey; Daley, Dave; Whitaker, Chris; Jones, Karen; Eames, Catrin; Edwards, Rhiannon T.			Parenting intervention in Sure Start services for children at risk of developing conduct disorder: pragmatic randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BEHAVIOR PROBLEMS; CHILDHOOD; ADULTHOOD; INVENTORY; PROGRAMS; FAMILIES	Objective To evaluate the effectiveness of a parenting programme as a preventive intervention with parents of preschool children considered to be at risk of developing conduct disorder. Design Pragmatic randomised controlled trial using a MOCK design with allocation by area. Setting Eleven Sure Start areas in north and mid-Wales. Participants 153 parents from socially disadvantaged areas, with children aged 36-59 months at risk of conduct disorder defined by scoring over the clinical cut off on the Eyberg child behaviour inventory. Participants were randomised on a 2:1 basis, 104 to intervention and 49 to remaining on the wait listing (control). Twenty (13%) were lost to follow-up six months later, 18 from the intervention group. Intervention The Webster-Stratton Incredible Years basic parenting programme, a 12 week group based intervention. Main outcome measures Problem behaviour in children and parenting skills assessed by self reports from parents and by direct observation in the home. Parents' self reported parenting competence, stress, and depression. Standardised and well validated instruments were used throughout. Results At follow-up, most of the measures of parenting and problem behaviour in children showed significant improvement in the intervention group. The intention to treat analysis for the primary outcome measure, the Eyberg child behaviour inventory, showed a mean difference between groups of 4.4 points (95% confidence interval 2.0 to 6.9, P < 0.001) on the problem scale with an effect size of 0.63, and a mean difference of 25.1 (14.9 to 35.2, P<0.001) on the intensity scale with an effect size of 0.89. Conclusion This community based study showed the effectiveness of an evidence based parenting intervention delivered with fidelity by regular Sure Start staff. It has influenced policy within Wales and provides lessons for England where, to date, Sure Start programmes have not been effective.	Univ Wales, Sch Psychol, Bangor LL57 2DG, Gwynedd, Wales; Univ Oxford, Dept Social Policy & Social Work, Oxford OX1 2JD, England; Univ Wales, Inst Med & Social Care Res, Ctr Hlth Econ, Bangor, Gwynedd, Wales	Bangor University; University of Oxford; Bangor University	Hutchings, J (corresponding author), Univ Wales, Sch Psychol, Bangor LL57 2DG, Gwynedd, Wales.	j.hutchings@bangor.ac.uk	Eames, Catrin/GWV-4358-2022; Daley, David/G-3799-2011	Eames, Catrin/0000-0002-9893-1182; hutchings, judy/0000-0003-2562-8104; Daley, David/0000-0002-3597-0408				Abidin RR., 1990, PARENTING STRESS IND, DOI [10.4236/psych.2018.97104, DOI 10.4236/PSYCH.2018.97104]; Arnold D.S., 1993, PSYCHOL ASSESSMENT, V9, P137, DOI [10.1037/1040-3590.5.2.137, DOI 10.1037/1040-3590.5.2.137]; Aspland Helen, 2003, Child Adolesc Ment Health, V8, P136, DOI 10.1111/1475-3588.00061; Attride-Stirling J, 2001, J COMMUNITY APPL SOC, V11, P179, DOI 10.1002/casp.613; Barlow J, 2000, J DEV BEHAV PEDIATR, V21, P356, DOI 10.1097/00004703-200010000-00006; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Belsky J, 2006, BMJ-BRIT MED J, V332, P1476, DOI 10.1136/bmj.38853.451748.2F; Broidy LM, 2003, DEV PSYCHOL, V39, P222, DOI 10.1037/0012-1649.39.2.222; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Coid J, 2003, EARLY PREVENTION ADU; Conners CK, 1994, USE PSYCHOL TESTING; Department for Training and Education, 2005, 05405 DEP TRAIN ED; *DSS, 2001 DSS HOUS AV INC; EDWARDS RT, 2007, BMJ; EYBERG SM, 1978, J CLIN CHILD PSYCHOL, V7, P113, DOI 10.1080/15374417809532835; Eyberg SM, 1981, DYADIC PARENT CHILD; Fergusson DM, 2005, J CHILD PSYCHOL PSYC, V46, P837, DOI 10.1111/j.1469-7610.2004.00387.x; Gardner F, 2006, J CHILD PSYCHOL PSYC, V47, P1123, DOI 10.1111/j.1469-7610.2006.01668.x; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Hutchings J, 1996, THESIS U WALES BANGO; HUTCHINGS J, 2004, HDB PARENTING; Hutchings J., 2004, SUPPORT START WORKIN, P69; KAZDIN AE, 1993, DEV PSYCHOPATHOL, V5, P277, DOI 10.1017/S0954579400004399; KENDALL PC, 1979, J CONSULT CLIN PSYCH, V47, P1020, DOI 10.1037/0022-006X.47.6.1020; MEADOWS P, 2006, NESS2006FR015 DEP ED; Mihalic S., 2002, BLUEPRINTS VIOLENCE; MORCH WT, 1998, INCREDIBLE YEARS NOR; *NAT I CLIN EXC, PAR TRAIN ED PROGR M; *OFF NAT STAT, 2005, SOC TRENDS; Office for National Statistics, 1999, MENT HLTH CHILDR AD; OFFORD DR, 1989, J AM ACAD CHILD ADOL, V28, P850; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Scott S, 2001, BRIT MED J, V323, P194, DOI 10.1136/bmj.323.7306.194; Scott S, 2001, BRIT MED J, V323, P191, DOI 10.1136/bmj.323.7306.191; Taylor T K, 1998, Clin Child Fam Psychol Rev, V1, P41, DOI 10.1023/A:1021848315541; Webster-Stratton C, 1998, J CONSULT CLIN PSYCH, V66, P715, DOI 10.1037/0022-006X.66.5.715; Webster-Stratton C, 1998, HDB PARENT TRAINING	37	237	242	0	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2007	334	7595					678	682		10.1136/bmj.39126.620799.55	http://dx.doi.org/10.1136/bmj.39126.620799.55			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	154ON	17350966	Green Published, Bronze			2022-12-28	WOS:000245517100034
J	Lo, I; Denef, VJ; VerBerkmoes, NC; Shah, MB; Goltsman, D; DiBartolo, G; Tyson, GW; Allen, EE; Ram, RJ; Detter, JC; Richardson, P; Thelen, MP; Hettich, RL; Banfield, JF				Lo, Ian; Denef, Vincent J.; VerBerkmoes, Nathan C.; Shah, Manesh B.; Goltsman, Daniela; DiBartolo, Genevieve; Tyson, Gene W.; Allen, Eric E.; Ram, Rachna J.; Detter, J. Chris; Richardson, Paul; Thelen, Michael P.; Hettich, Robert L.; Banfield, Jillian F.			Strain-resolved community proteomics reveals recombining genomes of acidophilic bacteria	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; MICROBIAL COMMUNITY; SP-NOV; MICROORGANISMS; LEPTOSPIRILLUM; POPULATION; PROTEINS; BIOFILM; OCEAN	Microbes comprise the majority of extant organisms, yet much remains to be learned about the nature and driving forces of microbial diversification. Our understanding of how microorganisms adapt and evolve can be advanced by genome-wide documentation of the patterns of genetic exchange, particularly if analyses target coexisting members of natural communities. Here we use community genomic data sets to identify, with strain specificity, expressed proteins from the dominant member of a genomically uncharacterized, natural, acidophilic biofilm. Proteomics results reveal a genome shaped by recombination involving chromosomal regions of tens to hundreds of kilobases long that are derived from two closely related bacterial populations. Inter-population genetic exchange was confirmed by multilocus sequence typing of isolates and of uncultivated natural consortia. The findings suggest that exchange of large blocks of gene variants is crucial for the adaptation to specific ecological niches within the very acidic, metal-rich environment. Mass-spectrometry-based discrimination of expressed protein products that differ by as little as a single amino acid enables us to distinguish the behaviour of closely related coexisting organisms. This is important, given that microorganisms grouped together as a single species may have quite distinct roles in natural systems(1-3) and their interactions might be key to ecosystem optimization. Because proteomic data simultaneously convey information about genome type and activity, strain-resolved community proteomics is an important complement to cultivation-independent genomic ( metagenomic) analysis(4-6) of microorganisms in the natural environment.	Univ Calif Berkeley, Berkeley, CA 94720 USA; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Joint Genome Inst, Walnut Creek, CA 94598 USA; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Banfield, JF (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	jbanfield@berkeley.edu	Hettich, Robert L/N-1458-2016; Thelen, Michael P/G-2032-2014; Tyson, Gene W/C-6558-2013; Thelen, Michael/C-6834-2008	Hettich, Robert L/0000-0001-7708-786X; Thelen, Michael P/0000-0002-2479-5480; Tyson, Gene W/0000-0001-8559-9427; Thelen, Michael/0000-0002-2479-5480; Banfield, Jill/0000-0001-8203-8771				Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Bond PL, 2000, APPL ENVIRON MICROB, V66, P3842, DOI 10.1128/AEM.66.9.3842-3849.2000; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Coram NJ, 2002, APPL ENVIRON MICROB, V68, P838, DOI 10.1128/AEM.68.2.838-845.2002; Dalluge JJ, 2002, CURR PROTEIN PEPT SC, V3, P181, DOI 10.2174/1389203024605377; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; JOHNSON DB, 1995, J MICROBIOL METH, V23, P205, DOI 10.1016/0167-7012(95)00015-D; Johnson DB, 2003, RES MICROBIOL, V154, P466, DOI 10.1016/S0923-2508(03)00114-1; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Majewski J, 1999, GENETICS, V152, P1459; Majewski J, 1999, GENETICS, V153, P1525; Manabe T, 1999, ELECTROPHORESIS, V20, P3116, DOI 10.1002/(SICI)1522-2683(19991001)20:15/16<3116::AID-ELPS3116>3.0.CO;2-0; Mau B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r44; Nesbo CL, 2006, GENETICS, V172, P759, DOI 10.1534/genetics.105.049312; Papke RT, 2004, SCIENCE, V306, P1928, DOI 10.1126/science.1103289; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; Tyson GW, 2005, APPL ENVIRON MICROB, V71, P6319, DOI 10.1128/AEM.71.10.6319-6324.2005; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Whitaker RJ, 2005, MOL BIOL EVOL, V22, P2354, DOI 10.1093/molbev/msi233	25	179	185	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					537	541		10.1038/nature05624	http://dx.doi.org/10.1038/nature05624			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17344860				2022-12-28	WOS:000245242900049
J	Nagao, K; Kikushima, K; Sakamoto, T; Koseki, K; Igarashi, M; Ishimatsu, S; Sato, A; Hori, S; Kanesaka, S; Hamabe, Y; Saito, D; Kitamura, S				Nagao, Ken; Kikushima, Kimio; Sakamoto, Tetsuya; Koseki, Kazuhide; Igarashi, Masaki; Ishimatsu, Shinichi; Sato, Akira; Hori, Shingo; Kanesaka, Shigeru; Hamabe, Yuichi; Saito, Daizo; Kitamura, Shinya		SOS-KANTO Study Grp	Cardiopulmonary resuscitation by bystanders with chest compression only (SOS-KANTO): an observational study	LANCET			English	Article							HOSPITAL CARDIAC-ARREST; BASIC LIFE-SUPPORT; RANDOMIZED CONTROLLED-TRIALS; VENTILATION; SURVIVAL; CPR; PROFESSIONALS; PERFORMANCE; GUIDELINES; STATEMENT	Background Mouth-to-mouth ventilation is a barrier to bystanders doing cardiopulmonary resuscitation (CPR), but few clinical studies have investigated the efficacy of bystander resuscitation by chest compressions without mouth-to-mouth ventilation (cardiac-only resuscitation). Methods We did a prospective, multicentre, observational study of patients who had out-of-hospital cardiac arrest. On arrival at the scene, paramedics assessed the technique of bystander resuscitation. The primary endpoint was favourable neurological outcome 30 days after cardiac arrest. Findings 4068 adult patients who had out-of-hospital cardiac arrest witnessed by bystanders were included; 439 (11%) received cardiac-only resuscitation from bystanders, 712 (18%) conventional CPR, and 2917 (72%) received no bystander CPR. Any resuscitation attempt was associated with a higher proportion having favourable neurological outcomes than no resuscitation (5.0% vs 2.2%, p<0.0001). Cardiac-only resuscitation resulted in a higher proportion of patients with favourable neurological outcomes than conventional CPR in patients with apnoea (6.2% vs 3.1%; p=0.0195), with shockable rhythm (19.4% vs 11.2%, p=0.041), and with resuscitation that started within 4 min of arrest (10.1% vs 5.1%, p=0.0221). However, there was no evidence for any benefit from the addition of mouth-to-mouth ventilation in any subgroup. The adjusted odds ratio for a favourable neurological outcome after cardiac-only resuscitation was 2.2 (95% Cl 1.2-4.2) in patients who received any resuscitation from bystanders. Interpretation Cardiac-only resuscitation by bystanders is the preferable approach to resuscitation for adult patients with witnessed out-of-hospital cardiac arrest, especially those with apnoea, shockable rhythm, or short periods of untreated arrest.	Surugadai Nihon Univ Hosp, Dept Emergency & Crit Care Med, SOS KANTO Comm, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018309, Japan	Nihon University	Nagao, K (corresponding author), Surugadai Nihon Univ Hosp, Dept Emergency & Crit Care Med, SOS KANTO Comm, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018309, Japan.	Kennagao@med.nihon-u.ac.jp						*AM HEART ASS, 2005, CIRCULATION, V102, P1; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Assar D, 2000, RESUSCITATION, V45, P7, DOI 10.1016/S0300-9572(00)00152-0; Becker LB, 1997, CIRCULATION, V96, P2102, DOI 10.1161/01.CIR.96.6.2102; Berg RA, 1997, CIRCULATION, V95, P1635; BERG RA, 1993, CIRCULATION, V88, P1907, DOI 10.1161/01.CIR.88.4.1907; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Braslow A, 1997, RESUSCITATION, V34, P207, DOI 10.1016/S0300-9572(97)01096-4; BRENNER BE, 1993, ARCH INTERN MED, V153, P1763, DOI 10.1001/archinte.153.15.1763; Chamberlain D, 2001, RESUSCITATION, V50, P27, DOI 10.1016/S0300-9572(01)00342-2; CHANDRA NC, 1994, CIRCULATION, V90, P3070, DOI 10.1161/01.CIR.90.6.3070; CLARK JJ, 1992, ANN EMERG MED, V21, P1464, DOI 10.1016/S0196-0644(05)80062-9; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Ewy GA, 2000, NEW ENGL J MED, V342, P1599, DOI 10.1056/NEJM200005253422109; GALLAGHER EJ, 1995, JAMA-J AM MED ASSOC, V274, P1922, DOI 10.1001/jama.274.24.1922; Hallstrom A, 2000, NEW ENGL J MED, V342, P1546, DOI 10.1056/NEJM200005253422101; HERLITZ J, 1994, BRIT HEART J, V72, P408; Holmberg M, 2001, EUR HEART J, V22, P511, DOI 10.1053/euhj.2000.2421; Holzer M, 2002, NEW ENGL J MED, V346, P549; IDRIS AH, 1994, RESUSCITATION, V28, P143, DOI 10.1016/0300-9572(94)90087-6; Iwami T, 2003, RESUSCITATION, V57, P145, DOI 10.1016/S0300-9572(03)00035-2; Kern KB, 2002, CIRCULATION, V105, P645, DOI 10.1161/hc0502.102963; Mashiko K, 2002, RESUSCITATION, V55, P241, DOI 10.1016/S0300-9572(02)00207-1; Nagao K, 2000, J AM COLL CARDIOL, V36, P776, DOI 10.1016/S0735-1097(00)00779-8; NOC M, 1995, CHEST, V108, P821, DOI 10.1378/chest.108.3.821; ORNATO JP, 1990, ANN EMERG MED, V19, P151, DOI 10.1016/S0196-0644(05)81800-1; Richmond N, 2004, CIRCULATION, V110, P455; Sanders AB, 2005, JAMA-J AM MED ASSOC, V293, P363, DOI 10.1001/jama.293.3.363; *SOS KANTO COMM, 2003, KANTO J JPN ASS ACUT, V24, P10; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; The Ministry of Health Labor and Welfare in Japan, GUID ETH EP SURV; Valenzuela TD, 2005, CIRCULATION, V112, P1259, DOI 10.1161/CIRCULATIONAHA.105.537282; VANHOEYWEGHEN RJ, 1993, RESUSCITATION, V26, P47, DOI 10.1016/0300-9572(93)90162-J; Waalewijn RA, 2001, RESUSCITATION, V50, P273, DOI 10.1016/S0300-9572(01)00354-9; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431; Willerson JT, 2000, CIRCULATION, V102, P1; Yu T, 2002, CIRCULATION, V106, P368, DOI 10.1161/01.CIR.0000021429.22005.2E	38	402	412	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2007	369	9565					920	926						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148BQ	17368153				2022-12-28	WOS:000245049900032
J	Kim, MH; Shen, L; Tao, HL; Martinez, TJ; Suits, AG				Kim, Myung Hwa; Shen, Lei; Tao, Hongli; Martinez, Todd J.; Suits, Arthur G.			Conformationally controlled chemistry: Excited-state dynamics dictate ground-state reaction	SCIENCE			English	Article							3S RYDBERG STATE; MULTIPHOTON IONIZATION; SINGLE-MOLECULE; FORMIC-ACID; PHOTODISSOCIATION; PHOTOELECTRON; FLUORESCENCE; MEMORY; CATION; IONS	Ion imaging reveals distinct photodissociation dynamics for propanal cations initially prepared in either the cis or gauche conformation, even though these isomers differ only slightly in energy and face a small interconversion barrier. The product kinetic energy distributions for the hydrogen atom elimination channels are bimodal, and the two peaks are readily assigned to propanoyl cation or hydroxyallyl cation coproducts. Ab initio multiple spawning dynamical calculations suggest that distinct ultrafast dynamics in the excited state deposit each conformer in isolated regions of the ground-state potential energy surface, and, from these distinct regions, conformer interconversion does not effectively compete with dissociation.	Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	University of Illinois System; University of Illinois Urbana-Champaign; Wayne State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Suits, AG (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	tjm@spawn.scs.uiuc.edu; asuits@chem.wayne.edu	Martinez, Todd J/F-4306-2010; Martinez, Todd/HDN-6985-2022; Shen, Lei/G-2671-2011	Martinez, Todd J/0000-0002-4798-8947; 				ATCHITY GJ, 1991, J CHEM PHYS, V95, P1862, DOI 10.1063/1.461036; Ben-Nun M, 2002, P NATL ACAD SCI USA, V99, P1769, DOI 10.1073/pnas.032658099; Ben-Nun M, 2002, ADV CHEM PHYS, V121, P439, DOI 10.1002/0471264318.ch7; CHANDLER DW, 1987, J CHEM PHYS, V87, P1445, DOI 10.1063/1.453276; Crim FF, 1996, J PHYS CHEM-US, V100, P12725, DOI 10.1021/jp9604812; Dannacher J, 2001, INT J MASS SPECTROM, V208, P147, DOI 10.1016/S1387-3806(01)00387-6; Dian BC, 2004, SCIENCE, V303, P1169, DOI 10.1126/science.1093731; Dian BC, 2002, SCIENCE, V296, P2369, DOI 10.1126/science.1071563; Eppink ATJB, 1997, REV SCI INSTRUM, V68, P3477, DOI 10.1063/1.1148310; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Hudson CE, 2003, J AM SOC MASS SPECTR, V14, P136, DOI 10.1016/S1044-0305(02)00864-4; Khriachtchev L, 2002, J AM CHEM SOC, V124, P10994, DOI 10.1021/ja0269791; Kim MH, 2005, J PHYS CHEM A, V109, P7839, DOI 10.1021/jp053143m; Kim MH, 2006, PHYS CHEM CHEM PHYS, V8, P2933, DOI 10.1039/b603927h; Komissarov AV, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2137312; Martinez TJ, 2006, ACCOUNTS CHEM RES, V39, P119, DOI 10.1021/ar040202q; Martinez-Nunez E, 2005, J PHYS CHEM A, V109, P2836, DOI 10.1021/jp050147i; METHA GF, 1994, J MOL SPECTROSC, V165, P32, DOI 10.1006/jmsp.1994.1109; Michalet X, 2006, CHEM REV, V106, P1785, DOI 10.1021/cr0404343; Min W, 2005, ACCOUNTS CHEM RES, V38, P923, DOI 10.1021/ar040133f; Park ST, 2002, NATURE, V415, P306, DOI 10.1038/415306a; Roos B.O., 1987, ADV CHEM PHYS, V69, P399, DOI DOI 10.1002/9780470142943.CH7; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Shand NC, 1997, J CHEM SOC FARADAY T, V93, P2883, DOI 10.1039/a701765k; Shemesh D, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1937407; Townsend D, 2004, SCIENCE, V306, P1158, DOI 10.1126/science.1104386; VARKONY DR, 2001, J CHEM PHYS, V114, P2601	27	89	89	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1561	1565		10.1126/science.1136453	http://dx.doi.org/10.1126/science.1136453			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363670				2022-12-28	WOS:000244934800048
J	Triboulet, R; Mari, B; Lin, YL; Chable-Bessia, C; Bennasser, Y; Lebrigand, K; Cardinaud, B; Maurin, T; Barbry, P; Baillat, V; Reynes, J; Corbeau, P; Jeang, KT; Benkirane, M				Triboulet, Robinson; Mari, Bernard; Lin, Yea-Lih; Chable-Bessia, Christine; Bennasser, Yamina; Lebrigand, Kevin; Cardinaud, Bruno; Maurin, Thomas; Barbry, Pascal; Baillat, Vincent; Reynes, Jacques; Corbeau, Pierre; Jeang, Kuan-Teh; Benkirane, Monsef			Suppression of microRNA-silencing pathway by HIV-1 during virus replication	SCIENCE			English	Article							CLUSTER; LATENCY; SIRNA; GENE	MicroRNAs ( miRNAs) are single-stranded noncoding RNAs of 19 to 25 nucleotides that function as gene regulators and as a host cell defense against both RNA and DNA viruses. We provide evidence for a physiological role of the miRNA-silencing machinery in controlling HIV-1 replication. Type III RNAses Dicer and Drosha, responsible for miRNA processing, inhibited virus replication both in peripheral blood mononuclear cells from HIV-1-infected donors and in latently infected cells. In turn, HIV-1 actively suppressed the expression of the polycistronic miRNA cluster miR-17/92. This suppression was found to be required for efficient viral replication and was dependent on the histone acetyltransferase Tat cofactor PCAF. Our results highlight the involvement of the miRNA-silencing pathway in HIV-1 replication and latency.	Inst Genet Humaine, Mol Virol Lab, Montpellier, France; Inst Genet Humaine, Lab Lentivirus & Transfert Genes, Montpellier, France; UNSA, CNRS, UMR 6097, Inst Pharmacol Mol & Cellulaire, Sophia Antipolis, France; Hop Gui de Chauliac, Serv Malad Infect & Trop, Montpellier, France; NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Universite de Montpellier; CHU de Montpellier; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Benkirane, M (corresponding author), Inst Genet Humaine, Mol Virol Lab, Montpellier, France.	bmonsef@igh.cnrs.fr	Jeang, Kuan-Teh/A-2424-2008; Barbry, Pascal/O-5021-2016; Mari, Bernard P/D-7445-2015; Mari, Bernard P/F-8960-2013; Mari, Bernard P/GVS-3100-2022; Mari, Bernard/Q-5832-2019; Bennasser, Yamina/M-4833-2017; maurin, thomas O/O-7494-2016	Barbry, Pascal/0000-0001-9632-6483; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard/0000-0002-0422-9182; maurin, thomas O/0000-0002-8467-3135	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000547, Z01AI000547] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Emiliani S, 1998, J VIROL, V72, P1666, DOI 10.1128/JVI.72.2.1666-1670.1998; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; MACKEWICZ C, 1992, AIDS RES HUM RETROV, V8, P1039, DOI 10.1089/aid.1992.8.1039; Marcello A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-7; Omoto S, 2005, J GEN VIROL, V86, P751, DOI 10.1099/vir.0.80449-0; Ott Melanie, 2004, Novartis Found Symp, V259, P182; Pomerantz Roger J, 2002, Curr Opin Investig Drugs, V3, P1133; Qu F, 2005, FEBS LETT, V579, P5958, DOI 10.1016/j.febslet.2005.08.041; Saumet A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-3; Tagawa H, 2005, LEUKEMIA, V19, P2013, DOI 10.1038/sj.leu.2403942; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Voinnet O, 2002, CURR OPIN PLANT BIOL, V5, P444, DOI 10.1016/S1369-5266(02)00291-1; Yeung ML, 2005, CELL RES, V15, P935, DOI 10.1038/sj.cr.7290371; Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81	22	496	558	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1579	1582		10.1126/science.1136319	http://dx.doi.org/10.1126/science.1136319			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17322031				2022-12-28	WOS:000244934800054
J	Lin, RT; Takahashi, K; Karjalainen, A; Hoshuyama, T; Wilson, D; Kameda, T; Chan, CC; Wen, CP; Furuya, S; Higashi, T; Chien, LC; Ohtaki, M				Lin, Ro-Ting; Takahashi, Ken; Karjalainen, Antti; Hoshuyama, Tsutomu; Wilson, Donald; Kameda, Takashi; Chan, Chang-Chuan; Wen, Chi-Pang; Furuya, Sugio; Higashi, Toshiaki; Chien, Lung-Chang; Ohtaki, Megu			Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis	LANCET			English	Article							PLEURAL MESOTHELIOMA; GREAT-BRITAIN; LUNG-CANCER; MORTALITY; COHORT; TRENDS; EPIDEMIOLOGY; EXPOSURE; PERIOD; MEN	Background The potential for a global epidemic of asbestos-related diseases is a growing concern. Our aim was to assess the ecological association between national death rates from diseases associated with asbestos and historical consumption of asbestos. Methods We calculated, for all countries with data, yearly age-adjusted mortality rates by sex (deaths per million population per year) for each disease associated with asbestos (pleural, peritoneal, and all mesothelioma, and asbestosis) in 2000-04 and mean per head asbestos consumption (kg per person per year) in 1960-69. We regressed death rates for the specified diseases against historical asbestos consumption, weighted by the size of sex-specific national populations. Findings Historical asbestos consumption was a significant predictor of death for all mesothelioma in both sexes (adjusted R-2=0.74, p<0.0001, 2.4-fold [95% Cl 2.0-2.9] mortality increase was predicted per unit consumption increase for men; 0.58, p<0.0001, and 1.6-fold [1.4-1.9] mortality increase was predicted for women); for pleural mesothelioma in men (0.29, p=0.0015, 1.8-fold [1.3-2.5]); for peritoneal mesothelioma in both sexes (0.54, p<0.0001, 2.2-fold [1.6-2.9] for men, 0.35, p=0.0008, and 1.4-fold for women [1.2-1.6]); and for asbestosis in men (0.79, p<0.0001, 2.7-fold [2.2-3.4]). Linear regression lines consistently had intercepts near zero. Interpretation Within the constraints of an ecological study, clear and plausible associations were shown between deaths from the studied diseases and historical asbestos consumption, especially for all mesothelioma in both sexes and asbestosis in men. Our data strongly support the recommendation that all countries should move towards eliminating use of asbestos.	Univ Occupat & Environm Hlth, Dept Environm Epidemiol, Inst Ind Ecol Sci, Kitakyushu, Fukuoka 8078555, Japan; Finnish Inst Occupat Hlth, Dept Epidemiol & Biostat, Helsinki, Finland; Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei 10764, Taiwan; Natl Hlth Res Inst, Ctr Hlth Policy Res & Dev, Taipei, Taiwan; Japan Occupat Safety & Hlth Resource Ctr, Tokyo, Japan; Univ Occupat & Environm Hlth, Dept Work Syst & Hlth, Inst Ind Ecol Sci, Kitakyushu, Fukuoka 807, Japan; Univ N Carolina, Sch Publ Hlth, Dept Biostat, Chapel Hill, NC USA; Hiroshima Univ, Dept Environmetr & Biometr, Res Inst Radiat Biol & Med, Hiroshima 730, Japan	University of Occupational & Environmental Health - Japan; Finnish Institute of Occupational Health; National Taiwan University; National Health Research Institutes - Taiwan; University of Occupational & Environmental Health - Japan; University of North Carolina; University of North Carolina Chapel Hill; Hiroshima University	Takahashi, K (corresponding author), Univ Occupat & Environm Hlth, Dept Environm Epidemiol, Inst Ind Ecol Sci, Kitakyushu, Fukuoka 8078555, Japan.	ktaka@med.uoeh-u.ac.jp	Lin, Ro-Ting/AFU-0875-2022; Wen, Chi-Pang/E-3851-2010; Ohtaki, Megu/S-9927-2018; Takahashi, Ken/AAX-7705-2020	Takahashi, Ken/0000-0002-7310-2257; Lin, Ro-Ting/0000-0002-2687-203X; CHAN, CHANG-CHUAN/0000-0002-7518-5236				Albin M, 1999, ENVIRON HEALTH PERSP, V107, P289, DOI 10.2307/3434419; [Anonymous], 2003, Cent Eur J Public Health, V11, P177; [Anonymous], 2006, ILO AD NEW MEAS OCC; Banaei A, 2000, OCCUP ENVIRON MED, V57, P488, DOI 10.1136/oem.57.7.488; Darnton AJ, 2006, ANN OCCUP HYG, V50, P29, DOI 10.1093/annhyg/mei038; Doll R., 1966, CANC INC 5 CONT TECH; Goldberg M, 2000, SCAND J WORK ENV HEA, V26, P52, DOI 10.5271/sjweh.510; Harington JS, 1998, AM J IND MED, V33, P321, DOI 10.1002/(SICI)1097-0274(199804)33:4<321::AID-AJIM2>3.0.CO;2-X; Henderson DW, 1997, SCAND J WORK ENV HEA, V23, P311; Hessel PA, 2005, THORAX, V60, P433, DOI 10.1136/thx.2004.037267; Hillerdal G, 1999, OCCUP ENVIRON MED, V56, P505, DOI 10.1136/oem.56.8.505; Hodgson JT, 2005, BRIT J CANCER, V92, P587, DOI 10.1038/sj.bjc.6602307; *INT LAB ORG, 2006, ASB IR GRIP LAT; JONES RD, 1988, SCAND J WORK ENV HEA, V14, P145, DOI 10.5271/sjweh.1938; Kazan-Allen L, 2005, LUNG CANCER, V49, pS3, DOI 10.1016/j.lungcan.2005.03.002; LaDou J, 2004, ENVIRON HEALTH PERSP, V112, P285, DOI 10.1289/ehp.6704; Liddell FDK, 1997, ANN OCCUP HYG, V41, P13, DOI 10.1016/S0003-4878(96)00044-0; Marinaccio A, 2005, INT J CANCER, V115, P142, DOI 10.1002/ijc.20820; McDonald JC, 1996, EUR RESPIR J, V9, P1932, DOI 10.1183/09031936.96.09091932; MCDONALD JC, 1991, EPIDEMIOLOGY MESOTHE; Montanaro F, 2003, CANCER CAUSE CONTROL, V14, P791, DOI 10.1023/A:1026300619747; Murayama T, 2006, AM J IND MED, V49, P1, DOI 10.1002/ajim.20246; Nurminen M, 2003, J OCCUP ENVIRON MED, V45, P1107, DOI 10.1097/01.jom.0000091682.95314.01; Pellucchi C, 2004, BRIT J CANCER, V90, P1022, DOI 10.1038/sj.bjc.6601638; PETO J, 1995, LANCET, V345, P535, DOI 10.1016/S0140-6736(95)90462-X; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Price B, 2004, AM J EPIDEMIOL, V159, P107, DOI 10.1093/aje/kwh025; SELIKOFF IJ, 1964, JAMA-J AM MED ASSOC, V188, P22; SELIKOFF IJ, 1991, TOXICOL IND HEALTH, V7, P117, DOI 10.1177/074823379100700513; Takahashi K, 1999, J OCCUP HEALTH, V41, P8, DOI 10.1539/joh.41.8; Takahashi K, 2003, INT J OCCUP ENV HEAL, V9, P244, DOI 10.1179/oeh.2003.9.3.244; Tossavainen A, 2004, INT J OCCUP ENV HEAL, V10, P22, DOI 10.1179/oeh.2004.10.1.22; United Nations, 2004, WORLD POP PROSP 2004; *USCB, 2005, INT DAT BAS INT PROG; VIRTA RL, 2003, 0383 USGS; *WHO, WHO MORT DAB WHO STA	36	165	169	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2007	369	9564					844	849		10.1016/S0140-6736(07)60412-7	http://dx.doi.org/10.1016/S0140-6736(07)60412-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144JC	17350453				2022-12-28	WOS:000244791300032
J	Taubert, M; Davies, EMR; Back, I				Taubert, Mark; Davies, Eleanor M. R.; Back, Ian			10-minute consultation - Dry mouth	BRITISH MEDICAL JOURNAL			English	Editorial Material									Holme Tower Marie Curie Ctr, Penarth CF64 3YR, S Glam, Wales; Fairwater Hlth Ctr, Cardiff CF5 3JT, S Glam, Wales		Taubert, M (corresponding author), Holme Tower Marie Curie Ctr, Penarth CF64 3YR, S Glam, Wales.	mtaubert@hotmail.com		Taubert, Mark/0000-0003-0454-5609				*BMA RPS, 2006571 BMA RPS; Guggenheimer J, 2003, J AM DENT ASSOC, V134, P61, DOI 10.14219/jada.archive.2003.0018; Miller M, 2001, CANCER NURS, V24, P241, DOI 10.1097/00002820-200108000-00001	3	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2007	334	7592					534	534		10.1136/bmj.39036.433542.68	http://dx.doi.org/10.1136/bmj.39036.433542.68			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148VV	17347241	Green Published			2022-12-28	WOS:000245106400047
J	Ijspeert, AJ; Crespi, A; Ryczko, D; Cabelguen, JM				Ijspeert, Auke Jan; Crespi, Alessandro; Ryczko, Dimitri; Cabelguen, Jean-Marie			From swimming to walking with a salamander robot driven by a spinal cord model	SCIENCE			English	Article							CENTRAL PATTERN GENERATOR; COUPLED NONLINEAR OSCILLATORS; NEURAL-NETWORKS; LOCOMOTION; TERRESTRIAL; LAMPREY; COORDINATION; GAITS; NEWT	The transition from aquatic to terrestrial locomotion was a key development in vertebrate evolution. We present a spinal cord model and its implementation in an amphibious salamander robot that demonstrates how a primitive neural circuit for swimming can be extended by phylogenetically more recent limb oscillatory centers to explain the ability of salamanders to switch between swimming and walking. The model suggests neural mechanisms for modulation of velocity, direction, and type of gait that are relevant for all tetrapods. It predicts that limb oscillatory centers have lower intrinsic frequencies than body oscillatory centers, and we present biological data supporting this.	Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Stn 14, CH-1015 Lausanne, Switzerland; Univ Bordeaux 2, F-33077 Bordeaux, France; INSERM, U862, F-33077 Bordeaux, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Ijspeert, AJ (corresponding author), Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Stn 14, CH-1015 Lausanne, Switzerland.	auke.ijspeert@epfl.ch	Crespi, Alessandro/M-6777-2014	Ryczko, Dimitri/0000-0003-3948-7728; Ijspeert, Auke/0000-0003-1417-9980; Crespi, Alessandro/0000-0001-9863-5220				Ashley-Ross MA, 2004, J EXP BIOL, V207, P461, DOI 10.1242/jeb.00769; Bem T, 2003, BIOL CYBERN, V88, P79, DOI 10.1007/s00422-002-0340-3; Cabelguen JM, 2003, J NEUROSCI, V23, P2434; Cheng JG, 1998, J NEUROSCI, V18, P4295; COHEN AH, 1980, EXP BRAIN RES, V41, P11; Cohen AH., 1988, NEURAL CONTROL RHYTH, P129; COLLINS JJ, 1994, BIOL CYBERN, V71, P375, DOI 10.1007/BF00198915; Combes D, 2004, J PHYSIOL-LONDON, V559, P17, DOI 10.1113/jphysiol.2004.069542; Delvolve I, 1997, J NEUROPHYSIOL, V78, P638, DOI 10.1152/jn.1997.78.2.638; Delvolve I, 1999, J NEUROPHYSIOL, V82, P1074, DOI 10.1152/jn.1999.82.2.1074; ERMENTROUT GB, 1994, SIAM J APPL MATH, V54, P478, DOI 10.1137/S0036139992231964; FROLICH LM, 1992, J EXP BIOL, V162, P107; Gao KQ, 2001, NATURE, V410, P574, DOI 10.1038/35069051; Golubitsky M, 1999, NATURE, V401, P693, DOI 10.1038/44416; GRILLNER S, 1995, TRENDS NEUROSCI, V18, P270, DOI 10.1016/0166-2236(95)93914-J; Grillner S, 1998, BRAIN RES REV, V26, P184, DOI 10.1016/S0165-0173(98)00002-2; Grillner S., 1997, NEURONS NETWORKS MOT, P3; Ijspeert AJ, 2005, NEUROINFORMATICS, V3, P171, DOI 10.1385/NI:3:3:171; Ijspeert AJ, 2001, BIOL CYBERN, V84, P331, DOI 10.1007/s004220000211; Roos P. R., 1964, Proceedings Akademie van Wetenschappen Amsterdam, V67C, P223; SCHONER G, 1988, SCIENCE, V239, P1513, DOI 10.1126/science.3281253; Szekely G., 1976, P765; TUNSTALL MJ, 1994, J PHYSIOL-LONDON, V474, P393, DOI 10.1113/jphysiol.1994.sp020031; Webb B, 2002, NATURE, V417, P359, DOI 10.1038/417359a; WHEATLEY M, 1994, J NEUROPHYSIOL, V71, P2025, DOI 10.1152/jn.1994.71.6.2025; WILLIAMS TL, 1990, J NEUROPHYSIOL, V64, P862, DOI 10.1152/jn.1990.64.3.862	26	696	744	23	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1416	1420		10.1126/science.1138353	http://dx.doi.org/10.1126/science.1138353			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347441	Green Submitted			2022-12-28	WOS:000244752200035
J	Rostom, A; Dube, C; Lewin, G; Tsertsvadze, A; Barrowman, N; Code, C; Sampson, M; Moher, D				Rostom, Alaa; Dube, Catherine; Lewin, Gabriela; Tsertsvadze, Alexander; Barrowman, Nicholas; Code, Catherine; Sampson, Margaret; Moher, David		US Preve	Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: A systematic review prepared for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							LONG-TERM USE; LOW-DOSE ASPIRIN; CARDIOVASCULAR EVENTS; RHEUMATOID-ARTHRITIS; GASTROINTESTINAL TOXICITY; CYCLO-OXYGENASE-2 INHIBITORS; ULCER COMPLICATIONS; ADENOMATOUS POLYPS; REDUCED RISK; METAANALYSIS	Purpose: To examine the benefits and harms of nonaspirin (non-ASA) nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase (COX-2) inhibitors for the prevention of colorectal cancer (CRC) and adenoma. Data Sources: MEDLINE (1966 to 2006), EMBASE (1980 to 2006), Cochrane Central Register of Controlled Trials, Cochrane Collaboration's registry of clinical trials, Cochrane Database of Systematic Reviews. Study Selection: Randomized, controlled trials and case-control and cohort studies of the effectiveness of NSAIDs for the prevention of CRC and colorectal adenoma were identified by multilevel screening by 2 independent reviewers. Systematic reviews of harms were sought. Data Extraction: Data abstraction, checking, and quality assessment were completed in duplicate. Data Synthesis: A single cohort study showed no effect of non-ASA NSAIDs on death due to CRC. Colorectal cancer incidence was reduced with non-ASA NSAIDs in cohort studies (relative risk, 0.61 [95% CI, 0.48 to 0.77]) and case-control studies (relative risk, 0.70 [CI, 0.63 to 0.78]). Colorectal adenoma incidence was also reduced with non-ASA NSAID use in cohort studies (relative risk, 0.64 [CI, 0.48 to 0.85]) and case-control studies (relative risk, 0.54 [CI, 0.4 to 0.74]) and by COX-2 inhibitors in randomized, controlled trials (relative risk, 0.72 [CI, 0.68 to 0.77]). The ulcer complication rate associated with non-ASA NSAIDs is 1.5% per year. Compared with non-ASA NSAIDs, COX-2 inhibitors reduce this risk but, in multi-year use, have a higher ulcer complication rate than placebo. Cyclooxygenase-2 inhibitors and nonnaproxen NSAIDs increase the risk for serious cardiovascular events (relative risk, 1.86 [CI, 1.33 to 2.59] for COX-2 inhibitors vs. placebo). Limitations: Heterogeneity in the dose, duration and frequency of use necessitated careful grouping for analysis. Conclusions: Cyclooxygenase-2 inhibitors and NSAIDs reduce the incidence of colonic adenomas. Nonsteroidal anti-inflammatory drugs also reduce the incidence of CRC. However, these agents are associated with important cardiovascular events and gastrointestinal harms. The balance of benefits to risk does not favor chemoprevention in average-risk individuals.	Univ Calgary, Div Gastroenterol, Hlth Sci Ctr, Calgary, AB T2N 4N1, Canada; Univ Ottawa, Childrens Hosp, Eastern Ontrario Res Inst, Chalmers Res Grp, Ottawa, ON, Canada; Carleton Univ, Ottawa, ON K1S 5B6, Canada	University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Ottawa; Carleton University	Rostom, A (corresponding author), Univ Calgary, Div Gastroenterol, Hlth Sci Ctr, 3330 Hosp Dr N W, Calgary, AB T2N 4N1, Canada.	arostom@ucalgary.ca	Barrowman, Nick/AAL-3166-2020	Barrowman, Nick/0000-0002-4704-9595; Sampson, Margaret/0000-0003-2550-9893; Moher, David/0000-0003-2434-4206				Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; ASANO TK, 2004, COCHRANE DATABASE SY; Ashcroft DM, 2001, ANN PHARMACOTHER, V35, P829; Baron JA, 2006, GASTROENTEROLOGY, V131, P1674, DOI 10.1053/j.gastro.2006.08.079; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Bigler J, 2001, CANCER RES, V61, P3566; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Boyapati SM, 2003, CANCER EPIDEM BIOMAR, V12, P631; Breuer-Katschinski B, 2000, DIGESTION, V61, P129, DOI 10.1159/000007745; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P162; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P193; Cerezo JG, 2003, EUR J CLIN PHARMACOL, V59, P169, DOI 10.1007/s00228-003-0579-1; Chan AT, 2004, ANN INTERN MED, V140, P157, DOI 10.7326/0003-4819-140-3-200402030-00006; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; Collet JP, 1999, BRIT J CANCER, V81, P62, DOI 10.1038/sj.bjc.6690651; Coogan PF, 2000, CANCER CAUSE CONTROL, V11, P249, DOI 10.1023/A:1008931708716; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Deeks JJ, 2002, BRIT MED J, V325, P619, DOI 10.1136/bmj.325.7365.619; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; Edwards JE, 2004, PAIN, V111, P286, DOI 10.1016/j.pain.2004.07.004; Eisen GM, 2005, ALIMENT PHARM THER, V21, P591, DOI 10.1111/j.1365-2036.2005.02383.x; Friedman GD, 1998, PHARMACOEPIDEM DR S, V7, P99, DOI 10.1002/(SICI)1099-1557(199803/04)7:2<99::AID-PDS320>3.0.CO;2-0; GANN PH, 1993, JNCI-J NATL CANCER I, V85, P1220, DOI 10.1093/jnci/85.15.1220; GARNER S, 2002, COCHRANE DATABASE SY; Garner SE, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005115; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; Goldstein JL, 2004, ALIMENT PHARM THER, V20, P527, DOI 10.1111/j.1365-2036.2004.02118.x; Hauret KG, 2004, AM J EPIDEMIOL, V159, P983, DOI 10.1093/aje/kwh130; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; *HLTH CAN, 2005, CEL VALD CARD SAF; Hooper L, 2004, BRIT MED J, V329, P948, DOI 10.1136/bmj.38232.680567.EB; Huang JQ, 2002, LANCET, V359, P14, DOI 10.1016/S0140-6736(02)07273-2; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Juarranz M, 2002, EUR J CANCER PREV, V11, P465, DOI 10.1097/00008469-200210000-00009; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kune GA, 2007, INT J EPIDEMIOL, V36, P951, DOI 10.1093/ije/dym193; LADENHEIM J, 1995, GASTROENTEROLOGY, V108, P1083, DOI 10.1016/0016-5085(95)90206-6; Lieberman DA, 2003, JAMA-J AM MED ASSOC, V290, P2959, DOI 10.1001/jama.290.22.2959; Lipworth Loren, 2004, Am J Ther, V11, P156, DOI 10.1097/00045391-200405000-00002; LOGAN RFA, 1993, BRIT MED J, V307, P285, DOI 10.1136/bmj.307.6899.285; Lynch PM, 2006, GASTROENTEROLOGY, V131, P2003, DOI 10.1053/j.gastro.2006.10.052; Martin C, 2002, GASTROENTEROLOGY, V123, P1770, DOI 10.1053/gast.2002.37053; MARTINEZ ME, 1995, CANCER EPIDEM BIOMAR, V4, P703; Morimoto LM, 2002, CANCER EPIDEM BIOMAR, V11, P1012; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; MUSCAT JE, 1994, CANCER-AM CANCER SOC, V74, P1847, DOI 10.1002/1097-0142(19941001)74:7<1847::AID-CNCR2820740704>3.0.CO;2-#; Ofman JJ, 2003, ARTHRIT RHEUM-ARTHR, V49, P508, DOI 10.1002/art.11192; PAGANINIHILL A, 1995, PREV MED, V24, P113, DOI 10.1006/pmed.1995.1020; Peleg II, 1996, DIGEST DIS SCI, V41, P1319, DOI 10.1007/BF02088554; Psaty BM, 2006, NEW ENGL J MED, V355, P950, DOI 10.1056/NEJMe068158; Ray WA, 2002, LANCET, V359, P118, DOI 10.1016/S0140-6736(02)07370-1; Reese S, 2001, JAMA-J AM MED ASSOC, V285, P1570; Reeves MJ, 1996, CANCER EPIDEM BIOMAR, V5, P955; RIGAU J, 1991, ANN INTERN MED, V115, P952, DOI 10.7326/0003-4819-115-12-952; Rodriguez LAG, 2000, EPIDEMIOLOGY, V11, P376, DOI 10.1097/00001648-200007000-00003; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; Rostom A, 2002, COCHRANE DATABASE SY; ROSTOM A, 2006, USE ASPIRIN NSAIDS P; ROSTOM A, 2004, 38 CAN COORD OFF HLT; Sandler RS, 1998, GASTROENTEROLOGY, V114, P441, DOI 10.1016/S0016-5085(98)70526-8; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1; Schoenfeld P., 1999, AM J MED, V107, p48S, DOI 10.1016/s0002-9343(99)00367-8; Seeff LC, 2004, CANCER-AM CANCER SOC, V100, P2093, DOI 10.1002/cncr.20276; Shaheen NJ, 2003, JNCI-J NATL CANCER I, V95, P154, DOI 10.1093/jnci/95.2.154; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Singh G, 2006, AM J MED, V119, P255, DOI 10.1016/j.amjmed.2005.09.054; Slattery ML, 2004, CANCER EPIDEM BIOMAR, V13, P538; Smalley W, 1999, ARCH INTERN MED, V159, P161, DOI 10.1001/archinte.159.2.161; Sorensen HT, 2003, BRIT J CANCER, V88, P1687, DOI 10.1038/sj.bjc.6600945; Tangrea JA, 2003, CANCER CAUSE CONTROL, V14, P403, DOI 10.1023/A:1024990617158; Thiis-Evensen E, 1999, SCAND J GASTROENTERO, V34, P414; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; Topol EJ, 2005, JAMA-J AM MED ASSOC, V293, P366, DOI 10.1001/jama.293.3.366; Tramer MR, 2000, PAIN, V85, P169, DOI 10.1016/S0304-3959(99)00267-5; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Watson DJ, 2002, ARCH INTERN MED, V162, P1105, DOI 10.1001/archinte.162.10.1105; Zhang JJ, 2006, JAMA-J AM MED ASSOC, V296, P1619, DOI 10.1001/jama.296.13.jrv60015	83	243	260	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2007	146	5					376	389		10.7326/0003-4819-146-5-200703060-00010	http://dx.doi.org/10.7326/0003-4819-146-5-200703060-00010			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144XK	17339623				2022-12-28	WOS:000244829600007
J	Csete, J				Csete, Joanne			AIDS and public security: the other side of the coin	LANCET			English	Editorial Material									Canadian HIV AIDS Legal Network, Toronto, ON M5R 2A7, Canada		Csete, J (corresponding author), Canadian HIV AIDS Legal Network, Toronto, ON M5R 2A7, Canada.	jcsete@aidslaw.ca						Azimi Negar, 2006, NEW YORK TIMES  1203, P63; PANT S, 2006, 16 INT AIDS C TOR CA; *UN DEV PROGR, 2004, THAIL RESP HIV AIDS, P54; *UNAIDS, 2006, UNAIDSPCB19067; *UNAIDS, 2006, RUSS FED COUNTR UPD; WOLFE D, 2004, NATION          0408; 2004, HUMAN RIGHTS WAT APR; 2002, HUMAN RIGHTS WAT JUL; 2004, PRAVDA          1019; 2004, ISN SECURITY WA 1018	10	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2007	369	9563					720	721		10.1016/S0140-6736(07)60334-1	http://dx.doi.org/10.1016/S0140-6736(07)60334-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143MP	17336630				2022-12-28	WOS:000244726700006
J	Lipscombe, LL; Hux, JE				Lipscombe, Lorraine L.; Hux, Janet E.			Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study	LANCET			English	Article							IMPAIRED GLUCOSE-TOLERANCE; RISING PREVALENCE; OBESITY; MELLITUS; BURDEN; RISK; LIFE	Background The prevalence of diabetes has been increasing greatly, but WHO's predicted 39% rise in the global rate of diabetes from 2000 to 2030 might be an underestimate. We aimed to assess diabetes trends in Ontario, Canada. Methods Using population-based data, including a validated diabetes database from the province of Ontario, Canada, we examined trends in diabetes prevalence and mortality from 1995 to 2005, and incidence from 1997 to 2003, in adults aged 20 years or older. Findings Age-adjusted and sex-adjusted diabetes prevalence increased by 69%, from 5.2% in a population of 7908 562 in 1995 to 8.8% of 9 276 945 in 2005. Prevalence increased by 27% from 6.9% in a population of 8 457 720 in 2000 to 8.8% of 9 276 945 in 2005. Although prevalence rates have remained higher in people aged 50 years or older (7.1% of 3 675 554) than in those aged 20-49 years (3.5% of 5 601391), rates increased to a greater extent in the younger population (94% vs 63%, p<0.0001). A 31% increase occurred in yearly incidence over 6 years, from 6.6 per 1000 in 1997 to 8.2 per 1000 in 2003. The adjusted mortality rate in people with diabetes fell by 25% from 1995 to 2005. Interpretation The prevalence of diabetes in Ontario, Canada increased substantially during the past 10 years, and by 2005 already exceeded the global rate that was predicted for 2030. This increase in prevalence is attributable to both rising incidence and declining mortality. Effective public-health interventions aimed at diabetes prevention are needed, as well as improved resources to manage the greater number of people living longer with the disease.	Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Womens Coll Hosp, Toronto, ON M5S 1B2, Canada	University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Womens College Hospital	Lipscombe, LL (corresponding author), Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada.	Lorraine.Lipscombe@ices.on.ca	Greiver, Michelle/N-8764-2015; Northe, Hilda/I-1916-2012	Greiver, Michelle/0000-0001-8957-0285; Northe, Hilda/0000-0002-8873-5014; Lipscombe, Lorraine/0000-0001-7412-7993				American Diabetes Association, 2004, DIABETES CARE, V27, pS11, DOI [10.2337/diacare.27.2007.S11, DOI 10.2337/DIACARE.27.2007.S11]; American Diabetes Association: Diagnosis and classification of diabetes mellitus, 2005, DIABETES CARE S1, V28, P537; Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; ATKINS RC, 2005, KIDNEY INT S, V94, P14, DOI DOI 10.1111/J.1523-1755.2005.09403.X; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Katzmarzyk PT, 2006, CAN MED ASSOC J, V174, P156, DOI 10.1503/cmaj.050806; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Luo J, 2002, INT J OBESITY, V26, P553, DOI 10.1038/sj.ijo.0801944; Manuel DG, 2004, DIABETES CARE, V27, P407, DOI 10.2337/diacare.27.2.407; McBean AM, 2004, DIABETES CARE, V27, P2317, DOI 10.2337/diacare.27.10.2317; Meltzer S, 1998, CAN MED ASSOC J, V159, pS1; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; *OTT STAT CAN, 2006, ANN DEM STAT 2005; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Rennie KL, 2005, OBES REV, V6, P11, DOI 10.1111/j.1467-789X.2005.00164.x; *STAT CAN, 2002, IMM CIT; *STAT CAN, 2006, HLTH STAT HLTH IND; *STAT CAN, 2002, 2001 COMM PROF; Stovring H, 2003, LANCET, V362, P537, DOI 10.1016/S0140-6736(03)14116-5; Tavani A, 2002, J CLIN EPIDEMIOL, V55, P1082, DOI 10.1016/S0895-4356(02)00486-9; Thomas RJ, 2003, ARCH INTERN MED, V163, P445, DOI 10.1001/archinte.163.4.445; *US BUR CENS, 2003, CURR POP REP; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2006, GLOB STRAT DIET PHYS; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	29	461	475	1	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2007	369	9563					750	756		10.1016/S0140-6736(07)60361-4	http://dx.doi.org/10.1016/S0140-6736(07)60361-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143MP	17336651				2022-12-28	WOS:000244726700031
J	Stone, AJ				Stone, Anthony J.			Water from first principles	SCIENCE			English	Editorial Material							CLUSTERS; SURFACE; ENERGY		Univ Cambridge, Chem Lab, Cambridge CB2 1EW, England	University of Cambridge	Stone, AJ (corresponding author), Univ Cambridge, Chem Lab, Lensfield Rd, Cambridge CB2 1EW, England.	ajs1@cam.ac.uk	Stone, Anthony/M-8040-2015	Stone, Anthony/0000-0002-3846-245X				AXILROD PM, 1943, J CHEM PHYS, V11, P299; Bukowski R, 2007, SCIENCE, V315, P1249, DOI 10.1126/science.1136371; Bukowski R, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2220040; Goldman N, 2005, PHILOS T R SOC A, V363, P493, DOI 10.1098/rsta.2004.1504; Hodges MP, 1997, J PHYS CHEM A, V101, P9163, DOI 10.1021/jp9716851; Mas EM, 2000, J CHEM PHYS, V113, P6687, DOI 10.1063/1.1311289; MILLOT C, 1992, MOL PHYS, V77, P439, DOI 10.1080/00268979200102541	7	20	20	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1228	1229		10.1126/science.1140758	http://dx.doi.org/10.1126/science.1140758			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332399				2022-12-28	WOS:000244564700034
J	Gray, RH; Kigozi, G; Serwadda, D; Makumbi, F; Watya, S; Nalugoda, F; Kiwanuka, N; Moulton, LH; Chaudhary, MA; Chen, MZ; Sewankambo, NK; Wabwire-Mangen, F; Bacon, MC; Williams, CFM; Opendi, P; Reynolds, SJ; Laeyendecker, O; Quinn, TC; Wawer, MJ				Gray, Ronald H.; Kigozi, Godfrey; Serwadda, David; Makumbi, Frederick; Watya, Stephen; Nalugoda, Fred; Kiwanuka, Noah; Moulton, Lawrence H.; Chaudhary, Mohammad A.; Chen, Michael Z.; Sewankambo, Nelson K.; Wabwire-Mangen, Fred; Bacon, Melanie C.; Williams, Carolyn F. M.; Opendi, Pius; Reynolds, Steven J.; Laeyendecker, Oliver; Quinn, Thomas C.; Wawer, Maria J.			Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial	LANCET			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; IMMUNODEFICIENCY-VIRUS TYPE-1; TARGET-CELLS; RISK; ACQUISITION; DISEASES; COHORT; HERPES; CAMPS	Background Ecological and observational studies suggest that male circumcision reduces the risk of HIV acquisition in men. Our aim was to investigate the effect of male circumcision on HIV incidence in men. Methods 4996 uncircumcised, HIV-negative men aged 15-49 years who agreed to HIV testing and counselling were enrolled in this randomised trial in rural Rakai district, Uganda. Men were randomly assigned to receive immediate circumcision (n=2474) or circumcision delayed for 24 months (2522). HIV testing, physical examination, and interviews were repeated at 6, 12, and 24 month follow-up visits. The primary outcome was HIV incidence. Analyses were done on a modified intention-to-treat basis. This trial is registered with ClinicaITrials.gov, with the number NCT00425984. Findings Baseline characteristics of the men in the intervention and control groups were much the same at enrolment. Retention rates were much the same in the two groups, with 90-92% of participants retained at all time points. In the modified intention-to-treat analysis, HIV incidence over 24 months was 0.66 cases per 100 person-years in the intervention group and 1.33 cases per 100 person-years in the control group (estimated efficacy of intervention 51%, 95% Cl 16-72; p=0.006). The as-treated efficacy was 55% (95% CI 22-75; p=0.002); efficacy from the Kaplan-Meier time-to-HIV-detection as-treated analysis was 60% (30-77; p=0.003). HIV incidence was lower in the intervention group than it was in the control group in all sociodemographic, behavioural, and sexually transmitted disease symptom subgroups. Moderate or severe adverse events occurred in 84 (3.6%) circumcisions; all resolved with treatment. Behaviours were much the same in both groups during follow-up. Interpretation Male circumcision reduced HIV incidence in men without behavioural disinhibition. Circumcision can be recommended for HIV prevention in men.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21215 USA; Rakai Hlth Sci Program, Entebbe, Uganda; Makerere Univ, Inst Publ Hlth, Kampala, Uganda; Makerere Univ, Mulago Hosp, Dept Surg, Urol Unit, Kampala, Uganda; Makerere Univ, Dept Med, Kampala, Uganda; NIAID, NIH, Bethesda, MD 20892 USA; Johns Hopkins Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Rakai Health Sciences Program; Makerere University; Makerere University; Mulago National Referral Hospital; Makerere University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Medicine	Gray, RH (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Suite E4132,615 N Wolfe St, Baltimore, MD 21215 USA.	rgray@jhsph.edu	Quinn, Thomas/A-2494-2010; Laeyendecker, Oliver B/B-9331-2009	Moulton, Lawrence/0000-0001-7041-7387; Laeyendecker, Oliver/0000-0002-6429-4760; Sewankambo, Nelson/0000-0001-9362-053X; Reynolds, Steven/0000-0002-5403-2759	FOGARTY INTERNATIONAL CENTER [D43TW001508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI051171, Z01AI001040, Z01AI000361] Funding Source: NIH RePORTER; FIC NIH HHS [D43 TW001508] Funding Source: Medline; NIAID NIH HHS [U01 AI051171] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baeten JM, 2005, J INFECT DIS, V191, P546, DOI 10.1086/427656; BAILEY RC, 2006, ASSESSMENT CLIN TRAD, P1; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Donoval BA, 2006, AM J CLIN PATHOL, V125, P386, DOI 10.1309/JVHQVDJDYKM58EPH; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gray R, 2004, AIDS, V18, P2428; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; GRAY RH, IN PRESS AIDS; HUSSAIN LA, 1995, IMMUNOLOGY, V85, P475; KABRA SG, 1990, LANCET, V335, P224, DOI 10.1016/0140-6736(90)90314-U; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Kumar S, 1999, LANCET, V353, P1251, DOI 10.1016/S0140-6736(05)66920-6; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lavreys L, 1999, J INFECT DIS, V180, P330, DOI 10.1086/314884; McCoombe SG, 2006, AIDS, V20, P1491, DOI 10.1097/01.aids.0000237364.11123.98; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Patterson BK, 2002, AM J PATHOL, V161, P867, DOI 10.1016/S0002-9440(10)64247-2; Reynolds SJ, 2004, LANCET, V363, P1039, DOI 10.1016/S0140-6736(04)15840-6; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Szabo R, 2000, BRIT MED J, V320, P1592, DOI 10.1136/bmj.320.7249.1592; WALSH PC, 1992, CAMPBELLS UROLOGY, P2972; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Zablotska IB, 2006, AIDS, V20, P1191, DOI 10.1097/01.aids.0000226960.25589.72	27	1568	1630	0	64	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2007	369	9562					657	666		10.1016/S0140-6736(07)60313-4	http://dx.doi.org/10.1016/S0140-6736(07)60313-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141RO	17321311				2022-12-28	WOS:000244596600027
J	Barzansky, B; Etzel, SI				Barzansky, Barbara; Etzel, Sylvia I.			Medical schools in the United States, 2005-2006	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Amer Med Assoc, Div Undergrad & Grad Med Educ, Chicago, IL 60610 USA	American Medical Association	Barzansky, B (corresponding author), Amer Med Assoc, Div Undergrad & Grad Med Educ, 515 N State St, Chicago, IL 60610 USA.								0	13	13	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2006	296	9					1147	1152		10.1001/jama.296.9.1147	http://dx.doi.org/10.1001/jama.296.9.1147			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	081DW	17370352				2022-12-28	WOS:000240298400019
J	Giocomo, LM; Zilli, EA; Fransen, E; Hasselmo, ME				Giocomo, Lisa M.; Zilli, Eric A.; Fransen, Erik; Hasselmo, Michael E.			Temporal frequency of subthreshold oscillations scales with entorhinal grid cell field spacing	SCIENCE			English	Article							CORTEX LAYER-II; HEAD DIRECTION CELLS; PATH-INTEGRATION; PLACE CELLS; NEURONS; MODEL; REPRESENTATION; HIPPOCAMPUS; MECHANISMS; DYNAMICS	Grid cells in layer II of rat entorhinal cortex fire to spatial locations in a repeating hexagonal grid, with smaller spacing between grid fields for neurons in more dorsal anatomical locations. Data from in vitro whole-cell patch recordings showed differences in frequency of subthreshold membrane potential oscillations in entorhinal neurons that correspond to different positions along the dorsal-to-ventral axis, supporting a model of physiological mechanisms for grid cell responses.	Boston Univ, Dept Psychol, Ctr Memory & Brain, Program Neurosci, Boston, MA 02215 USA; Royal Inst Technol, Sch Comp Sci & Commun, SE-10044 Stockholm, Sweden; Stockholm Brain Inst, SE-10044 Stockholm, Sweden	Boston University; Royal Institute of Technology	Giocomo, LM (corresponding author), Boston Univ, Dept Psychol, Ctr Memory & Brain, Program Neurosci, 2 Cummington St, Boston, MA 02215 USA.	giocomo@bu.edu; hasselmo@bu.edu		Hasselmo, Michael/0000-0002-9925-6377; Giocomo, Lisa/0000-0003-0416-2528	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH071702, R01MH061492, R01MH060013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016454] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA016454-04, R01 DA016454-05, R01 DA016454, DA16454] Funding Source: Medline; NIMH NIH HHS [MH71702, P50 MH071702, P50 MH071702-01A20004, R01 MH061492, R01 MH060013-05, R01 MH060013-06, R01 MH060013, MH60013, R01 MH061492-05] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Acker CD, 2003, J COMPUT NEUROSCI, V15, P71, DOI 10.1023/A:1024474819512; ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; [Anonymous], CONDITIONING CONSCIO; BLAIR HT, IN PRESS J NEUROSCI; BURGESS N, IN PRESS HIPPOCAMPUS; Dickson CT, 2000, J NEUROPHYSIOL, V83, P2562, DOI 10.1152/jn.2000.83.5.2562; Erchova I, 2004, J PHYSIOL-LONDON, V560, P89, DOI 10.1113/jphysiol.2004.069930; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; Fransen E, 2004, HIPPOCAMPUS, V14, P368, DOI 10.1002/hipo.10198; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hasselmo ME, 2005, NEURAL NETWORKS, V18, P1172, DOI 10.1016/j.neunet.2005.08.007; Knierim JJ, 1998, J NEUROPHYSIOL, V80, P425, DOI 10.1152/jn.1998.80.1.425; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; PAKINOS G, 1998, RAT BRAIN STEREOTAXI; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Sharp PE, 2001, TRENDS NEUROSCI, V24, P289, DOI 10.1016/S0166-2236(00)01797-5; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Taube JS, 2003, CEREB CORTEX, V13, P1162, DOI 10.1093/cercor/bhg102; White JA, 1998, J NEUROPHYSIOL, V80, P262, DOI 10.1152/jn.1998.80.1.262	28	283	291	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1719	1722		10.1126/science.1139207	http://dx.doi.org/10.1126/science.1139207			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379810	Green Accepted			2022-12-28	WOS:000245106900042
J	Qaseem, A; Snow, V; Barry, P; Hornbake, ER; Rodnick, JE; Tobolic, T; Ireland, B; Segal, JB; Bass, EB; Weiss, KB; Green, L; Owens, DK				Qaseem, Amir; Snow, Vincenza; Barry, Patricia; Hornbake, E. Rodney; Rodnick, Jonathan E.; Tobolic, Timothy; Ireland, Belinda; Segal, Jodi B.; Bass, Eric B.; Weiss, Kevin B.; Green, Lee; Owens, Douglas K.		Amer Coll Phys Panel	Current diagnosis of venous thromboembolism in primary care: A clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; SUSPECTED PULMONARY-EMBOLISM; D-DIMER TEST; ASYMPTOMATIC PATIENTS; HOSPITALIZED-PATIENTS; SYMPTOMATIC PATIENTS; COMPUTED-TOMOGRAPHY; MANAGEMENT; MODEL; PROBABILITY	This guideline summarizes the current approaches for the diagnosis of venous thromboembolism. The importance of early diagnosis to prevent mortality and morbidity associated with venous thromboembolism cannot be overstressed. This field is highly dynamic, however, and new evidence is emerging periodically that may change the recommendations. The purpose of this guideline is to present recommendations based on current evidence to clinicians to aid in the diagnosis of lower extremity deep venous thrombosis and pulmonary embolism.	Amer Coll Physicians, Philadelphia, PA 19106 USA; Merck Inst Aging & Hlth, Gloucester Point, VA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Amer Acad Family Phys, Leawood, KS USA; BJC Healthcare, St Louis, MO USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Northwestern Univ, Chicago, IL 60611 USA; Vet Affairs Edward Hines Jr Hosp, Chicago, IL USA; Univ Michigan, Ann Arbor, MI 48109 USA; Stanford Univ, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA USA	American College of Physicians; Merck & Company; University of California System; University of California San Francisco; Johns Hopkins University; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; University of Michigan System; University of Michigan; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.		; Casey, Donald/AFM-6658-2022	Peterson, Kevin/0000-0002-6914-8586; Casey, Donald/0000-0002-3820-598X; Bass, Eric/0000-0001-9106-527X				Anderson DR, 1999, ARCH INTERN MED, V159, P477, DOI 10.1001/archinte.159.5.477; Anderson DR, 2000, J EMERG MED, V19, P225, DOI 10.1016/S0736-4679(00)00225-0; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Aschwanden M, 1999, J VASC SURG, V30, P929, DOI 10.1016/S0741-5214(99)70019-4; BARRITT DW, 1960, LANCET, V1, P1309; BECKER DM, 1989, ARCH INTERN MED, V149, P1731, DOI 10.1001/archinte.149.8.1731; Brown MD, 2003, CLIN CHEM, V49, P1846, DOI 10.1373/clinchem.2003.022277; Brown MD, 2002, ANN EMERG MED, V40, P133, DOI 10.1067/mem.2002.124755; Chagnon I, 2002, AM J MED, V113, P269, DOI 10.1016/S0002-9343(02)01212-3; COGO A, 1995, HAEMOSTASIS, V25, P27; Constans J, 2001, THROMB HAEMOSTASIS, V86, P985; Cornuz J, 2002, AM J MED, V112, P198, DOI 10.1016/S0002-9343(01)01110-X; Dryjski M, 2001, J VASC SURG, V34, P1010, DOI 10.1067/mva.2001.119889; Fancher TL, 2004, BMJ-BRIT MED J, V329, P821, DOI 10.1136/bmj.38226.719803.EB; Funfsinn N, 2001, BLOOD COAGUL FIBRIN, V12, P165, DOI 10.1097/00001721-200104000-00001; Goodacre S, 2005, ANN INTERN MED, V143, P129, DOI 10.7326/0003-4819-143-2-200507190-00012; Gottlieb RH, 1999, J CLIN ULTRASOUND, V27, P415, DOI 10.1002/(SICI)1097-0096(199910)27:8<415::AID-JCU1>3.3.CO;2-Y; Ilkhanipour K, 2004, J EMERG MED, V27, P233, DOI 10.1016/j.jemermed.2004.04.010; INERMURAM HT, 2004, RADIOLOGY, V233, P806; Kassai B, 2004, THROMB HAEMOSTASIS, V91, P655, DOI 10.1160/TH03-11-0722; Kearon C, 1998, ANN INTERN MED, V128, P663, DOI 10.7326/0003-4819-128-8-199804150-00011; Kearon C, 2001, ANN INTERN MED, V135, P108, DOI 10.7326/0003-4819-135-2-200107170-00011; Kraaijenhagen RA, 2002, ARCH INTERN MED, V162, P907, DOI 10.1001/archinte.162.8.907; Lennox AF, 1999, J VASC SURG, V30, P794, DOI 10.1016/S0741-5214(99)70003-0; Mustafa BO, 2002, ARCH INTERN MED, V162, P401, DOI 10.1001/archinte.162.4.401; Oudega R, 2005, ANN INTERN MED, V143, P100, DOI 10.7326/0003-4819-143-2-200507190-00008; Quiroz R, 2005, JAMA-J AM MED ASSOC, V293, P2012, DOI 10.1001/jama.293.16.2012; Rathbun SW, 2000, ANN INTERN MED, V132, P227, DOI 10.7326/0003-4819-132-3-200002010-00009; Roy PM, 2005, BMJ-BRIT MED J, V331, P259, DOI 10.1136/bmj.331.7511.259; Ruiz-Gimenez N, 2004, THROMB HAEMOSTASIS, V91, P1237, DOI 10.1160/TH03-02-0080; Schutgens REG, 2003, CIRCULATION, V107, P593, DOI 10.1161/01.CIR.0000045670.12988.1E; SEGAL J, 2003, PUBLICATION; Segal JB, 2007, ANN FAM MED, V5, P63, DOI 10.1370/afm.648; Segal JB, 2007, ANN INTERN MED, V146, P211, DOI 10.7326/0003-4819-146-3-200702060-00150; Shields GP, 2002, ACAD EMERG MED, V9, P561, DOI 10.1111/j.1553-2712.2002.tb02292.x; Snow V, 2007, ANN INTERN MED, V146, P204, DOI 10.7326/0003-4819-146-3-200702060-00149; Stein PD, 2004, ANN INTERN MED, V140, P589, DOI 10.7326/0003-4819-140-8-200404200-00005; Tick LW, 2002, AM J MED, V113, P630, DOI 10.1016/S0002-9343(02)01347-5; Wells PS, 1999, THROMB HAEMOSTASIS, V81, P493; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; WELLS PS, 1995, ANN INTERN MED, V122, P47, DOI 10.7326/0003-4819-122-1-199501010-00008; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; WHITE RH, 1989, ANN INTERN MED, V111, P297, DOI 10.7326/0003-4819-111-4-297	45	71	91	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2007	146	6					454	458		10.7326/0003-4819-146-6-200703200-00013	http://dx.doi.org/10.7326/0003-4819-146-6-200703200-00013			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150CC	17371890				2022-12-28	WOS:000245192200008
J	Clayton, E; Doupe, DP; Klein, AM; Winton, DJ; Simons, BD; Jones, PH				Clayton, Elizabeth; Doupe, David P.; Klein, Allon M.; Winton, Douglas J.; Simons, Benjamin D.; Jones, Philip H.			A single type of progenitor cell maintains normal epidermis	NATURE			English	Article							LABEL-RETAINING CELLS; STEM-CELLS; MOUSE EPIDERMIS; IN-VIVO; DIVISIONS; SKIN; FOLLICLE; PROLIFERATION; NEUROGENESIS; EPITHELIUM	According to the current model of adult epidermal homeostasis, skin tissue is maintained by two discrete populations of progenitor cells: self-renewing stem cells; and their progeny, known as transit amplifying cells, which differentiate after several rounds of cell division(1-3). By making use of inducible genetic labelling, we have tracked the fate of a representative sample of progenitor cells in mouse tail epidermis at single-cell resolution in vivo at time intervals up to one year. Here we show that clone-size distributions are consistent with a new model of homeostasis involving only one type of progenitor cell. These cells are found to undergo both symmetric and asymmetric division at rates that ensure epidermal homeostasis. The results raise important questions about the potential role of stem cells on tissue maintenance in vivo.	Hutchison MRC Res Ctr, MRC Canc Cell Unit, Cambridge CB2 0XZ, England; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute	Jones, PH (corresponding author), Hutchison MRC Res Ctr, MRC Canc Cell Unit, Cambridge CB2 0XZ, England.	phj20@hutchison-mrc.cam.ac.uk	Simons, Benjamin/AAY-8920-2020; Jones, Philip/D-2464-2009; Doupe, David/M-7914-2017	Simons, Benjamin/0000-0002-3875-7071; Jones, Philip/0000-0002-5904-795X; Doupe, David/0000-0002-9748-9388	Medical Research Council [G0300723B] Funding Source: researchfish; MRC [MC_U105370181] Funding Source: UKRI; Medical Research Council [MC_U105370181] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Birner P, 2001, AM J PATHOL, V158, P1991, DOI 10.1016/S0002-9440(10)64670-6; Braun KM, 2004, J INVEST DERM SYMP P, V9, P196, DOI 10.1111/j.1087-0024.2004.09313.x; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Das T, 2003, NEURON, V37, P597, DOI 10.1016/S0896-6273(03)00066-7; Gambardella L, 2003, CURR OPIN CELL BIOL, V15, P771, DOI 10.1016/j.ceb.2003.10.011; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kameda T, 2003, EXP CELL RES, V283, P167, DOI 10.1016/S0014-4827(02)00031-9; Kemp R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh090; LAJTHA LG, 1979, DIFFERENTIATION, V14, P23, DOI 10.1111/j.1432-0436.1979.tb01007.x; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; MACKENZIE IC, 1970, NATURE, V226, P653, DOI 10.1038/226653a0; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Potten C S, 1981, Int Rev Cytol, V69, P271; POTTEN CS, 1974, CELL TISSUE KINET, V7, P77, DOI 10.1111/j.1365-2184.1974.tb00401.x; Ro S, 2005, EXP DERMATOL, V14, P838, DOI 10.1111/j.1600-0625.2005.00366.x; Ro S, 2004, EMBO REP, V5, P914, DOI 10.1038/sj.embor.7400218; Smart FM, 2000, J EXP MED, V191, P737, DOI 10.1084/jem.191.4.737; SMART IHM, 1970, BRIT J DERMATOL, V82, P276, DOI 10.1111/j.1365-2133.1970.tb12437.x; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Williams GH, 1998, P NATL ACAD SCI USA, V95, P14932, DOI 10.1073/pnas.95.25.14932; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	29	605	619	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					185	189		10.1038/nature05574	http://dx.doi.org/10.1038/nature05574			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17330052				2022-12-28	WOS:000244718100040
J	Boerma, JT; Stansfield, SK				Boerma, J. Ties; Stansfield, Sally K.			Health statistics 1 - Health statistics now: are we making the right investments?	LANCET			English	Article							EPIDEMIOLOGIC TRANSITION; INFORMATION; HIV/AIDS; LESSONS; TRENDS; DEATH	Increases in international funding for health have been accompanied by accelerating demand for more and better statistics, which are needed to track performance and ensure accountability. Worldwide interest in the monitoring of development, as exemplified in the Millennium Development Goals (MDGs), generates pressure for high-quality and timely data for reporting on country progress. This rapid escalation of demand has exposed major gaps in the supply of health statistics for developing countries but also provides major opportunities to increase the supply and use of sound health statistics. First, the emphasis on monitoring and evaluation is leading to proliferation of indicators and excessive reporting requirements, and needs to be refocused on systematic investments in data generation and analysis. Second, the risk of inadequate or poorly targeted investments can be kept to a minimum by understanding the causes of poor availability of health statistics, including lack of accurate measurement instruments, application of suboptimum methods of data collection, and inadequate use of methods and analyses to produce comparable estimates. Third, the preoccupation with MDGs does not take into account the rapid health transition, which implies that health statistics should systematically include a much wider array of health issues from acute infectious diseases to chronic non-communicable diseases and injuries, disaggregated by socioeconomic position. Fourth, the growing number of national household surveys, which are the main source of most population health statistics, need to be streamlined into cohesive and comprehensive country health survey programmes. Now is the time to accelerate the production and use of accurate, complete, and timely health statistics for decision-making by investing in country health information systems that should be based on an efficient and effective mix of standardised methods of data collection and analysis that meet country and international needs.	WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Boerma, JT (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	boermat@who.int						AbouZahr C, 2005, B WORLD HEALTH ORGAN, V83, P578; ABOUZAHR C, IN PRESS LANCET; [Anonymous], 2005, LANCET, V365, P1983; [Anonymous], 2006, WORK TOG HLTH; Bennett S, 2006, LANCET, V367, P79, DOI 10.1016/S0140-6736(06)67928-2; BOBADILLA JL, 1993, DIS CONTROL PRIORITI, P51; Boerma JT, 2003, LANCET, V362, P1929, DOI 10.1016/S0140-6736(03)14967-7; Bradshaw D, 2004, S AFRICAN NATL BURDE; Caldwell JC, 2004, POPUL DEV REV, V30, P297, DOI 10.1111/j.1728-4457.2004.014_1.x; Cleland J, 2004, SEX TRANSM INFECT, V80, P1, DOI 10.1136/sti.2004.013151; Ewbank D, 2001, CELLS AND SURVEYS: SHOULD BIOLOGICAL MEASURES BE INCLUDED IN SOCIAL SCIENCE RESEARCH, P64; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Frenk J., 1994, HLTH SOCIAL CHANGE I, P25; Garcia-Calleja JM, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010298; Hill K, 2006, B WORLD HEALTH ORGAN, V84, P225, DOI 10.2471/BLT.05.029744; Hill K, 2006, B WORLD HEALTH ORGAN, V84, P162, DOI 10.2471/BLT.06.030627; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; *MEASURE EV EQUITY, 2004, 1998 S AFR DEM HLTH; Moser KA, 2005, BRIT MED J, V331, P1180, DOI 10.1136/bmj.38659.588125.79; Murray, 2002, SUMMARY MEASURES POP, P205; Murray CJL, 2007, LANCET, V369, P862, DOI 10.1016/S0140-6736(07)60415-2; Murray CJL, 2004, BMJ-BRIT MED J, V329, P1096, DOI 10.1136/bmj.329.7474.1096; Murray CJL, 2003, LANCET, V362, P1022, DOI 10.1016/S0140-6736(03)14411-X; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Rowe AK, 2005, INT J EPIDEMIOL, V34, P712, DOI 10.1093/ije/dyi087; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; Smith K. R, 1990, INT ENVIRON AFFAIR, V2, P227; Stansfield SK, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1017; UNAIDS, 2006, GLOB REP AIDS EP; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; Walker N, 2003, AIDS, V17, P2215, DOI 10.1097/00002030-200310170-00010; WALKER N, IN PRESS LANCET; World Health Organization, 2005, HLTH MILL DEV GOALS; World Health Organization, 2006, WORLD HLTH STAT; World Health Organization, 1981, DEV IND MON PROGR HL	37	95	98	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2007	369	9563					779	786		10.1016/S0140-6736(07)60364-X	http://dx.doi.org/10.1016/S0140-6736(07)60364-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143MP	17336655				2022-12-28	WOS:000244726700035
J	Sugimoto, Y; Pou, P; Abe, M; Jelinek, P; Perez, R; Morita, S; Custance, O				Sugimoto, Yoshiaki; Pou, Pablo; Abe, Masayuki; Jelinek, Pavel; Perez, Ruben; Morita, Seizo; Custance, Oscar			Chemical identification of individual surface atoms by atomic force microscopy	NATURE			English	Article							ROOM-TEMPERATURE; SPECTROSCOPY; TRACKING	Scanning probe microscopy is a versatile and powerful method that uses sharp tips to image, measure and manipulate matter at surfaces with atomic resolution(1,2). At cryogenic temperatures, scanning probe microscopy can even provide electron tunnelling spectra that serve as fingerprints of the vibrational properties of adsorbed molecules(3-5) and of the electronic properties of magnetic impurity atoms(6,7), thereby allowing chemical identification. But in many instances, and particularly for insulating systems, determining the exact chemical composition of surfaces or nanostructures remains a considerable challenge. In principle, dynamic force microscopy should make it possible to overcome this problem: it can image insulator, semiconductor and metal surfaces with true atomic resolution(8-10), by detecting and precisely measuring(11-13) the short-range forces that arise with the onset of chemical bonding between the tip and surface atoms(14,15) and that depend sensitively on the chemical identity of the atoms involved. Here we report precise measurements of such short-range chemical forces, and show that their dependence on the force microscope tip used can be overcome through a normalization procedure. This allows us to use the chemical force measurements as the basis for atomic recognition, even at room temperature. We illustrate the performance of this approach by imaging the surface of a particularly challenging alloy system and successfully identifying the three constituent atomic species silicon, tin and lead, even though these exhibit very similar chemical properties and identical surface position preferences that render any discrimination attempt based on topographic measurements impossible.	Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; Univ Autonoma Madrid, Dept Fis Teor Mat Condensada, E-28049 Madrid, Spain; Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan; Acad Sci Czech Republ, Inst Phys, Prague 186253, Czech Republic	Osaka University; Autonomous University of Madrid; Japan Science & Technology Agency (JST); Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences	Custance, O (corresponding author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	oscar@afm.eei.eng.osaka-u.ac.jp	Abe, Masayuki/X-3707-2019; Pou, Pablo/C-3888-2012; Jelínek, Pavel/ABE-8589-2020; Jelinek, Pavel/G-1542-2010; Perez, Ruben/F-1849-2010; 清三, 森田/W-1919-2019; Abe, Masayuki/I-9274-2018; CUSTANCE, Oscar/H-2924-2011; Sugimoto, Yoshiaki/K-1691-2013	Abe, Masayuki/0000-0001-5619-3911; Pou, Pablo/0000-0002-5854-8218; Jelínek, Pavel/0000-0002-5645-8542; Jelinek, Pavel/0000-0002-5645-8542; Perez, Ruben/0000-0001-5896-541X; Sugimoto, Yoshiaki/0000-0003-3346-1586; Custance, Oscar/0000-0001-7931-603X				Abe M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2108112; Abe M, 2005, NANOTECHNOLOGY, V16, P3029, DOI 10.1088/0957-4484/16/12/050; ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; [Anonymous], 2005, PHYS REV LETT; Charrier A, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.115407; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Garcia R, 2002, SURF SCI REP, V47, P197, DOI 10.1016/S0167-5729(02)00077-8; Giessibl FJ, 2003, REV MOD PHYS, V75, P949, DOI 10.1103/RevModPhys.75.949; Giessibl FJ, 1997, PHYS REV B, V56, P16010, DOI 10.1103/PhysRevB.56.16010; Heinrich AJ, 2002, SCIENCE, V298, P1381, DOI 10.1126/science.1076768; Hembacher S, 2004, SCIENCE, V305, P380, DOI 10.1126/science.1099730; Hoffmann R, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.146103; Jelinek P, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.235101; Ke SH, 1999, PHYS REV B, V60, P11631, DOI 10.1103/PhysRevB.60.11631; Lantz MA, 2001, SCIENCE, V291, P2580, DOI 10.1126/science.1057824; Li JT, 1998, PHYS REV LETT, V80, P2893, DOI 10.1103/PhysRevLett.80.2893; Livshits AI, 1999, PHYS REV B, V59, P2436, DOI 10.1103/PhysRevB.59.2436; Madhavan V, 1998, SCIENCE, V280, P567, DOI 10.1126/science.280.5363.567; Oyabu N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106101; Pascual JI, 2003, NATURE, V423, P525, DOI 10.1038/nature01649; Perez R, 1997, PHYS REV LETT, V78, P678, DOI 10.1103/PhysRevLett.78.678; Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Sugimoto Y, 2005, APPL SURF SCI, V241, P23, DOI 10.1016/j.apsusc.2004.09.012; Sugimoto Y, 2005, NAT MATER, V4, P156, DOI 10.1038/nmat1297; Sugimoto Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.205329	26	496	506	15	309	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2007	446	7131					64	67		10.1038/nature05530	http://dx.doi.org/10.1038/nature05530			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330040				2022-12-28	WOS:000244525600037
J	Clasen, T; Schmidt, WP; Rabie, T; Roberts, I; Cairncross, S				Clasen, Thomas; Schmidt, Wolf-Peter; Rabie, Tamer; Roberts, Ian; Cairncross, Sandy			Interventions to improve water quality for preventing diarrhoea: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SANITATION; COUNTRIES	Objective To assess the effectiveness of interventions to improve the microbial quality of drinking water for preventing diarrhoea. Design Systematic review. Data sources Cochrane Infectious Diseases Group's trials register, CENTRAL, Medline, Embase, LILACS; hand searching; and correspondence with experts and relevant organisations. Study selection Randomised and quasi-randomised controlled trials of interventions to improve the microbial quality of drinking water for preventing diarrhoea in adults and in children in settings with endemic disease. Data extraction Allocation concealment, blinding, losses, to follow-up, type of intervention, outcome measures, and measures of effect. Pooled effect estimates were calculated within the appropriate subgroups. Data synthesis 33 reports from 21 countries documenting 42 comparisons were included. Variations in design, setting, and type and point of intervention, and variations in defining, assessing, calculating, and reporting outcomes limited the comparability of study results and pooling of results by meta-analysis. In general, interventions to improve the microbial quality of drinking water are effective in preventing diarrhoea. Effectiveness was not conditioned on the presence of improved water supplies or sanitation in the study setting and was not enhanced by combining the intervention with instructions on basic hygiene, a water storage vessel, or improved sanitation or water supplies-other common environmental interventions intended to prevent diarrhoea. Conclusion Interventions to improve water quality are generally effective for preventing diarrhoea in all ages and in under 5s. Significant heterogeneity among the trials suggests that the level of effectiveness may depend on a variety of conditions that research to date cannot fully explain.	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Publ Hlth, London WC1E 7HT, England; World Bank, Washington, DC 20433 USA	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; The World Bank	Clasen, T (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	thomas.clasen@lshtm.ac.uk		Schmidt, Wolf-Peter/0000-0001-7449-4152				[Anonymous], 2002, MANAGING WATER HOME; BLUM D, 1983, INT J EPIDEMIOL, V12, P357, DOI 10.1093/ije/12.3.357; BRISCOE J, 1984, AM J EPIDEMIOL, V120, P449, DOI 10.1093/oxfordjournals.aje.a113909; Briscoe J., 1986, EVALUATING HLTH IMPA; Colford John M. Jr., 2006, Journal of Water and Health, V4, P71, DOI 10.2166/wh.2006.018; CAIRNCROSS S, 1989, J TROP MED HYG, V92, P301; Cairncross S, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P771; Clasen T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004794.pub2; Clasen TF, 2004, TROP MED INT HEALTH, V9, P187, DOI 10.1046/j.1365-3156.2003.01191.x; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Egger M, 2001, SYSTEMATIC REV HLTH; ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757; ESREY SA, 1986, EPIDEMIOL REV, V8, P117, DOI 10.1093/oxfordjournals.epirev.a036290; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; ESREY SA, 1985, B WORLD HEALTH ORGAN, V64, P776; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; LINDSKOG U, 1987, SCAND J SOC MED, V15, P123, DOI 10.1177/140349488701500302; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Roy Sharon L., 2006, Journal of Water and Health, V4, P31, DOI 10.2166/wh.2006.017; VANDERSLICE J, 1995, AM J EPIDEMIOL, V141, P135, DOI 10.1093/oxfordjournals.aje.a117401; *WHO, PROGR MILL DEV GOALS; WHO and United Nations Children's Fund, 2000, GLOB WAT SUPPL SAN A; World Health Organization, 2005, WORLD HLTH REP 2005; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x	26	371	376	0	61	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2007	334	7597					782	785		10.1136/bmj.39118.489931.BE	http://dx.doi.org/10.1136/bmj.39118.489931.BE			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161SX	17353208	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000246037300028
J	Colquhoun, D				Colquhoun, David			Science degrees without the science	NATURE			English	Editorial Material									UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Colquhoun, D (corresponding author), UCL, Dept Pharmacol, London WC1E 6BT, England.		Colquhoun, David/C-1664-2008	Colquhoun, David/0000-0002-4263-017X				Barry CA, 2006, SOC SCI MED, V62, P2646, DOI 10.1016/j.socscimed.2005.11.025; Desmond Adrian, 1992, POLITICS EVOLUTION M; GOLDACRE B, 2007, GUARDIAN        0217; HARRIS M, 2003, U NHS PARTNERS CARE; HOLMES OW, 1842, HOM ITS KINDR DEL; Lancet, 2005, LANCET, V336, P690; 2000, QAA OTHER SUBJECTS A	7	25	25	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2007	446	7134					373	374		10.1038/446373a	http://dx.doi.org/10.1038/446373a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17377563				2022-12-28	WOS:000245079500018
J	Reineke, J; Tenzer, S; Rupnik, M; Koschinski, A; Hasselmayer, O; Schrattenholz, A; Schild, H; von Eichel-Streiber, C				Reineke, Jessica; Tenzer, Stefan; Rupnik, Maja; Koschinski, Andreas; Hasselmayer, Oliver; Schrattenholz, Andre; Schild, Hansjoerg; von Eichel-Streiber, Christoph			Autocatalytic cleavage of Clostridium difficile toxin	NATURE			English	Article							INOSITOL HEXAKISPHOSPHATE; PSEUDOMEMBRANOUS COLITIS; RHO-PROTEINS; CELLS; GENE; INTERNALIZATION; GLUCOSYLATION; HOMOLOGY; DISEASE; SITE	Clostridium difficile, the causative agent of nosocomial antibiotic-associated diarrhoea and pseudomembranous colitis, possesses two main virulence factors: the large clostridial cytotoxins A and B. It has been proposed that toxin B is cleaved by a cytosolic factor of the eukaryotic target cell during its cellular uptake. Here we report that cleavage of not only toxin B, but also all other large clostridial cytotoxins, is an autocatalytic process dependent on host cytosolic inositolphosphate cofactors. A covalent inhibitor of aspartate proteases, 1,2-epoxy-3-(p-nitrophenoxy)propane, completely blocked toxin B function on cultured cells and was used to identify its catalytically active protease site. To our knowledge this is the first report on a bacterial toxin that uses eukaryotic signals for induced autoproteolysis to deliver its toxic domain into the cytosol of target cells. On the basis of our data, we present an integrated model for the uptake and inositolphosphate-induced activation of toxin B.	Johannes Gutenberg Univ Mainz, Inst Med Mikrobiol & Hyg, D-55131 Mainz, Germany; Johannes Gutenberg Univ Mainz, Inst Immunol, D-55131 Mainz, Germany; Univ Maribor, Fac Med, SLO-2000 Maribor, Slovenia; Inst Publ Hlth Maribor, SLO-2000 Maribor, Slovenia; Univ Giessen, Rudolf Buchheim Inst Pharmakol, D-35392 Giessen, Germany; ProteoSys AG, D-55129 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Maribor; Justus Liebig University Giessen; ProteoSys AG	von Eichel-Streiber, C (corresponding author), Johannes Gutenberg Univ Mainz, Inst Med Mikrobiol & Hyg, Hochhaus Augustuspl, D-55131 Mainz, Germany.	schild@uni-mainz.de; veichel@uni-mainz.de	Tenzer, Stefan/AAE-2180-2020	Tenzer, Stefan/0000-0003-3034-0017				Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; Braun V, 1996, GENE, V181, P29, DOI 10.1016/S0378-1119(96)00398-8; BRAUN V, 1999, PATHOGENICITY ISLAND; Byrum J, 2004, NUCLEIC ACIDS RES, V32, P2776, DOI 10.1093/nar/gkh592; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1201; Davey P, 2006, EMERG INFECT DIS, V12, P211, DOI 10.3201/eid1202.05145; EICHELSTREIBER C, 1992, J BACTERIOL, V174, P6707; FERNANDEZPATRON C, 1995, ANAL BIOCHEM, V224, P263, DOI 10.1006/abio.1995.1039; Fishman N, 2006, AM J MED, V119, pS62, DOI 10.1016/j.amjmed.2006.04.004; FLORIN I, 1983, BIOCHIM BIOPHYS ACTA, V763, P383, DOI 10.1016/0167-4889(83)90100-3; FLORIN I, 1986, MICROB PATHOGENESIS, V1, P373, DOI 10.1016/0882-4010(86)90069-0; GEORGE RH, 1978, BRIT MED J, V1, P695, DOI 10.1136/bmj.1.6114.695; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; Gorbach SL, 1999, NEW ENGL J MED, V341, P1690, DOI 10.1056/NEJM199911253412211; GREEN GA, 1995, GENE, V161, P57, DOI 10.1016/0378-1119(95)00263-6; HENRIQUES B, 1987, MICROB PATHOGENESIS, V2, P455, DOI 10.1016/0882-4010(87)90052-0; HOFMANN F, 1995, MOL GEN GENET, V247, P670, DOI 10.1007/BF00290398; Hofmann F, 1997, J BIOL CHEM, V272, P11074; Hsu FF, 2003, J MASS SPECTROM, V38, P447, DOI 10.1002/jms.457; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; KARLSSON KA, 1995, CURR OPIN STRUC BIOL, V5, P622, DOI 10.1016/0959-440X(95)80054-9; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; LYERLY D M, 1988, Clinical Microbiology Reviews, V1, P1; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; McDonald L Clifford, 2005, Infect Control Hosp Epidemiol, V26, P672, DOI 10.1086/502600; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Moos M, 2000, METHOD ENZYMOL, V325, P114; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Rupnik M, 2005, J MED MICROBIOL, V54, P113, DOI 10.1099/jmm.0.45810-0; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; SAUERBORN M, 1994, INT J MED MICROBIO S, V24, P510; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; Shears SB, 2001, CELL SIGNAL, V13, P151, DOI 10.1016/S0898-6568(01)00129-2; Tenover FC, 2006, AM J INFECT CONTROL, V34, pS3, DOI 10.1016/j.ajic.2006.05.219; TUCKER KD, 1991, INFECT IMMUN, V59, P73, DOI 10.1128/IAI.59.1.73-78.1991; vonEichelStreiber C, 1996, TRENDS MICROBIOL, V4, P375, DOI 10.1016/0966-842X(96)10061-5; VONEICHELSTREIBER C, 1992, MOL GEN GENET, V233, P260, DOI 10.1007/BF00587587; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; York JD, 2001, ADV ENZYME REGUL, V41, P57, DOI 10.1016/S0065-2571(00)00025-X	46	182	198	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					415	419		10.1038/nature05622	http://dx.doi.org/10.1038/nature05622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17334356				2022-12-28	WOS:000245079500034
J	Serreze, MC; Holland, MM; Stroeve, J				Serreze, Mark C.; Holland, Marika M.; Stroeve, Julienne			Perspectives on the Arctic's shrinking sea-ice cover	SCIENCE			English	Review							AIR-TEMPERATURE; OCEAN; HALOCLINE; EVOLUTION; SHIFTS; TRENDS; MODEL; 20TH	Linear trends in arctic sea-ice extent over the period 1979 to 2006 are negative in every month. This ice loss is best viewed as a combination of strong natural variability in the coupled ice-ocean-atmosphere system and a growing radiative forcing associated with rising concentrations of atmospheric greenhouse gases, the latter supported by evidence of qualitative consistency between observed trends and those simulated by climate models over the same period. Although the large scatter between individual model simulations leads to much uncertainty as to when a seasonally ice-free Arctic Ocean might be realized, this transition to a new arctic state may be rapid once the ice thins to a more vulnerable state. Loss of the ice cover is expected to affect the Arctic's freshwater system and surface energy budget and could be manifested in middle latitudes as altered patterns of atmospheric circulation and precipitation.	Univ Colorado, Cooperat Inst Res Environm Sci, Natl Snow & Ice Data Ctr, Boulder, CO 80309 USA; Natl Ctr Atmospher Res, Boulder, CO 80307 USA	University of Colorado System; University of Colorado Boulder; National Center Atmospheric Research (NCAR) - USA	Serreze, MC (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Natl Snow & Ice Data Ctr, Campus Box 449, Boulder, CO 80309 USA.	serreze@kryos.colorado.edu	Stroeve, Julienne/ABE-7227-2020; Stroeve, Julienne/D-1525-2010	Holland, Marika/0000-0001-5621-8939				[Anonymous], 2006, EOS T AM GEOPHYS UN, DOI DOI 10.1029/2006EO460001; Arzel O, 2006, OCEAN MODEL, V12, P401, DOI 10.1016/j.ocemod.2005.08.002; Boyd TJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014047; Comiso JC, 2003, J CLIMATE, V16, P3498, DOI 10.1175/1520-0442(2003)016<3498:WTITAF>2.0.CO;2; Comiso JC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027341; Dickson RR, 2000, J CLIMATE, V13, P2671, DOI 10.1175/1520-0442(2000)013<2671:TAORTT>2.0.CO;2; Fowler C, 2004, IEEE GEOSCI REMOTE S, V1, P71, DOI 10.1109/LGRS.2004.824741; GILLETT NP, 2003, GEOPHYS MONOGR SER, V134, pCH9; Holland MM, 2006, J CLIMATE, V19, P6221, DOI 10.1175/JCLI3967.1; Holland MM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028024; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Lindsay RW, 2005, J CLIMATE, V18, P4879, DOI 10.1175/JCLI3587.1; Magnusdottir G, 2004, J CLIMATE, V17, P857, DOI 10.1175/1520-0442(2004)017<0857:TEONAS>2.0.CO;2; MANABE S, 1980, J GEOPHYS RES-OCEANS, V85, P5529, DOI 10.1029/JC085iC10p05529; Maslanik J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028269; Maslowski W, 2001, ANN GLACIOL, V33, P545, DOI 10.3189/172756401781818978; Overland JE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021752; Peterson BJ, 2006, SCIENCE, V313, P1061, DOI 10.1126/science.1122593; Polyakov IV, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023740; Polyakov IV, 2003, J CLIMATE, V16, P2067, DOI 10.1175/1520-0442(2003)016<2067:VATOAT>2.0.CO;2; Rigor IG, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019492; Rigor IG, 2002, J CLIMATE, V15, P2648, DOI 10.1175/1520-0442(2002)015<2648:ROSITT>2.0.CO;2; Rigor IG, 2000, J CLIMATE, V13, P896, DOI 10.1175/1520-0442(2000)013<0896:VISATO>2.0.CO;2; Rothrock DA, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002282; Rothrock DA, 1999, GEOPHYS RES LETT, V26, P3469, DOI 10.1029/1999GL010863; Serreze MC, 2006, CLIMATIC CHANGE, V76, P241, DOI 10.1007/s10584-005-9017-y; Sewall JO, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019133; Shimada K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025624; Singarayer JS, 2006, J CLIMATE, V19, P1109, DOI 10.1175/JCLI3649.1; Steele M, 1998, J GEOPHYS RES-OCEANS, V103, P10419, DOI 10.1029/98JC00580; Stirling I, 2006, ARCTIC, V59, P261; Stroeve JC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021810; STROEVE JC, 2006, ANN GLACIOL, V25, P382; Walczowski W, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025872; Weatherhead EC, 1998, J GEOPHYS RES-ATMOS, V103, P17149, DOI 10.1029/98JD00995; Woodgate RA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026931; Zhang XD, 2006, J CLIMATE, V19, P1730, DOI 10.1175/JCLI3767.1	37	947	1005	9	407	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1533	1536		10.1126/science.1139426	http://dx.doi.org/10.1126/science.1139426			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363664				2022-12-28	WOS:000244934800040
J	Chaves, SS; Gargiullo, P; Zhang, JX; Civen, R; Guris, D; Mascola, MPHL; Seward, JF				Chaves, Sandra S.; Gargiullo, Paul; Zhang, John X.; Civen, Rachel; Guris, Dalya; Mascola, M. P. H. Laurene; Seward, Jane F.			Loss of vaccine-induced immunity to varicella over time	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTBREAK; RESPONSES; POSTLICENSURE; CHILDREN; DECLINE; SAFETY; IMPACT	BACKGROUND: The introduction of universal varicella vaccination in 1995 has substantially reduced varicella-related morbidity and mortality in the United States. However, it remains unclear whether vaccine-induced immunity wanes over time, a condition that may result in increased susceptibility later in life, when the risk of serious complications may be greater than in childhood. METHODS: We examined 10 years (1995 to 2004) of active surveillance data from a sentinel population of 350,000 subjects to determine whether the severity and incidence of breakthrough varicella (with an onset of rash >42 days after vaccination) increased with the time since vaccination. We used multivariate logistic regression to adjust for the year of disease onset (calendar year) and the subject's age at both disease onset and vaccination. RESULTS: A total of 11,356 subjects were reported to have varicella during the surveillance period, of whom 1080 (9.5%) had breakthrough disease. Children between the ages of 8 and 12 years who had been vaccinated at least 5 years previously were significantly more likely to have moderate or severe disease than were those who had been vaccinated less than 5 years previously (risk ratio, 2.6; 95% confidence interval [CI], 1.2 to 5.8). The annual rate of breakthrough varicella significantly increased with the time since vaccination, from 1.6 cases per 1000 person-years (95% CI, 1.2 to 2.0) within 1 year after vaccination to 9.0 per 1000 person-years (95% CI, 6.9 to 11.7) at 5 years and 58.2 per 1000 person-years (95% CI, 36.0 to 94.0) at 9 years. CONCLUSIONS: A second dose of varicella vaccine, now recommended for all children, could improve protection from both primary vaccine failure and waning vaccine-induced immunity.	Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA	Centers for Disease Control & Prevention - USA	Chaves, SS (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop A-47, Atlanta, GA 30333 USA.	bev8@cdc.gov						Ampofo K, 2002, CLIN INFECT DIS, V34, P774, DOI 10.1086/338959; Arvin AM, 1996, INFECT DIS CLIN N AM, V10, P529, DOI 10.1016/S0891-5520(05)70312-3; Brisson M., 2003, Journal of Medical Virology, V70, pS31, DOI 10.1002/jmv.10317; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P389; Clements DA, 1999, PEDIATR INFECT DIS J, V18, P1047, DOI 10.1097/00006454-199912000-00004; Davis MM, 2004, PEDIATRICS, V114, P786, DOI 10.1542/peds.2004-0012; Galil K, 2002, NEW ENGL J MED, V347, P1909, DOI 10.1056/NEJMoa021662; Haddad MB, 2005, PEDIATRICS, V115, P1488, DOI 10.1542/peds.2004-1826; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; Krause PR, 2001, ARCH VIR S, V17, P7; Kuter B, 2004, PEDIATR INFECT DIS J, V23, P132, DOI 10.1097/01.inf.0000109287.97518.67; Lee BR, 2004, J INFECT DIS, V190, P477, DOI 10.1086/422041; Li S, 2002, PEDIATR INFECT DIS J, V21, P337, DOI 10.1097/00006454-200204000-00014; Lopez AS, 2006, PEDIATRICS, V117, pE1070, DOI 10.1542/peds.2005-2085; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Mullooly JP, 2004, VACCINE, V22, P1480, DOI 10.1016/j.vaccine.2003.10.021; Ngai AL, 1996, PEDIATR INFECT DIS J, V15, P49, DOI 10.1097/00006454-199601000-00011; Nguyen HQ, 2005, NEW ENGL J MED, V352, P450, DOI 10.1056/NEJMoa042271; Seward JF, 2002, JAMA-J AM MED ASSOC, V287, P606, DOI 10.1001/jama.287.5.606; Tugwell BD, 2004, PEDIATRICS, V113, P455, DOI 10.1542/peds.113.3.455; Vazquez M, 2004, JAMA-J AM MED ASSOC, V291, P851, DOI 10.1001/jama.291.7.851; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; Verstraeten T, 2003, PEDIATRICS, V112, P1039, DOI 10.1542/peds.112.2.e98; WATSON B, 1995, CLIN INFECT DIS, V20, P316, DOI 10.1093/clinids/20.2.316; WATSON B, 1995, J INFECT DIS, V172, P217, DOI 10.1093/infdis/172.1.217; Zhou FJ, 2005, JAMA-J AM MED ASSOC, V294, P797, DOI 10.1001/jama.294.7.797	26	215	241	2	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2007	356	11					1121	1129		10.1056/NEJMoa064040	http://dx.doi.org/10.1056/NEJMoa064040			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	145PO	17360990				2022-12-28	WOS:000244877200005
J	Kirschner, KL; Breslin, ML; Iezzoni, LI				Kirschner, Kristi L.; Breslin, Mary Lou; Iezzoni, Lisa I.			Structural impairments that limit access to health care for patients with disabilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVENTIVE SERVICES; BARRIERS		Northwestern Univ, Feinberg Sch Med, Rehabil Inst Chicago, Chicago, IL 60611 USA; Disabil Rights Educ & Def Fund, Berkeley, CA USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Inst Hlth Policy, Boston, MA USA	Northwestern University; Feinberg School of Medicine; Shirley Ryan AbilityLab; Harvard University; Harvard Medical School; Massachusetts General Hospital	Kirschner, KL (corresponding author), Northwestern Univ, Feinberg Sch Med, Rehabil Inst Chicago, 345 E Super St,Room 1136, Chicago, IL 60611 USA.	kkirschner@ric.org						Bancroft E., 2006, Morbidity and Mortality Weekly Report, V55, P1300; *BUR LAB STAT, 2005, NONF OCC INJ ILLN RE; Chan L, 1999, ARCH PHYS MED REHAB, V80, P642, DOI 10.1016/S0003-9993(99)90166-1; DeJong G, 2002, MILBANK Q, V80, P261, DOI 10.1111/1468-0009.t01-1-00004; *DEP VET AFF, 2006, BARR FREE DES GUID S; *DEP VET AFF DEP D, 2001, PAT CAR ERG RES GUID; Drainoni ML., 2006, J DIABIL POLICY STUD, V17, P101, DOI [10.1177/10442073060170020101, DOI 10.1177/10442073060170020101]; Iezzoni LI, 2000, AM J PUBLIC HEALTH, V90, P955, DOI 10.2105/AJPH.90.6.955; Iezzoni LI, 2003, WALKING FAILS MOBILI; Iezzoni Lisa I., 2006, MORE RAMPS GUIDE IMP; Kroll T, 2006, HEALTH SOC CARE COMM, V14, P284, DOI 10.1111/j.1365-2524.2006.00613.x; Marras WS, 1999, ERGONOMICS, V42, P904, DOI 10.1080/001401399185207; McCarthy EP, 2006, ANN INTERN MED, V145, P637, DOI 10.7326/0003-4819-145-9-200611070-00005; Nelson Audrey, 2004, Online J Issues Nurs, V9, P4; *PD HART RES ASS I, 2006, SAF PAT HANDL REP BA; Reis J, 2004, IT TAKES MORE RAMPS; Schroeder S., 1979, ESTIMATED COST ACCES; *STAT CAL OCC SAF, BACK INJ PREV GUID H; *US CENS BUR, AM DIS 1997; *US DEP HHS, STAT AG POP; *US DEP HHS OFF SU, 2005, SURG GEN CALL ACT IM; *US DEP JUST, 2006, ENF ADA STAT REP DEP; 2004, NURSING LAW LEGAL EA, V12	23	62	63	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2007	297	10					1121	1125		10.1001/jama.297.10.1121	http://dx.doi.org/10.1001/jama.297.10.1121			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	145KZ	17356035				2022-12-28	WOS:000244865200028
J	Lurie, N; Dubowitz, T				Lurie, Nicole; Dubowitz, Tamara			Health disparities and access to health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RACIAL DISPARITIES; CARE; QUALITY; PHYSICIANS; LIFE		RAND Corp, Ctr Populat Hlth & Hlth Dispar, Arlington, VA 22302 USA	RAND Corporation	Lurie, N (corresponding author), RAND Corp, Ctr Populat Hlth & Hlth Dispar, 1200 S Hayes St, Arlington, VA 22302 USA.	lurie@rand.org			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES012383] Funding Source: NIH RePORTER; NIEHS NIH HHS [5 P50 ES012383-04] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Aboul-Enein Faisal H, 2006, J Cult Divers, V13, P168; ACHESON D, 1998, REPORT INDEPENDENT I; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Eisenberg JM, 2000, JAMA-J AM MED ASSOC, V284, P2100, DOI 10.1001/jama.284.16.2100; Evans G.W., 1994, VULNERABLE BRAIN ENV, V3, P167; Finegold K, RACE ETHNICITY HLTH; Fuchs VR, 2002, HEALTH AFFAIR, V21, P207, DOI 10.1377/hlthaff.21.6.207; Gostin LO, 2007, JAMA-J AM MED ASSOC, V297, P87, DOI 10.1001/jama.297.1.87; Gruen RL, 2006, JAMA-J AM MED ASSOC, V296, P2467, DOI 10.1001/jama.296.20.2467; *HLTH CAN, 1986, ACH HLTH ALL FRAM HL; *I MED NAT AC, 2003, UN TREATM CONFR RAC; Kawachi I., 2003, NEIGHBORHOODS HLTH; Lynch JWKG, 2001, SOCIAL EPIDEMIOLOGY, P13; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; *NAT HLTH PLAN COL, 2006, RED RAC ETHN DISP IM; Seeman TE, 1997, ARCH INTERN MED, V157, P2259; Seid M, 2006, J PEDIATR-US, V149, P354, DOI 10.1016/j.jpeds.2006.04.024; SHALALA DE, 1996, NAT C MED PUBL HLTH; Taylor SE, 1997, ANNU REV PSYCHOL, V48, P411, DOI 10.1146/annurev.psych.48.1.411; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7; 2006, STATE NET CAPIT 1218, pR14	23	114	114	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2007	297	10					1118	1121		10.1001/jama.297.10.1118	http://dx.doi.org/10.1001/jama.297.10.1118			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	145KZ	17356034				2022-12-28	WOS:000244865200027
J	Levenson, R				Levenson, Ros			A patient's journey - Whooping cough	BRITISH MEDICAL JOURNAL			English	Editorial Material												ros@roslevenson.demon.co.uk							0	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2007	334	7592					532	533		10.1136/bmj.39120.556296.AE	http://dx.doi.org/10.1136/bmj.39120.556296.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148VV	17347240	Bronze, Green Published			2022-12-28	WOS:000245106400045
J	Rosenfeld, D; Dai, J; Yu, X; Yao, ZY; Xu, XH; Yang, X; Du, CL				Rosenfeld, Daniel; Dai, Jin; Yu, Xing; Yao, Zhanyu; Xu, Xiaohong; Yang, Xing; Du, Chuanli			Inverse relations between amounts of air pollution and orographic precipitation	SCIENCE			English	Article							SUPPRESSION; RAIN; SNOW	Particulate air pollution has been suggested as the cause of the recently observed decreasing trends of 10 to 25% in the ratio between hilly and upwind lowland precipitation, downwind of urban and industrial areas. We quantified the dependence of this ratio of the orographic-precipitation enhancement factor on the amounts of aerosols composed mostly of pollution in the free troposphere, based on measurements at Mt. Hua near Xi'an, in central China. The hilly precipitation can be decreased by 30 to 50% during hazy conditions, with visibility of less than 8 kilometers at the mountaintop. This trend shows the role of air pollution in the loss of significant water resources in hilly areas, which is a major problem in China and many other areas of the world.	Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel; Meteorol Inst Shaanxi Prov, Xian 710015, Peoples R China; Chinese Acad Meteorol Sci, Key Lab Cloud Phys & Weather Modificat, Chinese Meteorol Assoc, Beijing 100081, Peoples R China	Hebrew University of Jerusalem; Chinese Academy of Meteorological Sciences (CAMS)	Rosenfeld, D (corresponding author), Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel.	daniel.rosenfeld@huji.ac.il	Rosenfeld, Daniel/AAJ-4617-2021; Rosenfeld, Daniel/F-6077-2016	Rosenfeld, Daniel/0000-0002-0784-7656; Rosenfeld, Daniel/0000-0002-0784-7656				Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779; Borys RD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016855; Givati A, 2005, J APPL METEOROL, V44, P1298, DOI 10.1175/JAM2276.1; Givati A, 2004, J APPL METEOROL, V43, P1038, DOI [10.1175/1520-0450(2004)043<1038:QPSDTA>2.0.CO;2, 10.1175/1520-0450(2004)043&lt;1038:QPSDTA&gt;2.0.CO;2]; Griffith D A, 2005, J WEATHER MODIFICAT, V37, P14; GUNN R, 1957, J METEOROL, V14, P272, DOI 10.1175/1520-0469(1957)014<0272:AEIOTE>2.0.CO;2; Jirak IL, 2006, J APPL METEOROL CLIM, V45, P236, DOI 10.1175/JAM2328.1; Qiu JH, 2000, ATMOS ENVIRON, V34, P603; Rosenfeld D, 1999, GEOPHYS RES LETT, V26, P3105, DOI 10.1029/1999GL006066; Rosenfeld D, 2000, SCIENCE, V287, P1793, DOI 10.1126/science.287.5459.1793; Rosenfeld D, 2006, J APPL METEOROL CLIM, V45, P893, DOI 10.1175/JAM2380.1; [宗雪梅 Zong Xuemei], 2005, [气候与环境研究, Climatic and environmental research], V10, P201	12	216	263	4	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1396	1398		10.1126/science.1137949	http://dx.doi.org/10.1126/science.1137949			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347436				2022-12-28	WOS:000244752200029
J	Singh, S				Singh, Seema			Indian pharma enters the global arena	CELL			English	Editorial Material								Although known as a major supplier of generic drugs, India has begun to forge new alliances with big US and European pharma companies. Such collaborations are helping to shepherd Indian drug companies into a new era of innovative drug discovery, but regulations governing patents, drug approvals, and clinical trials are still in the process of being updated.											0	6	6	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					811	814		10.1016/j.cell.2007.02.031	http://dx.doi.org/10.1016/j.cell.2007.02.031			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350563	Bronze			2022-12-28	WOS:000245073400001
J	Gordon, DM				Gordon, Deborah M.			Control without hierarchy	NATURE			English	Editorial Material									Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Gordon, DM (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							GORDON DM, 2000, ANTS WORK; Haraway Donna J., 1976, CRYSTALS FABRICS FIE; Lewontin R.C., 2001, TRIPLE HELIX GENE OR, DOI 10.5061/dryad.f7m0cfxx6	3	38	38	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					143	143		10.1038/446143a	http://dx.doi.org/10.1038/446143a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344838				2022-12-28	WOS:000244718100025
J	Myers, PO; Chassot, G				Myers, Patrick O.; Chassot, Gilles			Floating kidneys	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Hosp Geneva, Geneva, Switzerland	University of Geneva	Myers, PO (corresponding author), Univ Hosp Geneva, Geneva, Switzerland.	patrick.myers@hcuge.ch							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2007	356	10					1048	1048		10.1056/NEJMicm060536	http://dx.doi.org/10.1056/NEJMicm060536			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143DC	17347458	Green Published			2022-12-28	WOS:000244699200009
J	Shara, MM; Martin, CD; Seibert, M; Rich, RM; Salim, S; Reitzel, D; Schiminovich, D; Deliyannis, CP; Sarrazine, AR; Kulkarni, SR; Ofek, EO; Brosch, N; Lepine, S; Zurek, D; De Marco, O; Jacoby, G				Shara, Michael M.; Martin, Christopher D.; Seibert, Mark; Rich, R. Michael; Salim, Samir; Reitzel, David; Schiminovich, David; Deliyannis, Constantine P.; Sarrazine, Angela R.; Kulkarni, Shri R.; Ofek, Eran O.; Brosch, Noah; Lepine, Sebastien; Zurek, David; De Marco, Orsola; Jacoby, George			An ancient nova shell around the dwarf nova Z Camelopardalis	NATURE			English	Article							EVOLUTION; SPACE; EMISSION; TIME; MASS	Cataclysmic variables ( classical novae and dwarf novae) are binary star systems in which a red dwarf transfers hydrogen-rich matter, by way of an accretion disk, to its white dwarf companion(1). In dwarf novae, an instability(2) is believed to episodically dump much of the accretion disk onto the white dwarf. The liberation of gravitational potential energy then brightens these systems by up to 100-fold every few weeks or months(2). Thermonuclear-powered eruptions thousands of times more luminous(3,4) occur in classical novae(5), accompanied by significant mass ejection(6) and formation of clearly visible shells(7,8) from the ejected material. Theory predicts that the white dwarfs in all dwarf novae must eventually accrete enough mass to undergo classical nova eruptions(9). Here we report a shell, an order of magnitude more extended than those detected around many classical novae, surrounding the prototypical dwarf nova Z Camelopardalis. The derived shell mass matches that of classical novae, and is inconsistent with the mass expected from a dwarf nova wind or a planetary nebula. The shell observationally links the prototypical dwarf nova Z Camelopardalis with an ancient nova eruption and the classical nova process.	Amer Museum Nat Hist, Dept Astrophys, New York, NY 10024 USA; CALTECH, Dept Phys Math & Astron, Pasadena, CA 91125 USA; Observ Carnegie Inst Washington, Pasadena, CA 91101 USA; Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; Columbia Univ, Dept Astron, New York, NY 10027 USA; Indiana Univ, Dept Astron, Bloomington, IN 47405 USA; Tel Aviv Univ, Wise Observ, Dept Astron & Astrophys, IL-69978 Ramat Aviv, Israel; WIYN Observ, Tucson, AZ 85726 USA	American Museum of Natural History (AMNH); California Institute of Technology; Carnegie Institution for Science; University of California System; University of California Los Angeles; Columbia University; Indiana University System; Indiana University Bloomington; Tel Aviv University	Shara, MM (corresponding author), Amer Museum Nat Hist, Dept Astrophys, 79th St & Cent Pk W, New York, NY 10024 USA.	mshara@amnh.org	Brosch, Noah/C-7889-2009	Brosch, Noah/0000-0002-7614-7565; Salim, Samir/0000-0003-2342-7501; De Marco, Orsola/0000-0002-1126-869X; Seibert, Mark/0000-0002-1143-5515				Baskill DS, 2001, MON NOT R ASTRON SOC, V328, P71, DOI 10.1046/j.1365-8711.2001.04880.x; BLOCKER T, 1995, ASTRON ASTROPHYS, V299, P755; Bode MF, 2004, ASTROPHYS J, V600, pL63, DOI 10.1086/381529; DODORICO S, 1976, ASTRON ASTROPHYS, V53, P443; DOPITA MA, 1977, ASTROPHYS J SUPPL S, V33, P437, DOI 10.1086/190435; Downes RA, 2000, ASTRON J, V120, P2007, DOI 10.1086/301551; Hog E, 2000, ASTRON ASTROPHYS, V355, pL27; Hubble E, 1929, ASTROPHYS J, V69, P103, DOI 10.1086/143167; Knigge C, 1997, ASTROPHYS J, V476, P291, DOI 10.1086/303607; Lundmark K, 1923, PASP, V35, P95, DOI [10.1086/123277, DOI 10.1086/123277]; MATTEI JA, 1996, AM ASS VAR STAR OBSE; OSAKI Y, 1974, PUBL ASTRON SOC JPN, V26, P429; Osterbrock DE, 1996, PUBL ASTRON SOC PAC, V108, P277, DOI 10.1086/133722; PAYNEGAPOSHKIN C, 1957, GALACTIC NOVAE, P53; ROBINSON EL, 1973, ASTROPHYS J, V186, P347, DOI 10.1086/152504; SHARA MM, 1986, ASTROPHYS J, V311, P163, DOI 10.1086/164762; SHARA MM, 1981, ASTROPHYS J, V243, P926, DOI 10.1086/158657; Simon V, 2002, ASTRON ASTROPHYS, V382, P910, DOI 10.1051/0004-6361:20011560; SZKODY P, 1986, ASTROPHYS J, V301, P286, DOI 10.1086/163897; Thorstensen JR, 2003, ASTRON J, V126, P3017, DOI 10.1086/379308; WADE RA, 1990, P IAU C, V122, P179; WARNER B, 1995, CATACLYSMIC VARIABLE, V7, P269; Yaron O, 2005, ASTROPHYS J, V623, P398, DOI 10.1086/428435; 2002, VELA SUPERNOVA REMNA	25	63	63	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					159	162		10.1038/nature05576	http://dx.doi.org/10.1038/nature05576			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344847				2022-12-28	WOS:000244718100034
J	Wigton, RS; Alguire, P				Wigton, Robert S.; Alguire, Patrick			The declining number and variety of procedures done by general internists: A resurvey of members of the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article								Background: A survey of general internist members of the American College of Physicians (ACP) in 1986 found that they did a large number and variety of procedures in their practices. Since then, changes in the practice of medicine, regulatory requirements, and availability of subspecialists may have affected the number and type of procedures done by internists. Objective: To determine the number and types of procedures currently done by general internist members of the ACP compared with 1986. Design: Mailed questionnaire. Setting: National probability sample of general internists. Participants: Respondents to a national survey of 2500 general internist members of the ACP who were similar in characteristics to those who participated in the 1986 survey. Of the 1389 questionnaires that were returned, 990 were from general internists who had completed the survey. Measurements: Responses to questions about procedures done and practice characteristics. Results: The number and variety of procedures done by general internists has decreased dramatically. On average, the percentage of general internists doing each procedure now is less than half of that in 1986. The average number of different procedures done in practice decreased from 16 in 1986 to 7 in 2004. As in the 1986 survey, the number of procedures related strongly to personal and practice characteristics. Internists who practice in smaller towns and smaller hospitals do twice as many procedures on average as those in larger cities and larger hospitals. The number and variety of procedures done by internists also increased with greater time spent in total patient care. Limitations: The number and type of procedures were determined by self-reporting, not direct observation. Conclusions: Both the number and variety of procedures done by general internists have decreased considerably since 1986. As in the 1986 survey, general internists who practice in smaller cities and smaller hospitals and those who spend more hours in patient care perform more procedures. Recommendations and practices for internal medicine residency training in procedures should be reexamined in light of these changes.	Univ Nebraska, Med Ctr, Coll Med, Omaha, NE 68198 USA; Amer Coll Physicians, Philadelphia, PA USA	University of Nebraska System; University of Nebraska Medical Center; American College of Physicians	Wigton, RS (corresponding author), Univ Nebraska, Med Ctr, Coll Med, 984285 Nebraska Med Ctr, Omaha, NE 68198 USA.	wigton@unmc.edu						Born PH, 1998, J FAM PRACTICE, V46, P319; Centor RM, 2006, AM J MED, V119, P172, DOI 10.1016/j.amjmed.2005.11.001; Ingelfinger JA, 1994, BIOSTATISTICS CLIN M, V3rd; Siegel S., 1988, NONPARAMETRIC STAT B; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487; WIGTON RS, 1989, ANN INTERN MED, V111, P1023, DOI 10.7326/0003-4819-111-12-1023; [No title captured]	7	72	73	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2007	146	5					355	360		10.7326/0003-4819-146-5-200703060-00007	http://dx.doi.org/10.7326/0003-4819-146-5-200703060-00007			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144XK	17339620				2022-12-28	WOS:000244829600004
J	Cheianov, VV; Fal'ko, V; Altshuler, BL				Cheianov, Vadim V.; Fal'ko, Vladimir; Altshuler, B. L.			The focusing of electron flow and a Veselago lens in graphene p-n junctions	SCIENCE			English	Article							BILAYER GRAPHENE; BERRYS PHASE; QUANTUM; GRAPHITE	The focusing of electric current by a single p-n junction in graphene is theoretically predicted. Precise focusing may be achieved by fine-tuning the densities of carriers on the n- and p-sides of the junction to equal values. This finding may be useful for the engineering of electronic lenses and focused beam splitters using gate-controlled n-p-n junctions in graphene-based transistors.	Univ Lancaster, Dept Phys, Lancaster LA1 4YB, England; Columbia Univ, Dept Phys, New York, NY 10027 USA; NEC Labs Amer, Princeton, NJ 08540 USA	Lancaster University; Columbia University; NEC Corporation	Cheianov, VV (corresponding author), Univ Lancaster, Dept Phys, Lancaster LA1 4YB, England.	v.cheianov@lancaster.ac.uk		Fal'ko, Vladimir/0000-0003-0828-0310	EPSRC [EP/D062918/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/C511743/1, EP/D062918/1, EP/C509358/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		ARNOLD VI, 1990, MATH ITS APPL SERIES, V62; Bernal JD, 1924, P R SOC LOND A-CONTA, V106, P749, DOI 10.1098/rspa.1924.0101; BERRY MV, 1976, ADV PHYS, V25, P1, DOI 10.1080/00018737600101342; Cheianov VV, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.226801; Cheianov VV, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.041403; Dresselhaus MS, 2002, ADV PHYS, V51, P1, DOI [10.1080/00018730110113644, 10.1080/00018738100101367]; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; FRIEDEL J, 1952, PHILOS MAG, V43, P153; HERNBACHER S, 2005, PHYS REV LETT, V94, DOI UNSP 056101; Katsnelson MI, 2006, NAT PHYS, V2, P620, DOI 10.1038/nphys384; Manoharan HC, 2000, NATURE, V403, P512, DOI 10.1038/35000508; McCann E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.086805; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2006, NAT PHYS, V2, P177, DOI 10.1038/nphys245; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Ohta T, 2006, SCIENCE, V313, P951, DOI 10.1126/science.1130681; Pendry J, 2003, NATURE, V423, P22, DOI 10.1038/423022a; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Saito R, 1998, PHYS PROPERTIES CARB; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	22	851	867	2	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1252	1255		10.1126/science.1138020	http://dx.doi.org/10.1126/science.1138020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332407	Green Submitted			2022-12-28	WOS:000244564700043
J	Bailey, RC; Moses, S; Parker, CB; Agot, K; Maclean, I; Krieger, JN; Williams, CFM; Campbell, RT; Ninya-Achola, JO				Bailey, Robert C.; Moses, Stephen; Parker, Corette B.; Agot, Kawango; Maclean, Ian; Krieger, John N.; Williams, Carolyn F. M.; Campbell, Richard T.; Ninya-Achola, Jeckoniah O.			Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial	LANCET			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; SUB-SAHARAN AFRICA; UNCIRCUMCISED MEN; TARGET-CELLS; RISK; UGANDA; SEROCONVERSION; COMPLICATIONS; METAANALYSIS; ASSOCIATION	Background Male circumcision could provide substantial protection against acquisition of HIV-1 infection. Our aim was to determine whether male circumcision had a protective effect against HIV infection, and to assess safety and changes in sexual behaviour related to this intervention. Methods We did a randomised controlled trial of 2784 men aged 18-24 years in Kisumu, Kenya. Men were randomly assigned to an intervention group (circumcision; n=1391) or a control group (delayed circumcision, 1393), and assessed by HIV testing, medical examinations, and behavioural interviews during follow-ups at 1, 3, 6, 12, 18, and 24 months. HIV seroincidence was estimated in an intention-to-treat analysis. This trial is registered with ClinicalTrials.gov, with the number NCT00059371. Findings The trial was stopped early on December 12, 2006, after a third interim analysis reviewed by the data and safety monitoring board. The median length of follow-up was 24 months. Follow-up for HIV status was incomplete for 240 (8.6%) participants. 22 men in the intervention group and 47 in the control group had tested positive for HIV when the study was stopped. The 2-year HIV incidence was 2.1% (95% CI 1.2-3.0) in the circumcision group and 4.2% (3.0-5.4) in the control group (p=0.0065); the relative risk of HIV infection in circumcised men was 0.47 (0.28-0.78), which corresponds to a reduction in the risk of acquiring an HIV infection of 53% (22-72). Adjusting for non-adherence to treatment and excluding four men found to be seropositive at enrolment, the protective effect of circumcision was 60% (32-77). Adverse events related to the intervention (21 events in 1.5% of those circumcised) resolved quickly. No behavioural. risk compensation after circumcision was observed. Interpretation Male circumcision significantly reduces the risk of HIV acquisition in young men in Africa. Where appropriate, voluntary, safe, and affordable circumcision services should be integrated with other HIV preventive interventions and provided as expeditiously as possible.	Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60612 USA; UNIM Project, Dept Med Microbiol, Kisumu, Kenya; Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; RTI Int, Res Triangle Pk, NC USA; Univ Washington, Sch Med, Dept Urol, Seattle, WA 98195 USA; NIAID, Div AIDS, NIH, Bethesda, MD 20892 USA; Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Manitoba; Research Triangle Institute; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Nairobi	Bailey, RC (corresponding author), Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, 1603 W Taylor St, Chicago, IL 60612 USA.	rcbailey@uic.edu	Campbell, Richard/W-6933-2019	Parker, Corette/0000-0002-6822-6845	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI050440] Funding Source: NIH RePORTER; NIAID NIH HHS [AI50440] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agot KE, 2007, JAIDS-J ACQ IMM DEF, V44, P66, DOI 10.1097/01.qai.0000242455.05274.20; ALCENA V, 1986, NEW YORK STATE J MED, V86, P446; [Anonymous], 1999, Pediatrics, V103, P686; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; AUVERT B, 2005, 3 IAS C HIV PATH TRE; Bailey R C, 2001, Lancet Infect Dis, V1, P223, DOI 10.1016/S1473-3099(01)00117-7; Bailey RC, 1999, J ACQ IMMUN DEF SYND, V22, P294; Bailey RC, 2006, ASSESSMENT CLIN TRAD; BONGAARTS J, 1989, AIDS, V3, P373, DOI 10.1097/00002030-198906000-00006; Buchbinder SP, 2005, JAIDS-J ACQ IMM DEF, V39, P82, DOI 10.1097/01.qai.0000134740.41585.f4; BUVE A, 2000, 13 INT C AIDS DURB S; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Cathcart P, 2006, BRIT J SURG, V93, P885, DOI 10.1002/bjs.5369; COX DR, 1975, BIOMETRIKA, V62, P269, DOI 10.2307/2335362; COX DR, 1972, J R STAT SOC B, V34, P187; Donoval BA, 2006, AM J CLIN PATHOL, V125, P386, DOI 10.1309/JVHQVDJDYKM58EPH; Drain PK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-172; FINK AJ, 1986, NEW ENGL J MED, V315, P1167; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Greenwood Major, 1926, REP PUBLIC HLTH MED, V33, P23; Halperin DT, 1999, LANCET, V354, P1813, DOI 10.1016/S0140-6736(99)03421-2; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KAPLAN GW, 1983, UROL CLIN N AM, V10, P543; Krieger JN, 2005, BJU INT, V96, P1109, DOI 10.1111/j.1464-410X.2005.05810.x; KRIEGER JN, IN PRESS UROL INT; LAN KKG, 1983, BIOMETRIKA, V74, P149; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MacDonald KS, 2001, AIDS, V15, P635, DOI 10.1097/00002030-200103300-00014; Magoha GAO, 1999, E AFR MED J, V76, P583; Manji KP, 2000, ANN TROP PAEDIATR, V20, P101, DOI 10.1080/02724936.2000.11748116; Mattson C L, 2004, East Afr Med J, V81, P230; McCoombe SG, 2006, AIDS, V20, P1491, DOI 10.1097/01.aids.0000237364.11123.98; *MIN FIN PLANN CEN, 2002, KEN 1999 POP HOUS CE, V7; *MOH CENTR BUR STA, 2003, KEN DEM HLTH SURV; MOSES S, 1990, INT J EPIDEMIOL, V19, P693, DOI 10.1093/ije/19.3.693; O'Farrell N, 2006, JAIDS-J ACQ IMM DEF, V43, P69, DOI 10.1097/01.qai.0000225014.61192.98; Patterson BK, 2002, AM J PATHOL, V161, P867, DOI 10.1016/S0002-9440(10)64247-2; Quinn TC, 2000, NEW ENGL J MED, V343, P364; Reynolds SJ, 2004, LANCET, V363, P1039, DOI 10.1016/S0140-6736(04)15840-6; SATEREN WB, 2006, 16 INT AIDS C TOR CA; SEED J, 1995, J ACQ IMMUN DEF SYND, V8, P83; Siegfried N, 2005, LANCET INFECT DIS, V5, P165, DOI 10.1016/S1473-3099(05)01309-5; United Nations Program on HIV/AIDS (UNAIDS), 2006, REP GLOB HIV AIDS EP; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; 2006, LANCET, V368, P424	49	1599	1666	0	120	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2007	369	9562					643	656		10.1016/S0140-6736(07)60312-2	http://dx.doi.org/10.1016/S0140-6736(07)60312-2			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141RO	17321310				2022-12-28	WOS:000244596600026
J	Chen, YMA; Kuo, SHS				Chen, Yi-Ming Arthur; Kuo, Steve Hsu-Sung			HIV-1 in Taiwan	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; INFECTIONS; CHINA; RECOMBINANT; STRAIN		Natl Yang Ming Univ, AIDS Prevent & Res Ctr, Taipei 112, Taiwan; Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; Ctr Dis Control, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Centers For Disease Control - Taiwan	Chen, YMA (corresponding author), Natl Yang Ming Univ, AIDS Prevent & Res Ctr, Taipei 112, Taiwan.	Arthur@ym.edu.tw						Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; *CDC, 2006, HIV AIDS DAT; Chen QF, 2005, CHINESE PHYS LETT, V22, P2005, DOI 10.1088/0256-307X/22/8/051; CHEN YM, 2002, J ACQ IMMUN DEF SYND, V26, P274; Chen YMA, 2006, EMERG INFECT DIS, V12, P703, DOI 10.3201/eid1204.050762; Cohen J, 2004, SCIENCE, V304, P1932, DOI 10.1126/science.304.5679.1932; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Hsieh SM, 1996, J FORMOS MED ASSOC, V95, P923; Hsueh PR, 2000, J INFECT DIS, V181, P1706, DOI 10.1086/315432; Hung CC, 2000, J ACQ IMMUN DEF SYND, V24, P378, DOI 10.1097/00126334-200008010-00013; Ko NY, 2006, SEX TRANSM DIS, V33, P467, DOI 10.1097/01.olq.0000204512.15297.5f; LAI SF, 2004, 15 INT AIDS C BANGK; Law WP, 2003, AIDS, V17, P2191, DOI 10.1097/00002030-200310170-00007; Lim WL, 2004, AIDS RES HUM RETROV, V20, P259, DOI 10.1089/088922204322996473; LIN YT, IN PRESS J INFECT DI; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; *WHO JOINT UN PROG, 2005, 2005 UPD HIV AIDS EP	18	90	90	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2007	369	9562					623	625		10.1016/S0140-6736(07)60291-8	http://dx.doi.org/10.1016/S0140-6736(07)60291-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	141RO	17321295				2022-12-28	WOS:000244596600007
J	Newell, ML; Barnighausen, T				Newell, Marie-Louise; Baernighausen, Till			Male circumcision to cut HIV risk in the general population	LANCET			English	Editorial Material							TRIAL; PREVENTION; KISUMU; KENYA; MEN		Univ Kwazulu Natal, Africa Ctr Hlth & Populat Studies, ZA-3935 Somkhele, Kwazulu Natal, South Africa; UCL, Ctr Paediatr Epidemiol & Biostat, Inst Child Hlth, London, England; Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA	University of Kwazulu Natal; University of London; University College London; Harvard University; Harvard T.H. Chan School of Public Health	Newell, ML (corresponding author), Univ Kwazulu Natal, Africa Ctr Hlth & Populat Studies, ZA-3935 Somkhele, Kwazulu Natal, South Africa.	mnewell@africacentre.ac.za	Newell, Marie-Louise/AAE-8222-2019; Ahmad, Khabir/I-6882-2019; Bärnighausen, Till/Y-2388-2019	Newell, Marie-Louise/0000-0002-1074-7699; Ahmad, Khabir/0000-0002-1569-0628; 				Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Krieger JN, 2005, BJU INT, V96, P1109, DOI 10.1111/j.1464-410X.2005.05810.x; OGODO O, 2007, SCIDEVNET       0205; *STAT S AFR, 2006, MID YEAR POP EST S A; TIMBERG C, 2006, WASHINGTON POST 0716; TIMBERG C, 2006, WASHINGTON POST 1013; WELZ T, IN PRESS AIDS; WESTERCAMP N, 2006, AIDS BEHAV; *WHO, 2005, UNAIDS STAT S AFR TR; 2003, MAIL GUARDIAN   1208; 2007, ECONOMIST COM   0201	13	29	31	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 24	2007	369	9562					617	619		10.1016/S0140-6736(07)60288-8	http://dx.doi.org/10.1016/S0140-6736(07)60288-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	141RO	17321292				2022-12-28	WOS:000244596600004
J	Patton, C				Patton, Cindy			Bullets, balance, or both: medicalisation in HIV treatment	LANCET			English	Article; Proceedings Paper	Meeting on Medicalisation in the 21st Century	JUN, 2005	New York, NY						Simon Fraser Univ, Hlth Res & Methods Training Facil, Vancouver, BC V6B 5K3, Canada	Simon Fraser University	Patton, C (corresponding author), Simon Fraser Univ, Hlth Res & Methods Training Facil, Vancouver, BC V6B 5K3, Canada.	healthlab@gmail.com						Epstein Steven., 1996, IMPURE SCI; Patton Cindy, 1990, INVENTING AIDS; Patton Cindy, 1996, FATAL ADVICE	3	8	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2007	369	9562					706	707		10.1016/S0140-6736(07)60322-5	http://dx.doi.org/10.1016/S0140-6736(07)60322-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	141RO	17321320				2022-12-28	WOS:000244596600036
J	Urban, P; De Benedetti, E				Urban, Philip; De Benedetti, Edoardo			Thrombosis: the last frontier of coronary stenting?	LANCET			English	Editorial Material							PACLITAXEL-ELUTING STENTS; RESTENOSIS; DISEASE		La Tour Hosp, Cardiovasc Dept, CH-1217 Geneva, Switzerland		Urban, P (corresponding author), La Tour Hosp, Cardiovasc Dept, CH-1217 Geneva, Switzerland.	philip.urban@latour.ch						Chen MS, 2006, AM HEART J, V151, P1260, DOI 10.1016/j.ahj.2005.08.011; Cutlip DE, 2004, CIRCULATION, V110, P1226, DOI 10.1161/01.CIR.0000140721.27004.4B; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Kastrati A, 2005, JAMA-J AM MED ASSOC, V294, P819, DOI 10.1001/jama.294.7.819; Moreno R, 2005, J AM COLL CARDIOL, V45, P954, DOI 10.1016/j.jacc.2004.11.065; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Motwani JG, 1998, CIRCULATION, V97, P916, DOI 10.1161/01.CIR.97.9.916; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; SERRUYS PW, 1991, NEW ENGL J MED, V324, P13, DOI 10.1056/NEJM199101033240103; Spaulding C, 2006, NEW ENGL J MED, V355, P1093, DOI 10.1056/NEJMoa062006; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Urban P, 2006, CIRCULATION, V113, P1434, DOI 10.1161/CIRCULATIONAHA.104.532242; Weisz G, 2006, J AM COLL CARDIOL, V47, p8B; Wenaweser P, 2005, EUR HEART J, V26, P1180, DOI 10.1093/eurheartj/ehi135	14	12	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2007	369	9562					619	621		10.1016/S0140-6736(07)60289-X	http://dx.doi.org/10.1016/S0140-6736(07)60289-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	141RO	17321293				2022-12-28	WOS:000244596600005
J	Samokhvalov, IM; Samokhvalova, NI; Nishikawa, S				Samokhvalov, Igor M.; Samokhvalova, Natalia I.; Nishikawa, Shin-ichi			Cell tracing shows the contribution of the yolk sac to adult haematopoiesis	NATURE			English	Article							STEM-CELLS; DEFINITIVE HEMATOPOIESIS; INTERFERON-GAMMA; REPORTER STRAIN; MOUSE EMBRYO; EXPRESSION; MICE; RECONSTITUTION; RECOMBINATION; CIRCULATION	The first haematopoietic stem cells (HSCs) appear in the aorta-gonad-mesonephros ( AGM) region, major vitelline and umbilical vessels, and placenta; however, whether they arise locally or from immigrant yolk sac precursor cells remains unclear. This issue is best addressed by measuring cell-lineage relationships rather than cell potentials. To undertake long-term in vivo tracing of yolk sac cells, we designed a non-invasive pulse-labelling system based on Cre/loxP recombination. Here we show that in Runx1(+/-) (runt-related transcription factor 1) heterozygous mice, yolk sac cells expressing Runx1 at embryonic day 7.5 develop into fetal lymphoid progenitors and adult HSCs. During mid-gestation the labelled ( embryonic day 7.5) yolk sac cells colonize the umbilical cord, the AGM region and subsequently the embryonic liver. This raises the possibility that some HSCs associated with major embryonic vasculature are derived from yolk sac precursors. We observed virtually no contribution of the labelled cells towards the yolk sac vasculature, indicating early segregation of endothelial and haematopoietic lineages.	RIKEN Kobe, Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo 6500047, Japan	RIKEN	Samokhvalov, IM (corresponding author), RIKEN Kobe, Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo 6500047, Japan.	igors@cdb.riken.jp						BROTHERTON TW, 1979, P NATL ACAD SCI USA, V76, P2853, DOI 10.1073/pnas.76.6.2853; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Igarashi H, 2001, P NATL ACAD SCI USA, V98, P15131, DOI 10.1073/pnas.011513098; Kellendonk C, 1999, J MOL BIOL, V285, P175, DOI 10.1006/jmbi.1998.2307; Kisanga ER, 2003, J STEROID BIOCHEM, V84, P361, DOI 10.1016/S0960-0760(03)00051-7; LIEN EA, 1991, CANCER RES, V51, P4837; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MINOT CS, 1912, MANUAL HUMAN EMBRYOL, P498; MullerSieburg CE, 1996, J EXP MED, V183, P1141, DOI 10.1084/jem.183.3.1141; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Palis J, 1999, DEVELOPMENT, V126, P5073; Samokhvalov IM, 2006, GENESIS, V44, P115, DOI 10.1002/gene.20190; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STEINER R, 1973, J CELL PHYSIOL, V81, P323, DOI 10.1002/jcp.1040810305; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Weissman I, 1978, FETAL HEMATOPOIETIC; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Young HA, 1997, BLOOD, V89, P583, DOI 10.1182/blood.V89.2.583; Yu JM, 1999, EXP HEMATOL, V27, P895, DOI 10.1016/S0301-472X(99)00009-0; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	30	329	345	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2007	446	7139					1056	1061		10.1038/nature05725	http://dx.doi.org/10.1038/nature05725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17377529				2022-12-28	WOS:000245950400044
J	Balchin, I; Whittaker, JC; Patel, R; Lamont, RF; Steer, PJ				Balchin, Imelda; Whittaker, John C.; Patel, Roshni; Lamont, Ronald F.; Steer, Philip J.			Racial variation in the association between gestational age and perinatal mortality: prospective study	BRITISH MEDICAL JOURNAL			English	Article							FETAL-GROWTH RESTRICTION; PROLONGED PREGNANCY; DEPRIVATION INDEXES; POST-TERM; ULTRASOUND; MANAGEMENT; DELIVERY; LONDON	Objectives To determine if the risks of perinatal mortality and antepartum stillbirth associated with post term birth increase earlier during pregnancy in South Asian and black women than in white women, and to investigate differences in the factors associated with antepartum stillbirth between the racial groups. Design Prospective study using logistic regression analysis. Setting 15 maternity units in north west London from 1988 to 2000. Participants 197 061 nulliparous women self reported as white, South Asian, or black, who delivered a single baby weighing at least 500 g at 24-43 completed weeks' gestation. Main outcome measures Gestation specific perinatal mortality, antepartum stillbirth rates, and independent factors for antepartum stillbirth by racial groups. Results The crude gestation specific perinatal mortality patterns for the three racial groups differed (P < 0.001). The perinatal mortality rate among black women was tower than among white women before 32 weeks but was higher thereafter. Perinatal mortality was highest among South Asian women at all gestational ages and increased the fastest at term. After adjusting for the confounders of antepartum stillbirth (placental abruption, congenital abnormality, low birth weight, birth weight < 10th centile, meconium passage, fever, maternal body mass index >= 30, and maternal age >= 30), the excess mortality among black women after 32 weeks was not significant. After adjusting for confounding, South Asian women still had a significantly higher risk of antepartum stillbirth (1.8, 95% confidence interval 1.2 to 2.7). Conclusions The risk of perinatal mortality increased earlier in gestation among South Asian women than among white women. The most important factor associated with antepartum stillbirth among white women was placental abruption, but among South Asian and black women it was birth weight below 2000 g.	Univ London Imperial Coll Sci Technol & Med, Acad Dept Obstet & Gynaecol, Fac Med, Chelsea & Westminster Hosp, London SW10 9NH, England; Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Univ Bristol, St Michaels Hosp, Div Obstet & Gynecol, Bristol BS2 8EG, Avon, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, Northwick Pk Hosp, Dept Obstet & Gynaecol, Harrow HA1 3UJ, Middx, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of Bristol; Imperial College London	Balchin, I (corresponding author), 41 Hockley Ave, London, England.	balchin@doctors.org.uk	Whittaker, John C/B-8609-2012	Whittaker, John C/0000-0002-3529-2379; Patel, Roshni/0000-0002-1399-3131				Balchin I, 2004, BJOG-INT J OBSTET GY, V111, P160, DOI 10.1046/j.1471-0528.2003.00026.x; Bardsley M, 2000, J PUBLIC HEALTH MED, V22, P406, DOI 10.1093/pubmed/22.3.406; Berman S, 1996, AM J OBSTET GYNECOL, V175, P73, DOI 10.1016/S0002-9378(96)70253-3; BJERKEDAL T, 1975, MED REGISTRATION BIR; CALLENBACH JC, 1979, OBSTET GYNECOL, V53, P721; Carstairs V, 1995, J EPIDEMIOL COMMUN H, V49, pS3, DOI 10.1136/jech.49.Suppl_2.S3; CHAMBERLAIN G, 1978, BRIT BIRTHS 1970 OBS; Clausson B, 1999, OBSTET GYNECOL, V94, P758, DOI 10.1016/S0029-7844(99)00387-7; CLEARY R, 1994, BRIT J OBSTET GYNAEC, V101, P1042, DOI 10.1111/j.1471-0528.1994.tb13579.x; CROWLEY P, 1997, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000170; CROWLEY P, 1989, EFFECTIVE CARE PREGN; Divon MY, 1998, AM J OBSTET GYNECOL, V178, P726, DOI 10.1016/S0002-9378(98)70482-X; Dolan SA, 1995, J EPIDEMIOL COMMUN H, V49, pS30, DOI 10.1136/jech.49.Suppl_2.S30; Floros J, 2001, PEDIATR INT, V43, P567, DOI 10.1046/j.1442-200X.2001.01474.x; GEIRSSON RT, 1991, BRIT J OBSTET GYNAEC, V98, P108, DOI 10.1111/j.1471-0528.1991.tb10323.x; Hilder L, 1998, BRIT J OBSTET GYNAEC, V105, P169, DOI 10.1111/j.1471-0528.1998.tb10047.x; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Huang DY, 2000, OBSTET GYNECOL, V95, P215, DOI 10.1016/S0029-7844(99)00536-0; Laursen M, 2004, AM J OBSTET GYNECOL, V190, P489, DOI 10.1016/j.ajog.2003.08.036; MARESH M, 1986, BRIT J OBSTET GYNAEC, V93, P1239, DOI 10.1111/j.1471-0528.1986.tb07858.x; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; *N W LOND STRAT HL, 1999, REF HLTH LOND KEY IS; Olesen AW, 2003, AM J OBSTET GYNECOL, V189, P222, DOI 10.1067/mob.2003.446; Onah HE, 2003, INT J GYNECOL OBSTET, V80, P255, DOI 10.1016/S0020-7292(02)00381-8; Patel RR, 2004, INT J EPIDEMIOL, V33, P107, DOI 10.1093/ije/dyg238; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Rasmussen S, 2003, EARLY HUM DEV, V71, P39, DOI 10.1016/S0378-3782(02)00111-1; Savitz DA, 2002, AM J OBSTET GYNECOL, V187, P1660, DOI 10.1067/mob.2002.127601; Steer P, 2004, SEMIN PERINATOL, V28, P59, DOI 10.1053/j.semperi.2003.10.013; THLIVERIS JA, 1978, GYNECOL OBSTET INVES, V9, P40, DOI 10.1159/000300969; VORHERR H, 1975, AM J OBSTET GYNECOL, V123, P67, DOI 10.1016/0002-9378(75)90951-5; WHO: recommended definitions terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths, 1977, ACTA OBSTET GYNECOL, V56, P247, DOI DOI 10.3109/00016347709162009	32	60	60	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 21	2007	334	7598					833	835		10.1136/bmj.39132.482025.80	http://dx.doi.org/10.1136/bmj.39132.482025.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	162MD	17337455	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000246090800032
J	Pappu, R; Schwab, SR; Cornelissen, I; Pereira, JP; Regard, JB; Xu, Y; Camerer, E; Zheng, YW; Huang, Y; Cyster, JG; Coughlin, SR				Pappu, Rajita; Schwab, Susan R.; Cornelissen, Ivo; Pereira, Joao P.; Regard, Jean B.; Xu, Ying; Camerer, Eric; Zheng, Yao-Wu; Huang, Yong; Cyster, Jason G.; Coughlin, Shaun R.			Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate	SCIENCE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; T-CELLS; MIGRATION; METABOLISM; FTY720; SYSTEM; THYMUS; ORGANS; S1P(1); MICE	Lymphocytes require sphingosine-1-phosphate (S1P) receptor-1 to exit lymphoid organs, but the source(s) of extracellular S1P and whether S1P directly promotes egress are unknown. By using mice in which the two kinases that generate S1P were conditionally ablated, we find that plasma S1P is mainly hematopoietic in origin, with erythrocytes a major contributor, whereas lymph S1P is from a distinct radiation-resistant source. Lymphocyte egress from thymus and secondary lymphoid organs was markedly reduced in kinase-deficient mice. Restoration of S1P to plasma rescued egress to blood but not lymph, and the rescue required lymphocyte expression of S1P-receptor-1. Thus, separate sources provide S1P to plasma and lymph to help lymphocytes exit the low-S1P environment of lymphoid organs. Disruption of compartmentalized S1P signaling is a plausible mechanism by which S1P-receptor-1 agonists function as immunosuppressives.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA; Univ Calif San Francisco, Drug Studies Unit, Dept Biopharmaceut Sci, San Francisco, CA 94080 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Coughlin, SR (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.	Jason.Cyster@ucsf.edu; Shaun.Coughlin@ucsf.edu	Camerer, Eric/K-4161-2017	Camerer, Eric/0000-0002-6271-7125; Pereira, Joao/0000-0002-5694-4938; Schwab, Susan/0000-0002-0834-0822	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065590] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Allende ML, 2002, BBA-MOL CELL BIOL L, V1582, P222, DOI 10.1016/S1388-1981(02)00175-0; Aoki S, 2005, J BIOCHEM, V138, P47, DOI 10.1093/jb/mvi100; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Foss FW, 2007, BIOORGAN MED CHEM, V15, P663, DOI 10.1016/j.bmc.2006.10.060; Hla T, 2003, PHARMACOL RES, V47, P401, DOI 10.1016/S1043-6618(03)00046-X; Kato S, 1997, MICROSC RES TECHNIQ, V38, P287, DOI 10.1002/(SICI)1097-0029(19970801)38:3<287::AID-JEMT9>3.0.CO;2-J; KOTANI M, 1967, Okajimas Folia Anatomica Japonica, V43, P61; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Leuker CE, 2001, J EXP MED, V193, P755, DOI 10.1084/jem.193.6.755; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; SLOOP CH, 1987, J LIPID RES, V28, P225; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; USHIKI T, 1986, CELL TISSUE RES, V244, P285; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Yang LB, 1999, BRIT J HAEMATOL, V107, P282, DOI 10.1046/j.1365-2141.1999.01697.x; Yatomi Y, 1997, J BIOL CHEM, V272, P5291, DOI 10.1074/jbc.272.8.5291; Yatomi Y, 2001, PROSTAG OTH LIPID M, V64, P107, DOI 10.1016/S0090-6980(01)00103-4; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628	26	685	708	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					295	298		10.1126/science.1139221	http://dx.doi.org/10.1126/science.1139221			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17363629				2022-12-28	WOS:000245654500056
J	Vallat, J; Cros, DP; Harris, NL; Siao, P; Hedley-Whyte, ET; Costenbader, KH				Vallat, Jean-Michel; Cros, Didier P.; Harris, Nancy Lee; Siao, Peter; Hedley-Whyte, E. Tessa; Costenbader, Karen H.			A 27-year-old woman with pain and swelling of the legs - Axonal neuropathy due to lymphoplasmacytic small-vessel vasculitis, associated with connective-tissue disease with features of Sjogren's syndrome, associated with autoimmune thyroiditis and autoimmune gastritis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PERNICIOUS-ANEMIA; REVISED CRITERIA; CLASSIFICATION; MANIFESTATIONS		Univ Limoges, Dept Neurol & Neuropathol, Limoges, France; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Div Neuropathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Universite de Limoges; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Vallat, J (corresponding author), Univ Limoges, Dept Neurol & Neuropathol, Limoges, France.		Hedley-Whyte, E Tessa/AAJ-9975-2021	Hedley-Whyte, E Tessa/0000-0002-1687-8905				CREANGE A, 1993, NEUROLOGY, V43, P1483, DOI 10.1212/WNL.43.8.1483; Delalande S, 2004, MEDICINE, V83, P280, DOI 10.1097/01.md.0000141099.53742.16; Denislic M, 1997, J NEUROL, V244, P383, DOI 10.1007/s004150050106; Dyck PJ, 2005, BRAIN, V128, P2480, DOI 10.1093/brain/awh662; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jennette JC, 1997, NEW ENGL J MED, V337, P1512, DOI 10.1056/NEJM199711203372106; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Kathiresan S, 2005, NEW ENGL J MED, V352, P2003, DOI 10.1056/NEJMcpc059010; LIGHTFOOT RW, 1990, ARTHRITIS RHEUM, V33, P1088; Mori K, 2005, BRAIN, V128, P2518, DOI 10.1093/brain/awh605; PEDROBOTET J, 1993, J CLIN GASTROENTEROL, V16, P146, DOI 10.1097/00004836-199303000-00014; Rodriguez-Cuartero A, 1998, SCAND J RHEUMATOL, V27, P83; ROGER D, 1995, DERMATOLOGY, V191, P164, DOI 10.1159/000246539; Said G, 2005, J NEUROL, V252, P633, DOI 10.1007/s00415-005-0833-9; Snow CF, 1999, ARCH INTERN MED, V159, P1289, DOI 10.1001/archinte.159.12.1289; Stell R, 1998, J CLIN NEUROSCI, V5, P110, DOI 10.1016/S0967-5868(98)90219-3; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	18	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1252	1259		10.1056/NEJMcpc079003	http://dx.doi.org/10.1056/NEJMcpc079003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377164				2022-12-28	WOS:000245101900012
J	Henningsen, P; Zipfel, S; Herzog, W				Henningsen, Peter; Zipfel, Stephan; Herzog, Wolfgang			Management of functional somatic syndromes	LANCET			English	Review							IRRITABLE-BOWEL-SYNDROME; MEDICALLY UNEXPLAINED SYMPTOMS; CHRONIC-FATIGUE-SYNDROME; TENSION-TYPE HEADACHE; PREMENSTRUAL-SYNDROME; NONULCER DYSPEPSIA; PHYSICAL SYMPTOMS; BACK-PAIN; SOMATOFORM DISORDERS; SPINAL MANIPULATION	Although functional somatic syndromes (FSS) show substantial overlap, treatment research is mostly confined to single syndromes, with a lack of valid and generally accepted diagnostic criteria across medical specialties. Here, we review management for the full variety of F S S, drawn from systematic reviews and meta-analyses since 2001, and give recommendations for a stepped care approach that differentiates between uncomplicated and complicated FSS. Non-pharmacological treatments involving active participation of patients, such as exercise and psychotherapy, seem to be more effective than those that involve passive physical measures, including injections and operations. Pharmacological agents with CNS action seem to be more consistently effective than drugs aiming at restoration of peripheral physiological dysfunction. A balance between biomedical, organ-oriented, and cognitive interpersonal approaches is most appropriate at this truly psychosomatic interface. in view of the iatrogenic component in the maintenance of FSS, doctor-centred interventions and close observation of the doctor-patient relationship are of particular importance.	Univ Munich, Univ Hosp, Dept Psychosomat Med & Psychotherapy, D-81675 Munich, Germany; Univ Tubingen, Univ Hosp, Dept Psychosomat Med & Psychotherapy, D-72074 Tubingen, Germany; Heidelberg Univ, Univ Hosp, Dept Psychosomat Med & Psychotherapy, D-6900 Heidelberg, Germany	University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg	Henningsen, P (corresponding author), Univ Munich, Univ Hosp, Dept Psychosomat Med & Psychotherapy, Langerstr 3, D-81675 Munich, Germany.			Zipfel, Stephan/0000-0003-1659-4440				Aaron LA, 2001, ANN INTERN MED, V134, P868, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00011; Abraham NS, 2004, ALIMENT PHARM THER, V19, P631, DOI 10.1111/j.1365-2036.2004.01878.x; Aggarwal VR, 2006, INT J EPIDEMIOL, V35, P468, DOI 10.1093/ije/dyi265; Airaksinen O, 2004, EUROPEAN GUIDELINES; Akehurst R, 2001, GUT, V48, P272, DOI 10.1136/gut.48.2.272; Al-Ani MZ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002778.PUB2; Allen LA, 2002, PSYCHOSOM MED, V64, P939, DOI 10.1097/01.PSY.0000024231.11538.8F; Allescher HD, 2001, SCAND J GASTROENTERO, V36, P934, DOI 10.1080/003655201750305440; Assendelft W, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000447.PUB2; Astin JA, 2002, CEPHALALGIA, V22, P617, DOI 10.1046/j.1468-2982.2002.00423.x; Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; Barsky AJ, 2005, ARCH GEN PSYCHIAT, V62, P903, DOI 10.1001/archpsyc.62.8.903; BASS C, 1995, J PSYCHOSOM RES, V39, P403, DOI 10.1016/0022-3999(94)00157-Z; Bijkerk CJ, 2004, ALIMENT PHARM THER, V19, P245, DOI 10.1111/j.0269-2813.2004.01862.x; Blanchard EB, 2005, J COGN PSYCHOTHER, V19, P101; Brandt LJ, 2002, AM J GASTROENTEROL, V97, pS7; Bronfort G, 2001, J MANIP PHYSIOL THER, V24, P457, DOI 10.1067/mmt.2001.117090; Bronfort G, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001878.PUB2; Brosseau L, 2002, SPINE, V27, P596, DOI 10.1097/00007632-200203150-00007; Brown RJ, 2004, PSYCHOL BULL, V130, P793, DOI 10.1037/0033-2909.130.5.793; Buffington CAT, 2004, J UROLOGY, V172, P1242, DOI 10.1097/01.ju.0000137953.49304.6c; BUSCH A, 2002, COCHRANE DB SYST REV, V2; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Chitkara DK, 2003, GASTROENTEROLOGY, V125, P1554, DOI 10.1016/j.gastro.2003.04.010; Cho HJ, 2006, CURR OPIN PSYCHIATR, V19, P67, DOI 10.1097/01.yco.0000194370.40062.b0; Cho HJ, 2005, PSYCHOSOM MED, V67, P301, DOI 10.1097/01.psy.0000156969.76986.e0; Cleare AJ, 2004, TRENDS ENDOCRIN MET, V15, P55, DOI 10.1016/j.tem.2003.12.002; Cremonini F, 2005, AM J GASTROENTEROL, V100, P1226, DOI 10.1111/j.1572-0241.2005.41657.x; Cremonini F, 2003, NEUROGASTROENT MOTIL, V15, P79, DOI 10.1046/j.1365-2982.2003.00389.x; Dickinson W Perry, 2003, Ann Fam Med, V1, P228, DOI 10.1370/afm.5; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Edmonds M, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003200.PUB2; Enck P, 2005, NEUROGASTROENT MOTIL, V17, P325, DOI 10.1111/j.1365-2982.2005.00676.x; Escobar JI, 2002, ENVIRON HEALTH PERSP, V110, P631, DOI 10.1289/ehp.02110s4631; Evans BW, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003960.PUB2; Fall M, 2004, EUR UROL, V46, P681, DOI 10.1016/j.eururo.2004.07.030; Ferrari R, 2005, ANN RHEUM DIS, V64, P1337, DOI 10.1136/ard.2004.034447; Ferrari R, 2001, MED HYPOTHESES, V56, P77, DOI 10.1054/mehy.2000.1115; Fiddler M, 2004, GEN HOSP PSYCHIAT, V26, P367, DOI 10.1016/j.genhosppsych.2004.04.001; Fink P, 2002, PSYCHOSOMATICS, V43, P93, DOI 10.1176/appi.psy.43.2.93; Furlan AD, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001351.pub2; Geurts JW, 2001, REGION ANESTH PAIN M, V26, P394, DOI 10.1053/rapm.2001.23673; Gobel H, 2001, J NEUROL, V248, pS34; Goldenberg DL, 2004, JAMA-J AM MED ASSOC, V292, P2388, DOI 10.1001/jama.292.19.2388; Guzman J, 2002, COCHRANE DB SYST REV, V1, P1, DOI [10.1002/14651858.CD000963, DOI 10.1002/14651858.CD000963]; Henningsen P, 2006, CURR OPIN PSYCHIATR, V19, P19, DOI 10.1097/01.yco.0000189880.11059.8d; Henningsen P, 2003, ACTA NEUROPSYCHIATR, V15, P157, DOI 10.1034/j.1601-5215.2003.00032.x; Henningsen P, 2003, PSYCHOSOM MED, V65, P528, DOI 10.1097/01.PSY.0000075977.90337.E7; Heymans MW, 2004, COCHRANE DB SYST REV, V4; Holdcraft LC, 2003, BEST PRACT RES CL RH, V17, P667, DOI 10.1016/S1521-6942(03)00037-8; Hotopf M, 2004, PSYCHOL MED, V34, P195, DOI 10.1017/S003329170300151X; Interian A, 2004, PSYCHOSOM MED, V66, P141, DOI 10.1097/01.PSY.0000107883.14385.EC; Jones BW, 2002, J CLIN PHARM THER, V27, P343, DOI 10.1046/j.1365-2710.2002.00426.x; Jones TF, 2000, NEW ENGL J MED, V342, P96, DOI 10.1056/NEJM200001133420206; Kamper SJ, 2014, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000335.PUB2; Khadilkar A, 2005, COCHRANE DB SYST REV, V3; Kilkens TOC, 2003, ALIMENT PHARM THER, V17, P43, DOI 10.1046/j.1365-2036.2003.01388.x; Kirmayer LJ, 2004, CAN J PSYCHIAT, V49, P663, DOI 10.1177/070674370404901003; KISELY S, 2005, COCHRANE DB SYST REV, V1; Kreutzer R, 2002, INT J HYG ENVIR HEAL, V205, P411, DOI 10.1078/1438-4639-00167; Kroenke K, 1994, Arch Fam Med, V3, P774; Lackner JA, 2004, J CONSULT CLIN PSYCH, V72, P1100, DOI 10.1037/0022-006X.72.6.1100; Lacour M, 2004, INT J HYG ENVIR HEAL, V207, P1, DOI 10.1078/1438-4639-00254; Laheij RJF, 2003, J CLIN GASTROENTEROL, V36, P315, DOI 10.1097/00004836-200304000-00007; Lenssinck MLB, 2004, PAIN, V112, P381, DOI 10.1016/j.pain.2004.09.026; Lesbros-Pantoflickova D, 2004, ALIMENT PHARM THER, V20, P1253, DOI 10.1111/j.1365-2036.2004.02267.x; List T, 2003, J OROFAC PAIN, V17, P301; Liu JP, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD004116.PUB2; Locke GR, 2004, AM J GASTROENTEROL, V99, P350, DOI 10.1111/j.1572-0241.2004.04043.x; Looper KJ, 2002, J CONSULT CLIN PSYCH, V70, P810, DOI 10.1037//0022-006X.70.3.810; Manheimer E, 2005, ANN INTERN MED, V142, P651, DOI 10.7326/0003-4819-142-8-200504190-00014; Manu Peter, 1999, FUNCTIONAL SOMATIC S; Mayou R, 2005, AM J PSYCHIAT, V162, P847, DOI 10.1176/appi.ajp.162.5.847; Mayou R, 2002, BRIT MED J, V325, P265, DOI 10.1136/bmj.325.7358.265; Mease Philip J, 2005, J Rheumatol, V32, P2270; MELCHART D, 2001, COCHRANE DB SYST REV, V1; MOAYYEDI P, 2005, COCHRANE DB SYST REV, V1; MOAYYEDI P, 2005, COCHRANE DB SYST REV, V1; Moja PL, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002919.pub2; OSTELO RW, 2005, COCHRANE DB SYST REV, V1; Page LA, 2003, J ROY SOC MED, V96, P223, DOI 10.1258/jrsm.96.5.223; Patel V, 2005, INT J EPIDEMIOL, V34, P853, DOI 10.1093/ije/dyi072; Perme B, 2005, GEN HOSP PSYCHIAT, V27, P215, DOI 10.1016/j.genhosppsych.2005.01.003; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Poynard T, 2001, ALIMENT PHARM THER, V15, P355, DOI 10.1046/j.1365-2036.2001.00937.x; Prousky J, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-3; QUARTERO AO, 2005, COCHRANE DB SYST REV, V4; Raine R, 2002, BMJ-BRIT MED J, V325, P1082, DOI 10.1136/bmj.325.7372.1082; Rains JC, 2005, HEADACHE, V45, pS92, DOI 10.1111/j.1526-4610.2005.4502003.x; Raspe H, 2004, SPINE, V29, P1017, DOI 10.1097/00007632-200405010-00013; Redstone HA, 2001, ALIMENT PHARM THER, V15, P1291, DOI 10.1046/j.1365-2036.2001.01044.x; Reid Steven, 2004, Clin Evid, P1578; Reuber M, 2005, J NEUROL NEUROSUR PS, V76, P307, DOI 10.1136/jnnp.2004.048280; Rief W, 2006, AM J PSYCHIAT, V163, P746, DOI 10.1176/appi.ajp.163.4.746-a; Rief W, 2005, PSYCHONEUROENDOCRINO, V30, P996, DOI 10.1016/j.psyneuen.2005.03.018; Ring A, 2005, SOC SCI MED, V61, P1505, DOI 10.1016/j.socscimed.2005.03.014; Rosendal M, 2005, FAM PRACT, V22, P419, DOI 10.1093/fampra/cmi033; Rosendal M, 2005, BRIT MED J, V330, P4, DOI 10.1136/bmj.330.7481.4; Rozen D, 2006, MT SINAI J MED, V73, P493; Rubin GJ, 2006, PSYCHOTHER PSYCHOSOM, V75, P12, DOI 10.1159/000089222; Ruddy RHA, 2005, COCHRANE DB SYST REV, V4; Saito YA, 2005, CLIN GASTROENTEROL H, V3, P1057, DOI 10.1016/S1542-3565(05)00184-9; Salerno SM, 2002, ARCH INTERN MED, V162, P19, DOI 10.1001/archinte.162.1.19; Salmon P, 2004, BRIT J GEN PRACT, V54, P171; Sim J, 2002, CLIN J PAIN, V18, P324, DOI 10.1097/00002508-200209000-00008; Smith RC, 2004, PSYCHOTHER PSYCHOSOM, V73, P36, DOI 10.1159/000074438; SOO S, 2005, COCHRANE DB SYST REV, V1; Spanier JA, 2003, ARCH INTERN MED, V163, P265, DOI 10.1001/archinte.163.3.265; Spiller R, 2006, CURR OPIN GASTROEN, V22, P13, DOI 10.1097/01.mog.0000194792.36466.5c; Staiger TO, 2003, SPINE, V28, P2540, DOI 10.1097/01.BRS.0000092372.73527.BA; Stevinson C, 2001, AM J OBSTET GYNECOL, V185, P227, DOI 10.1067/mob.2001.113643; STONES W, 2005, COCHRANE DB SYST REV, V3; Strassnig M, 2006, CURR OPIN PSYCHIATR, V19, P194, DOI 10.1097/01.yco.0000214348.38787.d3; Sullivan PF, 2005, PSYCHOL MED, V35, P1327, DOI 10.1017/S0033291705005222; Sullivan PF, 2005, PSYCHOL MED, V35, P1337, DOI 10.1017/S0033291705005210; Tofferi JK, 2004, ARTHRIT RHEUM-ARTHR, V51, P9, DOI 10.1002/art.20076; Tomkins GE, 2001, AM J MED, V111, P54, DOI 10.1016/S0002-9343(01)00762-8; Tu FF, 2005, OBSTET GYNECOL SURV, V60, P474, DOI 10.1097/01.ogx.0000162246.06900.9f; Turp J C, 2004, Clin Oral Investig, V8, P179, DOI 10.1007/s00784-004-0265-4; Waller E, 2004, J NERV MENT DIS, V192, P200, DOI 10.1097/01.nmd.0000116463.17588.07; Wei W, 2013, COCHRANE DB SYST REV, V30, P218; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Wessely S, 2004, BRIT J PSYCHIAT, V185, P95, DOI 10.1192/bjp.185.2.95; White PD, 2001, LANCET, V358, P1946, DOI 10.1016/S0140-6736(01)06961-6; Whitehead WE, 2002, GASTROENTEROLOGY, V122, P1140, DOI 10.1053/gast.2002.32392; Whiting P, 2001, JAMA-J AM MED ASSOC, V286, P1360, DOI 10.1001/jama.286.11.1360; Wilkinson S, 2003, COPING COMPLAINING A; Wood PB, 2005, INT REV NEUROBIOL, V67, P119, DOI 10.1016/S0074-7742(05)67005-5; Wyatt K, 2001, BMJ-BRIT MED J, V323, P776, DOI 10.1136/bmj.323.7316.776; Wyatt KM, 2004, BJOG-INT J OBSTET GY, V111, P585, DOI 10.1111/j.1471-0528.2004.00135.x; WYATT KM, 2002, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858; YELLAND MJ, 2004, COCHRANE DB SYST REV, V2	132	475	496	1	62	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2007	369	9565					946	955		10.1016/S0140-6736(07)60159-7	http://dx.doi.org/10.1016/S0140-6736(07)60159-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148BQ	17368156				2022-12-28	WOS:000245049900035
J	Chen, NJ; Mirtsos, C; Suh, D; Lu, YC; Lin, WJ; McKerlie, C; Lee, T; Baribault, H; Tian, H; Yeh, WC				Chen, Nien-Jung; Mirtsos, Christine; Suh, Daniel; Lu, Yong-Chen; Lin, Wen-Jye; McKerlie, Colin; Lee, Taeweon; Baribault, Helene; Tian, Hui; Yeh, Wen-Chen			C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a	NATURE			English	Article							CHEMOATTRACTANT RECEPTOR; COMPLEMENT; COMPONENT; NEUTROPHILS; ACTIVATION; PROTEIN; CLONING; REVEAL	Complement-derived anaphylatoxins regulate immune and inflammatory responses through G-protein-coupled receptor ( GPCR)mediated signalling(1-4). C5L2 ( also known as GPR77) is a relatively new GPCR thought to be a non-signalling receptor binding to C5a, on the basis of sequence information and experimental evidence(5-7). Here we show, using gene targeting, that C5L2 is required to facilitate C5a signalling in neutrophils, macrophages and fibroblasts in vitro. Deficiency of C5L2 results in reduced inflammatory cell infiltration, suggesting that C5L2 is critical for optimal C5a-mediated cell infiltration in certain in vivo settings. C5L2 is also involved in optimizing C3a-induced signals. Furthermore, like mice incapable of C3a/complement 3a receptor (C3aR) signalling(4,8,9), C5L2-deficient mice are hypersensitive to lipopolysaccharide (LPS)-induced septic shock, show reduced ovalbumin (OVA)-induced airway hyperresponsiveness and inflammation, and are mildly delayed in haematopoietic cell regeneration after gamma-irradiation. Our data indicate that C5L2 can function as a positive modulator for both C5a- and C3a-anaphylatoxin-induced responses.	Univ Toronto, Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Amgen San Francisco, San Francisco, CA 94080 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Amgen	Yeh, WC (corresponding author), Univ Toronto, Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada.	weny@amgen.com	Lu, Yong-Chen/G-4520-2014; Mohammed, Imran/J-8271-2012; Lin, Wen-Jye/D-1028-2016	Lu, Yong-Chen/0000-0002-0275-9825; Mohammed, Imran/0000-0002-8412-0768; McKerlie, Colin/0000-0002-2232-0967				BOKISCH VA, 1969, J EXP MED, V129, P1109, DOI 10.1084/jem.129.5.1109; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; Duncan GS, 1999, J IMMUNOL, V162, P3022; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; Gavrilyuk V, 2005, J NEUROCHEM, V92, P1140, DOI 10.1111/j.1471-4159.2004.02942.x; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Guo RF, 2004, SHOCK, V21, P1, DOI 10.1097/01.shk.0000105502.75189.5e; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Hsu MH, 1997, IMMUNOGENETICS, V47, P64, DOI 10.1007/s002510050327; Humbles AA, 2000, NATURE, V406, P998, DOI 10.1038/35023175; Kalant D, 2005, J BIOL CHEM, V280, P23936, DOI 10.1074/jbc.M406921200; Kalant D, 2003, J BIOL CHEM, V278, P11123, DOI 10.1074/jbc.M206169200; Kildsgaard J, 2000, J IMMUNOL, V165, P5406, DOI 10.4049/jimmunol.165.10.5406; Ohno M, 2000, MOL IMMUNOL, V37, P407, DOI 10.1016/S0161-5890(00)00067-5; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Perianayagam MC, 2002, KIDNEY INT, V61, P456, DOI 10.1046/j.1523-1755.2002.00139.x; PERRET JJ, 1992, BIOCHEM J, V288, P911, DOI 10.1042/bj2880911; Ratajczak MZ, 2004, LEUKEMIA, V18, P1482, DOI 10.1038/sj.leu.2403446; Riedemann NC, 2003, FASEB J, V17, P370, DOI 10.1096/fj.03-0708fje; Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; SHIN HS, 1968, SCIENCE, V162, P361, DOI 10.1126/science.162.3851.361; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354	24	184	196	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					203	207		10.1038/nature05559	http://dx.doi.org/10.1038/nature05559			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17322907				2022-12-28	WOS:000244718100044
J	Dalley, JW; Fryer, TD; Brichard, L; Robinson, ESJ; Theobald, DEH; Laane, K; Pena, Y; Murphy, ER; Shah, Y; Probst, K; Abakumova, I; Aigbirhio, FI; Richards, HK; Hong, Y; Baron, JC; Everitt, BJ; Robbins, TW				Dalley, Jeffrey W.; Fryer, Tim D.; Brichard, Laurent; Robinson, Emma S. J.; Theobald, David E. H.; Laeaene, Kristjan; Pena, Yolanda; Murphy, Emily R.; Shah, Yasmene; Probst, Katrin; Abakumova, Irina; Aigbirhio, Franklin I.; Richards, Hugh K.; Hong, Young; Baron, Jean-Claude; Everitt, Barry J.; Robbins, Trevor W.			Nucleus Accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement	SCIENCE			English	Article							SUBSTANCE USE; DRUG-ADDICTION; DOPAMINE; RATS; AVAILABILITY; PERSONALITY; STRIATUM; REINSTATEMENT; VULNERABILITY; ASSOCIATION	Stimulant addiction is often linked to excessive risk taking, sensation seeking, and impulsivity, but in ways that are poorly understood. We report here that a form of impulsivity in rats predicts high rates of intravenous cocaine self-administration and is associated with changes in dopamine (DA) function before drug exposure. Using positron emission tomography, we demonstrated that D2/3 receptor availability is significantly reduced in the nucleus accumbens of impulsive rats that were never exposed to cocaine and that such effects are independent of DA release. These data demonstrate that trait impulsivity predicts cocaine reinforcement and that D2 receptor dysfunction in abstinent cocaine addicts may, in part, be determined by premorbid influences.	Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England; Univ Nottingham, Sch Phys & Astron, Sir Peter Mansfield Magnet Resonance Ctr, Nottingham NG7 2RD, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Neurosurg Unit, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Neurol Unit, Cambridge CB2 2QQ, England	University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Nottingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Dalley, JW (corresponding author), Univ Cambridge, Behav & Clin Neurosci Inst, Downing St, Cambridge CB2 3EB, England.	jwd20@cam.ac.uk	Robinson, Emma/A-4572-2010; Robbins, Trevor W/A-7551-2008	Robinson, Emma/0000-0002-1299-6541; Dalley, Jeffrey/0000-0002-2282-3660; Murphy, Emily/0000-0002-8162-5306; Robbins, Trevor/0000-0003-0642-5977; Everitt, Barry/0000-0003-4431-6536; baron, jean-claude/0000-0002-5264-2588	Medical Research Council [G0001354B] Funding Source: researchfish; MRC [G0600196, G0001237, G0600986, G0401068, G9439390] Funding Source: UKRI; Medical Research Council [G9439390, G0600196, G0001237, G0001354, G0600986, G0401068] Funding Source: Medline; Wellcome Trust [076244] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Adams JB, 2003, AM J DRUG ALCOHOL AB, V29, P691, DOI 10.1081/ADA-120023465; BOLIA KI, 1999, J NEUROPSYCHIATRY CL, V11, P361; Caine SB, 2002, J NEUROSCI, V22, P2977, DOI 10.1523/JNEUROSCI.22-07-02977.2002; CAINE SB, 1994, J EXP ANAL BEHAV, V61, P213, DOI 10.1901/jeab.1994.61-213; Chakroun N, 2004, ENCEPHALE, V30, P564; Comings DE, 2000, PROG BRAIN RES, V126, P325; Dalley JW, 2005, PSYCHOPHARMACOLOGY, V182, P579, DOI 10.1007/s00213-005-0107-3; Dalley JW, 2005, NEUROPSYCHOPHARMACOL, V30, P525, DOI 10.1038/sj.npp.1300590; Dawe S, 2004, NEUROSCI BIOBEHAV R, V28, P343, DOI 10.1016/j.neubiorev.2004.03.007; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Gosnell BA, 2000, PSYCHOPHARMACOLOGY, V149, P286, DOI 10.1007/s002130000375; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; HOOKS MS, 1994, J NEUROSCI, V14, P6144; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Larson EB, 2005, PHARMACOL BIOCHEM BE, V82, P590, DOI 10.1016/j.pbb.2005.10.015; Laruelle M, 1997, NEUROPSYCHOPHARMACOL, V17, P162, DOI 10.1016/S0893-133X(97)00043-2; Lyvers M, 2000, EXP CLIN PSYCHOPHARM, V8, P225, DOI 10.1037/1064-1297.8.2.225; Mach RH, 1997, PHARMACOL BIOCHEM BE, V57, P477, DOI 10.1016/S0091-3057(96)00449-2; Mantsch JR, 2001, PSYCHOPHARMACOLOGY, V157, P31, DOI 10.1007/s002130100744; Martinez D, 2004, NEUROPSYCHOPHARMACOL, V29, P1190, DOI 10.1038/sj.npp.1300420; Morgan AD, 2005, PSYCHOPHARMACOLOGY, V178, P41, DOI 10.1007/s00213-004-1979-3; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; Mukherjee J, 1999, NUCL MED BIOL, V26, P519, DOI 10.1016/S0969-8051(99)00012-8; Nader MA, 2002, NEUROPSYCHOPHARMACOL, V27, P35, DOI 10.1016/S0893-133X(01)00427-4; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Najafabadi MS, 2005, AM J MED GENET B, V134B, P39, DOI 10.1002/ajmg.b.30117; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Paine TA, 2003, BEHAV BRAIN RES, V147, P135, DOI 10.1016/S0166-4328(03)00156-6; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perry JL, 2005, PSYCHOPHARMACOLOGY, V178, P193, DOI 10.1007/s00213-004-1994-4; Persico AM, 1996, BIOL PSYCHIAT, V40, P776, DOI 10.1016/0006-3223(95)00483-1; PETTIT HO, 1984, PSYCHOPHARMACOLOGY, V84, P167, DOI 10.1007/BF00427441; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; PIAZZA PV, 1991, BRAIN RES, V567, P169, DOI 10.1016/0006-8993(91)91452-7; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; ROBERTS DCS, 1977, PHARMACOL BIOCHEM BE, V6, P615, DOI 10.1016/0091-3057(77)90084-3; Sher KJ, 2000, J CONSULT CLIN PSYCH, V68, P818, DOI 10.1037/0022-006X.68.5.818; Toissaar M, 2006, NEUROSCI LETT, V403, P119, DOI 10.1016/j.neulet.2006.04.023; Uhl GR, 2004, ANN NY ACAD SCI, V1025, P1, DOI 10.1196/annals.1316.001; van der Kam EL, 2005, NEUROPHARMACOLOGY, V48, P685, DOI 10.1016/j.neuropharm.2004.12.014; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; VOLKOW ND, 1993, SYNAPSE, V14, P169, DOI 10.1002/syn.890140210; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	45	881	900	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1267	1270		10.1126/science.1137073	http://dx.doi.org/10.1126/science.1137073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332411	Green Accepted			2022-12-28	WOS:000244564700047
J	Wadman, M				Wadman, Meredith			A merger too far?	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2007	446	7131					15	15		10.1038/446015a	http://dx.doi.org/10.1038/446015a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330017				2022-12-28	WOS:000244525600012
J	Berkowitz, SA; Gerstenblith, G; Anderson, GF				Berkowitz, Scott A.; Gerstenblith, Gary; Anderson, Gerard F.			Medicare prescription drug coverage gap - Navigating the "doughnut hole" with patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Anderson, GF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Hampton House 302, Baltimore, MD 21205 USA.	ganderso@jhsph.edu						Berlowitz DR, 1998, NEW ENGL J MED, V339, P1957, DOI 10.1056/NEJM199812313392701; Centers for Medicare and Medicaid Services, MED YOU; CUBANSKI J, 2006, HLTH AFF MILLWO 1121, pW1; *DEST RX, PART D OPT; *KAIS FAM FDN, 2006, PRESCR DRUG COV MED; *KAIS FAM FDN, 2006, KAIS DAIL HLTH POL R; Mitka M, 2006, JAMA-J AM MED ASSOC, V296, P1720; *PRICEWATERHOUSECO, 2006, SIGN COV GAP MED PAR; SIMON S, 2006, NATL PUBLIC RAD 1007; Tseng CW, 2004, JAMA-J AM MED ASSOC, V292, P952, DOI 10.1001/jama.292.8.952; *US DEP HHS, 2006, MEDICARE        1013; *US FDA, 2005, INF IMP DRUGS; *US FDA, OR BOOK	13	9	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2007	297	8					868	870		10.1001/jama.297.8.868	http://dx.doi.org/10.1001/jama.297.8.868			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140DS	17327528				2022-12-28	WOS:000244485000029
J	Altman, DG; Bland, JM				Altman, Douglas G.; Bland, J. Martin			Missing data	BRITISH MEDICAL JOURNAL			English	Editorial Material									Canc Res UK NHS Ctr Stat Med, Oxford OX2 6UD, England; Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	Cancer Research UK; University of York - UK	Altman, DG (corresponding author), Canc Res UK NHS Ctr Stat Med, Oxford OX2 6UD, England.	doug.altman@cancecorg.uk						Burton A, 2004, BRIT J CANCER, V91, P4, DOI 10.1038/sj.bjc.6601907; EVANS SJW, 1991, BRIT MED J, V302, P302, DOI 10.1136/bmj.302.6772.302	2	118	121	1	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 24	2007	334	7590					424	424		10.1136/bmj.38977.682025.2C	http://dx.doi.org/10.1136/bmj.38977.682025.2C			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	142MQ	17322261	Green Published, Bronze			2022-12-28	WOS:000244654400038
J	Chang, JT; Palanivel, VR; Kinjyo, I; Schambach, F; Intlekofer, AM; Banerjee, A; Longworth, SA; Vinup, KE; Mrass, P; Oliaro, J; Killeen, N; Orange, JS; Russell, SM; Weninger, W; Reiner, SL				Chang, John T.; Palanivel, Vikram R.; Kinjyo, Ichiko; Schambach, Felix; Intlekofer, Andrew M.; Banerjee, Arnob; Longworth, Sarah A.; Vinup, Kristine E.; Mrass, Paul; Oliaro, Jane; Killeen, Nigel; Orange, Jordan S.; Russell, Sarah M.; Weninger, Wolfgang; Reiner, Steven L.			Asymmetric T lymphocyte division in the initiation of adaptive immune responses	SCIENCE			English	Article							DENDRITIC CELL-INTERACTIONS; ANTIGEN-PRESENTING CELLS; IN-VIVO; IMMUNOLOGICAL SYNAPSE; CUTTING EDGE; STEM-CELLS; DIFFERENTIATION; NODES; EFFECTOR; BET	A hallmark of mammalian immunity is the heterogeneity of cell fate that exists among pathogen-experienced lymphocytes. We show that a dividing T lymphocyte initially responding to a microbe exhibits unequal partitioning of proteins that mediate signaling, cell fate specification, and asymmetric cell division. Asymmetric segregation of determinants appears to be coordinated by prolonged interaction between the T cell and its antigen-presenting cell before division. Additionally, the first two daughter T cells displayed phenotypic and functional indicators of being differentially fated toward effector and memory lineages. These results suggest a mechanism by which a single lymphocyte can apportion diverse cell fates necessary for adaptive immunity.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA; Peter MacCallum Canc Inst, Immune Signalling Lab, Melbourne, Vic 2002, Australia; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; Swinburne Univ Technol, Ctr Microphoton, Fac Engn & Ind Sci, Hawthorn, Vic 3122, Australia	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; The Wistar Institute; Peter Maccallum Cancer Center; University of California System; University of California San Francisco; University of Pennsylvania; Swinburne University of Technology	Reiner, SL (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	sreiner@mail.med.upenn.edu	Schambach, Felix/B-9055-2009; Orange, Jordan S/D-5239-2009; Russell, Sarah M/B-9341-2009	Russell, Sarah M/0000-0001-5826-9641; orange, jordan/0000-0001-7117-7725; Oliaro, Jane/0000-0002-2097-6428; Kinjyo, Ichiko/0000-0001-7051-3790; Intlekofer, Andrew/0000-0001-9046-6549; Chang, John/0000-0003-0873-6218	NATIONAL CANCER INSTITUTE [R25CA087812, R21CA114114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061699, T32AI007532, R01AI053827, R56AI069380, R01AI042370, T32AI055428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007066] Funding Source: NIH RePORTER; NCI NIH HHS [CA114114, CA87812] Funding Source: Medline; NIAID NIH HHS [AI042370, R01 AI061699, AI007532, AI055428, AI061699, AI069380, T32 AI055428, AI053827] Funding Source: Medline; NIDDK NIH HHS [DK007066] Funding Source: Medline; NIGMS NIH HHS [GM007170] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; AMIGORENA S, COMMUNICATION; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Anderson AC, 2005, J IMMUNOL, V174, P890, DOI 10.4049/jimmunol.174.2.890; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Hommel M, 2003, J EXP MED, V197, P269, DOI 10.1084/jem.20021512; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lin J, 2005, J CELL BIOL, V170, P177, DOI 10.1083/jcb.200503032; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Martin P, 2005, P NATL ACAD SCI USA, V102, P9866, DOI 10.1073/pnas.0501202102; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004	40	623	638	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1687	1691		10.1126/science.1139393	http://dx.doi.org/10.1126/science.1139393			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17332376				2022-12-28	WOS:000245106900032
J	Eaton, DW; Frederiksen, A				Eaton, David W.; Frederiksen, Andrew			Seismic evidence for convection-driven motion of the North American plate	NATURE			English	Article							THERMAL STRUCTURE; DRIVING FORCES; HOTSPOT TRACK; MANTLE PLUME; POLAR WANDER; ATLANTIC; EASTERN; FLOW; GEOCHRONOLOGY; VELOCITY	Since the discovery of plate tectonics, the relative importance of driving forces of plate motion has been debated(1,2). Resolution of this issue has been hindered by uncertainties in estimates of basal traction, which controls the coupling between lithospheric plates and underlying mantle convection(2-4). Hotspot tracks preserve records of past plate motion(5) and provide markers with which the relative motion between a plate's surface and underlying mantle regions may be examined. Here we show that the 115-140-Myr surface expression of the Great Meteor hotspot track in eastern North America is misaligned with respect to its location at 200 km depth, as inferred from plate-reconstruction models and seismic tomographic studies(6). The misalignment increases with age and is consistent with westward displacement of the base of the plate relative to its surface, at an average rate of 3.8 +/- 1.8 mm yr(-1). Here age-constrained 'piercing points' have enabled direct estimation of relative motion between the surface and underside of a plate. The relative displacement of the base is approximately parallel to seismic fast axes and calculated mantle flow(7), suggesting that asthenospheric flow may be deforming the lithospheric keel and exerting a driving force on this part of the North American plate.	Univ Western Ontario, Dept Earth Sci, London, ON N6A 5B7, Canada; Univ Manitoba, Dept Geol Sci, Winnipeg, MB R3T 2N2, Canada	Western University (University of Western Ontario); University of Manitoba	Eaton, DW (corresponding author), Univ Western Ontario, Dept Earth Sci, London, ON N6A 5B7, Canada.	deaton@uwo.ca	Eaton, David/AAR-5939-2021; Frederiksen, Andrew/AAE-9330-2021	Frederiksen, Andrew/0000-0002-6938-6007				ADAMS J, 1991, NEOTECTONICS N AM, P161; Aktas K, 2006, TECTONOPHYSICS, V420, P267, DOI 10.1016/j.tecto.2006.01.020; Artemieva IM, 2004, GEOPHYS J INT, V157, P607, DOI 10.1111/j.1365-246X.2004.02195.x; Bokelmann GHR, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015925; Bokelmann GHR, 2002, GEOLOGY, V30, P1027, DOI 10.1130/0091-7613(2002)030<1027:WFDNA>2.0.CO;2; Bokelmann GHR, 2002, GEOPHYS J INT, V148, P278, DOI 10.1046/j.1365-246X.2002.01614.x; Conrad CP, 2004, GEOLOGY, V32, P177, DOI 10.1130/G20137.1; Conrad CP, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025621; Conrad CP, 2002, SCIENCE, V298, P207, DOI 10.1126/science.1074161; Courtillot V, 2003, EARTH PLANET SC LETT, V205, P295, DOI 10.1016/S0012-821X(02)01048-8; CROUGH ST, 1981, GEOLOGY, V9, P2, DOI 10.1130/0091-7613(1981)9<2:MHEIEN>2.0.CO;2; DARBYSHIRE FA, IN PRESS GEOPHYS J I; DUNCAN RA, 1991, REV GEOPHYS, V29, P31, DOI 10.1029/90RG02372; Eaton D, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019438; EBY GN, 1984, GEOLOGY, V12, P468, DOI 10.1130/0091-7613(1984)12<468:GOTMHA>2.0.CO;2; FORSYTH D, 1975, GEOPHYS J ROY ASTR S, V43, P163, DOI 10.1111/j.1365-246X.1975.tb00631.x; Fouch MJ, 2000, J GEOPHYS RES-SOL EA, V105, P6255, DOI 10.1029/1999JB900372; Heaman LM, 2000, EARTH PLANET SC LETT, V178, P253, DOI 10.1016/S0012-821X(00)00079-0; JORDAN TH, 1975, REV GEOPHYS, V13, P1, DOI 10.1029/RG013i003p00001; Lithgow-Bertelloni C, 1998, REV GEOPHYS, V36, P27, DOI 10.1029/97RG02282; Mareschal JC, 2000, CAN J EARTH SCI, V37, P399, DOI [10.1139/cjes-37-2-3-399, 10.1139/e98-106]; MORGAN WJ, 1983, TECTONOPHYSICS, V94, P123, DOI 10.1016/0040-1951(83)90013-6; Schettino A, 2005, GEOPHYS J INT, V163, P727, DOI 10.1111/j.1365-246X.2005.02638.x; Silver PG, 2002, SCIENCE, V295, P1054, DOI 10.1126/science.1066878; Sleep NH, 2002, GEOL SOC SPEC PUBL, V199, P135, DOI 10.1144/GSL.SP.2002.199.01.08; SLEEP NH, 1990, J GEOPHYS RES-SOLID, V95, P21983, DOI 10.1029/JB095iB13p21983; TARDUNO JA, 1995, NATURE, V378, P477, DOI 10.1038/378477a0; VANDECAR JC, 1995, NATURE, V378, P25, DOI 10.1038/378025a0; VANDERLEE S, 2005, AM GEOPHYS UNION MON, V157, P67; ZARTMAN RE, 1977, ANNU REV EARTH PL SC, V5, P257, DOI 10.1146/annurev.ea.05.050177.001353	30	80	81	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					428	431		10.1038/nature05675	http://dx.doi.org/10.1038/nature05675			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17377580				2022-12-28	WOS:000245079500037
J	Davey, G; Newport, M				Davey, Gail; Newport, Melanie			Podoconiosis: the most neglected tropical disease?	LANCET			English	Editorial Material							NON-FILARIAL ELEPHANTIASIS; ENDEMIC ELEPHANTIASIS; LOWER LEGS; DISTRICT; AREA		Fac Med, Addis Ababa, Ethiopia; Brighton & Sussex Med Sch, Brighton, E Sussex, England	University of Brighton; University of Sussex	Davey, G (corresponding author), Fac Med, Addis Ababa, Ethiopia.	nerurkar@ethionet.et		Davey, Gail/0000-0003-2796-7468; Newport, Melanie/0000-0002-8946-7525				Birrie HL, 1997, ETHIOPIAN MED J, V35, P245; CORACHAN M, 1988, TROP GEOGR MED, V40, P359; CRIVELLI PE, 1986, E AFR MED J, V63, P191; Davey G, 2007, T ROY SOC TROP MED H, V101, P91, DOI 10.1016/j.trstmh.2006.05.002; DELALLA F, 1988, T ROY SOC TROP MED H, V82, P895, DOI 10.1016/0035-9203(88)90032-6; Destas K, 2003, TROP DOCT, V33, P217, DOI 10.1177/004947550303300410; Dreyer G., 2002, BASIC LYMPHEDEMA MAN; FYFE NCM, 1985, T ROY SOC TROP MED H, V79, P645, DOI 10.1016/0035-9203(85)90180-4; Onapa AW, 2001, ACTA TROP, V78, P171, DOI 10.1016/S0001-706X(00)00185-6; PRICE EW, 1976, T ROY SOC TROP MED H, V70, P288, DOI 10.1016/0035-9203(76)90078-X; PRICE EW, 1984, TROP GEOGR MED, V36, P1; Price EW, 1990, PODOCONIOSIS NONFILA; RUIZ L, 1994, ACTA TROP, V57, P29, DOI 10.1016/0001-706X(94)90090-6; Tekola F, 2006, TROP MED INT HEALTH, V11, P1136, DOI 10.1111/j.1365-3156.2006.01658.x	14	29	29	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2007	369	9565					888	889		10.1016/S0140-6736(07)60425-5	http://dx.doi.org/10.1016/S0140-6736(07)60425-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148BQ	17368134				2022-12-28	WOS:000245049900008
J	Aeschlimann, M; Bauer, M; Bayer, D; Brixner, T; de Abajo, FJ; Pfeiffer, W; Rohmer, M; Spindler, C; Steeb, F				Aeschlimann, Martin; Bauer, Michael; Bayer, Daniela; Brixner, Tobias; Garcia de Abajo, F. Javier; Pfeiffer, Walter; Rohmer, Martin; Spindler, Christian; Steeb, Felix			Adaptive subwavelength control of nano-optical fields	NATURE			English	Article							QUANTUM CONTROL; FEMTOSECOND; PHASE; MICROSCOPY	Adaptive shaping of the phase and amplitude of femtosecond laser pulses has been developed into an efficient tool for the directed manipulation of interference phenomena, thus providing coherent control over various quantum-mechanical systems(1-10). Temporal resolution in the femtosecond or even attosecond range has been demonstrated, but spatial resolution is limited by diffraction to approximately half the wavelength of the light field (that is, several hundred nanometres). Theory has indicated(11,12) that the spatial limitation to coherent control can be overcome with the illumination of nanostructures: the spatial near-field distribution was shown to depend on the linear chirp of an irradiating laser pulse. An extension of this idea to adaptive control, combining multiparameter pulse shaping with a learning algorithm, demonstrated the generation of user-specified optical near-field distributions in an optimal and flexible fashion(13). Shaping of the polarization of the laser pulse 14,15 provides a particularly efficient and versatile nano-optical manipulation method(16,17). Here we demonstrate the feasibility of this concept experimentally, by tailoring the optical near field in the vicinity of silver nanostructures through adaptive polarization shaping of femtosecond laser pulses 14,15 and then probing the lateral field distribution by two-photon photoemission electron microscopy(18). In this combination of adaptive control(1-10) and nano-optics(19), we achieve subwave-length dynamic localization of electromagnetic intensity on the nanometre scale and thus overcome the spatial restrictions of conventional optics. This experimental realization of theoretical suggestions(11-13,16,17,20) opens a number of perspectives in coherent control, nano-optics, nonlinear spectroscopy, and other research fields in which optical investigations are carried out with spatial or temporal resolution.	Univ Wurzburg, Inst Phys, D-97074 Wurzburg, Germany; Tech Univ Kaiserslautern, Fachbereich Phys, D-67663 Kaiserslautern, Germany; Univ Kiel, Inst Expt & Angew Phys, D-24118 Kiel, Germany; Univ Bielefeld, Fak Phys, D-33516 Bielefeld, Germany; CSIC, Inst Opt, E-28006 Madrid, Spain	University of Wurzburg; University of Kaiserslautern; University of Kiel; University of Bielefeld; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Optica (Daza de Valdes)	Brixner, T (corresponding author), Univ Wurzburg, Inst Phys, D-97074 Wurzburg, Germany.	brixner@physik.uni-wuerzburg.de	Aeschlimann, Martin/D-7141-2011; Brixner, Tobias/S-1451-2016; Bauer, Michael/G-5111-2016; García de Abajo, Javier/A-6095-2009; Pfeiffer, Walter/A-6378-2012	Aeschlimann, Martin/0000-0003-3413-5029; Brixner, Tobias/0000-0002-6529-704X; Bauer, Michael/0000-0002-4391-9899; García de Abajo, Javier/0000-0002-4970-4565; 				Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; Baumert T, 1997, APPL PHYS B-LASERS O, V65, P779, DOI 10.1007/s003400050346; Brixner T, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125437; Brixner T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.093901; Brixner T, 2006, APPL PHYS B-LASERS O, V84, P89, DOI 10.1007/s00340-006-2202-5; Brixner T, 2003, APPL PHYS B-LASERS O, V76, P531, DOI 10.1007/s00340-003-1137-3; Brixner T, 2003, CHEMPHYSCHEM, V4, P418, DOI 10.1002/cphc.200200581; Brixner T, 2002, APPL PHYS B-LASERS O, V74, pS133, DOI 10.1007/s00340-002-0911-y; Brixner T, 2001, OPT LETT, V26, P557, DOI 10.1364/OL.26.000557; Brixner T, 2001, NATURE, V414, P57, DOI 10.1038/35102037; Brumer P., 2003, PRINCIPLES QUANTUM C; Cinchetti M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.047601; de Abajo FJG, 1998, PHYS REV LETT, V80, P5180; de Abajo FJG, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.115418; Dudovich N, 2002, NATURE, V418, P512, DOI 10.1038/nature00933; Feurer T, 2003, SCIENCE, V299, P374, DOI 10.1126/science.1078726; Hao E, 2004, J CHEM PHYS, V120, P357, DOI 10.1063/1.1629280; Herek JL, 2002, NATURE, V417, P533, DOI 10.1038/417533a; Iaconis C, 1998, OPT LETT, V23, P792, DOI 10.1364/OL.23.000792; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; Kubo A, 2005, NANO LETT, V5, P1123, DOI 10.1021/nl0506655; Meshulach D, 1998, NATURE, V396, P239, DOI 10.1038/24329; Novotny B. H., 2006, PRINCIPLES NANO OPTI; Sanchez EJ, 1999, PHYS REV LETT, V82, P4014, DOI 10.1103/PhysRevLett.82.4014; Schmidt O, 2002, APPL PHYS B-LASERS O, V74, P223, DOI 10.1007/s003400200803; Stockman MI, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.054202; Stockman MI, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.067402; Sukharev M, 2006, NANO LETT, V6, P715, DOI 10.1021/nl0524896; Swiech W, 1997, J ELECTRON SPECTROSC, V84, P171, DOI 10.1016/S0368-2048(97)00022-4; Weinacht TC, 1999, NATURE, V397, P233, DOI 10.1038/16654	30	436	442	6	197	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2007	446	7133					301	304		10.1038/nature05595	http://dx.doi.org/10.1038/nature05595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361179				2022-12-28	WOS:000244892900041
J	Wharam, JF; Landon, BE; Galbraith, AA; Kleinman, KP; Soumerai, SB; Ross-Degnan, D				Wharam, J. Frank; Landon, Bruce E.; Galbraith, Alison A.; Kleinman, Ken P.; Soumerai, Stephen B.; Ross-Degnan, Dennis			Emergency department use and subsequent hospitalizations among members of a high-deductible health plan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC DISEASE SCORE; INSURANCE STATUS; CLAIMS DATA; CARE; COST; ASSOCIATION; MORTALITY; ADMISSION; COVERAGE; EVENTS	Context Patients evaluated at emergency departments often present with nonemergency conditions that can be treated in other clinical settings. High-deductible health plans have been promoted as a means of reducing overutilization but could also be related to worse outcomes if patients defer necessary care. Objectives To determine the relationship between transition to a high-deductible health plan and emergency department use for low- and high-severity conditions and to examine changes in subsequent hospitalizations. Design, Setting, and Participants Analysis of emergency department visits and subsequent hospitalizations among 8724 individuals for 1 year before and after their employers mandated a switch from a traditional health maintenance organization plan to a high-deductible health plan, compared with 59 557 contemporaneous controls who remained in the traditional plan. All persons were aged 1 to 64 years and insured by a Massachusetts health plan between March 1, 2001, and June 30, 2005. Main Outcome Measures Rates of first and repeat emergency department visits classified as low, indeterminate, or high severity during the baseline and follow-up periods, as well as rates of inpatient admission after emergency department visits. Results Between the baseline and follow-up periods, emergency department visits among members who switched to high-deductible coverage decreased from 197.5 to 178.1 per 1000 members, while visits among controls remained at approximately 220 per 1000(- 10.0% adjusted difference in difference; 95% confidence interval [CI],- 16.6% to- 2.8%; P=. 007). The high-deductible plan was not associated with a change in the rate of first visits occurring during the study period (- 4.1% adjusted difference in difference; 95% CI, - 11.8% to 4.3%). Repeat visits in the high-deductible group decreased from 334.6 to 255.3 visits per 1000 members and increased from 321.1 to 334.4 per 1000 members in controls(- 24.9% difference in difference; 95% CI, - 37.5% to - 9.7%; P=. 002). Low-severity repeat emergency department visits decreased in the high-deductible group from 142.5 to 92.1 per 1000 members and increased in controls from 128.0 to 132.5 visits per 1000 members(- 36.4% adjusted difference in difference; 95% CI, - 51.1% to - 17.2%; P <. 001), whereas a small decrease in high-severity visits in the high-deductible group could not be excluded. The percentage of patients admitted from the emergency department in the high-deductible group decreased from 11.8% to 10.9% and increased from 11.9% to 13.6% among controls (- 24.7% adjusted difference in difference; 95% CI, - 41.0% to - 3.9%; P=. 02). Conclusions Traditional health plan members who switched to high-deductible coverage visited the emergency department less frequently than controls, with reductions occurring primarily in repeat visits for conditions that were not classified as high severity, and had decreases in the rate of hospitalizations from the emergency department. Further research is needed to determine long-term health care utilization patterns under high-deductible coverage and to assess risks and benefits related to clinical outcomes.	Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Pilgrim Hlth Care, Boston, MA USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Wharam, JF (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	jwharam@partners.org		Kleinman, Ken/0000-0002-5600-5834; Wharam, James/0000-0003-2053-0757	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS011843] Funding Source: NIH RePORTER; AHRQ HHS [U 18 HS 11843] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Ash AS, 2003, HEALTH SERV RES, V38, P1253, DOI 10.1111/1475-6773.00175; BAKER LC, 1994, HEALTH AFFAIR, V13, P162, DOI 10.1377/hlthaff.13.5.162; Bamezai A, 2005, ANN EMERG MED, V45, P483, DOI 10.1016/j.annemergmed.2004.08.029; Billings J, 2000, Issue Brief (Commonw Fund), P1; BILLINGS J, 2000, ISSUE BRIEF COMMONW, V433, P1; BINDMAN AB, 1991, JAMA-J AM MED ASSOC, V266, P1091, DOI 10.1001/jama.266.8.1091; BLUSTEIN J, 1995, NEW ENGL J MED, V332, P1138, DOI 10.1056/NEJM199504273321706; BUNTIN MB, 2006, HLTH AFF MILLWOOD, V25, pS516; BUSH GW, PRESIDENTS PROPOSAL; CANNON MF, HLTH SAVINGS ACCOUNT; CLARK DO, 1995, MED CARE, V33, P783, DOI 10.1097/00005650-199508000-00004; Cogan JF, 2005, HEALTH AFFAIR, V24, P1447, DOI 10.1377/hlthaff.24.6.1447; Cowen ME, 2002, MED CARE, V40, P650, DOI 10.1097/00005650-200208000-00004; Cowen ME, 1998, MED CARE, V36, P1108, DOI 10.1097/00005650-199807000-00016; *CTR MED MED SERV, FACT SHEET 2007 MED; Davis Karen, 2004, Issue Brief (Commonw Fund), P1; Derlet RW, 2000, ANN EMERG MED, V35, P63, DOI 10.1016/S0196-0644(00)70105-3; Fishman PA, 1999, MED CARE, V37, P874, DOI 10.1097/00005650-199909000-00004; Ginsburg PB, 2004, NEW ENGL J MED, V351, P1591, DOI 10.1056/NEJMp048159; Herzlinger RE, 2002, HARVARD BUS REV, V80, P44; Hsu J, 2006, HEALTH SERV RES, V41, P1801, DOI 10.1111/j.1475-6773.2006.00562.x; *I MED COMM FUT EM, FUT EM CAR KEY FIND; JOHNSON RE, 1994, J CLIN EPIDEMIOL, V47, P1191, DOI 10.1016/0895-4356(94)90106-6; *KAIS FAM FDN HLTH, EMPL HLTH BEN 2006 A; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Krieger N, 2003, AM J PUBLIC HEALTH, V93, P1655, DOI 10.2105/AJPH.93.10.1655; LANDA AS, MEDICAID OFFER HSA P; Lee TH, 2005, NEW ENGL J MED, V353, P1202, DOI 10.1056/NEJMp058209; Magid DJ, 1997, NEW ENGL J MED, V336, P1722, DOI 10.1056/NEJM199706123362406; Newhouse JP, 1996, FREE ALL LESSONS RAN; OGRADY KF, 1985, NEW ENGL J MED, V313, P484, DOI 10.1056/NEJM198508223130806; Palmisano DJ, 2004, JAMA-J AM MED ASSOC, V291, P2237, DOI 10.1001/jama.291.18.2237; RASELL ME, 1995, NEW ENGL J MED, V332, P1164, DOI 10.1056/NEJM199504273321711; Richardson DB, 2006, MED J AUSTRALIA, V184, P213, DOI 10.5694/j.1326-5377.2006.tb00204.x; Roblin DW, 2005, MED CARE, V43, P951, DOI 10.1097/01.mlr.0000178216.23514.b7; Ruger JP, 2003, ACAD EMERG MED, V10, P1285, DOI 10.1197/S1069-6563(03)00500-1; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Selby JV, 1996, NEW ENGL J MED, V334, P635, DOI 10.1056/NEJM199603073341006; Shearer G, 2004, HEALTH SERV RES, V39, P1159, DOI 10.1111/j.1475-6773.2004.00280.x; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; Sox CM, 1998, AM J MED, V105, P506, DOI 10.1016/S0002-9343(98)00324-6; Sprivulis PC, 2006, MED J AUSTRALIA, V184, P208, DOI 10.5694/j.1326-5377.2006.tb00203.x; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Travers DA, 2003, ACAD EMERG MED, V10, P1337, DOI 10.1197/S1069-6563(03)00536-0; Trzeciak S, 2003, EMERG MED J, V20, P402, DOI 10.1136/emj.20.5.402; U.S. Bureau of Census, 1994, GEOGR AR REF MAN; WUERZ RC, 1992, ANN EMERG MED, V21, P669, DOI 10.1016/S0196-0644(05)82777-5; YOO H, JANUARY CENSUS SHOWS; Yu W, 2004, AM J MANAG CARE, V10, P909; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	51	124	127	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2007	297	10					1093	1102		10.1001/jama.297.10.1093	http://dx.doi.org/10.1001/jama.297.10.1093			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	145KZ	17356030	Bronze			2022-12-28	WOS:000244865200023
J	Sharp, D				Sharp, David			Leprosy lessons from old bones	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							Boldsen JL, 2006, AM J PHYS ANTHROPOL, V130, P344, DOI 10.1002/ajpa.20363; Boldsen JL, 2005, AM J PHYS ANTHROPOL, V126, P159, DOI 10.1002/ajpa.20085; Donoghue HD, 2005, P ROY SOC B-BIOL SCI, V272, P389, DOI 10.1098/rspb.2004.2966; Fine PEM, 2007, B WORLD HEALTH ORGAN, V85, P2, DOI 10.2471/BLT.06.039206; HALLIBURTON R, 1946, 7 LEAGUE BOOTS, P224; HISLOP V, 2005, ISLAND; Nishida M, 2006, LEPROSY REV, V77, P203; Parascandola John, CHAULMOOGRA OIL TREA; Richards P., 1977, MEDIEVAL LEPER HIS N; WHO, LEPR TOD; Wokaunn M, 2006, CROAT MED J, V47, P759	11	2	3	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2007	369	9564					808	809		10.1016/S0140-6736(07)60385-7	http://dx.doi.org/10.1016/S0140-6736(07)60385-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144JC	17350434				2022-12-28	WOS:000244791300008
J	Kroenke, K; Spitzer, RL; Williams, JBW; Monahan, PO; Lowe, B				Kroenke, Kurt; Spitzer, Robert L.; Williams, Janet B. W.; Monahan, Patrick O.; Lowe, Bernd			Anxiety disorders in primary care: Prevalence, impairment, comorbidity, and detection	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; PATIENT HEALTH QUESTIONNAIRE; COGNITIVE-BEHAVIORAL THERAPY; CASE-FINDING INSTRUMENTS; MENTAL-DISORDERS; GENERALIZED ANXIETY; PANIC DISORDER; PSYCHOLOGICAL-PROBLEMS; SERVICE UTILIZATION	Background: Anxiety, although as common as depression, has received less attention and is often undetected and undertreated. Objective: To determine the current prevalence, impairment, and comorbidity of anxiety disorders in primary care and to evaluate a brief measure for detecting these disorders. Design: Criterion-standard study performed between November 2004 and June 2005. Setting: 15 U.S. primary care clinics. Participants: 965 randomly sampled patients from consecutive clinic patients who completed a self-report questionnaire and agreed to a follow-up telephone interview. Measurements: 7-item anxiety measure (Generalized Anxiety Disorder [GAD]-7 scale) in the clinic, followed by a telephone-administered, structured psychiatric interview by a mental health professional who was blinded to the GAD-7 results. Functional status (Medical Outcomes Study Short Form-20), depressive and somatic symptoms, and self-reported disability days and physician visits were also assessed. Results: Of the 965 patients, 19.5% (95% CI, 17.0% to 22.1%) had at least 1 anxiety disorder, 8.6% (CI, 6.9% to 10.6%) had posttraumatic stress disorder, 7.6% (CI, 5.9% to 9.4%) had a generalized anxiety disorder, 6.8% (CI, 5.3% to 8.6%) had a panic disorder, and 6.2% (CI, 4.7% to 7.9%) had a social anxiety disorder. Each disorder was associated with substantial impairment that increased significantly (P < 0.001) as the number of anxiety disorders increased. Many patients (41%) with an anxiety disorder reported no current treatment. Receiver-operating characteristic curve analysis showed that both the GAD-7 scale and its 2 core items (GAD-2) performed well (area under the curve, 0.80 to 0.91) as screening tools for all 4 anxiety disorders. Limitation: The study included a nonrandom sample of selected primary care practices. Conclusions: Anxiety disorders are prevalent, disabling, and often untreated in primary care. A 2-item screening test may enhance detection. Conclusions: Anxiety disorders are prevalent, disabling, and often untreated in primary care. A 2-item screening test may enhance detection.	Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA; Indiana Univ, Indianapolis, IN 46204 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Columbia Univ, New York, NY USA; Heidelberg Univ, Heidelberg, Germany	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Indiana University System; Indiana University-Purdue University Indianapolis; New York State Psychiatry Institute; Columbia University; Ruprecht Karls University Heidelberg	Kroenke, K (corresponding author), Regenstrief Inst Hlth Care, 1050 Wishard Blvd, Indianapolis, IN 46202 USA.	kkroenke@regenstrief.org	anand, amit/A-7222-2009; Löwe, Bernd/AAG-4038-2020	Kroenke, Kurt/0000-0002-0114-4669				Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Andrews G, 2001, BRIT J PSYCHIAT, V178, P145, DOI 10.1192/bjp.178.2.145; ANESHENSEL CS, 1982, PUBLIC OPIN QUART, V46, P110, DOI 10.1086/268703; Ansseau M, 2004, J AFFECT DISORDERS, V78, P49, DOI 10.1016/S0165-0327(02)00219-7; Barlow DH, 2004, BEHAV THER, V35, P205, DOI 10.1016/S0005-7894(04)80036-4; Barsky AJ, 2005, ARCH GEN PSYCHIAT, V62, P903, DOI 10.1001/archpsyc.62.8.903; Buist-Bouwman MA, 2005, ACTA PSYCHIAT SCAND, V111, P436, DOI 10.1111/j.1600-0447.2005.00513.x; CLEARY PD, 1984, MED CARE, V22, P796, DOI 10.1097/00005650-198409000-00003; Connor KM, 2001, DEPRESS ANXIETY, V14, P137, DOI 10.1002/da.1055; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Derogatis L R, 1974, Mod Probl Pharmacopsychiatry, V7, P79; Edlund MJ, 2004, MED CARE, V42, P1158, DOI 10.1097/00005650-200412000-00002; First M.B., 2014, STRUCTURED CLIN INTE; Gillock KL, 2005, GEN HOSP PSYCHIAT, V27, P392, DOI 10.1016/j.genhosppsych.2005.06.004; Greenberg PE, 1999, J CLIN PSYCHIAT, V60, P427, DOI 10.4088/JCP.v60n0702; Gross R, 2005, GEN HOSP PSYCHIAT, V27, P161, DOI 10.1016/j.genhosppsych.2005.01.006; Hing Esther, 2006, Adv Data, P1; Issakidis C, 2004, PSYCHOL MED, V34, P19, DOI 10.1017/S003329170300881X; Jackson JL, 2006, CNS SPECTRUMS, V11, P212, DOI 10.1017/S1092852900014383; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Kessler D, 1999, BRIT MED J, V318, P436, DOI 10.1136/bmj.318.7181.436; Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P1257, DOI 10.1097/01.jom.0000100000.70011.bb; Kroenke K, 1997, AM J MED, V103, P339, DOI 10.1016/S0002-9343(97)00241-6; Kroenke K, 1994, Arch Fam Med, V3, P774; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2000, PSYCHOTHER PSYCHOSOM, V69, P205, DOI 10.1159/000012395; Kroenke K., 2003, PRIM CARE COMPANI S, V5, P11; Leon A C, 1995, Arch Fam Med, V4, P857, DOI 10.1001/archfami.4.10.857; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Lowe B, 2003, J PSYCHOSOM RES, V55, P515, DOI 10.1016/S0022-3999(03)00072-2; Magruder KM, 2005, GEN HOSP PSYCHIAT, V27, P169, DOI 10.1016/j.genhosppsych.2004.11.001; Marciniak MD, 2005, DEPRESS ANXIETY, V21, P178, DOI 10.1002/da.20074; Marcus SC, 1997, AM J PSYCHIAT, V154, P1766, DOI 10.1176/ajp.154.12.1766; Means-Christensen A, 2003, INT J METH PSYCH RES, V12, P167, DOI 10.1002/mpr.154; Mendlowicz MV, 2000, AM J PSYCHIAT, V157, P669, DOI 10.1176/appi.ajp.157.5.669; MULROW CD, 1995, ANN INTERN MED, V122, P913, DOI 10.7326/0003-4819-122-12-199506150-00004; O'Malley PG, 1999, J FAM PRACTICE, V48, P980; Olfson M, 2000, ARCH FAM MED, V9, P876, DOI 10.1001/archfami.9.9.876; Olfson M, 1997, AM J PSYCHIAT, V154, P1734, DOI 10.1176/ajp.154.12.1734; ORMEL J, 1994, JAMA-J AM MED ASSOC, V272, P1741, DOI 10.1001/jama.272.22.1741; PASACRETA JV, 1997, INSTRUMENTS CLIN HLT, P342; Rapaport MH, 2005, AM J PSYCHIAT, V162, P1171, DOI 10.1176/appi.ajp.162.6.1171; REGIER DA, 1988, ARCH GEN PSYCHIAT, V45, P977; Rief W, 2004, J AFFECT DISORDERS, V82, P271, DOI 10.1016/j.jad.2003.11.006; Roy-Byrne PP, 1999, J CLIN PSYCHIAT, V60, P492, DOI 10.4088/JCP.v60n0713; Roy-Byrne PP, 2004, J CLIN PSYCHIAT, V65, P20; Sanderson K, 2002, PSYCHIATR SERV, V53, P80, DOI 10.1176/appi.ps.53.1.80; Sareen J, 2005, DEPRESS ANXIETY, V21, P193, DOI 10.1002/da.20072; Schonfeld WH, 1997, J AFFECT DISORDERS, V43, P105, DOI 10.1016/S0165-0327(96)01416-4; Sherbourne CD, 1996, ARCH GEN PSYCHIAT, V53, P889; Simon G, 1996, PSYCHOSOM MED, V58, P481, DOI 10.1097/00006842-199609000-00010; Simon GE, 1999, NEW ENGL J MED, V341, P1329, DOI 10.1056/NEJM199910283411801; SIMON GE, 1993, J PSYCHIAT RES, V27, P247, DOI 10.1016/0022-3956(93)90035-Z; SPITZER RL, 1995, JAMA-J AM MED ASSOC, V274, P1511, DOI 10.1001/jama.274.19.1511; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stein MB, 2005, MED CARE, V43, P1164, DOI 10.1097/01.mlr.0000185750.18119.fd; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; VonKorff M, 1996, J CLIN EPIDEMIOL, V49, P297, DOI 10.1016/0895-4356(95)00512-9; Wang PS, 2002, AM J PUBLIC HEALTH, V92, P92, DOI 10.2105/AJPH.92.1.92; Weiller E, 1998, BRIT J PSYCHIAT, V173, P18, DOI 10.1192/S0007125000293471; WELLS KB, 1988, J PSYCHIAT RES, V22, P207, DOI 10.1016/0022-3956(88)90006-4; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Williams JW, 2002, GEN HOSP PSYCHIAT, V24, P225, DOI 10.1016/S0163-8343(02)00195-0; Wittchen HU, 2002, J CLIN PSYCHIAT, V63, P24; Young AS, 2001, ARCH GEN PSYCHIAT, V58, P55, DOI 10.1001/archpsyc.58.1.55	69	2232	2265	15	284	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2007	146	5					317	325		10.7326/0003-4819-146-5-200703060-00004	http://dx.doi.org/10.7326/0003-4819-146-5-200703060-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144XK	17339617				2022-12-28	WOS:000244829600001
J	Coulibaly, F; Chiu, E; Ikeda, K; Gutmann, S; Haebel, PW; Schulze-Briese, C; Mori, H; Metcalf, P				Coulibaly, Fasseli; Chiu, Elaine; Ikeda, Keiko; Gutmann, Sascha; Haebel, Peter W.; Schulze-Briese, Clemens; Mori, Hajime; Metcalf, Peter			The molecular organization of cypovirus polyhedra	NATURE			English	Article							X-RAY-DIFFRACTION; CRYSTAL-STRUCTURE; PROTEIN; BODIES	Cypoviruses and baculoviruses are notoriously difficult to eradicate because the virus particles are embedded in micrometresized protein crystals called polyhedra(1,2). The remarkable stability of polyhedra means that, like bacterial spores, these insect viruses remain infectious for years in soil. The environmental persistence of polyhedra is the cause of significant losses in silkworm cocoon harvests but has also been exploited against pests in biological alternatives to chemical insecticides(3,4). Although polyhedra have been extensively characterized since the early 1900s(5), their atomic organization remains elusive(6). Here we describe the 2 angstrom crystal structure of both recombinant and infectious silkworm cypovirus polyhedra determined using crystals 5 - 12 micrometres in diameter purified from insect cells. These are the smallest crystals yet used for de novo X-ray protein structure determination(7). We found that polyhedra are made of trimers of the viral polyhedrin protein and contain nucleotides. Although the shape of these building blocks is reminiscent of some capsid trimers, polyhedrin has a new fold and has evolved to assemble in vivo into three-dimensional cubic crystals rather than icosahedral shells. The polyhedrin trimers are extensively cross-linked in polyhedra by non-covalent interactions and pack with an exquisite molecular complementarity similar to that of antigen - antibody complexes. The resulting ultrastable and sealed crystals shield the virus particles from environmental damage. The structure suggests that polyhedra can serve as the basis for the development of robust and versatile nanoparticles for biotechnological applications 8 such as microarrays(9) and biopesticides(4).	Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand; Prot Crystal Corp, Osaka 5410053, Japan; Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; Altana Pharma AG, D-78467 Constance, Germany; Kyoto Inst Technol, Kyoto 6068585, Japan	University of Auckland; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Altana; Kyoto Institute of Technology	Metcalf, P (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand.	peter.metcalf@auckland.ac.nz	Metcalf, Peter/B-4598-2011	Gutmann, Sascha/0000-0002-4242-8510; Coulibaly, Fasseli/0000-0003-3380-2117; Mori, Hajime/0000-0001-9219-6140				Anduleit K, 2005, PROTEIN SCI, V14, P2741, DOI 10.1110/ps.051516405; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belloncik S, 1998, VIRUSES, P337; Chang JH, 2003, J INVERTEBR PATHOL, V84, P30, DOI 10.1016/S0022-2011(03)00121-6; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Doye JPK, 2006, CURR OPIN COLLOID IN, V11, P40, DOI 10.1016/j.cocis.2005.10.002; Fields B. N., 2001, FIELDS VIROLOGY, V4; FUJIWARA T, 1984, APPL ENTOMOL ZOOL, V19, P402, DOI 10.1303/aez.19.402; Glaser RW, 1916, BIOL BULL-US, V30, P367, DOI 10.2307/1536363; GRIMES J, 1995, NATURE, V373, P167, DOI 10.1038/373167a0; Hill CL, 1999, NAT STRUCT BIOL, V6, P565, DOI 10.1038/9347; Ikeda K, 2006, PROTEOMICS, V6, P54, DOI 10.1002/pmic.200500022; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Liemann S, 2002, CELL, V108, P283, DOI 10.1016/S0092-8674(02)00612-8; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Miller L.K., 1997, BACULOVIRUSES; MORI H, 1993, J GEN VIROL, V74, P99, DOI 10.1099/0022-1317-74-1-99; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Riekel C, 2005, CURR OPIN STRUC BIOL, V15, P556, DOI 10.1016/j.sbi.2005.08.013; ROHRMANN GF, 1986, J GEN VIROL, V67, P1499, DOI 10.1099/0022-1317-67-8-1499; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Summers MD, 2006, ADV VIRUS RES, V68, P3, DOI 10.1016/S0065-3527(06)68001-9; Thorne RE, 2003, J APPL CRYSTALLOGR, V36, P1455, DOI 10.1107/S0021889803018375; Wodak SJ, 2003, ADV PROTEIN CHEM, V61, P9; Zhang H, 1999, J VIROL, V73, P1624, DOI 10.1128/JVI.73.2.1624-1629.1999	30	148	161	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					97	101		10.1038/nature05628	http://dx.doi.org/10.1038/nature05628			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330045				2022-12-28	WOS:000244525600045
J	Tonetti, MS; D'Aiuto, F; Nibali, L; Donald, A; Storry, C; Parkar, M; Suvan, J; Hingorani, AD; Vallance, P; Deanfield, J				Tonetti, Maurizio S.; D'Aiuto, Francesco; Nibali, Luigi; Donald, Ann; Storry, Clare; Parkar, Mohamed; Suvan, Jean; Hingorani, Aroon D.; Vallance, Patrick; Deanfield, John			Treatment of periodontitis and endothelial function	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR RISK-FACTORS; NITRIC-OXIDE; SYSTEMIC INFLAMMATION; ATHEROSCLEROSIS RISK; PROGNOSTIC VALUE; DISEASE; DYSFUNCTION; INFECTION; FIBRINOGEN	BACKGROUND: Systemic inflammation may impair vascular function, and epidemiologic data suggest a possible link between periodontitis and cardiovascular disease. METHODS: We randomly assigned 120 patients with severe periodontitis to community-based periodontal care (59 patients) or intensive periodontal treatment (61). Endothelial function, as assessed by measurement of the diameter of the brachial artery during flow (flow-mediated dilatation), and inflammatory biomarkers and markers of coagulation and endothelial activation were evaluated before treatment and 1, 7, 30, 60, and 180 days after treatment. RESULTS: Twenty-four hours after treatment, flow-mediated dilatation was significantly lower in the intensive-treatment group than in the control-treatment group (absolute difference, 1.4%; 95% confidence interval [CI], 0.5 to 2.3; P=0.002), and levels of C-reactive protein, interleukin-6, and the endothelial-activation markers soluble E-selectin and von Willebrand factor were significantly higher (P<0.05 for all comparisons). However, flow-mediated dilatation was greater and the plasma levels of soluble E-selectin were lower in the intensive-treatment group than in the control-treatment group 60 days after therapy (absolute difference in flow-mediated dilatation, 0.9%; 95% CI, 0.1 to 1.7; P=0.02) and 180 days after therapy (difference, 2.0%; 95% CI, 1.2 to 2.8; P<0.001). The degree of improvement was associated with improvement in measures of periodontal disease (r=0.29 by Spearman rank correlation, P=0.003). There were no serious adverse effects in either of the two groups, and no cardiovascular events occurred. CONCLUSIONS: Intensive periodontal treatment resulted in acute, short-term systemic inflammation and endothelial dysfunction. However, 6 months after therapy, the benefits in oral health were associated with improvement in endothelial function.	Univ Connecticut, Ctr Hlth, Dept Oral Hlth & Diagnost Sci, Farmington, CT 06032 USA; UCL, Eastman Dent Inst & Hosp, Periodontol Unit, London, England; UCL, Ctr Clin Pharmacol, London, England; UCL, Vasc Physiol Unit, London, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England	University of Connecticut; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Tonetti, MS (corresponding author), Univ Connecticut, Ctr Hlth, Dept Oral Hlth & Diagnost Sci, Farmington, CT 06032 USA.	tonetti@ergoperio.eu	Tonetti, Maurizio/ABE-2947-2020	Hingorani, Aroon/0000-0001-8365-0081; Deanfield, John/0000-0001-8806-6052				Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843; Amar S, 2003, ARTERIOSCL THROM VAS, V23, P1245, DOI 10.1161/01.ATV.0000078603.90302.4A; Bacon P. A., 2002, Autoimmunity Reviews, V1, P338, DOI 10.1016/S1568-9972(02)00100-3; Beck JD, 2001, ARTERIOSCL THROM VAS, V21, P1816, DOI 10.1161/hq1101.097803; Brunner H, 2005, J HYPERTENS, V23, P233, DOI 10.1097/00004872-200502000-00001; Charakida M, 2005, CIRCULATION, V111, P1660, DOI 10.1161/01.CIR.0000160365.18879.1C; D'Aiuto F, 2005, J DENT RES, V84, P269, DOI 10.1177/154405910508400312; D'Aiuto F, 2004, J DENT RES, V83, P156, DOI 10.1177/154405910408300214; D'Aiuto F, 2006, AM HEART J, V151, P977, DOI 10.1016/j.ahj.2005.06.018; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Dorn BR, 2000, FEMS MICROBIOL LETT, V187, P139, DOI 10.1016/S0378-1097(00)00191-9; Ebersole JL, 1997, CLIN EXP IMMUNOL, V107, P347, DOI 10.1111/j.1365-2249.1997.270-ce1162.x; Fichtlscherer S, 2004, CIRCULATION, V110, P1926, DOI 10.1161/01.CIR.0000143378.58099.8C; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Ganz P, 2003, CIRCULATION, V108, P2049, DOI 10.1161/01.CIR.0000089507.19675.F9; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Haque S, 2005, NAT CLIN PRACT CARD, V2, P423, DOI 10.1038/ncpcardio0270; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Herzberg M C, 1998, Ann Periodontol, V3, P151, DOI 10.1902/annals.1998.3.1.151; Hingorani AD, 2000, CIRCULATION, V102, P994, DOI 10.1161/01.CIR.102.9.994; Hujoel PP, 2000, JAMA-J AM MED ASSOC, V284, P1406, DOI 10.1001/jama.284.11.1406; KWEIDER M, 1993, SCOT MED J, V38, P73, DOI 10.1177/003693309303800304; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Loos BG, 2000, J PERIODONTOL, V71, P1528, DOI 10.1902/jop.2000.71.10.1528; Moncada S, 1997, ANN NY ACAD SCI, V811, P60, DOI 10.1111/j.1749-6632.1997.tb51989.x; Noack B, 2001, J PERIODONTOL, V72, P1221, DOI 10.1902/jop.2000.72.9.1221; Papapanou P N, 1996, Ann Periodontol, V1, P1, DOI 10.1902/annals.1996.1.1.1; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Qi MS, 2003, MICROB PATHOGENESIS, V35, P259, DOI 10.1016/j.micpath.2003.07.002; QUYYUMI AA, 1995, J CLIN INVEST, V95, P1747, DOI 10.1172/JCI117852; Scannapieco Frank A, 2003, Ann Periodontol, V8, P38, DOI 10.1902/annals.2003.8.1.38; Schwahn C, 2004, THROMB HAEMOSTASIS, V92, P244, DOI 10.1160/TH04-02-0092; Slade GD, 2003, ARCH INTERN MED, V163, P1172, DOI 10.1001/archinte.163.10.1172; Slade GD, 2000, J DENT RES, V79, P49, DOI 10.1177/00220345000790010701; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747	38	860	907	2	110	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2007	356	9					911	920		10.1056/NEJMoa063186	http://dx.doi.org/10.1056/NEJMoa063186			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140HV	17329698	Green Published			2022-12-28	WOS:000244496400006
J	Rose, N				Rose, Nikolas			Beyond medicalisation	LANCET			English	Article; Proceedings Paper	Meeting on Medicalisation in the 21st Century	JUN, 2005	New York, NY						London Sch Econ, Ctr Study Biosci Biomed Biotechnol & Soc, London WC2A 2AE, England	University of London; London School Economics & Political Science	Rose, N (corresponding author), London Sch Econ, Ctr Study Biosci Biomed Biotechnol & Soc, London WC2A 2AE, England.	N.Rose@lse.ac.uk	Rose, Nikolas S/D-1918-2010; Rose, Nikolas/A-4229-2013	Rose, Nikolas/0000-0003-4007-5077	Economic and Social Research Council [ES/E020585/1] Funding Source: researchfish; ESRC [ES/E020585/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Hacking Ian, 1986, RECONSTRUCTING INDIV, P222; KASS L, 2004, THERAPY BIOTECHNOLOG, pR21; Miller P, 1997, THEOR CULT SOC, V14, P1, DOI 10.1177/026327697014001001; Rose N., 1994, REASSESSING FOUCAULT, P48	4	150	171	0	27	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2007	369	9562					700	702		10.1016/S0140-6736(07)60319-5	http://dx.doi.org/10.1016/S0140-6736(07)60319-5			3	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141RO	17321317				2022-12-28	WOS:000244596600033
J	Gurnett, DA; Persoon, AM; Kurth, WS; Groene, JB; Averkamp, TF; Dougherty, MK; Southwood, DJ				Gurnett, D. A.; Persoon, A. M.; Kurth, W. S.; Groene, J. B.; Averkamp, T. F.; Dougherty, M. K.; Southwood, D. J.			The variable rotation period of the inner region of Saturn's plasma disk	SCIENCE			English	Article							RADIO; ENCELADUS	We show that the plasma and magnetic fields in the inner region of Saturn's plasma disk rotate in synchronism with the time-variable modulation period of Saturn's kilometric radio emission. This relation suggests that the radio modulation has its origins in the inner region of the plasma disk, most likely from a centrifugally driven convective instability and an associated plasma outflow that slowly slips in phase relative to Saturn's internal rotation. The slippage rate is determined by the electrodynamic coupling of the plasma disk to Saturn and by the drag force exerted by its interaction with the Enceladus neutral gas torus.	Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2AZ, England; European Space Agcy, F-75738 Paris, France	University of Iowa; Imperial College London; European Space Agency	Gurnett, DA (corresponding author), Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA.		Kurth, William/AAA-7334-2019	Kurth, William/0000-0002-5471-6202	Science and Technology Facilities Council [PP/D000912/1] Funding Source: researchfish; STFC [PP/D000912/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		BRIDGE HS, 1981, SCIENCE, V212, P217, DOI 10.1126/science.212.4491.217; CONNERNEY JEP, 1984, SATURN, P354; Cowley SWH, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025522; Davies M., 1996, CELESTIAL MECH, V63, P127, DOI DOI 10.1007/BF00693410; DESCH MD, 1981, GEOPHYS RES LETT, V8, P253, DOI 10.1029/GL008i003p00253; DESSLER AJ, 1981, PLANET SPACE SCI, V29, P215, DOI 10.1016/0032-0633(81)90035-0; Dougherty MK, 2006, SCIENCE, V311, P1406, DOI 10.1126/science.1120985; Espinosa SA, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2001JA005084; Esposito LW, 2005, SCIENCE, V307, P1251, DOI 10.1126/science.1105606; EVIATAR A, 1983, J GEOPHYS RES-SPACE, V88, P823, DOI 10.1029/JA088iA02p00823; Galopeau PHM, 2000, J GEOPHYS RES-SPACE, V105, P13089, DOI 10.1029/1999JA005089; Giampieri G, 2006, NATURE, V441, P62, DOI 10.1038/nature04750; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; Hansen KC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022835; HILL TW, 1981, J GEOPHYS RES-SPACE, V86, P9020, DOI 10.1029/JA086iA11p09020; HILL TW, 1979, J GEOPHYS RES-SPACE, V84, P6554, DOI 10.1029/JA084iA11p06554; Kaiser M. L., 1984, SATURN, P378; KURTH WS, 2007, GEOPHYS RES LETT, V34; LECACHEUX A, 1997, PLANETARY RADIO EMIS, V4; Persoon AM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024294; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; SISCOE GL, 1981, J GEOPHYS RES-SPACE, V86, P8471, DOI 10.1029/JA086iA10p08471; SMITH EJ, 1980, SCIENCE, V207, P407, DOI 10.1126/science.207.4429.407; SOUTHWOOD DJ, 1989, J GEOPHYS RES, V94, P299, DOI 10.1029/JA094iA01p00299; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290; WARWICK JW, 1981, SCIENCE, V212, P239, DOI 10.1126/science.212.4491.239; YANG YS, 1994, J GEOPHYS RES-SPACE, V99, P8755, DOI 10.1029/94JA00142; Young DT, 2005, SCIENCE, V307, P1262, DOI 10.1126/science.1106151; Zarka P, 1998, J GEOPHYS RES-PLANET, V103, P20159, DOI 10.1029/98JE01323	29	210	210	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					442	445		10.1126/science.1138562	http://dx.doi.org/10.1126/science.1138562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17379775				2022-12-28	WOS:000245813400055
J	Luo, JL; Tan, W; Ricono, JM; Korchynskyi, O; Zhang, M; Gonias, SL; Cheresh, DA; Karin, M				Luo, Jun-Li; Tan, Wei; Ricono, Jill M.; Korchynskyi, Olexandr; Zhang, Ming; Gonias, Steven L.; Cheresh, David A.; Karin, Michael			Nuclear cytokine-activated IKK alpha controls prostate cancer metastasis by repressing Maspin	NATURE			English	Article							NF-KAPPA-B; MAMMARY-GLAND DEVELOPMENT; TRANSCRIPTION FACTOR; TRANSGENIC MOUSE; BONE METASTASIS; TUMOR-GROWTH; EXPRESSION; CELLS; INFLAMMATION; PROGRESSION	Inflammation enhances tumour promotion through NF-kappa B-dependent mechanisms(1). NF-kappa B was also proposed to promote metastatogenesis through epithelial - mesenchymal transition(2). Yet a mechanistic link between inflammation and metastasis is missing. We identified a role for I kappa B kinase alpha (IKK alpha), activated by receptor activator of NF-kappa B (RANK/TNFRSF11A), in mammary epithelial proliferation during pregnancy(3). Owing to similarities between mammary and prostate epithelia, we examined IKK alpha involvement in prostate cancer and its progression. Here we show that a mutation that prevents IKK alpha activation slows down CaP growth and inhibits metastatogenesis in TRAMP mice, which express SV40 T antigen in the prostate epithelium(4). Decreased metastasis correlated with elevated expression of the metastasis suppressor Maspin(5), the ablation of which restored metastatic activity. IKK alpha activation by RANK ligand (RANKL/TNFSF11) inhibits Maspin expression in prostate epithelial cells, whereas repression of Maspin transcription requires nuclear translocation of active IKK alpha. The amount of active nuclear IKK alpha in mouse and human prostate cancer correlates with metastatic progression, reduced Maspin expression and infiltration of prostate tumours with RANKL-expressing inflammatory cells. We propose that tumour-infiltrating RANKL-expressing cells lead to nuclear IKK alpha activation and inhibition of Maspin transcription, thereby promoting the metastatic phenotype.	Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Baylor College of Medicine	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Tan, Weihong/AAA-4536-2020; Tan, Weihong/A-5412-2008; Korchynskyi, Olexandr/ADA-6398-2022	Tan, Weihong/0000-0002-8066-1524; Luo, Jun-Li/0000-0002-7625-4766; Korchynskyi, Olexandr/0000-0002-4557-4003	NCI NIH HHS [R01 CA127923] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA127923] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Chen EI, 2006, IUBMB LIFE, V58, P25, DOI 10.1080/15216540500531721; Cher ML, 2003, P NATL ACAD SCI USA, V100, P7847, DOI 10.1073/pnas.1331360100; Chuang CK, 2003, J FORMOS MED ASSOC, V102, P480; DeMarzo AM, 2003, LANCET, V361, P955, DOI 10.1016/S0140-6736(03)12779-1; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Lockett J, 2006, J CELL BIOCHEM, V97, P651, DOI 10.1002/jcb.20721; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Montironi R, 2006, BJU INT, V97, P485, DOI 10.1111/j.1464-410X.2005.05972.x; Morimoto-Tomita M, 2005, CLIN EXP METASTAS, V22, P513, DOI 10.1007/s10585-005-3585-0; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Sato N, 2004, ONCOGENE, V23, P1531, DOI 10.1038/sj.onc.1207269; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Zhang M, 2000, ONCOGENE, V19, P6053, DOI 10.1038/sj.onc.1204006; Zhang M, 1999, DEV BIOL, V215, P278, DOI 10.1006/dbio.1999.9442; Zou ZQ, 2002, CLIN CANCER RES, V8, P1172; Zou ZQ, 2000, J BIOL CHEM, V275, P6051, DOI 10.1074/jbc.275.9.6051; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	30	347	368	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					690	694		10.1038/nature05656	http://dx.doi.org/10.1038/nature05656			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17377533				2022-12-28	WOS:000245438300045
J	Furnes, H; de Wit, M; Staudigel, H; Rosing, M; Muehlenbachs, K				Furnes, Harald; de Wit, Maarten; Staudigel, Hubert; Rosing, Minik; Muehlenbachs, Karlis			A vestige of Earth's oldest ophiolite	SCIENCE			English	Article							ISUA GREENSTONE-BELT; WEST GREENLAND; 3.8-3.7 GA; COMPLEX; TECTONICS; ISOTOPE; RECORD; ROCKS	A sheeted-dike complex within the similar to 3.8-billion-year-old Isua supracrustal belt (ISB) in southwest Greenland provides the oldest evidence of oceanic crustal accretion by spreading. The geochemistry of the dikes and associated pillow lavas demonstrates an intraoceanic island arc and mid-ocean ridge-like setting, and their oxygen isotopes suggest a hydrothermal ocean-floor-type metamorphism. The pillows and dikes are associated with gabbroic and ultramafic rocks that together make up an ophiolitic association: the Paleoarchean Isua ophiolite complex. These sheeted dikes offer evidence for remnants of oceanic crust formed by sea-floor spreading of the earliest intact rocks on Earth.	Univ Bergen, Ctr Geobiol, Bergen, Norway; Univ Bergen, Dept Earth Sci, Bergen, Norway; Univ Cape Town, Africa Earth Observ Network, ZA-7700 Rondebosch, South Africa; Univ Cape Town, Dept Geol Sci, ZA-7700 Rondebosch, South Africa; Geoforsch Zentrum, Potsdam, Germany; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Copenhagen, Nord Ctr Earth Evolut, DK-1350 Copenhagen K, Denmark; Univ Copenhagen, Geol Museum, DK-1350 Copenhagen K, Denmark; Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada	University of Bergen; University of Bergen; National Research Foundation - South Africa; University of Cape Town; University of Cape Town; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Copenhagen; University of Copenhagen; University of Alberta	Furnes, H (corresponding author), Univ Bergen, Ctr Geobiol, Bergen, Norway.	harald.furnes@geo.uib.no	Rosing, Minik/A-9977-2013	Rosing, Minik/0000-0001-7559-661X				BICKLE MJ, 1994, J GEOL, V102, P121, DOI 10.1086/629658; Boyet M, 2003, EARTH PLANET SC LETT, V214, P427, DOI 10.1016/S0012-821X(03)00423-0; CRAWFORD AJ, 1989, BONINITES; De Wit MJ, 2004, DEV PREC G, V13, P599; Dilek Y, 2003, GEOL SOC SPEC PUBL, V218, P1, DOI 10.1144/GSL.SP.2003.218.01.01; Dilek Y, 2003, GEOL SOC SPEC PUBL, V218, P43, DOI 10.1144/GSL.SP.2003.218.01.04; Hamilton W.B, 2003, GSA TODAY, V13, P4, DOI [10.1130/1052-5173(2003)0132.0.CO;2, DOI 10.1130/1052-5173(2003)0132.0.CO;2, DOI 10.1130/1052-5173(2003)013<0004:AAE>2.0.CO;2]; HOLMDEN C, 1993, SCIENCE, V259, P1733, DOI 10.1126/science.259.5102.1733; Komiya T, 1999, J GEOL, V107, P515, DOI 10.1086/314371; Kusky T.M., 2004, PRECAMBRIAN OPHIOLIT; Kusky TM, 2001, SCIENCE, V292, P1142, DOI 10.1126/science.1059426; Muehlenbachs K, 1998, CHEM GEOL, V145, P263, DOI 10.1016/S0009-2541(97)00147-2; Myers JS, 2001, PRECAMBRIAN RES, V105, P129, DOI 10.1016/S0301-9268(00)00108-X; Nutman AP, 1997, CHEM GEOL, V141, P271, DOI 10.1016/S0009-2541(97)00084-3; Nutman AP, 1996, PRECAMBRIAN RES, V78, P1, DOI 10.1016/0301-9268(95)00066-6; NUTMAN AP, 1986, GREENLAND GEOL SURV, V154; Pearce J., 2003, GEOLOGICAL SOC AM SP, V373, P269, DOI DOI 10.1130/0-8137-2373-6.269; PEDERSEN RB, 1991, J GEODYN, V13, P183, DOI 10.1016/0264-3707(91)90038-G; Polat A, 2003, PRECAMBRIAN RES, V126, P197, DOI 10.1016/S0301-9268(03)00095-0; Polat A, 2002, CHEM GEOL, V184, P231, DOI 10.1016/S0009-2541(01)00363-1; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; Rosing MT, 1996, GEOLOGY, V24, P43, DOI 10.1130/0091-7613(1996)024<0043:EPOESS>2.3.CO;2; STAKES DS, 1992, J GEOPHYS RES-SOL EA, V97, P7043, DOI 10.1029/91JB02743; Stern RJ, 2005, GEOLOGY, V33, P557, DOI 10.1130/G21365.1; Touret JLR, 2003, PRECAMBRIAN RES, V126, P219, DOI 10.1016/S0301-9268(03)00096-2; ZHAI MG, 2002, SCIENCE, V295, pA923	26	219	225	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1704	1707		10.1126/science.1139170	http://dx.doi.org/10.1126/science.1139170			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379806				2022-12-28	WOS:000245106900037
J	Jarosz, E; Mitchell, DA; Wang, DW; Teague, WJ				Jarosz, Ewa; Mitchell, Douglas A.; Wang, David W.; Teague, William J.			Bottom-up determination of air-sea momentum exchange under a major tropical cyclone	SCIENCE			English	Article							DRAG COEFFICIENT; HURRICANE-IVAN; WIND SPEEDS; SHELF; VARIABILITY; CURRENTS; WAVES	As a result of increasing frequency and intensity of tropical cyclones, an accurate forecasting of cyclone evolution and ocean response is becoming even more important to reduce threats to lives and property in coastal regions. To improve predictions, accurate evaluation of the air-sea momentum exchange is required. Using current observations recorded during a major tropical cyclone, we have estimated this momentum transfer from the ocean side of the air-sea interface, and we discuss it in terms of the drag coefficient. For winds between 20 and 48 meters per second, this coefficient initially increases and peaks at winds of about 32 meters per second before decreasing.	USN, Res Lab, Stennis Space Ctr, MS 39529 USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Jarosz, E (corresponding author), USN, Res Lab, Stennis Space Ctr, MS 39529 USA.	ewa.jarosz@nrlssc.navy.mil						Andreas EL, 2004, J PHYS OCEANOGR, V34, P1429, DOI 10.1175/1520-0485(2004)034<1429:SSR>2.0.CO;2; Bye JAT, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003114; Donelan MA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019460; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Emanuel K, 2003, J ATMOS SCI, V60, P1420, DOI 10.1175/1520-0469(2003)060<1420:ASHFAE>2.0.CO;2; FERNANDEZ ED, 2006, J GEOPHYS RES, V111, DOI DOI 10.1029/2005JC003048; LARSEN SE, 2001, WIND STRESS OCEAN, pCH7; LENTZ SJ, 1994, J PHYS OCEANOGR, V24, P2461, DOI 10.1175/1520-0485(1994)024<2461:CDOTNC>2.0.CO;2; Lentz SJ, 2001, J PHYS OCEANOGR, V31, P2749, DOI 10.1175/1520-0485(2001)031<2749:TIOSOT>2.0.CO;2; Mitchell DA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023014; MITCHUM GT, 1982, J PHYS OCEANOGR, V12, P1310, DOI 10.1175/1520-0485(1982)012<1310:WDCOTW>2.0.CO;2; Moon IJ, 2004, J ATMOS SCI, V61, P2334, DOI 10.1175/1520-0469(2004)061<2334:EOSWOA>2.0.CO;2; Powell MD, 2003, NATURE, V422, P279, DOI 10.1038/nature01481; PRICE JF, 1994, J PHYS OCEANOGR, V24, P233, DOI 10.1175/1520-0485(1994)024<0233:FSRTAM>2.0.CO;2; Pringle JM, 2002, J PHYS OCEANOGR, V32, P3101, DOI 10.1175/1520-0485(2002)032<3101:EOWDUA>2.0.CO;2; Teague WJ, 2006, CONT SHELF RES, V26, P2559, DOI 10.1016/j.csr.2006.08.002; TEAGUE WJ, IN PRESS J PHYS OCEA; Wang DW, 2005, SCIENCE, V309, P896, DOI 10.1126/science.1112509	18	196	212	4	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1707	1709		10.1126/science.1136466	http://dx.doi.org/10.1126/science.1136466			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379807				2022-12-28	WOS:000245106900038
J	McCaffrey, R				McCaffrey, Robert			The next great earthquake	SCIENCE			English	Editorial Material							SUBDUCTION ZONE		Rensselaer Polytech Inst, Dept Earth & Environm Sci, Troy, NY 12180 USA	Rensselaer Polytechnic Institute	McCaffrey, R (corresponding author), Rensselaer Polytech Inst, Dept Earth & Environm Sci, Troy, NY 12180 USA.	mccafr@rpi.edu						CIFUENTES IL, 1989, J GEOPHYS RES-SOLID, V94, P665, DOI 10.1029/JB094iB01p00665; Goldfinger C, 2003, ANNU REV EARTH PL SC, V31, P555, DOI 10.1146/annurev.earth.31.100901.141246; HYNDMAN RD, 1993, J GEOPHYS RES-SOL EA, V98, P2039, DOI 10.1029/92JB02279; McCaffrey R, 1997, J GEOPHYS RES-SOL EA, V102, P22839, DOI 10.1029/97JB01827; MCCAFFREY R, 2006, EOS T AGU S, V87; MOLNAR P, 1979, B SEISMOL SOC AM, V69, P115; RUFF L, 1980, PHYS EARTH PLANET IN, V23, P240, DOI 10.1016/0031-9201(80)90117-X; RUFF LJ, 1989, PURE APPL GEOPHYS, V129, P263, DOI 10.1007/BF00874629; SCHOLZ CH, 1995, J GEOPHYS RES-SOL EA, V100, P22103, DOI 10.1029/95JB01869; Stein S, 2007, B SEISMOL SOC AM, V97, pS279, DOI 10.1785/0120050617; Titov V, 2005, SCIENCE, V309, P2045, DOI 10.1126/science.1114576; UYEDA S, 1979, J GEOPHYS RES, V84, P1049, DOI 10.1029/JB084iB03p01049	12	52	54	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1675	1676		10.1126/science.1140173	http://dx.doi.org/10.1126/science.1140173			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	148WA	17379797				2022-12-28	WOS:000245106900026
J	Fukami, T; Beaumont, HJE; Zhang, XX; Rainey, PB				Fukami, Tadashi; Beaumont, Hubertus J. E.; Zhang, Xue-Xian; Rainey, Paul B.			Immigration history controls diversification in experimental adaptive radiation	NATURE			English	Article							SPECIES-AREA RELATIONSHIP; PSEUDOMONAS-FLUORESCENS; SPECIATION; EVOLUTION; DETERMINISM; CONTINGENCY; ADAPTATION; DIVERGENCE; DIVERSITY; ISLANDS	Diversity in biological communities is a historical product of immigration, diversification and extinction(1-4), but the combined effect of these processes is poorly understood. Here we show that the order and timing of immigration controls the extent of diversification. When an ancestral bacterial genotype was introduced into a spatially structured habitat, it rapidly diversified into multiple niche-specialist types(5). However, diversification was suppressed when a niche-specialist type was introduced before, or shortly after, introduction of the ancestral genotype. In contrast, little suppression occurred when the same niche specialist was introduced relatively late. The negative impact of early arriving immigrants was attributable to the historically sensitive outcome of interactions involving neutral competition(3) and indirect facilitation. Ultimately, the entire boom-and-bust dynamics of adaptive radiation were altered. These results demonstrate that immigration and diversification are tightly linked processes, with small differences in immigration history greatly affecting the evolutionary emergence of diversity.	Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Hawaii System; University of Hawaii Manoa; University of Auckland	Fukami, T (corresponding author), Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA.	tfukami@hawaii.edu	Zhang, Xue-Xian/B-8143-2008; Zhang, Xue-Xian/AAP-1415-2020; Rainey, Paul/A-3207-2008; Fukami, Tadashi/A-2934-2010	Zhang, Xue-Xian/0000-0002-6536-3529; Rainey, Paul/0000-0003-0879-5795; Fukami, Tadashi/0000-0001-5654-4785				Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Cowie RH, 1995, EVOLUTION, V49, P1191, DOI 10.1111/j.1558-5646.1995.tb04446.x; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; DRAKE JA, 1991, AM NAT, V137, P1, DOI 10.1086/285143; Emerson BC, 2005, EVOLUTION, V59, P586; Emerson BC, 2005, NATURE, V434, P1015, DOI 10.1038/nature03450; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Fukami T, 2003, NATURE, V424, P423, DOI 10.1038/nature01785; Gavrilets S, 2005, P NATL ACAD SCI USA, V102, P18040, DOI 10.1073/pnas.0506330102; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; GILLESPIE RG, 1994, P NATL ACAD SCI USA, V91, P2290, DOI 10.1073/pnas.91.6.2290; Goymer P, 2006, GENETICS, V173, P515, DOI 10.1534/genetics.106.055863; Hubbell Stephen P., 2001, V32, pi; Kassen R, 2004, NATURE, V431, P984, DOI 10.1038/nature02923; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Losos JB, 2003, TRENDS ECOL EVOL, V18, P220, DOI 10.1016/S0169-5347(03)00037-5; MAC ARTHUR ROBERT H., 1967; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rainey PB, 1999, ENVIRON MICROBIOL, V1, P243, DOI 10.1046/j.1462-2920.1999.00040.x; RAINEY PB, 2005, INFLUENCE COOPERATIV, P83; Ricklefs R.E., 1993, J EVOLUTION BIOL, DOI DOI 10.1046/J.1420-9101.1993.6020171.X; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Taylor EB, 2000, P ROY SOC B-BIOL SCI, V267, P2375, DOI 10.1098/rspb.2000.1294; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Weiher E., 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237	30	171	172	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					436	439		10.1038/nature05629	http://dx.doi.org/10.1038/nature05629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17377582				2022-12-28	WOS:000245079500039
J	Taga, ME; Larsen, NA; Howard-Jones, AR; Walsh, CT; Walker, GC				Taga, Michiko E.; Larsen, Nicholas A.; Howard-Jones, Annaleise R.; Walsh, Christopher T.; Walker, Graham C.			BluB cannibalizes flavin to form the lower ligand of vitamin B-12	NATURE			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; REDUCED FLAVIN; COENZYME B-12; BIOSYNTHESIS; 5,6-DIMETHYLBENZIMIDAZOLE; TRANSFORMATION; MONOOXYGENASE; RIBOFLAVIN; MECHANISM	Vitamin B-12 (cobalamin) is among the largest known non-polymeric natural products, and the only vitamin synthesized exclusively by microorganisms(1). The biosynthesis of the lower ligand of vitamin B-12, 5,6-dimethylbenzimidazole (DMB), is poorly understood(1-3). Recently, we discovered that a Sinorhizobium meliloti gene, bluB, is necessary for DMB biosynthesis(4). Here we show that BluB triggers the unprecedented fragmentation and contraction of the bound flavin mononucleotide cofactor and cleavage of the ribityl tail to form DMB and D-erythrose 4-phosphate. Our structural analysis shows that BluB resembles an NAD(P)H-flavin oxidoreductase, except that its unusually tight binding pocket accommodates flavin mononucleotide but not NAD( P) H. We characterize crystallographically an early intermediate along the reaction coordinate, revealing molecular oxygen poised over reduced flavin. Thus, BluB isolates and directs reduced flavin to activate molecular oxygen for its own cannibalization. This investigation of the biosynthesis of DMB provides clarification of an aspect of vitamin B-12 that was otherwise incomplete, and may contribute to a better understanding of vitamin B-12-related disease.	MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Walsh, CT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	christopher_walsh@hms.harvard.edu		/0000-0001-7243-8261	NIGMS NIH HHS [R01 GM031030-25, R01 GM020011-30, R01 GM031030, R01 GM020011] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020011, R01GM031030] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Campbell GRO, 2006, P NATL ACAD SCI USA, V103, P4634, DOI 10.1073/pnas.0509384103; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; Eichhorn E, 1999, J BIOL CHEM, V274, P26639, DOI 10.1074/jbc.274.38.26639; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Gatti DL, 1996, BIOCHEMISTRY-US, V35, P567, DOI 10.1021/bi951344i; HECHT HJ, 1995, NAT STRUCT BIOL, V2, P1109, DOI 10.1038/nsb1295-1109; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HORIG JA, 1980, EUR J BIOCHEM, V105, P587, DOI 10.1111/j.1432-1033.1980.tb04536.x; Keck K, 1998, ARCH MICROBIOL, V171, P66, DOI 10.1007/s002030050679; Koike H, 1998, J MOL BIOL, V280, P259, DOI 10.1006/jmbi.1998.1871; KOLONKO B, 1992, Z NATURFORSCH C, V47, P171; Larsen NA, 2006, BIOCHEMISTRY-US, V45, P10184, DOI 10.1021/bi060950i; Lei BF, 1998, BIOCHEMISTRY-US, V37, P14623, DOI 10.1021/bi981841+; LINGENS B, 1992, EUR J BIOCHEM, V207, P981, DOI 10.1111/j.1432-1033.1992.tb17133.x; Lovering AL, 2001, J MOL BIOL, V309, P203, DOI 10.1006/jmbi.2001.4653; Maggio-Hall LA, 2003, ORG LETT, V5, P2211, DOI 10.1021/ol034530m; Malito E, 2004, P NATL ACAD SCI USA, V101, P13157, DOI 10.1073/pnas.0404538101; Renz P., 1999, Chemistry and biochemistry of B12., P557; RENZ P, 1970, FEBS LETT, V6, P187, DOI 10.1016/0014-5793(70)80053-9; RENZ P, 1972, FEBS LETT, V22, P124, DOI 10.1016/0014-5793(72)80236-9; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Tanner JJ, 1996, BIOCHEMISTRY-US, V35, P13531, DOI 10.1021/bi961400v; Tu SC, 2001, ANTIOXID REDOX SIGN, V3, P881, DOI 10.1089/15230860152665046; Warren MJ, 2006, P NATL ACAD SCI USA, V103, P4799, DOI 10.1073/pnas.0601030103	29	124	130	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					449	453		10.1038/nature05611	http://dx.doi.org/10.1038/nature05611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	148MO	17377583	Green Accepted			2022-12-28	WOS:000245079500042
J	Binder, AI				Binder, Allan I.			Cervical spondylosis and neck pain	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CLINICAL-TRIAL; FOLLOW-UP; SPINAL MANIPULATION; TRAPEZIUS MYALGIA; PHYSICAL-THERAPY; MANUAL THERAPY; EXERCISE; PHYSIOTHERAPY; MOBILIZATION; DISORDERS		East & N Hertfordshire NHS Trust, Lister Hosp, Stevenage SG1 4AB, Herts, England	Lister Hospital	Binder, AI (corresponding author), East & N Hertfordshire NHS Trust, Lister Hosp, Stevenage SG1 4AB, Herts, England.	allan.binder@nhs.net						Aker PD, 1996, BMJ-BRIT MED J, V313, P1291; Albright J, 2001, PHYS THER, V81, P1701; BINDER A, 2006, CLIN EVIDENCE; Binder AI, 2004, OXFORD TXB RHEUMATOL, V3rd, P1185; Boswell Mark V, 2003, Pain Physician, V6, P319; Bronfort G, 2001, SPINE, V26, P788, DOI 10.1097/00007632-200104010-00020; Bronfort Gert, 2004, Spine J, V4, P335, DOI 10.1016/j.spinee.2003.06.002; Canadian Chiropractic A, 2005, J CAN CHIROPR ASS, V49, P158; Dziedzic K, 2005, ARTHRIT RHEUM-ARTHR, V53, P214, DOI 10.1002/art.21087; Evans R, 2002, SPINE, V27, P2383, DOI 10.1097/00007632-200211010-00013; Fouyas IP, 2002, SPINE, V27, P736, DOI 10.1097/00007632-200204010-00011; Haines T.A., 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD004249.PUB2; Hoving JL, 2002, ANN INTERN MED, V136, P713, DOI 10.7326/0003-4819-136-10-200205210-00006; Hurwitz EL, 2002, AM J PUBLIC HEALTH, V92, P1634, DOI 10.2105/AJPH.92.10.1634; Hurwitz EL, 1996, SPINE, V21, P1746, DOI 10.1097/00007632-199608010-00007; Jordan A, 1998, SPINE, V23, P311, DOI 10.1097/00007632-199802010-00005; KARJALAINEN K, 2002, COCHRANE DB SYST REV; Kay TM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004250.pub3; KOES BW, 1992, BRIT MED J, V304, P601, DOI 10.1136/bmj.304.6827.601; Oduneye F., 2004, STEER SUCCINCT TIMEL, V4; Persson LCG, 1997, SPINE, V22, P751, DOI 10.1097/00007632-199704010-00007; Sarig-Bahat H, 2003, MANUAL THER, V8, P10, DOI 10.1054/math.2002.0480; VANDERHEIJDEN GJMG, 1995, PHYS THER, V75, P93, DOI 10.1093/ptj/75.2.93; Vernon HT, 2005, J MANIP PHYSIOL THER, V28, P443, DOI 10.1016/j.jmpt.2005.06.011; Viljanen M, 2003, BRIT MED J, V327, P475, DOI 10.1136/bmj.327.7413.475; Waling K, 2002, SPINE, V27, P789, DOI 10.1097/00007632-200204150-00002; Waling K, 2000, PAIN, V85, P201, DOI 10.1016/S0304-3959(99)00265-1; White AR, 1999, RHEUMATOLOGY, V38, P143, DOI 10.1093/rheumatology/38.2.143; Ylinen J, 2003, JAMA-J AM MED ASSOC, V289, P2509, DOI 10.1001/jama.289.19.2509	29	133	145	2	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2007	334	7592					527	531		10.1136/bmj.39127.608299.80	http://dx.doi.org/10.1136/bmj.39127.608299.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148VV	17347239	Green Published			2022-12-28	WOS:000245106400044
J	Hirsch, A; Windhausen, F; Tijssen, JGP; Verheugt, FWA; Cornel, JH; de Winter, RJ				Hirsch, Alexander; Windhausen, Fons; Tijssen, Jan G. P.; Verheugt, Freek W. A.; Hein Cornel, Jan; de Winter, Robbert J.		ICTUS investigators	Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study	LANCET			English	Article							PREDICTS ADVERSE OUTCOMES; RITA-3 RANDOMIZED-TRIAL; KINASE-MB ELEVATION; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; CONSERVATIVE STRATEGIES; ENZYME ELEVATION; UNSTABLE ANGINA; INTERVENTION; DAMAGE	Background The ICTUS trial was a study that compared an early invasive with a selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome (nSTE-ACS). The study reported no difference between the strategies for frequency of death, myocardial infarction, or rehospitalisation after 1 year. We did a follow-up study to assess the effects of these treatment strategies after 4 years. Methods 1200 patients with nSTE-ACS and an elevated cardiac troponin were enrolled from 42 hospitals in the Netherlands. Patients were randomly assigned either to an early invasive strategy, including early routine catheterisation and revascularisation. where appropriate, or to a more selective invasive strategy, where catheterisation was done if the patient had refractory angina or recurrent ischaemia. The main endpoints for the current follow-up study were death, recurrent myocardial infarction, or rehospitalisation for anginal symptoms within 3 years after randomisation, and cardiovascular mortality and all-cause mortality within 4 years. Analysis was by intention-to-treat. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN82153174. Findings The in-hospital revascularisation rate was 76% in the early invasive group and 40% in the selective invasive group. After 3 years, the cumulative rate for the combined endpoint was 30.0% in the early invasive group compared with 26.0% in the selective invasive group (hazard ratio 1.21; 95% Cl 0.97-1.50; p=0.09). Myocardial infarction was more frequent in the early invasive strategy group (106 [18.3%] vs 69 [12.3%]; HR 1.61; 1.19-2.18; p=0.002). Rates of death or spontaneous myocardial infarction were not different (76 [14.3%] patients in the early invasive and 63 [11.2%] patients in the selective invasive strategy [HR 1.19; 0.86-1.67; p=0.301). No difference in all-cause mortality (7.9% vs 7.7%; p=0.62) or cardiovascular mortality (4.5% vs 5.0%; p=0.97) was seen within 4 years. Interpretation Long-term follow-up of the ICTUS trial suggests that an early invasive strategy might not be better than a more selective invasive strategy in patients with nSTE-ACS and an elevated cardiac troponin, and implementation of either strategy might be acceptable in these patients.	Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1100 DD Amsterdam, Netherlands; Univ Med Ctr St Radboud, Dept Cardiol, Nijmegen, Netherlands; Med Ctr Alkmaar, Dept Cardiol, Alkmaar, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Medical Center Of Alkmaar	de Winter, RJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cardiol, B2-137,Meibergdreef 9,POB 22660, NL-1100 DD Amsterdam, Netherlands.	r.j.dewinter@amc.uva.nl	Hirsch, Alexander/AAF-5576-2020; Verheugt, F.W.A./H-8105-2014; cornel, jan hein/Y-7065-2019	Hirsch, Alexander/0000-0002-3315-2006; cornel, jan hein/0000-0002-1006-2112				Akkerhuis KM, 2002, CIRCULATION, V105, P554, DOI 10.1161/hc0502.104278; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050; Bhatt DL, 2005, CIRCULATION, V112, P906, DOI 10.1161/CIRCULATIONAHA.104.483297; BRAUNWALD E, 1994, CIRCULATION, V89, P1545; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cavallini C, 2005, EUR HEART J, V26, P1494, DOI 10.1093/eurheartj/ehi173; Cutlip DE, 2005, CIRCULATION, V112, P916, DOI 10.1161/CIRCULATIONAHA.104.478347; de Winter RJ, 2005, NEW ENGL J MED, V353, P1095, DOI 10.1056/NEJMoa044259; Fox KAA, 2005, LANCET, V366, P914, DOI 10.1016/S0140-6736(05)67222-4; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; HOENIG MR, 2006, COCHRANE DB SYST REV, V3; Lagerqvist B, 2005, HEART, V91, P1047, DOI 10.1136/hrt.2003.031369; Lagerqvist B, 2002, J AM COLL CARDIOL, V40, P1902, DOI 10.1016/S0735-1097(02)02572-X; Lagerqvist B, 2006, LANCET, V368, P998, DOI 10.1016/S0140-6736(06)69416-6; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Miller WL, 2006, EUR HEART J, V27, P1061, DOI 10.1093/eurheartj/ehi760; Oldgren J, 2004, THROMB HAEMOSTASIS, V91, P381, DOI 10.1160/TH03-07-0427; Roe MT, 2004, EUR HEART J, V25, P313, DOI 10.1016/j.ehj.2003.12.009; Yusuf S, 2001, NEW ENGL J MED, V345, P494	20	101	109	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2007	369	9564					827	835		10.1016/S0140-6736(07)60410-3	http://dx.doi.org/10.1016/S0140-6736(07)60410-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144JC	17350451				2022-12-28	WOS:000244791300030
J	Liu, YH; Wang, G; Wang, RJ; Zhao, DQ; Pan, MX; Wang, WH				Liu, Yan Hui; Wang, Gang; Wang, Ru Ju; Zhao, De Qian; Pan, Ming Xiang; Wang, Wei Hua			Super plastic bulk metallic glasses at room temperature	SCIENCE			English	Article							FREE-VOLUME CHANGES; POSITRON-ANNIHILATION; DEFORMATION; BEHAVIOR; COMPRESSION; STRENGTH; ALLOYS; STRESS; FLOW	In contrast to the poor plasticity that is usually observed in bulk metallic glasses, super plasticity is achieved at room temperature in ZrCuNiAl synthesized through the appropriate choice of its composition by controlling elastic moduli. Microstructures analysis indicates that the super plastic bulk metallic glasses are composed of hard regions surrounded by soft regions, which enable the glasses to undergo true strain of more than 160%. This finding is suggestive of a solution to the problem of brittleness in, and has implications for understanding the deformation mechanism of, metallic glasses.	Chinese Acad Sci, Inst Phys, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Physics, CAS	Wang, WH (corresponding author), Chinese Acad Sci, Inst Phys, POB 603, Beijing 100080, Peoples R China.	whw@aphy.iphy.ac.cn	Wang, Gang/K-2630-2012; LIU, Yanhui/B-1485-2009					ARGON AS, 1979, ACTA METALL MATER, V27, P47, DOI 10.1016/0001-6160(79)90055-5; Bei H, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.105503; Charalambides MN, 2005, J MATER SCI, V40, P3375, DOI 10.1007/s10853-005-2846-2; Chen MW, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.245502; Das J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.205501; Dimiduk DM, 2006, SCIENCE, V312, P1188, DOI 10.1126/science.1123889; Eckert J, 2006, INTERMETALLICS, V14, P876, DOI 10.1016/j.intermet.2006.01.003; El-Aguizy T, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1949467; GREER AL, 1995, SCIENCE, V267, P1947, DOI 10.1126/science.267.5206.1947; Gu XJ, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2206149; Hufnagel TC, 2002, J MATER RES, V17, P1441, DOI 10.1557/JMR.2002.0214; Ichitsubo T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.245501; Kanungo BP, 2004, INTERMETALLICS, V12, P1073, DOI 10.1016/j.intermet.2004.04.033; Kawamura Y, 1997, APPL PHYS LETT, V71, P779, DOI 10.1063/1.119643; Kumar KS, 2003, ACTA MATER, V51, P5743, DOI 10.1016/j.actamat.2003.08.032; Lewandowski JJ, 2005, PHIL MAG LETT, V85, P77, DOI 10.1080/09500830500080474; Lu J, 2003, ACTA MATER, V51, P3429, DOI 10.1016/S1359-6454(03)00164-2; Ma E, 2003, NAT MATER, V2, P7, DOI 10.1038/nmat797; Mukai T, 2002, INTERMETALLICS, V10, P1071, DOI 10.1016/S0966-9795(02)00137-1; Murali P, 2005, ACTA MATER, V53, P1467, DOI 10.1016/j.actamat.2004.11.040; Nagel C, 1999, PHYS REV B, V60, P9212, DOI 10.1103/PhysRevB.60.9212; Schiotz J, 2003, SCIENCE, V301, P1357, DOI 10.1126/science.1086636; Schroers J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.255506; SPAEPEN F, 1977, ACTA METALL MATER, V25, P407, DOI 10.1016/0001-6160(77)90232-2; Suh D, 2003, J MATER RES, V18, P2021, DOI 10.1557/JMR.2003.0283; Wang D, 2005, ACTA MATER, V53, P2969, DOI 10.1016/j.actamat.2005.03.012; Wang LM, 2000, APPL PHYS LETT, V77, P1147, DOI 10.1063/1.1289801; Wang WH, 2006, J APPL PHYS, V99, DOI 10.1063/1.2193060; Wright WJ, 2001, MATER TRANS, V42, P642, DOI 10.2320/matertrans.42.642; Xing LQ, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.180201; Zhang Y, 2006, NAT MATER, V5, P857, DOI 10.1038/nmat1758; Zhang ZF, 2005, PHIL MAG LETT, V85, P513, DOI 10.1080/09500830500395237; Zheng Q, 2006, SCRIPTA MATER, V55, P541, DOI 10.1016/j.scriptamat.2006.05.029	33	952	1016	34	678	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1385	1388		10.1126/science.1136726	http://dx.doi.org/10.1126/science.1136726			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347434				2022-12-28	WOS:000244752200025
J	Simon, A; Frisen, J				Simon, Andras; Frisen, Jonas			From stem cell to progenitor and back again	CELL			English	Editorial Material							REGENERATION	Under normal homeostatic conditions, tissue stem cells undergo long-term self renewal and produce progeny that differentiate into several different cell types. But what happens if the stem cells are lost? In a recent issue of Developmental Cell, Nakagawa et W. (2007) propose that the progeny of stem cells, called transit-amplifying progenitor cells, are able to replace lost stem cells.	Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet	Frisen, J (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se		Simon, Andras/0000-0002-1018-1891				Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X	5	13	13	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					825	826		10.1016/j.cell.2007.02.026	http://dx.doi.org/10.1016/j.cell.2007.02.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350567	Bronze			2022-12-28	WOS:000245073400005
J	Zaanen, J				Zaanen, Jan			Watching rush hour in the world of electrons	SCIENCE			English	Editorial Material							SUPERCONDUCTORS		Leiden State Univ, Dept Phys, NL-2333 AA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Zaanen, J (corresponding author), Leiden State Univ, Dept Phys, NL-2333 AA Leiden, Netherlands.	jan@lorentz.leidenuniv.nl						Abbamonte P, 2005, NAT PHYS, V1, P155, DOI 10.1038/nphys178; Anderson PW, 2006, J PHYS CHEM SOLIDS, V67, P1, DOI 10.1016/j.jpcs.2005.10.132; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Zaanen J, 2006, NATURE, V440, P1118, DOI 10.1038/4401118a; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391; 2006, NATURE PHYS, V2, P133; 2006, SCIENCE, V314, P1072	8	8	10	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1372	1373		10.1126/science.1139805	http://dx.doi.org/10.1126/science.1139805			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347429				2022-12-28	WOS:000244752200018
J	Hwang, J; Timusk, T; Carbotte, JP				Hwang, Jungseek; Timusk, Thomas; Carbotte, Jules P.			Scanning-tunnelling spectroscopy	NATURE			English	Letter							SUPERCONDUCTIVITY; BI2SR2CACU2O8+DELTA; SPECTRUM		McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada	McMaster University; Canadian Institute for Advanced Research (CIFAR)	Hwang, J (corresponding author), McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.	timusk@mcmaster.ca	Hwang, Jungseek/ABF-5223-2020	hwang, jungseek/0000-0002-2555-1218				Hwang J, 2004, NATURE, V427, P714, DOI 10.1038/nature02347; JAKLEVIC RC, 1966, PHYS REV LETT, V17, P1139, DOI 10.1103/PhysRevLett.17.1139; Lee J, 2006, NATURE, V442, P546, DOI 10.1038/nature04973; MCMILLAN WL, 1965, PHYS REV LETT, V14, P108, DOI 10.1103/PhysRevLett.14.108; Pilgram S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.117003; Scalapino DJ, 2006, NAT PHYS, V2, P593, DOI 10.1038/nphys398; Zasadzinski JF, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.017004; Zasadzinski JF, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.067005	8	8	8	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					E3	E4		10.1038/nature05709	http://dx.doi.org/10.1038/nature05709			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344807				2022-12-28	WOS:000244718100032
J	Heijnen, EMEW; Eijkemans, MJC; De Klerk, C; Polinder, S; Beckers, NGM; Klinkert, ER; Broekmans, FJ; Passchier, J; Velde, ERT; Fauser, BCJM				Heijnen, Esther M. E. W.; Eijkemans, Marinus J. C.; De Klerk, Cora; Polinder, Suzanne; Beckers, Nicole G. M.; Klinkert, Ellen R.; Broekmans, Frank J.; Passchier, Jan; Macklon, Nick S.; Fauser, Bart C. J. M.			A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial	LANCET			English	Article							SINGLE-EMBRYO-TRANSFER; INTRACYTOPLASMIC SPERM INJECTION; COST-EFFECTIVENESS ANALYSIS; OVARIAN STIMULATION; ASSISTED REPRODUCTION; LIVE BIRTH; RELEVANT STANDARD; GNRH ANTAGONIST; END-POINT; IVF	Background Mild in-vitro fertilisation (IVF) treatment might lessen both patients' discomfort and multiple births, with their associated risks. We aimed to test the hypothesis that mild IVF treatment can achieve the same chance of a pregnancy resulting in term livebirth within 1 year compared with standard treatment, and can also reduce patients' discomfort, multiple pregnancies, and costs. Methods We did a randomised, non-inferiority effectiveness trial. 404 patients were randomly assigned to undergo either mild treatment (mild ovarian stimulation with gonadotropin-releasing hormone [GnRH] antagonist cotreatment combined with single embryo transfer) or a standard treatment (stimulation with a GnRH agonist long-protocol and transfer of two embryos). Primary endpoints were proportion of cumulative pregnancies leading to term livebirth within 1 year after randomisation (with a non-inferiority threshold of -12.5%), total costs per couple up to 6 weeks after expected date of delivery, and overall discomfort for patients. Analysis was by intention to treat. This trial is registered as an International Standard Randomised Clinical Trial, number ISRCTN35766970. Findings The proportions of cumulative pregnancies that resulted in term livebirth after 1 year were 43.4% with mild treatment and 44.7% with standard treatment (absolute number of patients=86 for both groups). The lower limit of the one-sided 95% CI was -9.8%. The proportion of couples with multiple pregnancy outcomes was 0.5% with mild IVF treatment versus 13.1% (p<0.0001) with standard treatment, and mean total costs were E8333 and E10745, respectively (difference E2412, 95% CI 703-4131). There were no significant differences between the groups in the anxiety depression, physical discomfort, or sleep quality of the mother. Interpretation Over 1 year of treatment, cumulative rates of term livebirths and patients' discomfort are much the same for mild ovarian stimulation with single embryos transferred and for standard stimulation with two embryos transferred. However, a mild IVF treatment protocol can substantially reduce multiple pregnancy rates and overall costs.	Univ Med Ctr, Dept Reprod Med & Gynaecol, NL-3584 CX Utrecht, Netherlands; Erasmus MC, Dept Med Psychol & Psychotherapy, Rotterdam, Netherlands; Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; Erasmus MC, Div Reprod Med, Rotterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Fauser, BCJM (corresponding author), Univ Med Ctr, Dept Reprod Med & Gynaecol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	b.c.fauser@umcutrecht.nl	Eijkemans, Marinus J/D-8214-2013					Al-Inany H, 2002, HUM REPROD, V17, P874, DOI 10.1093/humrep/17.4.874; Collins JA, 2002, HUM REPROD UPDATE, V8, P265, DOI 10.1093/humupd/8.3.265; de Klerk C, 2006, HUM REPROD, V21, P721, DOI 10.1093/humrep/dei395; De Sutter P, 2002, HUM REPROD, V17, P2891, DOI 10.1093/humrep/17.11.2891; Delvigne A, 2003, HUM REPROD UPDATE, V9, P77, DOI 10.1093/humupd/dmg005; Eijkemans MJC, 2006, HUM REPROD, V21, P344, DOI 10.1093/humrep/dei332; Fauser BCJM, 2005, LANCET, V365, P1807, DOI 10.1016/S0140-6736(05)66478-1; Fauser BCJM, 1997, ENDOCR REV, V18, P71, DOI 10.1210/edrv.18.1.0290; Fauser BCJM, 1999, HUM REPROD, V14, P2681, DOI 10.1093/humrep/14.11.2681; Gerris J, 1999, HUM REPROD, V14, P2581, DOI 10.1093/humrep/14.10.2581; Gerris JMR, 2005, HUM REPROD UPDATE, V11, P105, DOI 10.1093/humupd/dmh049; Gold MR, 1996, COST EFFECTIVENESS H; Heijnen EMEW, 2004, HUM REPROD, V19, P1936, DOI 10.1093/humrep/deh368; Hohmann FP, 2003, J CLIN ENDOCR METAB, V88, P166, DOI 10.1210/jc.2002-020788; Huirne JAF, 2004, DRUGS, V64, P297, DOI 10.2165/00003495-200464030-00005; Jain T, 2002, NEW ENGL J MED, V347, P661, DOI 10.1056/NEJMsa013491; Johnson NP, 2003, HUM REPROD, V18, P947, DOI 10.1093/humrep/deg260; Kjellberg AT, 2006, HUM REPROD, V21, P210, DOI 10.1093/humrep/dei298; Kolibianakis EM, 2006, HUM REPROD UPDATE, V12, P651, DOI 10.1093/humupd/dml038; Leonard L G, 1998, J Obstet Gynecol Neonatal Nurs, V27, P329, DOI 10.1111/j.1552-6909.1998.tb02656.x; Lukassen HGM, 2005, HUM REPROD, V20, P702, DOI 10.1093/humrep/deh672; Macklon NS, 2006, ENDOCR REV, V27, P170, DOI 10.1210/er.2005-0015; Min JK, 2004, HUM REPROD, V19, P3, DOI 10.1093/humrep/deh028; Olivius C, 2004, FERTIL STERIL, V81, P258, DOI 10.1016/j.fertnstert.2003.06.029; Pandian Z, 2005, HUM REPROD, V20, P2681, DOI 10.1093/humrep/dei153; Petrou S, 2001, CHILD CARE HLTH DEV, V27, P97, DOI 10.1046/j.1365-2214.2001.00203.x; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Saldeen P, 2005, HUM REPROD, V20, P4, DOI 10.1093/humrep/deh610; Stolwijk AM, 2000, HUM REPROD, V15, P203, DOI 10.1093/humrep/15.1.203; Thurin A, 2004, NEW ENGL J MED, V351, P2392, DOI 10.1056/NEJMoa041032; Vail A, 2003, HUM REPROD, V18, P1000, DOI 10.1093/humrep/deg133; Wolner-Hanssen P, 1998, HUM REPROD, V13, P88, DOI 10.1093/humrep/13.1.88	32	223	229	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2007	369	9563					743	749		10.1016/S0140-6736(07)60360-2	http://dx.doi.org/10.1016/S0140-6736(07)60360-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143MP	17336650				2022-12-28	WOS:000244726700030
J	Schwartz, T; Bartal, G; Fishman, S; Segev, M				Schwartz, Tal; Bartal, Guy; Fishman, Shmuel; Segev, Mordechai			Transport and Anderson localization in disordered two-dimensional photonic lattices	NATURE			English	Article							WEAK-LOCALIZATION; DIFFUSION; SOLITONS; ABSENCE; LIGHT	One of the most interesting phenomena in solid-state physics is Anderson localization, which predicts that an electron may become immobile when placed in a disordered lattice(1). The origin of localization is interference between multiple scatterings of the electron by random defects in the potential, altering the eigenmodes from being extended ( Bloch waves) to exponentially localized(2). As a result, the material is transformed from a conductor to an insulator. Anderson's work dates back to 1958, yet strong localization has never been observed in atomic crystals, because localization occurs only if the potential ( the periodic lattice and the fluctuations superimposed on it) is time-independent. However, in atomic crystals important deviations from the Anderson model always occur, because of thermally excited phonons and electron - electron interactions. Realizing that Anderson localization is a wave phenomenon relying on interference, these concepts were extended to optics(3,4). Indeed, both weak(5-7,31) and strong(8-11) localization effects were experimentally demonstrated, traditionally by studying the transmission properties of randomly distributed optical scatterers ( typically suspensions or powders of dielectric materials). However, in these studies the potential was fully random, rather than being 'frozen' fluctuations on a periodic potential, as the Anderson model assumes. Here we report the experimental observation of Anderson localization in a perturbed periodic potential: the transverse localization of light caused by random fluctuations on a two-dimensional photonic lattice. We demonstrate how ballistic transport becomes diffusive in the presence of disorder, and that crossover to Anderson localization occurs at a higher level of disorder. Finally, we study how nonlinearities affect Anderson localization. As Anderson localization is a universal phenomenon, the ideas presented here could also be implemented in other systems ( for example, matter waves), thereby making it feasible to explore experimentally long-sought fundamental concepts, and bringing up a variety of intriguing questions related to the interplay between disorder and nonlinearity.	Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Segev, M (corresponding author), Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel.	msegev@tx.technion.ac.il	Fishman, Shmuel/O-4404-2016; Schwartz, Tal/C-1689-2014	Fishman, Shmuel/0000-0003-2119-859X; Schwartz, Tal/0000-0002-5022-450X				AKKERMANS E, 1985, J PHYS LETT-PARIS, V46, P1045, DOI 10.1051/jphyslet:0198500460220104500; ANDERSON PW, 1985, PHILOS MAG B, V52, P505, DOI 10.1080/13642818508240619; ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Bartal G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.163902; Berry M. V., 1997, European Journal of Physics, V18, P222, DOI 10.1088/0143-0807/18/3/017; Cao H, 1999, PHYS REV LETT, V82, P2278, DOI 10.1103/PhysRevLett.82.2278; Chabanov AA, 2000, NATURE, V404, P850, DOI 10.1038/35009055; Cohen O, 2005, NATURE, V433, P500, DOI 10.1038/nature03267; DERAEDT H, 1989, PHYS REV LETT, V62, P47, DOI 10.1103/PhysRevLett.62.47; DEVILLARD P, 1986, J STAT PHYS, V43, P423, DOI 10.1007/BF01020646; DOUCOT B, 1987, J PHYS-PARIS, V48, P527, DOI 10.1051/jphys:01987004804052700; Efremidis NK, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046602; Eisenberg H., 2002, THESIS WEIZMANN I SC; ETEMAD S, 1986, PHYS REV LETT, V57, P575, DOI 10.1103/PhysRevLett.57.575; Fleischer JW, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.023902; Fleischer JW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.123904; Fleischer JW, 2003, NATURE, V422, P147, DOI 10.1038/nature01452; Freedman B, 2006, NATURE, V440, P1166, DOI 10.1038/nature04722; JOHN S, 1984, PHYS REV LETT, V53, P2169, DOI 10.1103/PhysRevLett.53.2169; LEE PA, 1985, REV MOD PHYS, V57, P287, DOI 10.1103/RevModPhys.57.287; LI QM, 1988, PHYS REV B, V38, P11888, DOI 10.1103/PhysRevB.38.11888; MCKENNA MJ, 1992, PHYS REV LETT, V69, P1807, DOI 10.1103/PhysRevLett.69.1807; Mirlin AD, 2000, PHYS REP, V326, P259, DOI 10.1016/S0370-1573(99)00091-5; Pertsch T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.053901; Storzer M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.063904; Sukhorukov AA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.093901; Trompeter H, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.053903; VANALBADA MP, 1985, PHYS REV LETT, V55, P2692, DOI 10.1103/PhysRevLett.55.2692; Wiersma DS, 1997, NATURE, V390, P671, DOI 10.1038/37757; WOLF PE, 1985, PHYS REV LETT, V55, P2696, DOI 10.1103/PhysRevLett.55.2696	31	1132	1165	4	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					52	55		10.1038/nature05623	http://dx.doi.org/10.1038/nature05623			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330037				2022-12-28	WOS:000244525600034
J	Dunne, EF; Unger, ER; Sternberg, M; McQuillan, G; Swan, DC; Patel, SS; Markowitz, LE				Dunne, Eileen F.; Unger, Elizabeth R.; Sternberg, Maya; McQuillan, Geraldine; Swan, David C.; Patel, Sonya S.; Markowitz, Lauri E.			Prevalence of HPV infection among females in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; YOUNG-WOMEN; SELF; TYPE-16; SAMPLES; SEROPREVALENCE; ACCEPTABILITY; EPIDEMIOLOGY; ADOLESCENT	Context Human papillomavirus (HPV) infection is estimated to be the most common sexually transmitted infection. Baseline population prevalence data for HPV infection in the United States before widespread availability of a prophylactic HPV vaccine would be useful. Objective To determine the prevalence of HPV among females in the United States. Design, Setting, and Participants The National Health and Nutrition Examination Survey ( NHANES) uses a representative sample of the US noninstitutionalized civilian population. Females aged 14 to 59 years who were interviewed at home for NHANES 2003-2004 were examined in a mobile examination center and provided a self-collected vaginal swab specimen. Swabs were analyzed for HPV DNA by L1 consensus polymerase chain reaction followed by type-specific hybridization. Demographic and sexual behavior information was obtained from all participants. Main Outcome Measures HPV prevalence by polymerase chain reaction. Results The overall HPV prevalence was 26.8% (95% confidence interval [CI], 23.3%-30.9%) among US females aged 14 to 59 years (n= 1921). HPV prevalence was 24.5% ( 95% CI, 19.6%-30.5%) among females aged 14 to 19 years, 44.8% ( 95% CI, 36.3%-55.3%) among women aged 20 to 24 years, 27.4% ( 95% CI, 21.9%-34.2%) among women aged 25 to 29 years, 27.5% ( 95% CI, 20.8%-36.4%) among women aged 30 to 39 years, 25.2% ( 95% CI, 19.7%-32.2%) among women aged 40 to 49 years, and 19.6% (95% CI, 14.3%-26.8%) among women aged 50 to 59 years. There was a statistically significant trend for increasing HPV prevalence with each year of age from 14 to 24 years ( P <. 001), followed by a gradual decline in prevalence through 59 years (P=. 06). HPV vaccine types 6 and 11 (low-risk types) and 16 and 18 (high-risk types) were detected in 3.4% of female participants; HPV-6 was detected in 1.3% ( 95% CI, 0.8%-2.3%), HPV-11 in 0.1% ( 95% CI, 0.03%-0.3%), HPV-16 in 1.5% ( 95% CI, 0.9%-2.6%), and HPV-18 in 0.8% ( 95% CI, 0.4%-1.5%) of female participants. Independent risk factors for HPV detection were age, marital status, and increasing numbers of lifetime and recent sex partners. Conclusions HPV is common among females in the United States. Our data indicate that the burden of prevalent HPV infection among females was greater than previous estimates and was highest among those aged 20 to 24 years. However, the prevalence of HPV vaccine types was relatively low.	Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Bethesda, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Dunne, EF (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS E-02, Atlanta, GA 30333 USA.	dde9@cdc.gov		Unger, Elizabeth/0000-0002-2925-5635				[Anonymous], 2000, Vital Health Stat 2, P1; Baldwin S, 2005, GYNECOL ONCOL, V97, P612, DOI 10.1016/j.ygyno.2005.02.001; Bosch F Xavier, 2003, J Natl Cancer Inst Monogr, P3; Casella G., 2021, STAT INFERENCE; Castle PE, 2004, J INFECT DIS, V190, P458, DOI 10.1086/421916; *CDCP, ACIP PROV REC US QUA; Dzuba IG, 2002, J WOMEN HEALTH GEN-B, V11, P265, DOI 10.1089/152460902753668466; Franco EL, 1999, J INFECT DIS, V180, P1415, DOI 10.1086/315086; Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020, DOI 10.1128/JCM.36.10.3020-3027.1998; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Gravitt PE, 2001, CANCER EPIDEM BIOMAR, V10, P95; Kahn JA, 2005, SEX TRANSM INFECT, V81, P408, DOI 10.1136/sti.2004.012047; Korn EL., 1999, ANAL HLTH SURVEYS; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Lorenzato FR, 2002, AM J OBSTET GYNECOL, V186, P962, DOI 10.1067/mob.2002.122390; Manhart LE, 2006, SEX TRANSM DIS, V33, P502, DOI 10.1097/01.olq.0000204545.89516.0a; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Ogilvie GS, 2005, SEX TRANSM INFECT, V81, P207, DOI 10.1136/sti.2004.011858; Peyton CL, 2001, J INFECT DIS, V183, P1554, DOI 10.1086/320696; Revzina NV, 2005, INT J STD AIDS, V16, P528, DOI 10.1258/0956462054679214; *SAS I INC, 2002, SAS COMP MICR WIND E; Sellors JW, 2000, CAN MED ASSOC J, V163, P513; SHAH BV, 2004, SUDAAN USERS MANUAL; Stone KM, 2002, J INFECT DIS, V186, P1396, DOI 10.1086/344354; Tarkowski TA, 2004, J INFECT DIS, V189, P46, DOI 10.1086/380466; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; U.S. Census Bureau, RAT INC POV LEV; Vernon SD, 2000, J CLIN MICROBIOL, V38, P651, DOI 10.1128/JCM.38.2.651-655.2000; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	33	1029	1073	6	60	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2007	297	8					813	819		10.1001/jama.297.8.813	http://dx.doi.org/10.1001/jama.297.8.813			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140DS	17327523	Bronze			2022-12-28	WOS:000244485000024
J	Hellman, A; Chess, A				Hellman, Asaf; Chess, Andrew			Gene body-specific methylation on the active X chromosome	SCIENCE			English	Article							DNA METHYLATION; HPRT GENE; INACTIVATION; CELLS; SITES; WIDE; ARABIDOPSIS	Differential DNA methylation is important for the epigenetic regulation of gene expression. Allele-specific methylation of the inactive X chromosome has been demonstrated at promoter CpG islands, but the overall pattern of methylation on the active X (Xa) and inactive X ( Xi) chromosomes is unknown. We performed allele-specific analysis of more than 1000 informative loci along the human X chromosome. The Xa displays more than two times as much allele-specific methylation as Xi. This methylation is concentrated at gene bodies, affecting multiple neighboring CpGs. Before X inactivation, all of these Xa gene body-methylated sites are biallelically methylated. Thus, a bipartite methylation-demethylation program results in Xa-specific hypomethylation at gene promoters and hypermethylation at gene bodies. These results suggest a relationship between global methylation and expression potentiality.	Harvard Univ, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Hellman, A (corresponding author), Harvard Univ, Sch Med, Ctr Human Genet Res, 185 Cambridge St, Boston, MA 02114 USA.	hellman@chgr.mgh.harvard.edu; chess@chgr.mgh.harvard.edu						ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; FRANK D, 1991, NATURE, V351, P239, DOI 10.1038/351239a0; Gilbert SL, 1999, P NATL ACAD SCI USA, V96, P13825, DOI 10.1073/pnas.96.24.13825; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Hoffman LM, 2005, STEM CELLS, V23, P1468, DOI 10.1634/stemcells.2004-0371; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; LOCK LF, 1986, MOL CELL BIOL, V6, P914, DOI 10.1128/MCB.6.3.914; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Valley CM, 2006, CURR OPIN GENET DEV, V16, P240, DOI 10.1016/j.gde.2006.04.008; VIEGASPEQUIGNOT E, 1988, P NATL ACAD SCI USA, V85, P7657, DOI 10.1073/pnas.85.20.7657; VUAN E, 2006, CANCER RES, V66, P3443; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; YEN PH, 1984, P NATL ACAD SCI-BIOL, V81, P1759, DOI 10.1073/pnas.81.6.1759; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	24	498	513	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2007	315	5815					1141	1143		10.1126/science.1136352	http://dx.doi.org/10.1126/science.1136352			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17322062				2022-12-28	WOS:000244387600041
J	Taylor, A; Dunne, M; Bennington, S; Ansell, S; Gardner, I; Norreys, P; Broome, T; Findlay, D; Nelmes, R				Taylor, Andrew; Dunne, Mike; Bennington, Steve; Ansell, Stuart; Gardner, Ian; Norreys, Peter; Broome, Tim; Findlay, David; Nelmes, Richard			A route to the brightest possible neutron source?	SCIENCE			English	Review							FUSION ENERGY; IGNITION; LASERS; GAIN	We review the potential to develop sources for neutron scattering science and propose that a merger with the rapidly developing field of inertial fusion energy could provide a major step-change in performance. In stark contrast to developments in synchrotron and laser science, the past 40 years have seen only a factor of 10 increase in neutron source brightness. With the advent of thermonuclear ignition in the laboratory, coupled to innovative approaches in how this may be achieved, we calculate that a neutron source three orders of magnitude more powerful than any existing facility can be envisaged on a 20- to 30-year time scale. Such a leap in source power would transform neutron scattering science.	Rutherford Appleton Lab, Res Councils, Council Cent Lab, Didcot OX11 0QX, Oxon, England; Univ Edinburgh, Ctr Sci Extreme Condit, Edinburgh EH9 3JZ, Midlothian, Scotland; Scottish Univ Phys Alliance, Sch Phys, Edinburgh EH9 3JZ, Midlothian, Scotland	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Edinburgh; University of Edinburgh	Taylor, A (corresponding author), Rutherford Appleton Lab, Res Councils, Council Cent Lab, Didcot OX11 0QX, Oxon, England.	andrew.taylor@rl.ac.uk	Dunne, Mike/B-4318-2014	Dunne, Mike/0000-0001-8740-3870; Dunne, Mike/0000-0002-4978-5166				Atzeni S, 2005, PLASMA PHYS CONTR F, V47, pB769, DOI 10.1088/0741-3335/47/12B/S58; Atzeni S, 1997, NUCL FUSION, V37, P1665, DOI 10.1088/0029-5515/37/12/I01; COEN J, 1985, NUCL MAT, V133, P46; *ESS, ESS SCI CASE; *ISIS, ISIS SPALL NEUTR SOU; Kodama R, 2002, NATURE, V418, P933, DOI 10.1038/418933a; *LIN, LINAC COH LIGHT SOUR; LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025; Nakai S, 2004, REP PROG PHYS, V67, P321, DOI 10.1088/0034-4885/67/3/R04; NUCKOLLS J, 1972, NATURE, V239, P139, DOI 10.1038/239139a0; Picton DJ, 2005, NUCL INSTRUM METH A, V545, P363, DOI 10.1016/j.nima.2005.01.341; Sethian JD, 2003, NUCL FUSION, V43, P1693, DOI 10.1088/0029-5515/43/12/015; SKOLD K, 1987, NEUTRON SCATTERING C; TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664; 2001, FUSION ENG DESIGN, V55; ADV NEUTRON SOURCE; MCNPX VERSION 2 5 0; EUROPEAN XRAY FREE E; 2002, NATURE, V417, P883; SPALLATION NEUTRON S	20	41	42	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2007	315	5815					1092	1095		10.1126/science.1127185	http://dx.doi.org/10.1126/science.1127185			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17322053				2022-12-28	WOS:000244387600027
J	van Rooij, E; Sutherland, LB; Qi, XX; Richardson, JA; Hill, J; Olson, EN				van Rooij, Eva; Sutherland, Lillian B.; Qi, Xiaoxia; Richardson, James A.; Hill, Joseph; Olson, Eric N.			Control of stress-dependent cardiac growth and gene expression by a microRNA	SCIENCE			English	Article							MYOSIN HEAVY-CHAIN; THYROID-HORMONE RECEPTOR; HUMAN HEART; TRANSGENIC MICE; HYPERTROPHY; DIFFERENTIATION; HYPOTHYROIDISM; CARDIOMYOPATHY; PROLIFERATION; PHENOTYPE	The heart responds to diverse forms of stress by hypertrophic growth accompanied by fibrosis and eventual diminution of contractility, which results from down-regulation of alpha-myosin heavy chain (alpha MHC) and up-regulation of beta MHC, the primary contractile proteins of the heart. We found that a cardiac-specific microRNA (miR-208) encoded by an intron of the alpha MHC gene is required for cardiomyocyte hypertrophy, fibrosis, and expression of beta MHC in response to stress and hypothyroidism. Thus, the alpha MHC gene, in addition to encoding a major cardiac contractile protein, regulates cardiac growth and gene expression in response to stress and hormonal signaling through miR-208.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu						Abraham WT, 2002, MOL MED, V8, P750, DOI 10.1007/BF03402039; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen WJ, 2000, MOL CELL ENDOCRINOL, V162, P45, DOI 10.1016/S0303-7207(00)00203-3; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fatkin D, 2000, J CLIN INVEST, V106, P1351, DOI 10.1172/JCI11093; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; Ito M, 2001, TRENDS ENDOCRIN MET, V12, P127, DOI 10.1016/S1043-2760(00)00355-6; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; Kinugawa K, 2001, J CLIN ENDOCR METAB, V86, P5089, DOI 10.1210/jc.86.10.5089; Kinugawa K, 2001, CIRC RES, V89, P591, DOI 10.1161/hh1901.096706; Kiriazis H, 2000, ANNU REV PHYSIOL, V62, P321, DOI 10.1146/annurev.physiol.62.1.321; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Lowes BD, 1997, J CLIN INVEST, V100, P2315, DOI 10.1172/JCI119770; Mansen A, 2001, MOL ENDOCRINOL, V15, P2106, DOI 10.1210/me.15.12.2106; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morkin E, 2000, MICROSC RES TECHNIQ, V50, P522, DOI 10.1002/1097-0029(20000915)50:6<522::AID-JEMT9>3.0.CO;2-U; Nakao K, 1997, J CLIN INVEST, V100, P2362, DOI 10.1172/JCI119776; Ojamaa K, 2000, ENDOCRINOLOGY, V141, P2139, DOI 10.1210/en.141.6.2139; Pantos C, 2006, HORM METAB RES, V38, P308, DOI 10.1055/s-2006-925404; Park SW, 2005, MOL CELL, V19, P643, DOI 10.1016/j.molcel.2005.08.008; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; SCHUYLER GT, 1990, BASIC RES CARDIOL, V85, P481, DOI 10.1007/BF01931494; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Vadaszova A, 2004, PHYSIOL RES, V53, pS57; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wei T, 2005, J ENDOCRINOL INVEST, V28, P8, DOI 10.1007/BF03345522; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; YAO JL, 1992, CIRC RES, V71, P831, DOI 10.1161/01.RES.71.4.831; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	38	1285	1349	0	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					575	579		10.1126/science.1139089	http://dx.doi.org/10.1126/science.1139089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17379774				2022-12-28	WOS:000245983100038
J	Rao, C; Aziz, O; Panesar, SS; Jones, C; Morris, S; Darzi, A; Athanasiou, T				Rao, Christopher; Aziz, Omer; Panesar, Sukhmeet Singh; Jones, Catherine; Morris, Stephen; Darzi, Ara; Athanasiou, Thanos			Cost effectiveness analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; CORONARY-ARTERY; FOLLOW-UP; SURGERY; ANGIOPLASTY; RESTENOSIS; DISEASE; STENT	Objective To compare the cost effectiveness of percutaneous transluminal coronary artery stenting with minimally invasive internal thoracic artery bypass for isolated lesions of the left anterior descending artery. Design Cost effectiveness analysis. Data sources Embase, Medline, Cochrane, Google Scholar, and Health Technology Assessment databases (1966-2005), and reference sources for utility values and economical variables. Methods Decision analytical modelling and Markov simulation were used to model medium and long term costs, quality of life, and cost effectiveness after either intervention using data from referenced sources. Probabilistic sensitivity and alternative analyses were used to investigate the effect of uncertainty about the value of model variables and model structure. Results Stenting was the dominant strategy in the first two years, being both more effective and less costly than bypass surgery. In the third year bypass surgery still remained more expensive but became marginally more effective. As the incremental cost effectiveness was 1 pound 108 130.40 (E1 682 146.00; $2 179 194) per quality adjusted life year (QALY), the additional effectiveness could not be said to justify the additional cost at this stage. By five years, however, the incremental cost effectiveness ratio of 28 pound 042.95 per QALY began to compare favourably with other interventions. At 10 years the additional effectiveness of 0.132 QALYs (range -0.166 to 0.430) probably justified the additional cost of 829.02 pound (range 205.56 pound to 1452.48) pound, with an incremental cost effectiveness of 6274.02 pound per QALY. Sensitivity and alternative analysis showed the results were sensitive to the time horizon and stent type. Conclusions Minimally invasive left internal thoracic artery bypass may be a more cost effective medium and long term alternative to percutaneous transluminal coronary artery stenting.	St Marys Hosp, Imperial Coll London, Dept Biosurg & Surg Technol, London W2 1NY, England; Imperial Coll London, Tanaka Business Sch, London, England	Imperial College London; Imperial College London	Athanasiou, T (corresponding author), St Marys Hosp, Imperial Coll London, Dept Biosurg & Surg Technol, Praed St, London W2 1NY, England.	tathan5253@aol.com	Rao, Christopher/G-5330-2010	Rao, Christopher/0000-0003-3244-3888; Aziz, Omer/0000-0002-3765-2702; Morris, Stephen/0000-0002-5828-3563				Ades AE, 2006, HEALTH ECON, V15, P373, DOI 10.1002/hec.1068; Alderman EL, 2000, J AM COLL CARDIOL, V35, P1122; Argenziano M, 2006, ANN THORAC SURG, V81, P1666, DOI 10.1016/j.athoracsur.2005.11.007; Aziz O, 2007, BMJ-BRIT MED J, V334, P617, DOI 10.1136/bmj.39106.476215.BE; Briggs AH, 1997, HEALTH ECON, V6, P327, DOI 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W; *BRIT MED ASS ROYA, 2006, BRIT NAT FORM; Campbell MK, 1999, QJM-INT J MED, V92, P177, DOI 10.1093/qjmed/92.3.177; Casula Roberto, 2004, Expert Rev Cardiovasc Ther, V2, P589, DOI 10.1586/14779072.2.4.589; Clarke M, 2001, COCHRANE REV HDB 4 1; *DEP HLTH, 2006, NHS REF COSTS 2005; Drummond MF, 2004, METHODS EC EVALUATIO; George CJ, 1998, AM J CARDIOL, V81, P860, DOI 10.1016/S0002-9149(98)00004-6; Gray DT, 2003, J THORAC CARDIOV SUR, V125, P618, DOI 10.1067/mtc.2003.14; Heitjan DF, 2000, HEALTH ECON, V9, P327; Kappert U, 2001, EUR J CARDIO-THORAC, V20, P765, DOI 10.1016/S1010-7940(01)00859-4; Kind P, 2005, EQ 5D CONCEPTS METHO; King SB, 2000, J AM COLL CARDIOL, V35, P1116, DOI 10.1016/S0735-1097(00)00546-5; Macaya C, 1996, J AM COLL CARDIOL, V27, P255, DOI 10.1016/0735-1097(95)00473-4; Moher D, 2000, ONKOLOGIE, V23, P597, DOI 10.1159/000055014; *NAT I CLIN EXC, 2003, COR ART STENTS RAP R; National Institute for Clinical Excellence, 2004, GUID METH TECHN APPR; Niinami H, 2001, ANN THORAC SURG, V72, pS1041, DOI 10.1016/S0003-4975(01)02945-9; Petitti DB., 2000, META ANAL DECISION A; Popma JJ, 2002, CIRCULATION, V106, P1592, DOI 10.1161/01.CIR.0000033309.35425.A6; Reeves BC, 2004, HEALTH TECHNOL ASSES, V8, P1; Roiron C, 2006, HEART, V92, P641, DOI 10.1136/hrt.2005.061622; Serruys P W, 1999, Semin Interv Cardiol, V4, P209; Szende A., 2004, MEASURING SELF REPOR; *UK GOV ACT DEP, 2006, INT LIF TABL 2005; Wessely R, 2005, ANN INTERN MED, V143, P392, DOI 10.7326/0003-4819-143-5-200509060-00119; Yock CA, 2003, AM J MED, V115, P382, DOI 10.1016/S0002-9343(03)00296-1; ZIMMERMAN FH, 1995, J AM COLL CARDIOL, V26, P654, DOI 10.1016/0735-1097(95)00254-2	32	28	29	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2007	334	7594					621	624		10.1136/bmj.39112.480023.BE	http://dx.doi.org/10.1136/bmj.39112.480023.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	152DC	17337457	Green Published, Bronze			2022-12-28	WOS:000245340000035
J	Brandvain, Y; Barker, MS; Wade, MJ				Brandvain, Yaniv; Barker, Michael S.; Wade, Michael J.			Gene co-inheritance and gene transfer	SCIENCE			English	Article							EVOLUTION; NUCLEUS; RATES		Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Brandvain, Y (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	ybrandva@indiana.edu	Barker, Mike/AAE-7891-2019; Barker, Michael/A-9645-2010	Barker, Mike/0000-0001-7173-1319; 	NIGMS NIH HHS [R01GM65414] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065414] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Blanchard JL, 2000, TRENDS GENET, V16, P315, DOI 10.1016/S0168-9525(00)02053-9; ESHEL I, 1970, Theoretical Population Biology, V1, P88, DOI 10.1016/0040-5809(70)90043-2; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Wade MJ, 2006, EVOLUTION, V60, P643	7	13	16	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1685	1685		10.1126/science.1134789	http://dx.doi.org/10.1126/science.1134789			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379800				2022-12-28	WOS:000245106900030
J	Steinbrook, R				Steinbrook, Robert			HIV in India - The challenge ahead	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						LUCE E, 2007, SPITE GODS STRANGE R; Moses SA, 2006, AIDS S ASIA UNDERSTA; Steinbrook R, 2007, NEW ENGL J MED, V356, P1089, DOI 10.1056/NEJMp078009; *UN DEV PROGR, 2006, 2006 HUM DEV REP; World Health Organization, 2006, ANT THER HIV INF AD	5	45	45	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1197	+		10.1056/NEJMp078011	http://dx.doi.org/10.1056/NEJMp078011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148UP	17377154	Bronze			2022-12-28	WOS:000245101900001
J	Goekoop-Ruiterman, YPM; de Vries-Bouwstra, JK; Allaart, CF; van Zeben, D; Kerstens, PJSM; Hazes, JMW; Zwinderman, AH; Peeters, AJ; de Jonge-Bok, JM; Mallee, C; de Beus, WM; de Sonnaville, PBJ; Ewals, JAPM; Breedveld, FC; Dijkmans, BAC				Goekoop-Ruiterman, Yvonne P. M.; de Vries-Bouwstra, Jeska K.; Allaart, Cornelia F.; van Zeben, Derkjen; Kerstens, Pit J. S. M.; Hazes, J. Mieke W.; Zwinderman, Aelko H.; Peeters, Andre J.; de Jonge-Bok, Johanna M.; Mallee, Constant; de Beus, Wim M.; de Sonnaville, Peter B. J.; Ewals, Jacques A. P. M.; Breedveld, Ferdinand C.; Dijkmans, Ben A. C.			Comparison of treatment strategies in early rheumatoid arthritis - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							COLLEGE-OF-RHEUMATOLOGY; DISEASE-ACTIVITY SCORE; COMBINATION THERAPY; METHOTREXATE; SULFASALAZINE; CRITERIA; HYDROXYCHLOROQUINE; CYCLOSPORINE; MONOTHERAPY; ETANERCEPT	Background: In patients with early rheumatoid arthritis, initial combination therapies provide earlier clinical improvement and less progression of joint damage after 1 year compared with initial monotherapies (as demonstrated in the BeSt study). Objective: To evaluate whether the initial clinical and radiographic efficacy of combination therapies could be maintained during the second year of follow-up in patients with early rheumatoid arthritis. Design: Randomized, controlled clinical trial with blinded assessors. Setting: 18 peripheral and 2 university medical centers in the Netherlands. Patients: 508 patients with early active rheumatoid arthritis. Intervention: Sequential monotherapy (group 1), step-up combination therapy (group 2), initial combination therapy with tapered high-dose prednisone (group 3), or initial combination therapy with infliximab (group 4). Trimonthly treatment adjustments were made to achieve low disease activity. Measurements: Primary end points were functional ability (Health Assessment Questionnaire) and Sharp-van der Heijde score for radiographic joint damage. Results: Groups 3 and 4 had more rapid clinical improvement during the first year; all groups improved further to a mean functional ability score of 0.6 (overall, P = 0.257) and 42% were in remission (overall, P = 0.690) during the second year. Progression of joint damage remained better suppressed in groups 3 and 4 (median scores of 2.0, 2.0, 1.0, and 1.0 in groups 1, 2, 3, and 4, respectively [P= 0.004]). After 2 years, 33%, 31%, 36%, and 53% of patients in groups 1 through 4, respectively, were receiving single-drug therapy for initial treatment. There were no significant differences in toxicity. Limitations: Patients and physicians were aware of the allocated group, and the assessors were blinded. Conclusions: Currently available antirheumatic drugs can be highly effective in patients with early rheumatoid arthritis in a setting of tight disease control. Initial combination therapies seem to provide earlier clinical improvement and less progression of joint damage, but all treatment strategies eventually showed similar clinical improvements. In addition, combination therapy can be withdrawn successfully and less treatment adjustments are needed than with initial monotherapies.	Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands; Vrije Univ Amsterdam, Med Ctr, Jan Van Breemen Inst, Slotervaart Hosp, Amsterdam, Netherlands; Amsterdam Med Ctr, Amsterdam, Netherlands; Erasmus MC, Rotterdam, Netherlands; Sint Francis Hosp, Rotterdam, Netherlands; Reinier Graaf Gasthuis, Delft, Netherlands; Groene Hart Hosp, Gouda, Netherlands; Kennemer Gasthuis, Haarlem, Netherlands; Med Ctr Haaglanden, Leidschendam, Netherlands; Haga Hosp, The Hague, Netherlands; Oosterschelde Hosp, Goes, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Slotervaart Hospital; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Franciscus Gasthuis; Reinier de Graaf Hospital; Spaarne Hospital; Haaglanden Medical Center; Haga Hospital	Goekoop-Ruiterman, YPM (corresponding author), Leiden Univ, Med Ctr, Dept Rheumatol, C1-R,POB 9600, NL-2300 RC Leiden, Netherlands.	y.p.m.goekoop@lumc.nl						ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Breedveld FC, 2004, ANN RHEUM DIS, V63, P149, DOI 10.1136/ard.2003.013961; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Calguneri M, 1999, CLIN EXP RHEUMATOL, V17, P699; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; *CRIT COMM NEW YOR, 1994, NOM CRIT DIAGN; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Fransen J, 2004, ANN RHEUM DIS, V63, P1222, DOI 10.1136/ard.2003.018861; Genovese MC, 2002, ARTHRITIS RHEUM, V46, P1443, DOI 10.1002/art.10308; Gerards AH, 2003, ANN RHEUM DIS, V62, P291, DOI 10.1136/ard.62.4.291; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Maini RN, 2004, ARTHRITIS RHEUM-US, V50, P1051, DOI 10.1002/art.20159; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; ODell JR, 1996, NEW ENGL J MED, V334, P1287, DOI 10.1056/NEJM199605163342002; Pincus T, 2005, ARTHRITIS RHEUM-US, V52, P1009, DOI 10.1002/art.20941; Prevoo MLL, 1996, BRIT J RHEUMATOL, V35, P1101; Puolakka K, 2004, ARTHRITIS RHEUM, V50, P55, DOI 10.1002/art.11436; SIEGERT CEH, 1984, CLIN RHEUMATOL, V3, P305, DOI 10.1007/BF02032335; TUGWELL P, 1995, NEW ENGL J MED, V333, P137, DOI 10.1056/NEJM199507203330301; van der Klooster JM, 2003, INTENS CARE MED, V29, P2327, DOI 10.1007/s00134-003-1867-z; VANDERHEIJDE DM, 1989, LANCET, V1, P1036, DOI 10.1016/S0140-6736(89)92442-2; VANDERHEIJDE DMFM, 1993, J RHEUMATOL, V20, P579; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401	27	361	386	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2007	146	6					406	415		10.7326/0003-4819-146-6-200703200-00005	http://dx.doi.org/10.7326/0003-4819-146-6-200703200-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150CC	17371885				2022-12-28	WOS:000245192200002
J	Buzsaki, G				Buzsaki, Gyoergy			The structure of consciousness - Subjective awareness may depend on neural networks in the brain supporting complex wiring schemes and dynamic patterns of activity.	NATURE			English	Editorial Material									Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.			Buzsaki, Gyorgy/0000-0002-3100-4800				Buzsaki G., 2006, RHYTHMS BRAIN; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033	2	43	46	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2007	446	7133					267	267		10.1038/446267a	http://dx.doi.org/10.1038/446267a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145VC	17361165				2022-12-28	WOS:000244892900027
J	Pregibon, DC; Toner, M; Doyle, PS				Pregibon, Daniel C.; Toner, Mehmet; Doyle, Patrick S.			Multifunctional encoded particles for high-throughput biomolecule analysis	SCIENCE			English	Article							ARRAY; MICROCARRIERS; TECHNOLOGY; MICROARRAY	High-throughput screening for genetic analysis, combinatorial chemistry, and clinical diagnostics benefits from multiplexing, which allows for the simultaneous assay of several analytes but necessitates an encoding scheme for molecular identification. Current approaches for multiplexed analysis involve complicated or expensive processes for encoding, functionalizing, or decoding active substrates ( particles or surfaces) and often yield a very limited number of analyte-specific codes. We present a method based on continuous-flow lithography that combines particle synthesis and encoding and probe incorporation into a single process to generate multifunctional particles bearing over a million unique codes. By using such particles, we demonstrate a multiplexed, single-fluorescence detection of DNA oligomers with encoded particle libraries that can be scanned rapidly in a flow-through microfluidic channel. Furthermore, we demonstrate with high specificity the same multiplexed detection using individual multiprobe particles.	MIT, Dept Chem Engn, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, BioMEMS Resource Ctr, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Doyle, PS (corresponding author), MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	pdoyle@mit.edu	Abrams, William R/A-5782-2008; Doyle, Patrick S/H-7031-2013	Doyle, Patrick S/0000-0003-2147-9172	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NIBIB NIH HHS [P41 EB002503] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Battersby BJ, 2000, J AM CHEM SOC, V122, P2138, DOI 10.1021/ja993634i; Braeckmans K, 2003, NAT MATER, V2, P169, DOI 10.1038/nmat828; Braeckmans K, 2002, NAT REV DRUG DISCOV, V1, P447, DOI 10.1038/nrd817; Cunin F, 2002, NAT MATER, V1, P39, DOI 10.1038/nmat702; Dendukuri D, 2006, NAT MATER, V5, P365, DOI 10.1038/nmat1617; Evans M, 2003, ASSAY DRUG DEV TECHN, V1, P199; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Fenniri H, 2003, J AM CHEM SOC, V125, P10546, DOI 10.1021/ja035665q; Ferguson JA, 2000, ANAL CHEM, V72, P5618, DOI 10.1021/ac0008284; Finkel NH, 2004, ANAL CHEM, V76, p353A; FODOR SPA, 1993, NATURE, V364, P555, DOI 10.1038/364555a0; Fulton RJ, 1997, CLIN CHEM, V43, P1749; Gershon D, 2002, NATURE, V416, P885, DOI 10.1038/416885a; Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228; Hergt R, 1998, IEEE T MAGN, V34, P3745, DOI 10.1109/20.718537; MacBeath G, 2000, SCIENCE, V289, P1760; MCHUGH TM, 1988, J CLIN MICROBIOL, V26, P1957, DOI 10.1128/JCM.26.10.1957-1961.1988; MORAN EJ, 1995, J AM CHEM SOC, V117, P10787, DOI 10.1021/ja00148a039; Nicewarner-Pena SR, 2001, SCIENCE, V294, P137, DOI 10.1126/science.294.5540.137; NICOLAOU KC, 1995, ANGEW CHEM INT EDIT, V34, P2289, DOI 10.1002/anie.199522891; Nolan JP, 2002, TRENDS BIOTECHNOL, V20, P9, DOI 10.1016/S0167-7799(01)01844-3; Pregibon DC, 2006, LANGMUIR, V22, P5122, DOI 10.1021/la0534625; Rehman FN, 1999, NUCLEIC ACIDS RES, V27, P649, DOI 10.1093/nar/27.2.649; Rubina AY, 2003, BIOTECHNIQUES, V34, P1008, DOI 10.2144/03345rr01; SERVICE RF, 1995, SCIENCE, V270, P577, DOI 10.1126/science.270.5236.577; Sha MY, 2006, ANAL BIOANAL CHEM, V384, P658, DOI 10.1007/s00216-005-0225-0; Su X, 2005, NANO LETT, V5, P49, DOI 10.1021/nl0484088; Vaino AR, 2000, P NATL ACAD SCI USA, V97, P7692, DOI 10.1073/pnas.97.14.7692; Vasiliskov AV, 1999, BIOTECHNIQUES, V27, P592, DOI 10.2144/99273rr06; Xu HX, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng043; Zhao XW, 2006, CHEM MATER, V18, P2443, DOI 10.1021/cm060283f; Zhi ZL, 2003, ANAL CHEM, V75, P4125, DOI 10.1021/ac034165c	32	599	668	14	352	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1393	1396		10.1126/science.1134929	http://dx.doi.org/10.1126/science.1134929			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347435				2022-12-28	WOS:000244752200028
J	Organ, CL; Shedlock, AM; Meade, A; Pagel, M; Edwards, SV				Organ, Chris L.; Shedlock, Andrew M.; Meade, Andrew; Pagel, Mark; Edwards, Scott V.			Origin of avian genome size and structure in non-avian dinosaurs	NATURE			English	Article							CELL-SIZE; DNA-CONTENT; C-VALUE; EVOLUTION; STRATEGIES; PATTERNS; GROWTH	Avian genomes are small and streamlined compared with those of other amniotes by virtue of having fewer repetitive elements and less non-coding DNA(1,2). This condition has been suggested to represent a key adaptation for flight in birds, by reducing the metabolic costs associated with having large genome and cell sizes(3,4). However, the evolution of genome architecture in birds, or any other lineage, is difficult to study because genomic information is often absent for long-extinct relatives. Here we use a novel bayesian comparative method to show that bone-cell size correlates well with genome size in extant vertebrates, and hence use this relationship to estimate the genome sizes of 31 species of extinct dinosaur, including several species of extinct birds. Our results indicate that the small genomes typically associated with avian flight evolved in the saurischian dinosaur lineage between 230 and 250 million years ago, long before this lineage gave rise to the first birds. By comparison, ornithischian dinosaurs are inferred to have had much larger genomes, which were probably typical for ancestral Dinosauria. Using comparative genomic data, we estimate that genome-wide interspersed mobile elements, a class of repetitive DNA, comprised 5 - 12% of the total genome size in the saurischian dinosaur lineage, but was 7 - 19% of total genome size in ornithischian dinosaurs, suggesting that repetitive elements became less active in the saurischian lineage. These genomic characteristics should be added to the list of attributes previously considered avian but now thought to have arisen in non-avian dinosaurs, such as feathers(5), pulmonary innovations 6, and parental care and nesting	Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England	Harvard University; University of Reading	Organ, CL (corresponding author), Harvard Univ, Museum Comparat Zool, 26 Oxford St, Cambridge, MA 02138 USA.	corgan@oeb.harvard.edu	Edwards, Scott V./D-9071-2018	Edwards, Scott V./0000-0003-2535-6217	Natural Environment Research Council [NE/C51992X/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM075490] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM075490] Funding Source: Medline	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cavalier-Smith T., 1985, EVOLUTION GENOME SIZ, P104; Ellegren H, 2005, TRENDS ECOL EVOL, V20, P180, DOI 10.1016/j.tree.2005.01.015; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Gilks W. R., 1996, MARKOV CHAIN MONTE C, P1, DOI DOI 10.1201/B14835; Gregory TR, 1999, GENOME RES, V9, P317; Gregory TR, 2001, BLOOD CELL MOL DIS, V27, P830, DOI 10.1006/bcmd.2001.0457; Gregory TR, 2005, ANIMAL GENOME SIZE D; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HORNER JR, 1979, NATURE, V282, P296, DOI 10.1038/282296a0; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; HUGHES AL, 1995, NATURE, V377, P391, DOI 10.1038/377391a0; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kozlowski J, 2003, P NATL ACAD SCI USA, V100, P14080, DOI 10.1073/pnas.2334605100; Langer MC, 2004, DINOSAURIA, 2ND EDITION, P25; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; MORRIS SC, 1988, SCIENCE, V241, P1230, DOI 10.1126/science.241.4870.1230; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; RAUP DM, 1992, EXTINCTION BAD GENES, P3; Shedlock AM, 2006, SYST BIOL, V55, P902, DOI 10.1080/10635150601091924; Shedlock AM, 2007, P NATL ACAD SCI USA, V104, P2767, DOI 10.1073/pnas.0606204104; SZARSKI H, 1983, J THEOR BIOL, V105, P201, DOI 10.1016/S0022-5193(83)80002-2; THOMSON KS, 1978, J EXP ZOOL, V205, P315, DOI 10.1002/jez.1402050216; TIERSCH TR, 1991, J HERED, V82, P363, DOI 10.1093/oxfordjournals.jhered.a111105; VANDENBUSSCHE RA, 1995, MAMM GENOME, V6, P521, DOI 10.1007/BF00356168; Waltari E, 2002, AM NAT, V160, P539, DOI 10.1086/342079; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589	30	201	203	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					180	184		10.1038/nature05621	http://dx.doi.org/10.1038/nature05621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344851				2022-12-28	WOS:000244718100039
J	Van Lennep, JR; Romijn, JA; Harinck, HIJ				Roeters Van Lennep, Jeanine; Romijn, Johannes A.; Harinck, Hubertus I. J.			Multi-organ failure after a glucagon test	LANCET			English	Editorial Material									Leiden Univ Med Ctr, Dept Internal Med, NL-2300 RC Leiden, Netherlands; Leiden Univ Med Ctr, Dept Endocrinol, NL-2300 RC Leiden, Netherlands; Leiden Univ Med Ctr, Intens Care Unit, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	Van Lennep, JR (corresponding author), Leiden Univ Med Ctr, Dept Internal Med, Albinusdreef 2,POB 9600, NL-2300 RC Leiden, Netherlands.	j.e.roeters@lumc.nl						De Wilde D, 2004, EUR J EMERG MED, V11, P237, DOI 10.1097/01.mej.0000134729.95226.e7; Herbland A, 2005, AM J EMERG MED, V23, P565, DOI 10.1016/j.ajem.2004.12.001; LANDSBERG L, 2005, HARRISONS PRINCIPLES, P2148; MINAMORI Y, 1992, DIABETES CARE, V15, P1437, DOI 10.2337/diacare.15.10.1437	4	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2007	369	9563					798	798		10.1016/S0140-6736(07)60365-1	http://dx.doi.org/10.1016/S0140-6736(07)60365-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143MP	17336657				2022-12-28	WOS:000244726700037
J	Buckling, A				Buckling, Angus			Keep it local	SCIENCE			English	Editorial Material							EVOLUTION		Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Buckling, A (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	angus.buckling@zoology.oxford.ac.uk		Buckling, Angus/0000-0003-1170-4604				Boots M, 1999, P ROY SOC B-BIOL SCI, V266, P1933, DOI 10.1098/rspb.1999.0869; Boots M, 2007, SCIENCE, V315, P1284, DOI 10.1126/science.1137126; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Keeling M, 2000, P ROY SOC B-BIOL SCI, V267, P385, DOI 10.1098/rspb.2000.1013; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; SMITH J. M., 1964, Nature, V201, P1145, DOI 10.1038/2011145a0	7	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1227	1228		10.1126/science.1139839	http://dx.doi.org/10.1126/science.1139839			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332398				2022-12-28	WOS:000244564700033
J	Roberts, I; Smith, R; Evans, S				Roberts, Ian; Smith, Richard; Evans, Stephen			Doubts over head injury studies	BRITISH MEDICAL JOURNAL			English	Editorial Material							HIGH-DOSE MANNITOL; RANDOMIZED-TRIAL					Ian.Roberts@Lshtm.ac.uk		Evans, Stephen/0000-0002-1474-2596				Couzin J, 2006, SCIENCE, V312, P38, DOI 10.1126/science.312.5770.38; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Cruz J, 2002, NEUROSURGERY, V51, P628, DOI 10.1097/00006123-200209000-00006; Cruz J, 2001, NEUROSURGERY, V49, P864; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Marshall LF, 2004, J NEUROSURG, V100, P367, DOI 10.3171/jns.2004.100.3.0367; Wakai A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub2	7	30	32	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 24	2007	334	7590					392	394		10.1136/bmj.39118.480023.BE	http://dx.doi.org/10.1136/bmj.39118.480023.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	142MQ	17322250	Green Published, Green Accepted			2022-12-28	WOS:000244654400023
J	Gies, H				Gies, Hermann			Charge flipping and beyond	SCIENCE			English	Editorial Material							INITIO STRUCTURE SOLUTION		Ruhr Univ Bochum, Dept Geol Mineral & Geophys, D-44801 Bochum, Germany	Ruhr University Bochum	Gies, H (corresponding author), Ruhr Univ Bochum, Dept Geol Mineral & Geophys, D-44801 Bochum, Germany.	hermann.gies@ruhr-uni-bochum.de	Gies, Hermann/B-6637-2009	Gies, Hermann/0000-0002-2110-2458				Baerlocher C, 2007, Z KRISTALLOGR, V222, P47, DOI 10.1524/zkri.2007.222.2.47; Baerlocher C, 2007, SCIENCE, V315, P1113, DOI 10.1126/science.1137920; Oszlanyi G, 2004, ACTA CRYSTALLOGR A, V60, P134, DOI 10.1107/S0108767303027569; Oszlanyi G, 2005, ACTA CRYSTALLOGR A, V61, P147, DOI 10.1107/S0108767304027746; Oszlanyi G, 2006, J AM CHEM SOC, V128, P8392, DOI 10.1021/ja062131r; Rius J, 2004, Z KRISTALLOGR, V219, P826, DOI 10.1524/zkri.219.12.826.55866; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662	8	2	2	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2007	315	5815					1087	1088		10.1126/science.1140022	http://dx.doi.org/10.1126/science.1140022			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	138UA	17322051				2022-12-28	WOS:000244387600025
J	Chameides, W; Oppenheimer, M				Chameides, William; Oppenheimer, Michael			Carbon trading over taxes	SCIENCE			English	Editorial Material							DEFORESTATION		Environm Def, New York, NY 10010 USA; Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Princeton University; Princeton University	Chameides, W (corresponding author), Environm Def, 257 Pk Ave, New York, NY 10010 USA.	bchameides@environmentaldefense.org		Oppenheimer, Michael/0000-0002-9708-5914				Bonnie R, 2000, SCIENCE, V288, P1763, DOI 10.1126/science.288.5472.1763; Gibbard S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024550; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Keppler F, 2006, NATURE, V439, P187, DOI 10.1038/nature04420; Moutinho P., 2005, TROPICAL DEFORESTATI; *NICH I, IN PRESS HARN FARMS; OLANDER L, 2006, DO RECENT SCI FINDIN; Penman J., 2003, INTERGOVERNMENTAL PA; Santilli M, 2005, CLIMATIC CHANGE, V71, P267, DOI 10.1007/s10584-005-8074-6; Schellnhuber H J, 2006, AVOIDING DANGEROUS C; Schlesinger WH, 2006, SCIENCE, V314, P1217, DOI 10.1126/science.1137177; *US NAT SCI TECHN, 2005, NAT AC PREC ASS PROG; Yang CJ, 2007, CLIMATIC CHANGE, V80, P199, DOI 10.1007/s10584-006-9202-7	13	28	29	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1670	1670		10.1126/science.1138299	http://dx.doi.org/10.1126/science.1138299			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379793				2022-12-28	WOS:000245106900022
J	Matthey, D; Wang, JG; Wendt, S; Matthiesen, J; Schaub, R; Laegsgaard, E; Hammer, B; Besenbacher, F				Matthey, D.; Wang, J. G.; Wendt, S.; Matthiesen, J.; Schaub, R.; Laegsgaard, E.; Hammer, B.; Besenbacher, F.			Enhanced bonding of gold nanoparticles on oxidized TiO2(110)	SCIENCE			English	Article							CO OXIDATION; SUPPORTED GOLD; CATALYTIC-ACTIVITY; CARBON-MONOXIDE; AU NANOPARTICLES; ROOM-TEMPERATURE; OXYGEN; SURFACE; TITANIA; TIO2	We studied the nucleation of gold clusters on TiO2(110) surfaces in three different oxidation states by high-resolution scanning tunneling microscopy. The three TiO2(110) supports chosen were (i) reduced (having bridging oxygen vacancies), (ii) hydrated (having bridging hydroxyl groups), and (iii) oxidized (having oxygen adatoms). At room temperature, gold nanoclusters nucleate homogeneously on the terraces of the reduced and oxidized supports, whereas on the hydrated TiO2(110) surface, clusters form preferentially at the step edges. From interplay with density functional theory calculations, we identified two different gold-TiO2(110) adhesion mechanisms for the reduced and oxidized supports. The adhesion of gold clusters is strongest on the oxidized support, and the implications of this finding for catalytic applications are discussed.	Aarhus Univ, Interdisciplinary Nanosci Ctr INANO, DK-8000 Aarhus C, Denmark; Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Besenbacher, F (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr INANO, DK-8000 Aarhus C, Denmark.	fbe@inano.dk	Hammer, Bjørk/C-3701-2013; Besenbacher, Flemming/A-9623-2010; Schaub, Renald/B-1283-2014; Schaub, Renald/O-7418-2019; Matthiesen, Jesper/N-2477-2014	Hammer, Bjørk/0000-0002-7849-6347; Schaub, Renald/0000-0002-1712-3336; Schaub, Renald/0000-0002-1712-3336; Matthiesen, Jesper/0000-0003-1040-1919				Abu Haija M, 2006, SURF SCI, V600, P1497, DOI 10.1016/j.susc.2006.02.003; Bamwenda GR, 1997, CATAL LETT, V44, P83, DOI 10.1023/A:1018925008633; Beck TJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036104; Bikondoa O, 2006, NAT MATER, V5, P189, DOI 10.1038/nmat1592; Boccuzzi F, 2000, J PHYS CHEM B, V104, P5414, DOI 10.1021/jp000749w; Bond GC, 2000, GOLD BULL, V33, P41, DOI 10.1007/BF03216579; Campbell CT, 2002, SCIENCE, V298, P811, DOI 10.1126/science.1075094; Chen MS, 2004, SCIENCE, V306, P252, DOI 10.1126/science.1102420; Cosandey F, 2001, SURF REV LETT, V8, P73, DOI 10.1016/S0218-625X(01)00088-4; Del Vitto A, 2005, J PHYS CHEM B, V109, P8040, DOI 10.1021/jp044143+; Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0; Epling WS, 1998, SURF SCI, V412-13, P333, DOI 10.1016/S0039-6028(98)00446-4; Fu L, 2005, J PHYS CHEM B, V109, P3704, DOI 10.1021/jp045117e; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Guzman J, 2005, J AM CHEM SOC, V127, P3286, DOI 10.1021/ja043752s; Guzman J, 2004, J AM CHEM SOC, V126, P2672, DOI 10.1021/ja039426e; HARUTA M, 1989, J CATAL, V115, P301, DOI 10.1016/0021-9517(89)90034-1; Hutchings GJ, 2006, J CATAL, V242, P71, DOI 10.1016/j.jcat.2006.06.001; Iddir H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.039902; Iddir H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.081407; Kim TS, 2003, J AM CHEM SOC, V125, P2018, DOI 10.1021/ja028719p; Lee SS, 2004, J AM CHEM SOC, V126, P5682, DOI 10.1021/ja049436v; Meyer R, 2004, GOLD BULL, V37, P72, DOI 10.1007/BF03215519; Molina LM, 2004, J CHEM PHYS, V120, P7673, DOI 10.1063/1.1687337; Overbury SH, 2004, CATAL LETT, V95, P99, DOI 10.1023/B:CATL.0000027281.96719.42; Remediakis IN, 2005, ANGEW CHEM INT EDIT, V44, P1824, DOI 10.1002/anie.200461699; Schubert MM, 2001, J CATAL, V197, P113, DOI 10.1006/jcat.2000.3069; Schumacher B, 2003, CATAL LETT, V89, P109, DOI 10.1023/A:1024731812974; Tong X, 2005, J AM CHEM SOC, V127, P13516, DOI 10.1021/ja052778w; Valden M, 1998, SCIENCE, V281, P1647, DOI 10.1126/science.281.5383.1647; Wahlstrom E, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.026101; Wang JG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.136107; Wendt S, 2005, SURF SCI, V598, P226, DOI 10.1016/j.susc.2005.08.041; Worz AS, 2005, J PHYS CHEM B, V109, P18418, DOI 10.1021/jp054093o	34	436	440	11	382	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1692	1696		10.1126/science.1135752	http://dx.doi.org/10.1126/science.1135752			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379802				2022-12-28	WOS:000245106900033
J	Tomatsu, K; Nakatsuji, K; Iimori, T; Takagi, Y; Kusuhara, H; Ishii, A; Komori, F				Tomatsu, K.; Nakatsuji, K.; Iimori, T.; Takagi, Y.; Kusuhara, H.; Ishii, A.; Komori, F.			An atomic seesaw switch formed by tilted asymmetric Sn-Ge dimers on a Ge (001) surface	SCIENCE			English	Article							SINGLE; MOLECULES; DYNAMICS	When tin (Sn) atoms are deposited on a clean germanium (Ge) (001) surface at room temperature, buckled dimers originating from the Sn atoms are formed at the Ge-dimer position. We identified the dimer as a heterogeneous Sn-Ge dimer by reversing its buckling orientation with a scanning tunneling microscope (STM) at 80 kelvin. An atomic seesaw switch was formed for one-dimensional electronic conduction in the Ge dimer-row direction by using the STM to reversibly flip the buckling orientation of the Sn-Ge dimer and to set up standing-wave states.	Univ Tokyo, Inst Solid State Phys, Chiba 2778581, Japan; Spring 8, RIKEN, Harima Inst, Mikazuki, Hyogo 6795148, Japan; Tottori Univ, Dept Appl Math & Phys, Tottori 6808552, Japan	University of Tokyo; Japan Synchrotron Radiation Research Institute; RIKEN; Tottori University	Tomatsu, K (corresponding author), Univ Tokyo, Inst Solid State Phys, 5-1-5 Kashiwanoha, Chiba 2778581, Japan.		NAKATSUJI, Kan/D-1177-2015; Takagi, Yasumasa/O-4554-2016; Takagi, Yasumasa/Q-2459-2019	Takagi, Yasumasa/0000-0001-8064-3345; 				Collier CP, 2000, SCIENCE, V289, P1172, DOI 10.1126/science.289.5482.1172; Collier CP, 1999, SCIENCE, V285, P391, DOI 10.1126/science.285.5426.391; Donhauser ZJ, 2001, SCIENCE, V292, P2303, DOI 10.1126/science.1060294; EIGLER DM, 1991, NATURE, V352, P600, DOI 10.1038/352600a0; Lastapis M, 2005, SCIENCE, V308, P1000, DOI 10.1126/science.1108048; Nakatsuji K, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.241308; NEEDELS M, 1988, PHYS REV B, V38, P5543, DOI 10.1103/PhysRevB.38.5543; Ramachandran GK, 2003, SCIENCE, V300, P1413, DOI 10.1126/science.1083825; SMITH DPE, 1995, SCIENCE, V269, P371, DOI 10.1126/science.269.5222.371; Stroscio JA, 2004, SCIENCE, V306, P242, DOI 10.1126/science.1102370; Takagi Y, 2004, SURF SCI, V559, P1, DOI 10.1016/j.susc.2004.04.010; Terabe K, 2005, NATURE, V433, P47, DOI 10.1038/nature03190; TOMATSU K, IN PRESS SURF SCI; Xie FQ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.128303; Yasutake Y, 2005, NANO LETT, V5, P1057, DOI 10.1021/nl050490z	15	27	27	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1696	1698		10.1126/science.1137848	http://dx.doi.org/10.1126/science.1137848			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379803				2022-12-28	WOS:000245106900034
J	Reinhardt, UE				Reinhardt, Uwe E.			The trouble with US military medicine - Squalour at the Walter Reed Army Hospital shows how out of touch America's elites really are	BRITISH MEDICAL JOURNAL			English	Editorial Material									Princeton Univ, Princeton, NJ 08544 USA	Princeton University	Reinhardt, UE (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	reinhard@princeton.edu							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 17	2007	334	7593					565	565		10.1136/bmj.39153.611111.59	http://dx.doi.org/10.1136/bmj.39153.611111.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AP	17363825	Green Published			2022-12-28	WOS:000245404400030
J	Rahimi, AR; Spertus, JA; Reid, KJ; Bernheim, SM; Krumholz, HM				Rahimi, Ali R.; Spertus, John A.; Reid, Kimberly J.; Bernheim, Susannah M.; Krumholz, Harlan M.			Financial barriers to health care and outcomes after acute myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INVASIVE CARDIAC PROCEDURES; CORONARY-ARTERY DISEASE; SOCIOECONOMIC-STATUS; INSURANCE STATUS; MORTALITY; EVENTS; ANGINA; IMPACT; STATES	Context The prevalence and consequences of financial barriers to health care services and medications are not well documented for patients with an acute myocardial infarction (AMI). Objective To measure the baseline prevalence of self-reported financial barriers to health care services or medication ( as defined by avoidance due to cost) among individuals following AMI and their association with subsequent health care outcomes. Design, Setting, and Participants The Prospective Registry Evaluating Myocardial Infarction: Event and Recovery ( PREMIER), an observational, multicenter US study of patients with AMI over 12 months in 2498 individuals enrolled from January 2003 through June 2004. Main Outcome Measures Health status symptoms ( Seattle Angina Questionnaire [SAQ]), overall health status function ( Short Form-12), and rehospitalization. Results The prevalence of self-reported financial barriers to health care services or medication was 18.1% and 12.9%, respectively. Among individuals who reported financial barriers to health care services or medication, 68.9% and 68.5%, respectively, were insured. At 1-year follow-up, individuals with financial barriers to health care services were more likely to have lower SAQ quality-of-life score (77.9 vs 86.2; adjusted mean difference=- 4.0; 95% confidence interval [CI], - 6.3 to - 1.8), and increased rates of all-cause rehospitalization (49.3% vs 38.1%; adjusted hazard ratio [HR], 1.3; 95% CI, 1.1-1.5) and cardiac rehospitalization (25.7% vs 17.7%; adjusted HR, 1.3; 95% CI, 1.0-1.6). At 1-year follow-up, individuals with financial barriers to medication were more likely to have angina (34.9% vs 17.9%; adjusted odds ratio, 1.55; 95% CI, 1.1- 2.2), lower SAQ quality-of-life score (74.0 vs 86.1; adjusted mean difference=- 7.6; 95% CI, - 10.2 to - 4.9), and increased rates of all-cause rehospitalization (57.0% vs 37.8%; risk-adjusted HR, 1.5; 95% CI, 1.2-1.8) and cardiac rehospitalization (33.7% vs 17.3%; adjusted HR, 1.7; 95% CI, 1.3-2.2). Conclusion Financial barriers to health care services and medications are associated with worse recovery after AMI, manifested as more angina, poorer quality of life, and higher risk of rehospitalization.	Yale Univ, Sch Med, Dept Med, Sect Geriatr, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06520 USA; St Lukes Hosp, Mid Amer Heart Inst, Dept Cardiol, Kansas City, MO 64111 USA; Univ Missouri, Dept Cardiol, Kansas City, MO 64110 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Yale University; Yale University; Yale University; Yale University; Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Geriatr, 333 Cedar St,POB 208088, New Haven, CT 06520 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020; Spertus, John/ABD-3075-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077113] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL077113] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alter DA, 2006, ANN INTERN MED, V144, P82, DOI 10.7326/0003-4819-144-2-200601170-00005; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; Bashshur R, 1993, Med Care Rev, V50, P199, DOI 10.1177/107755879305000204; Braunwald E, 2002, CIRCULATION, V106, P1893, DOI 10.1161/01.CIR.0000037106.76139.53; DEWAN S, 2005, NY TIMES        0702; Garcia JA, 2003, J COMMUN HEALTH, V28, P167, DOI 10.1023/A:1022904206936; GILMER T, 2005, HLTH AFF MILLWOOD S; Hsu J, 2006, NEW ENGL J MED, V354, P2349, DOI 10.1056/NEJMsa054436; Kreindel S, 1997, ARCH INTERN MED, V157, P758, DOI 10.1001/archinte.157.7.758; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; Lange K., 1997, MATH STAT METHODS GE; MARTINEZ B, 2005, WALL STREET J   0628; Morden NE, 2005, HEALTH AFFAIR, V24, P1032, DOI 10.1377/hlthaff.24.4.1032; Piette JD, 2004, MED CARE, V42, P102, DOI 10.1097/01.mlr.0000108742.26446.17; Richards Suzanne, 2003, J Health Serv Res Policy, V8, P171, DOI 10.1258/135581903322029539; Sada MJ, 1998, J AM COLL CARDIOL, V31, P1474, DOI 10.1016/S0735-1097(98)00137-5; Salganicoff A., 2005, WOMEN HLTH CARE NATL; Schoen C, 2005, HLTH AFF MILLWOOD S; Selden TM, 2003, MED CARE, V41, P13; SHORT PF, 1995, JAMA-J AM MED ASSOC, V274, P1302; SMITH VR, 2004, CONTINUING MEDICAID; Spertus JA, 2006, AM HEART J, V151, P589, DOI 10.1016/j.ahj.2005.05.026; Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90; SPERTUS JA, 1994, AM J CARDIOL, V74, P1240, DOI 10.1016/0002-9149(94)90555-X; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wright BJ, 2005, HEALTH AFFAIR, V24, P1106, DOI 10.1377/hlthaff.24.4.1106	30	157	159	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2007	297	10					1063	1072		10.1001/jama.297.10.1063	http://dx.doi.org/10.1001/jama.297.10.1063			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	145KZ	17356027				2022-12-28	WOS:000244865200020
J	Dy, S; Lynn, J				Dy, Sydney; Lynn, Joanne			Getting services right for those sick enough to die	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE; PROGRAM		Johns Hopkins Univ, Baltimore, MD 21205 USA; RAND Corp, Arlington, VA 22202 USA	Johns Hopkins University; RAND Corporation	Dy, S (corresponding author), Johns Hopkins Univ, Baltimore, MD 21205 USA.	sdy@jhsph.edu						Aiken LS, 2006, J PALLIAT MED, V9, P111, DOI 10.1089/jpm.2006.9.111; American Academy of Hospice and Palliative Medicine Center to Advance Palliative Care Hospice and Palliative Nurses Association Last Acts Partnership National Hospice and Palliative Care Organization, 2004, J PALLIAT MED, V7, P611; *CMS, 2004, MED BEN POL MAN; Federal Interagency Foram on Aging-Related Statistics, 2006, OLD AM UPD 2006 KEY; FORD PE, 2003, J PALLIAT MED, V6, P645; GYSELS M, 2003, IMPROVING SUPPORTIVE; *HAST CTR, 1987, GUID TERM LIF SUST T; King N, 2005, PALLIATIVE MED, V19, P619, DOI 10.1191/0269216305pm1084oa; Kodner DL, 2006, HEALTH SOC CARE COMM, V14, P384, DOI 10.1111/j.1365-2524.2006.00655.x; Lorenz K, 2004, END OF LIFE CARE OUT; Lunney JR, 2002, J AM GERIATR SOC, V50, P1108, DOI 10.1046/j.1532-5415.2002.50268.x; LYNN J, 2004, SICK DEATH NOT GOING; *MEDPAC, 2006, REP C INCR VAL MED W, P59; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; *NAT I HLTH STAT O, 2005, J PALLIAT MED S, V8; *ONS, 2004, NAT POP PROJ; Temkin-Greener H, 2002, J AM GERIATR SOC, V50, P125, DOI 10.1046/j.1532-5415.2002.50018.x	17	20	20	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2007	334	7592					511	513		10.1136/bmj.39127.653704.80	http://dx.doi.org/10.1136/bmj.39127.653704.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148VV	17347238	Green Published			2022-12-28	WOS:000245106400039
J	Co, C; Wong, DT; Gierke, S; Chang, V; Taunton, J				Co, Carl; Wong, Derek T.; Gierke, Sarah; Chang, Vicky; Taunton, Jack			Mechanism of actin network attachment to moving membranes: Barbed end capture by N-WASP WH2 domains	CELL			English	Article							ALDRICH-SYNDROME PROTEIN; ARP2/3 COMPLEX; LISTERIA-MONOCYTOGENES; FORCE GENERATION; DENDRITIC ORGANIZATION; N-WASP-ARP2/3 COMPLEX; FILAMENT ELONGATION; ENA/VASP PROTEINS; ATP HYDROLYSIS; LIPID VESICLES	Actin filament networks exert protrusive and attachment forces on membranes and thereby drive membrane deformation and movement. Here, we show that N-WASP WH2 domains play a previously unanticipated role in vesicle movement by transiently attaching actin filament barbed ends to the membrane. To dissect the attachment mechanism, we reconstituted the propulsive motility of lipid-coated glass beads, using purified soluble proteins. N-WASP WH2 mutants assembled actin comet tails and initiated movement, but the comet tails catastrophically detached from the membrane. When presented on the surface of a lipid-coated bead, WH2 domains were sufficient to maintain comet tail attachment. In v-Src-transformed fibroblasts, N-WASP WH2 mutants were severely defective in the formation of circular podosome arrays. In addition to creating an attachment force, interactions between WH2 domains and barbed ends may locally amplify signals for dendritic actin nucleation.	Univ Calif San Francisco, UCB Cell Prop Lab, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Program Biol Sci, UCB Cell Prop Lab, San Francisco, CA 94158 USA; Univ Calif Berkeley, Joint Grad Grp Bioengn, Berkeley, CA 94720 USA; Univ Calif San Francisco, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Taunton, J (corresponding author), Univ Calif San Francisco, UCB Cell Prop Lab, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	taunton@cmp.ucsf.edu			NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066229] Funding Source: NIH RePORTER; NEI NIH HHS [PN2 EY 016546, PN2 EY016546] Funding Source: Medline; NIGMS NIH HHS [R01 GM066229, R01 GM066229-05, GM 066229] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alberts JB, 2004, PLOS BIOL, V2, P2054, DOI 10.1371/journal.pbio.0020412; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; Boukellal H, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061906; Cameron LA, 1999, P NATL ACAD SCI USA, V96, P4908, DOI 10.1073/pnas.96.9.4908; Cameron LA, 2001, CURR BIOL, V11, P130, DOI 10.1016/S0960-9822(01)00022-7; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Dayel MJ, 2004, PLOS BIOL, V2, P476, DOI 10.1371/journal.pbio.0020091; Dickinson RB, 2004, BIOPHYS J, V87, P2838, DOI 10.1529/biophysj.104.045211; Dickinson RB, 2002, BIOPHYS J, V82, P605, DOI 10.1016/S0006-3495(02)75425-8; Dutartre H, 1996, J CELL SCI, V109, P367; Egile C, 2005, PLOS BIOL, V3, P1902, DOI 10.1371/journal.pbio.0030383; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Gerbal F, 2000, EUR BIOPHYS J BIOPHY, V29, P134, DOI 10.1007/s002490050258; Giardini PA, 2003, P NATL ACAD SCI USA, V100, P6493, DOI 10.1073/pnas.1031670100; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; HOFFMAN GR, 2004, CELL, V110, P345; Hufner K, 2001, J BIOL CHEM, V276, P35761, DOI 10.1074/jbc.M106520200; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2000, J CELL SCI, V113, P4421; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Kuo SC, 2000, NATURE, V407, P1026, DOI 10.1038/35039544; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Marcy Y, 2004, P NATL ACAD SCI USA, V101, P5992, DOI 10.1073/pnas.0307704101; Martin AC, 2006, NAT CELL BIOL, V8, P826, DOI 10.1038/ncb1443; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Mizutani K, 2002, CANCER RES, V62, P669; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Olbris DJ, 2000, BBA-MOL CELL RES, V1495, P140, DOI 10.1016/S0167-4889(99)00156-1; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Samarin S, 2003, J CELL BIOL, V163, P131, DOI 10.1083/jcb.200303191; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Soo FS, 2005, P NATL ACAD SCI USA, V102, P16233, DOI 10.1073/pnas.0507022102; Spinardi L, 2004, EXP CELL RES, V295, P360, DOI 10.1016/j.yexcr.2004.01.007; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Upadhyaya A, 2003, CURR BIOL, V13, pR734, DOI 10.1016/j.cub.2003.08.051; Upadhyaya A, 2003, P NATL ACAD SCI USA, V100, P4521, DOI 10.1073/pnas.0837027100; Uruno T, 2003, J BIOL CHEM, V278, P26086, DOI 10.1074/jbc.M301997200; van der Gucht J, 2005, P NATL ACAD SCI USA, V102, P7847, DOI 10.1073/pnas.0502121102; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; Wiesner S, 2003, J CELL BIOL, V160, P387, DOI 10.1083/jcb.200207148; Yamaguchi H, 2000, P NATL ACAD SCI USA, V97, P12631, DOI 10.1073/pnas.190351397; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7; Zamanian JL, 2003, MOL BIOL CELL, V14, P1624, DOI 10.1091/mbc.E02-08-0494	64	140	142	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					901	913		10.1016/j.cell.2006.12.049	http://dx.doi.org/10.1016/j.cell.2006.12.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350575	Green Accepted, Bronze			2022-12-28	WOS:000245073400015
J	Gourse, RL; Keck, JL				Gourse, Richard L.; Keck, James L.			Magic spots cast a spell on DNA primase	CELL			English	Editorial Material							TRANSCRIPTION REGULATION; STRINGENT RESPONSE; BACILLUS-SUBTILIS; PPGPP; DKSA	The bacterial signaling molecules ppGpp and pppGpp regulate transcription initiation in response to starvation by altering RNA polymerase activity. In this issue, Wang et al. (2007) show that (p)ppGpp also inhibits DNA replication elongation by interfering with DNA primase activity. Halting replication may help cells to maintain genomic integrity during periods of transient nutrient limitatiom	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gourse, RL (corresponding author), Univ Wisconsin, Dept Bacteriol, 420 Henry Mall, Madison, WI 53706 USA.	rgourse@bact.wisc.edu; jlkeck@wisc.edu		Keck, James/0000-0002-5961-0220	NIGMS NIH HHS [R37 GM037048] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037048] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Autret S, 1999, MOL MICROBIOL, V31, P1665, DOI 10.1046/j.1365-2958.1999.01299.x; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Kasai K, 2006, J BACTERIOL, V188, P7111, DOI 10.1128/JB.00574-06; Keck JL, 2000, SCIENCE, V287, P2482, DOI 10.1126/science.287.5462.2482; Krasny L, 2004, EMBO J, V23, P4473, DOI 10.1038/sj.emboj.7600423; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030	9	7	7	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					823	824		10.1016/j.cell.2007.02.020	http://dx.doi.org/10.1016/j.cell.2007.02.020			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350566	Bronze			2022-12-28	WOS:000245073400004
J	Yoshimori, T				Yoshimori, Tamotsu			Autophagy: Paying Charon's toll	CELL			English	Review							PROGRAMMED CELL-DEATH; PROTEINS; APOPTOSIS; ABSENCE; DISEASE; GROWTH; ATG5; MICE	Autophagy (literally self-eating) has diverse cytoprotective functions but also is linked to programmed cell death (PCD). In this issue, Qu et al. (2007) analyze the role of autophagy in PCD during development. Unexpectedly they find that autophagy induces apoptotic cells to present a signal to ensure their clearance, which is crucial for mouse embryonic morphogenesis.	Osaka Univ, Dept Cell Regulat, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; CREST, Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Osaka University; Japan Science & Technology Agency (JST)	Yoshimori, T (corresponding author), Osaka Univ, Dept Cell Regulat, Res Inst Microbial Dis, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	tamyoshi@biken.osaka-u.ac.jp						Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103	19	66	74	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					833	836		10.1016/j.cell.2007.02.023	http://dx.doi.org/10.1016/j.cell.2007.02.023			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350570	Bronze			2022-12-28	WOS:000245073400008
J	Juliano, R				Juliano, Rudy			Clinical implications of basic research: Bugging tumors to put drugs on target	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA; Univ N Carolina, Sch Med, Carolina Ctr Canc Nanotechnol Excellence, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Juliano, R (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA.							Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Cheong I, 2006, SCIENCE, V314, P1308, DOI 10.1126/science.1130651; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Rolland JP, 2005, J AM CHEM SOC, V127, P10096, DOI 10.1021/ja051977c	4	7	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2007	356	9					954	955		10.1056/NEJMcibr067638	http://dx.doi.org/10.1056/NEJMcibr067638			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140HV	17329705				2022-12-28	WOS:000244496400014
J	Tomes, N				Tomes, Nancy			Patient empowerment and the dilemmas of late-modern medicalisation	LANCET			English	Article; Proceedings Paper	Meeting on Medicalisation in the 21st Century	JUN, 2005	New York, NY				MEDICALIZATION				Tomes, N (corresponding author), 59 Soundview Ave, Northport, NY 11731 USA.	ntomes@notes.cc.sunysb.edu						BASTIAN H, 1998, COCHRANE NEWS, V12, P6; Beck Ulrich., 1992, RISK SOC NEW MODERNI; *COCHR CONS NETW, CCNET; Conrad P, 2005, J HEALTH SOC BEHAV, V46, P3, DOI 10.1177/002214650504600102; Epstein Steven., 1996, IMPURE SCI; Giddens A., 1991, MODERNITY SELF IDENT; ILLICH I, 1975, MED NEMESIS, V4, P35; Lerner BH, 2001, BREAST CANC WARS HOP; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; METZL JM, 2003, PROZAC COUCH; METZL JM, 2003, PRIM PSYCHIAT, V10, P45; Tomes N, 2006, HEALTH AFFAIR, V25, P720, DOI 10.1377/hlthaff.25.3.720; Tomes N., 2006, HIST HLTH POLICY US, P83; *U WA, EV BAS PRACT TOOLS S; Williams SJ, 1996, SOC SCI MED, V42, P1609, DOI 10.1016/0277-9536(95)00313-4	15	46	46	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2007	369	9562					698	700		10.1016/S0140-6736(07)60318-3	http://dx.doi.org/10.1016/S0140-6736(07)60318-3			3	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	141RO	17321316				2022-12-28	WOS:000244596600032
J	Mullighan, CG; Goorha, S; Radtke, I; Miller, CB; Coustan-Smith, E; Dalton, JD; Girtman, K; Mathew, S; Ma, J; Pounds, SB; Su, XP; Pui, CH; Relling, MV; Evans, WE; Shurtleff, SA; Downing, JR				Mullighan, Charles G.; Goorha, Salil; Radtke, Ina; Miller, Christopher B.; Coustan-Smith, Elaine; Dalton, James D.; Girtman, Kevin; Mathew, Susan; Ma, Jing; Pounds, Stanley B.; Su, Xiaoping; Pui, Ching-Hon; Relling, Mary V.; Evans, William E.; Shurtleff, Sheila A.; Downing, James R.			Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia	NATURE			English	Article							B-CELL DEVELOPMENT; ZINC-FINGER PROTEIN; IKAROS GENE; BSAP PAX-5; DELETION; LYMPHOMA; DNA; EXPRESSION; DIFFERENTIATION; TRANSLOCATION	Chromosomal aberrations are a hallmark of acute lymphoblastic leukaemia ( ALL) but alone fail to induce leukaemia. To identify cooperating oncogenic lesions, we performed a genome-wide analysis of leukaemic cells from 242 paediatric ALL patients using high-resolution, single-nucleotide polymorphism arrays and genomic DNA sequencing. Our analyses revealed deletion, amplification, point mutation and structural rearrangement in genes encoding principal regulators of B lymphocyte development and differentiation in 40% of B-progenitor ALL cases. The PAX5 gene was the most frequent target of somatic mutation, being altered in 31.7% of cases. The identified PAX5 mutations resulted in reduced levels of PAX5 protein or the generation of hypomorphic alleles. Deletions were also detected in TCF3 ( also known as E2A), EBF1, LEF1, IKZF1 (IKAROS) and IKZF3 (AIOLOS). These findings suggest that direct disruption of pathways controlling B-cell development and differentiation contributes to B-progenitor ALL pathogenesis. Moreover, these data demonstrate the power of high-resolution, genome-wide approaches to identify new molecular lesions in cancer.	St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Biostat, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Downing, JR (corresponding author), St Jude Childrens Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	james.downing@stjude.org	Ganesh, Dunna Sai/AGX-5170-2022; Downing, James R./N-8102-2018; Mullighan, Charles/H-3253-2011; Pounds, Stanley B/N-2480-2018; Evans, William E./C-2069-2012; Relling, Mary/N-5032-2018; Pui, Ching-Hon/N-8076-2018	Mullighan, Charles/0000-0002-1871-1850; Pounds, Stanley B/0000-0002-9167-2114; Evans, William E./0000-0002-9333-5322; Pui, Ching-Hon/0000-0003-0303-5658				Bohlander SK, 2005, SEMIN CANCER BIOL, V15, P162, DOI 10.1016/j.semcancer.2005.01.008; Bond HM, 2004, BLOOD, V103, P2062, DOI 10.1182/blood-2003-07-2388; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Busslinger M, 1996, P NATL ACAD SCI USA, V93, P6129, DOI 10.1073/pnas.93.12.6129; Cave H, 2001, LEUKEMIA, V15, P371, DOI 10.1038/sj.leu.2402052; Cazzaniga G, 2001, CANCER RES, V61, P4666; Conte N, 2002, ONCOGENE, V21, P5619, DOI 10.1038/sj.onc.1205658; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Heerema NA, 2000, J CLIN ONCOL, V18, P3837, DOI 10.1200/JCO.2000.18.22.3837; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Jackson A, 2000, CANCER RES, V60, P2775; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Maier H, 2003, MOL CELL BIOL, V23, P1946, DOI 10.1128/MCB.23.6.1946-1960.2003; Martoriati A, 2005, ONCOGENE, V24, P1461, DOI 10.1038/sj.onc.1208256; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; OKUDA T, 1995, BLOOD, V85, P2321, DOI 10.1182/blood.V85.9.2321.bloodjournal8592321; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Peters UR, 1999, ONCOGENE, V18, P79, DOI 10.1038/sj.onc.1202256; RAIMONDI SC, 1995, BLOOD, V86, P1881, DOI 10.1182/blood.V86.5.1881.bloodjournal8651881; Raynaud S, 1996, BLOOD, V87, P2891, DOI 10.1182/blood.V87.7.2891.bloodjournal8772891; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Strehl S, 2003, LEUKEMIA, V17, P1121, DOI 10.1038/sj.leu.2402923; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Warming S, 2003, BLOOD, V101, P1934, DOI 10.1182/blood-2002-08-2652; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Wlodarska I, 2005, LEUKEMIA, V19, P1299, DOI 10.1038/sj.leu.2403813; Ying H, 1998, J IMMUNOL, V161, P4760	38	1309	1350	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					758	764		10.1038/nature05690	http://dx.doi.org/10.1038/nature05690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17344859				2022-12-28	WOS:000245626800032
J	Bass, SD				Bass, Steven D.			How does the proton spin?	SCIENCE			English	Editorial Material									Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria	University of Innsbruck	Bass, SD (corresponding author), Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria.	sbass@mail.cern.ch	Bass, Steven/ABF-8620-2022; Bass, Steven/AAG-1279-2020	Bass, Steven/0000-0002-2089-9661				Abe K, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.112003; Adeva B, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.112001; AIPAPETIAN A, 2007, PHYS REV D, V75; Airapetian A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.012005; ASHMAN J, 1989, NUCL PHYS B, V328, P1, DOI 10.1016/0550-3213(89)90089-8; Bass SD, 2005, REV MOD PHYS, V77, P1257, DOI 10.1103/RevModPhys.77.1257; Bass SD, 2006, INT J MOD PHYS A, V21, P4407, DOI 10.1142/S0217751X06034033; MALLOT G, ORGHEPEX0612055; Thomas AW, 2001, STRUCTURE NUCLEON	9	6	6	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1672	1673		10.1126/science.1140165	http://dx.doi.org/10.1126/science.1140165			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379795				2022-12-28	WOS:000245106900024
J	Grill, E; Christmann, A				Grill, Erwin; Christmann, Alexander			A plant receptor with a big family	SCIENCE			English	Editorial Material							ARABIDOPSIS; SUBUNIT		Tech Univ Munich, Dept Plant Sci, D-85350 Freising Weihenstephan, Germany	Technical University of Munich	Grill, E (corresponding author), Tech Univ Munich, Dept Plant Sci, Hochanger 4, D-85350 Freising Weihenstephan, Germany.	erwin.grill@wzw.tum.de	Christmann, Alexander/I-2655-2017	Christmann, Alexander/0000-0002-3242-0814				Christmann A, 2006, PLANT BIOLOGY, V8, P314, DOI 10.1055/s-2006-924120; Coursol S, 2003, NATURE, V423, P651, DOI 10.1038/nature01643; Devoto A, 2003, J MOL EVOL, V56, P77, DOI 10.1007/s00239-002-2382-5; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Grill E, 1998, SCIENCE, V282, P252, DOI 10.1126/science.282.5387.252; Hsieh MH, 2005, J EXP BOT, V56, P3137, DOI 10.1093/jxb/eri311; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; LIU X, 2007, SCIENCE         0308, DOI DOI 10.1126/SCIENCE.1135882; Liu XG, 2007, SCIENCE, V318, DOI 10.1126/science.1143320; Mishra G, 2006, SCIENCE, V312, P264, DOI 10.1126/science.1123769; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Perfus-Barbeoch L, 2004, CURR OPIN PLANT BIOL, V7, P719, DOI 10.1016/j.pbi.2004.09.013; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Zhao J, 2004, J BIOL CHEM, V279, P1794, DOI 10.1074/jbc.M309529200	15	13	15	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1676	1677		10.1126/science.1140761	http://dx.doi.org/10.1126/science.1140761			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17347413				2022-12-28	WOS:000245106900027
J	Holmes, A				Holmes, Andrew			Alan Graham MacDiarmid (1927-2007) - Pioneer of conducting polymers, and proud Antipodean. Obituary	NATURE			English	Biographical-Item									Univ Melbourne, Bio21 Inst, Parkville, Vic 3010, Australia	University of Melbourne	Holmes, A (corresponding author), Univ Melbourne, Bio21 Inst, Bldg 102,30 Flemington Rd, Parkville, Vic 3010, Australia.	aholmes@unimelb.edu.au							0	14	14	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2007	446	7134					390	390		10.1038/446390a	http://dx.doi.org/10.1038/446390a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17377574	Bronze			2022-12-28	WOS:000245079500029
J	Casarett, DJ; Quill, TE				Casarett, David J.; Quill, Timothy E.			"I'm not ready for hospice": Strategies for timely and effective hospice discussions	ANNALS OF INTERNAL MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PATIENT PREFERENCES; ACUTE EXACERBATION; PALLIATIVE CARE; ADVANCED CANCER; NURSING-HOMES; END; SURVIVAL; LIFE; MANAGEMENT	Hospice programs offer unique benefits for patients who are near the end of life and their families, and growing evidence indicates that hospice can provide high-quality care. Despite these benefits, many patients do not enroll in hospice, and those who enroll generally do so very late in the course of their illness. Some barriers to hospice referral arise from the requirements of hospice eligibility, which will be difficult to eliminate without major changes to hospice organization and financing. However, the challenges of discussing hospice create other barriers that are more easily remedied. The biggest communication barrier is that physicians are often unsure of how to talk with patients clearly and directly about their poor prognosis and limited treatment options (both requirements of hospice referral) without depriving them of hope. This article describes a structured strategy for discussing hospice, based on techniques of effective communication that physicians use in other "bad news" situations. This strategy can make hospice discussions both more compassionate and more effective.	Univ Penn, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; Univ Rochester, Med Ctr, Ctr Eth Humanities & Palliat Care, Rochester, NY 14642 USA	University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Rochester	Casarett, DJ (corresponding author), 3615 Chestnut St, Philadelphia, PA 19104 USA.	casarett@mail.med.upenn.edu						Alla F, 2000, AM HEART J, V139, P895, DOI 10.1016/S0002-8703(00)90023-1; [Anonymous], HOSPICE J; BRODY H, 1989, HASTINGS CENT REP, V19, P5, DOI 10.2307/3562634; Bruera E, 2001, J CLIN ONCOL, V19, P2883, DOI 10.1200/JCO.2001.19.11.2883; BUCKMAN R, 1992, BREAK BAD NEWS; Byock IR, 1996, J PAIN SYMPTOM MANAG, V11, P69, DOI 10.1016/0885-3924(95)00154-9; Casarett D, 2006, J AM GERIATR SOC, V54, P472, DOI 10.1111/j.1532-5415.2005.00628.x; Casarett D, 2005, J AM GERIATR SOC, V53, P249, DOI 10.1111/j.1532-5415.2005.53110.x; Casarett D, 2002, ALZ DIS ASSOC DIS, V16, P116, DOI 10.1097/00002093-200204000-00009; Casarett D, 2001, J CLIN ONCOL, V19, P2057, DOI 10.1200/JCO.2001.19.7.2057; Casarett D, 2005, JAMA-J AM MED ASSOC, V294, P211, DOI 10.1001/jama.294.2.211; Casarett DJ, 2004, J AM GERIATR SOC, V52, P1923, DOI 10.1111/j.1532-5415.2004.52520.x; Christakis NA, 2003, SOC SCI MED, V57, P465, DOI 10.1016/S0277-9536(02)00370-2; Christakis NA, 1998, ARCH INTERN MED, V158, P2389, DOI 10.1001/archinte.158.21.2389; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; CONILL C, 1990, CANCER, V65, P1864, DOI 10.1002/1097-0142(19900415)65:8<1864::AID-CNCR2820650832>3.0.CO;2-U; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Costello R, 1997, AM J MED, V102, P239, DOI 10.1016/S0002-9343(97)00017-X; Daugherty CK, 2002, J CLIN ONCOL, V20, P2752, DOI 10.1200/JCO.2002.20.11.2752; Emanuel EJ, 1999, NEW ENGL J MED, V341, P956, DOI 10.1056/NEJM199909233411306; Eng C, 1997, J AM GERIATR SOC, V45, P223, DOI 10.1111/j.1532-5415.1997.tb04513.x; Feuer DJ, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001219, DOI 10.1002/14651858.CD001219]; Grisso T, 1998, ASSESSING COMPETENCE; Higashi H, 2003, JPN J CLIN ONCOL, V33, P357, DOI 10.1093/jjco/hyg061; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; Holmes WC, 2002, J GEN INTERN MED, V17, P677, DOI 10.1046/j.1525-1497.2002.00746.x; Kutner JS, 2001, J PAIN SYMPTOM MANAG, V21, P473, DOI 10.1016/S0885-3924(01)00281-0; Lamont EB, 2001, ANN INTERN MED, V134, P1096, DOI 10.7326/0003-4819-134-12-200106190-00009; Lo B, 1999, ANN INTERN MED, V130, P744, DOI 10.7326/0003-4819-130-9-199905040-00015; Luchins DJ, 1997, J AM GERIATR SOC, V45, P1054, DOI 10.1111/j.1532-5415.1997.tb05966.x; McGorty EK, 2003, J EVAL CLIN PRACT, V9, P363, DOI 10.1046/j.1365-2753.2003.00406.x; Miller SC, 2003, J PAIN SYMPTOM MANAG, V26, P791, DOI 10.1016/S0885-3924(03)00284-7; Miller SC, 2002, J AM GERIATR SOC, V50, P507, DOI 10.1046/j.1532-5415.2002.50118.x; Miller Susan C, 2003, J Palliat Med, V6, P725, DOI 10.1089/109662103322515239; MOR V, 1984, CANCER-AM CANCER SOC, V53, P2002, DOI 10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W; Morrison RS, 2000, JAMA-J AM MED ASSOC, V284, P47, DOI 10.1001/jama.284.1.47; *NAT HOSP PALL CAR, 2006, NAT TREND SUMM 2004; PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1; Quill TE, 1996, ANN INTERN MED, V125, P763, DOI 10.7326/0003-4819-125-9-199611010-00010; Quill TE, 2001, ANN INTERN MED, V135, P551, DOI 10.7326/0003-4819-135-7-200110020-00022; Reese DJ, 1999, SOC WORK, V44, P549, DOI 10.1093/sw/44.6.549; Ripamonti C, 2002, INT J GYNECOL CANCER, V12, P135, DOI 10.1046/j.1525-1438.2002.01103.x; Ryan SD, 2004, CLIN GERIATR MED, V20, P783, DOI 10.1016/j.cger.2004.07.012; SCULLY T, 2002, COMMUNICATION   0524; SENEFF MG, 1995, JAMA-J AM MED ASSOC, V274, P1852, DOI 10.1001/jama.274.23.1852; Sloan JA, 2001, J CLIN ONCOL, V19, P3539, DOI 10.1200/JCO.2001.19.15.3539; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; TRAVER GA, 1979, AM REV RESPIR DIS, V119, P895; Vainio A, 1996, J PAIN SYMPTOM MANAG, V12, P3, DOI 10.1016/0885-3924(96)00042-5; Vigano A, 2000, ARCH INTERN MED, V160, P861, DOI 10.1001/archinte.160.6.861	52	85	86	1	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2007	146	6					443	449		10.7326/0003-4819-146-6-200703200-00011	http://dx.doi.org/10.7326/0003-4819-146-6-200703200-00011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	150CC	17371889				2022-12-28	WOS:000245192200006
J	Joyce, GF				Joyce, Gerald F.			A glimpse of biology's first enzyme	SCIENCE			English	Editorial Material							RNA; RIBOZYME; ORIGIN		Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Joyce, GF (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	gjoyce@scripps.edu						BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Ikawa Y, 2004, P NATL ACAD SCI USA, V101, P13750, DOI 10.1073/pnas.0405886101; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Robertson MP, 2007, SCIENCE, V315, P1549, DOI 10.1126/science.1136231; Robertson MP, 1999, NAT BIOTECHNOL, V17, P62, DOI 10.1038/5236; Rogers J, 2001, RNA, V7, P395, DOI 10.1017/S135583820100228X; Woese C, 1967, GENETIC CODE, P179	10	18	18	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2007	315	5818					1507	1508		10.1126/science.1140736	http://dx.doi.org/10.1126/science.1140736			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363651				2022-12-28	WOS:000244934800027
J	Truffer, M; Fahnestock, M				Truffer, Martin; Fahnestock, Mark			Rethinking ice sheet time scales	SCIENCE			English	Editorial Material							JAKOBSHAVN ISBRAE; DISCHARGE; GREENLAND; RETREAT; GLACIER; STREAM; ALASKA		Univ Alaska Fairbanks, Inst Geophys, Fairbanks, AK 99775 USA; Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA	University of Alaska System; University of Alaska Fairbanks; University System Of New Hampshire; University of New Hampshire	Truffer, M (corresponding author), Univ Alaska Fairbanks, Inst Geophys, Fairbanks, AK 99775 USA.	truffer@gi.alaska.edu	Fahnestock, Mark/N-2678-2013					Bindschadler RA, 2003, SCIENCE, V301, P1087, DOI 10.1126/science.1087231; Fricker HA, 2007, SCIENCE, V315, P1544, DOI 10.1126/science.1136897; Gray L, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021387; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; *IPCC WORK GROUP, 2007, 4 IPCC WORK GROUP; Joughin I, 2004, NATURE, V432, P608, DOI 10.1038/nature03130; Larsen CF, 2005, EARTH PLANET SC LETT, V237, P548, DOI 10.1016/j.epsl.2005.06.032; Luckman A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022519; O'Neel S, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2005JF000292; RIGOT E, 2006, SCIENCE, V311, P986; Smith AM, 2007, GEOLOGY, V35, P127, DOI 10.1130/G23036A.1; Vaughan DG, 2007, SCIENCE, V315, P1503, DOI 10.1126/science.1141111; Wingham DJ, 2006, NATURE, V440, P1033, DOI 10.1038/nature04660	13	28	29	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1508	1510		10.1126/science.1140469	http://dx.doi.org/10.1126/science.1140469			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363652				2022-12-28	WOS:000244934800028
J	Brumfiel, G				Brumfiel, Geoff			Quantum leap of faith	NATURE			English	News Item																			0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					245	245		10.1038/446245a	http://dx.doi.org/10.1038/446245a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361151	Bronze			2022-12-28	WOS:000244892900013
J	Cui, RT; Widlund, HR; Feige, E; Lin, JY; Wilensky, DL; Igras, VE; D'Orazio, J; Fung, CY; Schanbacher, CF; Granter, SR; Fisher, DE				Cui, Rutao; Widlund, Hans R.; Feige, Erez; Lin, Jennifer Y.; Wilensky, Dara L.; Igras, Viven E.; D'Orazio, John; Fung, Claire Y.; Schanbacher, Carl F.; Granter, Scott R.; Fisher, David E.			Central role of p53 in the suntan response and pathologic hyperpigmentation	CELL			English	Article							PROOPIOMELANOCORTIN GENE-EXPRESSION; MICROPHTHALMIA TRANSCRIPTION FACTOR; SQUAMOUS-CELL CARCINOMA; PLASMA BETA-ENDORPHIN; SKIN-CANCER; DNA-DAMAGE; MELANOCORTIN-1 RECEPTOR; ULTRAVIOLET-B; HUMAN MELANOCYTES; SV40-TRANSFORMED CELLS	UV-induced Pigmentation (suntanning) requires induction of a-melanocyte-stimulating hormone (alpha-MSH) secretion by keratinocytes- alpha-MSH and other bioactive pepticles are cleavage products Of pro-opiomelanocortin (POMC). Here we Provide biochemical and genetic evidence demonstrating that UV induction of POMC/MSH in skin is directly controlled by p53. Whereas p53 potently stimulates the POMC promoter in response to UV, the absence of p53, as in knockout mice, is associated with absence of the UV-tanning response. The same pathway produces beta-endorphin, another POMC derivative, which potentially contributes to sun-seeking behaviors. Furthermore, several instances of UV-independent pathologic Pigmentation are shown to involve p53 "mimicking" the tanning response. P53 thus functions as a sensor/effector for UV Pigmentation, which is a nearly constant environmental exposure. Moreover, this pathway is activated in numerous conditions of pathologic pigmentation and thus mimics the tanning response.	Harvard Univ, Sch Med, Melanoma Program Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat Hematol Oncol, Dana Farber Canc Inst,Childrens Hosp Boston, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Dept Dermatol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Fisher, DE (corresponding author), Harvard Univ, Sch Med, Melanoma Program Med Oncol, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	david_fisher@dfci.harvard.edu	Schanbacher, Carl/AAF-7641-2019	Widlund, Hans/0000-0002-7506-2447; Cui, Rutao/0000-0002-4377-9988				Abdel-Malek Z, 2000, PIGM CELL RES, V13, P156, DOI 10.1034/j.1600-0749.13.s8.28.x; Ananthaswamy HN, 1997, NAT MED, V3, P510, DOI 10.1038/nm0597-510; BARGONETTI J, 1991, CELL, V65, P1083, DOI 10.1016/0092-8674(91)90560-L; Barsh G, 2000, PIGM CELL RES, V13, P48, DOI 10.1034/j.1600-0749.13.s8.10.x; Bayerl C, 1995, PHOTODERMATOL PHOTO, V11, P149, DOI 10.1111/j.1600-0781.1995.tb00157.x; BLEEHEN SS, 1975, BRIT J DERMATOL, V93, P361, DOI 10.1111/j.1365-2133.1975.tb06509.x; BOUTILLIER AL, 1991, MOL ENDOCRINOL, V5, P1301, DOI 10.1210/mend-5-9-1301; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Bykov VJ, 2000, J INVEST DERMATOL, V114, P40, DOI 10.1046/j.1523-1747.2000.00821.x; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Chakraborty AK, 1996, BBA-MOL CELL RES, V1313, P130, DOI 10.1016/0167-4889(96)00063-8; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Commission Internationale de l'Eclairage (CIE), 1998, 007E1998 CIE S; Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200; Cui RT, 2005, J BIOL CHEM, V280, P39152, DOI 10.1074/jbc.M504655200; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Diffey BL, 1997, PHOTODERMATOL PHOTO, V13, P64, DOI 10.1111/j.1600-0781.1997.tb00110.x; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dunham WR, 1996, J INVEST DERMATOL, V107, P332, DOI 10.1111/1523-1747.ep12363174; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELLER MS, 1994, NATURE, V372, P413, DOI 10.1038/372413a0; Eller MS, 1996, P NATL ACAD SCI USA, V93, P1087, DOI 10.1073/pnas.93.3.1087; FARMER G, 1992, NATURE, V358, P83, DOI 10.1038/358083a0; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; FITZPATRICK TB, 1985, NEW ENGL J MED, V313, P818, DOI 10.1056/NEJM198509263131310; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; FRIEDMANN PS, 1987, J CELL PHYSIOL, V133, P88, DOI 10.1002/jcp.1041330111; Gambichler T, 2002, BRIT J DERMATOL, V147, P1207, DOI 10.1046/j.1365-2133.2002.04859.x; Gilchrest BA, 1996, PHOTOCHEM PHOTOBIOL, V63, P1, DOI 10.1111/j.1751-1097.1996.tb02988.x; Gottifredi V, 2000, COLD SPRING HARB SYM, V65, P483, DOI 10.1101/sqb.2000.65.483; Goukassian DA, 1999, J INVEST DERMATOL, V112, P25, DOI 10.1046/j.1523-1747.1999.00468.x; Granter SR, 2002, APPL IMMUNOHISTO M M, V10, P47, DOI 10.1097/00022744-200203000-00008; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Holick MF, 2001, LANCET, V357, P4, DOI 10.1016/S0140-6736(00)03560-1; Horikawa T, 1996, PIGM CELL RES, V9, P58, DOI 10.1111/j.1600-0749.1996.tb00089.x; Im SB, 1998, CANCER RES, V58, P47; Imokawa G, 2004, PIGM CELL RES, V17, P96, DOI 10.1111/j.1600-0749.2003.00126.x; IYENGAR B, 1994, MELANOMA RES, V4, P293; Kadekaro AL, 2003, ANN NY ACAD SCI, V994, P359, DOI 10.1111/j.1749-6632.2003.tb03200.x; Karalis KP, 2004, J BIOL CHEM, V279, P10837, DOI 10.1074/jbc.M313063200; KASTAN MB, 1991, CANCER RES, V51, P6304; Kaur M, 2006, J AM ACAD DERMATOL, V54, P919, DOI 10.1016/j.jaad.2006.01.062; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Khlgatian MK, 2002, J INVEST DERMATOL, V118, P126, DOI 10.1046/j.0022-202x.2001.01667.x; Kichina J, 1996, PIGM CELL RES, V9, P85, DOI 10.1111/j.1600-0749.1996.tb00094.x; King R, 1999, AM J PATHOL, V155, P731, DOI 10.1016/S0002-9440(10)65172-3; Kippenberger S, 1996, PIGM CELL RES, V9, P179, DOI 10.1111/j.1600-0749.1996.tb00107.x; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; LEVINS PC, 1983, LANCET, V2, P166; Li G, 1998, J INVEST DERMATOL, V110, P72, DOI 10.1046/j.1523-1747.1998.00090.x; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; LUBBE J, 1994, J INVEST DERMATOL, V102, P819, DOI 10.1111/1523-1747.ep12381544; LUNEC J, 1990, PATHOBIOLOGY, V58, P193, DOI 10.1159/000163583; MARCELO CL, 1978, J CELL BIOL, V79, P356, DOI 10.1083/jcb.79.2.356; Naysmith L, 2004, J INVEST DERMATOL, V122, P423, DOI 10.1046/j.0022-202X.2004.22221.x; Newell-Price J, 2003, J ENDOCRINOL, V177, P365, DOI 10.1677/joe.0.1770365; NORDLUND JJ, 1986, J INVEST DERMATOL, V86, P433, DOI 10.1111/1523-1747.ep12285717; PATHAK MA, 1983, J AM ACAD DERMATOL, V9, P724, DOI 10.1016/S0190-9622(83)70186-6; *PDR STAFF, 2005, PHYS DESK REF, P3267; Phillips A, 1997, MOL CELL BIOL, V17, P5952, DOI 10.1128/MCB.17.10.5952; Picon A, 1999, ONCOGENE, V18, P2627, DOI 10.1038/sj.onc.1202635; PICON A, 1995, J MOL ENDOCRINOL, V15, P187, DOI 10.1677/jme.0.0150187; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; SANDS AT, 1995, NATURE, V377, P162, DOI 10.1038/377162a0; SCHAUER E, 1994, J CLIN INVEST, V93, P2258, DOI 10.1172/JCI117224; SCHWARZ A, 1995, J INVEST DERMATOL, V104, P922, DOI 10.1111/1523-1747.ep12606202; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Sturm RA, 1998, MUTAT RES-FUND MOL M, V422, P69, DOI 10.1016/S0027-5107(98)00176-6; Suzuki I, 1999, J INVEST DERM SYMP P, V4, P29, DOI 10.1038/sj.jidsp.5640177; THERRIEN M, 1991, MOL CELL BIOL, V11, P3492, DOI 10.1128/MCB.11.7.3492; Tsatmali M, 2000, PIGM CELL RES, V13, P125, DOI 10.1034/j.1600-0749.13.s8.22.x; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wintzen M, 1996, J INVEST DERMATOL, V106, P673, DOI 10.1111/1523-1747.ep12345496; Wintzen M, 2001, EXP DERMATOL, V10, P305, DOI 10.1034/j.1600-0625.2001.100502.x; Zanello SB, 1999, ANN NY ACAD SCI, V885, P85; Zhang H, 2001, AM J PATHOL, V158, P381, DOI 10.1016/S0002-9440(10)63980-6; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	85	421	438	6	36	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					853	864		10.1016/j.cell.2006.12.045	http://dx.doi.org/10.1016/j.cell.2006.12.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350573	Bronze			2022-12-28	WOS:000245073400011
J	Wang, JD; Sanders, GM; Grossman, AD				Wang, Jue D.; Sanders, Glenn M.; Grossman, Alan D.			Nutritional control of elongation of DNA replication by (p)ppGpp	CELL			English	Article							BACILLUS-SUBTILIS SPORULATION; STRINGENT RESPONSE; ESCHERICHIA-COLI; DEVELOPMENTAL REGULATION; STATIONARY-PHASE; CHECKPOINT; PRIMASE; FORK; PROTEIN; RECA	DNA replication is highly regulated in most organisms. Although much research has focused on mechanisms that regulate initiation of replication, mechanisms that regulate elongation of replication are less well understood. We characterized a mechanism that regulates replication elongation in the bacterium Bacillus subtilis. Replication elongation was inhibited within minutes after amino acid starvation, regardless of where the replication forks were located on the chromosome. We found that small nucleotides ppGpp and pppGpp, which are induced upon starvation, appeared to inhibit replication directly by inhibiting primase, an essential component of the replication machinery. The replication forks arrested with (p)ppGpp did not recruit the recombination protein RecA, indicating that the forks are not disrupted. (p)ppGpp appear to be part of a surveillance mechanism that links nutrient availability to replication by rapidly inhibiting replication in starved cells, thereby preventing replication-fork disruption. This control may be important for cells to maintain genomic integrity.	MIT, Dept Biol, Cambridge, MA 02139 USA; Replidyne Inc, Louisville, CO 80027 USA	Massachusetts Institute of Technology (MIT)	Grossman, AD (corresponding author), MIT, Dept Biol, Bldg 68-530, Cambridge, MA 02139 USA.	adg@mit.edu	Wang, Jue/GVU-0480-2022	Wang, Jue/0000-0003-1503-170X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041934, R01GM084003, R37GM041934] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM084003, R01 GM041934, GM 41934, R37 GM041934] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Autret S, 1999, MOL MICROBIOL, V31, P1665, DOI 10.1046/j.1365-2958.1999.01299.x; Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Barnes MH, 1995, METHOD ENZYMOL, V262, P35; Belitskii B R, 1980, Mol Biol (Mosk), V14, P1342; Breier AM, 2005, P NATL ACAD SCI USA, V102, P3942, DOI 10.1073/pnas.0500812102; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; BROWN NC, 1970, P NATL ACAD SCI USA, V67, P1454, DOI 10.1073/pnas.67.3.1454; BRUAND C, 1995, EMBO J, V14, P2642, DOI 10.1002/j.1460-2075.1995.tb07262.x; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; COPELAND JC, 1971, SCIENCE, V172, P159, DOI 10.1126/science.172.3979.159; Corn JE, 2006, NUCLEIC ACIDS RES, V34, P4082, DOI 10.1093/nar/gkl363; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Duggin I.G., 2002, BACILLUS SUBTILIS IT, P87; Dworkin J, 2002, P NATL ACAD SCI USA, V99, P14089, DOI 10.1073/pnas.182539899; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Foti JJ, 2005, MOL CELL, V17, P549, DOI 10.1016/j.molcel.2005.01.012; Gautam A, 2001, J BIOL CHEM, V276, P8771, DOI 10.1074/jbc.M009538200; Griffiths DJF, 2001, MOL BIOL CELL, V12, P115, DOI 10.1091/mbc.12.1.115; Harwood C.R., 1990, MOL BIOL METHODS BAC; Inaoka T, 2002, J BACTERIOL, V184, P3923, DOI 10.1128/JB.184.14.3923-3930.2002; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P9419, DOI 10.1073/pnas.97.17.9419; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Krasny L, 2004, EMBO J, V23, P4473, DOI 10.1038/sj.emboj.7600423; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lemon K.P., 2002, BACILLUS SUBTILIS IT, P73; Lemon KP, 2000, MOL CELL, V6, P1321, DOI 10.1016/S1097-2765(00)00130-1; LEVINE A, 1995, MOL MICROBIOL, V15, P287, DOI 10.1111/j.1365-2958.1995.tb02243.x; LEVINE A, 1991, J MOL BIOL, V219, P605, DOI 10.1016/0022-2836(91)90657-R; LOPEZ JM, 1981, J BACTERIOL, V146, P605, DOI 10.1128/JB.146.2.605-613.1981; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Maric C, 1999, J MOL BIOL, V291, P775, DOI 10.1006/jmbi.1999.3017; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; OCHI K, 1982, J BACTERIOL, V151, P1062, DOI 10.1128/JB.151.2.1062-1065.1982; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; Renzette N, 2005, MOL MICROBIOL, V57, P1074, DOI 10.1111/j.1365-2958.2005.04755.x; Schneider DA, 2003, METHOD ENZYMOL, V370, P606; SCHREIBER G, 1995, CURR MICROBIOL, V30, P27, DOI 10.1007/BF00294520; Simmons LA, 2007, P NATL ACAD SCI USA, V104, P1360, DOI 10.1073/pnas.0607123104; Soultanas P, 2005, STRUCTURE, V13, P839, DOI 10.1016/j.str.2005.04.006; Sung HM, 2002, J BACTERIOL, V184, P5641, DOI 10.1128/JB.184.20.5641-5653.2002; TIMSON J, 1975, MUTAT RES, V32, P115, DOI 10.1016/0165-1110(75)90002-0; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; VASANTHA N, 1980, J BACTERIOL, V144, P1119, DOI 10.1128/JB.144.3.1119-1125.1980; Walker GC., 1996, E COLI SALMONELLA CE, V2, P1400; Wendrich TM, 1997, MOL MICROBIOL, V26, P65, DOI 10.1046/j.1365-2958.1997.5511919.x; WERNER R, 1971, NATURE-NEW BIOL, V233, P99, DOI 10.1038/newbio233099a0; Zhang Z, 1997, MOL CELL BIOL, V17, P6147, DOI 10.1128/MCB.17.10.6147; ZYSKIND JW, 1992, CELL, V69, P5, DOI 10.1016/0092-8674(92)90112-P	51	206	210	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					865	875		10.1016/j.cell.2006.12.043	http://dx.doi.org/10.1016/j.cell.2006.12.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350574	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000245073400012
J	Wright, GD				Wright, Gerard D.			A new target for antibiotic development	SCIENCE			English	Editorial Material									McMaster Univ, Antimicrobial Res Ctr, Dept Biochem & Biomed Sci, DeGroote Sch Med, Hamilton, ON L8N 3Z5, Canada	McMaster University	Wright, GD (corresponding author), McMaster Univ, Antimicrobial Res Ctr, Dept Biochem & Biomed Sci, DeGroote Sch Med, Hamilton, ON L8N 3Z5, Canada.	wrightge@mcmaster.ca	Wright, G/ABB-7666-2021	Wright, Gerard/0000-0002-9129-7131				Evrard C, 1998, J MOL BIOL, V276, P151, DOI 10.1006/jmbi.1997.1499; Halliday J, 2006, BIOCHEM PHARMACOL, V71, P957, DOI 10.1016/j.bcp.2005.10.030; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; Ostash B, 2005, CURR OPIN CHEM BIOL, V9, P459, DOI 10.1016/j.cbpa.2005.08.014; Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819; Walsh C., 2003, ANTIBIOTICS ACTIONS	6	18	19	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1373	1374		10.1126/science.1140374	http://dx.doi.org/10.1126/science.1140374			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143UP	17347430				2022-12-28	WOS:000244752200019
J	Fyhn, M; Hafting, T; Treves, A; Moser, MB; Moser, EI				Fyhn, Marianne; Hafting, Torkel; Treves, Alessandro; Moser, May-Britt; Moser, Edvard I.			Hippocampal remapping and grid realignment in entorhinal cortex	NATURE			English	Article							PLACE CELLS; PATH-INTEGRATION; MEMORY; REPRESENTATION; INPUT; MAPS; CODES; MODEL	A fundamental property of many associative memory networks is the ability to decorrelate overlapping input patterns before information is stored(1-5). In the hippocampus, this neuronal pattern separation is expressed as the tendency of ensembles of place cells 6 to undergo extensive 'remapping' in response to changes in the sensory or motivational inputs to the hippocampus(7-13). Remapping is expressed under some conditions as a change of firing rates in the presence of a stable place code ('rate remapping')(14), and under other conditions as a complete reorganization of the hippocampal place code in which both place and rate of firing take statistically independent values ('global remapping')(14). Here we show that the nature of hippocampal remapping can be predicted by ensemble dynamics in place-selective grid cells in the medial entorhinal cortex(15,16), one synapse upstream of the hippocampus. Whereas rate remapping is associated with stable grid fields, global remapping is always accompanied by a coordinate shift in the firing vertices of the grid cells. Grid fields of co-localized medial entorhinal cortex cells move and rotate in concert during this realignment. In contrast to the multiple environment-specific representations coded by place cells in the hippocampus, local ensembles of grid cells thus maintain a constant spatial phase structure, allowing position to be represented and updated by the same translation mechanism in all environments encountered by the animal.	Norwegian Univ Sci & Technol, Ctr Biol Memmory, NO-7489 Trondheim, Norway; SISSA, Int Sch Adv Studies, Cognit Neurosci Sector, I-34014 Trieste, Italy	Norwegian University of Science & Technology (NTNU); International School for Advanced Studies (SISSA)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Ctr Biol Memmory, NO-7489 Trondheim, Norway.	edvard.moser@ntnu.no	Treves, Alessandro/B-2318-2009	Hafting, Torkel/0000-0002-0928-3487; TREVES, Alessandro/0000-0001-7246-5673				Anderson MI, 2003, J NEUROSCI, V23, P8827; Battaglia FP, 1998, PHYS REV E, V58, P7738, DOI 10.1103/PhysRevE.58.7738; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kesner RP, 2000, CURR OPIN NEUROBIOL, V10, P260, DOI 10.1016/S0959-4388(00)00067-2; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1989, NEUROSCIENCE CONNECT, P1; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Naber PA, 1997, NEUROREPORT, V8, P2617, DOI 10.1097/00001756-199707280-00039; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Sharp PE, 1999, HIPPOCAMPUS, V9, P432, DOI 10.1002/(SICI)1098-1063(1999)9:4<432::AID-HIPO9>3.3.CO;2-G; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	30	432	444	3	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					190	194		10.1038/nature05601	http://dx.doi.org/10.1038/nature05601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17322902				2022-12-28	WOS:000244718100041
J	Piccart, M; Goldhirsch, A				Piccart, Martine; Goldhirsch, Aron			Keeping faith with trial volunteers	NATURE			English	Editorial Material							POSTMENOPAUSAL WOMEN; TAMOXIFEN THERAPY; RANDOMIZED-TRIAL; LETROZOLE		European Breast Canc Coalit, Milan, Italy; Int Breast Canc Study Grp, Bern, Switzerland	International Breast Cancer Study Group								Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; ANGELL M, 2006, NEW YORK REV BOOKS, V53; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; Drazen JM, 2002, NEW ENGL J MED, V347, P1362, DOI 10.1056/NEJMe020122; GILPIN K, 2004, NY TIMES        0602; Giordano SH, 2006, J CLIN ONCOL, V24, P2750, DOI 10.1200/JCO.2005.02.3028; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Mello MM, 2005, NEW ENGL J MED, V352, P2202, DOI 10.1056/NEJMsa044115; *NIH, 2000, ADJ THER BREAST CANC; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Regan MM, 2005, BREAST, V14, P582, DOI 10.1016/j.breast.2005.08.021; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; World Medical Association, DECL HELS	13	19	21	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					137	138		10.1038/446137a	http://dx.doi.org/10.1038/446137a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143JS	17344833				2022-12-28	WOS:000244718100021
J	Denes, P; Larson, JC; Lloyd-Jones, DM; Prineas, RJ; Greenland, P				Denes, Pablo; Larson, Joseph C.; Lloyd-Jones, Donald M.; Prineas, Ronald J.; Greenland, Philip			Major and minor ECG abnormalities in asymptomatic women and risk of cardiovascular events and mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; ESTROGEN PLUS PROGESTIN; ST-T ABNORMALITIES; ELECTROCARDIOGRAPHIC ABNORMALITIES; POSTMENOPAUSAL WOMEN; PROGNOSTIC VALUE; FOLLOW-UP; DEATH; MEN; ASSOCIATION	Context Data are sparse regarding the prevalence, incidence, and independent prognostic value of minor and/or major electrocardiographic ( ECG) abnormalities in asymptomatic postmenopausal women. There is no information on the effect, if any, of hormonal treatment on the prognostic value of the ECG. Objective To examine association of minor and major baseline and incident ECG abnormalities with long-term cardiovascular morbidity and mortality. Design, Setting, and Participants Post-hoc analysis of the estrogen plus progestin component of the Women's Health Initiative study, a randomized controlled primary prevention trial of 14 749 postmenopausal asymptomatic women with intact uterus who received 1 daily tablet containing 0.625 mg of oral conjugated equine estrogen and 2.5 mg of medroxyprogesterone acetate or a matching placebo. Participants were enrolled from 1993 to 1998, and the estrogen plus progestin trial was stopped on July 7, 2002. Main Outcome Measures The Novacode criteria were used to define minor, major, and incident ECG abnormalities. Cardiovascular end points included incident coronary heart disease (CHD) and cardiovascular disease (CVD) events. Results Among women with absent (n= 9744), minor ( n= 4095), and major ( n= 910) ECG abnormalities, there were 118, 91, and 37 incident CHD events, respectively. The incident annual CHD event rates per 10 000 women with absent, minor, or major ECG abnormalities were 21 (95% confidence interval [CI], 18- 26), 40 ( 95% CI, 32-49), and 75 ( 95% CI, 54-104), respectively. After 3 years of follow-up, 5% of women who had normal ECG at baseline developed new ECG abnormalities with an annual CHD event rate of 85 ( 95% CI, 44-164) per 10 000 women. The adjusted hazard ratios for CHD events were 1.55 ( 95% CI, 1.14-2.11) for minor baseline, 3.01 ( 95% CI, 2.03-4.46) for major baseline, and 2.60 ( 95% CI, 1.08-6.27) for incident ECG abnormalities. There were no significant interactions between hormone treatment assignment and ECG abnormalities for risk prediction of cardiovascular end points. For prediction of CHD events, the addition of ECG findings to the Framingham risk score increased from 0.69 to 0.74 the area under the receiver operating characteristic curve. Similar findings were found for incident CVD events. Conclusions Among asymptomatic postmenopausal women, clinically relevant baseline and incident ECG abnormalities are independently associated with increased risk of cardiovascular events and mortality, and the information is incremental to the established method of risk stratification.	Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Fred Hutchinson Canc Res Ctr, Womens Hlth Initiat Clin Coordinating Ctr, Seattle, WA 98104 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Epidemiol, Winston Salem, NC USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Fred Hutchinson Cancer Center; Wake Forest University; Wake Forest Baptist Medical Center	Denes, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, 251 E Huron,Feinberg 8-340, Chicago, IL 60611 USA.	p-denes@northwestern.edu	Lloyd-Jones, Donald M/C-5899-2009; Greenland, Philip/ABD-5528-2021	Lloyd-Jones, Donald/0000-0003-0847-6110				Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Ashley EA, 2000, CURR PROB CARDIOLOGY, V25, P7, DOI 10.1016/S0146-2806(00)70020-X; CEDRES BL, 1982, CIRCULATION, V65, P146, DOI 10.1161/01.CIR.65.1.146; Chen JG, 2006, MOL ENDOCRINOL, V20, P1, DOI 10.1210/me.2005-0192; CULLEN K, 1982, BRIT HEART J, V47, P209; Daviglus ML, 1999, JAMA-J AM MED ASSOC, V281, P530, DOI 10.1001/jama.281.6.530; De Bacquer D, 1998, J AM COLL CARDIOL, V32, P680, DOI 10.1016/S0735-1097(98)00303-9; De Bacquer D, 1998, HEART, V80, P570, DOI 10.1136/hrt.80.6.570; Greenland P, 2003, AM J CARDIOL, V91, P1068, DOI 10.1016/S0002-9149(03)00150-4; KANNEL WB, 1987, AM HEART J, V113, P370, DOI 10.1016/0002-8703(87)90280-8; KNUTSEN R, 1988, J CLIN EPIDEMIOL, V41, P293, DOI 10.1016/0895-4356(88)90134-5; LIAO YL, 1987, CIRCULATION, V75, P347, DOI 10.1161/01.CIR.75.2.347; LIAO YL, 1988, J AM COLL CARDIOL, V12, P1494, DOI 10.1016/S0735-1097(88)80016-0; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; *POOL PROJ RES GRO, 1978, J CHRON DIS, V31, P201, DOI DOI 10.1016/0021-9681(78)90073-5; Rautaharju PM, 2006, CIRCULATION, V113, P473, DOI 10.1161/CIRCULATIONAHA.104.496091; Rautaharju PM, 1998, J ELECTROCARDIOL, V31, P157, DOI 10.1016/S0022-0736(98)90132-7; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sigurdsson E, 1996, J AM COLL CARDIOL, V27, P1140, DOI 10.1016/0735-1097(95)00614-1; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	20	101	103	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2007	297	9					978	985		10.1001/jama.297.9.978	http://dx.doi.org/10.1001/jama.297.9.978			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143CP	17341712	Bronze			2022-12-28	WOS:000244697900027
J	Chan, CC; Chiu, HC				Chan, Chih-Chieh; Chiu, Hsien-Ching			Images in clinical medicine: Erythema ab igne	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Natl Taiwan Univ Hosp, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital	Chan, CC (corresponding author), Natl Taiwan Univ Hosp, Taipei 100, Taiwan.	hcc@ha.mc.ntu.edu.tw							0	14	14	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2007	356	9					E8	E8		10.1056/NEJMicm055084	http://dx.doi.org/10.1056/NEJMicm055084			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140HV	17329692				2022-12-28	WOS:000244496400010
J	McLean, DL; Fan, JY; Higashijima, S; Hale, ME; Fetcho, JR				McLean, David L.; Fan, Jingyi; Higashijima, Shin-ichi; Hale, Melina E.; Fetcho, Joseph R.			A topographic map of recruitment in spinal cord	NATURE			English	Article							LARVAL ZEBRAFISH; MOTONEURONS; INTERNEURONS; NEURONS; NETWORKS; MUSCLES; IDENTIFICATION; COORDINATION; ONTOGENY; IDENTITY	Animals move over a range of speeds by using rhythmic networks of neurons located in the spinal cord(1-6). Here we use electrophysiology and in vivo imaging in larval zebrafish ( Danio rerio) to reveal a systematic relationship between the location of a spinal neuron and the minimal swimming frequency at which the neuron is active. Ventral motor neurons and excitatory interneurons are rhythmically active at the lowest swimming frequencies, with increasingly more dorsal excitatory neurons engaged as swimming frequency rises. Inhibitory interneurons follow the opposite pattern. These inverted patterns of recruitment are independent of cell soma size among interneurons, but may be partly explained by concomitant dorso-ventral gradients in input resistance. Laser ablations of ventral, but not dorsal, excitatory interneurons perturb slow movements, supporting a behavioural role for the topography. Our results reveal an unexpected pattern of organization within zebrafish spinal cord that underlies the production of movements of varying speeds.	Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Okazaki Inst Integrat Biosci, Natl Inst Nat Sci, Aichi 4448787, Japan; Natl Inst Physiol Sci, Aichi 4448787, Japan	Cornell University; University of Chicago; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Fetcho, JR (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	jrf49@cornell.edu		Higashijima, Shin-ichi/0000-0001-6350-4992	NINDS NIH HHS [R01 NS026539-25, R01 NS026539] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026539] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bhatt DH, 2007, NEURON, V53, P91, DOI 10.1016/j.neuron.2006.11.011; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Budick SA, 2000, J EXP BIOL, V203, P2565; Combes D, 2004, J PHYSIOL-LONDON, V559, P17, DOI 10.1113/jphysiol.2004.069542; Drapeau P, 1999, J NEUROSCI METH, V88, P1, DOI 10.1016/S0165-0270(99)00008-4; FAN J, 2005, SOC NEUR ABSTR; FETCHO JR, 1987, BRAIN RES REV, V12, P243, DOI 10.1016/0165-0173(87)90001-4; FUIMAN LA, 1988, ANIM BEHAV, V36, P250, DOI 10.1016/S0003-3472(88)80268-9; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Hale ME, 2001, J COMP NEUROL, V437, P1, DOI 10.1002/cne.1266; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; Higashijima S, 2004, J COMP NEUROL, V480, P19, DOI 10.1002/cne.20279; Higashijima S, 2004, J NEUROSCI, V24, P5827, DOI 10.1523/JNEUROSCI.5342-03.2004; Jankowska E, 2001, J PHYSIOL-LONDON, V533, P31, DOI 10.1111/j.1469-7793.2001.0031b.x; Kiehn O, 2003, PROG NEUROBIOL, V70, P347, DOI 10.1016/S0301-0082(03)00091-1; Kimura Y, 2006, J NEUROSCI, V26, P5684, DOI 10.1523/JNEUROSCI.4993-05.2006; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; Li WC, 2004, J NEUROSCI, V24, P5840, DOI 10.1523/JNEUROSCI.1633-04.2004; LIU DW, 1988, J PHYSIOL-LONDON, V403, P73, DOI 10.1113/jphysiol.1988.sp017239; MASINO MA, 2005, SOC NEUR ABSTR; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; MYERS PZ, 1985, J COMP NEUROL, V236, P555, DOI 10.1002/cne.902360411; Ritter DA, 2001, J NEUROSCI, V21, P8956, DOI 10.1523/JNEUROSCI.21-22-08956.2001; ROBERTS A, 1990, SCI PROG, V74, P31; Stein PSG, 1998, ANN NY ACAD SCI, V860, P142, DOI 10.1111/j.1749-6632.1998.tb09045.x; Thorsen DH, 2004, J EXP BIOL, V207, P4175, DOI 10.1242/jeb.01285; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267	30	256	257	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					71	75		10.1038/nature05588	http://dx.doi.org/10.1038/nature05588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330042				2022-12-28	WOS:000244525600039
J	Bjelakovic, G; Nikolova, D; Gluud, LL; Simonetti, RG; Gluud, C				Bjelakovic, Goran; Nikolova, Dimitrinka; Gluud, Lise Lotte; Simonetti, Rosa G.; Gluud, Christian			Mortality in randomized trials of antioxidant supplements for primary and secondary prevention - Systematic review and meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							VITAMIN-E SUPPLEMENTATION; TRACE-ELEMENT SUPPLEMENTATION; NUTRITION INTERVENTION TRIALS; DISEASE-SPECIFIC MORTALITY; LONG-TERM SUPPLEMENTATION; PLACEBO-CONTROLLED TRIAL; NURSING-HOME RESIDENTS; QUALITY-OF-LIFE; DOUBLE-BLIND; CLINICAL-TRIAL	Context Antioxidant supplements are used for prevention of several diseases. Objective To assess the effect of antioxidant supplements on mortality in randomized primary and secondary prevention trials. Data Sources and Trial Selection We searched electronic databases and bibliographies published by October 2005. All randomized trials involving adults comparing beta carotene, vitamin A, vitamin C ( ascorbic acid), vitamin E, and selenium either singly or combined vs placebo or vs no intervention were included in our analysis. Randomization, blinding, and follow-up were considered markers of bias in the included trials. The effect of antioxidant supplements on all-cause mortality was analyzed with random-effects meta-analyses and reported as relative risk (RR) with 95% confidence intervals (CIs). Meta-regression was used to assess the effect of covariates across the trials. Data Extraction We included 68 randomized trials with 232 606 participants ( 385 publications). Data Synthesis When all low- and high-bias risk trials of antioxidant supplements were pooled together there was no significant effect on mortality ( RR, 1.02; 95% CI, 0.98-1.06). Multivariate meta-regression analyses showed that low- bias risk trials ( RR, 1.16; 95% CI, 1.05-1.29) and selenium ( RR, 0.998; 95% CI, 0.997-0.9995) were significantly associated with mortality. In 47 low- bias trials with 180 938 participants, the antioxidant supplements significantly increased mortality ( RR, 1.05; 95% CI, 1.02-1.08). In low- bias risk trials, after exclusion of selenium trials, beta carotene ( RR, 1.07; 95% CI, 1.02-1.11), vitamin A ( RR, 1.16; 95% CI, 1.10-1.24), and vitamin E ( RR, 1.04; 95% CI, 1.01-1.07), singly or combined, significantly increased mortality. Vitamin C and selenium had no significant effect on mortality. Conclusions Treatment with beta carotene, vitamin A, and vitamin E may increase mortality. The potential roles of vitamin C and selenium on mortality need further study.	Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Cochrane Hepatobiliary Grp,Copenhagen Trial Unit, Copenhagen, Denmark; Univ Nis, Dept Internal Med Gastroenterol & Hepatol, Nish 18000, Serbia; OSped V Cervello, Div Med, Palermo, Italy	Rigshospitalet; University of Copenhagen; University of Nis	Bjelakovic, G (corresponding author), Univ Nis, Dept Internal Med, Blvd Dr Zorana Djindjica 81, Nish 18000, Serbia.	goranb@junis.ni.ac.yu	Gluud, Christian/HGB-3191-2022; Gluud, Lise L/AAY-2120-2020; Gluud, Christian/AAY-1027-2021	Gluud, Lise L/0000-0002-9462-4468; Gluud, Christian/0000-0002-8861-0799; Nikolova, Dimitrinka/0000-0001-5976-6762; Bjelakovic, Goran/0000-0002-3796-9945				Allsup SJ, 2004, J AM GERIATR SOC, V52, P20, DOI 10.1111/j.1532-5415.2004.52005.x; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Atkins D, UPDATE EVIDENCE RAND; Avenell A, 2005, BMJ-BRIT MED J, V331, P324, DOI 10.1136/bmj.331.7512.324; Balluz LS, 2000, ARCH FAM MED, V9, P258, DOI 10.1001/archfami.9.3.258; Bast A, 2002, ENVIRON TOXICOL PHAR, V11, P251, DOI 10.1016/S1382-6689(01)00118-1; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berger MM, 2005, CLIN NUTR, V24, P172, DOI 10.1016/j.clnu.2004.10.003; Bjelakovic G, 2006, ALIMENT PHARM THER, V24, P281, DOI 10.1111/j.1365-2036.2006.02970.x; Bjelakovic G, 2004, LANCET, V364, P1219, DOI 10.1016/S0140-6736(04)17138-9; Bjelakovic G, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004183.PUB2; BJELAKOVIC G, 2003, COCHRANE LIB; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Boaz M, 2000, LANCET, V356, P1213, DOI 10.1016/S0140-6736(00)02783-5; Bonelli L, 1998, P INT SEL TELL DEV A, P91; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Brown BG, 2005, JAMA-J AM MED ASSOC, V293, P1387, DOI 10.1001/jama.293.11.1387; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Caraballoso M, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002141, DOI 10.1002/14651858.CD002141]; CHANDRA RK, 1992, LANCET, V340, P1124, DOI 10.1016/0140-6736(92)93151-C; Chylack LT, 2002, OPHTHAL EPIDEMIOL, V9, P49; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Collins EG, 2003, MED SCI SPORT EXER, V35, P384, DOI 10.1249/01.MSS.0000053658.82687.FF; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Correa P, 2000, JNCI-J NATL CANCER I, V92, P1881, DOI 10.1093/jnci/92.23.1881; Davies AA, 2006, JNCI-J NATL CANCER I, V98, P961, DOI 10.1093/jnci/djj263; de Waart FG, 2001, ATHEROSCLEROSIS, V158, P227, DOI 10.1016/S0021-9150(01)00420-8; DELAMAZA MP, 1995, J AM COLL NUTR, V14, P192; DEMETS DL, 1987, STAT MED, V6, P341, DOI 10.1002/sim.4780060325; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Desnuelle C, 2001, AMYOTROPH LATERAL SC, V2, P9, DOI 10.1080/146608201300079364; Devaraj S, 2005, NUTR REV, V63, P290, DOI 10.1301/nr.2005.aug.290-293; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; DIPLOCK AT, 1994, MOL ASPECTS MED, V15, P293, DOI 10.1016/0098-2997(94)90005-1; Diplock AT, 1998, BRIT J NUTR, V80, pS77, DOI 10.1079/BJN19980106; Duarte TL, 2005, FREE RADICAL RES, V39, P671, DOI 10.1080/10715760500104025; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Forman D, 2004, LANCET, V364, P1193, DOI 10.1016/S0140-6736(04)17153-5; GILLILAN RE, 1977, AM HEART J, V93, P444, DOI 10.1016/S0002-8703(77)80406-7; Girodon F, 1997, ANN NUTR METAB, V41, P98, DOI 10.1159/000177984; Girodon F, 1999, ARCH INTERN MED, V159, P748, DOI 10.1001/archinte.159.7.748; Gluud C, 2006, J HEPATOL, V44, P607, DOI 10.1016/j.jhep.2005.12.006; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Goodman GE, 2004, J NATL CANCER I, V96, P1743, DOI 10.1093/jnci/djh320; Graat JM, 2002, JAMA-J AM MED ASSOC, V288, P715, DOI 10.1001/jama.288.6.715; Graf M, 2005, J NEURAL TRANSM, V112, P649, DOI 10.1007/s00702-004-0220-1; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; GREENBERG ER, 1990, NEW ENGL J MED, V323, P789, DOI 10.1056/NEJM199009203231204; GREENBERG ER, 1994, NEW ENGL J MED, V331, P141, DOI 10.1056/NEJM199407213310301; Guallar E, 2005, ANN INTERN MED, V143, P143, DOI 10.7326/0003-4819-143-2-200507190-00014; Halliwell B, 1999, FREE RADICAL RES, V31, P261, DOI 10.1080/10715769900300841; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; HALLIWELL B, 1999, BIOL MED; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Herbert V, 1997, J AM DIET ASSOC, V97, P375, DOI 10.1016/S0002-8223(97)00089-8; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hercberg S, 1998, NUTRITION, V14, P513, DOI 10.1016/S0899-9007(98)00040-9; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hodis HN, 2002, CIRCULATION, V106, P1453, DOI 10.1161/01.CIR.0000029092.99946.08; Hogarth MB, 1996, AGE AGEING, V25, P453, DOI 10.1093/ageing/25.6.453; Huang HY, 2006, ANN INTERN MED, V145, P372, DOI 10.7326/0003-4819-145-5-200609050-00135; Jacobson JS, 2000, CANCER EPIDEM BIOMAR, V9, P1303; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1439, DOI 10.1001/archopht.119.10.1439; Kawanishi S, 2005, ANTIOXID REDOX SIGN, V7, P1728, DOI 10.1089/ars.2005.7.1728; Kimura H., 2005, Current Drug Targets - Inflammation and Allergy, V4, P489, DOI 10.2174/1568010054526287; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Klein EA, 2003, UROL ONCOL-SEMIN ORI, V21, P59, DOI 10.1016/S1078-1439(02)00301-0; Lee BM, 2003, MUTAT RES-FUND MOL M, V523, P265, DOI 10.1016/S0027-5107(02)00342-1; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; LI JY, 1993, J NATL CANCER I, V85, P1492, DOI 10.1093/jnci/85.18.1492; Limburg PJ, 2005, GASTROENTEROLOGY, V129, P863, DOI 10.1053/j.gastro.2005.06.024; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; MACHLIN LJ, 1987, FASEB J, V1, P441, DOI 10.1096/fasebj.1.6.3315807; Manuel-y-Keenoy BE, 2004, ATHEROSCLEROSIS, V175, P369, DOI 10.1016/j.atherosclerosis.2004.04.005; Marras C, 2005, NEUROLOGY, V64, P87, DOI 10.1212/01.WNL.0000148603.44618.19; Maxwell SRJ, 1999, DRUG SAFETY, V21, P253, DOI 10.2165/00002018-199921040-00002; McAlister FA, 2003, JAMA-J AM MED ASSOC, V289, P2545, DOI 10.1001/jama.289.19.2545; MCKEOWNEYSSEN G, 1988, CANCER RES, V48, P4701; McKevith B, 2003, J HUM NUTR DIET, V16, P257, DOI 10.1046/j.1365-277X.2003.00436.x; McNeil JJ, 2004, OPHTHALMOLOGY, V111, P75, DOI 10.1016/j.ophtha.2003.04.009; Meydani SN, 2004, JAMA-J AM MED ASSOC, V292, P828, DOI 10.1001/jama.292.7.828; Mezey E, 2004, J HEPATOL, V40, P40, DOI 10.1016/S0168-8278(03)00476-8; Millen AE, 2004, J AM DIET ASSOC, V104, P942, DOI 10.1016/j.jada.2004.03.022; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moon TE, 1997, CANCER EPIDEM BIOMAR, V6, P949; Mooney LA, 2005, CANCER EPIDEM BIOMAR, V14, P237; MURPHY S, 1992, AGE AGEING, V21, P435, DOI 10.1093/ageing/21.6.435; Nichter M, 2006, CULT MED PSYCHIAT, V30, P175, DOI 10.1007/s11013-006-9016-0; Palace VP, 1999, FREE RADICAL BIO MED, V26, P746, DOI 10.1016/S0891-5849(98)00266-4; *PAN MICR SUBC UPP, 2000, I MED FOOD NUTR BOAR, P1; Paolini M, 2003, MUTAT RES-REV MUTAT, V543, P195, DOI 10.1016/S1383-5742(03)00002-4; Papadopoulos AP, 1998, ACTA HORTIC, P89; PENN ND, 1991, AGE AGEING, V20, P169, DOI 10.1093/ageing/20.3.169; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; PIKE J, 1995, INT J VITAM NUTR RES, V65, P117; Podmore ID, 1998, NATURE, V392, P559, DOI 10.1038/33308; Prince MI, 2003, ALIMENT PHARM THER, V17, P137, DOI 10.1046/j.1365-2036.2003.01398.x; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Ratnam DV, 2006, J CONTROL RELEASE, V113, P189, DOI 10.1016/j.jconrel.2006.04.015; Rayman M, 2006, BIOL PSYCHIAT, V59, P147, DOI 10.1016/j.biopsych.2005.06.019; Richer S, 1996, J Am Optom Assoc, V67, P30; Richer Stuart, 2004, Optometry, V75, P216, DOI 10.1016/S1529-1839(04)70049-4; Ritenbaugh C, ROUTINE VITAMIN SUPP; Royle P, 2003, INT J TECHNOL ASSESS, V19, P591, DOI 10.1017/S0266462303000552; Salganik RI, 2001, J AM COLL NUTR, V20, p464S, DOI 10.1080/07315724.2001.10719185; Salonen RM, 2003, CIRCULATION, V107, P947, DOI 10.1161/01.CIR.0000050626.25057.51; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Sasazuki S, 2003, CANCER SCI, V94, P378, DOI 10.1111/j.1349-7006.2003.tb01450.x; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sharp S, 1998, STATA TECH B, V7, DOI DOI 10.1002/SIM.1187/FULL); Sies H., 1985, OXIDATIVE STRESS, V501, P1, DOI DOI 10.1016/B978-0-12-642760-8.50005-3; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Stanner SA, 2004, PUBLIC HEALTH NUTR, V7, P407, DOI 10.1079/PHN2003543; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Stevic Z, 2001, JUGOSLAV MED BIOHEM, V20, P223; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Takagi H, 2003, INT J VITAM NUTR RES, V73, P411, DOI 10.1024/0300-9831.73.6.411; TAKAMATSU S, 1995, J INT MED RES, V23, P342, DOI 10.1177/030006059502300504; Tam LS, 2005, J RHEUMATOL, V32, P275; terRiet G, 1995, J CLIN EPIDEMIOL, V48, P1453, DOI 10.1016/0895-4356(95)00053-4; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; vanPoppel G, 1997, CANCER LETT, V114, P195, DOI 10.1016/S0304-3835(97)04662-4; Vertuani S, 2004, CURR PHARM DESIGN, V10, P1677, DOI 10.2174/1381612043384655; Virtamo J, 2003, JAMA-J AM MED ASSOC, V290, P476, DOI 10.1001/jama.290.4.476; Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9; Waters DD, 2002, JAMA-J AM MED ASSOC, V288, P2432, DOI 10.1001/jama.288.19.2432; Wenzel G, 1993, Z Gesamte Inn Med, V48, P490; White KLM, 2002, BRIT J NUTR, V88, P265, DOI 10.1079/BJN2002619; Willcox JK, 2004, CRIT REV FOOD SCI, V44, P275, DOI 10.1080/10408690490468489; Witte KKA, 2005, EUR HEART J, V26, P2238, DOI 10.1093/eurheartj/ehi442; Wluka A, 2002, J RHEUMATOL, V29, P2585; You WC, 2001, EUR J CANCER PREV, V10, P257, DOI 10.1097/00008469-200106000-00009	136	1561	1652	3	197	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2007	297	8					842	857		10.1001/jama.297.8.842	http://dx.doi.org/10.1001/jama.297.8.842			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140DS	17327526				2022-12-28	WOS:000244485000027
J	Sano, M; Minamino, T; Toko, H; Miyauchi, H; Orimo, M; Qin, YJ; Akazawa, H; Tateno, K; Kayama, Y; Harada, M; Shimizu, I; Asahara, T; Hamada, H; Tomita, S; Molkentin, JD; Zou, YZ; Komuro, I				Sano, Masanori; Minamino, Tohru; Toko, Haruhiro; Miyauchi, Hideyuki; Orimo, Masayuki; Qin, Yingjie; Akazawa, Hiroshi; Tateno, Kaoru; Kayama, Yosuke; Harada, Mutsuo; Shimizu, Ippei; Asahara, Takayuki; Hamada, Hirofumi; Tomita, Shuhei; Molkentin, Jeffrey D.; Zou, Yunzeng; Komuro, Issei			p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-GROWTH; HYPOXIA; ANGIOGENESIS; HYPERTROPHY; P53; EXPRESSION; HEART; GENE; MICE	Cardiac hypertrophy occurs as an adaptive response to increased workload to maintain cardiac function(1). However, prolonged cardiac hypertrophy causes heart failure(2), and its mechanisms are largely unknown. Here we show that cardiac angiogenesis is crucially involved in the adaptive mechanism of cardiac hypertrophy and that p53 accumulation is essential for the transition from cardiac hypertrophy to heart failure. Pressure overload initially promoted vascular growth in the heart by hypoxia-inducible factor-1 (Hif-1)-dependent induction of angiogenic factors, and inhibition of angiogenesis prevented the development of cardiac hypertrophy and induced systolic dysfunction. Sustained pressure overload induced an accumulation of p53 that inhibited Hif-1 activity and thereby impaired cardiac angiogenesis and systolic function. Conversely, promoting cardiac angiogenesis by introducing angiogenic factors or by inhibiting p53 accumulation developed hypertrophy further and restored cardiac dysfunction under chronic pressure overload. These results indicate that the anti-angiogenic property of p53 may have a crucial function in the transition from cardiac hypertrophy to heart failure.	Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, Chiba 2608670, Japan; RIKEN, Ctr Dev Biol, Kobe Inst Biomed Res & Innovat, Stem Cell Translat Res,Chuo Ku, Kobe, Hyogo 6500047, Japan; Sapporo Med Univ, Dept Mol Med, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima 7708503, Japan; Childrens Hosp, Med Ctr, Dept Pediat, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA; Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai 200032, Peoples R China; Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Chiba University; Institute for Biomedical Research & Innovation (IBRI); RIKEN; Sapporo Medical University; Tokushima University; Cincinnati Children's Hospital Medical Center; Fudan University; Fudan University	Komuro, I (corresponding author), Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	komuro-tky@umin.ac.jp	Minamino, Tohru/P-8145-2018	Minamino, Tohru/0000-0003-1627-6151; Akazawa, Hiroshi/0000-0002-3574-9607; Molkentin, Jeffery/0000-0002-3558-6529; Shimizu, Ippei/0000-0003-3333-8131				Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Fei PW, 2004, CANCER CELL, V6, P597, DOI 10.1016/j.ccr.2004.10.012; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Goldman CK, 1998, P NATL ACAD SCI USA, V95, P8795, DOI 10.1073/pnas.95.15.8795; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; MARCUS ML, 1983, AM J MED, V75, P62, DOI 10.1016/0002-9343(83)90120-1; Morani A, 2006, P NATL ACAD SCI USA, V103, P7165, DOI 10.1073/pnas.0602194103; Patel TH, 2005, CARDIOVASC RES, V68, P144, DOI 10.1016/j.cardiores.2005.05.002; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Ravi R, 2000, GENE DEV, V14, P34; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shizukuda Y, 2005, MOL CELL BIOCHEM, V273, P25, DOI 10.1007/s11010-005-5905-8; Shyu KG, 2005, J BIOMED SCI, V12, P409, DOI 10.1007/s11373-005-3008-x; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Takimoto E, 2002, FASEB J, V16, DOI 10.1096/fj.01-0735com; TOMANEK RJ, 1990, J AM COLL CARDIOL, V15, P528, DOI 10.1016/0735-1097(90)90620-5; Tomita S, 2003, MOL CELL BIOL, V23, P6739, DOI 10.1128/MCB.23.19.6739-6749.2003; Yoon YS, 2005, CIRCULATION, V111, P2073, DOI 10.1161/01.CIR.0000162472.52990.36	24	681	704	6	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2007	446	7134					444	448		10.1038/nature05602	http://dx.doi.org/10.1038/nature05602			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17334357				2022-12-28	WOS:000245079500041
J	Hutton, EK; Hassan, ES				Hutton, Eileen K.; Hassan, Eman S.			Late vs early clamping of the umbilical cord in full-term neonates - Systematic review and meta-analysis of controlled trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; SYSTOLIC-TIME INTERVALS; IRON-DEFICIENCY ANEMIA; PLACENTAL TRANSFUSION; PRETERM INFANTS; NEWBORN-INFANT; INTRAVENTRICULAR HEMORRHAGE; RESPIRATORY DISTRESS; LEBOYER CHILDBIRTH; BLOOD-VISCOSITY	Context With few exceptions, the umbilical cord of every newborn is clamped and cut at birth, yet the optimal timing for this intervention remains controversial. Objective To compare the potential benefits and harms of late vs early cord clamping in term infants. Data Sources Search of 6 electronic databases (on November 15, 2006, starting from the beginning of each): the Cochrane Pregnancy and Childbirth Group trials register, the Cochrane Neonatal Group trials register, the Cochrane library, MEDLINE, EMBASE, and CINHAL; hand search of secondary references in relevant studies; and contact of investigators about relevant published research. Study Selection Controlled trials comparing late vs early cord clamping following birth in infants born at 37 or more weeks' gestation. Data Extraction Two reviewers independently assessed eligibility and quality of trials and extracted data for outcomes of interest: infant hematologic status; iron status; and risk of adverse events such as jaundice, polycythemia, and respiratory distress. Data Synthesis The meta-analysis included 15 controlled trials (1912 newborns). Late cord clamping was delayed for at least 2 minutes (n = 1001 newborns), while early clamping in most trials (n = 911 newborns) was performed immediately after birth. Benefits over ages 2 to 6 months associated with late cord clamping include improved hematologic status measured as hematocrit (weighted mean difference [WMD], 3.70%; 95% confidence interval [CI], 2.00%- 5.40%); iron status as measured by ferritin concentration (WMD, 17.89; 95% CI, 16.58-19.21) and stored iron (WMD, 19.90; 95% CI, 7.67-32.13); and a clinically important reduction in the risk of anemia (relative risk (RR), 0.53; 95% CI, 0.40-0.70). Neonates with late clamping were at increased risk of experiencing asymptomatic polycythemia (7 studies [ 403 neonates]: RR, 3.82; 95% CI, 1.11-13.21; 2 high-quality studies only [ 281 infants]: RR, 3.91; 95% CI, 1.00-15.36). Conclusions Delaying clamping of the umbilical cord in full-term neonates for a minimum of 2 minutes following birth is beneficial to the newborn, extending into infancy. Although there was an increase in polycythemia among infants in whom cord clamping was delayed, this condition appeared to be benign.	McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON L8N 3Z5, Canada; Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Western Reg Training Ctr Hlth Serv Res, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Hlth Care & Epidemiol, Vancouver, BC V6T 1W5, Canada	McMaster University; Child & Family Research Institute; University of British Columbia; University of British Columbia; University of British Columbia	Hutton, EK (corresponding author), McMaster Univ, Dept Obstet & Gynecol, 1200 Main St W,MDCL-3101, Hamilton, ON L8N 3Z5, Canada.	huttone@mcmaster.ca		Hutton, Eileen/0000-0003-0895-7395				Austin T, 1997, LANCET, V350, P1445, DOI 10.1016/S0140-6736(97)24046-8; AZIZ SFA, 1999, EARLY CORD CLAMPING; Blackburn S, 1995, Neonatal Netw, V14, P15; Booth IW, 1997, ARCH DIS CHILD, V76, P549, DOI 10.1136/adc.76.6.549; BUCKELS LJ, 1965, J PEDIATR-US, V67, P239, DOI 10.1016/S0022-3476(65)80246-3; Cernadas JMC, 2006, PEDIATRICS, V117, pE779, DOI 10.1542/peds.2005-1156; Chaparro CM, 2006, LANCET, V367, P1997, DOI 10.1016/S0140-6736(06)68889-2; *COCHR COLL NORD C, 2003, REVMAN COMP PROGR VE; De Marsh QB, 1942, AM J DIS CHILD, V63, P1123; DEEKS JJ, 2005, COCHRANE HDB SYSTEMA; Dixon LR, 1997, J PERINAT NEONAT NUR, V11, P1; Emhamed MO, 2004, TROP DOCT, V34, P218, DOI 10.1177/004947550403400410; EMMANOUILIDES GC, 1971, BIOL NEONATE, V18, P363; Ende N, 2006, MED HYPOTHESES, V66, P1157, DOI 10.1016/j.mehy.2005.12.024; FRANK DJ, 1967, AM J OBSTET GYNECOL, V97, P1142, DOI 10.1016/0002-9378(67)90479-6; Geethanath R M, 1997, Indian Pediatr, V34, P103; Grajeda R, 1997, AM J CLIN NUTR, V65, P425, DOI 10.1093/ajcn/65.2.425; Gupta Rajesh, 2002, Indian Pediatr, V39, P130; HOFMEYR GJ, 1988, S AFR MED J, V73, P104; HOFMEYR GJ, 1993, ONLINE J CURR C 1229; Ibrahim H M, 2000, J Perinatol, V20, P351, DOI 10.1038/sj.jp.7200408; *ICM FIGO, 2003, JOINT STAT MAN 3 STA; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; KINMOND S, 1993, BMJ-BRIT MED J, V306, P172, DOI 10.1136/bmj.306.6871.172; Lainez Villabona B, 2005, An Pediatr (Barc), V63, P14; LINDERKAMP O, 1992, ACTA PAEDIATR, V81, P745, DOI 10.1111/j.1651-2227.1992.tb12095.x; LINDERKAMP O, 1982, CLIN PERINATOL, V9, P559, DOI 10.1016/S0095-5108(18)31013-3; MATOTH Y, 1971, ACTA PAEDIATR SCAND, V60, P317, DOI 10.1111/j.1651-2227.1971.tb06663.x; McCAUSLAND A M, 1950, West J Surg Obstet Gynecol, V58, P591; McDonnell M, 1997, J PAEDIATR CHILD H, V33, P308, DOI 10.1111/j.1440-1754.1997.tb01606.x; Mercer JS, 2006, PEDIATRICS, V117, P1235, DOI 10.1542/peds.2005-1706; Mercer JS, 2001, J MIDWIFERY WOM HEAL, V46, P402, DOI 10.1016/S1526-9523(01)00196-9; Mercer JS, 2002, J PERINAT NEONAT NUR, V15, P56, DOI 10.1097/00005237-200203000-00007; Mercer Judith S, 2003, J Perinatol, V23, P466, DOI 10.1038/sj.jp.7210970; Morley G, 1998, OBG MANAGE       JUL, P29; MOSS AJ, 1967, PEDIATRICS, V40, P109; NARENDRA A, 1998, PEDIATR RES, V44, P454; NELLE M, 1995, AM J PERINAT, V12, P212, DOI 10.1055/s-2007-994455; NELLE M, 1993, AM J OBSTET GYNECOL, V169, P189, DOI 10.1016/0002-9378(93)90161-B; Nelle M, 1996, J PERINAT MED, V24, P513, DOI 10.1515/jpme.1996.24.5.513; Nelle M., 1998, PEDIATR RES, V44, P454, DOI 10.1203/00006450-199809000-00245; NELSON NM, 1980, NEW ENGL J MED, V302, P655, DOI 10.1056/NEJM198003203021203; OH W, 1986, PEDIATR CLIN N AM, V33, P523; Oh W, 2002, PEDIATR RES, V51, p365A; OH W, 1967, PEDIATRICS, V40, P6; OH W, 1967, ACTA PAEDIATR SCAND, VS, P137; *OXF MIDW RES GROU, 1991, MIDWIFERY, V7, P167; Papagno L., 1998, Acta Physiologica Pharmacologica et Therapeutica Latinoamericana, V48, P224; PELTONEN T, 1981, EUR J PEDIATR, V137, P141; Pisacane A, 1996, BMJ-BRIT MED J, V312, P136; Prendiville WJ, 2000, COCHRANE DB SYST REV, V3; Rabe H, 2000, EUR J PEDIATR, V159, P775, DOI 10.1007/PL00008345; Rabe H, 2004, COCHRANE DB SYST REV, V18, DOI [DOI 10.1002/14651858.CD003248.PUB2, 10.1002/14651858.CD003248.pub2]; Rabe H, 1998, PEDIATR RES, V44, P454, DOI [DOI 10.1203/00006450-199809000-00244, 10.1203/00006450-199809000-00244]; RAMAMURTHY RS, 1981, PEDIATRICS, V68, P168; SAIGAL S, 1972, PEDIATRICS, V49, P406; SHOHAT M, 1984, PEDIATRICS, V73, P7; Strauss RG, 2003, TRANSFUSION, V43, P1168, DOI 10.1046/j.1537-2995.2003.00454.x; USHER R, 1963, ACTA PAEDIATR, V52, P497, DOI 10.1111/j.1651-2227.1963.tb03809.x; Van Rheenen P, 2004, ANN TROP PAEDIATR, V24, P3, DOI 10.1179/027249304225013286; van Rheenen PF, 2006, BMJ-BRIT MED J, V333, P954, DOI 10.1136/bmj.39002.389236.BE; WARDROP CAJ, 1995, J PERINAT MED, V23, P139, DOI 10.1515/jpme.1995.23.1-2.139; Wharton BA, 1999, BRIT J HAEMATOL, V106, P270, DOI 10.1046/j.1365-2141.1999.01511.x; *WHO, 1998, WHORHTMSM984 DEP REP; Wilson EE, 1941, AM J DIS CHILD, V62, P320; YAO AC, 1969, LANCET, V2, P505; YAO AC, 1969, ACTA PAEDIATR SCAND, V58, P561, DOI 10.1111/j.1651-2227.1969.tb04762.x; YAO AC, 1974, BIOL NEONATE, V25, P186; YAO AC, 1977, ACTA PAEDIATR SCAND, V66, P489, DOI 10.1111/j.1651-2227.1977.tb07932.x; YAO AC, 1971, PEDIATRICS, V48, P865; YAO AC, 1969, LANCET, V2, P871; ZLOTKIN S, 2003, STRATEGIES PREVENTIO	72	262	283	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2007	297	11					1241	1252		10.1001/jama.297.11.1241	http://dx.doi.org/10.1001/jama.297.11.1241			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	147XO	17374818				2022-12-28	WOS:000245039300028
J	Ewy, GA				Ewy, Gordon A.			Cardiac arrest - guideline changes urgently needed	LANCET			English	Editorial Material							CARDIOPULMONARY-RESUSCITATION; CARDIOCEREBRAL RESUSCITATION; PERFUSION-PRESSURE; SURVIVAL; VENTILATION		Univ Arizona, Coll Med, Tucson, AZ 85724 USA	University of Arizona	Ewy, GA (corresponding author), Univ Arizona, Coll Med, Tucson, AZ 85724 USA.	gaewy@aol.com						[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Assar D, 2000, RESUSCITATION, V45, P7, DOI 10.1016/S0300-9572(00)00152-0; Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; BERG RA, 1993, CIRCULATION, V88, P1907, DOI 10.1161/01.CIR.88.4.1907; CHANDRA NC, 1994, CIRCULATION, V90, P3070, DOI 10.1161/01.CIR.90.6.3070; Ewy GA, 2005, CIRCULATION, V111, P2134, DOI 10.1161/01.CIR.0000162503.57657.FA; Ewy GA, 2000, NEW ENGL J MED, V342, P1599, DOI 10.1056/NEJM200005253422109; Holmberg M, 1998, RESUSCITATION, V36, P29, DOI 10.1016/S0300-9572(97)00089-0; Int Liaison Comm Resuscitation, 2005, RESUSCITATION, V67, P181, DOI 10.1016/j.resuscitation.2005.09.010; Kellum MJ, 2006, AM J MED, V119, P335, DOI 10.1016/j.amjmed.2005.11.014; KERN KB, 1988, RESUSCITATION, V16, P241, DOI 10.1016/0300-9572(88)90111-6; Kern KB, 2002, CIRCULATION, V105, P645, DOI 10.1161/hc0502.102963; Meursing BTJ, 2005, RESUSCITATION, V64, P279, DOI 10.1016/j.resuscitation.2004.10.016; Nagao K, 2007, LANCET, V369, P920; NOC M, 1995, CHEST, V108, P821, DOI 10.1378/chest.108.3.821; SANDERS AB, 1985, AM J EMERG MED, V3, P11, DOI 10.1016/0735-6757(85)90003-8; VANHOEYWEGHEN RJ, 1993, RESUSCITATION, V26, P47, DOI 10.1016/0300-9572(93)90162-J; YANG LY, 1994, CRIT CARE MED, V22, P879, DOI 10.1097/00003246-199405000-00027	19	40	43	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2007	369	9565					882	884		10.1016/S0140-6736(07)60422-X	http://dx.doi.org/10.1016/S0140-6736(07)60422-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148BQ	17368131				2022-12-28	WOS:000245049900005
J	Robertson, MP; Scott, WG				Robertson, Michael P.; Scott, William G.			The structural basis of ribozyme-catalyzed RNA assembly	SCIENCE			English	Article							IN-VITRO SELECTION; INTERVENING SEQUENCE; HAMMERHEAD RIBOZYME; LIGASE; POLYMERIZATION; OPTIMIZATION; TETRAHYMENA; CLEAVAGE; COMPLEX; ENZYME	Life originated, according to the RNA World hypothesis, from self-replicating ribozymes that catalyzed ligation of RNA fragments. We have solved the 2.6 angstrom crystal structure of a ligase ribozyme that catalyzes regiospecific formation of a 5' to 3' phosphodiester bond between the 5'-triphosphate and the 3'-hydroxyl termini of two RNA fragments. Invariant residues form tertiary contacts that stabilize a flexible stem of the ribozyme at the ligation site, where an essential magnesium ion coordinates three phosphates. The structure of the active site permits us to suggest how transition-state stabilization and a general base may catalyze the ligation reaction required for prebiotic RNA assembly.	Univ Calif Santa Cruz, Ctr Mol Biol RNA, Robert L Sinsheimer Labs, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Chem & Biochem, Robert L Sinsheimer Labs, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Scott, WG (corresponding author), Univ Calif Santa Cruz, Ctr Mol Biol RNA, Robert L Sinsheimer Labs, Santa Cruz, CA 95064 USA.	wgscott@chemistry.ucsc.edu		Scott, William/0000-0002-9273-3564	NIGMS NIH HHS [R01 GM087721] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bandyopadhyay D, 2003, J BIOMOL STRUCT DYN, V21, P447, DOI 10.1080/07391102.2003.10506939; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; Doudna JA, 2002, NATURE, V418, P222, DOI 10.1038/418222a; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; GERRIERTAKADA C, 1983, CELL, V35, P849; GESTELAND RF, 1993, RNA WORLD; Ikawa Y, 2004, P NATL ACAD SCI USA, V101, P13750, DOI 10.1073/pnas.0405886101; Jaeger L, 1999, P NATL ACAD SCI USA, V96, P14712, DOI 10.1073/pnas.96.26.14712; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Landweber LF, 1999, P NATL ACAD SCI USA, V96, P173, DOI 10.1073/pnas.96.1.173; Lawrence MS, 2005, RNA, V11, P1173, DOI 10.1261/rna.2110905; Lawrence MS, 2003, BIOCHEMISTRY-US, V42, P8748, DOI 10.1021/bi034228l; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; McGinness KE, 2003, CHEM BIOL, V10, P5, DOI 10.1016/S1074-5521(03)00003-6; PLEY HW, 1994, NATURE, V372, P68, DOI 10.1038/372068a0; Robertson MP, 2000, NUCLEIC ACIDS RES, V28, P1751, DOI 10.1093/nar/28.8.1751; Robertson MP, 2004, RNA, V10, P114, DOI 10.1261/rna.5900204; Robertson MP, 1999, NAT BIOTECHNOL, V17, P62, DOI 10.1038/5236; Robertson MP, 2001, NAT BIOTECHNOL, V19, P650, DOI 10.1038/90256; Robertson MP, 2001, RNA, V7, P513, DOI 10.1017/S1355838201002199; Rogers J, 1999, NATURE, V402, P323, DOI 10.1038/46335; SCOTT WG, 1995, CELL, V81, P991, DOI 10.1016/S0092-8674(05)80004-2; ZAUG AJ, 1986, SCIENCE, V231, P470, DOI 10.1126/science.3941911	24	73	78	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1549	1553		10.1126/science.1136231	http://dx.doi.org/10.1126/science.1136231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363667	Green Submitted			2022-12-28	WOS:000244934800044
J	Liu, KL; Lin, BR				Liu, Kao-Lang; Lin, Been-Ren			Small-bowel obstruction due to an internal hernia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Natl Taiwan Univ Hosp, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital	Liu, KL (corresponding author), Natl Taiwan Univ Hosp, Taipei 100, Taiwan.	wgl@ntumc.org		LIU, KAO-LANG/0000-0003-4100-8909; LIN, BEEN-REN/0000-0001-8354-1758					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2007	356	11					1152	1152		10.1056/NEJMicm062482	http://dx.doi.org/10.1056/NEJMicm062482			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	145PO	17360993				2022-12-28	WOS:000244877200008
J	Neubauer, S				Neubauer, Stefan			Mechanisms of disease - The failing heart - An engine out of fuel	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MYOCARDIAL FATTY-ACID; MAGNETIC-RESONANCE-SPECTROSCOPY; ACTIVATED RECEPTOR-ALPHA; CREATINE-KINASE SYSTEM; ENERGY PHOSPHATE METABOLITES; LEFT-VENTRICULAR FUNCTION; CORONARY-ARTERY-DISEASE; CARDIAC-HYPERTROPHY; DILATED CARDIOMYOPATHY; CONTRACTILE FUNCTION		Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England	University of Oxford	Neubauer, S (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England.	stefan.neubauer@cardiov.ox.ac.uk	Neubauer, Stefan/B-8448-2011	Neubauer, Stefan/0000-0001-9017-5645				Abel ED, 1999, J CLIN INVEST, V104, P1703, DOI 10.1172/JCI7605; American Heart Association, 2005, HEART DIS STROKE STA; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Ashrafian H, 2003, TRENDS GENET, V19, P263, DOI 10.1016/S0168-9525(03)00081-7; Barger PM, 2000, J CLIN INVEST, V105, P1723, DOI 10.1172/JCI9056; Beer M, 2002, J AM COLL CARDIOL, V40, P1267, DOI 10.1016/S0735-1097(02)02160-5; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; BITTNER V, 1991, MAGNET RESON MED, V17, P69, DOI 10.1002/mrm.1910170112; BOTTOMLEY PA, 1994, RADIOLOGY, V191, P593, DOI 10.1148/radiology.191.3.8184033; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Casademont Jordi, 2002, Heart Fail Rev, V7, P131, DOI 10.1023/A:1015372407647; Chandler MP, 2004, AM J PHYSIOL-HEART C, V287, pH1538, DOI 10.1152/ajpheart.00281.2004; Chandler MP, 2002, CIRC RES, V91, P278, DOI 10.1161/01.RES.0000031151.21145.59; CHAPOY PR, 1980, NEW ENGL J MED, V303, P1389, DOI 10.1056/NEJM198012113032403; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; CONWAY MA, 1991, LANCET, V338, P973, DOI 10.1016/0140-6736(91)91838-L; Crilley JG, 2003, J AM COLL CARDIOL, V41, P1776, DOI 10.1016/S0735-1097(02)03009-7; Davila-Roman VG, 2002, J AM COLL CARDIOL, V40, P271, DOI 10.1016/S0735-1097(02)01967-8; Dayer M, 2004, CLIN MED, V4, P13, DOI 10.7861/clinmedicine.4-1-13; De Sousa E, 1999, CIRC RES, V85, P68; Di Napoli P, 2005, HEART, V91, P161, DOI 10.1136/hrt.2003.031310; Essop MF, 2004, EUR HEART J, V25, P1765, DOI 10.1016/j.ehj.2004.08.019; Exil VJ, 2003, CIRC RES, V93, P448, DOI 10.1161/01.RES.0000088786.19197.E4; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Frantz S, 2004, BRIT J PHARMACOL, V141, P9, DOI 10.1038/sj.bjp.0705585; GARLICK PB, 1977, BIOCHEM BIOPH RES CO, V74, P1256, DOI 10.1016/0006-291X(77)91653-9; Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; GUDBJARNASON S, 1970, Journal of Molecular and Cellular Cardiology, V1, P325; Guertl B, 2000, INT J EXP PATHOL, V81, P349, DOI 10.1046/j.1365-2613.2000.00186.x; GUIMBAL C, 1993, J BIOL CHEM, V268, P8418; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; HARDY CJ, 1991, AM HEART J, V122, P795, DOI 10.1016/0002-8703(91)90527-O; Hermann HP, 1999, LANCET, V353, P1321, DOI 10.1016/S0140-6736(98)06423-X; Herrmann G, 1939, ANN INTERN MED, V12, P1233, DOI 10.7326/0003-4819-12-8-1233; HUG G, 1991, NEW ENGL J MED, V325, P1862, DOI 10.1056/NEJM199112263252607; Hugel S, 1999, AM J PHYSIOL-HEART C, V277, pH2167, DOI 10.1152/ajpheart.1999.277.6.H2167; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Ingwall JC, 2002, ATP HEART; INGWALL JS, 1982, AM J PHYSIOL, V242, pH729, DOI 10.1152/ajpheart.1982.242.5.H729; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; INGWALL JS, 1985, NEW ENGL J MED, V313, P1050, DOI 10.1056/NEJM198510243131704; Kaasik A, 2001, CIRC RES, V89, P153, DOI 10.1161/hh1401.093440; Kalsi KK, 1999, EUR J CLIN INVEST, V29, P469, DOI 10.1046/j.1365-2362.1999.00468.x; Karbowska J, 2003, CELL MOL BIOL LETT, V8, P49; Katz A.M., 2012, HEART FAILURE PATHOP; KHUCHUA ZA, 1989, BIOCHEM BIOPH RES CO, V165, P748, DOI 10.1016/S0006-291X(89)80030-0; Kurtz DM, 1998, P NATL ACAD SCI USA, V95, P15592, DOI 10.1073/pnas.95.26.15592; Lamb HJ, 1999, CIRCULATION, V99, P2261, DOI 10.1161/01.CIR.99.17.2261; Laser A, 1996, J MOL CELL CARDIOL, V28, P1531, DOI 10.1006/jmcc.1996.0143; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; Lee L, 2005, CIRCULATION, V112, P3280, DOI 10.1161/CIRCULATIONAHA.105.551457; Lewandowski ED, 2002, J NUCL CARDIOL, V9, P419, DOI 10.1067/mnc.2002.125811; Liao RL, 2002, CIRCULATION, V106, P2125, DOI 10.1161/01.CIR.0000034049.61181.F3; Liao RL, 1996, CIRC RES, V78, P893, DOI 10.1161/01.RES.78.5.893; LIONETTI V, CARDIOVASC RES; Liu JB, 2001, AM J PHYSIOL-HEART C, V281, pH1319, DOI 10.1152/ajpheart.2001.281.3.H1319; Lopaschuk GD, 2002, CIRCULATION, V105, P140, DOI 10.1161/circ.105.2.140; Luptak I, 2005, CIRCULATION, V112, P2339, DOI 10.1161/CIRCULATIONAHA.105.534594; Lygate CA, 2003, CARDIOVASC RES, V58, P632, DOI 10.1016/S0008-6363(03)00289-X; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; MANN DL, 2005, CIRCULATION, V112, pE75; Marin-Garcia J, 2001, CARDIOVASC RES, V52, P103, DOI 10.1016/S0008-6363(01)00368-6; MATALON R, 1993, J INHERIT METAB DIS, V16, P571, DOI 10.1007/BF00711684; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Morrow DA, 2005, CIRCULATION, V112, P3218, DOI 10.1161/CIRCULATIONAHA.105.581819; Murakami Y, 1999, CIRCULATION, V99, P942, DOI 10.1161/01.CIR.99.7.942; Murray AJ, 2004, LANCET, V364, P1786, DOI 10.1016/S0140-6736(04)17402-3; Nahrendorf M, 2005, CARDIOVASC RES, V65, P419, DOI 10.1016/j.cardiores.2004.10.006; NASCIMBEN L, 1995, CIRCULATION, V91, P1824, DOI 10.1161/01.CIR.91.6.1824; Nascimben L, 2004, HYPERTENSION, V44, P662, DOI 10.1161/01.HYP.0000144292.69599.0c; Nascimben L, 1996, CIRCULATION, V94, P1894, DOI 10.1161/01.CIR.94.8.1894; Neubauer S, 1999, CIRCULATION, V100, P1847, DOI 10.1161/01.CIR.100.18.1847; NEUBAUER S, 1995, J CLIN INVEST, V95, P1092, DOI 10.1172/JCI117756; Neubauer S, 1995, EUR HEART J, V16, P115, DOI 10.1093/eurheartj/16.suppl_O.115; NEUBAUER S, 1992, CIRCULATION, V86, P1810, DOI 10.1161/01.CIR.86.6.1810; Neubauer S, 1997, CIRCULATION, V96, P2190; NEUBAUER S, 2003, CARDIOVASCULAR MAGNE, P39; Ng TMH, 2004, PHARMACOTHERAPY, V24, P1366, DOI 10.1592/phco.24.14.1366.43145; Nikolaidis LA, 2004, CIRCULATION, V110, P955, DOI 10.1161/01.CIR.0000139339.85840.DD; Ning XH, 2000, J AM COLL CARDIOL, V36, P282, DOI 10.1016/S0735-1097(00)00689-6; OLSON R E, 1959, J Chronic Dis, V9, P442, DOI 10.1016/0021-9681(59)90172-9; OLSON RE, 1951, MEDICINE, V30, P21, DOI 10.1097/00005792-195102000-00002; Osorio JC, 2002, CIRCULATION, V106, P606, DOI 10.1161/01.CIR.0000023531.22727.C1; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; POOL PE, 1967, CIRC RES, V21, P365, DOI 10.1161/01.RES.21.3.365; Quigley AF, 2000, J CARD FAIL, V6, P47, DOI 10.1016/S1071-9164(00)00011-7; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; REGITZ V, 1992, AM J CARDIOL, V69, P1574, DOI 10.1016/0002-9149(92)90706-5; Remondino A, 2000, J MOL CELL CARDIOL, V32, P2025, DOI 10.1006/jmcc.2000.1234; Russell LK, 2005, J MOL CELL CARDIOL, V38, P81, DOI 10.1016/j.yjmcc.2004.10.010; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Schmidt-Schweda S, 2000, CLIN SCI, V99, P27, DOI 10.1042/CS19990235; Shen WQ, 1999, CIRCULATION, V100, P2113, DOI 10.1161/01.CIR.100.20.2113; Shiomi T, 2002, CIRCULATION, V106, P3126, DOI 10.1161/01.CIR.0000039346.31538.2C; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Starling RC, 1998, MOL CELL BIOCHEM, V180, P171, DOI 10.1023/A:1006876031121; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Taegtmeyer H, 2000, J AM COLL CARDIOL, V36, P1386, DOI 10.1016/S0735-1097(00)00870-6; Taegtmeyer H, 2004, CIRCULATION, V110, P894, DOI 10.1161/01.CIR.0000139340.88769.D5; Taylor M, 2001, J NUCL MED, V42, P55; ten Hove M, 2005, CIRCULATION, V111, P2477, DOI 10.1161/01.CIR.0000165147.99592.01; Ten Hove Michiel, 2005, J Mol Cell Cardiol, V38, P309, DOI 10.1016/j.yjmcc.2004.11.016; van Bilsen M, 2004, CARDIOVASC RES, V61, P218, DOI 10.1016/j.cardiores.2003.11.014; VATNER DE, 1984, P SOC EXP BIOL MED, V175, P5; Ventura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095; Vitale C, 2004, EUR HEART J, V25, P1814, DOI 10.1016/j.ehj.2004.06.034; Vitale GD, 2001, J NUCL MED, V42, P1730; Wallhaus TR, 2001, CIRCULATION, V103, P2441; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wallis J, 2005, CIRCULATION, V112, P3131, DOI 10.1161/CIRCULATIONAHA.105.572990; Weiss RG, 2005, P NATL ACAD SCI USA, V102, P808, DOI 10.1073/pnas.0408962102; WOLLENBERGER A, 1947, AM J PHYSIOL, V150, P733, DOI 10.1152/ajplegacy.1947.150.4.733; WYSS M, 1994, MOL CELL BIOCHEM, V133, P51, DOI 10.1007/BF01267947; Ye Y, 2001, CIRCULATION, V103, P1570; Zhang JY, 1997, CIRCULATION, V96, P334; Zhang JY, 1996, CIRCULATION, V94, P1089, DOI 10.1161/01.CIR.94.5.1089; ZHANG JY, 1993, J CLIN INVEST, V92, P993, DOI 10.1172/JCI116676	125	1527	1585	7	135	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2007	356	11					1140	1151		10.1056/NEJMra063052	http://dx.doi.org/10.1056/NEJMra063052			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	145PO	17360992				2022-12-28	WOS:000244877200007
J	Saarela, JM; Rai, HS; Doyle, JA; Endress, PK; Mathews, S; Marchant, AD; Briggs, BG; Graham, SW				Saarela, Jeffery M.; Rai, Hardeep S.; Doyle, James A.; Endress, Peter K.; Mathews, Sarah; Marchant, Adam D.; Briggs, Barbara G.; Graham, Sean W.			Hydatellaceae identified as a new branch near the base of the angiosperm phylogenetic tree	NATURE			English	Article							EARLY EVOLUTION; GENES; MITOCHONDRIAL; FAMILIES; GENOME	Although the relationship of angiosperms to other seed plants remains controversial 1, great progress has been made in identifying the earliest extant splits in flowering-plant phylogeny, with the discovery that the New Caledonian shrub Amborella trichopoda, the water lilies (Nymphaeales), and the woody Austrobaileyales constitute a basal grade of lines that diverged before the main radiation in the clade(2-8). By focusing attention on these ancient lines, this finding has re-written our understanding of angiosperm structural and reproductive biology, physiology, ecology and taxonomy(9-12). The discovery of a new basal lineage would lead to further re-evaluation of the initial angiosperm radiation, but would also be unexpected, as nearly all of the 460 flowering-plant families have been surveyed in molecular studies(10). Here we show that Hydatellaceae, a small family of dwarf aquatics that were formerly interpreted as monocots, are instead a highly modified and previously unrecognized ancient lineage of angiosperms. Molecular phylogenetic analyses of multiple plastid genes and associated noncoding regions from the two genera of Hydatellaceae identify this overlooked family as the sister group of Nymphaeales. This surprising result is further corroborated by evidence from the nuclear gene phytochrome C (PHYC), and by numerous morphological characters. This indicates that water lilies are part of a larger lineage that evolved more extreme and diverse modifications for life in an aquatic habitat than previously recognized.	Univ British Columbia, Fac Land & Food Syst, Ctr Biodivers Res, Plant Res Ctr, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, UBC Bot Garden, Vancouver, BC V6T 1Z4, Canada; Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; Univ Zurich, Inst Systemat Bot, CH-8008 Zurich, Switzerland; Harvard Univ, Arnold Arboretum, Cambridge, MA 02138 USA; Royal Bot Gardens, Sydney, NSW 2000, Australia	University of British Columbia; University of British Columbia; University of California System; University of California Davis; University of Zurich; Harvard University	Graham, SW (corresponding author), Univ British Columbia, Fac Land & Food Syst, Ctr Biodivers Res, Plant Res Ctr, 2357 Main Mall, Vancouver, BC V6T 1Z4, Canada.	swgraham@interchange.ubc.ca	Graham, Sean W/L-3944-2014; Mathews, Sarah/A-6513-2015	Graham, Sean W/0000-0001-8209-5231; Mathews, Sarah/0000-0002-5518-7541; Saarela, Jeffery/0000-0003-1790-4332				APPEL O, 1998, FAMILIES GENERA VASC, V4, P208; Borsch T, 2003, J EVOLUTION BIOL, V16, P558, DOI 10.1046/j.1420-9101.2003.00577.x; Bremer K, 2002, EVOLUTION, V56, P1374, DOI 10.1111/j.0014-3820.2002.tb01451.x; Burleigh JG, 2004, AM J BOT, V91, P1599, DOI 10.3732/ajb.91.10.1599; Chase Mark W., 2006, Aliso, V22, P63; COOKE DA, 1998, FAMILIES GENERA VASC, V4, P106; Dahlgren R.M.T., 1985, FAMILIES MONOCOTYLED, P520, DOI [10.1007/978-3-642-61663-1, DOI 10.1007/978-3-642-61663-1]; Doyle JA, 2005, GRANA, V44, P227, DOI 10.1080/00173130500424557; Doyle JA, 2000, INT J PLANT SCI, V161, pS121, DOI 10.1086/317578; Feild TS, 2004, PALEOBIOLOGY, V30, P82, DOI 10.1666/0094-8373(2004)030<0082:DADANI>2.0.CO;2; Graham SW, 2000, AM J BOT, V87, P1712, DOI 10.2307/2656749; Graham SW, 2002, MOL BIOL EVOL, V19, P1769, DOI 10.1093/oxfordjournals.molbev.a003999; GRAHAM SW, 2006, MONOCOTS COMP BIOL E, P3; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAMANN U, 1976, New Zealand Journal of Botany, V14, P193; HAMANN U, 1975, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V96, P154; Hamann U., 1998, FAMILIES GENERA VASC, V4, P231, DOI [DOI 10.1007/978-3-662-03531-3_23, 10.1007/978-3-662-03531-3_23]; Harden GJ., 1993, FLORA NEW S WALES VO, V4; Kim S, 2004, MOL PHYLOGENET EVOL, V31, P16, DOI 10.1016/j.ympev.2003.07.017; Leebens-Mack J, 2005, MOL BIOL EVOL, V22, P1948, DOI 10.1093/molbev/msi191; MADDISON DR, 2001, MACCLADE 4 ANAL PHYL; Mathews S, 2000, INT J PLANT SCI, V161, pS41, DOI 10.1086/317582; Michelangeli FA, 2003, AM J BOT, V90, P93, DOI 10.3732/ajb.90.1.93; Morrison D. A., 2000, MONOCOTS SYSTEMATICS; Qiu YL, 2005, INT J PLANT SCI, V166, P815, DOI 10.1086/431800; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Sun G, 2002, SCIENCE, V296, P899, DOI 10.1126/science.1069439; Swofford D. L., 1998, PAUP PHYLOGENETIC AN; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Williams JH, 2004, AM J BOT, V91, P332, DOI 10.3732/ajb.91.3.332; Zanis MJ, 2002, P NATL ACAD SCI USA, V99, P6848, DOI 10.1073/pnas.092136399	31	183	199	0	54	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 15	2007	446	7133					312	315		10.1038/nature05612	http://dx.doi.org/10.1038/nature05612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361182	Green Published			2022-12-28	WOS:000244892900044
J	Dion, MF; Kaplan, T; Kim, M; Buratowski, S; Friedman, N; Rando, OJ				Dion, Michael F.; Kaplan, Tommy; Kim, Minkyu; Buratowski, Stephen; Friedman, Nir; Rando, Oliver J.			Dynamics of replication-independent histone turnover in budding yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; GENOME-WIDE; PHO5 PROMOTER; IN-VIVO; CHROMATIN; BOUNDARIES; H2A.Z; MARKS; EUCHROMATIN; ELONGATION	Chromatin plays roles in processes governed by different time scales. To assay the dynamic behavior of chromatin in living cells, we used genomic tiling arrays to measure histone H3 turnover in G1-arrested Saccharomyces cerevisiae at single-nucleosome resolution over 4% of the genome, and at lower (similar to 265 base pair) resolution over the entire genome. We find that nucleosomes at promoters are replaced more rapidly than at coding regions and that replacement rates over coding regions correlate with polymerase density. In addition, rapid histone turnover is found at known chromatin boundary elements. These results suggest that rapid histone turnover serves to functionally separate chromatin domains and prevent spread of histone states.	Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Mol Genet & Biotechnol, Fac Med, IL-91120 Jerusalem, Israel; Harvard Univ, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Harvard University	Rando, OJ (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	Oliver.Rando@umassmed.edu	Kaplan, Tommy/T-2528-2017; Friedman, Nir/H-9692-2012; Kim, Minkyu/AAZ-8535-2021	Kaplan, Tommy/0000-0002-1892-5461; Friedman, Nir/0000-0002-9678-3550; Kim, Minkyu/0000-0001-9317-1658; Dion, Michael/0000-0002-0434-4236				Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Bi X, 2001, CURR OPIN GENET DEV, V11, P199, DOI 10.1016/S0959-437X(00)00179-9; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chiu YH, 2003, GENETICS, V165, P115; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Linger J, 2006, EUKARYOT CELL, V5, P1780, DOI 10.1128/EC.00202-06; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Schermer UJ, 2005, MOL CELL, V19, P279, DOI 10.1016/j.molcel.2005.05.028; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Thiriet C, 2005, GENE DEV, V19, P677, DOI 10.1101/gad.1265205; Yu Q, 2003, NUCLEIC ACIDS RES, V31, P1224, DOI 10.1093/nar/gkg200; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	26	413	420	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1405	1408		10.1126/science.1134053	http://dx.doi.org/10.1126/science.1134053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347438				2022-12-28	WOS:000244752200032
J	Lovering, AL; de Castro, LH; Lim, D; Strynadka, NCJ				Lovering, Andrew L.; de Castro, Liza H.; Lim, Daniel; Strynadka, Natalie C. J.			Structural insight into the transglycosylation step of bacterial cell-wall biosynthesis	SCIENCE			English	Article							KINETIC CHARACTERIZATION; CRYSTAL-STRUCTURE; GLYCOSYLTRANSFERASE MODULE; STAPHYLOCOCCUS-AUREUS; VANCOMYCIN RESISTANCE; BACTERIOPHAGE-LAMBDA; ESCHERICHIA-COLI; PROTEINS; PBP1B	Peptidoglycan glycosyltransferases (GTs) catalyze the polymerization step of cell-wall biosynthesis, are membrane-bound, and are highly conserved across all bacteria. Long considered the "holy grail" of antibiotic research, they represent an essential and easily accessible drug target for antibiotic-resistant bacteria, including methicillin-resistant Staphylococcus aureus. We have determined the 2.8 angstrom structure of a bifunctional cell-wall cross-linking enzyme, including its transpeptidase and GT domains, both unliganded and complexed with the substrate analog moenomycin. The peptidoglycan GTs adopt a fold distinct from those of other GT classes. The structures give insight into critical features of the catalytic mechanism and key interactions required for enzyme inhibition.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V5Z 1M9, Canada.	natalie@byron.biochem.ubc.ca		Lovering, Andrew/0000-0002-1856-7975				Barrett D, 2005, J BACTERIOL, V187, P2215, DOI 10.1128/JB.187.6.2215-2217.2005; Barrett DS, 2004, BIOCHEMISTRY-US, V43, P12375, DOI 10.1021/bi049142m; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007; Butaye P, 2001, ANTIMICROB AGENTS CH, V45, P1374, DOI 10.1128/AAC.45.5.1374-1378.2001; Contreras-Martel C, 2006, J MOL BIOL, V355, P684, DOI 10.1016/j.jmb.2005.10.030; Evrard C, 1998, J MOL BIOL, V276, P151, DOI 10.1006/jmbi.1997.1499; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Goldman RC, 2000, CURR MED CHEM, V7, P801; Halliday J, 2006, BIOCHEM PHARMACOL, V71, P957, DOI 10.1016/j.bcp.2005.10.030; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; Leung AKW, 2001, BIOCHEMISTRY-US, V40, P5665, DOI 10.1021/bi0028035; Ritzeler O, 1997, TETRAHEDRON, V53, P1675, DOI 10.1016/S0040-4020(96)01115-5; Schwartz B, 2002, BIOCHEMISTRY-US, V41, P12552, DOI 10.1021/bi026205x; Terrak M, 1999, MOL MICROBIOL, V34, P350, DOI 10.1046/j.1365-2958.1999.01612.x; Terrak M, 2006, J BACTERIOL, V188, P2528, DOI 10.1128/JB.188.7.2528-2532.2006; WALSH CT, 1993, SCIENCE, V261, P308, DOI 10.1126/science.8392747; Welzel P, 2005, CHEM REV, V105, P4610, DOI 10.1021/cr040634e; WELZEL P, 1987, TETRAHEDRON, V43, P585, DOI 10.1016/S0040-4020(01)89992-0	18	222	233	6	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1402	1405		10.1126/science.1136611	http://dx.doi.org/10.1126/science.1136611			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347437				2022-12-28	WOS:000244752200031
J	Lamsa, KP; Heeroma, JH; Somogyi, P; Rusakov, DA; Kullmann, DM				Lamsa, Karri P.; Heeroma, Joost H.; Somogyi, Peter; Rusakov, Dmitri A.; Kullmann, Dimitri M.			Anti-Hebbian long-term potentiation in the hippocampal feedback inhibitory circuit	SCIENCE			English	Article							AMPA RECEPTORS; INWARD RECTIFICATION; THETA OSCILLATIONS; IN-VIVO; INTERNEURONS; EXPRESSION; ACTIVATION; SYNAPSES; INPUT; MODEL	Long-term potentiation (LTP), which approximates Hebb's postulate of associative learning, typically requires depolarization-dependent glutamate receptors of the NMDA (N-methyl-D-aspartate) subtype. However, in some neurons, LTP depends instead on calcium-permeable AMPA-type receptors. This is paradoxical because intracellular polyamines block such receptors during depolarization. We report that LTP at synapses on hippocampal interneurons mediating feedback inhibition is "anti-Hebbian": It is induced by presynaptic activity but prevented by postsynaptic depolarization. Anti-Hebbian LTP may occur in interneurons that are silent during periods of intense pyramidal cell firing, such as sharp waves, and lead to their altered activation during theta activity.	UCL, Inst Neurol, London WC1N 3BG, England; Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford OX1 3HT, England	University of London; University College London; University of Oxford	Kullmann, DM (corresponding author), UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.	d.kullmann@ion.ucl.ac.uk	Kullmann, Dimitri M/A-3162-2009; Lamsa, Karri/T-2025-2019; Rusakov, Dmitri A/E-1987-2011; Rusakov, Dmitri/AAH-4529-2021; Heeroma, Joost/AFI-8727-2022; Heeroma, Joost/AAF-4310-2022; Heeroma, Joost/C-1749-2008	Kullmann, Dimitri M/0000-0001-6696-3545; Rusakov, Dmitri A/0000-0001-9539-9947; Rusakov, Dmitri/0000-0001-9539-9947; Lamsa, Karri/0000-0002-4609-1337	MRC [G0501424, G116/147, G0400627, MC_U138135973, G0600368] Funding Source: UKRI; Medical Research Council [G116/147, MC_U138135973, G0400627(76527), G0400627, G0600368(77987), G0600368, G0501424, G0400627(71256)] Funding Source: Medline; Wellcome Trust [071179] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; BLASCOIBANEZ JM, 1995, EUR J NEUROSCI, V7, P2170, DOI 10.1111/j.1460-9568.1995.tb00638.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Gillies MJ, 2002, J PHYSIOL-LONDON, V543, P779, DOI 10.1113/jphysiol.2002.024588; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Hebb Donald O., 1949, ORG BEHAV; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Laezza F, 2004, J NEUROPHYSIOL, V92, P3575, DOI 10.1152/jn.00425.2004; Laezza F, 1999, SCIENCE, V285, P1411, DOI 10.1126/science.285.5432.1411; Lamsa K, 2005, NAT NEUROSCI, V8, P916, DOI 10.1038/nn1486; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Mainen ZF, 1998, NAT NEUROSCI, V1, P579, DOI 10.1038/2812; Nyiri G, 2003, NEUROSCIENCE, V119, P347, DOI 10.1016/S0306-4522(03)00157-X; Perez Y, 2001, P NATL ACAD SCI USA, V98, P9401, DOI 10.1073/pnas.161493498; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Topolnik L, 2005, J NEUROSCI, V25, P990, DOI 10.1523/JNEUROSCI.4388-04.2005; Washburn MS, 1997, J NEUROSCI, V17, P9393	25	181	186	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1262	1266		10.1126/science.1137450	http://dx.doi.org/10.1126/science.1137450			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332410	Green Accepted			2022-12-28	WOS:000244564700046
J	Franco, LM; Dryden, NJ				Franco, Luis M.; Dryden, Natalie J.			Images in clinical medicine: Gastric-outlet obstruction	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	Franco, LM (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	njanetd@yahoo.com							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2007	356	9					942	942		10.1056/NEJMicm055086	http://dx.doi.org/10.1056/NEJMicm055086			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140HV	17329701				2022-12-28	WOS:000244496400009
J	Schiermeier, Q				Schiermeier, Quirin			Mountains to molehills	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2007	446	7131					22	23		10.1038/446022a	http://dx.doi.org/10.1038/446022a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330020				2022-12-28	WOS:000244525600015
J	Metzl, JM; Herzig, RM				Metzl, Jonathan M.; Herzig, Rebecca M.			Medicalisation in the 21st century: Introduction	LANCET			English	Editorial Material							MEDICALIZATION; DYSFUNCTION		Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; Univ Michigan, Womens Studies Program, Ann Arbor, MI 48109 USA; Bates Coll, Dept Women & Gender Studies, Lewiston, ME 04240 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Metzl, JM (corresponding author), Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.	jmetzl@umich.edu						CARLSON R, 1975, END MED; CONRAD P, 1975, SOC PROBL, V23, P12, DOI 10.1525/sp.1975.23.1.03a00020; FOX RC, 1977, DAEDALUS, V106, P9; ILICH I, 1975, LIMITS MED MED NEMES; Mason DJ, 2003, AM J NURS, V103, P7; Metzl JM, 2002, SIGNS, V27, P347, DOI 10.1086/495690; Moynihan R, 2003, BRIT MED J, V326, P45, DOI 10.1136/bmj.326.7379.45	7	31	34	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2007	369	9562					697	698		10.1016/S0140-6736(07)60317-1	http://dx.doi.org/10.1016/S0140-6736(07)60317-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	141RO	17321315				2022-12-28	WOS:000244596600031
J	Lu, PJ; Steinhardt, PJ				Lu, Peter J.; Steinhardt, Paul J.			Decagonal and quasi-crystalline tilings in medieval Islamic architecture	SCIENCE			English	Article								The conventional view holds that girih ( geometric star-and-polygon, or strapwork) patterns in medieval Islamic architecture were conceived by their designers as a network of zigzagging lines, where the lines were drafted directly with a straightedge and a compass. We show that by 1200 C. E. a conceptual breakthrough occurred in which girih patterns were reconceived as tessellations of a special set of equilateral polygons ("girih tiles") decorated with lines. These tiles enabled the creation of increasingly complex periodic girih patterns, and by the 15th century, the tessellation approach was combined with self-similar transformations to construct nearly perfect quasi-crystalline Penrose patterns, five centuries before their discovery in the West.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; Princeton Univ, Princeton Ctr Theoret Phys, Princeton, NJ 08544 USA	Harvard University; Princeton University; Princeton University	Lu, PJ (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	plu@fas.harvard.edu	Lu, Peter J/G-1971-2011	Lu, Peter J/0000-0003-1489-5725; Steinhardt, Paul/0000-0003-3488-1603				ABAS SJ, 1995, SYMMETRIES ISLAMIC G, P95; BONNER J, 2003, ISAMA BRIDGES C P, P1; BOURGOIN J, 1879, ELEMENTS ART AROBE T, P176; BRAVAIS A, 1850, J ECOLE POLYTECHNIQU, V33, P1; CHORBACHI WK, 1989, COMPUT MATH APPL, V17, P751, DOI 10.1016/0898-1221(89)90260-5; DEMIRIZ Y, 2000, ISLAM SANATINDA GEOM, P27; ELSAID I, 1976, GEOMETRIC CONCEPTS I, P85; ETTINGHAUSEN R, 2001, ISLAMIC ART ARCHITEC, P109; GARDNER M, 1989, PENROSE TILES TRAPDO, P1; GOLOMBEK L, 1988, TIMURID ARCHITECTURE, P246; GOODWIN G, 1971, HIST OTTOMAN ARCHITE, P58; HANKIN EH, 1925, DRAWING GEOMETRIC PA, P4; HILL D, 1964, ISLAMIC ARCHITECTURE, P53; HILLENBRAND R, 1994, ISLAMIC ARCHITECTURE, P182; ISHIMOTO Y, 1980, ISLAM SPACE DESIGN; JAMES D, 1988, QUARANS MAMLUKS, P54; LEVINE D, 1984, PHYS REV LETT, V53, P2477, DOI 10.1103/PhysRevLett.53.2477; LEVINE D, 1986, PHYS REV B, V34, P596, DOI 10.1103/PhysRevB.34.596; Makovicky E., 1992, FIVEFOLD SYMMETRY, P67; Necipoglu Gulru, 1995, TOPKAPI SCROLL GEOME; Ozdural A, 2000, HIST MATH, V27, P171, DOI 10.1006/hmat.1999.2274; Penrose R., 1974, B I MATH APPL, V10, P266; SCHMID H, 1980, MADRASA KALIFEN AL M; SCHNEIDER G, 1980, GEOMETRISCHE BAUORNA, P136; SEHEERTHOSS SP, 1968, DESIGN COLOR ISLAMIC	25	130	132	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1106	1110		10.1126/science.1135491	http://dx.doi.org/10.1126/science.1135491			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17322056				2022-12-28	WOS:000244387600031
J	Mundell, CG; Steele, IA; Smith, RJ; Kobayashi, S; Melandri, A; Guidorzi, C; Gomboc, A; Mottram, CJ; Clarke, D; Monfardini, A; Carter, D; Bersier, D				Mundell, Carole G.; Steele, Iain A.; Smith, Robert J.; Kobayashi, Shiho; Melandri, Andrea; Guidorzi, Cristiano; Gomboc, Andreja; Mottram, Chris J.; Clarke, David; Monfardini, Alessandro; Carter, David; Bersier, David			Early optical polarization of a gamma-ray burst afterglow	SCIENCE			English	Article							MAGNETIC-FIELD STRUCTURE; LIGHT CURVES; EMISSION; FLUX	We report the optical polarization of a gamma-ray burst (GRB) afterglow, obtained 203 seconds after the initial burst of gamma-rays from GRB 060418, using a ring polarimeter on the robotic Liverpool Telescope. Our robust (2 sigma) upper limit on the percentage of polarization, less than 8%, coincides with the fireball deceleration time at the onset of the afterglow. The combination of the rate of decay of the optical brightness and the low polarization at this critical time constrains standard models of GRB ejecta, ruling out the presence of a large-scale ordered magnetic field in the emitting region.	Liverpool John Moores Univ, Astrophys Res Inst, Birkenhead CH41 1LD, Merseyside, England; Univ Milano Bicocca, Dipartimento Fis, I-20126 Milan, Italy; Osserv Astron Brera, Ist Nazl Astrofis, I-23807 Merate, LC, Italy; Univ Ljubljana, Fac Math & Phys, Ljubljana 1000, Slovenia; Univ Glasgow, Dept Phys & Astron, Glasgow G12 8QQ, Lanark, Scotland; CNRS, Inst Neel, F-38042 Grenoble, France	Liverpool John Moores University; University of Milano-Bicocca; Istituto Nazionale Astrofisica (INAF); University of Ljubljana; University of Glasgow; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Mundell, CG (corresponding author), Liverpool John Moores Univ, Astrophys Res Inst, 12 Quays House,Egerton Wharf, Birkenhead CH41 1LD, Merseyside, England.	cgm@astro.livjm.ac.uk	Carter, David O/AAD-6617-2021	Melandri, Andrea/0000-0002-2810-2143; Guidorzi, Cristiano/0000-0001-6869-0835	Science and Technology Facilities Council [PP/E003303/1] Funding Source: researchfish; STFC [PP/E003303/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Barth AJ, 2003, ASTROPHYS J, V584, pL47, DOI 10.1086/373889; Bersier D, 2003, ASTROPHYS J, V583, pL63, DOI 10.1086/368158; Coburn W, 2003, NATURE, V423, P415, DOI 10.1038/nature01612; Covino S, 2002, ASTRON ASTROPHYS, V392, P865, DOI 10.1051/0004-6361:20021025; COVINO S, 1999, ASTRON ASTROPHYS, V348, P1; Drenkhahn G, 2002, ASTRON ASTROPHYS, V391, P1141, DOI 10.1051/0004-6361:20020839; FALCONE AD, 2006, 5009 GCN; Frail DA, 2001, ASTROPHYS J, V562, pL55, DOI 10.1086/338119; Granot J, 2005, ASTROPHYS J, V625, P263, DOI 10.1086/429536; Granot J, 2003, ASTROPHYS J, V594, pL83, DOI 10.1086/378733; Greiner J, 2003, NATURE, V426, P157, DOI 10.1038/nature02077; Gruzinov A, 1999, ASTROPHYS J, V511, P852, DOI 10.1086/306720; Kobayashi S, 2003, ASTROPHYS J, V582, pL75, DOI 10.1086/367691; Kobayashi S, 1999, ASTROPHYS J, V513, P669, DOI 10.1086/306868; Lazzati D, 2004, ASTRON ASTROPHYS, V422, P121, DOI 10.1051/0004-6361:20035951; Lyutikov M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/7/119; Lyutikov M, 2003, ASTROPHYS J, V597, P998, DOI 10.1086/378497; Meszaros P, 2006, REP PROG PHYS, V69, P2259, DOI 10.1088/0034-4885/69/8/R01; Mundell CG, 2007, ASTROPHYS J, V660, P489, DOI 10.1086/512605; Nousek JA, 2006, ASTROPHYS J, V642, P389, DOI 10.1086/500724; Piran T, 2005, AIP CONF PROC, V784, P164, DOI 10.1063/1.2077181; Piran T, 2004, REV MOD PHYS, V76, P1143, DOI 10.1103/RevModPhys.76.1143; Rossi EM, 2004, MON NOT R ASTRON SOC, V354, P86, DOI 10.1111/j.1365-2966.2004.08165.x; Rutledge RE, 2004, MON NOT R ASTRON SOC, V350, P1288, DOI 10.1111/j.1365-2966.2004.07665.x; Sagiv A, 2004, ASTROPHYS J, V615, P366, DOI 10.1086/423977; Sari R, 1998, ASTROPHYS J, V497, pL17, DOI 10.1086/311269; Willis DR, 2005, ASTRON ASTROPHYS, V439, P245, DOI 10.1051/0004-6361:20052693; Zhang B, 2006, ASTROPHYS J, V642, P354, DOI 10.1086/500723	29	69	69	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1822	1824		10.1126/science.1138484	http://dx.doi.org/10.1126/science.1138484			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17363631	Green Submitted			2022-12-28	WOS:000245280100036
J	Gorin, DJ; Toste, FD				Gorin, David J.; Toste, F. Dean			Relativistic effects in homogeneous gold catalysis	NATURE			English	Review							CYCLOISOMERIZATION REACTIONS; INTRAMOLECULAR HYDROARYLATION; INTERMOLECULAR HYDROAMINATION; RAUTENSTRAUCH REARRANGEMENT; SKELETAL REORGANIZATION; THEORETICAL CHEMISTRY; REDUCTIVE ELIMINATION; ORGANOGOLD COMPLEXES; CHEMICAL-PROPERTIES; CHIRALITY TRANSFER	Transition-metal catalysts containing gold present new opportunities for chemical synthesis, and it is therefore not surprising that these complexes are beginning to capture the attention of the chemical community. Cationic phosphine-gold(I) complexes are especially versatile and selective catalysts for a growing number of synthetic transformations. The reactivity of these species can be understood in the context of theoretical studies on gold; relativistic effects are especially helpful in rationalizing the reaction manifolds available to gold catalysts. This Review draws on experimental and computational data to present our current understanding of homogeneous gold catalysis, focusing on previously unexplored reactivity and its application to the development of new methodology.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Toste, FD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	fdtoste@berkeley.edu	Toste, F. Dean/Y-2556-2019	Toste, F. Dean/0000-0001-8018-2198; Gorin, David/0000-0003-4638-4209				Aguirre F, 2000, CHEM PHYS LETT, V318, P466, DOI 10.1016/S0009-2614(00)00044-0; Antoniotti S, 2005, J AM CHEM SOC, V127, P9976, DOI 10.1021/ja0530671; Arcadi A, 2003, GREEN CHEM, V5, P64, DOI 10.1039/b210165c; Asao N, 2002, J AM CHEM SOC, V124, P12650, DOI 10.1021/ja028128z; BAGUS PS, 1975, CHEM PHYS LETT, V33, P408, DOI 10.1016/0009-2614(75)85741-1; Barysz M, 1998, CHEM PHYS LETT, V285, P398, DOI 10.1016/S0009-2614(98)00025-6; Brouwer C, 2006, ANGEW CHEM INT EDIT, V45, P1744, DOI 10.1002/anie.200504495; Buzas A, 2006, ORG LETT, V8, P515, DOI 10.1021/ol053100o; Carvajal MA, 2004, J AM CHEM SOC, V126, P1465, DOI 10.1021/ja038416a; Chatani N, 2002, J AM CHEM SOC, V124, P10294, DOI 10.1021/ja0274554; CHATT J, 1953, J CHEM SOC, P2939, DOI 10.1039/jr9530002939; Christian B., 2005, ANGEW CHEM INT EDIT, V44, p2328 2334; Cinellu MA, 2005, ANGEW CHEM INT EDIT, V44, P6892, DOI 10.1002/anie.200501754; de Fremont P, 2005, ORGANOMETALLICS, V24, P2411, DOI 10.1021/om050111c; Desclaux J. P., 1974, Atomic Data and Nuclear Data Tables, V12, P311, DOI 10.1016/0092-640X(73)90020-X; DESCLAUX JP, 1976, CHEM PHYS LETT, V39, P300, DOI 10.1016/0009-2614(76)80080-2; DEWAR JS, 1951, B SOC CHIM FR, V18, pC71; Dube P, 2006, J AM CHEM SOC, V128, P12062, DOI 10.1021/ja064209+; Faza ON, 2006, J AM CHEM SOC, V128, P2434, DOI 10.1021/ja057127e; Fehr C, 2006, ANGEW CHEM INT EDIT, V45, P2901, DOI 10.1002/anie.200504543; Ferrer C, 2006, ANGEW CHEM INT EDIT, V45, P1105, DOI 10.1002/anie.200503484; Fleming I., 1976, FRONTIER ORBITALS OR; Fructos MR, 2005, ANGEW CHEM INT EDIT, V44, P5284, DOI 10.1002/anie.200501056; FUKUDA Y, 1987, HETEROCYCLES, V25, P297; FUKUDA Y, 1991, J ORG CHEM, V56, P3729, DOI 10.1021/jo00011a058; Furstner A, 2005, J AM CHEM SOC, V127, P8244, DOI 10.1021/ja050845g; Furstner A, 2002, J ORG CHEM, V67, P6264, DOI 10.1021/jo025962y; Furstner A, 2004, CHEM COMMUN, P2546, DOI 10.1039/b412354a; Furstner A, 2006, CHEM-EUR J, V12, P3006, DOI 10.1002/chem.200501299; Furstner A, 2001, J AM CHEM SOC, V123, P11863, DOI 10.1021/ja0109343; Gorin DJ, 2005, J AM CHEM SOC, V127, P11260, DOI 10.1021/ja053804t; Hashmi ASK, 2004, ORG LETT, V6, P4391, DOI 10.1021/ol0480067; Hashmi ASK, 2004, ANGEW CHEM INT EDIT, V43, P6545, DOI 10.1002/anie.200460232; Hashmi ASK, 2006, ADV SYNTH CATAL, V348, P709, DOI 10.1002/adsc.200606012; Hashmi ASK, 2000, ANGEW CHEM INT EDIT, V39, P2285, DOI 10.1002/1521-3773(20000703)39:13<2285::AID-ANIE2285>3.0.CO;2-F; Hashmi ASK, 2004, GOLD BULL, V37, P51; Hashmi ASK, 2003, GOLD BULL, V36, P3, DOI 10.1007/BF03214859; Hashmi ASK, 2005, ANGEW CHEM INT EDIT, V44, P6990, DOI 10.1002/anie.200502735; Hashmi ASK, 2000, J AM CHEM SOC, V122, P11553, DOI 10.1021/ja005570d; HEINEMANN C, 1995, J AM CHEM SOC, V117, P495, DOI 10.1021/ja00106a057; Hertwig RH, 1996, J PHYS CHEM-US, V100, P12253, DOI 10.1021/jp953064i; Hoffmann-Roder A, 2005, ORG BIOMOL CHEM, V3, P387, DOI 10.1039/b416516k; IRIKURA KK, 1994, J AM CHEM SOC, V116, P8733, DOI 10.1021/ja00098a036; ITO Y, 1986, J AM CHEM SOC, V108, P6405, DOI 10.1021/ja00280a056; Johansson MJ, 2005, J AM CHEM SOC, V127, P18002, DOI 10.1021/ja0552500; Kennedy-Smith JJ, 2004, J AM CHEM SOC, V126, P4526, DOI 10.1021/ja049487s; KOMIYA S, 1976, J AM CHEM SOC, V98, P7599, DOI 10.1021/ja00440a025; KOMIYA S, 1976, J AM CHEM SOC, V98, P7255, DOI 10.1021/ja00439a024; Li ZG, 2006, ORG LETT, V8, P4175, DOI 10.1021/ol0610035; Luzung MR, 2004, J AM CHEM SOC, V126, P10858, DOI 10.1021/ja046248w; Ma SM, 2006, ANGEW CHEM INT EDIT, V45, P200, DOI 10.1002/anie.200502999; Mamane V, 2004, CHEM-EUR J, V10, P4556, DOI 10.1002/chem.200400220; Mamane V, 2004, J AM CHEM SOC, V126, P8654, DOI 10.1021/ja048094q; Marion N, 2006, ANGEW CHEM INT EDIT, V45, P3647, DOI 10.1002/anie.200600571; Markham JP, 2005, J AM CHEM SOC, V127, P9708, DOI 10.1021/ja052831g; MCKELVEY DR, 1983, J CHEM EDUC, V60, P112, DOI 10.1021/ed060p112; MENDEZ M, 2003, CHEMTRACTS ORG CHEM, V16, P397; Miki K, 2003, TETRAHEDRON LETT, V44, P2019, DOI 10.1016/S0040-4039(03)00219-3; Mizushima E, 2003, ORG LETT, V5, P3349, DOI 10.1021/ol0353159; Morita N, 2006, ANGEW CHEM INT EDIT, V45, P1897, DOI 10.1002/anie.200503846; Munoz MP, 2005, ORGANOMETALLICS, V24, P1293, DOI 10.1021/om0491645; Nakamura I, 2006, ANGEW CHEM INT EDIT, V45, P4473, DOI 10.1002/anie.200601178; Nakanishi W, 2005, J AM CHEM SOC, V127, P1446, DOI 10.1021/ja045659+; Nechaev MS, 2004, J PHYS CHEM A, V108, P3134, DOI 10.1021/jp031185+; Nevado C, 2005, SYNTHESIS-STUTTGART, P167, DOI 10.1055/s-2005-861781; Nevado C, 2005, CHEM-EUR J, V11, P3155, DOI 10.1002/chem.200401069; Nguyen RV, 2006, ORG LETT, V8, P2397, DOI 10.1021/ol0607692; Nieto-Oberhuber C, 2006, CHEM-EUR J, V12, P1677, DOI 10.1002/chem.200501088; Nieto-Oberhuber C, 2004, ANGEW CHEM INT EDIT, V43, P2402, DOI 10.1002/anie.200353207; NORRBY LJ, 1991, J CHEM EDUC, V68, P110, DOI 10.1021/ed068p110; Oi S, 2001, ORGANOMETALLICS, V20, P3704, DOI 10.1021/om010316v; PITZER KS, 1979, ACCOUNTS CHEM RES, V12, P272; Prasad BAB, 2005, J AM CHEM SOC, V127, P12468, DOI 10.1021/ja053192c; PYYKKO P, 1979, ACCOUNTS CHEM RES, V12, P276, DOI 10.1021/ar50140a002; Pyykko P, 2005, INORG CHIM ACTA, V358, P4113, DOI 10.1016/j.ica.2005.06.028; Pyykko P, 2004, ANGEW CHEM INT EDIT, V43, P4412, DOI 10.1002/anie.200300624; PYYKKO P, 1988, CHEM REV, V88, P563, DOI 10.1021/cr00085a006; Raubenheimer HG, 2002, ORGANOMETALLICS, V21, P3173, DOI 10.1021/om020048g; RAUTENSTRAUCH V, 1984, J ORG CHEM, V49, P950, DOI 10.1021/jo00179a044; Reetz MT, 2003, EUR J ORG CHEM, V2003, P3485, DOI 10.1002/ejoc.200300260; Rosenfeld DC, 2006, ORG LETT, V8, P4179, DOI 10.1021/ol061174+; SCHERBAUM F, 1988, ANGEW CHEM INT EDIT, V27, P1544, DOI 10.1002/anie.198815441; Schwerdtfeger P, 2003, INORG CHEM, V42, P1334, DOI 10.1021/ic026098v; SCHWERDTFEGER P, 1990, INORG CHEM, V29, P3593, DOI 10.1021/ic00343a057; Sherry BD, 2004, J AM CHEM SOC, V126, P15978, DOI 10.1021/ja044602k; Shi XD, 2005, J AM CHEM SOC, V127, P5802, DOI 10.1021/ja051689g; Sromek AW, 2005, J AM CHEM SOC, V127, P10500, DOI 10.1021/ja053290y; Staben ST, 2004, ANGEW CHEM INT EDIT, V43, P5350, DOI 10.1002/anie.200460844; Straub BF, 2004, CHEM COMMUN, P1726, DOI 10.1039/b404876h; Suhre MH, 2005, ORG LETT, V7, P3925, DOI 10.1021/ol0514101; TAMAKI A, 1974, J ORGANOMET CHEM, V64, P411, DOI 10.1016/S0022-328X(00)92190-9; Teles JH, 1998, ANGEW CHEM INT EDIT, V37, P1415, DOI 10.1002/(SICI)1521-3773(19980605)37:10<1415::AID-ANIE1415>3.0.CO;2-N; Xu Q, 1997, J ORG CHEM, V62, P1594, DOI 10.1021/jo9620122; Yao XQ, 2004, J AM CHEM SOC, V126, P6884, DOI 10.1021/ja0482637; Yao XQ, 2006, ORG LETT, V8, P1953, DOI 10.1021/ol060645p; Zhang JL, 2006, J AM CHEM SOC, V128, P1798, DOI 10.1021/ja053864z; Zhang LM, 2005, J AM CHEM SOC, V127, P16804, DOI 10.1021/ja056419c; Zhang LM, 2005, J AM CHEM SOC, V127, P6962, DOI 10.1021/ja051110e; Zhang ZB, 2006, J AM CHEM SOC, V128, P9066, DOI 10.1021/ja062045r; Zhou CY, 2006, ORG LETT, V8, P325, DOI 10.1021/ol052696c	100	1507	1510	6	406	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					395	403		10.1038/nature05592	http://dx.doi.org/10.1038/nature05592			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17377576	Green Published			2022-12-28	WOS:000245079500031
J	Steg, PG; Bhatt, DL; Wilson, PWF; D'Agostino, R; Ohman, EM; Rother, J; Liau, CS; Hirsch, AT; Mas, JL; Ikeda, Y; Pencina, MJ; Goto, S				Steg, Ph. Gabriel; Bhatt, Deepak L.; Wilson, Peter W. F.; D'Agostino, Ralph, Sr.; Ohman, E. Magnus; Roether, Joachim; Liau, Chiau-Suong; Hirsch, Alan T.; Mas, Jean-Louis; Ikeda, Yasuo; Pencina, Michael J.; Goto, Shinya		REACH Registry Investigators	One-year cardiovascular event rates in outpatients with atherothrombosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROMES; PERIPHERAL ARTERIAL-DISEASE; TRANSIENT ISCHEMIC ATTACK; ATHEROSCLEROTIC VASCULAR-DISEASE; ACUTE MYOCARDIAL-INFARCTION; HEALTH-CARE PROFESSIONALS; RISK-FACTORS; NATIONAL-REGISTRY; GLOBAL REGISTRY; UNITED-STATES	Context Few data document current cardiovascular (CV) event rates in stable patients with atherothrombosis in a community setting. Differential event rates for patients with documented coronary artery disease (CAD), cerebrovascular disease (CVD), or peripheral arterial disease (PAD) or those at risk of these diseases have not been previously evaluated in a single international cohort. Objective To establish contemporary, international, 1-year CV event rates in outpatients with established arterial disease or with multiple risk factors for atherothrombosis. Design, Setting, and Participants The Reduction of Atherothrombosis for Continued Health (REACH) Registry is an international, prospective cohort of 68 236 patients with either established atherosclerotic arterial disease (CAD, PAD, CVD; n = 55 814) or at least 3 risk factors for atherothrombosis (n = 12 422), who were enrolled from 5587 physician practices in 44 countries in 2003- 2004. Main Outcome Measures Rates of CV death, myocardial infarction (MI), and stroke. Results As of July 2006, 1-year outcomes were available for 95.22% (n = 64 977) of participants. Cardiovascular death, MI, or stroke rates were 4.24% overall: 4.69% for those with established atherosclerotic arterial disease vs 2.15% for patients with multiple risk factors only. Among patients with established disease, CV death, MI, or stroke rates were 4.52% for patients with CAD, 6.47% for patients with CVD, and 5.35% for patients with PAD. The incidences of the end point of CV death, MI, or stroke or of hospitalization for atherothrombotic event(s) were 15.20% for CAD, 14.53% for CVD, and 21.14% for PAD patients with established disease. These event rates increased with the number of symptomatic arterial disease locations, ranging from 5.31% for patients with risk factors only to 12.58% for patients with 1, 21.14% for patients with 2, and 26.27% for patients with 3 symptomatic arterial disease locations (P < .001 for trend). Conclusions In this large, contemporary, international study, outpatients with established atherosclerotic arterial disease, or at risk of atherothrombosis, experienced relatively high annual CV event rates. Multiple disease locations increased the 1-year risk of CV events.	Hop Bichat Claude Bernard, Dept Cardiol, F-75018 Paris, France; Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA; Boston Univ, Dept Math & Stat, Stat & Consulting Unit, Boston, MA 02215 USA; Duke Univ, Div Cardiol, Durham, NC 27710 USA; Klinikum Minden, Dept Neurol, Minden, Germany; Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; Univ Minnesota, Sch Publ Hlth, Minneapolis Heart Inst Fdn, Minneapolis, MN USA; Hop St Anne, Ctr Raymond Garcin, Serv Neurol, F-75674 Paris, France; Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; Tokai Univ, Sch Med, Dept Med, Kanagawa 2591100, Japan	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Cleveland Clinic Foundation; Emory University; Boston University; Duke University; Ruhr University Bochum; National Taiwan University; National Taiwan University Hospital; University of Minnesota System; University of Minnesota Twin Cities; Minneapolis Heart Institute Foundation; University of Minnesota System; University of Minnesota Twin Cities; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Keio University; Tokai University	Steg, PG (corresponding author), Hop Bichat Claude Bernard, Dept Cardiol, 46 Rue Henri Huchard, F-75018 Paris, France.	gabriel.steg@bch.aphp.fr	STEG, Philippe Gabriel/Z-1567-2019; Wilson, Peter W.F./J-2455-2016; Goto, Shinya/AAU-6045-2020; Statsenko, Mikhail E./N-7573-2015	Goto, Shinya/0000-0002-6821-1504; Statsenko, Mikhail E./0000-0002-3306-0312; Pencina, Michael/0000-0001-5798-8855; STEG, Philippe Gabriel/0000-0001-6896-2941				Adams RJ, 2003, STROKE, V34, P2310, DOI 10.1161/01.STR.0000090125.28466.E2; Agnelli G, 2001, AM HEART J, V141, P190, DOI 10.1067/mhj.2001.112404; Arima H, 2006, STROKE, V37, P1497, DOI 10.1161/01.STR.0000221212.36860.c9; Barron HV, 1998, CIRCULATION, V97, P1150, DOI 10.1161/01.CIR.97.12.1150; Belch JJF, 2003, ARCH INTERN MED, V163, P884, DOI 10.1001/archinte.163.8.884; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Brown DL, 2005, STROKE, V36, P1285, DOI 10.1161/01.STR.0000165926.74213.e3; Budaj A, 2005, CIRCULATION, V111, P3242, DOI 10.1161/CIRCULATIONAHA.104.512806; CHANG IM, 1982, J CHRON DIS, V35, P669, DOI 10.1016/0021-9681(82)90019-4; Creager MA, 2004, CIRCULATION, V109, P2634, DOI 10.1161/01.CIR.0000128522.98016.19; Davidoff F, STRENGTHENING REPORT; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Diehm C, 2006, EUR HEART J, V27, P1743, DOI 10.1093/eurheartj/ehl092; Fox KAA, 2002, EUR HEART J, V23, P1177, DOI 10.1053/euhj.2001.3081; Hasdai D, 2002, EUR HEART J, V23, P1190, DOI 10.1053/euhj.2002.3193; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hirsch AT, 2004, ANGIOLOGY, V55, P233, DOI 10.1177/000331970405500301; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; MAYNARD C, 1995, AM J CARDIOL, V76, P548, DOI 10.1016/S0002-9149(99)80152-0; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Menotti A, 1996, STROKE, V27, P381, DOI 10.1161/01.STR.27.3.381; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Ohman EM, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.11.004; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Sacco RL, 2006, CIRCULATION, V113, pE409, DOI 10.1161/circ.113.10.e409; Sacco RL, 2004, STROKE, V35, P2263, DOI 10.1161/01.STR.0000142374.33919.92; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Steg PG, 2002, AM J CARDIOL, V90, P358, DOI 10.1016/S0002-9149(02)02489-X; Touze E, 2005, STROKE, V36, P2748, DOI 10.1161/01.STR.0000190118.02275.33; Vickrey BG, 2002, STROKE, V33, P901, DOI 10.1161/hs0402.105246; Wilterdink JL, 1998, NEUROLOGY, V51, pS23, DOI 10.1212/WNL.51.3_Suppl_3.S23; Witt BJ, 2005, ANN INTERN MED, V143, P785, DOI 10.7326/0003-4819-143-11-200512060-00006; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	35	990	1079	2	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2007	297	11					1197	1206		10.1001/jama.297.11.1197	http://dx.doi.org/10.1001/jama.297.11.1197			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	147XO	17374814				2022-12-28	WOS:000245039300023
J	Greenspan, SL; Nelson, JB; Trump, DL; Resnick, NM				Greenspan, Susan L.; Nelson, Joel B.; Trump, Donald L.; Resnick, Neil M.			Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							HORMONE AGONISTS; POSTMENOPAUSAL OSTEOPOROSIS; DOUBLE-BLIND; FRACTURE; RISK; CARCINOMA; DENSITY; TRENDS; WOMEN; PAMIDRONATE	Background: Androgen deprivation therapy (ADT) in men with prostate cancer is associated with bone loss and fractures. Objective: To determine whether once-weekly oral bisphosphonate can prevent bone loss and reduce bone turnover in men receiving ADT. Design: Randomized, double-blind, placebo-controlled, partial crossover trial. First-year, preplanned analysis of a 2-group, parallel-design phase. Setting: University medical center. Patients: 112 men with nonmetastatic prostate cancer receiving ADT. Intervention: Alendronate, 70 mg once weekly, or placebo. All patients received calcium and vitamin D supplementation. Measurements: Bone mineral density of the spine and hip and markers of bone resorption and formation. Results: At baseline, 39% of men had osteoporosis and 52% had low bone mass. In men treated with alendronate, bone mineral density increased over 1 year by 3.7% (95% Cl, 2.8% to 4.6%; P < 0.001) at the spine and 1.6% (Cl, 0.4% to 2.8%; P = 0.008) at the femoral neck. Men in the placebo group had losses of 1.4% (Cl, -2.7% to - 0.03%; P = 0.045) at the spine and 0.7% (Cl, -1.5% to 0.01%; P = 0.081) at the femoral neck. At 12 months, the difference between the 2 groups was 5.1 percentage points (Cl, 3.5 to 6.7 percentage points; P < 0.001) at the spine and was 2.3 percentage points (Cl, 1.0 to 3.7 percentage points; P < 0.001) at the femoral neck. Bone turnover statistically significantly decreased with active therapy compared with placebo. The groups did not differ in adverse events. Limitations: The study was short (1 year) and was not powered to detect differences in the frequency of fractures. Conclusions: Bone loss that occurred with ADT was prevented and improved with once-weekly oral alendronate. Because most men have low bone mass or osteoporosis, physicians should assess their patients' bone density and provide preventive and therapeutic measures as appropriate.	Roswell Pk Canc Inst, Buffalo, NY 14263 USA; Univ Pittsburgh, Pittsburgh, PA USA	Roswell Park Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Greenspan, SL (corresponding author), 3471 5th Ave,Suite 1110,Kaufman Med Bldg, Pittsburgh, PA 15213 USA.				NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK062895, R01DK061536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NCRR NIH HHS [M01-RR00056] Funding Source: Medline; NIA NIH HHS [P30 AG024827] Funding Source: Medline; NIDDK NIH HHS [K24 DK062895, R01 DK61536] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berruti A, 2002, J UROLOGY, V167, P2361, DOI 10.1016/S0022-5347(05)64985-3; Binkley N, 2006, J CLIN DENSITOM, V9, P4, DOI 10.1016/j.jocd.2006.05.002; CATALONA WJ, 1994, NEW ENGL J MED, V331, P996; Cooperberg MR, 2003, J NATL CANCER I, V95, P981, DOI 10.1093/jnci/95.13.981; Cooperberg MR, 2004, J CLIN ONCOL, V22, P2141, DOI 10.1200/JCO.2004.10.062; Daniell HW, 1997, J UROLOGY, V157, P439, DOI 10.1016/S0022-5347(01)65165-6; DAWSONHUGHES B, 1987, AM J CLIN NUTR, V46, P685, DOI 10.1093/ajcn/46.4.685; Diamond TH, 2001, CANCER-AM CANCER SOC, V92, P1444, DOI 10.1002/1097-0142(20010915)92:6<1444::AID-CNCR1468>3.0.CO;2-M; Garnero P, 1996, J BONE MINER RES, V11, P1531; Greenspan SL, 2005, J CLIN ENDOCR METAB, V90, P6410, DOI 10.1210/jc.2005-0183; Hatano T, 2000, BJU INT, V86, P449, DOI 10.1046/j.1464-410X.2000.00774.x; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Kiratli BJ, 2001, UROLOGY, V57, P127, DOI 10.1016/S0090-4295(00)00895-5; Krupski TL, 2004, CANCER-AM CANCER SOC, V101, P541, DOI 10.1002/cncr.20388; McClung M, 1998, ANN INTERN MED, V128, P253, DOI 10.7326/0003-4819-128-4-199802150-00001; Oefelein MG, 2001, J UROLOGY, V166, P1724, DOI 10.1016/S0022-5347(05)65661-3; Orwoll E, 2000, NEW ENGL J MED, V343, P604, DOI 10.1056/NEJM200008313430902; Rosen CJ, 2005, NEW ENGL J MED, V353, P595, DOI 10.1056/NEJMcp043801; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Smith MR, 2003, J UROLOGY, V169, P2008, DOI 10.1097/01.ju.0000063820.94994.95; Smith MR, 2004, J CLIN ENDOCR METAB, V89, P3841, DOI 10.1210/jc.2003-032058; Smith MR, 2001, NEW ENGL J MED, V345, P948, DOI 10.1056/NEJMoa010845; Stoch SA, 2001, J CLIN ENDOCR METAB, V86, P2787, DOI 10.1210/jc.86.6.2787; Townsend MF, 1997, CANCER, V79, P545, DOI 10.1002/(SICI)1097-0142(19970201)79:3<545::AID-CNCR17>3.0.CO;2-3; *US DEP HHS OFF SU, 2004, BON HLTH OST REP SUR; Wei JT, 1999, UROLOGY, V54, P607, DOI 10.1016/S0090-4295(99)00301-5; Zeliadt SB, 2004, UROLOGY, V64, P1171, DOI 10.1016/j.urology.2004.07.037	29	222	227	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2007	146	6					416	424		10.7326/0003-4819-146-6-200703200-00006	http://dx.doi.org/10.7326/0003-4819-146-6-200703200-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150CC	17371886				2022-12-28	WOS:000245192200003
J	Waksman, R				Waksman, Ron			ACUITY-PCI: one drug does not fit all	LANCET			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; BIVALIRUDIN; ENOXAPARIN; HEPARIN; TRIAL		Washington Hosp Ctr, Washington, DC 20010 USA	MedStar Washington Hospital Center	Waksman, R (corresponding author), Washington Hosp Ctr, Washington, DC 20010 USA.	ron.waksman@medstar.net						Boersma E, 1999, CIRCULATION, V100, P2045, DOI 10.1161/01.CIR.100.20.2045; Kinnaird TD, 2003, AM J CARDIOL, V92, P930, DOI 10.1016/S0002-9149(03)00972-X; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; Stone GW, 2007, LANCET, V369, P907, DOI 10.1016/S0140-6736(07)60450-4; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; White HD, 2006, AM HEART J, V152, P1042, DOI 10.1016/j.ahj.2006.08.002; Yusuf S, 2006, NEW ENGL J MED, V354, P1464	7	16	16	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 17	2007	369	9565					881	882		10.1016/S0140-6736(07)60421-8	http://dx.doi.org/10.1016/S0140-6736(07)60421-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148BQ	17368130				2022-12-28	WOS:000245049900004
J	Altman, E				Altman, Ehud			Critical insights	SCIENCE			English	Editorial Material							BOSE-EINSTEIN CONDENSATION; ATOMS; GAS		Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Altman, E (corresponding author), Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel.	altman@wisemail.weizmann.ac.il	Altman, Ehud/C-1514-2010	Altman, Ehud/0000-0003-4068-8287				ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Andrews MR, 1997, SCIENCE, V275, P637, DOI 10.1126/science.275.5300.637; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; Donner T, 2007, SCIENCE, V315, P1556, DOI 10.1126/science.1138807; GOLDNER LS, 1993, J LOW TEMP PHYS, V93, P131, DOI 10.1007/BF00682285; Ritter S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.090402	7	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2007	315	5818					1504	1505		10.1126/science.1140809	http://dx.doi.org/10.1126/science.1140809			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363649				2022-12-28	WOS:000244934800025
J	Vaughan, DG; Arthern, R				Vaughan, David G.; Arthern, Robert			Why is it hard to predict the future of ice sheets?	SCIENCE			English	Editorial Material							WEST ANTARCTICA		British Antarctic Survey, NERC, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Vaughan, DG (corresponding author), British Antarctic Survey, NERC, Madingley Rd, Cambridge CB3 0ET, England.	dgv@bas.ac.uk	Vaughan, David/C-8348-2011	Vaughan, David/0000-0002-9065-0570	Natural Environment Research Council [bas010018] Funding Source: researchfish; NERC [bas010018] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; Arthern RJ, 2006, PHILOS T R SOC A, V364, P1841, DOI 10.1098/rsta.2006.1801; Fricker HA, 2007, SCIENCE, V315, P1544, DOI 10.1126/science.1136897; Holt JW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025561; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; *IPCC WORK GROUP, 2007, 4 IPCC; Luckman A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025428; PAYNE A, 2006, PHILOS T R SOC LON A, V364, P1844; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Schoof C, 2007, J FLUID MECH, V573, P27, DOI 10.1017/S0022112006003570; Stone JO, 2003, SCIENCE, V299, P99, DOI 10.1126/science.1077998; Truffer M, 2007, SCIENCE, V315, P1508, DOI 10.1126/science.1140469; Weertman J., 1974, J GLACIOL, V13, P3, DOI [DOI 10.3189/S0022143000023327, 10.3189/S0022143000023327]; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	14	104	108	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1503	1504		10.1126/science.1141111	http://dx.doi.org/10.1126/science.1141111			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363648				2022-12-28	WOS:000244934800024
J	Mallet, J				Mallet, James			Hybrid speciation	NATURE			English	Review							SEXUAL SELECTION; HYBRIDIZATION; EVOLUTION; POLYPLOIDY; ANIMALS; PLANTS; TELEOSTEI; ORIGIN; DIVERSITY; HABITAT	Botanists have long believed that hybrid speciation is important, especially after chromosomal doubling (allopolyploidy). Until recently, hybridization was not thought to play a very constructive part in animal evolution. Now, new genetic evidence suggests that hybrid speciation, even without polyploidy, is more common in plants and also animals than we thought.	UCL, Dept Biol, Galton Lab, London NW1 2HE, England	University of London; University College London	Mallet, J (corresponding author), UCL, Dept Biol, Galton Lab, 4 Stephenson Way, London NW1 2HE, England.	j.mallet@ucl.ac.uk	mallet, james L.B./B-5114-2008	Mallet, James/0000-0002-3370-0367	Natural Environment Research Council [NER/A/S/2003/00419] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Abbott RJ, 2004, BIOL J LINN SOC, V82, P467, DOI 10.1111/j.1095-8312.2004.00333.x; Ainouche ML, 2004, BIOL J LINN SOC, V82, P475, DOI 10.1111/j.1095-8312.2004.00334.x; ANDERSON E, 1954, EVOLUTION, V8, P378, DOI 10.2307/2405784; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; ASTAUROV BL, 1969, ANNU REV GENET, V3, P99, DOI 10.1146/annurev.ge.03.120169.000531; Barton NH, 2006, CURR BIOL, V16, pR647, DOI 10.1016/j.cub.2006.07.032; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; BULLINI L, 1994, TRENDS ECOL EVOL, V9, P422, DOI 10.1016/0169-5347(94)90124-4; BUTLIN R, 1987, TRENDS ECOL EVOL, V2, P8, DOI 10.1016/0169-5347(87)90193-5; Coyne J.A., 2004, SPECIATION; DEMARAIS BD, 1992, P NATL ACAD SCI USA, V89, P2747, DOI 10.1073/pnas.89.7.2747; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Evans PD, 2006, P NATL ACAD SCI USA, V103, P18178, DOI 10.1073/pnas.0606966103; Fisher R.A., 1930, GENETICAL THEORY NAT; Gompert Z, 2006, SCIENCE, V314, P1923, DOI 10.1126/science.1135875; Grant BR, 1996, ECOLOGY, V77, P500, DOI 10.2307/2265625; Grant PR, 2005, AM NAT, V166, P56, DOI 10.1086/430331; GRANT V, 1981, PLANT SPECIATION; Gross BL, 2005, J HERED, V96, P241, DOI 10.1093/jhered/esi026; Husband BC, 2000, P ROY SOC B-BIOL SCI, V267, P217, DOI 10.1098/rspb.2000.0990; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; Lotsy J. P., 1916, EVOLUTION MEANS HYBR; Mable BK, 2004, BIOL J LINN SOC, V82, P453, DOI 10.1111/j.1095-8312.2004.00332.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/S0169-5347(00)89105-3; Mavarez J, 2006, NATURE, V441, P868, DOI 10.1038/nature04738; Mayr E., 1963, ANIMAL SPECIES EVOLU; Meyer A, 2006, MOL ECOL, V15, P721, DOI 10.1111/j.1365-294X.2006.02810.x; Muller HJ, 1925, AM NAT, V59, P346, DOI 10.1086/280047; Nolte AW, 2005, P ROY SOC B-BIOL SCI, V272, P2379, DOI 10.1098/rspb.2005.3231; Ortiz-Barrientos D, 2004, PLOS BIOL, V2, P2256, DOI 10.1371/journal.pbio.0020416; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Ramsey J, 2002, ANNU REV ECOL SYST, V33, P589, DOI 10.1146/annurev.ecolsys.33.010802.150437; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Schwarz D, 2005, NATURE, V436, P546, DOI 10.1038/nature03800; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Stebbins G.L., 1971, PROCESSES ORGANIC EV; TUNNER HG, 1979, NATURWISSENSCHAFTEN, V66, P268, DOI 10.1007/BF00571614; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	45	1173	1246	24	440	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					279	283		10.1038/nature05706	http://dx.doi.org/10.1038/nature05706			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361174				2022-12-28	WOS:000244892900035
J	Schellart, WP; Freeman, J; Stegman, DR; Moresi, L; May, D				Schellart, W. P.; Freeman, J.; Stegman, D. R.; Moresi, L.; May, D.			Evolution and diversity of subduction zones controlled by slab width	NATURE			English	Article							MANTLE FLOW; SEISMIC ANISOTROPY; TRENCH MIGRATION; PLATE; ROLLBACK; REGION; CONVECTION; TECTONICS; RHEOLOGY; BENEATH	Subducting slabs provide the main driving force for plate motion and flow in the Earth's mantle(1-4), and geodynamic, seismic and geochemical studies offer insight into slab dynamics and subduction-induced flow(3-15). Most previous geodynamic studies treat subduction zones as either infinite in trench-parallel extent(3,5,6) (that is, two-dimensional) or finite in width but fixed in space(7,16). Subduction zones and their associated slabs are, however, limited in lateral extent (250-7,400 km) and their three-dimensional geometry evolves over time. Here we show that slab width controls two first-order features of plate tectonics - the curvature of subduction zones and their tendency to retreat backwards with time. Using three-dimensional numerical simulations of free subduction, we show that trench migration rate is inversely related to slab width and depends on proximity to a lateral slab edge. These results are consistent with retreat velocities observed globally, with maximum velocities (6-16 cm yr(-1)) only observed close to slab edges (<1,200 km), whereas far from edges (>2,000 km) retreat velocities are always slow (<2.0 cm yr(-1)). Models with narrow slabs (<= 1,500 km) retreat fast and develop a curved geometry, concave towards the mantle wedge side. Models with slabs intermediate in width (similar to 2,000-3,000 km) are sublinear and retreat more slowly. Models with wide slabs (>= 4,000 km) are nearly stationary in the centre and develop a convex geometry, whereas trench retreat increases towards concave-shaped edges. Additionally, we identify periods (5-10 Myr) of slow trench advance at the centre of wide slabs. Such wide-slab behaviour may explain mountain building in the central Andes, as being a consequence of its tectonic setting, far from slab edges.	Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Monash Univ, Sch Math Sci, Melbourne, Vic 3800, Australia	Australian National University; Monash University	Schellart, WP (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia.	wouter.schellart@anu.edu.au	Schellart, Wouter/A-1467-2008; Moresi, Louis/H-1390-2011; Stegman, Dave/F-5794-2010; May, Dave/E-6381-2010	Moresi, Louis/0000-0003-3685-174X; Stegman, Dave/0000-0001-8012-6145; May, Dave/0000-0003-2471-7498; Schellart, Wouter/0000-0002-9802-0143				Barker PF, 2001, EARTH-SCI REV, V55, P1, DOI 10.1016/S0012-8252(01)00055-1; Christensen UR, 1996, EARTH PLANET SC LETT, V140, P27, DOI 10.1016/0012-821X(96)00023-4; Coblentz DD, 1996, J GEOPHYS RES-SOL EA, V101, P8643, DOI 10.1029/96JB00090; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; DVORKIN J, 1993, TECTONOPHYSICS, V227, P63, DOI 10.1016/0040-1951(93)90087-Z; ELSASSER WM, 1971, J GEOPHYS RES, V76, P1101, DOI 10.1029/JB076i005p01101; FORSYTH D, 1975, GEOPHYS J ROY ASTR S, V43, P163, DOI 10.1111/j.1365-246X.1975.tb00631.x; Ghosh P, 2006, SCIENCE, V311, P511, DOI 10.1126/science.1119365; Govers R, 2005, EARTH PLANET SC LETT, V236, P505, DOI 10.1016/j.epsl.2005.03.022; GRIFFITHS RW, 1995, EARTH PLANET SC LETT, V133, P1, DOI 10.1016/0012-821X(95)00027-A; GURNIS M, 1988, NATURE, V335, P317, DOI 10.1038/335317a0; Gvirtzman Z, 1999, NATURE, V401, P782, DOI 10.1038/44555; KERR RC, 1991, J GEOL, V99, P457, DOI 10.1086/629506; Kincaid C, 2003, NATURE, V425, P58, DOI 10.1038/nature01923; KINCAID C, 1987, J GEOPHYS RES-SOLID, V92, P13832, DOI 10.1029/JB092iB13p13832; Kley J, 1998, GEOLOGY, V26, P723, DOI 10.1130/0091-7613(1998)026<0723:TSACTI>2.3.CO;2; O'Neill C, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000784; Pearce JA, 2001, NATURE, V410, P457, DOI 10.1038/35068542; Peyton V, 2001, GEOPHYS RES LETT, V28, P379, DOI 10.1029/2000GL012200; RUSSO RM, 1994, SCIENCE, V263, P1105, DOI 10.1126/science.263.5150.1105; Schellart WP, 2006, EARTH-SCI REV, V76, P191, DOI 10.1016/j.earscirev.2006.01.002; Schellart WP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019528; Schellart WP, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB002970; Sdrolias M, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001090; Stegman DR, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001056; Turner S, 1998, GEOLOGY, V26, P1019, DOI 10.1130/0091-7613(1998)026<1019:UGTMMF>2.3.CO;2; VOGT PR, 1973, NATURE, V241, P189, DOI 10.1038/241189a0; Wortel MJR, 2000, SCIENCE, V290, P1910, DOI 10.1126/science.290.5498.1910; Zhong SJ, 1996, NATURE, V383, P245, DOI 10.1038/383245a0; ZHONG SJ, 1995, SCIENCE, V267, P838, DOI 10.1126/science.267.5199.838	30	452	461	9	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2007	446	7133					308	311		10.1038/nature05615	http://dx.doi.org/10.1038/nature05615			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361181				2022-12-28	WOS:000244892900043
J	Horton, R				Horton, Richard			Health as an instrument of foreign policy	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Horton, R (corresponding author), Lancet, London NW1 7BY, England.							*COMMM AFR, 2005, OUR COMM INT; Crisp N., 2007, GLOBAL HLTH PARTNERS; DONALDSON L, 2007, HLTH IS GLOBAL PROPO; DONALDSON L, 2007, LANCET, DOI DOI 10.1016/20140-6736(07)60327-4; Drager N, 2007, B WORLD HEALTH ORGAN, V85, P162, DOI 10.2471/BLT.07.041079; GOLDENBERG S, 2007, GUARDIAN        0302, P25; Horton R, 2006, LANCET, V368, P1395, DOI 10.1016/S0140-6736(06)69492-0; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; MEYER C, 2007, SUNDAY TIMES CU 0304, P46; Store JG, 2007, B WORLD HEALTH ORGAN, V85, P167; 2007, ECONOMIST       0303, P48	11	28	28	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2007	369	9564					806	807		10.1016/S0140-6736(07)60378-X	http://dx.doi.org/10.1016/S0140-6736(07)60378-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144JC	17350433				2022-12-28	WOS:000244791300007
J	Rasch, B; Buechel, C; Gais, S; Born, J				Rasch, Bjoern; Buechel, Christian; Gais, Steffen; Born, Jan			Odor cues during slow-wave sleep prompt declarative memory consolidation	SCIENCE			English	Article							REACTIVATION; HIPPOCAMPUS; ACTIVATION; SYSTEMS	Sleep facilitates memory consolidation. A widely held model assumes that this is because newly encoded memories undergo covert reactivation during sleep. We cued new memories in humans during sleep by presenting an odor that had been presented as context during prior learning, and so showed that reactivation indeed causes memory consolidation during sleep. Re-exposure to the odor during slow-wave sleep (SWS) improved the retention of hippocampus-dependent declarative memories but not of hippocampus-independent procedural memories. Odor re-exposure was ineffective during rapid eye movement sleep or wakefulness or when the odor had been omitted during prior learning. Concurring with these findings, functional magnetic resonance imaging revealed significant hippocampal activation in response to odor re-exposure during SWS.	Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, D-20246 Hamburg, Germany	University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf	Rasch, B (corresponding author), Univ Lubeck, Dept Neuroendocrinol, Ratzeburger Allee 160-23A, D-23538 Lubeck, Germany.	rasch@kfg.uni-luebeck.de; born@kfg.uni-luebeck.de	Rasch, Björn/A-3119-2015; Born, Jan/K-2596-2016	Rasch, Björn/0000-0001-7607-3415; Born, Jan/0000-0002-1847-6248				Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Carskadon MA, 2004, SLEEP, V27, P402; Chu S, 2002, MEM COGNITION, V30, P511, DOI 10.3758/BF03194952; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Gordon W.C., 1981, P319; Herz RS, 2004, NEUROPSYCHOLOGIA, V42, P371, DOI 10.1016/j.neuropsychologia.2003.08.009; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Parker A, 2001, APPL COGNITIVE PSYCH, V15, P159, DOI 10.1002/1099-0720(200103/04)15:2<159::AID-ACP694>3.0.CO;2-D; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Sommer T, 2005, LEARN MEMORY, V12, P343, DOI 10.1101/lm.90405; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Zelano C, 2005, NEURON, V48, P431, DOI 10.1016/j.neuron.2005.10.009	29	744	777	8	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1426	1429		10.1126/science.1138581	http://dx.doi.org/10.1126/science.1138581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143UP	17347444				2022-12-28	WOS:000244752200038
J	Ryan, PG; Bloomer, P; Moloney, CL; Grant, TJ; Delport, W				Ryan, Peter G.; Bloomer, Paulette; Moloney, Coleen L.; Grant, Tyron J.; Delport, Wayne			Ecological speciation in South Atlantic island finches	SCIENCE			English	Article							TRISTAN-DA-CUNHA; DARWINS FINCHES; INACCESSIBLE ISLAND; SYMPATRIC SPECIATION; DISRUPTIVE SELECTION; HYBRIDIZATION; EVOLUTION; PERSPECTIVE; NESOSPIZA; OCEAN	Examples of sympatric speciation in nature are rare and hotly debated. We describe the parallel speciation of finches on two small islands in the Tristan da Cunha archipelago in the South Atlantic Ocean. Nesospiza buntings are a classic example of a simple adaptive radiation, with two species on each island: an abundant small-billed dietary generalist and a scarce large-billed specialist. Their morphological diversity closely matches the available spectrum of seed sizes, and genetic evidence suggests that they evolved independently on each island. Speciation is complete on the smaller island, where there is a single habitat with strongly bimodal seed size abundance, but is incomplete on the larger island, where a greater diversity of habitats has resulted in three lineages. Our study suggests that the buntings have undergone parallel ecological speciation.	Univ Cape Town, Natl Res Fdn Ctr Excellence, Dept Sci & Technol, Percy FitzPatrick Inst, ZA-7701 Rondebosch, South Africa; Univ Pretoria, Dept Genet, Mol Ecol & Evolut Programme, ZA-0002 Pretoria, South Africa	National Research Foundation - South Africa; University of Cape Town; University of Pretoria	Ryan, PG (corresponding author), Univ Cape Town, Natl Res Fdn Ctr Excellence, Dept Sci & Technol, Percy FitzPatrick Inst, ZA-7701 Rondebosch, South Africa.	Peter.Ryan@uct.ac.za	Bloomer, Paulette/F-5501-2010; Moloney, Coleen/B-4363-2009; Delport, Wayne/C-1744-2008	Bloomer, Paulette/0000-0002-6357-0153; Moloney, Coleen/0000-0001-6663-8814; Ryan, Peter/0000-0002-3356-2056				ABBOTT I, 1978, J ZOOL, V184, P119; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Burger R, 2006, AM NAT, V167, P190, DOI 10.1086/499375; Burns KJ, 2002, EVOLUTION, V56, P1240; Coyne J.A., 2004, SPECIATION; Dieckmann U., 2004, ADAPTIVE SPECIATION; Gavrilets S, 2003, EVOLUTION, V57, P2197; Grant P.R., 1999, RECOGNITION STATES L, V2; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Grant PR, 2005, AM NAT, V166, P56, DOI 10.1086/430331; Grant PR, 2004, EVOLUTION, V58, P1588; Kopp M, 2006, EVOLUTION, V60, P1537; Lack D., 1947, DARWINS FINCHES; Mayr E., 1982, GROWTH BIOL THOUGHT; OLLIER CD, 1984, Z GEOMORPHOL, V28, P367; Petren K, 2005, MOL ECOL, V14, P2943, DOI 10.1111/j.1365-294X.2005.02632.x; Polechova J, 2005, EVOLUTION, V59, P1194; PREECE RC, 1986, J BIOGEOGR, V13, P1, DOI 10.2307/2844847; ROUX JP, 1992, BOTHALIA, V22, P93, DOI 10.4102/abc.v22i1.828; Ryan PG, 2001, CONDOR, V103, P429, DOI 10.1650/0010-5422(2001)103[0429:MHIAHB]2.0.CO;2; RYAN PG, 1994, AUK, V111, P314, DOI 10.2307/4088596; RYAN PG, 1992, THESIS U CAPE TOWN; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; SMITH TB, 1993, NATURE, V363, P618, DOI 10.1038/363618a0; Sorenson MD, 2003, NATURE, V424, P928, DOI 10.1038/nature01863; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; Zink RM, 2002, AUK, V119, P864, DOI 10.1642/0004-8038(2002)119[0864:ANPOTE]2.0.CO;2	28	106	114	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1420	1423		10.1126/science.1138829	http://dx.doi.org/10.1126/science.1138829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347442				2022-12-28	WOS:000244752200036
J	Simon, MD; Chu, FX; Racki, LR; de la Cruz, CC; Burlingame, AL; Panning, B; Narlikar, GJ; Shokat, KM				Simon, Matthew D.; Chu, Feixia; Racki, Lisa R.; de la Cruz, Cecile C.; Burlingame, Alma L.; Panning, Barbara; Narlikar, Geeta J.; Shokat, Kevan M.			The site-specific installation of methyl-lysine analogs into recombinant histones	CELL			English	Article							NUCLEOSOME MOBILITY; CHROMATIN-STRUCTURE; EPIGENETIC CONTROL; MOLECULAR-BASIS; PHD FINGER; H3; PROTEINS; LIGATION; BINDING; NURF	Histone lysine residues can be mono-, di-, or trimethylated. These posttranslational modifications regulate the affinity of effector proteins and may also impact chromatin structure independent of their role as adaptors. In order to study histone lysine methylation, particularly in the context of chromatin, we have developed a chemical approach to install analogs of methyl lysine into recombinant proteins. This approach allows for the rapid generation of large quantities of histones in which the site and degree of methylation can be specified. We demonstrate that these methyl-lysine analogs (MLAs) are functionally similar to their natural counterparts. These methylated histones, were used to examine the influence of specific lysine methylation on the binding of effecter proteins and the rates of nucleosme remodeling. This simple method of introducing site-specific and degree-specific methylation into recombinant histones provides a powerful tool to investigate the biochemical mechanisms by which lysine methylation influences chromatin structure and function.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Shokat, KM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	shokat@cmp.ucsf.edu	Simon, Matthew/ABF-9127-2020	Simon, Matthew/0000-0001-7423-5265	Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [RR 001614, S10 RR019934, RR 019934, P41 RR001614] Funding Source: Medline; NIGMS NIH HHS [R01 GM085186] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614, S10RR019934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085186] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chu FX, 2006, MOL CELL PROTEOMICS, V5, P194, DOI 10.1074/mcp.M500285-MCP200; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Clapier CR, 2002, NUCLEIC ACIDS RES, V30, P649, DOI 10.1093/nar/30.3.649; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; GLOSS LM, 1995, BIOCHEMISTRY-US, V34, P3990, DOI 10.1021/bi00012a017; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; He S, 2003, P NATL ACAD SCI USA, V100, P12033, DOI 10.1073/pnas.2035256100; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Hopkins CE, 2005, ARCH BIOCHEM BIOPHYS, V443, P1, DOI 10.1016/j.abb.2005.08.020; ITANO HA, 1972, J BIOL CHEM, V247, P4819; Ivanova AV, 1998, NAT GENET, V19, P192, DOI 10.1038/566; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Kenyon G L, 1977, Methods Enzymol, V47, P407; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MEANS GE, 1968, BIOCHEMISTRY-US, V7, P2192, DOI 10.1021/bi00846a023; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nekrasov M, 2005, EMBO REP, V6, P348, DOI 10.1038/sj.embor.7400376; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; RAFTERY MA, 1966, J BIOL CHEM, V241, P3457; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Shogren-Knaak MA, 2004, METHOD ENZYMOL, V375, P62; Shogren-Knaak MA, 2003, J BIOL CHEM, V278, P15744, DOI 10.1074/jbc.M301445200; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; Turner BM, 2005, NAT STRUCT MOL BIOL, V12, P110, DOI 10.1038/nsmb0205-110; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Zubarev RA, 1998, J AM CHEM SOC, V120, P3265, DOI 10.1021/ja973478k	45	342	351	3	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					1003	1012		10.1016/j.cell.2006.12.041	http://dx.doi.org/10.1016/j.cell.2006.12.041			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350582	Bronze, Green Accepted			2022-12-28	WOS:000245073400022
J	McCann, K				McCann, Kevin			Protecting biostructure	NATURE			English	Editorial Material									Univ Guelph, Dept Zool, Guelph, ON N1G 2W1, Canada	University of Guelph	McCann, K (corresponding author), Univ Guelph, Dept Zool, Guelph, ON N1G 2W1, Canada.							Tewfik A, 2005, ECOLOGY, V86, P2726, DOI 10.1890/04-1537	1	141	145	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2007	446	7131					29	29		10.1038/446029a	http://dx.doi.org/10.1038/446029a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330028	Bronze			2022-12-28	WOS:000244525600022
J	Sawires, SR; Dworkin, SL; Fiamma, A; Peacock, D; Szekeres, G; Coates, TJ				Sawires, Sharif R.; Dworkin, Shari L.; Fiamma, Agnes; Peacock, Dean; Szekeres, Greg; Coates, Thomas J.			Male circumcision and HIV/AIDS: challenges and opportunities	LANCET			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; URINARY-TRACT-INFECTIONS; NEONATAL CIRCUMCISION; CERVICAL-CANCER; HIV PREVENTION; RISK; TRANSMISSION; RAKAI; MEN; SEROCONVERSION		Univ Calif Los Angeles, Program Global Hlth, David Geffen Sch Med, Dept Med,Div Infect Dis,AIDS Policy Dev Ctr, Los Angeles, CA 90024 USA; Columbia Univ, Dept Psychiat, New York, NY USA; Sonke Gender Justice, Cape Town, South Africa	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Columbia University	Sawires, SR (corresponding author), Univ Calif Los Angeles, Program Global Hlth, David Geffen Sch Med, Dept Med,Div Infect Dis,AIDS Policy Dev Ctr, 10940 Wilshire Blvd,Suite 1220, Los Angeles, CA 90024 USA.	SSawires@mednet.ucla.edu			NIMH NIH HHS [P50 MH043520, P30 MH43520, P30 MH043520] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH043520, P30MH043520] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adami HO, 2002, NEW ENGL J MED, V346, P1160, DOI 10.1056/NEJM200204113461511; Ahmed A, 1999, ANN TROP PAEDIATR, V19, P113, DOI 10.1080/02724939992743; Bailey RC, 2006, ASSESSMENT CLIN TRAD; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; CAMERON DW, 1989, LANCET, V2, P403; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Donoval BA, 2006, AM J CLIN PATHOL, V125, P386, DOI 10.1309/JVHQVDJDYKM58EPH; EUVERT B, 2005, PLOS MED, V2, pE298; Fergusson DM, 2006, PEDIATRICS, V118, P1971, DOI 10.1542/peds.2006-1175; FERGUSSON DM, 1988, PEDIATRICS, V81, P537; Gifford SM., 1986, ANTHR EPIDEMIOLOGY I, P213; Global HIV Prevention Working Group, 2006, NEW APPR HIV PREV AC; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Krieger JN, 2005, BJU INT, V96, P1109, DOI 10.1111/j.1464-410X.2005.05810.x; Lavreys L, 1999, J INFECT DIS, V180, P330, DOI 10.1086/314884; Magoha GAO, 1999, E AFR MED J, V76, P583; MEHENDALE SM, 1995, J INFECT DIS, V172, P1486, DOI 10.1093/infdis/172.6.1486; MOSES S, 1990, INT J EPIDEMIOL, V19, P693, DOI 10.1093/ije/19.3.693; *NAT RES COUNC COR, 1996, UND RISK INF DEC DEM; Oaks L, 2003, RISK CULTURE AND HEALTH INEQUALITY: SHIFTING PERCEPTIONS OF DANGER AND BLAME, P3; Okeke Linus I, 2006, BMC Urol, V6, P21; Pidgeon N., 1992, ROYALSOCIETY STUDY G, P89; Reynolds SJ, 2004, LANCET, V363, P1039, DOI 10.1016/S0140-6736(04)15840-6; Schoen EJ, 2006, J UROLOGY, V175, P1111, DOI 10.1016/S0022-5347(05)00399-X; Schoen EJ, 2005, ARCH DIS CHILD, V90, P772, DOI 10.1136/adc.2004.066761; Schoen EJ, 2000, PEDIATRICS, V105, P620, DOI 10.1542/peds.105.3.620; Schoen EJ, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.3.e36; Siegfried N, 2005, LANCET INFECT DIS, V5, P165, DOI 10.1016/S1473-3099(05)01309-5; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Singh-Grewal D, 2005, ARCH DIS CHILD, V90, P853, DOI 10.1136/adc.2004.049353; *UNAIDS, 2006, FACT SHEET MAL CIRC; [UNAIDS USAID WHO CDC Policy Project], 2004, COV SEL SERV HIV AID; UNAIDS, 2006, REP GLOB AIDS EP; Van Howe RS, 2005, J R SOC PROMO HEALTH, V125, P259, DOI 10.1177/146642400512500607; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; WENTE M, TROUBLE AFRICA; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; WISWELL TE, 1989, PEDIATRICS, V83, P1011; WISWELL TE, 1985, PEDIATRICS, V75, P901; WISWELL TE, 1993, CLIN PEDIATR, V32, P130, DOI 10.1177/000992289303200301	45	66	68	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2007	369	9562					708	713		10.1016/S0140-6736(07)60323-7	http://dx.doi.org/10.1016/S0140-6736(07)60323-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	141RO	17321321	Green Accepted			2022-12-28	WOS:000244596600037
J	Baerlocher, C; Gramm, F; Massuger, L; McCusker, LB; He, ZB; Hovmoller, S; Zou, XD				Baerlocher, Christian; Gramm, Fabian; Massueger, Lars; McCusker, Lynne B.; He, Zhanbing; Hovmoeller, Sven; Zou, Xiaodong			Structure of the polycrystalline zeolite catalyst IM-5 solved by enhanced charge flipping	SCIENCE			English	Article							INITIO STRUCTURE SOLUTION; POWDER DIFFRACTION; PROGRAM; SYSTEM	Despite substantial advances in crystal structure determination methodology for polycrystalline materials, some problems have remained intractable. A case in point is the zeolite catalyst IM-5, whose structure has eluded determination for almost 10 years. Here we present a charge-flipping structure-solution algorithm, extended to facilitate the combined use of powder diffraction and electron microscopy data. With this algorithm, we have elucidated the complex structure of IM-5, with 24 topologically distinct silicon atoms and an unusual two-dimensional medium-pore channel system. This powerful approach to structure solution can be applied without modification to any type of polycrystalline material ( e. g., catalysts, ceramics, pharmaceuticals, complex metal alloys) and is therefore pertinent to a diverse range of scientific disciplines.	Swiss Fed Inst Technol, Crystallog Lab, CH-8093 Zurich, Switzerland; Stockholm Univ, SE-10691 Stockholm, Sweden	Swiss Federal Institutes of Technology Domain; ETH Zurich; Stockholm University	McCusker, LB (corresponding author), Swiss Fed Inst Technol, Crystallog Lab, CH-8093 Zurich, Switzerland.	mccusker@mat.ethz.ch	Massuger, Leon F.A.G./H-8072-2014	McCusker, Lynne/0000-0003-0074-1733				Baerlocher C, 2004, Z KRISTALLOGR, V219, P782, DOI 10.1524/zkri.219.12.782.55863; Baerlocher C., 2007, ATLAS ZEOLITE FRAMEW, DOI [10.1016/B978-0-444-53064-6.X5186-X, DOI 10.1016/B978-044453064-6/50201-2]; Baerlocher Ch., 1977, DLS 76 DISTANCE LEAS; Baerlocher C, 2007, Z KRISTALLOGR, V222, P47, DOI 10.1524/zkri.2007.222.2.47; BENAZZI E, 2003, Patent No. 6667267; Benazzi E., 1998, WO Pat., Patent No. [98/17581, 9817581]; Brenner S, 2002, J APPL CRYSTALLOGR, V35, P243, DOI 10.1107/S0021889802001759; Corma A, 2000, J CATAL, V189, P382, DOI 10.1006/jcat.1999.2718; Corma A, 2003, NAT MATER, V2, P493, DOI 10.1038/nmat921; Corma A, 2002, J CATAL, V206, P125, DOI 10.1006/jcat.2001.3469; David W. I. F., 2002, STRUCTURE DETERMINAT; DUPLAN JL, 2005, Patent No. 20050222475; ESTERMANN MA, 1993, J APPL CRYSTALLOGR, V26, P396, DOI 10.1107/S0021889892012871; Gramm F, 2006, NATURE, V444, P79, DOI 10.1038/nature05200; Grosse-Kunstleve RW, 1997, J APPL CRYSTALLOGR, V30, P985, DOI 10.1107/S0021889897005013; HOVMOLLER S, 1992, ULTRAMICROSCOPY, V41, P121, DOI 10.1016/0304-3991(92)90102-P; KOKOTAILO GT, 1978, NATURE, V272, P437, DOI 10.1038/272437a0; Lee SH, 2003, J CATAL, V215, P151, DOI 10.1016/S0021-9517(02)00178-1; Oszlanyi G, 2004, ACTA CRYSTALLOGR A, V60, P134, DOI 10.1107/S0108767303027569; Oszlanyi G, 2005, ACTA CRYSTALLOGR A, V61, P147, DOI 10.1107/S0108767304027746; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Serra JM, 2005, STUD SURF SCI CATAL, V158, P1757; Serra JM, 2004, J CATAL, V227, P459, DOI 10.1016/j.jcat.2004.08.006; Wu JS, 2006, NAT MATER, V5, P647, DOI 10.1038/nmat1687; YONG K, 1990, ACTA CRYSTALLOGR A, V46, P41; ZOU XD, 1993, ULTRAMICROSCOPY, V52, P436, DOI 10.1016/0304-3991(93)90058-6; Zou XD, 2004, ULTRAMICROSCOPY, V98, P187, DOI 10.1016/j.ultramic.2003.08.025; Zou XD, 2003, ACTA CRYSTALLOGR A, V59, P526, DOI 10.1107/S0108767303018051	28	195	206	4	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1113	1116		10.1126/science.1137920	http://dx.doi.org/10.1126/science.1137920			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17322057				2022-12-28	WOS:000244387600033
J	Kouzarides, T				Kouzarides, Tony			SnapShot: Histone-modifying enzymes	CELL			English	Editorial Material							LYSINE METHYLATION; GENE-EXPRESSION; CODE; H3		Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England	University of Cambridge	Kouzarides, T (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England.			Kouzarides, Tony/0000-0002-8918-4162				Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	12	65	69	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 23	2007	128	4					802	+		10.1016/j.cell.2007.02.018	http://dx.doi.org/10.1016/j.cell.2007.02.018			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148TX	17320515	Bronze			2022-12-28	WOS:000245098600020
J	Alho, OP; Koivunen, P; Penna, T; Teppo, H; Koskela, M; Luotonen, J				Alho, Olli-Pekka; Koivunen, Petri; Penna, Tomi; Teppo, Heikki; Koskela, Markku; Luotonen, Jukka			Tonsillectomy versus watchful waiting in recurrent streptococcal pharyngitis in adults: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMPLICATIONS; INFECTIONS; DISEASE	Objective To determine the short term efficacy and safety of tonsillectomy for recurrent streptococcal pharyngitis in adults. Design Randomised controlled trial. Setting Academic referral centre in Finland. Participants 70 adults with documented recurrent episodes of streptococcal group A pharyngitis. Intervention Instant tonsillectomy (n=36) or remaining on waiting list as control (n=34). Main outcome measures Percentage change in the risk of an episode of streptococcal pharyngitis at 90 days. Rates of all episodes of pharyngitis and days with symptoms and adverse effects. Results The mean (SD) follow-up was 164 (63) days in the control group and 170 (12) days in the tonsillectomy group. At 90 days, streptococcal pharyngitis had recurred in 24% (8/34) in the control group and 3% (1/36) in the tonsillectomy group (difference 21%; 95% confidence interval 6% to 36%). The number needed to undergo tonsillectomy to prevent one recurrence was 5 (3 to 16). During the whole follow-up, the rates of other episodes of pharyngitis and days with throat pain and fever were significantly tower in the tonsillectomy group than in the control group. The most common morbidity related to tonsillectomy was postoperative throat pain (mean length 13 days, SD 4). Conclusions Adults with a history of documented recurrent episodes of streptococcal pharyngitis were less likely to have further streptococcal or other throat infections or days with throat pain if they had their tonsils removed.	Univ Oulu, Dept Otolaryngol, FIN-90014 Oulu, Finland; Oulu Univ Hosp, Dept Med Microbiol, FIN-90029 Oulu, Finland	University of Oulu; University of Oulu	Alho, OP (corresponding author), Univ Oulu, Dept Otolaryngol, POB 5000, FIN-90014 Oulu, Finland.	opalho@cc.outu.fi						Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Bisno AL, 2002, CLIN INFECT DIS, V35, P113, DOI 10.1086/340949; Bisno AL, 2001, NEW ENGL J MED, V344, P205, DOI 10.1056/NEJM200101183440308; Burton MJ, 2000, COCHRANE DB SYST REV; CHAMOVITZ R, 1960, PEDIATRICS, V26, P355; Cooper RJ, 2001, ANN INTERN MED, V134, P509, DOI 10.7326/0003-4819-134-6-200103200-00019; FEINSTEIN AR, 1970, NEW ENGL J MED, V282, P285, DOI 10.1056/NEJM197002052820601; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mattila PS, 2001, ARCH OTOLARYNGOL, V127, P37, DOI 10.1001/archotol.127.1.37; McLeod RS, 1999, WORLD J SURG, V23, P1210, DOI 10.1007/s002689900649; PARADISE JL, 1984, NEW ENGL J MED, V310, P674, DOI 10.1056/NEJM198403153101102; Randall DA, 1998, OTOLARYNG HEAD NECK, V118, P61, DOI 10.1016/S0194-5998(98)70376-6; Schulz KF, 2002, LANCET, V359, P515, DOI 10.1016/S0140-6736(02)07683-3; TEWARY AK, 1993, J LARYNGOL OTOL, V107, P703, DOI 10.1017/S0022215100124181; van Staaij BK, 2005, ARCH DIS CHILD, V90, P19, DOI 10.1136/adc.2003.047530	16	36	37	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2007	334	7600					939	941		10.1136/bmj.39140.632604.55	http://dx.doi.org/10.1136/bmj.39140.632604.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165YN	17347187	Green Published, Bronze			2022-12-28	WOS:000246343800038
J	Ishii, N; Nakahigashi, K; Baba, T; Robert, M; Soga, T; Kanai, A; Hirasawa, T; Naba, M; Hirai, K; Hoque, A; Ho, PY; Kakazu, Y; Sugawara, K; Igarashi, S; Harada, S; Masuda, T; Sugiyama, N; Togashi, T; Hasegawa, M; Takai, Y; Yugi, K; Arakawa, K; Iwata, N; Toya, Y; Nakayama, Y; Nishioka, T; Shimizu, K; Mori, H; Tomita, M				Ishii, Nobuyoshi; Nakahigashi, Kenji; Baba, Tomoya; Robert, Martin; Soga, Tomoyoshi; Kanai, Akio; Hirasawa, Takashi; Naba, Miki; Hirai, Kenta; Hoque, Aminul; Ho, Pei Yee; Kakazu, Yuji; Sugawara, Kaori; Igarashi, Saori; Harada, Satoshi; Masuda, Takeshi; Sugiyama, Naoyuki; Togashi, Takashi; Hasegawa, Miki; Takai, Yuki; Yugi, Katsuyuki; Arakawa, Kazuharu; Iwata, Nayuta; Toya, Yoshihiro; Nakayama, Yoichi; Nishioka, Takaaki; Shimizu, Kazuyuki; Mori, Hirotada; Tomita, Masaru			Multiple high-throughput analyses monitor the response of E-coli to perturbations	SCIENCE			English	Article							METABOLIC NETWORK; INTEGRATION; ROBUSTNESS; GENOMICS; STRESS; SYSTEM	Analysis of cellular components at multiple levels of biological information can provide valuable functional insights. We performed multiple high-throughput measurements to study the response of Escherichia coli cells to genetic and environmental perturbations. Analysis of metabolic enzyme gene disruptants revealed unexpectedly small changes in messenger RNA and proteins for most disruptants. Overall, metabolite levels were also stable, reflecting the rerouting of fluxes in the metabolic network. In contrast, E. coli actively regulated enzyme levels to maintain a stable metabolic state in response to changes in growth rate. E. coli thus seems to use complementary strategies that result in a metabolic network robust against perturbations.	Keio Univ, Inst Adv Biosci, Yamagata 9970017, Japan; Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa 2528520, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan; Kyushu Inst Technol, Dept Biosci & Bioinformat, Fukuoka 8208502, Japan; Human Metabolome Technol Inc, Tsuruoka, Japan	Keio University; Keio University; Nara Institute of Science & Technology; Kyoto University; Kyushu Institute of Technology	Tomita, M (corresponding author), Keio Univ, Inst Adv Biosci, Yamagata 9970017, Japan.	mt@sfc.keio.ac.jp	Mori, Hirotada/B-4934-2011; Ho, Pei Yee/G-6841-2012; Robert, Martin/B-3970-2009; Soga, Tomoyoshi/B-8105-2014; Hirasawa, Takashi/G-4458-2016; Kanai, Akio/C-4921-2014; Shimizu, Kazuyuki/GVT-4698-2022	Robert, Martin/0000-0002-7082-5142; Soga, Tomoyoshi/0000-0001-9502-2509; Hirasawa, Takashi/0000-0002-5183-2953; Kanai, Akio/0000-0002-6362-2419; Shimizu, Kazuyuki/0000-0002-4847-0197; Arakawa, Kazuharu/0000-0002-2893-4919; Toya, Yoshihiro/0000-0001-9670-6961; Sugiyama, Naoyuki/0000-0001-7633-8495				Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; DALDAL F, 1983, J MOL BIOL, V168, P285, DOI 10.1016/S0022-2836(83)80019-9; Fong SS, 2006, J BIOL CHEM, V281, P8024, DOI 10.1074/jbc.M510016200; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Mukhopadhyay A, 2006, J BACTERIOL, V188, P4068, DOI 10.1128/JB.01921-05; SKINNER AJ, 1974, J BACTERIOL, V118, P1183, DOI 10.1128/JB.118.3.1183-1185.1974; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Toyoda T, 2004, BIOINFORMATICS, V20, P1759, DOI 10.1093/bioinformatics/bth165; Vemuri GN, 2005, MICROBIOL MOL BIOL R, V69, P197, DOI 10.1128/MMBR.69.2.197-216.2005	19	504	516	2	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					593	597		10.1126/science.1132067	http://dx.doi.org/10.1126/science.1132067			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17379776				2022-12-28	WOS:000245983100044
J	Bukowski, R; Smith, GCS; Malone, FD; Ball, RH; Nyberg, DA; Comstock, CH; Hankins, GDV; Berkowitz, RL; Gross, SJ; Dugoff, L; Craigo, SD; Timor-Tritsch, IE; Carr, SR; Wolfe, HM; D'Alton, ME				Bukowski, R.; Smith, G. C. S.; Malone, F. D.; Ball, R. H.; Nyberg, D. A.; Comstock, C. H.; Hankins, G. D. V.; Berkowitz, R. L.; Gross, S. J.; Dugoff, L.; Craigo, S. D.; Timor-Tritsch, I. E.; Carr, S. R.; Wolfe, H. M.; D'Alton, M. E.		FASTER Res Consortium	Fetal growth in early pregnancy and risk of delivering low birth weight infant: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							1ST-TRIMESTER GROWTH; PRETERM BIRTH; ORIGINS; AGE	Objective To determine if first trimester fetal growth is associated with birth weight, duration of pregnancy, and the risk of delivering a small for gestational age infant. Design Prospective cohort study of 38 033 pregnancies between 1999 and 2003. Setting 15 centres representing major regions of the United States. Participants 976 women from the original cohort who conceived as the result of assisted reproductive technology, had a first trimester ultrasound measurement of fetal crown-rump length, and delivered live singleton infants without evidence of chromosomal or congenital abnormalities. First trimester growth was expressed as the difference between the observed and expected size of the fetus, expressed as equivalence to days of gestational age, Main outcome measures Birth weight, duration of pregnancy, and risk of delivering a small for gestational age infant. Results For each one day increase in the observed size of the fetus, birth weight increased by 28.2 (95% confidence interval 14.6 to 41.2) g. The association was substantially attenuated by adjustment for duration of pregnancy (adjusted coefficient 17.1 (6.6 to 27.5) g). Further adjustments for maternal characteristics and complications of pregnancy did not have a significant effect. The risk of delivering a small for gestational age infant decreased with increasing size in the first trimester, (odds ratio for a one day increase 0.87, 0.81 to 0.94). The association was not materially affected by adjustment for maternal characteristics or complications of pregnancy. Conclusion Variation in birth weight may be determined, at least in part, by fetal growth in the first 12 weeks after conception through effects on timing of delivery and fetal growth velocity.	Univ Texas, Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Bukowski, R (corresponding author), Univ Texas, Med Branch, Dept Obstet & Gynecol, 301 Univ Blvd, Galveston, TX 77555 USA.	rkbukows@utmb.edu	Malone, Fergal/D-6233-2012; Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997; Timor-Tritsch, Ilan/0000-0001-9774-3107	NICHD NIH HHS [R01 HD 38625] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; BahadoSingh RO, 1997, AM J OBSTET GYNECOL, V176, P976, DOI 10.1016/S0002-9378(97)70388-0; Barker D. J. P., 1994, MOTHERS BABIES DIS L; Bloomfield FH, 2003, SCIENCE, V300, P606, DOI 10.1126/science.1080803; Gardosi J, 2000, BRIT J OBSTET GYNAEC, V107, P228, DOI 10.1111/j.1471-0528.2000.tb11694.x; GLUCKMAN PD, 1984, FETAL PHYSL MED, P511; HADLOCK FP, 1992, RADIOLOGY, V182, P501, DOI 10.1148/radiology.182.2.1732970; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Salomon LJ, 2005, ULTRASOUND OBST GYN, V26, P512, DOI 10.1002/uog.1966; Smith GCS, 2002, NATURE, V417, P916, DOI 10.1038/417916a; Smith GCS, 2004, SEMIN PERINATOL, V28, P41, DOI 10.1053/j.semperi.2003.10.012; Smith GCS, 1998, NEW ENGL J MED, V339, P1817, DOI 10.1056/NEJM199812173392504; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6	16	145	147	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2007	334	7598					836	838		10.1136/bmj.39129.637917.AE	http://dx.doi.org/10.1136/bmj.39129.637917.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	162MD	17355993	Green Published, Bronze			2022-12-28	WOS:000246090800033
J	Maheswaran, R; Pearson, T; Munro, J; Jiwa, M; Campbell, MJ; Nicholl, J				Maheswaran, Ravi; Pearson, Tim; Munro, James; Jiwa, Moyez; Campbell, Michael J.; Nicholl, Jon			Impact of NHS walk-in centres on primary care access times: ecological study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PROVIDERS	Objective To examine whether walk-in centres contribute to shorter waiting times for a general practice appointment. Design Ecological study. Setting 2 509 general practices in 56 primary care trusts in England; 32 walk-in centres within 3 km of one of these practices. Main outcome measure Waiting time to next available general practitioner appointment (April 2003 to December 2004), from national monthly primary care access survey. Results The percentage of practices achieving the target waiting time of less than 48 hours to see a general practitioner increased from 67% to 87% over the 21 month study period (adjusted odds ratio 1.07 (95% confidence interval 1.06 to 1.08) per increase in month). Achievement of the waiting time target decreased with increasing multiple deprivation (0.57 (0.49 to 0.67) for most versus least deprived third) and increased with increasing practice population size (1.02 (1.00 to 1.04) per 1000 increase). No evidence was found that increasing distance from a walk-in centre was associated with decreasing odds of achieving the waiting time target (1.00 (0.99 to 1.01) per km increase). Increasing "exposure" to a walk-in centre, modelled with a distance decay function based on attendance rates, also showed little evidence of association with achievement of the waiting time target (1.02 (0.97 to 1.08) for interquartile range increase). No evidence existed that the rate of increase in achieving the 48 hour target over time was enhanced by proximity or "exposure" to a walk-in centre. Results were similar when the analysis was rerun with data for 2003 only (done because pressure in 2004 to meet the government's deadline might have led to other changes that could have masked any walk-in centre effect). Conclusions No evidence existed that walk-in centres shortened waiting times for access to primary care, and the results do not support the use of walk-in centres for this purpose.	Univ Sheffield, Publ Hlth GIS Unit, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England; Univ Sheffield, Hlth Serv Res Unit, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England; Univ Sheffield, Inst Gen Practice, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Maheswaran, R (corresponding author), Univ Sheffield, Publ Hlth GIS Unit, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England.	r.maheswaran@sheffield.ac.uk	Jiwa, Moyez/A-1325-2008; Campbell, Michael J/I-4253-2014; Nicholl, Jon/B-8257-2008	Campbell, Michael J/0000-0003-3529-2739; Jiwa, Moyez/0000-0002-0948-4166; Maheswaran, Ravi/0000-0002-3899-4421				Chalder M, 2003, BRIT MED J, V326, P532, DOI 10.1136/bmj.326.7388.532; *DEP HLTH, ROCROR0120 DEP HLTH; *DEP HLTH, ROCROR0120; Department of Health, 2002, DEL NHS PLAN NEXT ST; *DH PMDU JOINT WOR, PCAS VAL; Hsu RT, 2003, BRIT MED J, V326, P530, DOI 10.1136/bmj.326.7388.530; Jackson CJ, 2005, FAM PRACT, V22, P269, DOI 10.1093/fampra/cmi018; *OFF DEP PRIM MIN, 2004, SUP OUTP AR LOW LAYE; Pope C, 2005, PUBLIC HEALTH, V119, P39, DOI 10.1016/j.puhe.2003.12.014; Rosen R, 2002, J ADV NURS, V39, P241, DOI 10.1046/j.1365-2648.2002.02270.x; *ROYAL COLL GEN PR, 1999, DISC PAP IMPL GEN PR; Salisbury C, 2002, BRIT J GEN PRACT, V52, P554	12	14	14	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2007	334	7598					838	841		10.1136/bmj.39122.704051.55	http://dx.doi.org/10.1136/bmj.39122.704051.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	162MD	17350967	Green Published, Bronze			2022-12-28	WOS:000246090800034
J	Ota, KG; Kuraku, S; Kuratani, S				Ota, Kinya G.; Kuraku, Shigehiro; Kuratani, Shigeru			Hagfish embryology with reference to the evolution of the neural crest	NATURE			English	Article							VERTEBRATE EVOLUTION; HEAD; MIGRATION; SEQUENCES; ORIGIN; SLUG	Hagfish, which lack both jaws and vertebrae, have long been the subject of intense interest owing to their position at a crucial point in the evolutionary transition to a truly vertebrate body plan(1-4). However, unlike the comparatively well characterized vertebrate agnathan lamprey, little is known about hagfish development. The inability to analyse hagfish at early embryonic stages has frustrated attempts to resolve questions with important phylogenetic implications, including fundamental ones relating to the emergence of the neural crest(1,5,6). Here we report the obtainment of multiple pharyngula-stage embryos of the hagfish species Eptatretus burgeri and our preliminary analyses of their early development. We present histological evidence of putative neural crest cells, which appear as delaminated cells that migrate along pathways corresponding to neural crest cells in fish and amphibians(2,7-11). Molecular cloning studies further revealed the expression of several regulatory genes, including cognates of Pax6, Pax3/7, SoxEa and Sox9, suggesting that the hagfish neural crest is specified by molecular mechanisms that are general to vertebrates. We propose that the neural crest emerged as a population of de-epithelialized migratory cells in a common vertebrate ancestor, and suggest that the possibility of classical and molecular embryology in hagfish opens up new approaches to clarifying the evolutionary history of vertebrates.	RIKEN, Ctr Dev Biol, Lab Evolutionary Morphol, Kobe, Hyogo 6500047, Japan	RIKEN	Kuratani, S (corresponding author), RIKEN, Ctr Dev Biol, Lab Evolutionary Morphol, Kobe, Hyogo 6500047, Japan.	saizo@cdb.riken.jp	Kuraku, Shigehiro/B-2801-2009; Kuratani, Shigeru/J-4146-2014	Kuraku, Shigehiro/0000-0003-1464-8388; Kuratani, Shigeru/0000-0001-9717-7221				BRONNERFRASER M, 1993, J NEUROBIOL, V24, P233, DOI 10.1002/neu.480240209; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; COLLAZO A, 1993, DEVELOPMENT, V118, P363; Conel JL, 1942, J COMP NEUROL, V76, P191, DOI 10.1002/cne.900760202; Dean B., 1899, EMBRYOLOGY BDELLOSTO, P220; EISEN JS, 1993, DEV BIOL, V159, P50, DOI 10.1006/dbio.1993.1220; Furlong RF, 2002, ZOOL SCI, V19, P593, DOI 10.2108/zsj.19.593; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Goodrich ES., 1930, STUDIES STRUCTURE DE, DOI [DOI 10.5962/BHL.TITLE.82144, 10.5962/bhl.title.82144]; Gorbman A, 1997, ZOOL SCI, V14, P375, DOI 10.2108/zsj.14.375; GORBMAN A, 1985, EVOLUTIONARY BIOL PR, P165; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Hall BK, 1999, NEURAL CREST DEV EVO; Holmgren N., 1946, ACTA ZOOLOGICA, V27, P1, DOI [10.1111/j.1463-6395.1946.tb00019.x, DOI 10.1111/J.1463-6395.1946.TB00019.X]; Janvier P., 1996, EARLY VERTEBRATES; Jeffery WR, 2004, NATURE, V431, P696, DOI 10.1038/nature02975; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Le Douarin NM, 1999, NEURAL CREST, V2; Locascio A, 2002, P NATL ACAD SCI USA, V99, P16841, DOI 10.1073/pnas.262525399; Lovtrup S., 1977, PHYLOGENY VERTEBRATA; Mallat J, 1998, MOL BIOL EVOL, V15, P1706, DOI 10.1093/oxfordjournals.molbev.a025897; McCauley DW, 2006, NATURE, V441, P750, DOI 10.1038/nature04691; McCauley DW, 2003, DEVELOPMENT, V130, P2317, DOI 10.1242/dev.00451; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Ota KG, 2006, ZOOL SCI, V23, P403, DOI 10.2108/zsj.23.403; Shu DG, 2003, NATURE, V421, P526, DOI 10.1038/nature01264; Takezaki N, 2003, MOL BIOL EVOL, V20, P287, DOI 10.1093/molbev/msg040; WICHT H, 1995, PHILOS T ROY SOC B, V349, P119, DOI 10.1098/rstb.1995.0098; Wicht H, 1998, BIOLOGY OF HAGFISHES, P431	30	156	163	3	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2007	446	7136					672	675		10.1038/nature05633	http://dx.doi.org/10.1038/nature05633			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17377535				2022-12-28	WOS:000245438300041
J	Bonell, C; Fletcher, A; McCambridge, J				Bonell, C.; Fletcher, A.; McCambridge, J.			Improving school ethos may reduce substance misuse and teenage pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED-TRIAL; RISK		Univ London London Sch Hyg & Trop Med, Ctr Res Drugs & Hlth Behav, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Bonell, C (corresponding author), Univ London London Sch Hyg & Trop Med, Ctr Res Drugs & Hlth Behav, Keppel St, London WC1E 7HT, England.	chris.bonell@lshtm.ac.uk						Bond L, 2004, J EPIDEMIOL COMMUN H, V58, P997, DOI 10.1136/jech.2003.009449; Bonell C, 2005, J EPIDEMIOL COMMUN H, V59, P223, DOI 10.1136/jech.2004.023374; BOREHAM R, 2004, DRUG USE SMOKING DRI; DiCenso A, 2002, BMJ-BRIT MED J, V324, P1426, DOI 10.1136/bmj.324.7351.1426; Faggiano F, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003020.pub2; Flay BR, 2004, ARCH PEDIAT ADOL MED, V158, P377, DOI 10.1001/archpedi.158.4.377; FOXCROFT DR, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003024; *OFF NAT STAT, 2005, HLTH STAT Q, V26, P58; Patton GC, 2006, AM J PUBLIC HEALTH, V96, P1582, DOI 10.2105/AJPH.2004.047399; Thomas R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001293.pub2; United Nations Population Division, 2002, WORLD URB PROSP 2001; West P, 2004, RES PAP EDUC, V19, P261, DOI DOI 10.1080/02671522.2004.10058645	12	49	49	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2007	334	7594					614	616		10.1136/bmj.39139.414005.AD	http://dx.doi.org/10.1136/bmj.39139.414005.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	152DC	17379908	Green Accepted, Green Published			2022-12-28	WOS:000245340000033
J	Camm, AJ; Savelieva, I				Camm, A. John; Savelieva, Irina			Some patients with paroxysmal atrial fibrillation should carry flecainide or propafenone to self treat	BRITISH MEDICAL JOURNAL			English	Article									Univ London, St Georges, Div Cardiac & Vasc Sci, London SW17 0RE, England	St Georges University London; University of London	Camm, AJ (corresponding author), Univ London, St Georges, Div Cardiac & Vasc Sci, London SW17 0RE, England.	jcamm@sgul.ac.uk							0	7	8	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 24	2007	334	7594					637	637		10.1136/bmj.39143.720602.BE	http://dx.doi.org/10.1136/bmj.39143.720602.BE			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	152DC	17379911	Green Published			2022-12-28	WOS:000245340000039
J	Melcak, I; Hoelz, A; Blobel, G				Melcak, Ivo; Hoelz, Andre; Blobel, Guenter			Structure of Nup58/45 suggests flexible nuclear pore diameter by intermolecular sliding	SCIENCE			English	Article							IMPORTIN-BETA; P62 COMPLEX; FG REPEAT; EXPORT; TRANSPORT; PROTEINS; CONFIGURATIONS; VISUALIZATION; GLYCOPROTEINS; NUCLEOPORINS	The nucleoporins Nup58 and Nup45 are part of the central transport channel of the nuclear pore complex, which is thought to have a flexible diameter. In the crystal structure of an alpha-helical region of mammalian Nup58/45, we identified distinct tetramers, each consisting of two antiparallel hairpin dimers. The intradimeric interface is hydrophobic, whereas dimer-dimer association occurs through large hydrophilic residues. These residues are laterally displaced in various tetramer conformations, which suggests an intermolecular sliding by 11 angstroms. We propose that circumferential sliding plays a role in adjusting the diameter of the central transport channel.	Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Hoelz, A (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, 1230 York Ave, New York, NY 10021 USA.	hoelza@rockefeller.edu; blobel@rockefeller.edu	Hoelz, Andre/AAB-6978-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111461] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM111461] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKEY CW, 1989, J CELL BIOL, V109, P971, DOI 10.1083/jcb.109.3.971; AKEY CW, 1990, BIOPHYS J, V58, P341, DOI 10.1016/S0006-3495(90)82381-X; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Bernad R, 2006, J BIOL CHEM, V281, P19378, DOI 10.1074/jbc.M512585200; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; GUAN TL, 1995, MOL BIOL CELL, V6, P1591, DOI 10.1091/mbc.6.11.1591; Hu TH, 1998, GENE, V221, P245, DOI 10.1016/S0378-1119(98)00467-3; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; Hurt E, 1999, J CELL BIOL, V144, P389, DOI 10.1083/jcb.144.3.389; HURT EC, 1988, EMBO J, V7, P4323, DOI 10.1002/j.1460-2075.1988.tb03331.x; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Kiseleva E, 1996, J MOL BIOL, V260, P304, DOI 10.1006/jmbi.1996.0401; Kiseleva E, 1998, J CELL SCI, V111, P223; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; REICHELT R, 1990, J CELL BIOL, V110, pB83; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Slutsky M, 2004, BIOPHYS J, V87, P4021, DOI 10.1529/biophysj.104.050765; STOFFTER D, 2003, J MOL BIOL, V32, P119; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; WENTE SR, 1992, J CELL BIOL, V119, P705, DOI 10.1083/jcb.119.4.705	28	94	95	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1729	1732		10.1126/science.1135730	http://dx.doi.org/10.1126/science.1135730			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379812				2022-12-28	WOS:000245106900045
J	Toomey, DR; Jousselin, D; Dunn, RA; Wilcock, WSD; Detrick, RS				Toomey, Douglas R.; Jousselin, David; Dunn, Robert A.; Wilcock, William S. D.; Detrick, R. S.			Skew of mantle upwelling beneath the East Pacific Rise governs segmentation	NATURE			English	Article							MELT SUPPLY BENEATH; SPREADING CENTER; CRUSTAL STRUCTURE; MIDOCEAN RIDGE; OCEANIC-CRUST; MAGMA CHAMBER; 9-DEGREES-10-DEGREES-N; DISCONTINUITIES; CLIPPERTON; EVOLUTION	Mantle upwelling is essential to the generation of new oceanic crust at mid-ocean ridges, and it is generally assumed that such upwelling is symmetric beneath active ridges. Here, however, we use seismic imaging to show that the isotropic and anisotropic structure of the mantle is rotated beneath the East Pacific Rise. The isotropic structure defines the pattern of magma delivery from the mantle to the crust. We find that the segmentation of the rise crest between transform faults correlates well with the distribution of mantle melt. The azimuth of seismic anisotropy constrains the direction of mantle flow, which is rotated nearly 10 degrees anticlockwise from the plate-spreading direction. The mismatch between the locus of mantle melt delivery and the morphologic ridge axis results in systematic differences between areas of on-axis and off-axis melt supply. We conclude that the skew of asthenospheric upwelling and transport governs segmentation of the East Pacific Rise and variations in the intensity of ridge crest processes.	Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA; Nancy Univ, CRPG, F-54501 Vandoeuvre Les Nancy, France; Univ Hawaii, SOEST, Dept Geol & Geophys, Honolulu, HI 96822 USA; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	University of Oregon; Universite de Lorraine; University of Hawaii System; University of Washington; University of Washington Seattle; Woods Hole Oceanographic Institution	Toomey, DR (corresponding author), Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA.	drt@uoregon.edu	Dunn, Robert A/L-9892-2014	Dunn, Robert A/0000-0003-1434-5512; Toomey, Douglas/0000-0003-2873-4084; Wilcock, William/0000-0001-7224-7246				Barth GA, 1996, J GEOPHYS RES-SOL EA, V101, P17951, DOI 10.1029/96JB00814; BATIZA R, 1992, J GEOPHYS RES-SOL EA, V97, P6779, DOI 10.1029/92JB00172; BELL RE, 1992, NATURE, V357, P583, DOI 10.1038/357583a0; Ben Ismail W, 1998, TECTONOPHYSICS, V296, P145; Blackman DK, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000248; Canales JP, 2003, GEOPHYS J INT, V152, P766, DOI 10.1046/j.1365-246X.2003.01885.x; CARBOTTE S, 1992, J GEOPHYS RES-SOL EA, V97, P6959, DOI 10.1029/91JB03065; Crawford WC, 2002, EARTH PLANET SC LETT, V203, P117, DOI 10.1016/S0012-821X(02)00831-2; DETRICK RS, 1987, NATURE, V326, P35, DOI 10.1038/326035a0; Dunn RA, 1997, NATURE, V388, P259, DOI 10.1038/40831; Dunn RA, 2001, SCIENCE, V291, P1955, DOI 10.1126/science.1057683; Dunn RA, 2000, J GEOPHYS RES-SOL EA, V105, P23537, DOI 10.1029/2000JB900210; FAUL UH, 1994, GEOPHYS RES LETT, V21, P29, DOI 10.1029/93GL03051; Fornari DJ, 1998, J GEOPHYS RES-SOL EA, V103, P9827, DOI 10.1029/98JB00028; Gripp AE, 2002, GEOPHYS J INT, V150, P321, DOI 10.1046/j.1365-246X.2002.01627.x; Hammond WC, 2000, J GEOPHYS RES-SOL EA, V105, P10987, DOI 10.1029/2000JB900042; HAYMON RM, 1991, EARTH PLANET SC LETT, V104, P513, DOI 10.1016/0012-821X(91)90226-8; Jousselin D, 1998, J GEOPHYS RES-SOL EA, V103, P18153, DOI 10.1029/98JB01493; Kent GM, 2000, NATURE, V406, P614, DOI 10.1038/35020543; KENT GM, 1993, J GEOPHYS RES-SOL EA, V98, P13945, DOI 10.1029/93JB00705; KEY K, 2006, EOS S, V87; LANGMUIR CH, 1986, NATURE, V322, P422, DOI 10.1038/322422a0; LONSDALE P, 1989, J GEOPHYS RES-SOLID, V94, P12197, DOI 10.1029/JB094iB09p12197; MACDONALD KC, 1991, SCIENCE, V253, P986, DOI 10.1126/science.253.5023.986; MACDONALD KC, 1988, NATURE, V335, P217, DOI 10.1038/335217a0; NICOLAS A, 1989, STRUCTURES OPHIOLITE, P70; Nicolas A., 1987, FORMATION ANISOTROPY, DOI DOI 10.1029/GD016P0111; PARMENTIER EM, 1990, NATURE, V348, P325, DOI 10.1038/348325a0; PERFIT MR, 1994, GEOLOGY, V22, P375, DOI 10.1130/0091-7613(1994)022<0375:SSSATV>2.3.CO;2; Pockalny RA, 1997, J GEOPHYS RES-SOL EA, V102, P3167, DOI 10.1029/96JB03391; Richards MA, 1996, EARTH PLANET SC LETT, V137, P19, DOI 10.1016/0012-821X(95)00209-U; SCHEIRER DS, 1993, J GEOPHYS RES-SOL EA, V98, P7871, DOI 10.1029/93JB00015; SCHOUTEN H, 1985, NATURE, V317, P225, DOI 10.1038/317225a0; SEMPERE JC, 1986, TECTONICS, V5, P881, DOI 10.1029/TC005i006p00881; Singh SC, 2006, NATURE, V442, P287, DOI 10.1038/nature04939; Smith MC, 2001, GEOCHEM GEOPHY GEOSY, V2; Soule SA, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000912; Tian T, 2000, GEOPHYS RES LETT, V27, P2369, DOI 10.1029/1999GL011191; TOOMEY DR, 1990, NATURE, V347, P639, DOI 10.1038/347639a0; TOOMEY DR, 1994, J GEOPHYS RES-SOL EA, V99, P24135, DOI 10.1029/94JB01942; VERA EE, 1990, J GEOPHYS RES-SOLID, V95, P15529, DOI 10.1029/JB095iB10p15529; Von Damm KL, 2000, J GEOPHYS RES-SOL EA, V105, P11203, DOI 10.1029/1999JB900414; White SM, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000571; WHITEHEAD JA, 1984, NATURE, V312, P146, DOI 10.1038/312146a0; WRIGHT DJ, 1995, J GEOPHYS RES-SOL EA, V100, P6097, DOI 10.1029/94JB02876	45	91	92	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					409	414		10.1038/nature05679	http://dx.doi.org/10.1038/nature05679			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17377578	Green Submitted			2022-12-28	WOS:000245079500033
J	Muller-Wille, S				Mueller-Wille, Staffan			Plant taxonomy - The love of plants - Carl Linnaeus's use of erotic language to describe plants ultimately helped him to recruit a global network of specimen collectors.	NATURE			English	Editorial Material									Univ Exeter, ESRC Ctr Genom Soc, Exeter EX4 4PJ, Devon, England	UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of Exeter	Muller-Wille, S (corresponding author), Univ Exeter, ESRC Ctr Genom Soc, Exeter EX4 4PJ, Devon, England.							Blunt W., 2004, LINNAEUS COMPLEAT NA, V1st ed; KOERNER L, 1999, LINNAEUS NATURE NATI; *NAT HIST MUS, LINN PLANT NAM TYP P	3	1	2	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					268	268		10.1038/446268a	http://dx.doi.org/10.1038/446268a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361166	Bronze			2022-12-28	WOS:000244892900028
J	Luft, HS				Luft, Harold S.			Universal health care coverage - A potential hybrid solution	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INSURANCE-COVERAGE; ENROLLMENT; LIFE		Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94118 USA	University of California System; University of California San Francisco	Luft, HS (corresponding author), Univ Calif San Francisco, Inst Hlth Policy Studies, 3333 Calif St,Suite 265, San Francisco, CA 94118 USA.	hal.luft@ucsf.edu						Balla SJ, 1998, AM POLIT SCI REV, V92, P663, DOI 10.2307/2585488; Chernew M, 2005, HEALTH SERV RES, V40, P1021, DOI 10.1111/j.1475-6773.2005.00409.x; CONWELL LJ, 2005, 73 AG HEALTHC RES QU; Cooper PF, 1997, HEALTH AFFAIR, V16, P142, DOI 10.1377/hlthaff.16.6.142; Cotter D, 2006, HEALTH AFFAIR, V25, P1249, DOI 10.1377/hlthaff.25.5.1249; DENAVASWALT C, 2006, P60231 US CENS BUR; Farber HS, 2000, J HEALTH ECON, V19, P93, DOI 10.1016/S0167-6296(99)00027-2; Foote SB, 2002, J HEALTH POLIT POLIC, V27, P707, DOI 10.1215/03616878-27-5-707; FUCHS VR, 1996, AM ECON REV, V86, P124; Gabel JR, 2001, HEALTH AFFAIR, V20, P196, DOI 10.1377/hlthaff.20.4.196; Goodman DC, 2006, HEALTH AFFAIR, V25, P521, DOI 10.1377/hlthaff.25.2.521; MACHLIN SR, 2006, 126 AG HLTH CAR RES; *MEDPAC, 2006, DAT BOOK HEALTHC SPE; Polsky D, 2005, HEALTH SERV RES, V40, P1259, DOI 10.1111/j.1475-6773.2005.00415.x; Selden TM, 2006, HEALTH AFFAIR, V25, P1568, DOI 10.1377/hlthaff.25.6.1568; Shen YC, 2006, HEALTH SERV RES, V41, P2074, DOI 10.1111/j.1475-6773.2006.00590.x; Wennberg JE, 2004, BMJ-BRIT MED J, V328, P607, DOI 10.1136/bmj.328.7440.607; WENNBERG JE, 2004, HLTH AFF MILLWO 1007; WENNBERG JE, 2002, HLTH AFF MILLWO 0213; World Health Organization, 2000, WORLD HLTH REP 2000	20	8	8	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2007	297	10					1115	1118		10.1001/jama.297.10.1115	http://dx.doi.org/10.1001/jama.297.10.1115			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	145KZ	17356033				2022-12-28	WOS:000244865200026
J	Yanofsky, C				Yanofsky, Charles			Establishing the triplet nature of the genetic code	CELL			English	Article							FINE STRUCTURE; PROTEINS	In 1961, Crick, Barnett, Brenner, and Watts-Tobin (Crick et al., 1961) designed an elegant experimental strategy to determine the nature of the genetic code. Remarkably, they reached the correct conclusion despite the absence of technology to analyze and compare DNA and protein sequences.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Yanofsky, C (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	yanofsky@cmgm.stanford.edu						Beadle GW, 1941, P NATL ACAD SCI USA, V27, P499, DOI 10.1073/pnas.27.11.499; BECKWITH J, 1999, MICROBIOLOGY CENTENA, P384; BENZER S, 1959, P NATL ACAD SCI USA, V45, P1607, DOI 10.1073/pnas.45.11.1607; BENZER S, 1960, GENETICS, V47, P403; BRENNER S, 1958, NATURE, V182, P983, DOI 10.1038/182983a0; BRENNER S, 1961, J MOL BIOL, V3, P121, DOI 10.1016/S0022-2836(61)80015-6; BRENNER S, 1957, P NATL ACAD SCI USA, V43, P687, DOI 10.1073/pnas.43.8.687; CRICK F H, 1958, Symp Soc Exp Biol, V12, P138; CRICK FH, 1961, NATURE, V192, P1227, DOI 10.1038/1921227a0; CRICK FHC, 1957, P NATL ACAD SCI USA, V43, P416, DOI 10.1073/pnas.43.5.416; INGRAM VM, 1958, BIOCHIM BIOPHYS ACTA, V28, P539, DOI 10.1016/0006-3002(58)90516-X; MILLER JH, 1996, DISCOVERING MOL GENE; NIRENBERG M, 1961, P NATL ACAD SCI USA, V47, P1588, DOI 10.1073/pnas.47.10.1588; Ridley M., 2006, F CRICK DISCOVERER G; SANGER F, 1951, BIOCHEM J, V49, P481, DOI 10.1042/bj0490481	15	36	37	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					815	818		10.1016/j.cell.2007.02.029	http://dx.doi.org/10.1016/j.cell.2007.02.029			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350564	Bronze			2022-12-28	WOS:000245073400002
J	Abbott, A				Abbott, Alison			A place in the sun	NATURE			English	News Item								Novartis has declared it's intention to become he world leader in vaccines since it took over Chiron and continued with it's vaccine research. Now Novartis aims to double last years sales by 2011. The business today has half-a-dozen vaccines in late-stage clinical trials for diseases such as meningitis and influenza.											0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					124	125		10.1038/446124a	http://dx.doi.org/10.1038/446124a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344823	Bronze			2022-12-28	WOS:000244718100010
J	Savaldi-Goldstein, S; Peto, C; Chory, J				Savaldi-Goldstein, Sigal; Peto, Charles; Chory, Joanne			The epidermis both drives and restricts plant shoot growth	NATURE			English	Article							ARABIDOPSIS-THALIANA; BRASSINOSTEROID BIOSYNTHESIS; STEM ELONGATION; LEAF-SHAPE; GENE; EXPRESSION; CYTOCHROME-P450; CELLS; WALL	The size of an organism is genetically determined, yet how a plant or animal achieves its final size is largely unknown. The shoot of higher plants has a simple conserved body plan based on three major tissue systems: the epidermal (L1), sub-epidermal (L2) and inner ground and vascular (L3) tissues. Which tissue system drives or restricts growth has been a subject of debate for over a century(1-4). Here, we use dwarf, brassinosteroid biosynthesis and brassinosteroid response mutants in conjunction with tissue-specific expression of these components as tools to examine the role of the epidermis in shoot growth. We show that expression of the brassinosteroid receptor or a brassinosteroid biosynthetic enzyme in the epidermis, but not in the vasculature, of null mutants is sufficient to rescue their dwarf phenotypes. Brassinosteroid signalling from the epidermis is not sufficient to establish normal vascular organization. Moreover, shoot growth is restricted when brassinosteroids are depleted from the epidermis and brassinosteroids act locally within a leaf. We conclude that the epidermis both promotes and restricts shoot growth by providing a nonautonomous signal to the ground tissues.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Neuronal Struct & Funct Lab, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	chory@salk.edu						Baima S, 1995, DEVELOPMENT, V121, P4171; Bishop GJ, 1996, PLANT CELL, V8, P959, DOI 10.1105/tpc.8.6.959; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Choe SW, 1999, PLANT CELL, V11, P207, DOI 10.1105/tpc.11.2.207; DALE JE, 1988, ANNU REV PLANT PHYS, V39, P267, DOI 10.1146/annurev.arplant.39.1.267; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Gallagher KL, 2005, GENE DEV, V19, P189, DOI 10.1101/gad.1271005; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; GREEN PB, 1994, J EXP BOT, V45, P1775, DOI 10.1093/jxb/45.Special_Issue.1775; Kurata T, 2005, CURR OPIN PLANT BIOL, V8, P600, DOI 10.1016/j.pbi.2005.09.005; Kutschera U, 2001, PLANT BIOLOGY, V3, P466, DOI 10.1055/s-2001-17731; Nakamura S, 2003, REC RES DEV MAGNET M, V1, P1; Nakaya M, 2002, PLANT CELL PHYSIOL, V43, P239, DOI 10.1093/pcp/pcf024; Neff MM, 1999, P NATL ACAD SCI USA, V96, P15316, DOI 10.1073/pnas.96.26.15316; Peters WS, 1996, BOT ACTA, V109, P264, DOI 10.1111/j.1438-8677.1996.tb00572.x; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; Sessions A, 1999, PLANT J, V20, P259, DOI 10.1046/j.1365-313x.1999.00594.x; Symons GM, 2004, PLANT PHYSIOL, V135, P2196, DOI 10.1104/pp.104.043034; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Tsukaya H, 2006, ANNU REV PLANT BIOL, V57, P477, DOI 10.1146/annurev.arplant.57.032905.105320; Turk EM, 2003, PLANT PHYSIOL, V133, P1643, DOI 10.1104/pp.103.030882; Turner S, 2003, ARABIDOPSIS BOOK, pe0073, DOI 10.1199/tab.0073; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	26	309	321	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					199	202		10.1038/nature05618	http://dx.doi.org/10.1038/nature05618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344852				2022-12-28	WOS:000244718100043
J	Mann, CC				Mann, Charles C.			Archaeology - Mystery towers in Peru are an ancient solar calendar	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1206	1207		10.1126/science.315.5816.1206a	http://dx.doi.org/10.1126/science.315.5816.1206a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332383				2022-12-28	WOS:000244564700005
J	Hawkes, N				Hawkes, Nigel			Time to face up to "scandal" of funding formula - The government is in denial about the effects of funding inequities on primary care trust deficits	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes@thetimes.co.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 24	2007	334	7590					395	395		10.1136/bmj.39129.718067.59	http://dx.doi.org/10.1136/bmj.39129.718067.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	142MQ	17322251	Green Published			2022-12-28	WOS:000244654400024
J	Surani, MA; Hayashi, K; Hajkova, P				Surani, M. Azim; Hayashi, Katsuhiko; Hajkova, Petra			Genetic and epigenetic regulators of pluripotency	CELL			English	Review							PRIMORDIAL GERM-CELLS; HISTONE ARGININE METHYLATION; X-CHROMOSOME; STEM-CELLS; DNA METHYLTRANSFERASES; MOUSE DEVELOPMENT; NONCODING RNA; SELF-RENEWAL; ES CELLS; CHROMATIN		Univ Cambridge, Wellcome Trust Canc Res UK, Gurdon Inst, Cambridge CB2 1QN, England	Cancer Research UK; University of Cambridge	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	as10021@mole.bio.cam.ac.uk	Hu, Ruogu/B-2203-2008	Hajkova, Petra/0000-0003-4145-1468; Surani, Azim/0000-0002-8640-4318	Medical Research Council [G0300723B] Funding Source: researchfish; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)		Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Anne J, 2007, DEVELOPMENT, V134, P137, DOI 10.1242/dev.02687; Arney KL, 2001, INT J DEV BIOL, V45, P533; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bao SQ, 2005, EMBO REP, V6, P748, DOI 10.1038/sj.embor.7400461; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; De la Fuente R, 2006, NAT CELL BIOL, V8, P1448, DOI 10.1038/ncb1513; Deshpande G, 2004, DEVELOPMENT, V131, P1247, DOI 10.1242/dev.01004; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Durcova-Hills G, 2006, STEM CELLS, V24, P1441, DOI 10.1634/stemcells.2005-0424; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Geiman TM, 2000, P NATL ACAD SCI USA, V97, P4772, DOI 10.1073/pnas.97.9.4772; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hata K, 2002, DEVELOPMENT, V129, P1983; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Houlard M, 2006, PLOS GENET, V2, P1686, DOI 10.1371/journal.pgen.0020181; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kanatsu-Shinohara M, 2005, DEVELOPMENT, V132, P4155, DOI 10.1242/dev.02004; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Kishigami S, 2007, J REPROD DEVELOP, V53, P165, DOI 10.1262/jrd.18098; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Lepikhov Konstantin, 2004, BMC Developmental Biology, V4, P1; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Martinho RG, 2004, CURR BIOL, V14, P159, DOI 10.1016/j.cub.2003.12.036; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Maurange C, 2006, CURR OPIN GENET DEV, V16, P485, DOI 10.1016/j.gde.2006.08.007; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakamura A, 1996, SCIENCE, V274, P2075, DOI 10.1126/science.274.5295.2075; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rathjen J, 1999, J CELL SCI, V112, P601; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Richardson RT, 2006, J BIOL CHEM, V281, P21526, DOI 10.1074/jbc.M603816200; Roberts C, 2002, MOL CELL BIOL, V22, P2318, DOI 10.1128/MCB.22.7.2318-2328.2002; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Schaner CE, 2003, DEV CELL, V5, P747, DOI 10.1016/S1534-5807(03)00327-7; Schumacher A, 1996, NATURE, V383, P250, DOI 10.1038/383250a0; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Solter D, 2004, COLD SPRING HARB SYM, V69, P11, DOI 10.1101/sqb.2004.69.11; Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104; Surani MA, 2004, COLD SPRING HARB SYM, V69, P1, DOI 10.1101/sqb.2004.69.40; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAM PPL, 1994, DEVELOPMENT, V120, P2925; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Torres-Padilla ME, 2006, INT J DEV BIOL, V50, P455, DOI 10.1387/ijdb.052073mt; van der Heijden GW, 2005, MECH DEVELOP, V122, P1008, DOI 10.1016/j.mod.2005.04.009; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yagi H, 1998, BLOOD, V92, P108, DOI 10.1182/blood.V92.1.108.413k11_108_117; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yeo S, 2005, MOL CELLS, V20, P423; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zernicka-Goetz MZ, 2005, NAT REV MOL CELL BIO, V6, P919, DOI 10.1038/nrm1782	109	482	510	2	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2007	128	4					747	762		10.1016/j.cell.2007.02.010	http://dx.doi.org/10.1016/j.cell.2007.02.010			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148TX	17320511	Bronze			2022-12-28	WOS:000245098600016
J	Veiga-Fernandes, H; Coles, MC; Foster, KE; Patel, A; Williams, A; Natarajan, D; Barlow, A; Pachnis, V; Kioussis, D				Veiga-Fernandes, Henrique; Coles, Mark C.; Foster, Katie E.; Patel, Amisha; Williams, Adam; Natarajan, Dipa; Barlow, Amanda; Pachnis, Vassilis; Kioussis, Dimitris			Tyrosine kinase receptor RET is a key regulator of Peyer's Patch organogenesis	NATURE			English	Article							PERIPHERAL LYMPHOID ORGANS; BETA-DEFICIENT MICE; ABNORMAL-DEVELOPMENT; LYMPHOTOXIN-ALPHA; NERVOUS-SYSTEM; LACKING GDNF; T-CELLS; EXPRESSION; DEFECTS; TISSUES	Normal organogenesis requires co-ordinate development and interaction of multiple cell types, and is seemingly governed by tissue specific factors. Lymphoid organogenesis during embryonic life is dependent on molecules the temporal expression of which is tightly regulated. During this process, haematopoietic 'inducer' cells interact with stromal 'organizer' cells, giving rise to the lymphoid organ primordia(1). Here we show that the haematopoietic cells in the gut exhibit a random pattern of motility before aggregation into the primordia of Peyer's patches, a major component of the gut-associated lymphoid tissue. We further show that a CD45(+)CD4(-)CD3(-)Il7R alpha(-) c-Kit(+) CD11c(+) haematopoietic population expressing lymphotoxin has an important role in the formation of Peyer's patches. A subset of these cells expresses the receptor tyrosine kinase RET, which is essential for mammalian enteric nervous system formation(2). We demonstrate that RET signalling is also crucial for Peyer's patch formation. Functional genetic analysis revealed that Gfra3-deficiency results in impairment of Peyer's patch development, suggesting that the signalling axis RET/GFR alpha 3/ARTN is involved in this process. To support this hypothesis, we show that the RET ligand ARTN is a strong attractant of gut haematopoietic cells, inducing the formation of ectopic Peyer's patch-like structures. Our work strongly suggests that the RET signalling pathway, by regulating the development of both the nervous and lymphoid system in the gut, has a key role in the molecular mechanisms that orchestrate intestine organogenesis.	Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England; Natl Inst Med Res, MRC, Div Mol Neurobiol, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Kioussis, D (corresponding author), Natl Inst Med Res, MRC, Div Mol Immunol, Ridgeway Mill Hill, London NW7 1AA, England.	dkiouss@nimr.mrc.ac.uk		Veiga-Fernandes, Henrique/0000-0001-6216-1836; Pachnis, Vassilis/0000-0001-9733-7686	Medical Research Council [MC_U117537087, MC_U117512796, G0601156] Funding Source: Medline; MRC [MC_U117537087, G0601156, MC_U117512796] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adachi S, 1997, INT IMMUNOL, V9, P507, DOI 10.1093/intimm/9.4.507; Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; BANKS TA, 1995, J IMMUNOL, V155, P1685; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Coles MC, 2006, P NATL ACAD SCI USA, V103, P13457, DOI 10.1073/pnas.0604183103; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; de Graaff E, 2001, GENE DEV, V15, P2433, DOI 10.1101/gad.205001; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Hashi H, 2001, J IMMUNOL, V166, P3702, DOI 10.4049/jimmunol.166.6.3702; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Nishino J, 1999, NEURON, V23, P725, DOI 10.1016/S0896-6273(01)80031-3; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Vargas-Leal V, 2005, J IMMUNOL, V175, P2301, DOI 10.4049/jimmunol.175.4.2301; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643	33	202	209	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					547	551		10.1038/nature05597	http://dx.doi.org/10.1038/nature05597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17322904				2022-12-28	WOS:000245242900051
J	Baran, PS; Maimone, TJ; Richter, JM				Baran, Phil S.; Maimone, Thomas J.; Richter, Jeremy M.			Total synthesis of marine natural products without using protecting groups	NATURE			English	Article							ENANTIOSELECTIVE SYNTHESIS; HAPALOSIPHON-FONTINALIS; CARBONYL-COMPOUNDS; ORGANIC-SYNTHESIS; ALKALOIDS; HAPALINDOLES; PALLADIUM; INDOLES; CYCLIZATION; DISCOVERY	The field of organic synthesis has made phenomenal advances in the past fifty years, yet chemists still struggle to design synthetic routes that will enable them to obtain sufficient quantities of complex molecules for biological and medical studies. Total synthesis is therefore increasingly focused on preparing natural products in the most efficient manner possible. Here we describe the preparative-scale, enantioselective, total syntheses of members of the hapalindole, fischerindole, welwitindolinone and ambiguine families, each constructed without the need for protecting groups - the use of such groups adds considerably to the cost and complexity of syntheses. As a consequence, molecules that have previously required twenty or more steps to synthesize racemically in milligram amounts can now be obtained as single enantiomers in significant quantities in ten steps or less. Through the extension of the general principles demonstrated here, it should be possible to access other complex molecular architectures without using protecting groups.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pbaran@scripps.edu						Baran PS, 2006, J AM CHEM SOC, V128, P14028, DOI 10.1021/ja0659673; Baran PS, 2005, J AM CHEM SOC, V127, P15394, DOI 10.1021/ja056171r; Baran PS, 2005, ANGEW CHEM INT EDIT, V44, P609, DOI 10.1002/anie.200462048; Baran PS, 2004, J AM CHEM SOC, V126, P7450, DOI 10.1021/ja047874w; BERTZ SH, 1982, J AM CHEM SOC, V104, P5801, DOI 10.1021/ja00385a049; BURNS B, 1988, TETRAHEDRON LETT, V29, P4329, DOI 10.1016/S0040-4039(00)80489-X; Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y; Corey E.J., 1995, LOGIC CHEM SYNTHESIS; D?rwald F.Z., 2005, SIDE REACTIONS ORGAN; ESCHENMOSER A, 1988, ANGEW CHEM INT EDIT, V27, P5, DOI 10.1002/anie.198800051; EVANS DA, 2004, SYNTHESIS DESIGN OXI; Faber K, 2018, BIOTRANSFORMATIONS O, P134, DOI 10.1007/978-3-319-61590-5; Green T. W., 1999, PROTECTIVE GROUPS OR, V3rd; HEATHCOCK CH, 1992, ANGEW CHEM INT EDIT, V31, P665, DOI 10.1002/anie.199206653; HENDRICKSON JB, 1975, J AM CHEM SOC, V97, P5784, DOI 10.1021/ja00853a023; HERRMANN WA, 1995, ANGEW CHEM INT EDIT, V34, P1844, DOI 10.1002/anie.199518441; Hoffmann RW, 2006, SYNTHESIS-STUTTGART, P3531, DOI 10.1055/s-2006-950311; HOVEYDA AH, 1993, CHEM REV, V93, P1307, DOI 10.1021/cr00020a002; Hudlicky T, 1996, CHEM REV, V96, P3, DOI 10.1021/cr950012g; Kocienski P. J, 2005, PROTECTING GROUPS; LAROCK RC, 1987, TETRAHEDRON LETT, V28, P5291, DOI 10.1016/S0040-4039(00)96710-8; MEHTA G, 1994, J CHEM SOC CHEM COMM, P2759, DOI 10.1039/c39940002759; MOORE RE, 1984, J AM CHEM SOC, V106, P6456, DOI 10.1021/ja00333a079; MOORE RE, 1987, J ORG CHEM, V52, P1036, DOI 10.1021/jo00382a012; MURATAKE H, 1990, TETRAHEDRON, V46, P6351, DOI 10.1016/S0040-4020(01)96007-7; Nicolaou K., 2003, CLASSICS TOTAL SYNTH, VII; Nicolaou KC, 2006, ANGEW CHEM INT EDIT, V45, P7134, DOI 10.1002/anie.200601872; Nicolaou K.C., 1996, CLASSICS TOTAL SYNTH; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P4442, DOI 10.1002/anie.200500368; Nicolaou KC, 2004, P NATL ACAD SCI USA, V101, P11929, DOI 10.1073/pnas.0403799101; OIKAWA Y, 1977, J ORG CHEM, V42, P1213, DOI 10.1021/jo00427a024; Raveh A, 2007, J NAT PROD, V70, P196, DOI 10.1021/np060495r; Reisman SE, 2006, J AM CHEM SOC, V128, P1448, DOI 10.1021/ja057640s; Schkeryantz JM, 1999, J AM CHEM SOC, V121, P11964, DOI 10.1021/ja9925249; Scholz U, 2000, NAT PROD REP, V17, P349, DOI 10.1039/a902278c; SEEBACH D, 1990, ANGEW CHEM INT EDIT, V29, P1320, DOI 10.1002/anie.199013201; Service RF, 1999, SCIENCE, V285, P184, DOI 10.1126/science.285.5425.184; SHELLHAMER DF, 1991, J CHEM SOC PERK T 2, P401, DOI 10.1039/p29910000401; Sierra M. A., 2004, DEAD ENDS DETOURS DI; SMITKA TA, 1992, J ORG CHEM, V57, P857, DOI 10.1021/jo00029a014; STRATMANN K, 1994, J AM CHEM SOC, V116, P9935, DOI 10.1021/ja00101a015; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; Turro N. J., 1991, MODERN MOL PHOTOCHEM; Vanderwal CD, 2003, J AM CHEM SOC, V125, P5393, DOI 10.1021/ja021472b; Wender P. A., 1993, ORGANIC SYNTHESIS TH, P27; Wender PA, 1996, CHEM REV, V96, P1, DOI 10.1021/cr9500803; Wilson RM, 2006, J ORG CHEM, V71, P8329, DOI 10.1021/jo0610053; Wohler F., 1828, ANN PHYS CHEM, V88, P253, DOI DOI 10.1002/ANDP.18280880206	48	377	391	6	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2007	446	7134					404	408		10.1038/nature05569	http://dx.doi.org/10.1038/nature05569			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	148MO	17377577				2022-12-28	WOS:000245079500032
J	Kaasalainen, M; Durech, J; Warner, BD; Krugly, YN; Gaftonyuk, NM				Kaasalainen, Mikko; Durech, Josef; Warner, Brian D.; Krugly, Yurij N.; Gaftonyuk, Ninel M.			Acceleration of the rotation of asteroid 1862 Apollo by radiation torques	NATURE			English	Article							SPIN-STATE; YARKOVSKY	The anisotropic reflection and thermal re-emission of sunlight from an asteroid's surface acts as a propulsion engine. The net propulsion force (Yarkovsky effect) changes the orbital dynamics of the body at a rate that depends on its physical properties; for irregularly shaped bodies, the propulsion causes a net torque (the Yarkovsky-O'Keefe-Radzievskii-Paddack or YORP effect) that can change the object's rotation period and the direction of its rotation axis(1,2). The Yarkovsky effect has been observed directly 3, and there is also indirect evidence of its role in the orbital evolution of asteroids over long time intervals(4-6). So far, however, only indirect evidence exists for the YORP effect through the clustering of the directions of rotation axes in asteroid families(6-8). Here we report a change in the rotation rate of the asteroid 1862 Apollo, which is best explained by the YORP mechanism. The change is fairly large and clearly visible in photometric lightcurves, amounting to one extra rotation cycle in just 40 years even though Apollo's size is well over one kilometre. This confirms the prediction that the YORP effect plays a significant part in the dynamical evolution of asteroids.	Univ Helsinki, Rolf Nevanlinna Inst, Dept Math & Stat, FI-00014 Helsinki, Finland; Charles Univ Prague, Astron Inst, Prague 18000, Czech Republic; Palmer Divide Observ, Colorado Springs, CO 80908 USA; Kharkov Natl Univ, Inst Astron, UA-61022 Kharkov, Ukraine; Crimean Astrophys Observ, UA-98680 Simeiz, Ukraine	University of Helsinki; Charles University Prague; Ministry of Education & Science of Ukraine; VN Karazin Kharkiv National University; Russian Academy of Sciences; Crimean Astrophysical Observatory	Kaasalainen, M (corresponding author), Univ Helsinki, Rolf Nevanlinna Inst, Dept Math & Stat, POB 68, FI-00014 Helsinki, Finland.	mikko.kaasalainen@helsinki.fi	Ďurech, Josef/C-5634-2017; Kaasalainen, Mikko/G-4236-2014; Krugly, Yurij/O-7164-2018	Ďurech, Josef/0000-0003-4914-3646; Krugly, Yurij/0000-0002-3171-9873				Binzel R. P., 2002, ASTEROIDS, VIII, P255; Bottke W. F., 2002, ASTEROIDS, P395; Bottke WF, 2001, SCIENCE, V294, P1693, DOI 10.1126/science.1066760; Bottke WF, 2006, ANNU REV EARTH PL SC, V34, P157, DOI 10.1146/annurev.earth.34.031405.125154; Britt D. T., 2002, ASTEROIDS 3, VIII, P485; Capek D, 2004, ICARUS, V172, P526, DOI 10.1016/j.icarus.2004.07.003; Chesley SR, 2003, SCIENCE, V302, P1739, DOI 10.1126/science.1091452; HARRIS AW, 1987, ICARUS, V70, P246, DOI 10.1016/0019-1035(87)90132-1; Harris AW, 1998, ICARUS, V131, P291, DOI 10.1006/icar.1997.5865; Kaasalainen M, 2001, ICARUS, V153, P37, DOI 10.1006/icar.2001.6674; Kaasalainen M., 2002, ASTEROIDS, VIII, P139; KAASALAINEN M, IN PRESS NEAR EARTH; Kaasalainen M, 2006, INVERSE PROBL, V22, P749, DOI 10.1088/0266-5611/22/3/002; Kaasalainen S, 2005, ASTRON ASTROPHYS, V440, P1177, DOI 10.1051/0004-6361:20053199; La Spina A, 2004, NATURE, V428, P400, DOI 10.1038/nature02411; LAGERKVIST CI, 2001, ASTEROID PHOTOMETRIC; Marchis F, 2006, ICARUS, V185, P39, DOI 10.1016/j.icarus.2006.06.001; Morbidelli A, 2003, ICARUS, V163, P120, DOI 10.1016/S0019-1035(03)00047-2; OSTRO SJ, 2006, 8627 IAU; Ostro SJ, 2006, SCIENCE, V314, P1276, DOI 10.1126/science.1133622; PADDACK SJ, 1969, J GEOPHYS RES, V74, P4379, DOI 10.1029/JB074i017p04379; Rubincam DP, 2000, ICARUS, V148, P2, DOI 10.1006/icar.2000.6485; Vokrouhlicky D, 2006, ICARUS, V184, P1, DOI 10.1016/j.icarus.2006.04.007; Vokrouhlicky D, 2006, ICARUS, V182, P118, DOI 10.1016/j.icarus.2005.12.010; Vokrouhlicky D, 2005, ICARUS, V175, P419, DOI 10.1016/j.icarus.2004.11.017; Vokrouhlicky D, 2004, ASTRON ASTROPHYS, V414, pL21, DOI 10.1051/0004-6361:20031739; Vokrouhlicky D, 2003, NATURE, V425, P147, DOI 10.1038/nature01948; Vokrouhlicky D, 2002, ICARUS, V159, P449, DOI 10.1006/icar.2002.6918	28	101	101	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					420	422		10.1038/nature05614	http://dx.doi.org/10.1038/nature05614			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17344861				2022-12-28	WOS:000245079500035
J	Heath, I; Nessa, J				Heath, Iona; Nessa, John			Objectification of physicians and loss of therapeutic power	LANCET			English	Editorial Material									Caversham Grp Practice, London NW5 2UP, England; Univ Bergen, Inst Gen Practice, Bergen, Norway	University of Bergen	Heath, I (corresponding author), Caversham Grp Practice, London NW5 2UP, England.	iona.heath@dsl.pipex.com						Ainsworth-Vaughn N, 1998, CLAIMING POWER DOCTO; BRANTHWAITE A, 1981, BRIT MED J, V282, P1576, DOI 10.1136/bmj.282.6276.1576; deCraen AJM, 1996, BRIT MED J, V313, P1624, DOI 10.1136/bmj.313.7072.1624; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; DOWRICK C, 2005, DEPRESSION; Ekeland Tor-Johan., 1997, INT J PSYCHOTHERAPY, V2, P77; Fleshner Monika, 2004, Behav Cogn Neurosci Rev, V3, P114, DOI 10.1177/1534582304269027; Kiecolt-Glaser JK, 2002, ANNU REV PSYCHOL, V53, P83, DOI 10.1146/annurev.psych.53.100901.135217; Krupnick JL, 1996, J CONSULT CLIN PSYCH, V64, P532, DOI 10.1037/0022-006X.64.3.532; Moerman DE, 1997, ANTHR MED CULTURE ME; Moynihan R, 2006, PLOS MED, V3, P425, DOI 10.1371/journal.pmed.0030191; Nessa J, 1998, J MED ETHICS, V24, P394, DOI 10.1136/jme.24.6.394	12	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2007	369	9565					886	888		10.1016/S0140-6736(07)60424-3	http://dx.doi.org/10.1016/S0140-6736(07)60424-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148BQ	17368133				2022-12-28	WOS:000245049900007
J	Law, KS; Stohl, A				Law, Kathy S.; Stohl, Andreas			Arctic air pollution: Origins and impacts	SCIENCE			English	Review							SNOW; VARIABILITY; TRANSPORT; CHEMISTRY; ALBEDO; RECORD; SMOKE; SOOT; NOX	Notable warming trends have been observed in the Arctic. Although increased human-induced emissions of long-lived greenhouse gases are certainly the main driving factor, air pollutants, such as aerosols and ozone, are also important. Air pollutants are transported to the Arctic, primarily from Eurasia, leading to high concentrations in winter and spring ( Arctic haze). Local ship emissions and summertime boreal forest fires may also be important pollution sources. Aerosols and ozone could be perturbing the radiative budget of the Arctic through processes specific to the region: Absorption of solar radiation by aerosols is enhanced by highly reflective snow and ice surfaces; deposition of light-absorbing aerosols on snow or ice can decrease surface albedo; and tropospheric ozone forcing may also be contributing to warming in this region. Future increases in pollutant emissions locally or in mid-latitudes could further accelerate global warming in the Arctic.	Univ Paris 06, Serv Aeron, CNRS, IPSL, F-75252 Paris 05, France; Norwegian Inst Air Res, NILU, N-2027 Kjeller, Norway	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Norwegian Institute for Air Research	Law, KS (corresponding author), Univ Paris 06, Serv Aeron, CNRS, IPSL, Boite 102,4 Pl Jussieu, F-75252 Paris 05, France.	kathy.law@aero.jussieu.fr; ast@nilu.no	Stohl, Andreas/A-7535-2008; Law, Kathy/Q-1290-2018	Stohl, Andreas/0000-0002-2524-5755; Law, Kathy/0000-0003-4479-903X				*AMSP, 2006, AC POLL ARCT HAZ AC; Ariya PA, 2004, TELLUS B, V56, P397, DOI 10.1111/j.1600-0889.2004.00118.x; BARRIE LA, 1988, NATURE, V334, P138, DOI 10.1038/334138a0; BARRIE LA, 1986, ATMOS ENVIRON, V20, P643, DOI 10.1016/0004-6981(86)90180-0; Browell EV, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD001390; Brown SS, 2006, SCIENCE, V311, P67, DOI 10.1126/science.1120120; Burkhart JF, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006771; CARLSON TN, 1981, ATMOS ENVIRON, V15, P1473, DOI 10.1016/0004-6981(81)90354-1; CLARKE AD, 1985, ATMOS ENVIRON, V19, P2045, DOI 10.1016/0004-6981(85)90113-1; Davis D, 2004, ATMOS ENVIRON, V38, P5375, DOI 10.1016/j.atmosenv.2004.04.039; Domine F, 2002, SCIENCE, V297, P1506, DOI 10.1126/science.1074610; Eckhardt S, 2003, ATMOS CHEM PHYS, V3, P1769, DOI 10.5194/acp-3-1769-2003; Emmons LK, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002665; Fromm M, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005350; Gabric AJ, 2005, TELLUS B, V57, P391, DOI 10.1111/j.1600-0889.2005.00163.x; Garrett TJ, 2006, NATURE, V440, P787, DOI 10.1038/nature04636; Hansen J, 2004, P NATL ACAD SCI USA, V101, P423, DOI 10.1073/pnas.2237157100; HOLLAND MM, 2006, GEOPHYS RES LETT, V33, DOI DOI 10.1029/2004GL028024; Honrath RE, 2002, ATMOS ENVIRON, V36, P2629, DOI 10.1016/S1352-2310(02)00132-2; Houghton J. T., 2001, CLIMATE CHANGE 2001; Hsu NC, 1999, GEOPHYS RES LETT, V26, P1165, DOI 10.1029/1999GL900155; IVERSEN T, 1984, GEOPHYS RES LETT, V11, P457, DOI 10.1029/GL011i005p00457; Iziomon MG, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006223; Jonson JE, 2006, ATMOS CHEM PHYS, V6, P51, DOI 10.5194/acp-6-51-2006; Klonecki A, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002199; Koch D, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005296; Mitchell Jr J.M, 1957, J ATMOS TERR PHYS S, P195; Nordenskiold A E, 1883, Science, V2, P732, DOI 10.1126/science.ns-2.44.732; OLTMANS SJ, 2006, ATMOS ENVIRON, V40, DOI DOI 10.1016/J.ATMOSERV.2006.01.029; PENKETT SA, 1986, NATURE, V319, P655, DOI 10.1038/319655a0; Quinn PK, 2007, TELLUS B, V59, P99, DOI 10.1111/j.1600-0889.2006.00236.x; Quinn PK, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001248; Rankin AM, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002492; RASCH PJ, 2005, EOS S, V86; Real E, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007576; Sharma S, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006581; Shindell D, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006348; SJOSTEDT SJ, 2007, ATMOS ENVIRON, V41, DOI DOI 10.1016/J.ATMOSENV.2006.08.058; Solberg S, 1996, J ATMOS CHEM, V25, P33, DOI 10.1007/BF00053285; Stocks BJ, 1998, CLIMATIC CHANGE, V38, P1, DOI 10.1023/A:1005306001055; Stohl A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007216; Stohl A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006888; Stohl A, 2007, ATMOS CHEM PHYS, V7, P511, DOI 10.5194/acp-7-511-2007; STROUD C, 2003, ATMOS ENVIRON, V37, DOI DOI 10.1016/51382-2310(03)00353-4; Tarasick DW, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004643; TWOMEY S, 1977, J ATMOS SCI, V34, P1149, DOI 10.1175/1520-0469(1977)034<1149:TIOPOT>2.0.CO;2; WARREN SG, 1980, J ATMOS SCI, V37, P2734, DOI 10.1175/1520-0469(1980)037<2734:AMFTSA>2.0.CO;2; WHITLOW S, 1994, TELLUS B, V46, P234, DOI 10.1034/j.1600-0889.1994.t01-2-00006.x; Xie ZQ, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006253; Zeng T, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006706	50	328	341	10	246	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1537	1540		10.1126/science.1137695	http://dx.doi.org/10.1126/science.1137695			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363665	Green Published			2022-12-28	WOS:000244934800041
J	Mayr, C; Hemann, MT; Bartel, DP				Mayr, Christine; Hemann, Michael T.; Bartel, David P.			Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation	SCIENCE			English	Article							MESSENGER-RNAS; PROTEIN GENE; C GENE; MICRORNAS; EXPRESSION; SEQUENCE; LIPOMAS; ADENOMA; FUSION; FAMILY	MicroRNAs ( miRNAs) are similar to 22-nucleotide RNAs that can pair to sites within messenger RNAs to specify posttranscriptional repression of these messages. Aberrant miRNA expression can contribute to tumorigenesis, but which of the many miRNA-target relationships are relevant to this process has been unclear. Here, we report that chromosomal translocations previously associated with human tumors disrupt repression of High Mobility Group A2 (Hmga2) by let-7 miRNA. This disrupted repression promotes anchorage-independent growth, a characteristic of oncogenic transformation. Thus, losing miRNA-directed repression of an oncogene provides a mechanism for tumorigenesis, and disrupting a single miRNA-target interaction can produce an observable phenotype in mammalian cells.	MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), MIT, Howard Hughes Med Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068348] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline; NIDDK NIH HHS [R01 DK068348-02, R01 DK068348-01, R01 DK068348, R01 DK068348-03] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baldassarre G, 2001, P NATL ACAD SCI USA, V98, P7970, DOI 10.1073/pnas.141224998; Battista S, 1999, CANCER RES, V59, P4793; Borrmann L, 2001, ONCOGENE, V20, P4537, DOI 10.1038/sj.onc.1204577; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fedele M, 1998, ONCOGENE, V17, P413, DOI 10.1038/sj.onc.1201952; Fedele M, 2002, ONCOGENE, V21, P3190, DOI 10.1038/sj.onc.1205428; Fedele M, 2001, CARCINOGENESIS, V22, P1583, DOI 10.1093/carcin/22.10.1583; Geurts JMW, 1997, CANCER RES, V57, P13; Geurts JMW, 1997, CANCER GENET CYTOGEN, V95, P198, DOI 10.1016/S0165-4608(96)00411-6; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Inoue N, 2006, BLOOD, V108, P4232, DOI 10.1182/blood-2006-05-025148; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Mine N, 2001, JPN J CANCER RES, V92, P135, DOI 10.1111/j.1349-7006.2001.tb01075.x; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Petit MMR, 1996, GENOMICS, V36, P118, DOI 10.1006/geno.1996.0432; Schoenmakers EFPM, 1999, CANCER RES, V59, P19; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; Sgarra R, 2004, FEBS LETT, V574, P1, DOI 10.1016/j.febslet.2004.08.013; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	27	897	971	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1576	1579		10.1126/science.1137999	http://dx.doi.org/10.1126/science.1137999			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17322030	Green Accepted			2022-12-28	WOS:000244934800053
J	Bruno, B; Rotta, M; Patriarca, F; Mordini, N; Allione, B; Carnevale-Schianca, F; Giaccone, L; Sorasio, R; Omede, P; Baldi, I; Bringhen, S; Massaia, M; Aglietta, M; Levis, A; Gallamini, A; Fanin, R; Palumbo, A; Storb, R; Ciccone, G; Boccadoro, M				Bruno, Benedetto; Rotta, Marcello; Patriarca, Francesca; Mordini, Nicola; Allione, Bernardino; Carnevale-Schianca, Fabrizio; Giaccone, Luisa; Sorasio, Roberto; Omede, Paola; Baldi, Ileana; Bringhen, Sara; Massaia, Massimo; Aglietta, Massimo; Levis, Alessandro; Gallamini, Andrea; Fanin, Renato; Palumbo, Antonio; Storb, Rainer; Ciccone, Giovannino; Boccadoro, Mario			A comparison of allografting with autografting for newly diagnosed myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; 1ST COMPLETE REMISSION; MULTIPLE-MYELOMA; ALLOGENEIC TRANSPLANTATION; CHEMOTHERAPY; TRIAL; LEUKEMIA; RANDOMIZATION	BACKGROUND: In this trial of the treatment of newly diagnosed multiple myeloma, we compared a protocol that entailed a hematopoietic stem-cell autograft followed by an allograft from an HLA-identical sibling with a protocol of tandem autografts. METHODS: We enrolled 162 consecutive patients with newly diagnosed myeloma who were 65 years of age or younger and who had at least one sibling. All patients were initially treated with vincristine, doxorubicin, and dexamethasone, followed by melphalan and autologous stem-cell rescue. Patients with an HLA-identical sibling then received nonmyeloablative total-body irradiation and stem cells from the sibling. Patients without an HLA-identical sibling received two consecutive myeloablative doses of melphalan, each of which was followed by autologous stem-cell rescue. The primary end points were overall survival and event-free survival. RESULTS: After a median follow-up of 45 months (range, 21 to 90), the median overall survival and event-free survival were longer in the 80 patients with HLA-identical siblings than in the 82 patients without HLA-identical siblings (80 months vs. 54 months, P=0.01; and 35 months vs. 29 months, P=0.02, respectively). Among patients who completed their assigned treatment protocols, treatment-related mortality did not differ significantly between the double-autologous-transplant group (46 patients) and the autograft-allograft group (58 patients, P=0.09), but disease-related mortality was significantly higher in the double-autologous-transplant group (43% vs. 7%, P<0.001). The cumulative incidence rates of grades II, III, and IV graft-versus-host disease (GVHD) combined and of grade IV GVHD in the autograft-allograft group were 43% and 4%, respectively. Overall, 21 of 58 patients (36%) were in complete remission after a median follow-up of 38 months (range, 10 to 72) after allografting. Of the 46 patients who received two autografts, 25 (54%) died. CONCLUSIONS: Among patients with newly diagnosed myeloma, survival in recipients of a hematopoietic stem-cell autograft followed by a stem-cell allograft from an HLA-identical sibling is superior to that in recipients of tandem stem-cell autografts.	Univ Turin, San Giovanni Battista Hosp, Turin, Italy; Univ Udine, I-33100 Udine, Italy; Santa Croce & Carle Hosp, Cuneo, Italy; Santi Antonio & Biagio Hosp, Alessandria, Italy; Inst Canc Res & Treatment, Candiolo, Italy; Ctr Prevenz Oncol Reg Piemonte, Turin, Italy; Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA	A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; University of Udine; Azienda Ospedaliera SS Antonio Biagio Cesare Arrigo; IRCCS Fondazione del Piemonte per l'Oncologia; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Bruno, B (corresponding author), Azienda Osped San Giovanni Battista, Div Univ Ematol, Via Genova 3, I-10126 Turin, Italy.	benedetto.bruno@unito.it	Patriarca, Francesca/ABH-9856-2020; Ciccone, Giovannino/K-3136-2016; Baldi, Ileana/J-2788-2019	Ciccone, Giovannino/0000-0001-7644-9574; Baldi, Ileana/0000-0002-8578-9164; Boccadoro, Mario/0000-0001-8130-5209; Bruno, Benedetto/0000-0002-7299-6770; MASSAIA, Massimo/0000-0002-0021-1428; AGLIETTA, Massimo/0000-0002-2255-7972	NCI NIH HHS [P01 CA078902, CA78902] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA078902] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aschan J, 1996, LANCET, V348, P346, DOI 10.1016/S0140-6736(05)64525-4; Attal M, 2004, NEW ENGL J MED, V350, P1467; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Balduzzi A, 2005, LANCET, V366, P635, DOI 10.1016/S0140-6736(05)66998-X; Barlogie B, 2006, J CLIN ONCOL, V24, P2687, DOI 10.1200/JCO.2006.04.004; Barlogie B, 2006, J CLIN ONCOL, V24, P929, DOI 10.1200/JCO.2005.04.5807; Barlogie B, 2006, BRIT J HAEMATOL, V135, P158, DOI 10.1111/j.1365-2141.2006.06271.x; Bensinger WI, 1996, BLOOD, V88, P2787, DOI 10.1182/blood.V88.7.2787.bloodjournal8872787; Child JA, 2003, NEW ENGL J MED, V348, P1875, DOI 10.1056/NEJMoa022340; Corradini P, 1999, J CLIN ONCOL, V17, P208, DOI 10.1200/JCO.1999.17.1.208; COX DR, 1972, J R STAT SOC B, V34, P187; GAHRTON G, 1991, NEW ENGL J MED, V325, P1267, DOI 10.1056/NEJM199110313251802; Gahrton G, 2001, BRIT J HAEMATOL, V113, P209, DOI 10.1046/j.1365-2141.2001.02726.x; GAHRTON G, 1995, J CLIN ONCOL, V13, P1312, DOI 10.1200/JCO.1995.13.6.1312; Garban F, 2006, BLOOD, V107, P3474, DOI 10.1182/blood-2005-09-3869; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Greipp PR, 2005, J CLIN ONCOL, V23, P6281, DOI 10.1200/JCO.2005.07.904; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kroger N, 2002, BLOOD, V100, P755, DOI 10.1182/blood-2002-01-0131; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Kyle RA, 2005, NEW ENGL J MED, V352, P1163; Lawsky R, 2006, NEW ENGL J MED, V354, P884; Le Blanc R, 2001, BONE MARROW TRANSPL, V28, P841, DOI 10.1038/sj.bmt.1703253; Lowsky R, 2005, NEW ENGL J MED, V353, P1321, DOI 10.1056/NEJMoa050642; Maloney DG, 2003, BLOOD, V102, P3447, DOI 10.1182/blood-2002-09-2955; Palumbo A, 2004, BLOOD, V104, P3052, DOI 10.1182/blood-2004-02-0408; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Suciu S, 2003, BLOOD, V102, P1232, DOI 10.1182/blood-2002-12-3714; SULLIVAN KM, 1991, SEMIN HEMATOL, V28, P250; Tricot G, 1996, BLOOD, V87, P1196, DOI 10.1182/blood.V87.3.1196.bloodjournal8731196; Wheatley K, 2004, INT J EPIDEMIOL, V33, P15, DOI 10.1093/ije/dyg313; Woods WG, 2001, BLOOD, V97, P56, DOI 10.1182/blood.V97.1.56	34	376	392	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2007	356	11					1110	1120		10.1056/NEJMoa065464	http://dx.doi.org/10.1056/NEJMoa065464			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	145PO	17360989				2022-12-28	WOS:000244877200004
J	Kostis, WJ; Demissie, K; Marcella, SW; Shao, YH; Wilson, AC; Moreyra, AE				Kostis, William J.; Demissie, Kitaw; Marcella, Stephen W.; Shao, Yu-Hsuan; Wilson, Alan C.; Moreyra, Abel E.		MIDAS 10 Study Grp	Weekend versus weekday admission and mortality from myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASSOCIATION TASK-FORCE; PRACTICE GUIDELINES COMMITTEE; ACUTE CORONARY SYNDROMES; IN-HOSPITAL MORTALITY; AMERICAN-COLLEGE; ACC/AHA GUIDELINES; UNSTABLE ANGINA; OUTCOMES; MANAGEMENT; STATEWIDE	BACKGROUND: Management of acute myocardial infarction requires urgent diagnostic and therapeutic procedures, which may not be uniformly available throughout the week. METHODS: We examined differences in mortality between patients admitted on weekends and those admitted on weekdays for a first acute myocardial infarction, using the Myocardial Infarction Data Acquisition System. All such admissions in New Jersey from 1987 to 2002 (231,164) were included and grouped in 4-year intervals. RESULTS: There were no significant differences in demographic characteristics, coexisting conditions, or infarction site between patients admitted on weekends and those admitted on weekdays. However, patients admitted on weekends were less likely to undergo invasive cardiac procedures, especially on the first and second days of hospitalization (P<0.001). In the interval from 1999 to 2002 (59,786 admissions), mortality at 30 days was significantly higher for patients admitted on weekends (12.9% vs. 12.0%, P=0.006). The difference became significant the day after admission (3.3% vs. 2.7%, P<0.001) and persisted at 1 year (1% absolute difference in mortality). The difference in mortality at 30 days remained significant after adjustment for demographic characteristics, coexisting conditions, and site of infarction (hazard ratio, 1.048; 95% confidence interval [CI], 1.022 to 1.076; P<0.001), but it became nonsignificant after additional adjustment for invasive cardiac procedures (hazard ratio, 1.023; 95% CI, 0.997 to 1.049; P=0.09). CONCLUSIONS: For patients with myocardial infarction, admission on weekends is associated with higher mortality and lower use of invasive cardiac procedures. Our findings suggest that the higher mortality on weekends is mediated in part by the lower rate of invasive procedures, and we speculate that better access to care on weekends could improve the outcome for patients with acute myocardial infarction.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Sch Publ Hlth, Dept Epidemiol, New Brunswick, NJ 08903 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kostis, WJ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Sch Publ Hlth, Dept Epidemiol, 1 Robert Wood Johnson Pl,POB 19, New Brunswick, NJ 08903 USA.	kostiswj@umdnj.edu	Shao, Yu-Hsuan Joni/AFE-6001-2022	Shao, Yu-Hsuan/0000-0002-0757-1901; Kostis, William/0000-0002-0543-9798				ABBUD ZA, 1995, AM HEART J, V130, P51, DOI 10.1016/0002-8703(95)90235-X; Al Falluji N, 2002, AM HEART J, V144, P636, DOI 10.1067/mhj.2002.124351; Alpert JS, 2001, J AM COLL CARDIOL, V37, P973; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Anderson HV, 2005, CIRCULATION, V112, P2786, DOI 10.1161/CIRCULATIONAHA.105.553727; Angus DC, 2006, CRIT CARE MED, V34, P1016, DOI 10.1097/01.CCM.0000206105.05626.15; Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; ANTMAN EM, 2005, J AM COLL CARDIOL, V45, P1376; Babaev A, 2005, JAMA-J AM MED ASSOC, V294, P448, DOI 10.1001/jama.294.4.448; Barnett MJ, 2002, MED CARE, V40, P530, DOI 10.1097/00005650-200206000-00010; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Bell CM, 2004, AM J MED, V117, P175, DOI 10.1016/j.amjmed.2004.02.047; BELL CM, 2001, NEW ENGL J MED, V345, P1580; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Cannon Christopher, 2003, J Invasive Cardiol, V15 Suppl B, p22B; Cram P, 2004, AM J MED, V117, P151, DOI 10.1016/j.amjmed.2004.02.035; Eagle KA, 2005, J AM COLL CARDIOL, V46, P1242, DOI 10.1016/j.jacc.2004.12.083; ELLIS SG, 1995, CIRCULATION, V92, P741, DOI 10.1161/01.CIR.92.4.741; Fox KAA, 2005, LANCET, V366, P914, DOI 10.1016/S0140-6736(05)67222-4; JARO MA, 1989, J AM STAT ASSOC, V84, P414, DOI 10.2307/2289924; KOSTIS JB, 1994, CIRCULATION, V90, P1715, DOI 10.1161/01.CIR.90.4.1715; Kostis JB, 2001, AM J CARDIOL, V88, P837, DOI 10.1016/S0002-9149(01)01888-4; Magid DJ, 2005, JAMA-J AM MED ASSOC, V294, P803, DOI 10.1001/jama.294.7.803; MOREYRA AE, 1998, DIS MANAGE CLIN OUTC, V6, P175; Peters RW, 1996, AM J CARDIOL, V78, P1198, DOI 10.1016/S0002-9149(96)00595-4; Quaas A, 2004, POSTGRAD MED J, V80, P411, DOI 10.1136/pgmj.2003.011247; Ryan JW, 2005, CIRCULATION, V112, P3049, DOI 10.1161/CIRCULATIONAHA.105.582346; SHENG A, 1993, J GEN INTERN MED, V8, P573, DOI 10.1007/BF02599642; Smith SC, 2001, CIRCULATION, V103, P3019, DOI 10.1161/01.CIR.103.24.3019; VANDERPALEN J, 1995, NEW ZEAL MED J, V108, P332	30	474	478	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2007	356	11					1099	1109		10.1056/NEJMoa063355	http://dx.doi.org/10.1056/NEJMoa063355			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	145PO	17360988				2022-12-28	WOS:000244877200003
J	Gardner, CD; Kiazand, A; Alhassan, S; Kim, S; Stafford, RS; Balise, RR; Kraemer, HC; King, AC				Gardner, Christopher D.; Kiazand, Alexandre; Alhassan, Sofiya; Kim, Soowon; Stafford, Randall S.; Balise, Raymond R.; Kraemer, Helena C.; King, Abby C.			Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-FAT DIET; DENSITY-LIPOPROTEIN CHOLESTEROL; LOW-CARBOHYDRATE-DIET; BLOOD-PRESSURE; HIGH-PROTEIN; MONOUNSATURATED FAT; PHYSICAL-ACTIVITY; RANDOMIZED-TRIAL; BODY-COMPOSITION; ENERGY DENSITY	Context Popular diets, particularly those low in carbohydrates, have challenged current recommendations advising a low-fat, high-carbohydrate diet for weight loss. Potential benefits and risks have not been tested adequately. Objective To compare 4 weight-loss diets representing a spectrum of low to high carbohydrate intake for effects on weight loss and related metabolic variables. Design, Setting, and Participants Twelve-month randomized trial conducted in the United States from February 2003 to October 2005 among 311 free-living, over-weight/ obese ( body mass index, 27-40) nondiabetic, premenopausal women. Intervention Participants were randomly assigned to follow the Atkins (n=77), Zone (n=79), LEARN (n=79), or Ornish (n= 76) diets and received weekly instruction for 2 months, then an additional 10-month follow-up. Main Outcome Measures Weight loss at 12 months was the primary outcome. Secondary outcomes included lipid profile (low-density lipoprotein, high-density lipoprotein, and non-high-density lipoprotein cholesterol, and triglyceride levels), percentage of body fat, waist-hip ratio, fasting insulin and glucose levels, and blood pressure. Outcomes were assessed at months 0, 2, 6, and 12. The Tukey studentized range test was used to adjust for multiple testing. Results Weight loss was greater for women in the Atkins diet group compared with the other diet groups at 12 months, and mean 12-month weight loss was significantly different between the Atkins and Zone diets ( P <. 05). Mean 12-month weight loss was as follows: Atkins, - 4.7 kg (95% confidence interval [CI], - 6.3 to - 3.1 kg), Zone, - 1.6 kg ( 95% CI, - 2.8 to - 0.4 kg), LEARN, - 2.6 kg (- 3.8 to - 1.3 kg), and Ornish, - 2.2 kg (- 3.6 to - 0.8 kg). Weight loss was not statistically different among the Zone, LEARN, and Ornish groups. At 12 months, secondary outcomes for the Atkins group were comparable with or more favorable than the other diet groups. Conclusions In this study, premenopausal overweight and obese women assigned to follow the Atkins diet, which had the lowest carbohydrate intake, lost more weight and experienced more favorable overall metabolic effects at 12 months than women assigned to follow the Zone, Ornish, or LEARN diets. While questions remain about long-term effects and mechanisms, a low-carbohydrate, high-protein, high-fat diet may be considered a feasible alternative recommendation for weight loss.	Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	Stanford University; Stanford University	Gardner, CD (corresponding author), Hoover Pavil,N229,211 Quarry Rd, Stanford, CA 94305 USA.	cgardner@stanford.edu	King, Abby/AAD-5257-2021; Stafford, Randall/F-3974-2017	Stafford, Randall/0000-0003-1805-1271; Kim, Soowon/0000-0002-6637-0018; King, Abby/0000-0002-7949-8811; Balise, Raymond/0000-0002-9856-5901	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT001098] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000070] Funding Source: NIH RePORTER	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALLAIN CC, 1974, CLIN CHEM, V20, P470; *AM COLL SPORTS ME, 2000, PHYS FITN TEST INT; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Atkins RC, 2002, ATKINS NEW DIET REVO; Berneis KK, 2002, J LIPID RES, V43, P1363, DOI 10.1194/jlr.R200004-JLR200; Blackburn GL, 2001, CLEV CLIN J MED, V68, P761, DOI 10.3949/ccjm.68.9.761; Bravata DM, 2003, JAMA-J AM MED ASSOC, V289, P1837, DOI 10.1001/jama.289.14.1837; Brehm BJ, 2003, J CLIN ENDOCR METAB, V88, P1617, DOI 10.1210/jc.2002-021480; BROWNELL KD, 2000, LEARN MANUAL WEIGHT; Connor WE, 1997, NEW ENGL J MED, V337, P562; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Drewnowski A, 2004, AM J PREV MED, V27, P154, DOI 10.1016/j.amepre.2004.06.011; Ello-Martin JA, 2005, AM J CLIN NUTR, V82, p236S, DOI 10.1093/ajcn/82.1.236S; Farnsworth E, 2003, AM J CLIN NUTR, V78, P31, DOI 10.1093/ajcn/78.1.31; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Foster GD, 2005, AM J CLIN NUTR, V82, p230S, DOI 10.1093/ajcn/82.1.230S; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; FREEDMAN M, 2001, OBESITY REV S1, V9, P1, DOI DOI 10.1038/0BY.2001.113; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gardner CD, 1996, JAMA-J AM MED ASSOC, V276, P875, DOI 10.1001/jama.276.11.875; Gardner CD, 2000, AM J CARDIOL, V86, P299, DOI 10.1016/S0002-9149(00)00918-8; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Katan MB, 1997, NEW ENGL J MED, V337, P563; Kim S, 2006, INT J EPIDEMIOL, V35, P60, DOI 10.1093/ije/dyi255; King AC, 1998, MED SCI SPORT EXER, V30, P1086, DOI 10.1097/00005768-199807000-00011; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krauss RM, 2006, AM J CLIN NUTR, V83, P1025, DOI 10.1093/ajcn/83.5.1025; LOTT JA, 1975, CLIN CHEM, V21, P1754; Luscombe-Marsh ND, 2005, AM J CLIN NUTR, V81, P762, DOI 10.1093/ajcn/81.4.762; MORGAN CR, 1963, DIABETES, V12, P115, DOI 10.2337/diab.12.2.115; *NIH, 1998, OBES RES S2, V6, pS51, DOI DOI 10.1001/JAMA.2012.39; Noakes M, 2005, AM J CLIN NUTR, V81, P1298; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ornish D., 2001, EAT MORE WEIGH LESS; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987; SAMPSON EJ, 1975, CLIN CHEM, V21, P1983; SEARS B, 1995, ENTER ZONE; Stern L, 2004, ANN INTERN MED, V140, P778, DOI 10.7326/0003-4819-140-10-200405180-00007; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; TRINDER P., 1969, Journal of Clinical Pathology, V22, P158, DOI 10.1136/jcp.22.2.158; WARNICK GR, 1978, J LIPID RES, V19, P65; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41; WOOD PD, 1988, NEW ENGL J MED, V319, P1173, DOI 10.1056/NEJM198811033191801; WOOD PD, 1991, NEW ENGL J MED, V325, P461, DOI 10.1056/NEJM199108153250703; Yancy WS, 2004, ANN INTERN MED, V140, P769, DOI 10.7326/0003-4819-140-10-200405180-00006	49	657	672	1	95	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2007	297	9					969	977		10.1001/jama.297.9.969	http://dx.doi.org/10.1001/jama.297.9.969			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143CP	17341711	Bronze			2022-12-28	WOS:000244697900026
J	Howden-Chapman, P; Matheson, A; Crane, J; Viggers, H; Cunningham, M; Blakely, T; Cunningham, C; Woodward, A; Saville-Smith, K; O'Dea, D; Kennedy, M; Baker, M; Waipara, N; Chapman, R; Davie, G				Howden-Chapman, Philippa; Matheson, Anna; Crane, Julian; Viggers, Helen; Cunningham, Malcolm; Blakely, Tony; Cunningham, Chris; Woodward, Alistair; Saville-Smith, Kay; O'Dea, Des; Kennedy, Martin; Baker, Michael; Waipara, Nick; Chapman, Ralph; Davie, Gabrielle			Effect of insulating existing houses on health inequality: cluster randomised study in the community	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To determine whether insulating existing houses increases indoor temperatures and improves occupants' health and wellbeing. Design Community based, cluster, single blinded randomised study. Setting Seven low income communities in New Zealand. Participants 1350 households containing 4407 participants. Intervention Installation of a standard retrofit insulation package. Main outcome measures Indoor temperature and relative humidity, energy consumption, self reported health, wheezing, days off school and work, visits to general practitioners, and admissions to hospital. Results Insulation was associated with a small increase in bedroom temperatures during the winter (0.5 degrees C) and decreased relative humidity (-2.3%), despite energy consumption in insulated houses being 81% of that in uninsulated houses. Bedroom temperatures were below 10 degrees C for 1.7 fewer hours each day in insulated homes than in uninsulated ones. These changes were associated with reduced odds in the insulated homes of fair or poor self rated health (adjusted odds ratio 0.50, 95% confidence interval 0.38 to 0.68), self reports of wheezing in the past three months (0.57, 0.47 to 0.70), self reports of children taking a day off school (0.49, 0.31 to 0.80), and self reports of adults taking a day off work (0.62, 0.46 to 0.83). Visits to general practitioners were less often reported by occupants of insulated homes (0.73, 0.62 to 0.87). Hospital admissions for respiratory conditions were also reduced (0.53, 0.22 to 1.29), but this reduction was not statistically significant (P=0.16). Conclusion Insulating existing houses led to a significantly warmer, drier indoor environment and resulted in improved self rated health, self reported wheezing, days off school and work, and visits to general practitioners as well as a trend for fewer hospital admissions for respiratory conditions.	Univ Otago, He Kainga Oranga Housing & Hlth Res Programme, Wellington, New Zealand; Univ Otago, Dept Med, Wellington, New Zealand; Univ Otago, Dept Publ Hlth, Wellington, New Zealand; Bldg Res Assoc New Zealand, Porirua City, New Zealand; Massey Univ, Res Ctr Maori Hlth & Dev, Wellington, New Zealand; Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand; CRESA, Wellington, New Zealand; Minist Environm, Wellington, New Zealand; Landcare Res, Auckland, New Zealand; Victoria Univ Wellington, Sch Geog Environm & Earth Sci, Wellington, New Zealand	University of Otago; University of Otago; University of Otago; Massey University; University of Auckland; Landcare Research - New Zealand; Victoria University Wellington	Howden-Chapman, P (corresponding author), Univ Otago, He Kainga Oranga Housing & Hlth Res Programme, POB 7343, Wellington, New Zealand.	howdenc@wnmeds.ac.nz	Waipara, Nick W/J-7328-2013; Health, Hauora/HCH-4744-2022; viggers, helen/AAN-9442-2020	Waipara, Nick W/0000-0002-8193-8302; viggers, helen/0000-0001-7325-6865; Davie, Gabrielle/0000-0001-5466-5364; Matheson, Anna/0000-0002-3916-2053; Woodward, Alistair/0000-0001-5425-6018; Chapman, Ralph/0000-0002-3437-8525				Blakely T, 2005, SOC SCI MED, V61, P2233, DOI 10.1016/j.socscimed.2005.02.011; CHAPMAN R, 2004, RETROFITTING HOUSES; Greening LA, 2000, ENERG POLICY, V28, P389, DOI 10.1016/S0301-4215(00)00021-5; HIRST E, 1985, ENERGY, V10, P861, DOI 10.1016/0360-5442(85)90119-7; Isaacs N, 2003, ENERGY USE NZ HOUSEH; LEGRAND J, 1984, EC SOCIAL PROBLEMS; MARSHH A, 1999, HOME SWEET HOME IMPA; MELKAS TA, 2000, EUROPEAN J PUBLIC S, V10, P43; *NAT I WAT ATM RES, 2004, CLIM NZ; Oakley A, 1998, BRIT MED J, V317, P1239, DOI 10.1136/bmj.317.7167.1239; Thomson H, 2006, J EPIDEMIOL COMMUN H, V60, P108, DOI 10.1136/jech.2005.038885; Thomson H, 2004, BMJ-BRIT MED J, V328, P282, DOI 10.1136/bmj.328.7434.282; Thomson H, 2001, BRIT MED J, V323, P187, DOI 10.1136/bmj.323.7306.187	13	290	290	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2007	334	7591					460	464		10.1136/bmj.39070.573032.80	http://dx.doi.org/10.1136/bmj.39070.573032.80			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144NB	17324975	Bronze, Green Published			2022-12-28	WOS:000244802000032
J	Willoughby, HE				Willoughby, Hugh E.			Forecasting hurricane intensity and impacts	SCIENCE			English	Editorial Material									Florida Int Univ, Dept Earth Sci, Miami, FL 33199 USA	State University System of Florida; Florida International University	Willoughby, HE (corresponding author), Florida Int Univ, Dept Earth Sci, Miami, FL 33199 USA.	hugh.willoughby@fiu.edu		Willoughby, Hugh/0000-0002-0420-9034				Black ML, 2002, MON WEATHER REV, V130, P2291, DOI 10.1175/1520-0493(2002)130<2291:EPHJOA>2.0.CO;2; Houze RA, 2007, SCIENCE, V315, P1235, DOI 10.1126/science.1135650; LIU Y, 1997, MON WEATHER REV, V123, P3073; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Shay LK, 2000, MON WEATHER REV, V128, P1366, DOI 10.1175/1520-0493(2000)128<1366:EOAWOF>2.0.CO;2; Vickery PJ, 2000, J STRUCT ENG-ASCE, V126, P1222, DOI 10.1061/(ASCE)0733-9445(2000)126:10(1222); Willoughby HE, 1996, B AM METEOROL SOC, V77, P543, DOI 10.1175/1520-0477(1996)077<0543:HAIFDO>2.0.CO;2; Zhang Z, 1997, B AM METEOROL SOC, V78, P2785, DOI 10.1175/1520-0477(1997)078<2785:EFOHT>2.0.CO;2	8	9	10	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1232	1233		10.1126/science.1140041	http://dx.doi.org/10.1126/science.1140041			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	141FR	17332402				2022-12-28	WOS:000244564700037
J	Covino, S				Covino, Stefano			Astronomy - A closer look at a gamma-ray burst	SCIENCE			English	Editorial Material							LINEAR-POLARIZATION; MAGNETIC-FIELD; LIGHT CURVES; AFTERGLOW; EMISSION; MODEL		Osserv Astron Brera, I-23807 Merate, LC, Italy	Istituto Nazionale Astrofisica (INAF)	Covino, S (corresponding author), Osserv Astron Brera, Via Emilio Bianchi 46, I-23807 Merate, LC, Italy.	stefano.covino@brera.inaf.it	Covino, Stefano/AAQ-5188-2021	Covino, Stefano/0000-0001-9078-5507				Fan YZ, 2006, MON NOT R ASTRON SOC, V369, P197, DOI 10.1111/j.1365-2966.2006.10280.x; Ghisellini G, 1999, MON NOT R ASTRON SOC, V309, pL7, DOI 10.1046/j.1365-8711.1999.03025.x; Granot J, 2003, ASTROPHYS J, V594, pL83, DOI 10.1086/378733; Gruzinov A, 1999, ASTROPHYS J, V511, P852, DOI 10.1086/306720; Lazzati D, 2003, ASTRON ASTROPHYS, V410, P823, DOI 10.1051/0004-6361:20031321; Lyutikov M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/7/119; Lyutikov M, 2003, ASTROPHYS J, V597, P998, DOI 10.1086/378497; Meszaros P, 2006, REP PROG PHYS, V69, P2259, DOI 10.1088/0034-4885/69/8/R01; Mundell CG, 2007, SCIENCE, V315, P1822, DOI 10.1126/science.1138484; Piran T, 1999, PHYS REP, V314, P575, DOI 10.1016/S0370-1573(98)00127-6; Rossi EM, 2004, MON NOT R ASTRON SOC, V354, P86, DOI 10.1111/j.1365-2966.2004.08165.x; Sagiv A, 2004, ASTROPHYS J, V615, P366, DOI 10.1086/423977; Sari R, 1999, ASTROPHYS J, V524, pL43, DOI 10.1086/312294; Zhang B, 2005, ASTROPHYS J, V628, P315, DOI 10.1086/429787; Zhang B, 2007, CHINESE J ASTRON AST, V7, P1, DOI 10.1088/1009-9271/7/1/01	16	6	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2007	315	5820					1798	1799		10.1126/science.1140172	http://dx.doi.org/10.1126/science.1140172			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17363627	Green Submitted			2022-12-28	WOS:000245280100026
J	Zaph, C; Troy, AE; Taylor, BC; Berman-Booty, LD; Guild, KJ; Du, YR; Yost, EA; Gruber, AD; May, MJ; Greten, FR; Eckmann, L; Karin, M; Artis, D				Zaph, Colby; Troy, Amy E.; Taylor, Betsy C.; Berman-Booty, Lisa D.; Guild, Katherine J.; Du, Yurong; Yost, Evan A.; Gruber, Achim D.; May, Michael J.; Greten, Florian R.; Eckmann, Lars; Karin, Michael; Artis, David			Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis	NATURE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; KAPPA-B ACTIVATION; CHRONIC INFLAMMATION; DENDRITIC CELLS; INHIBITION; INVOLVEMENT; INFECTIONS; RESISTANCE; SURVIVAL	Intestinal epithelial cells ( IECs) provide a primary physical barrier against commensal and pathogenic microorganisms in the gastrointestinal ( GI) tract, but the influence of IECs on the development and regulation of immunity to infection is unknown(1). Here we show that IEC-intrinsic I kappa B kinase ( IKK)-beta-dependent gene expression is a critical regulator of responses of dendritic cells and CD4(+) T cells in the GI tract. Mice with an IEC-specific deletion of IKK-beta show a reduced expression of the epithelial-cell-restricted cytokine thymic stromal lymphopoietin in the intestine and, after infection with the gut-dwelling parasite Trichuris, fail to develop a pathogen-specific CD4(+) T helper type 2 (T(H)2) response and are unable to eradicate infection. Further, these animals show exacerbated production of dendritic-cell-derived interleukin-12/23p40 and tumour necrosis factor-alpha, increased levels of CD4(+) T-cell-derived interferon-gamma and interleukin-17, and develop severe intestinal inflammation. Blockade of proinflammatory cytokines during Trichuris infection ablates the requirement for IKK-beta in IECs to promote CD4(+) T(H)2 cell-dependent immunity, identifying an essential function for IECs in tissue-specific conditioning of dendritic cells and limiting type 1 cytokine production in the GI tract. These results indicate that the balance of IKK-beta-dependent gene expression in the intestinal epithelium is crucial in intestinal immune homeostasis by promoting mucosal immunity and limiting chronic inflammation.	Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA; Free Univ Berlin, Dept Vet Pathol, D-14163 Berlin, Germany; Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Pennsylvania; University of Pennsylvania; Free University of Berlin; University of California System; University of California San Diego; University of California System; University of California San Diego	Artis, D (corresponding author), Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA.	dartis@vet.upenn.edu	Gruber, Achim D./ABA-4514-2021; Greten, Florian R/AAF-5196-2020	Greten, Florian R/0000-0002-3928-6080; Zaph, Colby/0000-0002-9889-9848; Artis, David/0000-0002-1753-4100; May, Michael/0000-0002-2485-3716	NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Artis D, 2002, J IMMUNOL, V169, P4481, DOI 10.4049/jimmunol.169.8.4481; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; Egan LJ, 2004, P NATL ACAD SCI USA, V101, P2452, DOI 10.1073/pnas.0306734101; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Schopf LR, 2002, J IMMUNOL, V168, P2383, DOI 10.4049/jimmunol.168.5.2383; Tilney LG, 2005, J EXP ZOOL PART A, V303A, P927, DOI 10.1002/jez.a.214; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Zhou YH, 2001, AM J RESP CELL MOL, V25, P486, DOI 10.1165/ajrcmb.25.4.4578; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360	28	416	430	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					552	556		10.1038/nature05590	http://dx.doi.org/10.1038/nature05590			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17322906				2022-12-28	WOS:000245242900052
J	Roberts, DM; Aaron, CK				Roberts, Darren M.; Aaron, Cynthia K.			Managing acute organophosphorus pesticide poisoning	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CHOLINESTERASE INHIBITION; MANAGEMENT		Childrens Hosp Michigan, Reg Poison Ctr, Detroit, MI 48201 USA; Australian Natl Univ, S Asian Clin Toxicol Res Collaborat, Canberra, ACT, Australia	Children's Hospital of Michigan; Australian National University	Aaron, CK (corresponding author), Childrens Hosp Michigan, Reg Poison Ctr, Detroit, MI 48201 USA.	caaron@dmc.org	Roberts, Darren/A-8986-2013; Aaron, Cynthia/AAZ-4258-2021	Roberts, Darren/0000-0001-9101-7577; Aaron, Cynthia/0000-0003-1608-8345	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Buckley NA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005085; Buckley NA, 2004, BMJ-BRIT MED J, V329, P1231, DOI 10.1136/bmj.329.7476.1231; Carlock LL, 1999, J TOXICOL ENV HEAL B, V2, P105, DOI 10.1080/109374099281197; Daly FFS, 2006, EMERG MED J, V23, P396, DOI 10.1136/EMJ.2005.030312; Eddleston M, 2000, QJM-INT J MED, V93, P715, DOI 10.1093/qjmed/93.11.715; Eddleston M, 2006, QJM-INT J MED, V99, P513, DOI 10.1093/qjmed/hcl065; Eddleston M, 2005, LANCET, V366, P1452, DOI 10.1016/S0140-6736(05)67598-8; Eddleston M, 2004, CRIT CARE, V8, pR391, DOI 10.1186/cc2953; EDDLESTON M, 2005, CLIN TOXICOL, V43, P442; Eddleston Michael, 2005, Clin Evid, P1744; Eyer Florian, 2003, Toxicological Reviews, V22, P143, DOI 10.2165/00139709-200322030-00003; Eyer Peter, 2003, Toxicological Reviews, V22, P165, DOI 10.2165/00139709-200322030-00004; Karalliedde Lakshman, 2006, Toxicol Rev, V25, P1, DOI 10.2165/00139709-200625010-00001; Lai MW, 2006, CLIN TOXICOL, V44, P803, DOI 10.1080/15563650600907165; Little Mark, 2004, Emerg Med Australas, V16, P456, DOI 10.1111/j.1742-6723.2004.00649.x; LOTTI M, 1995, CLIN CHEM, V41, P1814; Lotti Marcello, 2005, Toxicol Rev, V24, P37, DOI 10.2165/00139709-200524010-00003; NAMBA T, 1971, B WORLD HEALTH ORGAN, V44, P289; NOLAN RJ, 1984, TOXICOL APPL PHARM, V73, P8, DOI 10.1016/0041-008X(84)90046-2; Pawar KS, 2006, LANCET, V368, P2136, DOI 10.1016/S0140-6736(06)69862-0; Roberts D, 2004, QJM-INT J MED, V97, P697, DOI 10.1093/qjmed/hch114; Roberts DM, 2005, ANAESTH INTENS CARE, V33, P469, DOI 10.1177/0310057X0503300408; Sungur M, 2001, CRIT CARE, V5, P211, DOI 10.1186/cc1025; THIERMANN H, 2005, CHEM-BIOL INTERACT, V157, P158; Worek F, 1999, ARCH TOXICOL, V73, P7, DOI 10.1007/s002040050580	25	76	81	6	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2007	334	7594					629	634		10.1136/bmj.39134.566979.BE	http://dx.doi.org/10.1136/bmj.39134.566979.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	152DC	17379909	Green Published			2022-12-28	WOS:000245340000037
J	Brennecke, J; Aravin, AA; Stark, A; Dus, M; Kellis, M; Sachidanandam, R; Hannon, GJ				Brennecke, Julius; Aravin, Alexei A.; Stark, Alexander; Dus, Monica; Kellis, Manolis; Sachidanandam, Ravi; Hannon, Gregory J.			Discrete small RNA-generating loci as master regulators of transposon activity in Drosophila	CELL			English	Article							R HYBRID DYSGENESIS; P-ELEMENTS; SUBTELOMERIC HETEROCHROMATIN; CYTOTYPE DETERMINATION; MOLECULAR-BASIS; COPY NUMBER; MELANOGASTER; PIWI; GENE; FLAMENCO	Drosophila Piwi-family proteins have been implicated in transposon control. Here, we examine piwi-interacting RNAs (piRNAs) associated with each Drosophila Piwi protein and find that Piwi and Aubergine bind RNAs that are predominantly antisense to transposons, whereas Ago3 complexes contain predominantly sense piRNAs. As in mammals, the majority of Drosophila piRNAs are derived from discrete genomic loci. These loci comprise mainly defective transposon sequences, and some have previously been identified as master regulators of transposon activity. Our data suggest that heterochromatic piRNA loci interact with potentially active, euchromatic transposons to form an adaptive system for transposon control. Complementary relationships between sense and antisense piRNA populations suggest an amplification loop wherein each piRNA-directed cleavage event generates the 5' end of a new piRNA. Thus, sense piRNAs, formed following cleavage of transposon mRNAs may enhance production of antisense piRNAs, complementary to active elements, by directing cleavage of transcripts from master control loci.	Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; MIT, Broad Inst, Ctr Genome Res, Cambridge, MA 02141 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hannon, GJ (corresponding author), Watson Sch Biol Sci, Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Kellis, Manolis/ABE-7385-2020; sachidanandam, ravi/Q-6916-2019; Stark, Alexander/D-1473-2012; Brennecke, Julius/T-5883-2019; Hannon, Gregory/AAB-3568-2019; Brennecke, Julius/C-1626-2015	Kellis, Manolis/0000-0001-7113-9630; sachidanandam, ravi/0000-0001-9844-4459; Stark, Alexander/0000-0003-2611-0841; Brennecke, Julius/0000-0002-5141-0814; Brennecke, Julius/0000-0002-5141-0814				Abad JP, 2004, MOL BIOL EVOL, V21, P1613, DOI 10.1093/molbev/msh174; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; BIEMONT C, 1990, GENET RES, V56, P3, DOI 10.1017/S0016672300028822; Blumenstiel JP, 2005, P NATL ACAD SCI USA, V102, P15965, DOI 10.1073/pnas.0508192102; BREGLIANO JC, 1980, SCIENCE, V207, P606, DOI 10.1126/science.6766221; BUCHETON A, 1984, CELL, V38, P153, DOI 10.1016/0092-8674(84)90536-1; BUCHETON A, 1995, TRENDS GENET, V11, P349, DOI 10.1016/S0168-9525(00)89105-2; BUCHETON A, 1990, TRENDS GENET, V6, P16, DOI 10.1016/0168-9525(90)90044-7; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Castro JP, 2004, GENETICA, V121, P107, DOI 10.1023/B:GENE.0000040382.48039.a2; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Desset S, 2003, GENETICS, V164, P501; ENGELS WR, 1979, GENETICS, V92, P161; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Harris AN, 2001, DEVELOPMENT, V128, P2823; HOSKINS RA, 2002, GENOME BIOL, V0003; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; KARPEN GH, 1992, GENETICS, V132, P737; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; KIDWELL MG, 1977, GENETICS, V86, P813; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Marin L, 2000, GENETICS, V155, P1841; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; MISRA S, 1990, CELL, V62, P269, DOI 10.1016/0092-8674(90)90365-L; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; PELISSON A, 1987, MOL GEN GENET, V207, P306, DOI 10.1007/BF00331594; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; PELISSON A, 1981, MOL GEN GENET, V183, P123, DOI 10.1007/BF00270149; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; PRUDHOMME N, 1995, GENETICS, V139, P697; Reiss D, 2004, MOL GENET GENOMICS, V272, P336, DOI 10.1007/s00438-004-1061-1; Robert V, 2001, GENETICS, V158, P701; Roche SE, 1998, GENETICS, V149, P1839; Ronsseray S, 1998, GENETICS, V149, P1857; RONSSERAY S, 1991, GENETICS, V129, P501; RUBIN GM, 1982, CELL, V29, P987, DOI 10.1016/0092-8674(82)90462-7; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Savitsky M, 2006, GENE DEV, V20, P345, DOI 10.1101/gad.370206; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smyth DR, 1997, CURR BIOL, V7, pR793, DOI 10.1016/S0960-9822(06)00407-6; Stuart JR, 2002, GENETICS, V162, P1641; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333	56	1720	1803	9	162	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1089	1103		10.1016/j.cell.2007.01.043	http://dx.doi.org/10.1016/j.cell.2007.01.043			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17346786	Bronze			2022-12-28	WOS:000245396200016
J	Weijers, JWH; Schefuss, E; Schouten, S; Damste, JSS				Weijers, Johan W. H.; Schefuss, Enno; Schouten, Stefan; Damste, Jaap S. Sinninghe			Coupled thermal and hydrological evolution of tropical Africa over the last deglaciation	SCIENCE			English	Article							GLACIAL MAXIMUM; CLIMATE VARIABILITY; PALEOCLIMATE; RECONSTRUCTION; TEMPERATURE; VEGETATION; RAINFALL; BASIN	We analyzed the distribution of branched tetraether membrane lipids derived from soil bacteria in a marine sediment record that was recovered close to the Congo River outflow, and the results enabled us to reconstruct large-scale continental temperature changes in tropical Africa that span the past 25,000 years. Tropical African temperatures gradually increased from similar to 21 degrees to 25 degrees C over the last deglaciation, which is a larger warming than estimated for the tropical Atlantic Ocean. A direct comparison with sea-surface temperature estimates from the same core revealed that the land-sea temperature difference was, through the thermal pressure gradient, an important control on central African precipitation patterns.	Netherlands Inst Sea Res, Dept Marine Biogeochem & Toxicol, NL-1790 AB Den Burg, Texel, Netherlands; Deutsch Forschungsgemeinschat Res Ctr Ocean Margi, D-28359 Bremen, Germany	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Bremen	Weijers, JWH (corresponding author), Netherlands Inst Sea Res, Dept Marine Biogeochem & Toxicol, POB 59, NL-1790 AB Den Burg, Texel, Netherlands.	jweijers@nioz.nl	Schefuß, Enno/A-7101-2015; Damste, Jaap S Sinninghe/F-6128-2011	Schefuß, Enno/0000-0002-5960-930X; Damste, Jaap S Sinninghe/0000-0002-8683-1854				Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Bard E, 1999, SCIENCE, V284, P1133, DOI 10.1126/science.284.5417.1133; Blunier T, 1997, GEOPHYS RES LETT, V24, P2683, DOI 10.1029/97GL02658; BONNEFILLE R, 1990, NATURE, V346, P347, DOI 10.1038/346347a0; Camberlin P, 2001, INT J CLIMATOL, V21, P973, DOI 10.1002/joc.673; CHALIE F, 1995, CR ACAD SCI II, V320, P205; Farrera I, 1999, CLIM DYNAM, V15, P823, DOI 10.1007/s003820050317; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; HEATON THE, 1986, QUATERNARY RES, V25, P79, DOI 10.1016/0033-5894(86)90045-1; Holmgren K, 2003, QUATERNARY SCI REV, V22, P2311, DOI 10.1016/S0277-3791(03)00204-X; Hopmans EC, 2004, EARTH PLANET SC LETT, V224, P107, DOI 10.1016/j.epsl.2004.05.012; Johnson DW, 1998, WATER AIR SOIL POLL, V105, P251, DOI 10.1023/A:1005039711434; Kazadi SN, 1996, J GEOPHYS RES-ATMOS, V101, P21351, DOI 10.1029/96JD01869; Kulongoski JT, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019238; Leng MJ, 2004, QUATERNARY SCI REV, V23, P811, DOI 10.1016/j.quascirev.2003.06.012; McDermott F, 2004, QUATERNARY SCI REV, V23, P901, DOI 10.1016/j.quascirev.2003.06.021; Menot G, 2006, SCIENCE, V313, P1623, DOI 10.1126/science.1130511; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; Powers LA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022014; Ramstein G, 1998, CLIM DYNAM, V14, P233, DOI 10.1007/s003820050220; Schaefer JM, 2006, SCIENCE, V312, P1510, DOI 10.1126/science.1122872; Schefuss E, 2005, NATURE, V437, P1003, DOI 10.1038/nature03945; Shin SI, 2003, CLIM DYNAM, V20, P127, DOI 10.1007/s00382-002-0260-x; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; Weijers JWH, 2007, GEOCHIM COSMOCHIM AC, V71, P703, DOI 10.1016/j.gca.2006.10.003; Weijers JWH, 2006, ENVIRON MICROBIOL, V8, P648, DOI 10.1111/j.1462-2920.2005.00941.x; WILLMOTT CJ, 1995, INT J CLIMATOL, V15, P221, DOI 10.1002/joc.3370150207; Wyputta U, 2001, CLIM DYNAM, V17, P923, DOI 10.1007/s003820100155; [No title captured]	29	229	246	6	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1701	1704		10.1126/science.1138131	http://dx.doi.org/10.1126/science.1138131			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379805				2022-12-28	WOS:000245106900036
J	Calif, E; Stahl, S				Calif, Edward; Stahl, Shalom			Dupuytren's contracture	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Rambam Med Ctr, Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology	Calif, E (corresponding author), Rambam Med Ctr, Haifa, Israel.	edikal@hotmail.com							0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					E11	E11		10.1056/NEJMicm064050	http://dx.doi.org/10.1056/NEJMicm064050			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377153				2022-12-28	WOS:000245101900011
J	Klenerman, P; McMichael, A				Klenerman, Paul; McMichael, Andrew			Finding footprints among the trees	SCIENCE			English	Editorial Material							T-LYMPHOCYTE RESPONSES; HEPATITIS-C VIRUS; PRIMARY INFECTION; ESCAPE VARIANTS; HLA; EVOLUTION; HIV; TRANSMISSION; ADAPTATION; MUTATIONS		Univ Oxford, Nuffield Dept Clin Med, Oxford OX1 3SY, England; Univ Oxford, John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England	University of Oxford; University of Oxford	Klenerman, P (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Peter Medawar Bldg, Oxford OX1 3SY, England.	andrew.mcmichael@ndm.ox.ac.uk		klenerman, paul/0000-0003-4307-9161	Medical Research Council [MC_U137884177] Funding Source: Medline; MRC [MC_U137884177] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Gaudieri S, 2006, J VIROL, V80, P11094, DOI 10.1128/JVI.00912-06; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Iversen AKN, 2006, NAT IMMUNOL, V7, P179, DOI 10.1038/ni1298; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; McMichael A, 2002, SCIENCE, V296, P1410, DOI 10.1126/science.1072492; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Ray SC, 2005, J EXP MED, V201, P1753, DOI 10.1084/jem.20050122; Yeh WW, 2006, J VIROL, V80, P8168, DOI 10.1128/JVI.00068-06	18	10	10	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2007	315	5818					1505	1507		10.1126/science.1140768	http://dx.doi.org/10.1126/science.1140768			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363650				2022-12-28	WOS:000244934800026
J	Lewis, RS				Lewis, Richard S.			The molecular choreography of a store-operated calcium channel	NATURE			English	Article							CATION CHANNEL; CRAC CHANNELS; CA2+ SENSOR; STIM1; DEPLETION; ORAI1; ACTIVATION; RELEASE; TRPC1; OSCILLATIONS	Store-operated calcium channels (SOCs) serve essential functions from secretion and motility to gene expression and cell growth. A fundamental mystery is how the depletion of Ca2+ from the endoplasmic reticulum (ER) activates Ca2+ entry through SOCs in the plasma membrane. Recent studies using genetic approaches have identified genes encoding the ER Ca2+ sensor and a prototypic SOC, the Ca2+-release-activated Ca2+ (CRAC) channel. New findings reveal a unique mechanism for channel activation, in which the CRAC channel and its sensor migrate independently to closely apposed sites of interaction in the ER and the plasma membrane.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Lewis, RS (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	rslewis@stanford.edu		Lewis, Richard/0000-0002-6010-7403	NIGMS NIH HHS [R01 GM045374] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045374] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Bolotina VM, 2005, TRENDS BIOCHEM SCI, V30, P378, DOI 10.1016/j.tibs.2005.05.009; Demaurex N, 2003, CELL CALCIUM, V34, P109, DOI 10.1016/S0143-4160(03)00081-2; DOLMETSCH RE, 1994, J GEN PHYSIOL, V103, P365, DOI 10.1085/jgp.103.3.365; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; Franzini-Armstrong C, 2005, ANN NY ACAD SCI, V1047, P76, DOI 10.1196/annals.1341.007; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; LEWIS RS, 1989, CELL REGUL, V1, P99, DOI 10.1091/mbc.1.1.99; Lintschinger B, 2000, J BIOL CHEM, V275, P27799; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Luik RM, 2007, TRENDS MOL MED, V13, P103, DOI 10.1016/j.molmed.2007.01.004; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; PRAKRIYA M, 2004, MOL CELLULAR INSIGHT, P121; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; PUTNEY JW, 1993, ENDOCR REV, V14, P610, DOI 10.1210/er.14.5.610; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	42	400	434	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2007	446	7133					284	287		10.1038/nature05637	http://dx.doi.org/10.1038/nature05637			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361175				2022-12-28	WOS:000244892900036
J	Coombe, R				Coombe, Rebecca			How specialist training reform sparked crisis of confidence	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmjgroup.com							0	6	6	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2007	334	7592					508	509		10.1136/bmj.39146.640613.59	http://dx.doi.org/10.1136/bmj.39146.640613.59			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148VV	17347235	Green Published			2022-12-28	WOS:000245106400036
J	Donaldson, L; Banatvala, N				Donaldson, Liam; Banatvala, Nicholas			Health is global: proposals for a UK Government-wide strategy	LANCET			English	Article								Global health enables the harmonisation of international and domestic-health concerns-its outlook is much wider than a development or foreign-assistance perspective alone. Engaging globally in health requires the creation of relevant and effective partnerships to implement solutions for shared or common problems. To build on the UK's achievements and leadership in global health, the central government Department of Health is now leading the development of a UK Government-wide global strategy. This paper describes the rationale and process for developing the new UK Government-wide strategy for global health and highlights some of the issues that must be discussed.	Dept Hlth, London SE1 8UG, England		Banatvala, N (corresponding author), Dept Hlth, Wellington House, London SE1 8UG, England.	nick.banatvala@dh.gsi.gov.uk		Banatvala, Nick/0000-0001-8130-154X				[Anonymous], 2006, Lancet, V368, P964; [Anonymous], 2005, PREV CHRON DIS VIT I; Bloom DE, 1998, WORLD BANK ECON REV, V12, P419, DOI 10.1093/wber/12.3.419; Bristol N, 2006, LANCET, V367, P384, DOI 10.1016/S0140-6736(06)68122-1; Brownlie J., 2006, FORESIGHT INFECT DIS; BRUNDTLAND GH, 1999, WHY INVESTING GLOBAL; Crisp N, GLOBAL HLTH PARTNERS; Department of Health, 2007, HLTH IS GLOB PROP UK; Department of Health, 2002, GETT AH CURV STRAT C; Dixon S, 2002, BRIT MED J, V324, P232, DOI 10.1136/bmj.324.7331.232; Feldbaum H, 2006, PLOS MED, V3, P774, DOI 10.1371/journal.pmed.0030171; *GLOB HLTH SEC IN, INTR GLOBA HLTH SEC; *HER MAJ TREAS, 2006, STERN REV FIN REP; *HLTH PROT AG, WHAT IS POL 210; Horton R, 2006, LANCET, V368, P1395, DOI 10.1016/S0140-6736(06)69492-0; Hunt P, 2006, EC SOCIAL CULTURAL R; *INT TASK FORC GLO, M GLOB CHALL; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jezek Z, 1988, HUMAN MONKEYPOX; Juma C, 2005, LANCET, V365, P1105; LEVINE R, 2004, KINDER M MILLIONS S; Merianos A, 2005, LANCET, V366, P1249, DOI 10.1016/S0140-6736(05)67508-3; Singh JA, 2007, PLOS MED, V4, P19, DOI 10.1371/journal.pmed.0040050; Stott R, 2006, BRIT MED J, V333, P983, DOI 10.1136/bmj.39028.427164.BE; TOOLE MJ, 1993, LANCET, V341, P1193, DOI 10.1016/0140-6736(93)91013-C; *TRANSP INT, 2006, REP TRANS INT GLOB C; Transparency International, 2006, GLOB CORR REP 2006; *UK HLTH PROT AG, 2006, MIGR HLTH INF DIS NO; *UN MILL DEV GOALS, WHAT MILL DEV GOALS; *UNAIDS, 2006, REP GLOB AIDS EP 200; United Nations, 2006, DEL ON REP HIGH LEV; *US I MED, 1997, AM VIT INT GLOB HLTH; WHO, 2001, MACR HLTH INV HLTH D; World Health Organization, COMM SOC DET HLTH	34	33	33	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2007	369	9564					857	861		10.1016/S0140-6736(07)60327-4	http://dx.doi.org/10.1016/S0140-6736(07)60327-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144JC	17350456	Bronze, Green Published			2022-12-28	WOS:000244791300035
J	Richards, T				Richards, Tessa			My illness, my record	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com							0	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2007	334	7592					510	510		10.1136/bmj.39146.615081.59	http://dx.doi.org/10.1136/bmj.39146.615081.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148VV	17347237	Green Published			2022-12-28	WOS:000245106400038
J	Stone, GW				Stone, Gregg W.			Non-ST-elevation acute coronary syndromes	LANCET			English	Editorial Material							RANDOMIZED-TRIAL; STRATEGY; METAANALYSIS; OUTCOMES; IMPACT		Columbia Univ, Med Ctr, New York, NY 10027 USA; Cardiovasc Res Fdn, New York, NY USA	Columbia University; Cardiovascular Research Foundation (CRF)	Stone, GW (corresponding author), Columbia Univ, Med Ctr, New York, NY 10027 USA.	gs2184@columbia.edu						Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Fox KAA, 2005, LANCET, V366, P914, DOI 10.1016/S0140-6736(05)67222-4; Hirsch A, 2007, LANCET, V369, P827, DOI 10.1016/S0140-6736(07)60410-3; Lagerqvist B, 2006, LANCET, V368, P998, DOI 10.1016/S0140-6736(06)69416-6; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Moscucci M, 2003, EUR HEART J, V24, P1815, DOI 10.1016/S0195-668X(03)00485-8; Rao SV, 2005, AM J CARDIOL, V96, P1200, DOI 10.1016/j.amjcard.2005.06.056; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Yusuf S, 2006, JAMA-J AM MED ASSOC, V295, P1519	14	12	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2007	369	9564					801	803		10.1016/S0140-6736(07)60382-1	http://dx.doi.org/10.1016/S0140-6736(07)60382-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144JC	17350430				2022-12-28	WOS:000244791300004
J	Oren, M; Bartek, J				Oren, Moshe; Bartek, Jiri			The sunny side of p53	CELL			English	Editorial Material							SUPPRESSOR; ROLES	Skin, the largest organ of our body, is often plagued by cancer because of exposure to ultraviolet radiation from the sun. A report by Cui et al. (2007) in this issue of Cell explains	Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; Danish Canc Soc, Inst Canc Biol, Copenhagen, Denmark; Danish Canc Soc, Ctr Genotox Stress Res, Copenhagen, Denmark	Weizmann Institute of Science; Danish Cancer Society; Danish Cancer Society	Oren, M (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.	moshe.oren@weizmann.ac.il; jb@cancer.dk	Bartek, Jiri/G-5870-2014	Oren, Moshe/0000-0003-4311-7172	NATIONAL CANCER INSTITUTE [R37CA040099] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA 40099] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; Brash DE, 2006, BRIT J DERMATOL, V154, P8, DOI 10.1111/j.1365-2133.2006.07230.x; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Millington GWM, 2006, CLIN EXP DERMATOL, V31, P407, DOI 10.1111/j.1365-2230.2006.02128.x; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002	9	34	35	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					826	828		10.1016/j.cell.2007.02.027	http://dx.doi.org/10.1016/j.cell.2007.02.027			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350568	Bronze			2022-12-28	WOS:000245073400006
J	Poolman, B; Geertsma, ER; Slotboom, DJ				Poolman, Bert; Geertsma, Eric R.; Slotboom, Dirk-Jan			A missing link in membrane protein evolution	SCIENCE			English	Editorial Material							MULTIDRUG TRANSPORTER; ESCHERICHIA-COLI; TOPOLOGY; EMRE		Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; Univ Groningen, Zernile Inst Adv Mat, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Poolman, B (corresponding author), Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.poolman@rug.nl	Poolman, Bert/D-1882-2012	Geertsma, Eric R./0000-0002-2789-5444				Chang G, 2006, SCIENCE, V314, P1875, DOI 10.1126/science.314.5807.1875b; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; IBARRETXENABELA.I, 2003, EMBO J, V22, P6175; Ninio S, 2004, FEBS LETT, V562, P193, DOI 10.1016/S0014-5793(04)00240-6; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Rath A, 2006, J BIOL CHEM, V281, P15546, DOI 10.1074/jbc.M600434200; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x	10	11	12	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1229	1231		10.1126/science.1140073	http://dx.doi.org/10.1126/science.1140073			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332400	Green Submitted			2022-12-28	WOS:000244564700035
J	Wolfberg, AJ				Wolfberg, Adam J.			Becoming a physician: The patient as ally - Learning the pelvic examination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Tufts Univ New England Med Ctr, Boston, MA 02111 USA	Tufts Medical Center	Wolfberg, AJ (corresponding author), Tufts Univ New England Med Ctr, Boston, MA 02111 USA.							Berry RE, 2003, AM J OBSTET GYNECOL, V189, P634, DOI 10.1067/S0002-9378(03)00876-7; Ubel PA, 2003, AM J OBSTET GYNECOL, V188, P575, DOI 10.1067/mob.2003.85	2	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2007	356	9					889	890		10.1056/NEJMp068016	http://dx.doi.org/10.1056/NEJMp068016			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140HV	17329694				2022-12-28	WOS:000244496400002
J	Bush, RW				Bush, Roger W.			Reducing waste in US health care systems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VENTILATOR-ASSOCIATED PNEUMONIA; COSTS; QUALITY		Virginia Mason Med Ctr, Seattle, WA 98101 USA	Virginia Mason Medical Center	Bush, RW (corresponding author), Virginia Mason Med Ctr H8GME, 925 Seneca St, Seattle, WA 98101 USA.	roger.bush@vmmc.org						[Anonymous], ERR IS HUM BUILD SAF; Bodenheimer T, 2005, ANN INTERN MED, V142, P996, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00009; Bodenheimer T, 2005, ANN INTERN MED, V143, P26, DOI 10.7326/0003-4819-143-1-200507050-00007; Bodenheimer T, 2005, ANN INTERN MED, V142, P932, DOI 10.7326/0003-4819-142-11-200506070-00012; Bodenheimer T, 2005, ANN INTERN MED, V142, P847, DOI 10.7326/0003-4819-142-10-200505170-00010; *COMM FUND, 2005 BIENN HLTH INS; *COMM FUND, PUBL VIEWS SHAP FUT; *I HEALTHC IMPR, 5 MILL LIV CAMP; *I HEALTHC IMPR, PREV VENT ACQ PNEUM; Ibrahim EH, 2001, CHEST, V120, P555, DOI 10.1378/chest.120.2.555; Institute of Medicine (IOM), CROSS QUAL CHASM IOM; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Ohno T., 2019, TOYOTA PRODUCTION SY, V1st ed., DOI [10.4324/9780429273018, DOI 10.4324/9780429273018]; *RAND HLTH, 1 NAT REP CARD QUAL; Rello J, 2002, CHEST, V122, P2115, DOI 10.1378/chest.122.6.2115; *US BUR CENS, 2005, INC POV HLTH INS COV	16	73	75	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2007	297	8					871	874		10.1001/jama.297.8.871	http://dx.doi.org/10.1001/jama.297.8.871			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140DS	17327529				2022-12-28	WOS:000244485000030
J	McLellan, F				McLellan, Faith			Medicalisation: a medical nemesis	LANCET			English	Editorial Material									Lancet, New York, NY 10010 USA		McLellan, F (corresponding author), Lancet, New York, NY 10010 USA.			McLellan, Faith/0000-0003-0744-1450					0	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2007	369	9562					627	628		10.1016/S0140-6736(07)60293-1	http://dx.doi.org/10.1016/S0140-6736(07)60293-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	141RO	17321297				2022-12-28	WOS:000244596600009
J	Wu, ZY; Sullivan, SG; Wang, Y; Rotheram-Borus, M; Detels, R				Wu, Zunyou; Sullivan, Sheena G.; Wang, Yu; Rotheram-Borus, MaryJane; Detels, Roger			Evolution of China's response to HIV/AIDS	LANCET			English	Article							SEXUALLY-TRANSMITTED-DISEASES; COMMERCIAL PLASMA DONORS; HIV RISK BEHAVIOR; HIGH PREVALENCE; COLLEGE-STUDENTS; DRUG-USERS; SEX; MEN; TRANSMISSION; INFECTION	Four factors have driven China's response to the HIV/AIDS pandemic: (1) existing government structures and networks of relationships; (2) increasing scientific information; (3) external influences that underscored the potential consequences of an HIV/AIDS pandemic and thus accelerated strategic planning; and (4) increasing political commitment at the highest levels. China's response culminated in legislation to control HIV/AIDS-the AIDS Prevention and Control Regulations. Three major initiatives are being scaled up concurrently. First, the government has prioritised interventions to control the epidemic in injection drug users, sex workers, men who have sex with men, and plasma donors. Second, routine HIV testing is being implemented in populations at high risk of infection. Third, the government is providing treatment for infected individuals. These bold programmes have emerged from a process of gradual and prolonged dialogue and collaboration between officials at every level of government, researchers, service providers, policymakers, and politicians, and have led to decisive action.	Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA; Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; Edith Cowan Univ, Perth, WA, Australia; Univ Calif Los Angeles, Ctr HIV Identificat, Prevent & Treatment Serv, Los Angeles, CA USA	University of California System; University of California Los Angeles; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Edith Cowan University; University of California System; University of California Los Angeles	Detels, R (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA.	detels@ucla.edu		Sullivan, Sheena G./0000-0002-0856-0294	FIC NIH HHS [D43TW000013, D43 TW000013, U2R TW006918, U2R TW006918-03, U2R TW006918-02] Funding Source: Medline; NIAID NIH HHS [U19 AI051915, U19AI51915] Funding Source: Medline; PHS HHS [U2RTW006918] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW000013, U2RTW006918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOWTELL W, 2006, FIGHTING RISING TIDE, P19; Chen HT, 2005, AIDS EDUC PREV, V17, P503, DOI 10.1521/aeap.2005.17.6.503; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; Choi KH, 2006, AIDS EDUC PREV, V18, P33, DOI 10.1521/aeap.2006.18.1.33; Choi KH, 2004, AIDS EDUC PREV, V16, P19, DOI 10.1521/aeap.16.1.19.27721; Choi KH, 2003, LANCET, V361, P2125, DOI 10.1016/S0140-6736(03)13690-2; DAIS S, 2004, HUMAN RIGHTS WATCH, V17, P1; Gibson DR, 1999, AIDS, V13, P1807, DOI 10.1097/00002030-199910010-00002; Gil VE, 1996, SOC SCI MED, V42, P141, DOI 10.1016/0277-9536(95)00064-X; Gill B, 2004, DEFUSING CHINAS TIME; Gossop M, 2002, AIDS CARE, V14, P77, DOI 10.1080/09540120220097955; HE Z, 2005, CHINA DAILY     0528; HEREK GM, 1999, AM BEHAV SCI, V42, P1102; Hesketh T, 2005, SEX TRANSM INFECT, V81, P108, DOI 10.1136/sti.2004.009704; Humeniuk R, 2005, DRUG ALCOHOL REV, V24, P285, DOI 10.1080/09595230500167528; HUSAIN L, 2004, LEEDS E ASIA PAPERS; Jiang J, 2006, SEX TRANSM DIS, V33, P118, DOI 10.1097/01.olq.0000199763.14766.2b; Keyuan Zou, 2001, CRIMINAL LAW FORUM, P459; Koralage Nadeeja, 2004, BMJ, V328, P975, DOI 10.1136/bmj.328.7446.975-a; Kulsudjarit K, 2004, ANN NY ACAD SCI, V1025, P446, DOI 10.1196/annals.1316.055; Li D, 2003, LAW POLICIES REGULAT; Li XM, 2004, HEALTH PROMOT INT, V19, P345, DOI 10.1093/heapro/dah308; Lieber E, 2006, AIDS BEHAV, V10, P463, DOI 10.1007/s10461-005-9047-5; LIU B, 2006, NEEDLE EXCHANGE PROG; Liu H, 2006, SEX TRANSM DIS, V33, P68, DOI 10.1097/01.olq.0000187266.29927.11; Liu HJ, 2006, SEX TRANSM DIS, V33, P111, DOI 10.1097/01.olq.0000199762.28231.ee; Ma Y., 1990, CHINESE J EPIDEMIOLO, V11, P184, DOI DOI 10.1007/S10461-010-9797-6; Malcolm A., 1998, CRITICAL PUBLIC HLTH, V8, P347, DOI [10.1080/09581599808402920, DOI 10.1080/09581599808402920]; Marsch LA, 1998, ADDICTION, V93, P515, DOI 10.1046/j.1360-0443.1998.9345157.x; *MIN HLTH CHIN, 2005, CHIN HEALTHC SYST RE; *MIN HLTH PEOPL RE, 1987, 2 MIN HLTH PEOPL REP; *MIN HLTH STAT DEV, 1998, 38 MIN HLTH STAT DEV; Ministry of Health of the People's Republic of China, 1986, 49 MIN HLTH PEOPL RE; *NAT DRUG AB SURV, 2001, ANN REP DRUG SURV 20; *NAT PEOPL C STAND, 1991, DEC STRICT PROH PROS; *NAT PEOPL C STAND, 1990, DEC PROH NARC DRUGS; *NAT PEOPL C STAND, 1987, 46 NAT PEOPL C STAND; *NAT PEOPL C STAND, 1998, 93 NAT PEOPL C STAND; *PEOPL REP CHIN ST, 2001, 40 PEOPL REP CHIN ST; Qian Han-Zhu, 2006, Harm Reduct J, V3, P4, DOI 10.1186/1477-7517-3-4; Qian ZH, 2005, SEX TRANSM INFECT, V81, P442, DOI 10.1136/sti.2004.014258; Saich J, 2006, AIDS SOCIAL POLICY C, P177; Settle Edmund, 2003, AIDS CHINA ANNOTATED; *STAT COUNC AIDS W, 2004, JOINT ASS HIV AIDS P; *STAT COUNC PEOPL, 2006, CHIN ACT PLAN RED PR; Sullivan LE, 2005, ADDICTION, V100, P150, DOI 10.1111/j.1360-0443.2004.00963.x; Teixeira PR, 2004, AIDS, V18, pS5, DOI 10.1097/00002030-200406003-00002; *UNAIDS, STIGM DISCR FACT SHE; United Nations Theme Group on HIV/AIDS, 2002, CHIN TIT PER 2001 UP; *UNODC, 2006, WORLD DRUG REP; WANG LH, 2006, EPIDEMICS RESPONSES; Watts J, 2006, LANCET, V367, P803, DOI 10.1016/S0140-6736(06)68318-9; Watts J, 2003, LANCET, V362, P1983, DOI 10.1016/S0140-6736(03)15085-4; *WHO UNAIDS MIN HL, 2006, 2005 UPD HIV AIDS EP; *WHO UNFPA UNICEF, 2000, NEW DAT PREV MOTH TO; Wong WCW, 2006, SEX TRANSM INFECT, V82, P127, DOI 10.1136/sti.2005.016790; WU Z, 2002, SUSTAINABILITY EFFEC; WU Z, 1997, FINAL REPORT INTERVE; Wu Z., 2004, 15 INT AIDS C BANGK; WU Z, 2002, 14 INT AIDS C BARC S; WU Z, 2006, EPIDEMICS RESPONSES; WU Z, 2002, EVALUATION NEEDLE SO; WU Z, 1998, 12 INT AIDS C GEN SW; Wu Z., 2005, INT C RED DRUG REL H; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; WU ZY, 1995, LANCET, V346, P61, DOI 10.1016/S0140-6736(95)92698-4; Wu ZY, 2005, AIDS EDUC PREV, V17, P12, DOI 10.1521/aeap.17.1.12.58686; Wu ZY, 2004, AIDS EDUC PREV, V16, P7, DOI 10.1521/aeap.16.3.5.7.35521; Wu ZY, 1999, AIDS EDUC PREV, V11, P353; Wu ZY, 2001, HEALTH POLICY PLANN, V16, P41, DOI 10.1093/heapol/16.1.41; Xue B, 2005, INT J STD AIDS, V16, P459, DOI 10.1258/0956462054308477; Yang HM, 2005, SEX TRANSM DIS, V32, P270, DOI 10.1097/01.olq.0000162360.11910.5a; Yang HM, 2004, AIDS EDUC PREV, V16, P557, DOI 10.1521/aeap.16.6.557.53792; Yap L., 2002, International Journal of Drug Policy, V13, P57, DOI 10.1016/S0955-3959(01)00118-9; Zhang BC, 2005, CELL RES, V15, P858, DOI 10.1038/sj.cr.7290359; Zhang F., 2006, AIDS SOCIAL POLICY C, P96; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zhang HS, 2004, AIDS BEHAV, V8, P105, DOI 10.1023/B:AIBE.0000030242.46843.71; Zhang K, 1999, AIDS CARE, V11, P581, DOI 10.1080/09540129947730; Zhao CZ, 2004, ANN NY ACAD SCI, V1025, P439, DOI 10.1196/annals.1316.054; Zhuang K, 2003, JAIDS-J ACQ IMM DEF, V33, P649, DOI 10.1097/00126334-200308150-00015; Zunyou Wu, 2006, FIGHTING RISING TIDE, P76; 2006, XINHUA NEWS AGE 0516; 2006, XINHUA NEWS AGE 0323; 2005, PEOPLES DAILY O 0319; 1996, AIDS WKLY PLUS  0812, P19; 2006, XINHUA NEWS AGE 0226; 2006, CHINA DAILY     0405; 2004, CHINA DAILY     1130; 2006, CHINA DAILY     0223	90	385	431	0	65	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2007	369	9562					679	690		10.1016/S0140-6736(07)60315-8	http://dx.doi.org/10.1016/S0140-6736(07)60315-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	141RO	17321313	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000244596600029
J	Kamien, RD				Kamien, Randall D.			Better geometry through chemistry	SCIENCE			English	Editorial Material									Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	University of Pennsylvania	Kamien, RD (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.	kamien@physics.upenn.edu		Kamien, Randall/0000-0003-1598-5626				DiDonna BA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.215504; Feynman Richard P, 1963, FEYNMAN LECT PHYS, V2; Klein Y, 2007, SCIENCE, V315, P1116, DOI 10.1126/science.1135994; Lobkovsky AE, 1997, PHYS REV E, V55, P1577, DOI 10.1103/PhysRevE.55.1577; Maldovan M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165123	6	12	12	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2007	315	5815					1083	1084		10.1126/science.1138506	http://dx.doi.org/10.1126/science.1138506			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	138UA	17322048				2022-12-28	WOS:000244387600022
J	Kuncel, NR; Hezlett, SA				Kuncel, Nathan R.; Hezlett, Sarah A.			Assessment - Standardized tests predict graduate students' success	SCIENCE			English	Editorial Material							SCHOLASTIC APTITUDE-TEST; TEST-SCORES; MEDICAL-SCHOOL; ACADEMIC-PERFORMANCE; ADMISSION TEST; MCAT SCORES; LAW-SCHOOL; TEST BIAS; VALIDITY; SELECTION		Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; Personnel Decis Res Inst, Minneapolis, MN 55402 USA	University of Minnesota System; University of Minnesota Twin Cities	Kuncel, NR (corresponding author), Univ Minnesota, Dept Psychol, 75 E River Rd, Minneapolis, MN 55455 USA.	kunce001@umn.edu						Allalouf A, 1998, J EDUC MEAS, V35, P31, DOI 10.1111/j.1745-3984.1998.tb00526.x; American Educational Research Association, 1999, STAND ED PSYCH TEST; BECKER BJ, 1990, REV EDUC RES, V60, P373, DOI 10.3102/00346543060003373; BRAUN HI, 1985, 7913P GRE ED TEST SE; CLEARY TA, 1968, J EDUC MEAS, V5, P115, DOI 10.1111/j.1745-3984.1968.tb00613.x; GAUGLER BB, 1987, J APPL PSYCHOL, V72, P493, DOI 10.1037/0021-9010.72.3.493; HIGGINS JPT, 2005, COCHRANE HDB SYSTEMA; HOJAT M, 1985, J MED EDUC, V60, P911; Hunter J.E., 1990, METHODS META ANAL CO, DOI DOI 10.4135/9781483398105; JONES RF, 1984, J MED EDUC, V59, P527; Julian ER, 2005, ACAD MED, V80, P910, DOI 10.1097/00001888-200510000-00010; Koenig JA, 1998, ACAD MED, V73, P1095, DOI 10.1097/00001888-199810000-00021; KULIK JA, 1984, PSYCHOL BULL, V95, P179, DOI 10.1037/0033-2909.95.2.179; Kuncel NR, 2004, J PERS SOC PSYCHOL, V86, P148, DOI 10.1037/0022-3514.86.1.148; Kuncel NR, 2001, PSYCHOL BULL, V127, P162, DOI 10.1037/0033-2909.127.1.162; KUNCEL NR, IN PRESS ACAD MANAGE; Kuncel NR, 2005, AM J PHARM EDUC, V69, P339, DOI DOI 10.5688/AJ690351; LEARY LF, 1983, 831 GMAC RR; LINN RL, 1975, J LEGAL EDUC, V27, P293; LINN RL, 1984, J EDUC MEAS, V21, P245, DOI 10.1111/j.1745-3984.1984.tb01032.x; MESSICK S, 1981, PSYCHOL BULL, V89, P191, DOI 10.1037/0033-2909.89.2.191; Powers DE, 1999, J EDUC MEAS, V36, P93, DOI 10.1111/j.1745-3984.1999.tb00549.x; POWERS DE, 1984, J EDUC PSYCHOL, V76, P266; POWERS DE, 1985, J EDUC MEAS, V22, P121, DOI 10.1111/j.1745-3984.1985.tb01052.x; SCHMITT N, 1984, PERS PSYCHOL, V37, P407, DOI 10.1111/j.1744-6570.1984.tb00519.x; Sireci SG, 2006, EDUC PSYCHOL MEAS, V66, P305, DOI 10.1177/0013164405282455; Stark S, 2004, J APPL PSYCHOL, V89, P497, DOI 10.1037/0021-9010.89.3.497; STRICKER LJ, 1993, J EDUC PSYCHOL, V85, P710, DOI 10.1037/0022-0663.85.4.710; Taylor HC, 1939, J APPL PSYCHOL, V23, P565, DOI 10.1037/h0057079; Thorndike R.L., 1949, PERSONNEL SELECTION; VANCOUVER JB, 1990, ACAD MED, V65, P694, DOI 10.1097/00001888-199011000-00012; Wrightman L. F., 1998, LSAC NATL LONGITUDIN; WRIGHTMAN LF, 1990, RR9003 LAW SCH ADM C; WRIGHTMAN LF, 1990, RR9002 LSAC; WRIGHTMAN LF, 2000, RR9905 LAW SCH ADM C; YOUNG JW, 1991, J EDUC MEAS, V28, P37, DOI 10.1111/j.1745-3984.1991.tb00342.x; Zwick R., 2002, FAIR GAME	37	163	167	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2007	315	5815					1080	1081		10.1126/science.1136618	http://dx.doi.org/10.1126/science.1136618			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	138UA	17322046				2022-12-28	WOS:000244387600020
J	Day, JW; Boesch, DF; Clairain, EJ; Kemp, GP; Laska, SB; Mitsch, WJ; Orth, K; Mashriqui, H; Reed, DJ; Shabman, L; Simenstad, CA; Streever, BJ; Twilley, RR; Watson, CC; Wells, JT; Whigham, DF				Day, John W., Jr.; Boesch, Donald F.; Clairain, Ellis J.; Kemp, G. Paul; Laska, Shirley B.; Mitsch, William J.; Orth, Kenneth; Mashriqui, Hassan; Reed, Denise J.; Shabman, Leonard; Simenstad, Charles A.; Streever, Bill J.; Twilley, Robert R.; Watson, Chester C.; Wells, John T.; Whigham, Dennis F.			Restoration of the Mississippi Delta: Lessons from Hurricanes Katrina and Rita	SCIENCE			English	Review							WETLAND LOSS; RIVER DELTA; LAND LOSS; LOUISIANA; BASIN; SEDIMENTATION; VEGETATION; SHORELINE; ENERGY; PLAIN	Hurricanes Katrina and Rita showed the vulnerability of coastal communities and how human activities that caused deterioration of the Mississippi Deltaic Plain (MDP) exacerbated this vulnerability. The MDP formed by dynamic interactions between river and coast at various temporal and spatial scales, and human activity has reduced these interactions at all scales. Restoration efforts aim to re-establish this dynamic interaction, with emphasis on reconnecting the river to the deltaic plain. Science must guide MDP restoration, which will provide insights into delta restoration elsewhere and generally into coasts facing climate change in times of resource scarcity.	Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; Univ Maryland, Ctr Environm Sci, Cambridge, MD 21613 USA; USA, Corps Engineers, Engineer Res & Dev Ctr, Vicksburg, MS 39180 USA; Louisiana State Univ, Hurricane Ctr, Baton Rouge, LA 70803 USA; Univ New Orleans, Dept Sociol, New Orleans, LA 70148 USA; Ohio State Univ, Columbus, OH 43202 USA; USA, Inst Water Resources, Corps Engineers, Alexandria, VA 22315 USA; Louisiana State Univ, Dept Civil & Environm Engn, Baton Rouge, LA 70803 USA; Univ New Orleans, Dept Geol & Geophys, New Orleans, LA 70148 USA; Resources Future Inc, Washington, DC 20036 USA; Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98015 USA; BP Explorat Alaska, Anchorage, AK 99519 USA; Colorado State Univ, Engn Res Ctr, Ft Collins, CO 80523 USA; Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA	Louisiana State University System; Louisiana State University; University System of Maryland; University of Maryland Center for Environmental Science; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Geospatial Research Laboratory (GRL); Louisiana State University System; Louisiana State University; University of Louisiana System; University of New Orleans; University System of Ohio; Ohio State University; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Louisiana State University System; Louisiana State University; University of Louisiana System; University of New Orleans; Resources for the Future; University of Washington; University of Washington Seattle; BP; Colorado State University; William & Mary; Virginia Institute of Marine Science; Smithsonian Institution; Smithsonian Environmental Research Center	Day, JW (corresponding author), Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA.	johnday@lsu.edu		Whigham, Dennis/0000-0003-1488-820X; Boesch, Donald/0000-0002-8154-133X				[Anonymous], 2003, WATER AIR SOIL POLL, DOI DOI 10.1007/s10584-010-0003-7; BARRAS JA, 1994, 9401 NAT WETL RES CT; BAUMANN RH, 1984, SCIENCE, V224, P1093, DOI 10.1126/science.224.4653.1093; Boesch D.F., 2006, NEW FRAMEWORK PLANNI; BOESCH DF, 1994, J COASTAL RES, V20; Boumans RMJ, 1997, ECOL ENG, V9, P37, DOI 10.1016/S0925-8574(97)00028-1; BRITSCH LD, 1993, J COASTAL RES, V9, P324; CAHOON DR, 1995, MAR GEOL, V128, P1, DOI 10.1016/0025-3227(95)00087-F; Coleman JM, 1998, J COASTAL RES, V14, P698; Conner W.H., 1989, Wetlands Ecology and Management, V1, P45; Costanza R, 2006, FRONT ECOL ENVIRON, V4, P465, DOI 10.1890/1540-9295(2006)4[465:ANVFNO]2.0.CO;2; Danielsen F, 2005, SCIENCE, V310, P643, DOI 10.1126/science.1118387; Day JW, 2000, ESTUARIES, V23, P425, DOI 10.2307/1353136; Day JW, 2003, BIOTECHNOL ADV, V22, P135, DOI 10.1016/j.biotechadv.2003.08.012; Day JW, 1997, COAST MANAGE, V25, P115, DOI 10.1080/08920759709362315; Day JW, 2005, ECOL ENG, V24, P253, DOI 10.1016/j.ecoleng.2004.11.015; DAY RH, 1990, ENVIRON MANAGE, V14, P229, DOI 10.1007/BF02394040; Dean RG, 2006, COAST ENG, V53, P149, DOI 10.1016/j.coastaleng.2005.10.005; Deffeyes Kenneth, 2001, HUBBERTS PEAK IMPEND; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Fisk H.N., 1954, J SEDIMENT PETROL, V24, P76, DOI [10.1306/D4269661-2B26-11D7-8648000102C1865D, DOI 10.1306/D4269661-2B26-11D7-8648000102C1865D]; Gagliano S.M., 1981, T GULF COAST ASS GEO, V31, P295; Gramling R, 2005, J COASTAL RES, P112; Hall C, 2003, NATURE, V426, P318, DOI 10.1038/nature02130; Hoyos CD, 2006, SCIENCE, V312, P94, DOI 10.1126/science.1123560; *INT PERF EV TASK, 2006, 0003806 MMTF US ARM; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; KESEL RH, 1989, ENVIRON GEOL WATER S, V13, P183, DOI 10.1007/BF01665368; Koch EW, 1999, MAR ECOL PROG SER, V184, P63, DOI 10.3354/meps184063; LASKA S, 2006, NAT NAZ OBSERVER, V31, P2; *LOUIS WETL CONS R, 1998, COAST 2050 SUST COAS; LOVELACE JK, 1994, 94371 US GEOL SURV; Mashriqui HS, 2006, COASTAL ENV WATER QU, P481; MENDELSSOHN IA, 1991, J COASTAL RES, V7, P137; Mendelssohn IA, 2003, ECOL ENG, V21, P115, DOI 10.1016/j.ecoleng.2003.09.006; Mendelssohn IA, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P59; Mitsch WJ, 2001, BIOSCIENCE, V51, P373, DOI 10.1641/0006-3568(2001)051[0373:RNLTTG]2.0.CO;2; Mitsch WJ, 2006, ECOL ENG, V26, P55, DOI 10.1016/j.ecoleng.2005.09.005; Mitsch WJ, 2003, ECOLOGICAL ENG ECOSY; MORTON RA, 2002, GULF COAST ASS GEOL, V52, P707; *NAT RES COUNC, 2005, DRAW LOUIS NEW MAP A; *NAT WETL RES CTR, US GEOL SURV; PENLAND S, 1988, J SEDIMENT PETROL, V58, P932; RABALAIS NN, 1994, ESTUARIES, V17, P850, DOI 10.2307/1352753; RAUPACH MR, 1981, ANNU REV FLUID MECH, V13, P97, DOI 10.1146/annurev.fl.13.010181.000525; REID RO, 1976, J WATERWAY DIV-ASCE, V102, P61; Roberts HH, 1997, J COASTAL RES, V13, P605; Saucier R.T., 1994, GEOMORPHOLOGY QUATER, V1; Stone GW, 1998, J COASTAL RES, V14, P900; SWENSON EM, 1987, ESTUAR COAST SHELF S, V24, P599, DOI 10.1016/0272-7714(87)90101-6; SWERISON EM, 1994, HURRICAN ANDREW IN L; Turner R.E., 2002, APPROACHES COASTAL W; Turner RE, 2006, SCIENCE, V314, P449, DOI 10.1126/science.1129116; *US ARM CORPS ENG, 1963, HURR STUD MORG CIT L; *US ARM CORPS ENG, 2004, LOUIS COAST AR LOUIS; WELLS JT, 1987, ESTUAR COAST SHELF S, V25, P111, DOI 10.1016/0272-7714(87)90029-1	57	506	514	8	350	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1679	1684		10.1126/science.1137030	http://dx.doi.org/10.1126/science.1137030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379799				2022-12-28	WOS:000245106900029
J	Liu, XG; Yue, YL; Li, B; Nie, YL; Li, W; Wu, WH; Ma, LG				Liu, Xigang; Yue, Yanling; Li, Bin; Nie, Yanli; Li, Wei; Wu, Wei-Hua; Ma, Ligeng			A G protein-coupled receptor is a plasma membrane receptor for the plant hormone abscisic acid	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; GAMMA-SUBUNIT; ION CHANNELS; GENE; SYSTEM; GPA1; GCR1	The plant hormone abscisic acid (ABA) regulates many physiological and developmental processes in plants. The mechanism of ABA perception at the cell surface is not understood. Here, we report that a G protein-coupled receptor genetically and physically interacts with the G protein a subunit GPA1 to mediate all known ABA responses in Arabidopsis. Overexpressing this receptor results in an ABA-hypersensitive phenotype. This receptor binds ABA with high affinity at physiological concentration with expected kinetics and stereospecificity. The binding of ABA to the receptor leads to the dissociation of the receptor-GPA1 complex in yeast. Our results demonstrate that this G protein-coupled receptor is a plasma membrane ABA receptor.	Natl Inst Biol Sci, Beijing 102206, Peoples R China; Hebei Normal Univ, Mol & Cellular Biol Lab, Shiziazhuang 050016, Hebei, Peoples R China; China Agr Univ, State Key Lab Plant Physiol & Biochem, Coll Biol Sci, Beijing 100094, Peoples R China	National Institute of Biological Sciences, Beijing; Hebei Normal University; China Agricultural University	Ma, LG (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China.	maligeng@nibs.ac.cn						ANDERSON BE, 1994, PLANT PHYSIOL, V104, P1177, DOI 10.1104/pp.104.4.1177; Assmann SM, 2005, SCIENCE, V310, P71, DOI 10.1126/science.1118580; Colucci G, 2002, P NATL ACAD SCI USA, V99, P4736, DOI 10.1073/pnas.072087699; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; GILROY S, 1992, P NATL ACAD SCI USA, V89, P3591, DOI 10.1073/pnas.89.8.3591; Jeannette E, 1999, PLANT J, V18, P13, DOI 10.1046/j.1365-313X.1999.00423.x; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; MA H, 1990, P NATL ACAD SCI USA, V87, P3821, DOI 10.1073/pnas.87.10.3821; MA H, 1994, PLANT MOL BIOL, V26, P1611, DOI 10.1007/BF00016493; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Plakidou-Dymock S, 1998, CURR BIOL, V8, P315, DOI 10.1016/S0960-9822(98)70131-9; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046; WARD JM, 1995, PLANT CELL, V7, P833, DOI 10.1105/tpc.7.7.833; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	25	151	187	3	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1712	1716		10.1126/science.1135882	http://dx.doi.org/10.1126/science.1135882			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17347412				2022-12-28	WOS:000245106900040
J	Clarke, JTR				Clarke, Joe T. R.			Narrative review: Fabry disease	ANNALS OF INTERNAL MEDICINE			English	Review							ENZYME-REPLACEMENT THERAPY; ALPHA-GALACTOSIDASE-A; QUALITY-OF-LIFE; CLINICAL-MANIFESTATIONS; PERIPHERAL-NERVE; CEREBRAL HYPERPERFUSION; RENAL-DISEASE; GASTROINTESTINAL SYMPTOMS; CARDIAC MANIFESTATIONS; HEMODIALYSIS-PATIENTS	Fabry disease is an X-linked, hereditary, lysosomal storage disease caused by deficiency of the enzyme alpha-galactosidase A, which results in the accumulation of the neutral glycosphingolipid globotriaosylceramide (Gb3) in the walls of small blood vessels, nerves, dorsal root ganglia, renal glomerular and tubular epithelial cells, and cardiomyocytes. It is a complex, multisystem disorder that is characterized clinically by chronic pain and acroparesthesia, gastrointestinal disturbances, characteristic skin lesions (angiokeratomata), progressive renal impairment, cardiomyopathy, and stroke. Enzyme replacement therapy (ERT) with intravenous infusions of recombinant human a-galactosidase A consistently decreases Gb3 levels in plasma and clears lysosomal inclusions from vascular endothelial cells. The effects of ERT on other tissues are not as obvious, suggesting that treatment must be initiated early in the course of the disease to be optimally effective or that some complications of the disease are not responsive to enzymes delivered intravenously.	Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON, Canada; CHU Sherbrooke, Hop Fleurimont, Sherbrooke, PQ J1H 5N4, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Sherbrooke	Clarke, JTR (corresponding author), Hosp Sick Children, Div Clin & Metab Genet, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jtrc@sickkids.ca						Baehner F, 2003, J INHERIT METAB DIS, V26, P617, DOI 10.1023/B:BOLI.0000005658.14563.77; Banerjee T K, 2004, Eur Rev Med Pharmacol Sci, V8, P275; Banikazemi M, 2005, MOL GENET METAB, V85, P255, DOI 10.1016/j.ymgme.2005.04.009; Banikazemi M, 2007, ANN INTERN MED, V146, P77, DOI 10.7326/0003-4819-146-2-200701160-00148; Barbey F, 2006, ARTERIOSCL THROM VAS, V26, P839, DOI 10.1161/01.ATV.0000209649.60409.38; BISHOP DF, 1981, J BIOL CHEM, V256, P1307; BISHOP DF, 1988, P NATL ACAD SCI USA, V85, P3903, DOI 10.1073/pnas.85.11.3903; BISHOP DF, 1986, P NATL ACAD SCI USA, V83, P4859, DOI 10.1073/pnas.83.13.4859; Brady RO, 2006, ANNU REV MED, V57, P283, DOI 10.1146/annurev.med.57.110104.115650; Branton MH, 2002, MEDICINE, V81, P122, DOI 10.1097/00005792-200203000-00003; CABLE WJL, 1982, NEUROLOGY, V32, P347, DOI 10.1212/WNL.32.4.347; Chimenti C, 1999, Cardiologia, V44, P469; CLARKE JTR, 1976, BIOCHIM BIOPHYS ACTA, V431, P317, DOI 10.1016/0005-2760(76)90152-1; COLUCCI WS, 1982, NEW ENGL J MED, V307, P926, DOI 10.1056/NEJM198210073071505; Cybulla M, 2005, AM J KIDNEY DIS, V45, pE82, DOI 10.1053/j.ajkd.2005.01.036; Deegan PB, 2006, J MED GENET, V43, P347, DOI 10.1136/jmg.2005.036327; Dehout F, 2004, J INHERIT METAB DIS, V27, P499, DOI 10.1023/B:BOLI.0000037342.59612.69; Desnick RJ, 2004, J PEDIATR-US, V144, pS20, DOI 10.1016/j.jpeds.2004.01.051; Dobrovolny R, 2005, J MOL MED, V83, P647, DOI 10.1007/s00109-005-0656-2; Dutsch M, 2002, J CLIN NEUROPHYSIOL, V19, P575; EFTHIMIOU J, 1986, POSTGRAD MED J, V62, P285, DOI 10.1136/pgmj.62.726.285; Elliott PM, 2006, HEART, V92, P357, DOI 10.1136/hrt.2004.054015; Eng CM, 2006, GENET MED, V8, P539, DOI 10.1097/01.gim.0000237866.70357.c6; FILLINGKATZ MR, 1989, NEUROLOGY, V39, P598, DOI 10.1212/WNL.39.4.598; *FOS INV, 2003, ACTA PAEDIATR, V92, P14; *FOS INV, 2005, ACTA PAEDIATR, V94, P24; Frustaci A, 2001, NEW ENGL J MED, V345, P25, DOI 10.1056/NEJM200107053450104; GADOTH N, 1983, J MED GENET, V20, P309, DOI 10.1136/jmg.20.4.309; GEMIGNANI F, 1984, EUR NEUROL, V23, P173, DOI 10.1159/000115700; Germain DP, 2001, CONTRIB NEPHROL, V136, P234; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Giacomini PS, 2004, CAN J NEUROL SCI, V31, P112, DOI 10.1017/S0317167100002936; Gold KF, 2002, QUAL LIFE RES, V11, P317, DOI 10.1023/A:1015511908710; GOLDMAN ME, 1986, J AM COLL CARDIOL, V7, P1157, DOI 10.1016/S0735-1097(86)80238-8; Gomes I, 2003, J NEUROL SCI, V214, P21, DOI 10.1016/S0022-510X(03)00172-2; GREWAL RP, 1992, ACTA NEUROL BELG, V92, P36; GREWAL RP, 1992, CLIN NEUROL NEUROSUR, V94, P177, DOI 10.1016/0303-8467(92)90079-I; Grunfeld JP, 2001, J INHERIT METAB DIS, V24, P71, DOI 10.1023/A:1012475908718; Gupta S, 2005, MEDICINE, V84, P261, DOI 10.1097/01.md.0000178976.62537.6b; Hauser AC, 2004, J INTERN MED, V255, P629, DOI 10.1111/j.1365-2796.2004.01300.x; HELIN I, 1979, SCAND J UROL NEPHROL, V13, P335, DOI 10.3109/00365597909179548; Hilz MJ, 2004, NEUROLOGY, V62, P1066, DOI 10.1212/01.WNL.0000118207.84514.40; Hoffmann B, 2005, J MED GENET, V42, P247, DOI 10.1136/jmg.2004.025791; Hoffmann B, 2004, EUR J GASTROEN HEPAT, V16, P1067, DOI 10.1097/00042737-200410000-00020; Ichinose Mayuri, 2005, Clin Exp Nephrol, V9, P228, DOI 10.1007/s10157-005-0369-4; *INT COLL FABR DIS, 2001, NEW ENGL J MED, V345, P9; Jardim L, 2004, J INHERIT METAB DIS, V27, P229, DOI 10.1023/B:BOLI.0000028794.04349.91; Kalliokoski RJ, 2006, J INHERIT METAB DIS, V29, P112, DOI 10.1007/s10545-006-0221-3; Kampmann C, 2002, Z KARDIOL, V91, P786, DOI 10.1007/s00392-002-0848-5; KEUSCH GT, 1995, INFECT IMMUN, V63, P1138, DOI 10.1128/IAI.63.3.1138-1141.1995; Ko YH, 1996, ARCH PATHOL LAB MED, V120, P86; Kolodny EH, 2002, J AM SOC NEPHROL, V13, pS150, DOI 10.1097/01.ASN.0000015239.57436.18; KORNREICH R, 1989, T ASSOC AM PHYSICIAN, V102, P30; Lee K, 2003, GLYCOBIOLOGY, V13, P305, DOI 10.1093/glycob/cwg034; Linhart A, 2000, AM HEART J, V139, P1101, DOI 10.1067/mhj.2000.105105; Linhart A, 2002, ACTA PAEDIATR, V91, P15, DOI 10.1080/080352502762457851; Linhart A, 2001, J INHERIT METAB DIS, V24, P75, DOI 10.1023/A:1012428009627; LOUISE CB, 1995, INFECT IMMUN, V63, P2766, DOI 10.1128/IAI.63.7.2766-2769.1995; Luciano CA, 2002, MUSCLE NERVE, V26, P622, DOI 10.1002/mus.10236; MacDermot J, 2001, EUR J PHARMACOL, V429, P121, DOI 10.1016/S0014-2999(01)01312-7; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; Mach L, 2002, BIOL CHEM, V383, P751, DOI 10.1515/BC.2002.078; Maier EM, 2006, ACTA PAEDIATR, V95, P30, DOI 10.1080/08035320600618809; Mehta A, 2004, EUR J CLIN INVEST, V34, P236, DOI 10.1111/j.1365-2362.2004.01309.x; MEHTA J, 1977, ADV CARDIOL, V21, P220; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Mignani R, 2004, KIDNEY INT, V65, P1381, DOI 10.1111/j.1523-1755.2004.00514.x; Moore DF, 2002, STROKE, V33, P525, DOI 10.1161/hs0202.102601; Moore DF, 2001, J NEUROIMAGING, V11, P303, DOI 10.1111/j.1552-6569.2001.tb00051.x; Moore DF, 2001, CIRCULATION, V104, P1506, DOI 10.1161/hc3801.096352; Moore DF, 2004, J MAGN RESON IMAGING, V20, P674, DOI 10.1002/jmri.20162; Mori T, 2000, EXP HEMATOL, V28, P1260, DOI 10.1016/S0301-472X(00)00538-5; Nakao S, 2003, KIDNEY INT, V64, P801, DOI 10.1046/j.1523-1755.2003.00160.x; NISSENSON AR, 1989, Q J MED, V73, P1055; Owens CL, 2006, HUM PATHOL, V37, P764, DOI 10.1016/j.humpath.2006.01.021; Palecek T, 2006, HEART VESSELS, V21, P13, DOI 10.1007/s00380-005-0852-6; PELLISSIER JF, 1981, MUSCLE NERVE, V4, P381, DOI 10.1002/mus.880040506; Perrot A, 2002, HERZ, V27, P699, DOI 10.1007/s00059-002-2429-9; Pisani A, 2005, AM J KIDNEY DIS, V46, P120, DOI 10.1053/j.ajkd.2005.03.016; Ramaswami U, 2006, ACTA PAEDIATR, V95, P86, DOI 10.1080/08035250500275022; Ries M, 2005, PEDIATRICS, V115, pE344, DOI 10.1542/peds.2004-1678; Ries M, 2003, J INHERIT METAB DIS, V26, P413, DOI 10.1023/A:1025127723729; Rolfs A, 2005, LANCET, V366, P1794, DOI 10.1016/S0140-6736(05)67635-0; Rosenthal D, 2004, AM J KIDNEY DIS, V44, DOI 10.1053/j.ajkd.2004.07.018; ROWE JW, 1978, ANGIOLOGY, V29, P562, DOI 10.1177/000331977802900709; Sakuraba H, 2006, J HUM GENET, V51, P180, DOI 10.1007/s10038-005-0342-9; Schafer Ellen, 2005, Hum Mutat, V25, P412; Schiffmann R, 2003, MUSCLE NERVE, V28, P703, DOI 10.1002/mus.10497; Schiffmann R, 2005, LANCET, V366, P1754, DOI 10.1016/S0140-6736(05)67636-2; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schiffmann R, 2006, VIRCHOWS ARCH, V448, P337, DOI 10.1007/s00428-005-0089-x; Schiffmann R, 2006, NEPHROL DIAL TRANSPL, V21, P345, DOI 10.1093/ndt/gfi152; Sessa A, 2003, J NEPHROL, V16, P310; Shah JS, 2005, AM J CARDIOL, V96, P842, DOI 10.1016/j.amjcard.2005.05.033; SHELLEY ED, 1995, PEDIATR DERMATOL, V12, P215, DOI 10.1111/j.1525-1470.1995.tb00161.x; SHETH KJ, 1980, ANN NEUROL, V7, P319, DOI 10.1002/ana.410070406; SIMA AAF, 1978, ARCH NEUROL-CHICAGO, V35, P291, DOI 10.1001/archneur.1978.00500290037007; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; *STUD MULT IT MAL, 2003, ACTA PAEDIATR, V92, P6; SUNG JH, 1979, J NEUROPATH EXP NEUR, V38, P87, DOI 10.1097/00005072-197903000-00001; Tanaka M, 2005, CLIN NEPHROL, V64, P281; Thurberg BL, 2004, J INVEST DERMATOL, V122, P900, DOI 10.1111/j.0022-202X.2004.22425.x; Thurberg BL, 2002, KIDNEY INT, V62, P1933, DOI 10.1046/j.1523-1755.2002.00675.x; VITAL A, 1984, CLIN NEUROPATHOL, V3, P168; VONSCHEIDT W, 1991, NEW ENGL J MED, V324, P395, DOI 10.1056/NEJM199102073240607; Weidemann F, 2003, CIRCULATION, V108, P1299, DOI 10.1161/01.CIR.0000091253.71282.04; Wendrich K, 2001, CONTRIB NEPHROL, V136, P241; Whybra C, 2001, J INHERIT METAB DIS, V24, P715, DOI 10.1023/A:1012993305223; Wilcox WR, 2004, AM J HUM GENET, V75, P65, DOI 10.1086/422366; Yam GHF, 2006, AM J PHYSIOL-CELL PH, V290, pC1076, DOI 10.1152/ajpcell.00426.2005	111	134	148	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2007	146	6					425	433		10.7326/0003-4819-146-6-200703200-00007	http://dx.doi.org/10.7326/0003-4819-146-6-200703200-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150CC	17371887				2022-12-28	WOS:000245192200004
J	Robine, JM; Michel, JP; Herrmann, FR				Robine, Jean-Marie; Michel, Jean-Pierre; Herrmann, Francois R.			Who will care for the oldest people?	BRITISH MEDICAL JOURNAL			English	Editorial Material							LONG-TERM-CARE; UNITED-STATES; HEALTH-CARE; DISABILITY; POPULATION; FUTURE		Geneva Sch Med, Dept Rehabil & Geriatr, CH-1226 Thonex Geneva, Switzerland; Univ Hosp, CH-1226 Thonex Geneva, Switzerland		Herrmann, FR (corresponding author), Geneva Sch Med, Dept Rehabil & Geriatr, CH-1226 Thonex Geneva, Switzerland.	francois.herrmann@hcuge.ch	HERRMANN, Francois R/B-6710-2011; Robine, Jean-Marie/F-5439-2011; HERRMANN, Francois/M-7390-2019	HERRMANN, Francois R/0000-0003-1312-1517; Robine, Jean-Marie/0000-0002-4111-6195; HERRMANN, Francois/0000-0003-1312-1517				Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; [Anonymous], 2003, LANCET, V361, P1755; CHERNEW ME, 2005, HLTH AFF MILLWOOD S2, V24; Cutler DM, 2003, NEW ENGL J MED, V349, P1084, DOI 10.1056/NEJMe038129; DYER O., 2006, BMJ-BRIT MED J, V332, P1052, DOI [10.1136/bmj.332.7549.1052-c, DOI 10.1136/BMJ.332.7549.1052-C]; Ebrahim S, 1999, LANCET, V353, P1990, DOI 10.1016/S0140-6736(99)00195-6; EVANS JG, 1995, BRIT MED J, V311, P644, DOI 10.1136/bmj.311.7006.644; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Goulding MR, 2003, JAMA-J AM MED ASSOC, V289, P1371; Heath I, 2002, BRIT MED J, V324, P1534, DOI 10.1136/bmj.324.7353.1534; Manton KG, 2001, P NATL ACAD SCI USA, V98, P6354, DOI 10.1073/pnas.111152298; Morris J, 2006, BRIT MED J, V332, P1166, DOI 10.1136/bmj.38835.6698540.47; OGAWA N, 2005, ASIAN POPULATION STU, V1, P207, DOI DOI 10.1080/17441730500317451; Raleigh VS, 1997, BRIT MED J, V315, P442, DOI 10.1136/bmj.315.7106.442; Robine JM, 2004, J GERONTOL A-BIOL, V59, P590, DOI 10.1093/gerona/59.6.M590; Singer BH, 1998, P NATL ACAD SCI USA, V95, P15618, DOI 10.1073/pnas.95.26.15618; Spillman BC, 2004, MILBANK Q, V82, P157, DOI 10.1111/j.0887-378X.2004.00305.x; Spillman BC, 2000, MILBANK Q, V78, P347, DOI 10.1111/1468-0009.00177; Stuck AE, 2004, LANCET, V364, P1641, DOI 10.1016/S0140-6736(04)17365-0; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	20	57	60	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 17	2007	334	7593					570	571		10.1136/bmj.39129.397373.BE	http://dx.doi.org/10.1136/bmj.39129.397373.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AP	17363829	Green Published			2022-12-28	WOS:000245404400034
J	Sazawal, S; Black, RE; Ramsan, M; Chwaya, HM; Dutta, A; Dhingra, U; Stoltzfus, RJ; Othman, MK; Kabole, FM				Sazawal, Sunil; Black, Robert E.; Ramsan, Mahdi; Chwaya, Hababu M.; Dutta, Arup; Dhingra, Usha; Stoltzfus, Rebecca J.; Othman, Mashavi K.; Kabole, Fatma M.			Effect of zinc supplementation on mortality in children aged 1-48 months: a community-based randomised placebo-controlled trial	LANCET			English	Article							PRESCHOOL-CHILDREN; DOUBLE-BLIND; CYTOKINE PRODUCTION; AFRICAN CHILDREN; VITAMIN-A; INFANTS; MORBIDITY; DIARRHEA; MEASLES; GROWTH	Background Studies from Asia have suggested that zinc supplementation can reduce morbidity and mortality in children, but evidence from malarious populations in Africa has been inconsistent. Our aim was to assess the effects of zinc supplementation on overall mortality in children in Pemba, Zanzibar. Methods We enrolled 42 546 children aged 1-36 months, contributing a total of 56 507 child-years in a randomised, double-blind, placebo-controlled trial in Pemba, Zanzibar. Randomisation was by household. 21274 children received daily supplementation with zinc 10 mg (5 mg in children younger than 12 months) for mean 484.7 days (SD 306.6). 21272 received placebo. The primary endpoint was overall mortality, and analysis was by intention to treat. This study is registered as an International Standard Randomised Clinical Trial, number ISRCTN59549825. Findings Overall, there was a non-significant 7% (95% CI -6% to 19%; p=0.29) reduction in the relative risk of all-cause mortality associated with zinc supplementation. Interpretation We believe that a meta-analysis of all studies of mortality and morbidity, will help to make evidence-based recommendations for the role of zinc supplementation in public health policy to improve mortality, morbidity; growth, and development in young children.	Johns Hopkins Univ, Blomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; Publ Hlth Lab Ivo Carneri, Pemba, Zanzibar, Tanzania; Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Johns Hopkins University; Cornell University	Black, RE (corresponding author), Johns Hopkins Univ, Blomberg Sch Publ Hlth, Dept Int Hlth, Room 8527,615 N Wolfe St, Baltimore, MD 21205 USA.	rblack@jhsph.edu		Black, Robert/0000-0001-9926-7984				ALLEN LH, 1994, EUR J CLIN NUTR, V48, pS75; ANKER M, 1999, 4 WHOCDSCSRISR; Atabani S, 2000, CLIN DIAGN LAB IMMUN, V7, P111, DOI 10.1128/CDLI.7.1.111-113.2000; Baqui AH, 2002, BRIT MED J, V325, P1059, DOI 10.1136/bmj.325.7372.1059; BATES CJ, 1993, BRIT J NUTR, V69, P243, DOI 10.1079/BJN19930026; Beck FWJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE1002, DOI 10.1152/ajpendo.1997.272.6.E1002; Benn CS, 2005, BMJ-BRIT MED J, V331, P1428, DOI 10.1136/bmj.38670.639340.55; BETTGER WJ, 1981, LIFE SCI, V28, P1425, DOI 10.1016/0024-3205(81)90374-X; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Brooks WA, 2005, AM J CLIN NUTR, V82, P605, DOI 10.1093/ajcn/82.3.605; Brooks WA, 2005, LANCET, V366, P999, DOI 10.1016/S0140-6736(05)67109-7; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Buck RH, 2002, CLIN EXP IMMUNOL, V128, P490, DOI 10.1046/j.1365-2249.2002.01851.x; CLARK IA, 1976, NATURE, V259, P309, DOI 10.1038/259309a0; Cobra C, 1997, J NUTR, V127, P574, DOI 10.1093/jn/127.4.574; Fischer JE, 2000, J INFECT DIS, V182, P1029, DOI 10.1086/315806; FORTHAL DN, 1995, J INFECT DIS, V172, P1587, DOI 10.1093/infdis/172.6.1587; Gans HA, 1999, J IMMUNOL, V162, P5569; Garly ML, 2004, PEDIATR INFECT DIS J, V23, P1086, DOI 10.1097/01.inf.0000145700.77286.94; GEBHARD RL, 1983, J NUTR, V113, P855, DOI 10.1093/jn/113.4.855; GHISHAN FK, 1984, J PEDIATR GASTR NUTR, V3, P608, DOI 10.1097/00005176-198409000-00022; HUBER SA, 1994, J VIROL, V68, P5126, DOI 10.1128/JVI.68.8.5126-5132.1994; Iqbal A. S. M., 2001, Indian Journal of Pediatrics, V68, P523, DOI 10.1007/BF02723246; Kabir Z, 2005, INDIAN PEDIATR, V42, P541; Kikafunda JK, 1998, AM J CLIN NUTR, V68, P1261, DOI 10.1093/ajcn/68.6.1261; KREBS NF, 1986, AM J CLIN NUTR, V43, P288, DOI 10.1093/ajcn/43.2.288; Lira PIC, 1998, AM J CLIN NUTR, V68, p418S, DOI 10.1093/ajcn/68.2.418S; Mahalanabis D, 2004, AM J CLIN NUTR, V79, P430; Makonnen B, 2003, J TROP PEDIATRICS, V49, P340, DOI 10.1093/tropej/49.6.340; Massaga JJ, 2003, LANCET, V361, P1853, DOI 10.1016/S0140-6736(03)13504-0; Moran TM, 1999, J INFECT DIS, V180, P579, DOI 10.1086/314952; Muller O, 2001, BMJ-BRIT MED J, V322, P1567, DOI 10.1136/bmj.322.7302.1567; Nelson W., 1969, J QUAL TECHNOL, V1, P27, DOI DOI 10.1080/00224065.1969.11980344; Osendarp SJM, 2002, AM J CLIN NUTR, V76, P1401, DOI 10.1093/ajcn/76.6.1401; Osendarp SJM, 2001, LANCET, V357, P1080, DOI 10.1016/S0140-6736(00)04260-4; Pit DSS, 2000, ALLERGY, V55, P732, DOI 10.1034/j.1398-9995.2000.00477.x; Ribeiro-do-Couto LM, 2001, EUR J IMMUNOL, V31, P3394, DOI 10.1002/1521-4141(200111)31:11<3394::AID-IMMU3394>3.0.CO;2-B; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Sazawal S, 1996, J NUTR, V126, P443, DOI 10.1093/jn/126.2.443; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Sazawal S, 1998, PEDIATRICS, V102, P1, DOI 10.1542/peds.102.1.1; Sazawal S, 2001, PEDIATRICS, V108, P1280, DOI 10.1542/peds.108.6.1280; Sempertegui F, 1996, EUR J CLIN NUTR, V50, P42; Shankar AH, 2000, AM J TROP MED HYG, V62, P663, DOI 10.4269/ajtmh.2000.62.663; Therneau TM, 1997, STAT MED, V16, P2029, DOI 10.1002/(SICI)1097-0258(19970930)16:18<2029::AID-SIM637>3.0.CO;2-H; *UN, 2001, ROAD MAP IMPLEMENTAT; VALENTINERBRANT.P, 2006, VACCINE         0202; Walker CLF, 2006, J PEDIATR GASTR NUTR, V43, P357, DOI 10.1097/01.mpg.0000232018.40907.00	49	100	103	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2007	369	9565					927	934		10.1016/S0140-6736(07)60452-8	http://dx.doi.org/10.1016/S0140-6736(07)60452-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148BQ	17368154				2022-12-28	WOS:000245049900033
J	Bailey, H; Wu, AHB				Bailey, Helen; Wu, Alan H. B.			Bright green serum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94110 USA	University of California System; University of California San Francisco	Bailey, H (corresponding author), Univ Calif San Francisco, San Francisco, CA 94110 USA.	wualan@labmed2.ucsf.edu							0	4	4	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2007	356	11					E10	E10		10.1056/NEJMicm060578	http://dx.doi.org/10.1056/NEJMicm060578			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	145PO	17360985				2022-12-28	WOS:000244877200009
J	Lewis, GD; Holmes, CB; Holmvang, G; Butterton, JR; Harris, NL; Bazari, H				Lewis, Gregory D.; Holmes, Charles B.; Holmvang, Godtfred; Butterton, Joan R.; Harris, Nancy Lee; Bazari, Hasan			Case 8-2007: A 48-year-old man with chest pain followed by cardiac arrest - Helicobacter cinaedi myopericarditis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENDOMYOCARDIAL BIOPSY; ACUTE PERICARDITIS; LYMPHOCYTIC MYOCARDITIS; DILATED CARDIOMYOPATHY; CAMPYLOBACTER-CINAEDI; GIANT-CELL; BACTEREMIA; PATIENT; DIAGNOSIS		Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Lewis, GD (corresponding author), Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA.							Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; Badorff C, 2001, HEART, V86, P489, DOI 10.1136/heart.86.5.489; Barbaro G, 1998, NEW ENGL J MED, V339, P1093, DOI 10.1056/NEJM199810153391601; Barbaro G, 2002, NEW ENGL J MED, V347, P140; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Caforio ALP, 1997, EUR HEART J, V18, P270; Chimenti C, 2001, CIRCULATION, V104, P168, DOI 10.1161/01.CIR.104.2.168; CHOW LH, 1989, J AM COLL CARDIOL, V14, P915, DOI 10.1016/0735-1097(89)90465-8; Chugh SS, 2000, CIRCULATION, V102, P649, DOI 10.1161/01.CIR.102.6.649; Clancy CE, 2005, PHYSIOL REV, V85, P33, DOI 10.1152/physrev.00005.2004; Cooper LT, 1997, NEW ENGL J MED, V336, P1860, DOI 10.1056/NEJM199706263362603; Cunningham C, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-16; DAVIDOFF R, 1991, CIRCULATION, V83, P953, DOI 10.1161/01.CIR.83.3.953; Dec GW, 2003, MYOCARDITIS: FROM BENCH TO BEDSIDE, P257; Friedrich MG, 1998, CIRCULATION, V97, P1802, DOI 10.1161/01.CIR.97.18.1802; Frustaci A, 2002, CHEST, V122, P1348, DOI 10.1378/chest.122.4.1348; GINZTON LE, 1982, CIRCULATION, V65, P1004, DOI 10.1161/01.CIR.65.5.1004; GRAYSON ML, 1989, MED J AUSTRALIA, V150, P214; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; HAUCK AJ, 1989, MAYO CLIN PROC, V64, P1235, DOI 10.1016/S0025-6196(12)61286-5; HIRATA K, 1995, AM J CARDIOL, V76, P1207, DOI 10.1016/S0002-9149(99)80342-7; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Imazio M, 2004, J AM COLL CARDIOL, V43, P1042, DOI 10.1016/j.jacc.2003.09.055; KIEHLBAUCH JA, 1995, J CLIN MICROBIOL, V33, P2940, DOI 10.1128/JCM.33.11.2940-2947.1995; KIEHLBAUCH JA, 1994, ANN INTERN MED, V121, P90, DOI 10.7326/0003-4819-121-2-199407150-00002; Lasry S, 2000, CLIN INFECT DIS, V31, P201, DOI 10.1086/313930; Lauer B, 1997, J AM COLL CARDIOL, V30, P1354, DOI 10.1016/S0735-1097(97)00317-3; Mahrholdt H, 2004, CIRCULATION, V109, P1250, DOI 10.1161/01.CIR.0000118493.13323.81; MAMMEN MP, 1995, CLIN INFECT DIS, V21, P1055, DOI 10.1093/clinids/21.4.1055; OLIVA PB, 1973, NEW ENGL J MED, V288, P745, DOI 10.1056/NEJM197304122881501; ORLICEK SL, 1993, J CLIN MICROBIOL, V31, P569, DOI 10.1128/JCM.31.3.569-571.1993; PARKER MM, 1984, ANN INTERN MED, V100, P483, DOI 10.7326/0003-4819-100-4-483; Plautz CU, 2005, AM J EMERG MED, V23, P510, DOI 10.1016/j.ajem.2004.03.014; SACKS LV, 1991, REV INFECT DIS, V13, P1066; Simons E, 2004, INFECTION, V32, P367, DOI 10.1007/s15010-004-3152-7; Smith SC, 1997, CIRCULATION, V95, P163, DOI 10.1161/01.CIR.95.1.163; SPODICK DH, 1973, CIRCULATION, V48, P575, DOI 10.1161/01.CIR.48.3.575; Sullivan AK, 1997, INT J STD AIDS, V8, P59, DOI 10.1258/0956462971918634; Tee W, 1996, SCAND J INFECT DIS, V28, P199, DOI 10.3109/00365549609049078; Thiru Y, 2000, CRIT CARE MED, V28, P2979, DOI 10.1097/00003246-200008000-00049; TOTTEN PA, 1985, J INFECT DIS, V151, P131, DOI 10.1093/infdis/151.1.131; Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X; Turner A, 1999, CRIT CARE MED, V27, P1775, DOI 10.1097/00003246-199909000-00012; VANDAMME P, 1991, INT J SYST BACTERIOL, V41, P88, DOI 10.1099/00207713-41-1-88; Wanby P, 2001, SCAND J INFECT DIS, V33, P860, DOI 10.1080/003655401753186213; Wu LA, 2001, MAYO CLIN PROC, V76, P1030, DOI 10.4065/76.10.1030; ZAYAS R, 1995, AM J CARDIOL, V75, P378, DOI 10.1016/S0002-9149(99)80558-X; Zhang L, 2005, CIRCULATION, V112, pU765; Zimetbaum PJ, 2003, NEW ENGL J MED, V348, P933, DOI 10.1056/NEJMra022700	50	15	15	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2007	356	11					1153	1162		10.1056/NEJMcpc079002	http://dx.doi.org/10.1056/NEJMcpc079002			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	145PO	17360994				2022-12-28	WOS:000244877200010
J	Garson, A; Blumenthal, D				Garson, Arthur, Jr.; Blumenthal, David			State-federal partnerships for access to care - An end and a means	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; Harvard Univ, Sch Med, Boston, MA USA	University of Virginia; Harvard University; Harvard Medical School	Garson, A (corresponding author), Univ Virginia, Sch Med, McKim 3027,POB 800793, Charlottesville, VA 22908 USA.	garson@virginia.edu						AARON HJ, 2004, HLTH AFF MILLWOOD S; CAREY MA, 2007, CQ HEALTHBEST N 0117; Coughlin TA, 2006, HEALTH AFFAIR, V25, pW204, DOI 10.1377/hlthaff.25.w204; Curtis RE, 2001, INQUIRY-J HEALTH CAR, V38, P159, DOI 10.5034/inquiryjrnl_38.2.159; GARSON A, 2004, HARVARD HLTH POLICY, V5, P47; GILMER T, 2005, HLTH AFF MILLWOOD S; HADLEY J, 2003, HLTH AFF MILLWOOD S; *HARV INT PROGR HL, 2006, STRAT HLTH CAR REF C; *I MED COMM CONS U, 2002, CAR COV TOO LITTL TO, P73; *I MED COMM RAP AD, 2002, FOST RAP ADV HLTH CA, pCH5; NORRIS K, 2004, DETROIT FREE PR 1025; RESCHOVSKY JD, 2001, EMPLOYER HLTH INSURA; ROSENBERG SN, 2003, PUBLICATION COMMONWE, V662; Steinbrook R, 2006, NEW ENGL J MED, V354, P2095, DOI 10.1056/NEJMp068097; Woolhandler S, 2004, INT J HEALTH SERV, V34, P65, DOI 10.2190/MJJW-GA0V-78KT-9RGX	15	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2007	297	10					1112	1115		10.1001/jama.297.10.1112	http://dx.doi.org/10.1001/jama.297.10.1112			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	145KZ	17356032				2022-12-28	WOS:000244865200025
J	Dickert, N; DeRiemer, K; Duffy, PE; Garcia-Garcia, L; Mutabingwa, TK; Sina, BJ; Tindana, P; Lie, R				Dickert, N.; DeRiemer, K.; Duffy, P. E.; Garcia-Garcia, L.; Mutabingwa, T. K.; Sina, B. J.; Tindana, P.; Lie, R.			Ancillary-care responsibilities in observational research: two cases, two issues	LANCET			English	Article							INTERNATIONAL CONSENSUS OPINION; RESISTANT TUBERCULOSIS; DEVELOPING-COUNTRIES; MEDICAL RESEARCHERS; CLINICAL CARE; STANDARD; DEBATE		Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA; Univ Calif Davis, Sch Med, Davis, CA 95616 USA; Seattle Biomed Res Inst, Seattle, WA 98109 USA; Inst Nacl Salud Publ, TB Unit, Cuernavaca 62508, Morelos, Mexico; London Sch Hyg & Trop Med, London WC1, England; Muheza, Tanga, Tanzania; NIH, Div Int Training & Res, Fogarty Int Ctr, Bethesda, MD 20892 USA; NIH, Dept Clin Bioeth, Bethesda, MD 20892 USA; Ghana Hlth Serv, Navrongo Hlth Res Ctr, Navrongo, Ghana	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Davis; Center for Infectious Disease Research; Instituto Nacional de Salud Publica; University of London; London School of Hygiene & Tropical Medicine; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); National Institutes of Health (NIH) - USA; Ghana Health Service; Navrongo Health Research Center	Dickert, N (corresponding author), Johns Hopkins Univ, Sch Med, 600 N Wolfe St, Baltimore, MD 21287 USA.	dicker@jhmi.edu	García, Maria de Lourdes/I-2724-2019	García, Maria de Lourdes/0000-0001-5262-1157; Tindana, Paulina/0000-0002-9171-2083; DeRiemer, Kathryn/0000-0002-8375-7505	FOGARTY INTERNATIONAL CENTER [K01TW000001] Funding Source: NIH RePORTER; FIC NIH HHS [K01 TW000001, K01 TW000001-07, K01 TW000001-08] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Belsky L, 2004, BRIT MED J, V328, P1494, DOI 10.1136/bmj.328.7454.1494; Burgos M, 2005, CLIN INFECT DIS, V40, P968, DOI 10.1086/428582; Council for International Organizations of Medical Sciences WHO, 2002, INT ETH GUID BIOM RE; DeRiemer K, 2005, LANCET, V365, P1239, DOI 10.1016/S0140-6736(05)74812-1; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; Levine C, 2004, HASTINGS CENT REP, V34, P17, DOI 10.2307/3528172; Lie RK, 2004, J MED ETHICS, V30, P190, DOI 10.1136/jme.2003.006031; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Richardson HS, 2004, HASTINGS CENT REP, V34, P25, DOI 10.2307/3528248; Schuklenk U, 2004, J MED ETHICS, V30, P194, DOI 10.1136/jme.2003.006981; SINGER P, 1972, PHILOS PUBLIC AFF, V1, P229; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Varmus H, 1997, NEW ENGL J MED, V337, P1003, DOI 10.1056/NEJM199710023371411; *WMA, 2000, WORLD MED ASS DECL H	15	19	19	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 10	2007	369	9564					874	877		10.1016/S0140-6736(07)60416-4	http://dx.doi.org/10.1016/S0140-6736(07)60416-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144JC	17350458	Green Accepted			2022-12-28	WOS:000244791300037
J	Nadel, S; Goldstein, B; Williams, MD; Dalton, H; Peters, M; Macias, WL; Abd-Allah, SA; Levy, H; Angle, R; Wang, DZ; Sundin, DP; Giroir, B				Nadel, Simon; Goldstein, Brahm; Williams, Mark D.; Dalton, Heidi; Peters, Mark; Macias, William L.; Abd-Allah, Shamel A.; Levy, Howard; Angle, Robinette; Wang, Dazhe; Sundin, David P.; Giroir, Brett		RESOLVE study grp	Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial	LANCET			English	Article							OPEN-LABEL TRIAL; EPIDEMIOLOGY; SAFETY; ENHANCE; RISK	Background Drotrecogin alfa (activated) (DrotAA) is used for the treatment of adults with severe sepsis who have a high risk of dying. A phase 1b open-label study has indicated that the pharmacokinetics and pharmacodynamics of DrotAA are similar in children and adults. We initiated the RESOLVE (REsearching severe Sepsis and Organ dysfunction in children: a gLobal perspectiVE) trial to investigate the efficacy and safety of the drug in children. Methods Children aged between 38 weeks' corrected gestational age and 17 years with sepsis-induced cardiovascular and respiratory failure were randomly assigned to receive placebo or DrotAA (24 mu g/kg/h) for 96 h. We used a prospectively defined, novel primary endpoint of Composite Time to Complete Organ Failure Resolution (CTCOFR) score. Secondary endpoints were 28-day mortality, major amputations, and safety. Analysis was by intention-to-treat. This trial is registered with clinicaltrials.gov, number NCT00049764. Findings 477 patients were enrolled; 237 received placebo, and 240 DrotAA. Our results showed no significant difference between groups in CTCOFR score (p=0.72) or in 28-day mortality (placebo 17.5%; DrotAA, 17.2%; p=0.93). Although there was no difference in overall serious bleeding events during the 28-day study period (placebo 6.8%; DrotAA 6.7%; p=0.97), there were numerically more instances of CNS bleeding in the DrotAA group (11 [4.6%], vs 5 [2.1%] in placebo, p=0.13), particularly in children younger than 60 days. For CTCOFR score days 1-14, correlation coefficient was -0.016 (95% CI -0.106 to 0.74); relative risk for 28-day mortality was 1.06 (95% CI 0.66 to 1.46) for DrotAA compared with placebo. Interpretation Although we did not record any efficacy of DrotAA in children with severe sepsis, serious bleeding events were similar between groups and the overall safety profile acceptable, except in children younger than 60 days. However, we gained important insights into clinical and laboratory characteristics of childhood severe sepsis, and have identified issues that need to be addressed in future trials in critically ill children.	DARPA, Def Sci Off, Arlington, VA 22203 USA; St Marys Hosp & Imperial Coll, London, England; Oregon Hlth & Sci Univ, Div Pediat Crit Care, Portland, OR 97201 USA; Lilly Res Labs, Indianapolis, IN USA; George Washington Univ, Childrens Natl Med Ctr, Washington, DC USA; Great Ormond St Hosp Sick Children, Pediat Intens Care Unit, London WC1N 3JH, England; Loma Linda Univ, Childrens Hosp, Loma Linda, CA 92350 USA; Univ Texas, SW Med Ctr, Dallas, TX USA	United States Department of Defense; Defense Advanced Research Projects Agency (DARPA); Imperial College London; Oregon Health & Science University; Eli Lilly; Children's National Health System; George Washington University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Children's Hospital Los Angeles; Loma Linda University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Giroir, B (corresponding author), DARPA, Def Sci Off, 3701 N Fairfax Dr, Arlington, VA 22203 USA.	Brett.Giroir@darpa.mil	Peters, Mark/AAD-7518-2019	Peters, Mark/0000-0003-3653-4808; Gedeit, Rainer/0000-0003-2420-9493				Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Anderson MR, 1997, PEDIATR CLIN N AM, V44, P179, DOI 10.1016/S0031-3955(05)70469-7; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Barton P, 2004, PEDIATRICS, V113, P7, DOI 10.1542/peds.113.1.7; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Butt W, 2001, PEDIATR CLIN N AM, V48, P601, DOI 10.1016/S0031-3955(05)70330-8; Dhainaut JF, 2004, J THROMB HAEMOST, V2, P1924, DOI 10.1111/j.1538-7836.2004.00955.x; Goldstein B, 2006, PEDIATR CRIT CARE ME, V7, P200, DOI 10.1097/01.PCC.0000217470.68764.36; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Hazelzet JA, 1996, THROMB HAEMOSTASIS, V76, P932; Macias WL, 2004, CRIT CARE MED, V32, P2385, DOI 10.1097/01.CCM.0000147440.71142.AC; Martinot A, 1997, PEDIATR EMERG CARE, V13, P277, DOI 10.1097/00006565-199708000-00011; Mou SS, 2004, NEW ENGL J MED, V351, P1635, DOI 10.1056/NEJMoa041065; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Vincent JL, 2005, CRIT CARE MED, V33, P2266, DOI 10.1097/01.CCM.0000181729.46010.83; Watson RS, 2003, AM J RESP CRIT CARE, V167, P695, DOI 10.1164/rccm.200207-682OC	16	338	360	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2007	369	9564					836	843		10.1016/S0140-6736(07)60411-5	http://dx.doi.org/10.1016/S0140-6736(07)60411-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144JC	17350452				2022-12-28	WOS:000244791300031
J	Bazigou, E; Apitz, H; Johansson, J; Loren, CE; Hirst, EMA; Chen, PL; Palmer, RH; Salecker, I				Bazigou, Eleni; Apitz, Holger; Johansson, Jana; Loren, Christina E.; Hirst, Elizabeth M. A.; Chen, Pei-Ling; Palmer, Ruth H.; Salecker, Iris			Anterograde jelly belly and Alk receptor tyrosine kinase signaling mediates retinal axon targeting in Drosophila	CELL			English	Article							ANAPLASTIC LYMPHOMA KINASE; NON-HODGKINS-LYMPHOMA; VISUAL-SYSTEM; GLIAL-CELLS; NERVOUS-SYSTEM; SYNAPTIC SPECIFICITY; NEURONAL DEVELOPMENT; PHOTORECEPTOR AXONS; LAYER-SELECTION; ROLLING PEBBLES	Anaplastic lymphoma kinase (Alk) has been proposed to regulate neuronal development based on its expression pattern in vertebrates and invertebrates; however, its function in vivo is unknown. We demonstrate that Alk and its ligand Jelly belly (Jeb) play a central role as an anterograde, signaling pathway mediating neuronal circuit assembly in the Drosophila visual system. Alk is expressed and required in target neurons in the optic lobe, whereas Jeb is primarily generated by photoreceptor axons and functions in the eye to control target selection of R1-R6 axons in the lamina and R8 axons in the medulla. Impaired Jeb/Alk function affects layer-specific expression of three cell-adhesion molecules, Dumbfounded/Kirre, Roughest/IrreC, and Flamingo, in the medulla. Moreover, loss of flamingo in target neurons causes some R8-axon targeting errors observed in jeb and Alk mosaic animals. Together, these findings suggest that Jeb/Alk signaling helps R-cell axons to shape their environment for target recognition.	Umea Univ, Umea Ctr Mol Pathogenesis, S-90187 Umea, Sweden; Natl Inst Med Res, MRC, Div Mol Neurobiol, London NW7 1AA, England; Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Umea University; MRC National Institute for Medical Research; Stanford University	Palmer, RH (corresponding author), Umea Univ, Umea Ctr Mol Pathogenesis, S-90187 Umea, Sweden.	ruth.palmer@ucmp.umu.se; isaleck@nimr.mrc.ac.uk	Chen, Phang-Lang/J-5031-2013; Salecker, Iris/V-1228-2018	Apitz, Holger/0000-0003-0551-2403; Salecker, Iris/0000-0003-3775-7763	Medical Research Council [MC_U117581332] Funding Source: Medline; MRC [MC_U117581332] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Chotard C, 2005, NEURON, V48, P237, DOI 10.1016/j.neuron.2005.09.019; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Englund C, 2003, NATURE, V425, P512, DOI 10.1038/nature01950; Fabian-Fine R, 2003, J NEUROSCI, V23, P10732; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; GONG QH, 1995, NEURON, V14, P91, DOI 10.1016/0896-6273(95)90243-0; HALTER DA, 1995, DEVELOPMENT, V121, P317; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Huang Z, 1998, DEVELOPMENT, V125, P3753; Hurley SP, 2006, J COMP NEUROL, V495, P202, DOI 10.1002/cne.20887; Ito K, 1997, DEVELOPMENT, V124, P761; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee HH, 2003, NATURE, V425, P507, DOI 10.1038/nature01916; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Loren CE, 2001, GENES CELLS, V6, P531, DOI 10.1046/j.1365-2443.2001.00440.x; Marques G, 2005, J NEUROBIOL, V64, P417, DOI 10.1002/neu.20165; Mast JD, 2006, SEMIN CELL DEV BIOL, V17, P42, DOI 10.1016/j.semcdb.2005.11.004; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; Mehta SQ, 2005, NEURON, V46, P219, DOI 10.1016/j.neuron.2005.02.029; Meinertzhagen Ian A., 1993, P1363; Meiniel A, 2001, MICROSC RES TECHNIQ, V52, P484, DOI 10.1002/1097-0029(20010301)52:5<484::AID-JEMT1034>3.0.CO;2-0; Menon SD, 2005, J CELL BIOL, V169, P909, DOI 10.1083/jcb.200501126; Menon SD, 2001, DEV CELL, V1, P691, DOI 10.1016/S1534-5807(01)00075-2; MISMER D, 1987, GENETICS, V116, P565; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Motegi A, 2004, J CELL SCI, V117, P3319, DOI 10.1242/jcs.01183; Newsome TP, 2000, DEVELOPMENT, V127, P851; Oh SW, 2003, GENETICS, V163, P195; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Papatsenko D, 2001, MECH DEVELOP, V101, P143, DOI 10.1016/S0925-4773(00)00581-5; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Pulford K, 2004, J CELL PHYSIOL, V199, P330, DOI 10.1002/jcp.10472; RAYMOND PA, 1983, J NEUROSCI, V3, P1092; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; SALECKER I, 1995, J COMP NEUROL, V352, P33, DOI 10.1002/cne.903520104; Salinas PC, 2005, BIOCHEM SOC T, V33, P1295, DOI 10.1042/BST0331295; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Souttou B, 2001, J BIOL CHEM, V276, P9526, DOI 10.1074/jbc.M007333200; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Stute C, 2004, DEVELOPMENT, V131, P743, DOI 10.1242/dev.00972; Suh GSB, 2002, NEURON, V33, P35, DOI 10.1016/S0896-6273(01)00576-1; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; Vernersson E, 2006, GENE EXPR PATTERNS, V6, P448, DOI 10.1016/j.modgep.2005.11.006; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Weiss JB, 2001, CELL, V107, P387, DOI 10.1016/S0092-8674(01)00540-2; Yang LH, 2003, DEV CELL, V4, P359, DOI 10.1016/S1534-5807(03)00059-5; Ye B, 2005, TRENDS CELL BIOL, V15, P64, DOI 10.1016/j.tcb.2004.12.003; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	66	111	113	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					961	975		10.1016/j.cell.2007.02.024	http://dx.doi.org/10.1016/j.cell.2007.02.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350579	Bronze			2022-12-28	WOS:000245073400019
J	Andrews-Hanna, JC; Phillips, RJ; Zuber, MT				Andrews-Hanna, Jeffrey C.; Phillips, Roger J.; Zuber, Maria T.			Meridiani Planum and the global hydrology of Mars	NATURE			English	Article							ORBITER LASER ALTIMETER; INTERNAL STRUCTURE; TERRA-MERIDIANI; BURNS FORMATION; EVOLUTION; SYSTEMS; WET	The Opportunity Mars Exploration Rover found evidence for groundwater activity in the Meridiani Planum region of Mars(1,2) in the form of aeolian and fluvial sediments(3) composed of sulphate-rich grains. These sediments appear to have experienced diagenetic modification in the presence of a fluctuating water table(3-5). In addition to the extensive secondary aqueous alteration, the primary grains themselves probably derive from earlier playa evaporites(1,2,4). Little is known, however, about the hydrologic processes responsible for this environmental history - particularly how such extensive evaporite deposits formed in the absence of a topographic basin. Here we investigate the origin of these deposits, in the context of the global hydrology of early Mars, using numerical simulations, and demonstrate that Meridiani is one of the few regions of currently exposed ancient crust predicted to have experienced significant groundwater upwelling and evaporation. The global groundwater flow would have been driven primarily by precipitation-induced recharge and evaporative loss, with the formation of the Tharsis volcanic rise possibly playing a role through the burial of aquifers and induced global deformation. These results suggest that the deposits formed as a result of sustained groundwater upwelling and evaporation, rather than ponding within an enclosed basin. The evaporite formation coincided with a transition to more arid conditions(6) that increased the relative impact of a deep-seated, global-scale hydrology on the surface evolution.	Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63130 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Washington University (WUSTL); Washington University (WUSTL); Massachusetts Institute of Technology (MIT)	Andrews-Hanna, JC (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	jhanna@mit.edu						Arvidson RE, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002728; BAKER VR, 1986, J GEOPHYS RES-SOLID, V91, P3561, DOI 10.1029/JB091iB03p03561; BANERDT WB, 1986, J GEOPHYS RES-SOLID, V91, P403, DOI 10.1029/JB091iB01p00403; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; DEMING D, 1990, J GEOPHYS RES-SOLID, V95, P6669, DOI 10.1029/JB095iB05p06669; Edgett K.S., 2005, MARS, V1, P5, DOI DOI 10.1555/MARS.2005.0002; Grotzinger JP, 2005, EARTH PLANET SC LETT, V240, P11, DOI 10.1016/j.epsl.2005.09.039; Habermehl M. A, 1980, J AUST GEOL GEOPHYS, V5, P9; HANDFORD CR, 1991, EVAPORITES PETROLEUM, P1, DOI DOI 10.1016/S0070-4571(08)70259-0; Hanna JC, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002330; Harrison KP, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002455; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Hynek BM, 2004, NATURE, V431, P156, DOI 10.1038/nature02902; Hynek BM, 2003, GEOLOGY, V31, P757, DOI 10.1130/G19607.1; Hynek BM, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001891; Lane MD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017183; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; McLennan SM, 2005, EARTH PLANET SC LETT, V240, P95, DOI 10.1016/j.epsl.2005.09.041; Moller P, 1997, J GEOPHYS RES-SOL EA, V102, P18233, DOI 10.1029/96JB02899; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; PHILLIPS RJ, 1990, J GEOPHYS RES-SOLID, V95, P5089, DOI 10.1029/JB095iB04p05089; PHILLIPS RJ, 2005, EOS, V86; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Smoot JP., 1991, DEV SEDIMENTOL, V50, P189, DOI [10.1016/S0070-4571(08)70261-9, DOI 10.1016/S0070-4571(08)70261-9]; SOLOMON SC, 1982, J GEOPHYS RES, V87, P9755, DOI 10.1029/JB087iB12p09755; Squyres SW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002771; Squyres SW, 2006, SCIENCE, V313, P1403, DOI 10.1126/science.1130890; Williams RME, 2001, J GEOPHYS RES-PLANET, V106, P23737, DOI 10.1029/2000JE001409; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	30	188	189	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					163	166		10.1038/nature05594	http://dx.doi.org/10.1038/nature05594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344848				2022-12-28	WOS:000244718100035
J	Pappachan, JM; Bino, BC				Pappachan, Joseph M.; Bino, Benjamin C.			Calcified left atrial thrombus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Kottayam Med Coll, Kerala, India		Pappachan, JM (corresponding author), Kottayam Med Coll, Kerala, India.	drpappachan@yahoo.co.in	Pappachan, Joseph M/AAA-2230-2021	Pappachan, Joseph M/0000-0003-0886-5255					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2007	356	10					E9	E9		10.1056/NEJMicm060213	http://dx.doi.org/10.1056/NEJMicm060213			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143DC	17347456				2022-12-28	WOS:000244699200010
J	Ledger, WL				Ledger, William L.			Favourable outcomes from "mild" in-vitro fertilisation	LANCET			English	Editorial Material									Univ Sheffield, Acad Unit Reprod & Dev Med, Sheffield S10 2SF, S Yorkshire, England	University of Sheffield	Ledger, WL (corresponding author), Univ Sheffield, Acad Unit Reprod & Dev Med, Sheffield S10 2SF, S Yorkshire, England.	w.ledger@sheffield.ac.uk	Ledger, William/L-9089-2017	Ledger, William/0000-0001-6465-4343				Fauser BCJM, 1999, HUM REPROD, V14, P2681, DOI 10.1093/humrep/14.11.2681; Gerris JMR, 2005, HUM REPROD UPDATE, V11, P105, DOI 10.1093/humupd/dmh049; Hamberger L, 2005, Minerva Ginecol, V57, P15; Heijnen EMEW, 2007, LANCET, V369, P743, DOI 10.1016/S0140-6736(07)60360-2; *HUM FERT EMBR AUT, MULT BIRTHS SINGL EM; *HUM FERT EMBR AUT, FACTS FIG; *INT SOC NAT CYCL, 2006, 1 WORLD C NAT CYCL M; *NAT I CLIN EXC, 2004, CLIN GUID, V11; Peterson BD, 2006, FERTIL STERIL, V85, P802, DOI 10.1016/j.fertnstert.2005.09.020	9	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2007	369	9563					717	718		10.1016/S0140-6736(07)60332-8	http://dx.doi.org/10.1016/S0140-6736(07)60332-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143MP	17336628				2022-12-28	WOS:000244726700004
J	Schneider, T				Schneider, Tapio			Climate modelling - Uncertainty in climate-sensitivity estimates	NATURE			English	Letter									CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Schneider, T (corresponding author), CALTECH, Pasadena, CA 91125 USA.	tapio@caltech.edu	Schneider, Tapio/A-7038-2014	Schneider, Tapio/0000-0001-5687-2287				DRAPER D, 1995, J R STAT SOC B, V57, P45, DOI 10.1111/j.2517-6161.1995.tb02015.x; Hegerl GC, 2006, NATURE, V440, P1029, DOI 10.1038/nature04679; HEGERL GC, IN PRESS J CLIMAT; Little R.J.A., 2002, STAT ANAL MISSING DA; MILLER AJ, 1984, J ROY STAT SOC A STA, V147, P389, DOI 10.2307/2981576	5	7	8	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2007	446	7131					E1	E1		10.1038/nature05707	http://dx.doi.org/10.1038/nature05707			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17329998	Bronze			2022-12-28	WOS:000244525600030
J	Papadakis, M; Fee, P; Wilhelm, T; Andrew, D; Connolly, J				Papadakis, Michael; Fee, Peter; Wilhelm, Thomas; Davenport, Andrew; Connolly, John			Facial weakness in a haemodialysis patient	LANCET			English	Editorial Material							NEUROTOXICITY; ACYCLOVIR; DIALYSIS		UCL, Ctr Nephrol, London NW3 2QG, England; Royal Free Hosp, Dept Radiol, London NW3 2QG, England	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Connolly, J (corresponding author), UCL, Ctr Nephrol, London NW3 2QG, England.	J.Connolly@medsch.ucl.ac.uk						DAVENPORT A, 1992, AM J KIDNEY DIS, V20, P647, DOI 10.1016/S0272-6386(12)70234-2; Davenport A, 2001, AM J KIDNEY DIS, V37, P457, DOI 10.1053/ajkd.2001.22068; LEONARD A, 1975, ANN INTERN MED, V82, P650, DOI 10.7326/0003-4819-82-5-650; MACDIARMAIDGORDON AR, 1992, NEPHRON, V62, P280, DOI 10.1159/000187059	4	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 24	2007	369	9562					714	714		10.1016/S0140-6736(07)60324-9	http://dx.doi.org/10.1016/S0140-6736(07)60324-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	141RO	17321322				2022-12-28	WOS:000244596600038
J	Plaut, JJ; Picardi, G; Safaeinili, A; Ivanov, AB; Milkovich, SM; Cicchetti, A; Kofman, W; Mouginot, J; Farrell, WM; Phillips, RJ; Clifford, SM; Frigeri, A; Orosei, R; Federico, C; Williams, IP; Gurnett, DA; Nielsen, E; Hagfors, T; Heggy, E; Stofan, ER; Plettemeier, D; Watters, TR; Leuschen, CJ; Edenhofer, P				Plaut, Jeffrey J.; Picardi, Giovanni; Safaeinili, Ali; Ivanov, Anton B.; Milkovich, Sarah M.; Cicchetti, Andrea; Kofman, Wlodek; Mouginot, Jeremie; Farrell, William M.; Phillips, Roger J.; Clifford, Stephen M.; Frigeri, Alessandro; Orosei, Roberto; Federico, Costanzo; Williams, Iwan P.; Gurnett, Donald A.; Nielsen, Erling; Haegfors, Tor; Heggy, Essam; Stofan, Ellen R.; Plettemeier, Dirk; Watters, Thomas R.; Leuschen, Carlton J.; Edenhofer, Peter			Subsurface radar sounding of the south polar layered deposits of Mars	SCIENCE			English	Article							CAP; REGION	The ice-rich south polar layered deposits of Mars were probed with the Mars Advanced Radar for Subsurface and Ionospheric Sounding on the Mars Express orbiter. The radar signals penetrate deep into the deposits (more than 3.7 kilometers). For most of the area, a reflection is detected at a time delay that is consistent with an interface between the deposits and the substrate. The reflected power from this interface indicates minimal attenuation of the signal, suggesting a composition of nearly pure water ice. Maps were generated of the topography of the basal interface and the thickness of the layered deposits. A set of buried depressions is seen within 300 kilometers of the pole. The thickness map shows an asymmetric distribution of the deposits and regions of anomalous thickness. The total volume is estimated to be 1.6 x 10(6) cubic kilometers, which is equivalent to a global water layer approximately 11 meters thick.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Roma La Sapienza, Infocom Dept, I-00184 Rome, Italy; Lab Planetol Grenoble, F-38041 Grenoble, France; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Lunar & Planetary Inst, Houston, TX 77058 USA; Univ Perugia, Dipartimento Sci Terra, I-06123 Perugia, Italy; Ist Nazl Astrofis, Ist Fis Spazio Interplanetario, I-00133 Rome, Italy; Queen Mary Univ London, Sch Math Sci, Astron Unit, London E1 4NS, England; Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; Proxemy Res, Laytonville, MD 20882 USA; Tech Univ Dresden, Fak Elekrtotech & Informat Tech, D-01062 Dresden, Germany; Smithsonian Inst, Ctr Earth & Planetary Studies, Natl Air & Space Museum, Washington, DC 20560 USA; Univ Kansas, Ctr Remote Sensing Ice Sheets, Lawrence, KS 66045 USA; Ruhr Univ Bochum, Fak Elektrotech & Informat Tech, D-44780 Bochum, Germany	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Sapienza University Rome; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Washington University (WUSTL); University of Perugia; Istituto Nazionale Astrofisica (INAF); University of London; Queen Mary University London; University of Iowa; Max Planck Society; Technische Universitat Dresden; Smithsonian Institution; University of Kansas; Ruhr University Bochum	Plaut, JJ (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.		Mouginot, Jeremie/G-7045-2015; Heggy, Essam/E-8250-2013; Kofman, Wlodek/C-4556-2008; Heggy, Essam/AAL-8124-2020; Frigeri, Alessandro/F-2151-2010; Ivanov, Anton B/C-8944-2014; Farrell, William/I-4865-2013	Mouginot, Jeremie/0000-0001-9155-5455; Heggy, Essam/0000-0001-7476-2735; Kofman, Wlodek/0000-0002-6744-8796; Heggy, Essam/0000-0001-7476-2735; Frigeri, Alessandro/0000-0002-9140-3977; Ivanov, Anton B/0000-0001-8376-8581; Williams, Iwan Prys/0000-0002-8069-1344; CICCHETTI, ANDREA/0000-0002-9588-6531				Bibring JP, 2004, NATURE, V428, P627, DOI 10.1038/nature02461; BLASIUS RK, 1982, ICARUS, V50, P140; Byrne S, 2003, SCIENCE, V299, P1051, DOI 10.1126/science.1080148; CLIFFORD SM, 1987, J GEOPHYS RES-SOLID, V92, P9135, DOI 10.1029/JB092iB09p09135; CUTTS JA, 1973, J GEOPHYS RES, V78, P4231, DOI 10.1029/JB078i020p04231; DAVIES C, 2004, EOS S, V85; HEGGY E, 2006, 4 INT C MARS POL SCI; HOWARD AD, 1982, ICARUS, V50, P161, DOI 10.1016/0019-1035(82)90123-3; KIEFFER HH, 1990, J GEOPHYS RES-SOLID, V95, P1481, DOI 10.1029/JB095iB02p01481; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; MURRAY BC, 1972, ICARUS, V17, P328, DOI 10.1016/0019-1035(72)90004-8; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Picardi G., 2004, EUROPEAN SPACE AGENC, P51; Schenk PM, 2000, J GEOPHYS RES-PLANET, V105, P24529, DOI 10.1029/1999JE001054; Sibson R., 1981, BRIEF DESCRIPTION NA, P21, DOI DOI 10.1002/ADVS.201700552; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; TANAKA K, 2005, 20051271 US GEOL SUR; Thomas P., 1992, MARS, P767; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X	19	228	232	4	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					92	95		10.1126/science.1139672	http://dx.doi.org/10.1126/science.1139672			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17363628				2022-12-28	WOS:000245470500038
J	Sansom, OJ; Meniel, VS; Muncan, V; Phesse, TJ; Wilkins, JA; Reed, KR; Vass, JK; Athineos, D; Clevers, H; Clarke, AR				Sansom, Owen J.; Meniel, Valerie S.; Muncan, Vanesa; Phesse, Toby J.; Wilkins, Julie A.; Reed, Karen R.; Vass, J. Keith; Athineos, Dimitris; Clevers, Hans; Clarke, Alan R.			Myc deletion rescues Apc deficiency in the small intestine	NATURE			English	Article							BETA-CATENIN; C-MYC; COLORECTAL-CANCER; APOPTOSIS; EXPRESSION; TARGET; CELLS; GENE; IDENTIFICATION; EPITHELIUM	The APC gene encodes the adenomatous polyposis coli tumour suppressor protein, germline mutation of which characterizes familial adenomatous polyposis (FAP), an autosomal intestinal cancer syndrome(1). Inactivation of APC is also recognized as the key early event in the development of sporadic colorectal cancers(2,3), and its loss results in constitutive activity of the beta-catenin-Tcf4 transcription complex(3). The proto-oncogene c-MYC has been identified as a target of the Wnt pathway in colorectal cancer cells in vitro(4), in normal crypts in vivo(5) and in intestinal epithelial cells acutely transformed on in vivo deletion of the APC gene(6); however, the significance of this is unclear. Therefore, to elucidate the role Myc has in the intestine after Apc loss, we have simultaneously deleted both Apc and Myc in the adult murine small intestine. Here we show that loss of Myc rescued the phenotypes of perturbed differentiation, migration, proliferation and apoptosis, which occur on deletion of Apc. Remarkably, this rescue occurred in the presence of high levels of nuclear beta-catenin. Array analysis revealed that Myc is required for the majority of Wnt target gene activation following Apc loss. These data establish Myc as the critical mediator of the early stages of neoplasia following Apc loss.	Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; Univ Cardiff Wales, Cardiff Sch Biosci, Cardiff CF10 3US, Wales; Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands	Beatson Institute; Cardiff University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Sansom, OJ (corresponding author), Beatson Inst Canc Res, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	o.sansom@beatson.gla.ac.uk	Reed, Karen/B-8813-2011; clarke, alan r/P-2820-2014; Clarke, Alan R/A-6256-2008	Reed, Karen/0000-0002-7467-1718; Phesse, Toby/0000-0001-9568-4916; Athineos, Dimitris/0000-0001-5298-7941; Clarke, Alan/0000-0002-4281-426X; Sansom, Owen J./0000-0001-9540-3010	Medical Research Council [G0301154] Funding Source: Medline; MRC [G0301154] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Hay T, 2005, ONCOGENE, V24, P3842, DOI 10.1038/sj.onc.1208533; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li Q, 1999, MOL CELL BIOL, V19, P5339; Malliri A, 2006, J BIOL CHEM, V281, P543, DOI 10.1074/jbc.M507582200; Merritt AJ, 1997, ONCOGENE, V14, P2759, DOI 10.1038/sj.onc.1201126; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; Oskarsson T, 2005, NAT CELL BIOL, V7, P215, DOI 10.1038/ncb0305-215; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Sansom OJ, 2005, J BIOL CHEM, V280, P28463, DOI 10.1074/jbc.M500191200; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0	23	475	481	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					676	679		10.1038/nature05674	http://dx.doi.org/10.1038/nature05674			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17377531	Bronze			2022-12-28	WOS:000245438300042
J	Goldacre, B				Goldacre, Ben			How doctors can get behind the headlines	BRITISH MEDICAL JOURNAL			English	Editorial Material												ben@badscience.net		Goldacre, Ben/0000-0002-5127-4728				2007, DAILY TELEGRAPH 0213, P13	1	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 24	2007	334	7594					613	613		10.1136/bmj.39160.566285.47	http://dx.doi.org/10.1136/bmj.39160.566285.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	152DC	17379907	Green Published			2022-12-28	WOS:000245340000032
J	Barrangou, R; Fremaux, C; Deveau, H; Richards, M; Boyaval, P; Moineau, S; Romero, DA; Horvath, P				Barrangou, Rodolphe; Fremaux, Christophe; Deveau, Helene; Richards, Melissa; Boyaval, Patrick; Moineau, Sylvain; Romero, Dennis A.; Horvath, Philippe			CRISPR provides acquired resistance against viruses in prokaryotes	SCIENCE			English	Article							DNA; REPEATS; ELEMENTS; STRAIN; EVOLUTIONARY; SEQUENCES; BACTERIA; SYSTEM; GENES; PHAGE	Clustered regularly interspaced short palindromic repeats (CRISPR) are a distinctive feature of the genomes of most Bacteria and Archaea and are thought to be involved in resistance to bacteriophages. We found that, after viral challenge, bacteria integrated new spacers derived from phage genomic sequences. Removal or addition of particular spacers modified the phage-resistance phenotype of the cell. Thus, CRISPR, together with associated cas genes, provided resistance against phages, and resistance specificity is determined by spacer-phage sequence similarity.	Danisco France SAS, F-86220 Dange St Romain, France; Danisco USA Inc, Madison, WI 53716 USA; Univ Laval, Dept Biochem & Microbiol, Felix Herelle Reference Ctr Bacterial Viruses, Grp Rech Ecol Buccale,Fac Sci & Genie, Ste Foy, PQ G1K 7P4, Canada	Laval University	Horvath, P (corresponding author), Danisco France SAS, Boite Postale 10, F-86220 Dange St Romain, France.	philippe.horvath@danisco.com	Moineau, Sylvain/I-7231-2019; HORVATH, Philippe/K-5266-2015; Moineau, Sylvain/N-3578-2013; Barrangou, Rodolphe/I-2878-2014	Moineau, Sylvain/0000-0002-2832-5101; HORVATH, Philippe/0000-0003-2015-8123; Barrangou, Rodolphe/0000-0002-0648-3504				Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Brussow H, 2001, ANNU REV MICROBIOL, V55, P283, DOI 10.1146/annurev.micro.55.1.283; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; DeBoy RT, 2006, J BACTERIOL, V188, P2364, DOI 10.1128/JB.188.7.2364-2374.2006; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; GROENEN PMA, 1993, MOL MICROBIOL, V10, P1057, DOI 10.1111/j.1365-2958.1993.tb00976.x; HAIT DH, 2005, PLOS COMPUT BIOL, V1, pE60; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Levesque C, 2005, APPL ENVIRON MICROB, V71, P4057, DOI 10.1128/AEM.71.7.4057-4068.2005; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2002, NUCLEIC ACIDS RES, V30, P482, DOI 10.1093/nar/30.2.482; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mongodin EF, 2005, J BACTERIOL, V187, P4935, DOI 10.1128/JB.187.14.4935-4944.2005; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Russell WM, 2001, APPL ENVIRON MICROB, V67, P4361, DOI 10.1128/AEM.67.9.4361-4364.2001; Sturino JM, 2006, NAT REV MICROBIOL, V4, P395, DOI 10.1038/nrmicro1393	19	3528	4017	101	2198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1709	1712		10.1126/science.1138140	http://dx.doi.org/10.1126/science.1138140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379808				2022-12-28	WOS:000245106900039
J	Hijiya, N; Hudson, MM; Lensing, S; Zacher, M; Onciu, M; Behm, FG; Razzouk, BI; Ribeiro, RC; Rubnitz, JE; Sandlund, JT; Rivera, GK; Evans, WE; Relling, MV; Pui, CH				Hijiya, Nobuko; Hudson, Melissa M.; Lensing, Shelly; Zacher, Margie; Onciu, Mihaela; Behm, Fred G.; Razzouk, Bassem I.; Ribeiro, Raul C.; Rubnitz, Jeffrey E.; Sandlund, John T.; Rivera, Gaston K.; Evans, William E.; Relling, Mary V.; Pui, Ching-Hon			Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CANCER SURVIVOR; TOTAL-THERAPY; BRAIN-TUMORS; CRANIAL RADIOTHERAPY; MYELOID-LEUKEMIA; ADVERSE EVENTS; COMPETING RISK; 2ND NEOPLASMS; CHILDREN; CHEMOTHERAPY	Context Little is known about the incidence of secondary neoplasms after 15 to 20 years in children and adolescents who were treated for acute lymphoblastic leukemia. Objectives To investigate the cumulative incidence of secondary neoplasms in pediatric patients treated for acute lymphoblastic leukemia over 30 years and to characterize late-occurring tumors. Design, Setting, and Patients Retrospective study of 2169 patients with acute lymphoblastic leukemia treated between 1962 and 1998 at St Jude Children's Research Hospital, Memphis, Tenn, who achieved complete remission and had a median follow-up time of 18.7 years (range, 2.4-41.3 years). Main Outcome Measures Cumulative incidences of secondary neoplasms in first remission and standard incidence ratios of observed rates compared with rates of cancer development in the general US population. Results Secondary neoplasms developed as the first event in 123 patients and comprised 46 myeloid malignancies, 3 lymphomas, 14 basal cell carcinomas, 16 other carcinomas, 6 sarcomas, 16 meningiomas, and 22 other brain tumors. The cumulative incidence of secondary neoplasm was 4.17% (SE, 0.46%) at 15 years and increased substantially after 20 years, reaching 10.85% (SE, 1.27%) at 30 years. When meningiomas and basal cell carcinomas were excluded, the overall cumulative incidence was 3.99% (SE, 0.44%) at 15 years and 6.27% (SE, 0.83%) at 30 years, representing a 13.5-fold increase in overall risk compared with the general population. The cumulative incidence of each tumor type at 30 years was 2.19% (SE, 0.32%) for myeloid malignancy, 0.17% (SE, 0.10%) for lymphoma, 3.00% (SE, 0.59%) for brain tumor, 4.91% (SE, 1.04%) for carcinoma, and 0.57% (SE, 0.37%) for sarcoma. Conclusions The cumulative incidence of secondary neoplasms increases steadily over 30 years after treatment of acute lymphoblastic leukemia. Although the majority of the late-occurring secondary neoplasms are low-grade tumors, the increase in incidence of more aggressive malignant neoplasms is significantly higher than expected in the general population. These results suggest that lifelong follow-up of acute lymphoblastic leukemia survivors is needed to ascertain the full impact of treatment and other leukemia-related factors on secondary neoplasm development.	St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Biostat, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pediat, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pharmaceut Sci & Pharm, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Ctr Pediat Pharmacokinet & Therapeut, Memphis, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Hijiya, N (corresponding author), St Jude Childrens Hosp, Dept Oncol, MS 260,332 N Lauderdale St, Memphis, TN 38105 USA.	nobuko.hijiya@stjude.org	Rubnitz, Jeffrey E/N-2619-2018; Pui, Ching-Hon/N-8076-2018; Relling, Mary/N-5032-2018; Hudson, Melissa M/N-4441-2018; Evans, William E./C-2069-2012	Rubnitz, Jeffrey E/0000-0001-9885-3527; Pui, Ching-Hon/0000-0003-0303-5658; Hudson, Melissa M/0000-0001-6984-2407; Evans, William E./0000-0002-9333-5322; Razzouk, Bassem/0000-0003-0536-6135	NATIONAL CANCER INSTITUTE [R01CA036401, R01CA060419, R37CA036401, P30CA021765, P01CA071907, U01CA060419, R29CA051001, R01CA078224, R01CA051001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER; NCI NIH HHS [CA-71907, CA-78224, CA-21765, CA-36401, CA-51001, CA-60419] Funding Source: Medline; NIGMS NIH HHS [GM-61393] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bassal M, 2006, J CLIN ONCOL, V24, P476, DOI 10.1200/JCO.2005.02.7235; Bhatia S, 2002, BLOOD, V99, P4257, DOI 10.1182/blood.V99.12.4257; Bogni A, 2006, LEUKEMIA, V20, P239, DOI 10.1038/sj.leu.2404059; Breslow N E, 1987, IARC Sci Publ, P1; Dalton VMK, 1998, J CLIN ONCOL, V16, P2848, DOI 10.1200/JCO.1998.16.8.2848; Edick MJ, 2005, GENE CHROMOSOME CANC, V42, P107, DOI 10.1002/gcc.20121; Evans WE, 1998, NEW ENGL J MED, V338, P499, DOI 10.1056/NEJM199802193380803; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gaynon PS, 2000, LEUKEMIA, V14, P2223, DOI 10.1038/sj.leu.2401939; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Kalbfleisch JD, 2002, STAT ANAL FAILURE TI, P247; Loning L, 2000, BLOOD, V95, P2770, DOI 10.1182/blood.V95.9.2770.009k16_2770_2775; *NCI DCCPS, 2004, SEER STAT DAT INC SE; NEGLIA JP, 1991, NEW ENGL J MED, V325, P1330, DOI 10.1056/NEJM199111073251902; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Perkins JL, 2005, J CLIN ONCOL, V23, P3733, DOI 10.1200/JCO.2005.06.237; Pui CH, 2005, J CLIN ONCOL, V23, P7936, DOI 10.1200/JCO.2004.01.0033; PUI CH, 1995, LEUKEMIA, V9, P1680; Pui CH, 2003, NEW ENGL J MED, V349, P640, DOI 10.1056/NEJMoa035091; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; PUI CH, 1991, J CLIN ONCOL, V9, P1341, DOI 10.1200/JCO.1991.9.8.1341; PUI CH, 1991, NEW ENGL J MED, V325, P1682, DOI 10.1056/NEJM199112123252402; Pui CH, 1998, BLOOD, V92, P411, DOI 10.1182/blood.V92.2.411.414k34_411_415; Relling MV, 2003, BLOOD, V101, P3862, DOI 10.1182/blood-2002-08-2405; Relling MV, 1999, LANCET, V354, P34, DOI 10.1016/S0140-6736(98)11079-6; RIVERA GK, 1991, LANCET, V337, P61, DOI 10.1016/0140-6736(91)90733-6; Schrappe M, 2000, BLOOD, V95, P3310; Silverman LB, 2001, BLOOD, V97, P1211, DOI 10.1182/blood.V97.5.1211; SIMONE J, 1972, CANCER-AM CANCER SOC, V30, P1488, DOI 10.1002/1097-0142(197212)30:6<1488::AID-CNCR2820300612>3.0.CO;2-D; Strojan P, 2000, INT J RADIAT ONCOL, V48, P65, DOI 10.1016/S0360-3016(00)00609-X; Walter AW, 1998, J CLIN ONCOL, V16, P3761, DOI 10.1200/JCO.1998.16.12.3761; Zwerdling T, 2002, J PEDIAT HEMATOL ONC, V24, P199, DOI 10.1097/00043426-200203000-00008	33	203	211	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2007	297	11					1207	1215		10.1001/jama.297.11.1207	http://dx.doi.org/10.1001/jama.297.11.1207			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	147XO	17374815	Bronze			2022-12-28	WOS:000245039300024
J	Godfray, HCJ				Godfray, H. C. J.			Linnaeus in the information age	NATURE			English	Editorial Material									Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Godfray, HCJ (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.				NERC [NE/C001532/1] Funding Source: UKRI; Natural Environment Research Council [NE/C001532/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))			0	72	86	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					259	260		10.1038/446259a	http://dx.doi.org/10.1038/446259a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361160				2022-12-28	WOS:000244892900022
J	Goldston, D				Goldston, David			Washington, we have a problem	NATURE			English	Editorial Material											Goldston, D (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.								0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					244	244		10.1038/446244a	http://dx.doi.org/10.1038/446244a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361150	Bronze			2022-12-28	WOS:000244892900012
J	Porter, ME; Teisberg, EO				Porter, Michael E.; Teisberg, Elizabeth Olmsted			How physicians can change the future of health care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY; VOLUME; PERFORMANCE; MORTALITY; SERVICES; SURGERY; LESSONS; STATE	Today's preoccupation with cost shifting and cost reduction undermines physicians and patients. Instead, health care reform must focus on improving health and health care value for patients. We propose a strategy for reform that is market based but physician led. Physician leadership is essential. Improving the value of health care is something only medical teams can do. The right kind of competition - competition to improve results - will drive dramatic improvement. With such positive-sum competition, patients will receive better care, physicians will be rewarded for excellence, and costs will be contained. Physicians can lead this change and return the practice of medicine to its appropriate focus: enabling health and effective care. Three principles should guide this change: ( 1) the goal is value for patients, ( 2) medical practice should be organized around medical conditions and care cycles, and ( 3) results - risk-adjusted outcomes and costs - must be measured. Following these principles, professional satisfaction will increase and current pressures on physicians will decrease. If physicians fail to lead these changes, they will inevitably face ever-increasing administrative control of medicine. Improving health and health care value for patients is the only real solution. Value-based competition on results provides a path for reform that recognizes the role of health professionals at the heart of the system.	Harvard Univ, Cambridge, MA 02138 USA; Univ Virginia, Darden Grad Sch Business, Charlottesville, VA USA	Harvard University; University of Virginia	Porter, ME (corresponding author), Harvard Univ, Sch Business, Inst Strategy & Competitiveness, Soldiers Field Rd, Boston, MA 02163 USA.	mporter@hbs.edu						Batalden Paul, 2002, Qual Manag Health Care, V11, P45; Begg CB, 2002, NEW ENGL J MED, V346, P1138, DOI 10.1056/NEJMsa011788; Berwick DM, 2003, HEALTH AFFAIR, V22, P8, DOI 10.1377/hlthaff.22.6.8; Berwick DM, 2003, MED CARE, V41, pI30; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; BOHMER RMJ, 2005, 05047 HARV BUS SCH; Chassin MR, 2002, HEALTH AFFAIR, V21, P40, DOI 10.1377/hlthaff.21.4.40; ENTHOVEN AC, 2005, HLTH AFF MILLWOO JUL; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Ferguson TB, 2002, J THORAC CARDIOV SUR, V123, P869, DOI 10.1067/mtc.2002.121679; Ferguson TB, 2000, ANN THORAC SURG, V69, P680, DOI 10.1016/S0003-4975(99)01538-6; GAWANDE A, 2004, NEW YORKER       DEC, P6; Goetzel RZ, 2005, HEALTH CARE FINANC R, V26, P1; Grover FL, 2001, ANN SURG, V234, P464, DOI 10.1097/00000658-200110000-00006; GROVER FL, 2005, I MED SUBC PAY PERF; HEDEEN A, 2000, CBOC PERFORMANCE EVA; HERZLINGER RE, 1999, MARKET DRIVEN HLTH C; Herzlinger ReginaE., 2004, CONSUMER DRIVEN HLTH; HUCKMAN RS, 2003, 03083 HARV BUS SCH; Iezzoni LI, 2003, RISK ADJUSTMENT MEAS; Institute of Medicine, 2001, CROSSING QUALITY CHA; JAMES BC, MANAGING CLIN PROCES; JAMES BC, QUALITY CONTROLS COS; Kizer KW, 2003, NEW ENGL J MED, V349, P2159, DOI 10.1056/NEJMe038166; Knaus WA, 2005, MAYO CLIN PROC, V80, P164, DOI 10.4065/80.2.164; KOHN KT, 1999, ERR HUMAN BUILDING S; MARWICK C, 1992, JAMA-J AM MED ASSOC, V268, P2142, DOI 10.1001/jama.268.16.2142; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; *MIDW BUS GROUP HL, 2003, RED COSTS POOR QUAL; Orringer MB, 2001, ANN THORAC SURG, V72, P1, DOI 10.1016/S0003-4975(01)02791-6; PORTER ME, 1994, HARVARD BUS REV, V72, P131; Reinhardt UE, 2006, HEALTH AFFAIR, V25, P57, DOI 10.1377/hlthaff.25.1.57; RELMAN AS, 2005, NEW REPUBLIC    0307, P23; *SAR MEM HOSP, 2002, DAT AN DRIV ICU IMPR; Schechter MS, 2005, J PEDIATR-US, V147, P295, DOI 10.1016/j.jpeds.2005.03.044; SHOWSTACK JA, 1987, JAMA-J AM MED ASSOC, V257, P785, DOI 10.1001/jama.257.6.785; *SOC THOR SURG, 2003, NAT AD CARD SURG DAT; *ST MAR MED CTR, 2002, APACHE HIGHL WAYS IM; Starfield B, 2000, JAMA-J AM MED ASSOC, V284, P483, DOI 10.1001/jama.284.4.483; Starfield B, 2000, ANNU REV PUBL HEALTH, V21, P569, DOI 10.1146/annurev.publhealth.21.1.569; Uhlig Paul N, 2002, Jt Comm J Qual Improv, V28, P666; *US DEP VET AFF, FISC YEAR 2006 PERF; US Department of Veterans Affairs, VA DOD CLIN PRACT GU; Wennberg JE, 2004, BMJ-BRIT MED J, V328, P607, DOI 10.1136/bmj.328.7440.607; Wennberg JE, 2006, CARE PATIENTS SEVERE; Wennberg JE, 1999, DARTMOUTH ATLAS HLTH; Young GJ, 1997, HEALTH CARE MANAGE R, V22, P72, DOI 10.1097/00004010-199710000-00010; VHA PREVENTION INDEX	49	250	254	0	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2007	297	10					1103	1111		10.1001/jama.297.10.1103	http://dx.doi.org/10.1001/jama.297.10.1103			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	145KZ	17356031				2022-12-28	WOS:000244865200024
J	Franck, L; Chantler, C; Dixon, M				Franck, Linda; Chantler, Cyril; Dixon, Michael			Should NICE evaluate complementary and alternative medicine?	BRITISH MEDICAL JOURNAL			English	Article									UCL, Inst Child Hlth, London WC1N 1EH, England; Kings Fund, London W1G OAN, England; NHS Alliance, Nottingham DN22 6JD, England	University of London; University College London	Franck, L (corresponding author), UCL, Inst Child Hlth, London WC1N 1EH, England.	l.franck@ich.ucl.ac.uk	; Colquhoun, David/C-1664-2008	Franck, Linda/0000-0003-4291-9181; Colquhoun, David/0000-0002-4263-017X					0	15	15	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2007	334	7592					506	506		10.1136/bmj.39122.512211.BE	http://dx.doi.org/10.1136/bmj.39122.512211.BE			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148VV	17347233	Green Submitted, Green Published			2022-12-28	WOS:000245106400034
J	Cai, L; Marshall, TW; Uetrecht, AC; Schafer, DA; Bear, JE				Cai, Liang; Marshall, Thomas W.; Uetrecht, Andrea C.; Schafer, Dorothy A.; Bear, James E.			Coronin 1B coordinates Arp2/3 complex and cofilin activities at the leading edge	CELL			English	Article							ACTIN-DEPOLYMERIZING FACTOR; LIM-KINASE; ENA/VASP PROTEINS; CROSS-LINKING; POLYMERIZATION; SLINGSHOT; PHOSPHATASES; PROMOTES; FAMILY; CELLS	Actin filament formation and turnover within the treadmilling actin filament array at the leading edge of migrating cells are interdependent and coupled, but the mechanisms coordinating these two activities are not understood. We report that Coronin 1B interacts simultaneously with Arp2/3 complex and Slingshot (SSH1L) phosphatase, two regulators of actin filament formation and turnover, respectively. Coronin 1B inhibits filament nucleation by Arp2/3 complex and this inhibition is attenuated by phosphorylation of Coronin 1B at Serine 2, a site targeted by SSH1L. Coronin 1B also directs SSH1L to lamellipodia where SSH1L likely regulates Cofilin activity via dephosphorylation. Accordingly, depleting Coronin 1B increases phospho-Cofilin levels, and alters lamellipodial dynamics and actin filament architecture at the leading edge. We conclude that Coronin 1B's coordination of filament formation by Arp2/3 complex and filament turnover by Cofilin is required for effective lamellipodial protrusion and cell migration.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Dev Biol, Sch Med, Chapel Hill, NC 27599 USA; Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; Univ Virginia, Dept Cell Biol, Charlottesville, VA 22904 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Virginia; University of Virginia	Bear, JE (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	jbear@email.unc.edu			NCI NIH HHS [P30 CA016086, 1U54 CA 119343, CA 16086] Funding Source: Medline; NIGMS NIH HHS [R01 GM067222, R01 GM083035, GM 067222, R01 GM083035-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016086, U54CA119343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067222, R01GM083035] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; BRYAN J, 1985, J CELL BIOL, V101, P1236, DOI 10.1083/jcb.101.4.1236; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; Cohen PTW, 2002, J CELL SCI, V115, P241; CONDEELIS J, 1988, CELL MOTIL CYTOSKEL, V10, P77, DOI 10.1002/cm.970100113; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; DesMarais V, 2004, J CELL SCI, V117, P3499, DOI 10.1242/jcs.01211; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; DINUBILE MJ, 1995, MOL BIOL CELL, V6, P1659, DOI 10.1091/mbc.6.12.1659; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Hinz B, 1999, EXP CELL RES, V251, P234, DOI 10.1006/excr.1999.4541; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; Mishima M, 1999, J CELL SCI, V112, P2833; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Ponti A, 2005, BIOPHYS J, V89, P3456, DOI 10.1529/biophysj.104.058701; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Shao D, 2006, CELL MOTIL CYTOSKEL, V63, P395, DOI 10.1002/cm.20131; Sim ATR, 1999, CELL CALCIUM, V26, P209, DOI 10.1054/ceca.1999.0072; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stanyon CA, 1999, INT J BIOCHEM CELL B, V31, P389, DOI 10.1016/S1357-2725(98)00116-2; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; SVITKINA TM, 2005, J CELLS, V3, P277; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Yamakita Y, 2003, J BIOL CHEM, V278, P17937, DOI 10.1074/jbc.M208739200; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	49	171	176	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					915	929		10.1016/j.cell.2007.01.031	http://dx.doi.org/10.1016/j.cell.2007.01.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350576	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000245073400016
J	Qu, XP; Zou, ZJ; Sun, QH; Luby-Phelps, K; Cheng, PF; Hogan, RN; Gilpin, C; Levine, B				Qu, Xueping; Zou, Zhongju; Sun, Qihua; Luby-Phelps, Kate; Cheng, Pengfei; Hogan, Robert N.; Gilpin, Christopher; Levine, Beth			Autophagy gene-dependent clearance of apoptotic cells during embryonic development	CELL			English	Article							DEATH; PHOSPHATIDYLSERINE; DIFFERENTIATION; ENGULFMENT; SURVIVAL; SIGNALS; REDISTRIBUTION; INHIBITION; CAVITATION; MECHANISMS	Autophagy is commonly observed in metazoan organisms during programmed cell death (PCD), but its function in dying cells has been unclear. We studied the role of autophagy in embryonic cavitation, the earliest PCD process in mammalian development. Embryoid bodies (EBs) derived from cells lacking the autophagy genes, atg5 or beclin 1, fail to cavitate. This defect is due to persistence of cell corpses, rather than impairment of PCD. Dying cells in autophagy gene null EBs fail to express the "eat-me" signal, phosphaticlylserine exposure, and secrete lower levels of the "come-get-me" signal, lysophosphatidylcholine. These defects are associated with low levels of cellular ATIP and are reversed by treatment with the metabolic substrate, methylpyruvate. Moreover, mice lacking atg5 display a defect in apoptotic corpse engulfment during embryonic development. We conclude that autophagy contributes to dead-cell clearance during PCD by a mechanism that likely involves the generation of energy-dependent engulfment signals.	Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Ophthalmol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Levine, B (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu		Luby-Phelps, Katherine/0000-0002-8378-1409	NATIONAL CANCER INSTITUTE [R01CA109618, R01CA084254, R56CA109618] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA109618, CA 109618, R01 CA 084254] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baehrecke EH, 2003, CELL DEATH DIFFER, V10, P940, DOI 10.1038/sj.cdd.4401280; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Marguet D, 1999, NAT CELL BIOL, V1, P454, DOI 10.1038/15690; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Murray P, 2001, DIFFERENTIATION, V68, P227, DOI 10.1046/j.1432-0436.2001.680410.x; Ng YS, 2004, LAB INVEST, V84, P1209, DOI 10.1038/labinvest.3700150; POIRIER F, 1991, DEVELOPMENT, V113, P1105; Ravichandran KS, 2003, CELL, V113, P817, DOI 10.1016/S0092-8674(03)00471-9; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Takacs-Vellai K, 2005, CURR BIOL, V15, P1513, DOI 10.1016/j.cub.2005.07.035; van den Eijnde SM, 1998, APOPTOSIS, V3, P9, DOI 10.1023/A:1009650917818; Xiao YJ, 2001, ANAL BIOCHEM, V290, P302, DOI 10.1006/abio.2001.5000; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	37	500	522	0	37	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					931	946		10.1016/j.cell.2006.12.044	http://dx.doi.org/10.1016/j.cell.2006.12.044			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350577	Bronze			2022-12-28	WOS:000245073400017
J	Greenman, C; Stephens, P; Smith, R; Dalgliesh, GL; Hunter, C; Bignell, G; Davies, H; Teague, J; Butler, A; Edkins, S; O'Meara, S; Vastrik, I; Schmidt, EE; Avis, T; Barthorpe, S; Bhamra, G; Buck, G; Choudhury, B; Clements, J; Cole, J; Dicks, E; Forbes, S; Gray, K; Halliday, K; Harrison, R; Hills, K; Hinton, J; Jenkinson, A; Jones, D; Menzies, A; Mironenko, T; Perry, J; Raine, K; Richardson, D; Shepherd, R; Small, A; Tofts, C; Varian, J; Webb, T; West, S; Widaa, S; Yates, A; Cahill, DP; Louis, DN; Goldstraw, P; Nicholson, AG; Brasseur, F; Looijenga, L; Weber, BL; Chiew, YE; Defazio, A; Greaves, MF; Green, AR; Campbell, P; Birney, E; Easton, DF; Chenevix-Trench, G; Tan, MH; Khoo, SK; Teh, BT; Yuen, ST; Leung, SY; Wooster, R; Futreal, PA; Stratton, MR				Greenman, Christopher; Stephens, Philip; Smith, Raffaella; Dalgliesh, Gillian L.; Hunter, Christopher; Bignell, Graham; Davies, Helen; Teague, Jon; Butler, Adam; Edkins, Sarah; O'Meara, Sarah; Vastrik, Imre; Schmidt, Esther E.; Avis, Tim; Barthorpe, Syd; Bhamra, Gurpreet; Buck, Gemma; Choudhury, Bhudipa; Clements, Jody; Cole, Jennifer; Dicks, Ed; Forbes, Simon; Gray, Kris; Halliday, Kelly; Harrison, Rachel; Hills, Katy; Hinton, Jon; Jenkinson, Andy; Jones, David; Menzies, Andy; Mironenko, Tatiana; Perry, Janet; Raine, Keiran; Richardson, Dave; Shepherd, Rebecca; Small, Alexandra; Tofts, Calli; Varian, Jennifer; Webb, Tony; West, Sofie; Widaa, Sara; Yates, Andy; Cahill, Daniel P.; Louis, David N.; Goldstraw, Peter; Nicholson, Andrew G.; Brasseur, Francis; Looijenga, Leendert; Weber, Barbara L.; Chiew, Yoke-Eng; deFazio, Anna; Greaves, Mel F.; Green, Anthony R.; Campbell, Peter; Birney, Ewan; Easton, Douglas F.; Chenevix-Trench, Georgia; Tan, Min-Han; Khoo, Sok Kean; Teh, Bin Tean; Yuen, Siu Tsan; Leung, Suet Yi; Wooster, Richard; Futreal, P. Andrew; Stratton, Michael R.			Patterns of somatic mutation in human cancer genomes	NATURE			English	Article							KINASE GENE FAMILY; HUMAN LUNG-CANCER; COLORECTAL CANCERS; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; BREAST-CANCER; BETA RECEPTOR; PROTEIN; TITIN; INACTIVATION	Cancers arise owing to mutations in a subset of genes that confer growth advantage. The availability of the human genome sequence led us to propose that systematic resequencing of cancer genomes for mutations would lead to the discovery of many additional cancer genes. Here we report more than 1,000 somatic mutations found in 274 megabases (Mb) of DNA corresponding to the coding exons of 518 protein kinase genes in 210 diverse human cancers. There was substantial variation in the number and pattern of mutations in individual cancers reflecting different exposures, DNA repair defects and cellular origins. Most somatic mutations are likely to be 'passengers' that do not contribute to oncogenesis. However, there was evidence for 'driver' mutations contributing to the development of the cancers studied in approximately 120 genes. Systematic sequencing of cancer genomes therefore reveals the evolutionary diversity of cancers and implicates a larger repertoire of cancer genes than previously anticipated.	Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; EMBL, European Bioinformat Inst, Cambridge CB10 1SD, England; Massachusetts Gen Hosp, Neurosurg Serv, Mol Pathol Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Royal Brompton Hosp, London SW3 6NP, England; Ludwig Inst Canc Res, B-1200 Brussels, Belgium; Erasmus MC, Daniel den Hoed Canc Ctr, Josephine Nefkens Inst, Lab Pathol Expt Pathooncol, NL-3000 DR Rotterdam, Netherlands; Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA; Westmead Hosp, Dept Gynaecol Oncol, Westmead, NSW 2145, Australia; Univ Sydney, Westmead Inst Canc Res, Westmead Millennium Inst, Westmead, NSW 2145, Australia; Inst Canc Res, Sutton SM2 5NG, Surrey, England; Addenbrookes NHS Trust, Dept Haematol, Cambridge CB2 0QQ, England; Univ Cambridge, Cambridge CB2 0QQ, England; Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Cambridge CB1 8RN, England; Univ Queensland, Royal Brisbane Hosp, Queensland Inst Med Res, Herston, Qld 4029, Australia; Van Andel Res Inst, Grand Rapids, MI 49503 USA; Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China	University of Cambridge; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Royal Brompton Hospital; Ludwig Institute for Cancer Research; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Pennsylvania; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of London; Institute of Cancer Research - UK; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cancer Research UK; University of Cambridge; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland; Van Andel Institute; University of Hong Kong	Futreal, PA (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	paf@sanger.ac.uk; mrs@sanger.ac.uk	Looijenga, Leendert/B-8145-2019; Leung, Suet Yi/C-4340-2009; Tan, Min Han/D-9205-2014; Vastrik, Imre/C-2690-2009; Dalgliesh, Gillian/B-7799-2008; Chenevix-Trench, Georgia/AAV-2014-2020; Choudhury, Bhudipa/D-3863-2011; deFazio, Anna/D-3939-2013; Yuen, Siu/K-6311-2014; DeFazio, Anna/O-2385-2019; Leung, Suet Yi/T-9620-2019	Looijenga, Leendert/0000-0002-8146-1911; Tan, Min Han/0000-0002-0644-3457; Dalgliesh, Gillian/0000-0001-8526-5064; Chenevix-Trench, Georgia/0000-0002-1878-2587; Choudhury, Bhudipa/0000-0002-1392-6414; deFazio, Anna/0000-0003-0057-4744; DeFazio, Anna/0000-0003-0057-4744; Richardson, David/0000-0003-0247-9118; Jenkinson, Andrew/0000-0002-0703-6984; Leung, Suet Yi/0000-0001-8614-4619; Green, Anthony/0000-0002-9795-0218; Gray, Kristian/0000-0002-7035-7107; Hunter, Christopher/0000-0002-1335-0881; Buck, Gemma/0000-0001-5289-1050; Cahill, Daniel/0000-0003-2552-6546; Avis, Tim/0000-0001-6120-5729; Yates, Andrew/0000-0002-8886-4772; Vastrik, Imre/0000-0001-6658-9311; Birney, Ewan/0000-0001-8314-8497; Raine, Keiran/0000-0002-5634-1539; Teh, Bin Tean/0000-0003-1514-1124	Medical Research Council [G0300723B] Funding Source: researchfish; Wellcome Trust [077012, 088340] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)		Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bignell G, 2006, GENE CHROMOSOME CANC, V45, P42, DOI 10.1002/gcc.20265; Bogoyevitch MA, 2004, BBA-PROTEINS PROTEOM, V1697, P89, DOI 10.1016/j.bbapap.2003.11.016; Brose MS, 2002, CANCER RES, V62, P6997; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Futreal PA, 2001, NATURE, V409, P850, DOI 10.1038/35057046; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Granzier HL, 2005, ADV PROTEIN CHEM, V71, P89, DOI 10.1016/S0065-3233(04)71003-7; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Irusta PM, 2002, J BIOL CHEM, V277, P38627, DOI 10.1074/jbc.M204890200; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Karran P, 2003, BIOCHIMIE, V85, P1149, DOI 10.1016/j.biochi.2003.10.007; Kushida Tatsuya, 2006, Pac Symp Biocomput, P152; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lonardi S, 2005, CANCER TREAT REV, V31, P79, DOI 10.1016/j.ctrv.2004.12.005; Machado C, 2000, J CELL BIOL, V151, P639, DOI 10.1083/jcb.151.3.639; Machado C, 1998, J CELL BIOL, V141, P321, DOI 10.1083/jcb.141.2.321; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Teng DHF, 1997, CANCER RES, V57, P4177; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699; Wilkie AOM, 2002, AM J MED GENET, V112, P266, DOI 10.1002/ajmg.10775; Yang ZH, 2003, GENETICS, V165, P695; Zastrow MS, 2006, J CELL SCI, V119, P239, DOI 10.1242/jcs.02728	39	2206	2790	1	239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					153	158		10.1038/nature05610	http://dx.doi.org/10.1038/nature05610			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344846	Green Accepted			2022-12-28	WOS:000244718100033
J	Robinson, AL; Donahue, NM; Shrivastava, MK; Weitkamp, EA; Sage, AM; Grieshop, AP; Lane, TE; Pierce, JR; Pandis, SN				Robinson, Allen L.; Donahue, Neil M.; Shrivastava, Manish K.; Weitkamp, Emily A.; Sage, Amy M.; Grieshop, Andrew P.; Lane, Timothy E.; Pierce, Jeffrey R.; Pandis, Spyros N.			Rethinking organic aerosols: Semivolatile emissions and photochemical aging	SCIENCE			English	Article							AIR-POLLUTION SOURCES; SOURCE APPORTIONMENT; SECONDARY; DILUTION; MASS; OH; TROPOSPHERE; COMBUSTION; TRACERS; PM2.5	Most primary organic-particulate emissions are semivolatile; thus, they partially evaporate with atmospheric dilution, creating substantial amounts of low-volatility gas-phase material. Laboratory experiments show that photo-oxidation of diesel emissions rapidly generates organic aerosol, greatly exceeding the contribution from known secondary organic-aerosol precursors. We attribute this unexplained secondary organic-aerosol production to the oxidation of low-volatility gas-phase species. Accounting for partitioning and photochemical processing of primary emissions creates a more regionally distributed aerosol and brings model predictions into better agreement with observations. Controlling organic particulate-matter concentrations will require substantial changes in the approaches that are currently used to measure and regulate emissions.	Carnegie Mellon Univ, Ctr Atmospher Particle Studies, Pittsburgh, PA 15213 USA; Univ Patras, Dept Chem Engn, Patras 26500, Greece	Carnegie Mellon University; University of Patras	Robinson, AL (corresponding author), Carnegie Mellon Univ, Ctr Atmospher Particle Studies, Pittsburgh, PA 15213 USA.	alr@andrew.cmu.edu; nmd@andrew.cmu.edu	Grieshop, Andrew/AAL-1174-2020; Worsnop, Douglas R/D-2817-2009; Pierce, Jeffrey R/E-4681-2013; Robinson, Allen/I-5713-2012; Pandis, Spyros/AAW-3089-2021; Robinson, Allen L/M-3046-2014; Donahue, Neil M/A-2329-2008; Studies, Center for Atmospheric Particle/AAR-6731-2020; Pandis, Spyros/D-3680-2013	Grieshop, Andrew/0000-0002-6470-9946; Worsnop, Douglas R/0000-0002-8928-8017; Pierce, Jeffrey R/0000-0002-4241-838X; Robinson, Allen/0000-0003-1053-7090; Pandis, Spyros/0000-0001-8085-9795; Robinson, Allen L/0000-0002-1819-083X; Donahue, Neil M/0000-0003-3054-2364; 				Atkinson R, 2003, CHEM REV, V103, P4605, DOI 10.1021/cr0206420; Bahreini R, 2005, ENVIRON SCI TECHNOL, V39, P5674, DOI 10.1021/es048061a; Bloss WJ, 2005, FARADAY DISCUSS, V130, P425, DOI 10.1039/b419090d; Cabada JC, 2004, AEROSOL SCI TECH, V38, P140, DOI 10.1080/02786820390229084; Chung MY, 2003, ATMOS ENVIRON, V37, pS159, DOI 10.1016/S1352-2310(03)00388-1; de Gouw JA, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005623; Donahue NM, 2006, ENVIRON SCI TECHNOL, V40, P2635, DOI 10.1021/es052297c; Heald CL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023831; Heard DE, 2003, CHEM REV, V103, P5163, DOI 10.1021/cr020522s; HILDEMANN LM, 1989, AEROSOL SCI TECH, V10, P193, DOI 10.1080/02786828908959234; Johnson D, 2006, ATMOS CHEM PHYS, V6, P403, DOI 10.5194/acp-6-403-2006; Kanakidou M, 2005, ATMOS CHEM PHYS, V5, P1053, DOI 10.5194/acp-5-1053-2005; Koo BY, 2003, ATMOS ENVIRON, V37, P4757, DOI 10.1016/j.atmosenv.2003.08.016; Lim YB, 2005, ENVIRON SCI TECHNOL, V39, P9229, DOI 10.1021/es051447g; Lipsky EM, 2006, ENVIRON SCI TECHNOL, V40, P155, DOI 10.1021/es050319p; Odum JR, 1996, ENVIRON SCI TECHNOL, V30, P2580, DOI 10.1021/es950943+; Pun BK, 2003, ENVIRON SCI TECHNOL, V37, P3647, DOI 10.1021/es0341541; Schauer JJ, 1999, ENVIRON SCI TECHNOL, V33, P1578, DOI 10.1021/es980081n; Schauer JJ, 2002, ENVIRON SCI TECHNOL, V36, P1169, DOI 10.1021/es0108077; Schauer JJ, 2001, ENVIRON SCI TECHNOL, V35, P1716, DOI 10.1021/es001331e; Schauer JJ, 1996, ATMOS ENVIRON, V30, P3837, DOI 10.1016/1352-2310(96)00085-4; Shrivastava MK, 2006, ENVIRON SCI TECHNOL, V40, P2671, DOI 10.1021/es0522231; TURPIN BJ, 1995, ATMOS ENVIRON, V29, P3527, DOI 10.1016/1352-2310(94)00276-Q; Volkamer R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026899; VULUKURU S, 2006, J GEOPHYS RES, V111, pS1012; Zhang Q, 2005, ATMOS CHEM PHYS, V5, P3289, DOI 10.5194/acp-5-3289-2005; Zheng M, 2002, ENVIRON SCI TECHNOL, V36, P2361, DOI 10.1021/es011275x	27	1290	1320	40	918	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1259	1262		10.1126/science.1133061	http://dx.doi.org/10.1126/science.1133061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332409				2022-12-28	WOS:000244564700045
J	Carrez, P; Ferre, D; Cordier, P				Carrez, Philippe; Ferre, Denise; Cordier, Patrick			Implications for plastic flow in the deep mantle from modelling dislocations in MgSiO3 minerals	NATURE			English	Article							POST-PEROVSKITE PHASE; SHEAR ANISOTROPY; STACKING-FAULTS; SLIP SYSTEMS	The dynamics of the Earth's interior is largely controlled by mantle convection, which transports radiogenic and primordial heat towards the surface. Slow stirring of the deep mantle is achieved in the solid state through high-temperature creep of rocks, which are dominated by the mineral MgSiO3 perovskite. Transformation of MgSiO3 to a 'post-perovskite' phase(1-3) may explain the peculiarities of the lowermost mantle, such as the observed seismic anisotropy(4), but the mechanical properties of these mineralogical phases are largely unknown(5-7). Plastic flow of solids involves the motion of a large number of crystal defects, named dislocations(8). A quantitative description of flow in the Earth's mantle requires information about dislocations in high-pressure minerals and their behaviour under stress. This property is currently out of reach of direct atomistic simulations using either empirical interatomic potentials or ab initio calculations. Here we report an alternative to direct atomistic simulations based on the framework of the Peierls - Nabarro model(9,10). Dislocation core models are proposed for MgSiO3 perovskite ( at 100 GPa) and post-perovskite ( at 120 GPa). We show that in perovskite, plastic deformation is strongly influenced by the orthorhombic distortions of the unit cell. In silicate post-perovskite, large dislocations are relaxed through core dissociation, with implications for the mechanical properties and seismic anisotropy of the lowermost mantle.	Univ Lille 1, CNRS, UMR 8008, Lab Struct & Proprietes Etat Solide, F-59655 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Carrez, P (corresponding author), Univ Lille 1, CNRS, UMR 8008, Lab Struct & Proprietes Etat Solide, F-59655 Villeneuve Dascq, France.	Patrick.Cordier@univ-lille1.fr	Cordier, Patrick/D-2357-2012	Cordier, Patrick/0000-0002-1883-2994; Carrez, Philippe/0000-0003-1295-9377				BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Cai W, 2004, DISLOCAT S, V12, P1; Carrez P, 2006, EUR J MINERAL, V18, P149, DOI 10.1127/0935-1221/2006/0018-0149; Cawkwell MJ, 2005, SCIENCE, V309, P1059, DOI 10.1126/science.1114704; Chisholm MF, 2005, SCIENCE, V307, P701, DOI 10.1126/science.1105962; Cordier P, 2004, NATURE, V428, P837, DOI 10.1038/nature02472; CORDIER P, 2005, MINERAL BEHAV EXTREM, P389; Durinck J, 2005, PHYS CHEM MINER, V32, P646, DOI 10.1007/s00269-005-0041-2; Durinck J, 2005, AM MINERAL, V90, P1072, DOI 10.2138/am.2005.1738; Hirth J. P., 1972, THEORY DISLOCATIONS; Hytch MJ, 2003, NATURE, V423, P270, DOI 10.1038/nature01638; Iitaka T, 2004, NATURE, V430, P442, DOI 10.1038/nature02702; Jia CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.225506; JOOS B, 1994, PHYS REV B, V50, P5890, DOI 10.1103/PhysRevB.50.5890; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Lu G, 2000, PHYS REV B, V62, P3099, DOI 10.1103/PhysRevB.62.3099; Merkel S, 2006, SCIENCE, V311, P644, DOI 10.1126/science.1121808; Miranda CR, 2005, COMPUT PHYS COMMUN, V169, P24, DOI 10.1016/j.cpc.2005.03.007; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; NABARRO FRN, 1947, P PHYS SOC LOND, V59, P256, DOI 10.1088/0959-5309/59/2/309; NIWA K, UNPUB GEOPHYS RES LE; Oganov AR, 2005, NATURE, V438, P1142, DOI 10.1038/nature04439; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; Peierls R, 1940, P PHYS SOC, V52, P34, DOI 10.1088/0959-5309/52/1/305; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Santillan J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026423; Setter N, 2000, ACTA MATER, V48, P151, DOI 10.1016/S1359-6454(99)00293-1; VITEK V, 1968, PHILOS MAG, V18, P773, DOI 10.1080/14786436808227500; Walker AM, 2005, PHYS CHEM CHEM PHYS, V7, P3235, DOI 10.1039/b505716g; Walker AM, 2004, NAT MATER, V3, P715, DOI 10.1038/nmat1213; Wookey J, 2005, NATURE, V438, P1004, DOI 10.1038/nature04345	32	65	67	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					68	70		10.1038/nature05593	http://dx.doi.org/10.1038/nature05593			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330041				2022-12-28	WOS:000244525600038
J	Shrestha, MP; Scott, RM; Joshi, DM; Mammen, MP; Thapa, GB; Thapa, N; Myint, KSA; Fourneau, M; Kuschner, RA; Shrestha, SK; David, MP; Seriwatana, J; Vaughn, DW; Safary, A; Endy, TP; Innis, BL				Shrestha, Mrigendra Prasad; Scott, Robert McNair; Joshi, Durga Man; Mammen, Mammen P., Jr.; Thapa, Gyan Bahadur; Thapa, Narbada; Myint, Khin Saw Aye; Fourneau, Marc; Kuschner, Robert A.; Shrestha, Sanjaya Kumar; David, Marie Pierre; Seriwatana, Jitvimol; Vaughn, David W.; Safary, Assad; Endy, Timothy P.; Innis, Bruce L.			Safety and efficacy of a recombinant hepatitis E vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							E VIRUS-INFECTION; PHYLOGENETIC ANALYSIS; DISEASE; IMMUNOGLOBULIN; NEPAL	BACKGROUND: Hepatitis E virus (HEV) is an important cause of viral hepatitis. We evaluated the safety and efficacy of an HEV recombinant protein (rHEV) vaccine in a phase 2, randomized, double-blind, placebo-controlled trial. METHODS: In Nepal, we studied 2000 healthy adults susceptible to HEV infection who were randomly assigned to receive three doses of either the rHEV vaccine or placebo at months 0, 1, and 6. Active (including hospital) surveillance was used to identify acute hepatitis and adverse events. The primary end point was the development of hepatitis E after three vaccine doses. RESULTS: A total of 1794 subjects (898 in the vaccine group and 896 in the placebo group) received three vaccine doses; the total vaccinated cohort was followed for a median of 804 days. After three vaccine doses, hepatitis E developed in 69 subjects, of whom 66 were in the placebo group. The vaccine efficacy was 95.5% (95% confidence interval [CI], 85.6 to 98.6). In an intention-to-treat analysis that included all 87 subjects in whom hepatitis E developed after the first vaccine dose, 9 subjects were in the vaccine group, with a vaccine efficacy of 88.5% (95% CI, 77.1 to 94.2). Among subjects in a subgroup randomly selected for analysis of injection-site findings and general symptoms (reactogenicity subgroup) during the 8-day period after the administration of any dose, the proportion of subjects with adverse events was similar in the two study groups, except that injection-site pain was increased in the vaccine group (P=0.03). CONCLUSIONS: In a high-risk population, the rHEV vaccine was effective in the prevention of hepatitis E.	GlaxoSmithKline Biol, Rixensart, Belgium; GlaxoSmithKline Biol, King Of Prussia, PA USA; Walter Reed Army Inst Res, Med Sci Res Unit Nepal, Kathmandu, Nepal; Nepalese Army, Kathmandu, Nepal; Armed Forces Inst Med Sci, Bangkok, Thailand; Walter Reed Army Inst Res, Silver Spring, MD USA; Army Med Res & Mat Command, Mil Infect Dis Res Program, Ft Detrick, MD USA	GlaxoSmithKline; GlaxoSmithKline; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Innis, BL (corresponding author), GlaxoSmithKline Inc, 2301 Renaissance Blvd, King Of Prussia, PA 19406 USA.	bruce.2.innis@gsk.com	Myint, Khin/HHS-2027-2022	Myint, Khin/0000-0002-2087-7331; Innis, Bruce/0000-0002-1753-7248				Balayan MS, 1997, J VIRAL HEPATITIS, V4, P155, DOI 10.1046/j.1365-2893.1997.00145.x; Banatvala JE, 2003, J VIRAL HEPATITIS, V10, P1, DOI 10.1046/j.1365-2893.2003.00400.x; Berke T, 1997, J MED VIROL, V52, P419, DOI 10.1002/(SICI)1096-9071(199708)52:4&lt;419::AID-JMV13&gt;3.0.CO;2-B; Clayson ET, 1997, J INFECT DIS, V176, P763, DOI 10.1086/517296; Clayson ET, 1998, J MED VIROL, V54, P178, DOI 10.1002/(SICI)1096-9071(199803)54:3&lt;178::AID-JMV6&gt;3.0.CO;2-2; CLAYSON ET, 1995, J INFECT DIS, V172, P927, DOI 10.1093/infdis/172.4.927; Emerson SU, 2003, REV MED VIROL, V13, P145, DOI 10.1002/rmv.384; Innis BL, 2002, CLIN DIAGN LAB IMMUN, V9, P639, DOI 10.1128/CDLI.9.3.639-648.2002; Krawczynski K, 2005, VIRAL HEPATITIS, 3RD EDITION, P624, DOI 10.1002/9780470987131.ch41; Labrique AB, 1999, EPIDEMIOL REV, V21, P162, DOI 10.1093/oxfordjournals.epirev.a017994; PURCELL RH, 1994, P NATL ACAD SCI USA, V91, P9195; PURCELL RH, 1994, P NATL ACAD SCI USA, V91, P2401, DOI 10.1073/pnas.91.7.2401; Purcell RH, 2005, VIRAL HEPATITIS, 3RD EDITION, P635, DOI 10.1002/9780470987131.ch42; Robinson RA, 1998, PROTEIN EXPRES PURIF, V12, P75, DOI 10.1006/prep.1997.0817; Safary A, 2001, INTERVIROLOGY, V44, P162, DOI 10.1159/000050043; Schofield DJ, 2003, VACCINE, V22, P257, DOI 10.1016/j.vaccine.2003.07.008; Seriwatana J, 2002, CLIN DIAGN LAB IMMUN, V9, P1072, DOI 10.1128/CDLI.9.5.1072-1078.2002; Tsarev SA, 1999, J MED VIROL, V57, P68, DOI 10.1002/(SICI)1096-9071(199901)57:1&lt;68::AID-JMV10&gt;3.0.CO;2-E; Tsarev SA, 1997, VACCINE, V15, P1834, DOI 10.1016/S0264-410X(97)00145-X; Worm HC, 2004, DRUGS, V64, P1517, DOI 10.2165/00003495-200464140-00002; Worm HC, 2002, WIEN KLIN WOCHENSCHR, V114, P663	21	347	371	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2007	356	9					895	903		10.1056/NEJMoa061847	http://dx.doi.org/10.1056/NEJMoa061847			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140HV	17329696				2022-12-28	WOS:000244496400004
J	Furniss, R; Ormond-Walshe, S				Furniss, Richard; Ormond-Walshe, Sarah			An alternative to the clinical negligence system	BRITISH MEDICAL JOURNAL			English	Editorial Material									Lincolns Inn, London WC2A 3UP, England		Ormond-Walshe, S (corresponding author), Lincolns Inn, London WC2A 3UP, England.	Sarahow@22ob.com						Department of Health, 2003, MAK AM CONS PAP SETT	1	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 24	2007	334	7590					400	402		10.1136/bmj.39050.696192.94	http://dx.doi.org/10.1136/bmj.39050.696192.94			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	142MQ	17322256	Green Published			2022-12-28	WOS:000244654400027
J	Ofo, E; O'Reilly, B; O'Doherty, A				Ofo, E.; 'Reilly, B.; O'Doherty, A.			Olfactory loss	BRITISH MEDICAL JOURNAL			English	Editorial Material									Basildon & Thurrock Univ Hosp NHS Fdn Trust, Basildon SS16 5NL, England; Hassengate Med Ctr, Stanford Hope SS17 0PH, England		Ofo, E (corresponding author), Basildon & Thurrock Univ Hosp NHS Fdn Trust, Basildon SS16 5NL, England.	eofo@hotmail.com						Bromley SM, 2000, AM FAM PHYSICIAN, V61, P427; Holbrook Eric H, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P54, DOI 10.1097/00020840-200302000-00012; Parker JN, 2002, OFFICIAL PATIENTS SO	3	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 24	2007	334	7590					423	423		10.1136/bmj.39035.624583.68	http://dx.doi.org/10.1136/bmj.39035.624583.68			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	142MQ	17322260	Green Published			2022-12-28	WOS:000244654400037
J	Waters, MR; Stafford, TW				Waters, Michael R.; Stafford, Thomas W., Jr.			Redefining the age of Clovis: Implications for the peopling of the Americas	SCIENCE			English	Article							RADIOCARBON; COLONIZATION; DATES	The Clovis complex is considered to be the oldest unequivocal evidence of humans in the Americas, dating between 11,500 and 10,900 radiocarbon years before the present ( C-14 yr B. P.). Adjusted C-14 dates and a reevaluation of the existing Clovis date record revise the Clovis time range to 11,050 to 10,800 C-14 yr B. P. In as few as 200 calendar years, Clovis technology originated and spread throughout North America. The revised age range for Clovis overlaps non-Clovis sites in North and South America. This and other evidence imply that humans already lived in the Americas before Clovis.	Texas A&M Univ, Ctr Study First Amer, Dept Anthropol, College Stn, TX 77843 USA; Texas A&M Univ, Ctr Study First Amer, Dept Geog, College Stn, TX 77843 USA; Stafford Res Labs, Lafayette, CO 80026 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Waters, MR (corresponding author), Texas A&M Univ, Ctr Study First Amer, Dept Anthropol, 4352 TAMU, College Stn, TX 77843 USA.	mwaters@tamu.edu	Waters, Michael/ABI-2377-2020; Waters, Michael R/A-9430-2009	Waters, Michael/0000-0003-2660-3355; 				Anderson DG, 2000, AM ANTIQUITY, V65, P43, DOI 10.2307/2694807; Barbetti M, 2004, NUCL INSTRUM METH B, V223, P366, DOI 10.1016/j.nimb.2004.04.071; Bondevik S, 2006, SCIENCE, V312, P1514, DOI 10.1126/science.1123300; Bonnichsen R., 1991, CLOVIS ORIGINS ADAPT, P309; Bradley B, 2004, WORLD ARCHAEOL, V36, P459, DOI 10.1080/0043824042000303656; COLIINS MB, 1999, CLOVIS BLADE TECHNOL; Dillehay T. D., 1997, ARCHAEOLOGICAL CONTE, VII; Fairbanks RG, 2005, QUATERNARY SCI REV, V24, P1781, DOI 10.1016/j.quascirev.2005.04.007; Fiedel SJ, 2000, J ARCHAEOL RES, V8, P39, DOI 10.1023/A:1009400309773; Fiedel SJ, 1999, AM ANTIQUITY, V64, P95, DOI 10.2307/2694348; Frison G, 1996, MILL IRON SITE; GOEBEL T, 2006, 30 GREAT BAS ANTHR C; Hamilton T.D., 1999, ICE AGE PEOPLES N AM, P156; HAYNES CV, 1992, RADIOCARBON AFTER FOUR DECADES, P355; Haynes Jr C.V., 2005, PALEOAMERICAN ORIGIN, P113; HOFFECKER JF, 1993, SCIENCE, V259, P46, DOI 10.1126/science.259.5091.46; Johnson J.R., 1999, P 5 CAL ISL S WASH D, P541; Joyce DJ, 2006, QUATERN INT, V142, P44, DOI 10.1016/j.quaint.2005.03.004; Kromer B, 2004, RADIOCARBON, V46, P1203, DOI 10.1017/S0033822200033099; Mandryk CAS, 2001, QUATERNARY SCI REV, V20, P301, DOI 10.1016/S0277-3791(00)00115-3; Miotti L, 2003, QUATERN INT, V109, P95, DOI 10.1016/S1040-6182(02)00206-9; Overstreet David F., 2005, PALEOAMERICAN ORIGIN, P183; Pearson GA, 2004, SETTLEMENT OF THE AMERICAN CONTINENTS, P85; ROOSEVELT AC, 2002, MEMOIRS CALIFORNIA A, V27, P159; STAFFORD TW, 1991, J ARCHAEOL SCI, V18, P35, DOI 10.1016/0305-4403(91)90078-4; Tankersley KB, 2004, SETTLEMENT OF THE AMERICAN CONTINENTS, P49; WARD GK, 1978, ARCHAEOMETRY, V20, P19, DOI 10.1111/j.1475-4754.1978.tb00208.x	27	413	426	3	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1122	1126		10.1126/science.1137166	http://dx.doi.org/10.1126/science.1137166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	138UA	17322060				2022-12-28	WOS:000244387600036
J	Ludwig, DS				Ludwig, David S.			Clinical update: the low-glycaemic-index diet	LANCET			English	Article							FAT; CARBOHYDRATE; GLUCOSE; WEIGHT; RISK		Childrens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544				Alfenas RCG, 2005, DIABETES CARE, V28, P2123, DOI 10.2337/diacare.28.9.2123; Brand-Miller J, 2003, DIABETES CARE, V26, P2261, DOI 10.2337/diacare.26.8.2261; Canadian Diabetes Association, 1999, CAN J DIABETES CARE, V23, P56; Chiasson Jean-Louis, 2006, Endocr Pract, V12 Suppl 1, P25; Connor H, 2003, DIABETIC MED, V20, P786, DOI 10.1046/j.1464-5491.2003.01104.x; EATON SB, 1985, NEW ENGL J MED, V312, P283, DOI 10.1056/NEJM198501313120505; Ebbeling C B, 2001, Adv Pediatr, V48, P179; Flint A, 2004, BRIT J NUTR, V91, P979, DOI 10.1079/BJN20041124; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; JENKINS DJA, 1981, AM J CLIN NUTR, V34, P362, DOI 10.1093/ajcn/34.3.362; Lichtenstein AH, 2003, J WOMEN HEALTH GEN-B, V12, P109, DOI 10.1089/154099903321576493; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Pawlak DB, 2004, LANCET, V364, P778, DOI 10.1016/S0140-6736(04)16937-7; Perlstein R., 1997, Australian Journal of Nutrition and Dietetics, V54, P57; Pittas AG, 2005, DIABETES CARE, V28, P2939, DOI 10.2337/diacare.28.12.2939; *UN FAO, 1997, JOINT FAO WHO EXP CO; Willett WC, 2002, AM J MED, V113, P47, DOI 10.1016/S0002-9343(01)00992-5; Wolever TMS, 1996, J NUTR, V126, P2807; WOLEVER TMS, 1991, AM J CLIN NUTR, V54, P846, DOI 10.1093/ajcn/54.5.846	20	36	36	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2007	369	9565					890	892		10.1016/S0140-6736(07)60427-9	http://dx.doi.org/10.1016/S0140-6736(07)60427-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148BQ	17368136				2022-12-28	WOS:000245049900010
J	Oliveri, P; Davidson, EH				Oliveri, Paola; Davidson, Eric H.			Built to run, not fail	SCIENCE			English	Editorial Material							GENE REGULATORY NETWORKS		CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Oliveri, P (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	poliveri@caltech.edu; davidson@caltech.edu		Oliveri, Paola/0000-0002-3477-8529	NICHD NIH HHS [HD-37105] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Davidson E. H., 2001, DEV EVOLUTION; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davidson EH, 2006, REG GEN GEN REG; Kiefer JC, 2007, DEV BIOL, V303, P611, DOI 10.1016/j.ydbio.2006.11.042; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Minokawa T, 2004, GENE EXPR PATTERNS, V4, P449, DOI 10.1016/j.modgep.2004.01.009; Oliveri P, 2006, DEVELOPMENT, V133, P4173, DOI 10.1242/dev.02577	8	38	38	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1510	1511		10.1126/science.1140979	http://dx.doi.org/10.1126/science.1140979			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363653				2022-12-28	WOS:000244934800029
J	Shepherd, A; Wingham, D				Shepherd, Andrew; Wingham, Duncan			Recent sea-level contributions of the Antarctic and Greenland ice sheets	SCIENCE			English	Review							SURFACE MASS-BALANCE; DISCHARGE; ACCELERATION; VARIABILITY; SNOWFALL; GROWTH; SHELF; RISE	After a century of polar exploration, the past decade of satellite measurements has painted an altogether new picture of how Earth's ice sheets are changing. As global temperatures have risen, so have rates of snowfall, ice melting, and glacier flow. Although the balance between these opposing processes has varied considerably on a regional scale, data show that Antarctica and Greenland are each losing mass overall. Our best estimate of their combined imbalance is about 125 gigatons per year of ice, enough to raise sea level by 0.35 millimeters per year. This is only a modest contribution to the present rate of sea-level rise of 3.0 millimeters per year. However, much of the loss from Antarctica and Greenland is the result of the flow of ice to the ocean from ice streams and glaciers, which has accelerated over the past decade. In both continents, there are suspected triggers for the accelerated ice discharge-surface and ocean warming, respectively- and, over the course of the 21st century, these processes could rapidly counteract the snowfall gains predicted by present coupled climate models.	UCL, Ctr Polar Observat & Modeling, Dept Earth Sci, London WC1E 6BT, England; Univ Edinburgh, Ctr Polar Observat & Modeling, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland	University of London; University College London; University of Edinburgh	Wingham, D (corresponding author), UCL, Ctr Polar Observat & Modeling, Dept Earth Sci, Mortimer St, London WC1E 6BT, England.	Shepherd@edu.ac.uk; djw@cporn.ucl.ac.uk	Thompson, Renee L/A-9675-2012	Shepherd, Andrew/0000-0002-4914-1299	Natural Environment Research Council [cpom10001] Funding Source: researchfish; NERC [cpom10001] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; Anandakrishnan S, 1997, GEOPHYS RES LETT, V24, P265, DOI 10.1029/96GL04016; Arthern RJ, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2004JD005667; Benson C. S., 1962, THESIS CALTECH, DOI [10.7907/G7V2-0T57, DOI 10.7907/G7V2-0T57]; BENTLEY CR, 1991, P INT C ROL POL REG, P481; Bindschadler R, 2006, SCIENCE, V311, P1720, DOI 10.1126/science.1125226; Box JE, 2006, J CLIMATE, V19, P2783, DOI 10.1175/JCLI3738.1; Chen JL, 2006, SCIENCE, V313, P1958, DOI 10.1126/science.1129007; CHURCH JA, 2001, CLIMATE CHANGE 2001, P641; Davis CH, 2004, INT GEOSCI REMOTE SE, P1152; Davis CH, 2005, SCIENCE, V308, P1898, DOI 10.1126/science.1110662; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Horwath M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025550; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Jacobs SS, 2002, SCIENCE, V297, P386, DOI 10.1126/science.1069574; JACOBS SS, 1992, NATURE, V360, P29, DOI 10.1038/360029a0; Johannessen OM, 2005, SCIENCE, V310, P1013, DOI 10.1126/science.1115356; Joughin I, 2004, NATURE, V432, P608, DOI 10.1038/nature03130; Joughin I, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017609; Krabill W, 2000, SCIENCE, V289, P428, DOI 10.1126/science.289.5478.428; Lowe AL, 2002, QUATERNARY SCI REV, V21, P1879, DOI 10.1016/S0277-3791(02)00006-9; Luckman A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025428; Luthcke SB, 2006, SCIENCE, V314, P1286, DOI 10.1126/science.1130776; Monaghan AJ, 2006, PHILOS T R SOC A, V364, P1683, DOI 10.1098/rsta.2006.1795; Monaghan AJ, 2006, SCIENCE, V313, P827, DOI 10.1126/science.1128243; Munk W, 2003, SCIENCE, V300, P2041, DOI 10.1126/science.1085534; Nakada M, 2000, MAR GEOL, V167, P85, DOI 10.1016/S0025-3227(00)00018-9; Payne AJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021284; Ramillien G, 2006, GLOBAL PLANET CHANGE, V53, P198, DOI 10.1016/j.gloplacha.2006.06.003; Reeh N, 1997, SCIENCE, V278, P207; Rignot E, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020697; Rignot E, 2002, SCIENCE, V297, P1502, DOI 10.1126/science.1073888; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Rignot EJ, 1998, SCIENCE, V281, P549, DOI 10.1126/science.281.5376.549; Rignot EJ, 1997, SCIENCE, V276, P934, DOI 10.1126/science.276.5314.934; Rott H, 1996, SCIENCE, V271, P788, DOI 10.1126/science.271.5250.788; Shepherd A, 2003, SCIENCE, V302, P856, DOI 10.1126/science.1089768; Shepherd A, 2001, SCIENCE, V291, P862, DOI 10.1126/science.291.5505.862; Stern N., 2006, EC CLIMATE CHANGE ST; Thomas R, 2004, SCIENCE, V306, P255, DOI 10.1126/science.1099650; van Lipzig NPM, 2002, INT J CLIMATOL, V22, P1197, DOI 10.1002/joc.798; Velicogna I, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023955; Velicogna I, 2006, SCIENCE, V311, P1754, DOI 10.1126/science.1123785; Velicogna I, 2006, NATURE, V443, P329, DOI 10.1038/nature05168; Weertman J., 1974, J GLACIOL, V13, P3, DOI [DOI 10.3189/S0022143000023327, 10.3189/S0022143000023327]; Wingham DJ, 2006, PHILOS T R SOC A, V364, P1627, DOI 10.1098/rsta.2006.1792; Wingham DJ, 2006, NATURE, V440, P1033, DOI 10.1038/nature04660; Wingham DJ, 1998, SCIENCE, V282, P456, DOI 10.1126/science.282.5388.456; Zwally HJ, 2005, J GLACIOL, V51, P509, DOI 10.3189/172756505781829007; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	50	227	238	4	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1529	1532		10.1126/science.1136776	http://dx.doi.org/10.1126/science.1136776			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363663				2022-12-28	WOS:000244934800039
J	Wilker, EW; van Vugt, MATM; Artim, SA; Huang, PH; Petersen, CP; Reinhardt, HC; Feng, Y; Sharp, PA; Sonenberg, N; White, FM; Yaffe, MB				Wilker, Erik W.; van Vugt, Marcel A. T. M.; Artim, Steven A.; Huang, Paul H.; Petersen, Christian P.; Reinhardt, H. Christian; Feng, Yun; Sharp, Phillip A.; Sonenberg, Nahum; White, Forest M.; Yaffe, Michael B.			14-3-3 sigma controls mitotic translation to facilitate cytokinesis	NATURE			English	Article							RIBOSOME ENTRY SITE; BREAST-CANCER; CELL-CYCLE; MAMMALIAN-CELLS; EARLY EVENT; SIGMA GENE; HYPERMETHYLATION; PROTEIN; EXPRESSION; INITIATION	14-3-3 proteins are crucial in a wide variety of cellular responses including cell cycle progression, DNA damage checkpoints and apoptosis. One particular 14-3-3 isoform, sigma, is a p53-responsive gene, the function of which is frequently lost in human tumours, including breast and prostate cancers as a result of either hypermethylation of the 14-3-3 sigma promoter or induction of an oestrogen-responsive ubiquitin ligase that specifically targets 14-3-3 sigma for proteasomal degradation(1-9). Loss of 14-3-3 sigma protein occurs not only within the tumours themselves but also in the surrounding pre-dysplastic tissue (so-called field cancerization), indicating that 14-3-3 sigma might have an important tumour suppressor function that becomes lost early in the process of tumour evolution(3,9). The molecular basis for the tumour suppressor function of 14-3-3 sigma is unknown. Here we report a previously unknown function for 14-3-3 sigma as a regulator of mitotic translation through its direct mitosis-specific binding to a variety of translation/ initiation factors, including eukaryotic initiation factor 4B in a stoichiometric manner. Cells lacking 14-3-3 sigma, in marked contrast to normal cells, cannot suppress cap-dependent translation and do not stimulate cap-independent translation during and immediately after mitosis. This defective switch in the mechanism of translation results in reduced mitotic-specific expression of the endogenous internal ribosomal entry site (IRES)-dependent form of the cyclin-dependent kinase Cdk11 (p58 PITSLRE), leading to impaired cytokinesis, loss of Polo-like kinase-1 at the midbody, and the accumulation of binucleate cells. The aberrant mitotic phenotype of 14-3-3 sigma-depleted cells can be rescued by forced expression of p58 PITSLRE or by extinguishing cap-dependent translation and increasing cap-independent translation during mitosis by using rapamycin. Our findings show how aberrant mitotic translation in the absence of 14-3-3 sigma impairs mitotic exit to generate binucleate cells and provides a potential explanation of how 14-3-3 sigma-deficient cells may progress on the path to aneuploidy and tumorigenesis.	MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA; McGill Univ, McGill Canc Ctr, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	Massachusetts Institute of Technology (MIT); McGill University	Yaffe, MB (corresponding author), MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA.	myaffe@mit.edu	Petersen, Christian P./GZG-4541-2022; Huang, Paul H./H-8591-2015	Petersen, Christian P./0000-0001-7552-6865; Huang, Paul H./0000-0003-3972-5087; White, Forest/0000-0002-1545-1651; /0000-0003-4503-9024				Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Gasco M, 2002, ONCOGENE, V21, P1876, DOI 10.1038/sj.onc.1205256; HERSHEY JWB, 1994, BIOCHIMIE, V76, P847, DOI 10.1016/0300-9084(94)90186-4; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Iwata N, 2000, ONCOGENE, V19, P5298, DOI 10.1038/sj.onc.1203898; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Li TY, 2004, MOL CELL BIOL, V24, P3188, DOI 10.1128/MCB.24.8.3188-3197.2004; Liu XQ, 2004, J CELL SCI, V117, P3233, DOI 10.1242/jcs.01173; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Moreira JMA, 2004, MOL CELL PROTEOMICS, V3, P410, DOI 10.1074/mcp.M300134-MCP200; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639; PRESCOTT DM, 1962, EXP CELL RES, V26, P260, DOI 10.1016/0014-4827(62)90176-3; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Qin XL, 2004, J BIOL CHEM, V279, P13721, DOI 10.1074/jbc.M312854200; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Suzuki H, 2000, CANCER RES, V60, P4353; Umbricht CB, 2001, ONCOGENE, V20, P3348, DOI 10.1038/sj.onc.1204438; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Vercoutter-Edouart AS, 2001, CANCER RES, V61, P76; Villaret DB, 2000, LARYNGOSCOPE, V110, P374, DOI 10.1097/00005537-200003000-00008; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200	30	172	184	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					329	332		10.1038/nature05584	http://dx.doi.org/10.1038/nature05584			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361185				2022-12-28	WOS:000244892900048
J	Vapattanawong, P; Hogan, MC; Hanvoravongchai, P; Gakidou, E; Vos, T; Lopez, AD; Lim, SS				Vapattanawong, Patama; Hogan, Margaret C.; Hanvoravongchai, Piya; Gakidou, Emmanuela; Vos, Theo; Lopez, Alan D.; Lim, Stephen S.			Reductions in child mortality levels and inequalities in Thailand: analysis of two censuses	LANCET			English	Article							MILLENNIUM DEVELOPMENT GOALS; HEALTH IMPACTS; POOR; DETERMINANTS; PROGRESS; CARE	Background Thailand's progress in reducing the under-five mortality rate (U5MR) puts the country on track to achieve the fourth Millennium Development Goal (MDG). Whether this success has been accompanied by a widening or narrowing of the child mortality gap between the poorest and richest populations is unknown. We aimed to measure changes in child-mortality inequalities by household-level socioeconomic strata of the Thai population between 1990 and 2000. Methods We measured changes in the distribution of the U5MR by economic strata using data from the 1990 and 2000 censuses. Economic status was measured using household assets and characteristics. The U5MR was estimated using the Trussell version of the Brass indirect method. Findings Average household economic status improved and inequalities declined between the two censuses. There were substantially larger reductions in U5MR in the poorer segments of the population. Excess child mortality risk between the poorest and richest quintile decreased by 55% (95% CI 39% to 68%). The concentration index, measured using percentiles of economic status, in 1990 was -0.20 (-0.23 to -0.18), whereas in 2000 it had dropped to -0.12 (-0.15 to -0.08), a 43% (22% to 63%) reduction. Interpretation These findings draw attention to the feasibility of incorporating equity measurement into census data. Thailand has achieved both an impressive average decrease in U5MR and substantial reductions in U5MR inequality over a 10 year period. Contributing factors include overall economic growth and poverty reduction, improved insurance coverage, and a scaling-up and more equitable distribution of primary health-care infrastructure and intervention coverage. Understanding the factors that have led to Thailand's success could help inform countries struggling to meet the fourth MDG and reduce inequality.	Minist Publ Hlth, SPICE Project, Dept Med Serv, Nonthaburi 11000, Thailand; Mahidol Univ, Inst Populat & Social Res, Bangkok 10700, Thailand; Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; Int Hlth Policy Program, Nonthaburi, Thailand; Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand; Harvard Initiat Global Hlth, Cambridge, MA USA	Ministry of Public Health - Thailand; Mahidol University; University of Queensland; Chulalongkorn University; Harvard University	Hogan, MC (corresponding author), Minist Publ Hlth, SPICE Project, Dept Med Serv, Nonthaburi 11000, Thailand.	m.hogan@sph.uq.edu.au	Lopez, Alan/AAA-2734-2022; Lim, Stephen S/B-4055-2012; Vos, Theo/F-3324-2010; Hanvoravongchai, Piya/A-1569-2012; Lopez, Alan D/F-1487-2010	Hanvoravongchai, Piya/0000-0003-4256-1271; Lopez, Alan D/0000-0001-5818-6512	NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG 17625-01] Funding Source: Medline; Wellcome Trust [071842/Z/03/Z] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ahmad OB, 2000, B WORLD HEALTH ORGAN, V78, P1175; [Anonymous], 1983, REGIONAL MODEL LIFE; [Anonymous], 2005, MILLENNIUM DEV GOALS; Balisacan A.M., 2006, INEQUALITY ASIA SYNT; Bohning D, 1999, J Epidemiol Biostat, V4, P115; CHAYOVAN N, 1987, THAILAND DEMOGRAPHIC; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; Evans DB, 2005, BMJ-BRIT MED J, V331, P1133, DOI 10.1136/bmj.331.7525.1133; Ferguson B, 2003, HLTH SYSTEMS PERFORM; FOFACK H, 1999, DYNAMICS INCOME INEQ; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; Green A, 2000, INT J HEALTH PLAN M, V15, P39, DOI 10.1002/(SICI)1099-1751(200001/03)15:1<39::AID-HPM567>3.0.CO;2-9; Gwatkin DR, 2005, LANCET, V365, P813, DOI 10.1016/S0140-6736(05)17992-6; HILL K, DATA SOURCES ESTIMAT, pCH2; Hill K, 2007, INT J EPIDEMIOL, V36, P374, DOI 10.1093/ije/dyl257; Hosseinpoor AR, 2005, B WORLD HEALTH ORGAN, V83, P837; KACHONDHAM Y, 1993, HEALTH POLICY PLANN, V8, P208, DOI 10.1093/heapol/8.3.208; Moser KA, 2005, BRIT MED J, V331, P1180, DOI 10.1136/bmj.38659.588125.79; Nitayarumphong S., 1990, Health Policy and Planning, V5, P246, DOI 10.1093/heapol/5.3.246; NOREE T, 2005, THAILANDS COUNTRY PA; Pannarunothai S, 2000, HEALTH POLICY PLANN, V15, P303, DOI 10.1093/heapol/15.3.303; PANNARUNOTHAI S, 2002, HLTH INSURANCE SYSTE; Pongou R, 2006, INT J EPIDEMIOL, V35, P648, DOI 10.1093/ije/dyl016; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; SRITHAMRONGSAWA.S, 2002, HLTH INSURANCE SYSTE; Supakankunti S, 2000, HEALTH POLICY PLANN, V15, P85, DOI 10.1093/heapol/15.1.85; Suraratdecha C, 2005, HEALTH POLICY, V73, P272, DOI [10.1016/j.healthpol.2004.11.019, 10.1016/j.healthpol.2004.05.005]; SUWEE W, 20 POP CENS C 2002 U; Tangcharoensathien V, 2004, B WORLD HEALTH ORGAN, V82, P750; Tangcharoensathien V, 2000, SOC SCI MED, V51, P789, DOI 10.1016/S0277-9536(00)00061-7; *THAI NAT EC DEV B, 2004, GROSS PROV PROD; UN Department of Economic and Social Affairs Population Division, WORLD CONTR US; *UN DEV PROGR, 2002, HUM DEV REP; *UN POP DIV, WORLD POP PROSP 2004; United Nations, 1983, MAN X IND TECHN DEM; United Nations, 2000, UN MILL DECL GEN ASS; Wagstaff A, 2000, B WORLD HEALTH ORGAN, V78, P19; Wang LM, 2003, HEALTH POLICY, V65, P277, DOI 10.1016/S0168-8510(03)00039-3; *WHO, SEARO COUNTR HLTH PR; WIBULPOLPRASERT S, 1991, HEALTH POLICY PLANN, V6, P354, DOI 10.1093/heapol/6.4.354; WIBULPOLPRASERT S, 2005, THAILAND HLTH PROFIL; Wibulpolprasert Suwit, 2003, Hum Resour Health, V1, P12, DOI 10.1186/1478-4491-1-12; *WORLD BANK, SPREADSH COMP CONC I; *WORLD BANK, CONC CURV; *WORLD BANK, CONC IND; World Health Organization, 2005, HLTH MILL DEV GOALS; World Health Organization, 2000, WORLD HLTH REP 2000	47	49	49	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2007	369	9564					850	855		10.1016/S0140-6736(07)60413-9	http://dx.doi.org/10.1016/S0140-6736(07)60413-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144JC	17350454				2022-12-28	WOS:000244791300033
J	Burkett, V; Groat, CG; Reed, D				Burkett, Virginia; Groat, C. G.; Reed, Denise			Hurricanes not the key to a sustainable coast	SCIENCE			English	Letter									US Geol Survey, Lafayette, LA 71449 USA; Univ Texas, Jackson Sch Geosci, Austin, TX 78712 USA; Univ New Orleans, Dept Earth & Environm Sci, New Orleans, LA 70148 USA	United States Department of the Interior; United States Geological Survey; University of Texas System; University of Texas Austin; University of Louisiana System; University of New Orleans	Burkett, V (corresponding author), US Geol Survey, 700 Cajundome Blvd, Lafayette, LA 71449 USA.							BARRAS JA, 2006, 0612742006 US GEOL S; Coleman JM, 1998, J COASTAL RES, V14, P698; *EFGC, REP TECHN GROUP ENV; *NAT RES COUNC, 2006, DRAW LOUIS NEW MAP A, P115; REED DJ, 1989, ESTUARIES, V12, P222, DOI 10.2307/1351901; Uchupi E, 1975, OCEAN BASINS MARGINS, V3; WRIGHT LD, 1995, ESTUARIES, V18, P494, DOI 10.2307/1352367; PRELIMINARY ESTIMATE	8	6	6	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1366	1367		10.1126/science.315.5817.1366	http://dx.doi.org/10.1126/science.315.5817.1366			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347427				2022-12-28	WOS:000244752200013
J	Fisher, RD; Chung, HY; Zhai, QT; Robinson, H; Sundquist, WI; Hill, CP				Fisher, Robert D.; Chung, Hyo-Young; Zhai, Qianting; Robinson, Howard; Sundquist, Wesley I.; Hill, Christopher P.			Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding	CELL			English	Article							BINDING PARTNER; HUMAN HOMOLOG; PROTEIN; ALIX; TSG101; DOMAIN; PATHWAY; BRO1; GAG; P6	ALIX/AIP1 functions in enveloped virus budding, endosomal protein sorting, and many other cellular processes. Retroviruses, including HIV-1, SIV, and EIAV, bind and recruit ALIX through YPXnL late-domain motifs (X = any residue; In = 1-3). Crystal structures reveal that human ALIX is composed of an N-terminal Bro1 domain and a central domain that is composed of two extended three-helix bundles that form elongated arms that fold back into a "V." The structures also reveal conformational flexibility in the arms that suggests that the V domain may act as a flexible hinge in response to ligand binding. YPXnL late domains bind in a conserved hydrophobic pocket on the second arm near the apex of the V, whereas CHMP4/ ESCRT-III proteins bind a conserved hydrophobic patch on the Bro1 domain, and both interactions are required for virus budding. ALIX therefore serves as a flexible, extended scaffold that connects retroviral Gag proteins to ESCRT-III and other cellular-budding machinery.	Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Utah System of Higher Education; University of Utah; United States Department of Energy (DOE); Brookhaven National Laboratory	Sundquist, WI (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	wes@biochem.utah.edu; chris@biochem.utah.edu	zhai, qianting/G-1301-2013		NIAID NIH HHS [AI 051174, R01 AI051174] Funding Source: Medline; NIGMS NIH HHS [GM 066521, P50 GM082545] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545, P01GM066521] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alroy I, 2005, P NATL ACAD SCI USA, V102, P1478, DOI 10.1073/pnas.0408717102; Bibollet-Ruche F, 2004, J VIROL, V78, P7748, DOI 10.1128/JVI.78.14.7748-7762.2004; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Cabezas A, 2005, J CELL SCI, V118, P2625, DOI 10.1242/jcs.02382; Chatellard-Causse C, 2002, J BIOL CHEM, V277, P29108, DOI 10.1074/jbc.M204019200; Chen CP, 2005, J BIOL CHEM, V280, P40474, DOI 10.1074/jbc.M509317200; DEJOURNETT RE, 2006, BIOCHEM J, V401, P521; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Geminard C, 2004, TRAFFIC, V5, P181, DOI 10.1111/j.1600-0854.2004.0167.x; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Ichioka F, 2005, BIOSCI BIOTECH BIOCH, V69, P861, DOI 10.1271/bbb.69.861; Katoh K, 2003, J BIOL CHEM, V278, P39104, DOI 10.1074/jbc.M301604200; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Odorizzi G, 2006, J CELL SCI, V119, P3025, DOI 10.1242/jcs.03072; Olsen JC, 1998, GENE THER, V5, P1481, DOI 10.1038/sj.gt.3300768; Pineda-Molina E, 2006, TRAFFIC, V7, P1007, DOI 10.1111/j.1600-0854.2006.00440.x; Puffer BA, 1997, J VIROL, V71, P6541, DOI 10.1128/JVI.71.9.6541-6546.1997; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Sadoul R, 2006, BIOL CELL, V98, P69, DOI 10.1042/BC20050007; Schmidt MHH, 2003, J CELL SCI, V116, P2845, DOI 10.1242/jcs.00522; Schmidt MHH, 2004, MOL CELL BIOL, V24, P8981, DOI 10.1128/MCB.24.20.8981-8993.2004; Schmidt MHH, 2005, J BIOL CHEM, V280, P3414, DOI 10.1074/jbc.M409839200; Segura-Morales C, 2005, J BIOL CHEM, V280, P27004, DOI 10.1074/jbc.M413735200; Shibata H, 2004, J BIOCHEM, V135, P117, DOI 10.1093/jb/mvh014; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Tsuda M, 2006, FEBS LETT, V580, P3296, DOI 10.1016/j.febslet.2006.05.005; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Vincent O, 2003, MOL CELL BIOL, V23, P1647, DOI 10.1128/MCB.23.5.1647-1655.2003; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wang Margaret Q, 2003, J Biol, V3, P4, DOI 10.1186/1475-4924-3-4	43	250	259	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					841	852		10.1016/j.cell.2007.01.035	http://dx.doi.org/10.1016/j.cell.2007.01.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350572	Bronze			2022-12-28	WOS:000245073400010
J	Sheen, J; He, P				Sheen, Jen; He, Ping			Nuclear actions in innate immune signaling	CELL			English	Editorial Material							RESISTANCE PROTEIN	Innate immunity in plants and animals is mediated through pattern recognition receptors, which were thought to initiate signaling in the cytoplasm to activate defense pathways. Shen et al. (2006) and Burch-Smith et al. (2007) now provide compelling evidence that certain plant disease resistance proteins, which detect specific pathogenic effectors, act in the nucleus to trigger downstream signaling and defense pathways.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol,Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Sheen, J (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol,Dept Genet, Boston, MA 02114 USA.	sheen@molbio.mgh.harvard.edu		He, Ping/0000-0002-5926-8349				Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; SHEN QH, 2006, SCIENCE         1221; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Ueda H, 2006, PLANT MOL BIOL, V61, P31, DOI 10.1007/s11103-005-5817-8; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523	10	7	8	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					821	823		10.1016/j.cell.2007.02.019	http://dx.doi.org/10.1016/j.cell.2007.02.019			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350565	Bronze			2022-12-28	WOS:000245073400003
J	Soker, N				Soker, Noam			Nebulae around evolved stars	SCIENCE			English	Editorial Material									Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Soker, N (corresponding author), Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel.	soker@physics.technion.ac.il						Balick B, 2002, ANNU REV ASTRON ASTR, V40, P439, DOI 10.1146/annurev.astro.40.060401.093849; Morris T, 2007, SCIENCE, V315, P1103, DOI 10.1126/science.1136351	2	0	0	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2007	315	5815					1086	1087		10.1126/science.1139937	http://dx.doi.org/10.1126/science.1139937			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	138UA	17322050				2022-12-28	WOS:000244387600024
J	Hobbs, R				Hobbs, Richard			Should we ditch impact factors? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Hobbs, R (corresponding author), Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.	f.d.r.hobbs@bham.ac.uk							0	17	17	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 17	2007	334	7593					569	569		10.1136/bmj.39146.545752.BE	http://dx.doi.org/10.1136/bmj.39146.545752.BE			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AP	17363828	Green Published			2022-12-28	WOS:000245404400033
J	van Swinderen, B				van Swinderen, Bruno			Attention-like processes in Drosophila require short-term memory genes	SCIENCE			English	Article							MELANOGASTER; MUTANTS; BRAIN; DUNCE; CONTEXT; SYSTEM	Although there is much behavioral evidence for complex brain functions in insects, it is not known whether insects have selective attention. In humans, selective attention is a dynamic process restricting perception to a succession of salient stimuli, while less relevant competing stimuli are suppressed. Local field potential recordings in the brains of flies responding to visual novelty revealed attention-like processes with stereotypical temporal properties. These processes were modulated by genes involved in short-term memory formation, namely dunce and rutabaga. Attention defects in these mutants were associated with distinct optomotor effects in behavioral assays.	Inst Neurosci, San Diego, CA 92121 USA		van Swinderen, B (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.	van@nsi.edu		van Swinderen, Bruno/0000-0001-6552-7418				Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Brembs B, 2006, LEARN MEMORY, V13, P618, DOI 10.1101/lm.318606; DAUWALDER B, 1995, J NEUROSCI, V15, P3490; DAVIS RL, 1995, MOL CELL BIOCHEM, V149, P271, DOI 10.1007/BF01076588; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; Engel JE, 1996, J NEUROSCI, V16, P3486; FOLKERS E, 1982, J INSECT PHYSIOL, V28, P535, DOI 10.1016/0022-1910(82)90034-8; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gong ZF, 1998, J INSECT PHYSIOL, V44, P1149, DOI 10.1016/S0022-1910(98)00076-6; Guo FZ, 2005, SCIENCE, V309, P307, DOI 10.1126/science.1111280; HEISENBERG M, 1948, STUDIES BRAIN FUNCTI; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Tang SM, 2004, SCIENCE, V305, P1020, DOI 10.1126/science.1099839; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; van Swinderen B, 2005, BIOESSAYS, V27, P321, DOI 10.1002/bies.20195; van Swinderen B, 2003, NAT NEUROSCI, V6, P579, DOI 10.1038/nn1054; van Swinderen B, 2006, J NEUROBIOL, V66, P1195, DOI 10.1002/neu.20300; VANSWINDEREN B, 2006, J NEUROBIOL     1207, DOI DOI 10.1002/NEU.20334; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749	24	75	76	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1590	1593		10.1126/science.1137931	http://dx.doi.org/10.1126/science.1137931			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363675				2022-12-28	WOS:000244934800057
J	Douglas, JF; Iwasawa, H; Sun, Z; Fedorov, AV; Ishikado, M; Saitoh, T; Eisaki, H; Bando, H; Iwase, T; Ino, A; Arita, M; Shimada, K; Namatame, H; Taniguchi, M; Masui, T; Tajima, S; Fujita, K; Uchida, SI; Aiura, Y; Dessau, DS				Douglas, John F.; Iwasawa, Hideaki; Sun, Zhe; Fedorov, Alexei V.; Ishikado, Motoyuki; Saitoh, Tomohiko; Eisaki, Hiroshi; Bando, Hiroshi; Iwase, Takeshi; Ino, Akihiro; Arita, Masashi; Shimada, Kenya; Namatame, Hirofumi; Taniguchi, Masaki; Masui, Takahiko; Tajima, Setsuko; Fujita, Kazuhiro; Uchida, Shin-ichi; Aiura, Yoshihiro; Dessau, Daniel S.			Superconductors - Unusual oxygen isotope effects in cuprates?	NATURE			English	Letter									Univ Colorado, Dept Phys, Boulder, CO 80309 USA; Univ Tokyo, Dept Appl Phys, Tokyo 1628601, Japan; Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; Univ Tokyo, Dept Phys, Tokyo 1138656, Japan; Hiroshima Univ, Grad Sch Sci, Higashihiroshima 7398526, Japan; Hiroshima Univ, Hiroshima Synchrotron Radiat Ctr, Higashihiroshima 7390046, Japan; Osaka Univ, Dept Phys, Osaka 5600043, Japan	University of Colorado System; University of Colorado Boulder; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Tokyo; Hiroshima University; Hiroshima University; Osaka University	Douglas, JF (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.	y.aiura@aist.go.jp	INO, Akihiro/AAC-5750-2019; Iwasawa, Hideaki/ABE-8018-2021; Sun, Zhe/AAU-6242-2020; Shimada, Kenya/G-5080-2016; Aiura, Yoshihiro/K-8382-2018; Eisaki, Hiroshi/F-6317-2018; Shimada, Kenya/ABG-8603-2021; Iwasawa, Hideaki/R-9402-2019; Sun, Zhe/AAA-9363-2021	INO, Akihiro/0000-0001-9901-1807; Iwasawa, Hideaki/0000-0001-6760-4085; Shimada, Kenya/0000-0002-1945-2352; Aiura, Yoshihiro/0000-0002-4478-7680; Eisaki, Hiroshi/0000-0002-8299-6416; Shimada, Kenya/0000-0002-1945-2352; Fedorov, Alexei/0000-0003-3510-3117; Saitoh, Tomohiko/0000-0002-2699-2381				de Lozanne A, 2006, NATURE, V442, P522, DOI 10.1038/442522a; FRANCK JP, 1994, PHYSICAL PROPERTIES, V4, P189; Gweon GH, 2004, NATURE, V430, P187, DOI 10.1038/nature02731; Lee J, 2006, NATURE, V442, P546, DOI 10.1038/nature04973	4	33	33	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					E5	E5		10.1038/nature05738	http://dx.doi.org/10.1038/nature05738			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361133	Bronze			2022-12-28	WOS:000244892900037
J	Knapp, S; Polaszek, A; Watson, M				Knapp, Sandra; Polaszek, Andrew; Watson, Mark			Spreading the word	NATURE			English	Editorial Material							NAMES		Nat Hist Museum, Dept Bot, London SW7 5BD, England; Nat Hist Museum, Int Commiss Zool Nomenclature, London SW7 5BD, England; Royal Bot Garden Edinburgh, Edinburgh EH3 5LR, Midlothian, Scotland	Natural History Museum London; Natural History Museum London	Knapp, S (corresponding author), Nat Hist Museum, Dept Bot, Cromwell Rd, London SW7 5BD, England.		Knapp, Sandra/A-4856-2011	Knapp, Sandra/0000-0001-7698-3945; Watson, Mark/0000-0002-4989-3976				Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a; Knapp S, 2006, TAXON, V55, P2, DOI 10.2307/25065662; Knapp S, 2004, PHILOS T R SOC B, V359, P611, DOI 10.1098/rstb.2003.1445; Lughadha EN, 2004, PHILOS T R SOC B, V359, P681, DOI 10.1098/rstb.2003.1446; Polaszek A, 2005, NATURE, V437, P477, DOI 10.1038/437477a	5	24	31	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					261	262		10.1038/446261a	http://dx.doi.org/10.1038/446261a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361161				2022-12-28	WOS:000244892900023
J	Krzemien, J; Dubois, L; Makki, R; Meister, M; Vincent, A; Crozatier, M				Krzemien, Joanna; Dubois, Laurence; Makki, Rami; Meister, Marie; Vincent, Alain; Crozatier, Michele			Control of blood cell homeostasis in Drosophila larvae by the posterior signalling centre	NATURE			English	Article							STEM-CELLS; HEMATOPOIESIS; NICHE; MELANOGASTER; INSIGHTS; DELTA	Drosophila haemocytes ( blood cells) originate from a specialized haematopoietic organ - the lymph gland. Larval haematopoietic progenitors (prohaemocytes) give rise to three types of circulating haemocytes: plasmatocytes, crystal cells and lamellocytes. Lamellocytes, which are devoted to encapsulation of large foreign bodies, only differentiate in response to specific immune threats, such as parasitization by wasps. Here we show that a small cluster of signalling cells, termed the PSC ( posterior signalling centre)(1), controls the balance between multipotent prohaemocytes and differentiating haemocytes, and is necessary for the massive differentiation of lamellocytes that follows parasitization. Communication between the PSC and haematopoietic progenitors strictly depends on the PSC-restricted expression of Collier, the Drosophila orthologue of mammalian early B-cell factor. PSC cells act, in a non-cell-autonomous manner, to maintain JAK/STAT signalling activity in prohaemocytes, preventing their premature differentiation. Serrate-mediated Notch signalling from the PSC is required to maintain normal levels of col transcription. The key role of the PSC in controlling blood cell homeostasis is reminiscent of interactions between haematopoietic progenitors and their microenvironment in vertebrates(2 - 4), thus further highlighting the interest of Drosophila as a model system for studying the evolution of haematopoiesis and cellular innate immunity.	Univ Toulouse 3, CNRS, UMR 5547, Ctr Dev Biol, F-31062 Toulouse 09, France; Univ Toulouse 3, CNRS, IFR 109, Ctr Dev Biol, F-31062 Toulouse, France; Jagiellonian Univ, Inst Zool, PL-30060 Krakow, Poland; CNRS, UPR 9022, IBMC, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Jagiellonian University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Crozatier, M (corresponding author), Univ Toulouse 3, CNRS, UMR 5547, Ctr Dev Biol, 118 Route Narbonne, F-31062 Toulouse 09, France.	crozat@cict.fr	Vincent, Alain/AAE-4712-2019; Makki, Rami/F-9236-2012					Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; Bataille L, 2005, DEVELOPMENT, V132, P4635, DOI 10.1242/dev.02034; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Crozatier M, 1999, DEVELOPMENT, V126, P1495; de Joussineau C, 2003, NATURE, V426, P555, DOI 10.1038/nature02157; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; KIMBLE J, 2005, WORMBOOK; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; RIZKI RM, 1984, P NATL ACAD SCI-BIOL, V81, P6154, DOI 10.1073/pnas.81.19.6154; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Sepp KJ, 1999, GENETICS, V151, P1093; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Sun X, 1996, DEVELOPMENT, V122, P2465; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	28	242	251	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					325	328		10.1038/nature05650	http://dx.doi.org/10.1038/nature05650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361184				2022-12-28	WOS:000244892900047
J	Bazari, H; Jaff, MR; Mannstadt, M; Yan, SF; Farhat, MR				Bazari, Hasan; Jaff, Michael R.; Mannstadt, Michael; Yan, Shaofeng; Farhat, Maha R.			A woman with diabetic renal disease and nonhealing skin ulcers - Calciphylaxis, extensive, involving the right leg. Atherosclerotic vascular disease with ischemic ulcer on the heel and osteomyelitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAVENOUS-SODIUM THIOSULFATE; PERITONEAL-DIALYSIS; CUTANEOUS NECROSIS; HYPERBARIC-OXYGEN; RISK-FACTORS; PROTEIN-S; CALCIFICATION; THERAPY; FAILURE; PATIENT		Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Cardiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Vasc Surg, Boston, MA 02114 USA; Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Bazari, H (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Mannstadt, Michael/AAO-1124-2020	Mannstadt, Michael/0000-0003-0867-9778; Yan, Shaofeng/0000-0001-9654-2100				Angelis M, 1997, SURGERY, V122, P1083, DOI 10.1016/S0039-6060(97)90212-9; Arch-Ferrer JE, 2003, SURGERY, V134, P941, DOI 10.1016/j.surg.2003.07.001; Arepally GM, 2006, NEW ENGL J MED, V355, P809, DOI 10.1056/NEJMcp052967; Barri YM, 1997, AM J KIDNEY DIS, V29, P773, DOI 10.1016/S0272-6386(97)90133-5; Beus KS, 2004, OTOLARYNG CLIN N AM, V37, P941, DOI 10.1016/j.otc.2004.03.001; Block GA, 2004, NEW ENGL J MED, V350, P1516, DOI 10.1056/NEJMoa031633; BRAND FN, 1989, DIABETES, V38, P504, DOI 10.2337/diabetes.38.4.504; Bryant JH., 1901, GUYS HOSP REP, V55, P17; Budisavljevic MN, 1996, J AM SOC NEPHROL, V7, P978; Chertow GM, 2003, AM J NEPHROL, V23, P307, DOI 10.1159/000072822; Cicone JS, 2004, AM J KIDNEY DIS, V43, P1104, DOI 10.1053/j.ajkd.2004.03.018; Coates T, 1998, AM J KIDNEY DIS, V32, P384, DOI 10.1053/ajkd.1998.v32.pm9740153; Fine A, 2002, KIDNEY INT, V61, P2210, DOI 10.1046/j.1523-1755.2002.00375.x; Goli AK, 2005, SOUTH MED J, V98, P736, DOI 10.1097/01.SMJ.0000154316.22472.97; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Guerra G, 2005, NEPHROL DIAL TRANSPL, V20, P1260, DOI 10.1093/ndt/gfh825; HAFNER J, 1995, J AM ACAD DERMATOL, V33, P954, DOI 10.1016/0190-9622(95)90286-4; Kang AS, 2000, SURGERY, V128, P967, DOI 10.1067/msy.2000.110429; KANT KS, 1992, AM J KIDNEY DIS, V19, P264; Langan SM, 2005, INT J DERMATOL, V44, P623, DOI 10.1111/j.1365-4632.2005.02591.x; London NJM, 2000, BRIT MED J, V320, P1589, DOI 10.1136/bmj.320.7249.1589; MEHTA RL, 1990, AM J MED, V88, P252, DOI 10.1016/0002-9343(90)90150-C; Moe SM, 2003, PEDIATR NEPHROL, V18, P969, DOI 10.1007/s00467-003-1276-0; Monney P, 2004, NEPHROL DIAL TRANSPL, V19, P2130, DOI 10.1093/ndt/gfh305; Oh Dennis H., 1999, Journal of the American Academy of Dermatology, V40, P979, DOI 10.1016/S0190-9622(99)70087-3; Olin JW, 2000, NEW ENGL J MED, V343, P864, DOI 10.1056/NEJM200009213431207; PARFITT AM, 1969, ARCH INTERN MED, V124, P544, DOI 10.1001/archinte.124.5.544; Pennington M, 2002, BRIT J DERMATOL, V146, P511, DOI 10.1046/j.1365-2133.2002.04611.x; Podymow T, 2001, NEPHROL DIAL TRANSPL, V16, P2176, DOI 10.1093/ndt/16.11.2176; RAPER RF, 1985, NEPHRON, V39, P389, DOI 10.1159/000183411; ROE SM, 1994, AM SURGEON, V60, P81; Rudwaleit M, 1996, AM J NEPHROL, V16, P344, DOI 10.1159/000169021; SELYE H, 1962, J INVEST DERMATOL, V39, P259, DOI 10.1038/jid.1962.111; Sewell LD, 2004, ARCH DERMATOL, V140, P1045, DOI 10.1001/archderm.140.9.1045; Sharma A, 2006, BRIT J DERMATOL, V155, P1295, DOI 10.1111/j.1365-2133.2006.07540.x; VASSA N, 1994, AM J KIDNEY DIS, V23, P878, DOI 10.1016/S0272-6386(12)80145-4; Vattikuti R, 2004, AM J PHYSIOL-ENDOC M, V286, pE686, DOI 10.1152/ajpendo.00552.2003; Velasco N, 2006, NEPHROL DIAL TRANSPL, V21, P1999, DOI 10.1093/ndt/gfl114; Wilmer WA, 2002, SEMIN DIALYSIS, V15, P172, DOI 10.1046/j.1525-139X.2002.00052.x; WINKELMA.RK, 1970, BRIT J DERMATOL, V83, P263, DOI 10.1111/j.1365-2133.1970.tb15697.x	40	28	29	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2007	356	10					1049	1057		10.1056/NEJMcpc069038	http://dx.doi.org/10.1056/NEJMcpc069038			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143DC	17347459				2022-12-28	WOS:000244699200011
J	Tenoever, BR; Ng, SL; Chua, MA; McWhirter, SM; Garcia-Sastre, A; Maniatis, T				tenOever, Benjamin R.; ng, Sze-Li Ng; Chua, Mark A.; McWhirter, Sarah M.; Garcia-Sastre, Adolfo; Maniatis, Tom			Multiple functions of the IKK-related kinase IKK epsilon in interferon-mediated antiviral immunity	SCIENCE			English	Article							STAT1; LIPOPOLYSACCHARIDE; INFECTION	IKK epsilon is an IKK ( inhibitor of nuclear factor kappa B kinase)-related kinase implicated in virus induction of interferon-beta (IFN beta). We report that, although mice lacking IKK epsilon produce normal amounts of IFN beta, they are hypersusceptible to viral infection because of a defect in the IFN signaling pathway. Specifically, a subset of type I IFN-stimulated genes are not activated in the absence of IKK epsilon because the interferon-stimulated gene factor 3 complex (ISGF3) does not bind to promoter elements of the affected genes. We demonstrate that IKK epsilon is activated by IFN beta and that IKK epsilon directly phosphorylates signal transducer and activator of transcription 1 (STAT1), a component of ISGF3. We conclude that IKK epsilon plays a critical role in the IFN-inducible antiviral transcriptional response.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; Mt Sinai Sch Med, Microbiol Grad Sch Training Program, New York, NY 10029 USA; Mt Sinai Sch Med, Emerging Pathogens Inst, New York, NY 10029 USA	Harvard University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Maniatis, T (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	maniatis@mcb.harvard.edu		Garcia-Sastre, Adolfo/0000-0002-6551-1827	NIAID NIH HHS [R01AI46954, P01AI058113, F31 AI056678, U19AI62623] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062623, F31AI056678, P01AI058113, R01AI046954] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; George CX, 2005, J BIOL CHEM, V280, P15020, DOI 10.1074/jbc.M500476200; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; QURESHI SA, 1995, P NATL ACAD SCI USA, V92, P3829, DOI 10.1073/pnas.92.9.3829; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Sweeney SE, 2006, ANN RHEUM DIS, V65, pA32; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9	19	271	284	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1274	1278		10.1126/science.1136567	http://dx.doi.org/10.1126/science.1136567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332413				2022-12-28	WOS:000244564700049
J	Von Drygalski, A; Curtis, BR; Bougie, DW; McFarland, JG; Ahl, S; Limbu, I; Baker, KR; Aster, RH				Von Drygalski, Annette; Curtis, Brian R.; Bougie, Daniel W.; McFarland, Janice G.; Ahl, Scott; Limbu, Indra; Baker, Kelty R.; Aster, Richard H.			Vancomycin-induced immune thrombocytopenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPARIN-INDUCED THROMBOCYTOPENIA; DEPENDENT ANTIBODIES; NEUTROPENIA	BACKGROUND: Vancomycin has only rarely been implicated as a cause of thrombocytopenia, and there is only limited evidence that this complication is caused by immune mechanisms. We conducted a study to determine whether thrombocytopenia is caused by vancomycin-dependent antibodies in patients being treated with vancomycin. METHODS: We identified and characterized vancomycin-dependent, platelet-reactive antibodies in patients who had been referred for testing during a 5-year period because of a clinical suspicion of vancomycin-induced thrombocytopenia. We obtained clinical information about the patients from their referring physicians. RESULTS: Drug-dependent, platelet-reactive antibodies of the IgG class, the IgM class, or both were identified in 34 patients, and clinical follow-up information was obtained from 29 of these patients. The mean nadir platelet count in these patients was 13,600 per cubic millimeter, and severe bleeding occurred in 10 patients (34%). Platelet levels returned to baseline in all 26 surviving patients after vancomycin was stopped. In 15 patients, the drug was continued for 1 to 14 days while other possible causes of thrombocytopenia were investigated. Vancomycin-dependent antibodies were not found in 25 patients who had been given vancomycin and in whom thrombocytopenia did not develop. CONCLUSIONS: Severe bleeding can occur in patients with vancomycin-induced immune thrombocytopenia. The detection of vancomycin-dependent antiplatelet antibodies in patients receiving the antibiotic in whom thrombocytopenia develops, and the absence of antibodies in patients given the drug in whom platelet counts remain stable, indicate that these antibodies are the cause of the thrombocytopenia.	Blood Ctr Wisonsin, Blood Res Inst, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin; Baylor College of Medicine	Aster, RH (corresponding author), Blood Ctr Wisonsin, Blood Res Inst, 8727 Watertown Plank Rd, Milwaukee, WI 53226 USA.	richard.aster@bcw.edu	Curtis, Brian R/AAT-7861-2020		NHLBI NIH HHS [R01 HL013629, HL-13629] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL013629, R01HL013629, R56HL013629] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aster RH, 2005, TOXICOLOGY, V209, P149, DOI 10.1016/j.tox.2004.12.031; Bougie DW, 2006, BLOOD, V108, P922, DOI 10.1182/blood-2006-01-009803; Bougie DW, 2002, BLOOD, V100, P2071, DOI 10.1182/blood.V100.6.2071.h81802002071_2071_2076; CHRISTIE DJ, 1990, BLOOD, V75, P518; Crowther MA, 2005, J CRIT CARE, V20, P348, DOI 10.1016/j.jcrc.2005.09.008; CURTIS BR, 1994, BLOOD, V84, P176, DOI 10.1182/blood.V84.1.176.bloodjournal841176; Curtis BR, 2002, BLOOD, V99, P2054, DOI 10.1182/blood.V99.6.2054; Davoren A, 2006, AM J HEMATOL, V81, P36, DOI 10.1002/ajh.20490; DeLoughery TG, 2005, CRIT CARE CLIN, V21, P531, DOI 10.1016/j.ccc.2005.05.003; Garner SF, 2005, BRIT J HAEMATOL, V129, P279, DOI 10.1111/j.1365-2141.2005.05430.x; George JN, 1998, ANN INTERN MED, V129, P886, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00009; Kojouri K, 2000, J Okla State Med Assoc, V93, P519; Kuruppu JC, 1999, AM J HEMATOL, V60, P249, DOI 10.1002/(SICI)1096-8652(199903)60:3<249::AID-AJH20>3.3.CO;2-8; Lo GK, 2006, J THROMB HAEMOST, V4, P759, DOI 10.1111/j.1538-7836.2006.01787.x; Marraffa J, 2003, PHARMACOTHERAPY, V23, P1195, DOI 10.1592/phco.23.10.1195.32765; Michelson A., 2002, PLATELETS, P593; MILSTEEN S, 1987, AM J MED SCI, V294, P110, DOI 10.1097/00000441-198708000-00010; Mizon P, 1997, VOX SANG, V73, P49, DOI 10.1046/j.1423-0410.1997.7310049.x; MORRIS A, 1991, J INFECTION, V22, P217, DOI 10.1016/S0163-4453(05)80002-7; PARKER CW, 1981, ARTHRITIS RHEUM, V24, P1024, DOI 10.1002/art.1780240808; Peterson JA, 2005, TRANSFUSION, V45, P1487, DOI 10.1111/j.1537-2995.2005.00561.x; Reddy JC, 2004, ARCH INTERN MED, V164, P218, DOI 10.1001/archinte.164.2.218; Rybak MJ, 2006, CLIN INFECT DIS, V42, pS35, DOI 10.1086/491712; Segarra-Newnham M, 2004, ANN PHARMACOTHER, V38, P1855, DOI 10.1345/aph.1E187; Shulman N. Raphael, 1993, Transfusion Medicine Reviews, V7, P215; VISENTIN GP, 1991, BLOOD, V77, P2668; Warkentin TE, 2004, SEMIN THROMB HEMOST, V30, P273, DOI 10.1055/s-2004-831039	28	111	114	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2007	356	9					904	910		10.1056/NEJMoa065066	http://dx.doi.org/10.1056/NEJMoa065066			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140HV	17329697				2022-12-28	WOS:000244496400005
J	Lareau, LF; Inada, M; Green, RE; Wengrod, JC; Brenner, SE				Lareau, Liana F.; Inada, Maki; Green, Richard E.; Wengrod, Jordan C.; Brenner, Steven E.			Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements	NATURE			English	Article							MESSENGER-RNA DECAY; PROTEIN-KINASE; HUMAN GENOME; IDENTIFICATION; EVENTS; EXPRESSION; ENHANCERS; DROSOPHILA; ROLES; EXON	The human and mouse genomes share a number of long, perfectly conserved nucleotide sequences, termed ultraconserved elements(1). Whereas these regions can act as transcriptional enhancers when upstream of genes, those within genes are less well understood. In particular, the function of ultraconserved elements that overlap alternatively spliced exons of genes encoding RNA-binding proteins is unknown(1,2). Here we report that in every member of the human SR family of splicing regulators, highly or ultraconserved elements are alternatively spliced, either as alternative 'poison cassette exons' containing early in-frame stop codons, or as alternative introns in the 3' untranslated region. These alternative splicing events target the resulting messenger RNAs for degradation by means of an RNA surveillance pathway called nonsense-mediated mRNA decay. Mouse orthologues of the human SR proteins exhibit the same unproductive splicing patterns. Three SR proteins have been previously shown to direct splicing of their own transcripts, and one of these is known to autoregulate its expression by coupling alternative splicing with decay(3-5); our results suggest that unproductive splicing is important for regulation of the entire SR family. We find that unproductive splicing associated with conserved regions has arisen independently in different SR genes, suggesting that splicing factors may readily acquire this form of regulation.	Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Brenner, SE (corresponding author), Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA.	brenner@compbio.berkeley.edu	Brenner, Steven E/A-8729-2008	Brenner, Steven E/0000-0001-7559-6185; Green, Richard/0000-0003-0516-5827				Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Duncan PI, 1997, MOL CELL BIOL, V17, P5996, DOI 10.1128/MCB.17.10.5996; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Garcia-Sacristan A, 2005, CELL RES, V15, P495, DOI 10.1038/sj.cr.7290319; GE H, 1991, CELL, V66, P373, DOI 10.1016/0092-8674(91)90626-A; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Hughes JR, 2005, P NATL ACAD SCI USA, V102, P9830, DOI 10.1073/pnas.0503401102; Iida K, 2006, MOL BIOL EVOL, V23, P1085, DOI 10.1093/molbev/msj118; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jumaa H, 1997, EMBO J, V16, P5077, DOI 10.1093/emboj/16.16.5077; Kalyna M, 2006, NUCLEIC ACIDS RES, V34, P4395, DOI 10.1093/nar/gkl570; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kumar S, 2005, EMBO J, V24, P2646, DOI 10.1038/sj.emboj.7600723; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Lejeune F, 2001, J BIOL CHEM, V276, P7850, DOI 10.1074/jbc.M009510200; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Morrison M, 1997, P NATL ACAD SCI USA, V94, P9782, DOI 10.1073/pnas.94.18.9782; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Paillusson A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni052; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Sanford JR, 2005, BIOCHEM SOC T, V33, P443, DOI 10.1042/BST0330443; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zorio DAR, 1997, MOL CELL BIOL, V17, P946, DOI 10.1128/MCB.17.2.946	30	434	437	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2007	446	7138					926	929		10.1038/nature05676	http://dx.doi.org/10.1038/nature05676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17361132	Green Published			2022-12-28	WOS:000245785700045
J	Griffin, SC; Barber, JA; Manca, A; Sculpher, MJ; Thompson, SG; Buxton, MJ; Hemingway, H				Griffin, S. C.; Barber, J. A.; Manca, A.; Sculpher, M. J.; Thompson, S. G.; Buxton, M. J.; Hemingway, H.			Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-ARTERY-DISEASE; RANDOMIZED-TRIALS; MEDICAL THERAPY; ANGIOPLASTY; UNDERUSE; SURGERY; METAANALYSIS; SURVIVAL; STENTS	Objective To assess whether revascularisation that is considered to be clinically appropriate is also cost effective. Design Prospective observational study comparing cost effectiveness of coronary artery bypass grafting, percutaneous coronary intervention, or medical management within groups of patients rated as appropriate for revascularisation. Setting Three tertiary care centres in London. Participants Consecutive, unselected patients rated as clinically appropriate (using a nine member Delphi panel) to receive coronary artery bypass grafting only (n=815); percutaneous coronary intervention only (n=385); or both revascularisation procedures (n=520). Main outcome measure Cost per quality adjusted life year gained over six year follow-up, calculated with a National Health Service cost perspective and discounted at 3.5%/year. Results Coronary artery bypass grafting cost 22 pound 000 (E33 000; $43 000) per quality adjusted life year gained compared with percutaneous coronary intervention among patients appropriate for coronary artery bypass grafting only (59% probability of being cost effective at a cost effectiveness threshold of 30 pound 000 per quality adjusted life year) and 19 pound 000 per quality adjusted life year gained compared with medical management among those appropriate for both types of revascularisation (probability of being cost effective 63%). In none of the three appropriateness groups was percutaneous coronary intervention cost effective at a threshold of 30 pound 000 per quality adjusted life year. Among patients rated appropriate for percutaneous coronary intervention only, the cost per quality adjusted life year gained for percutaneous coronary intervention compared with medical management was 47 pound 000, exceeding usual cost effectiveness thresholds; in these patients, medical management was most likely to be cost effective (probability 54%). Conclusions Among patients judged clinically appropriate for coronary revascularisation, coronary artery bypass grafting seemed cost effective but percutaneous coronary intervention did not. Cost effectiveness analysis based on observational data suggests that the clinical benefit of percutaneous coronary intervention may not be sufficient to justify its cost.	UCL, Sch Med, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; UCL, Dept Stat Sci, London WC1E 6BT, England; UCL Hosp NHS Trust, UCLH UCL Biomed Res Ctr, London, England; MRC, Biostat Unit, Cambridge CB2 2BW, England; Brunel Univ, Hlth Econ Res Grp, London, England	University of London; University College London; UCL Medical School; University of York - UK; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; MRC Biostatistics Unit; Brunel University	Hemingway, H (corresponding author), UCL, Sch Med, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	h.hemingway@ud.ac.uk	Hemingway, Harry/C-1219-2009; Griffin, Susan/AAE-8970-2020	Hemingway, Harry/0000-0003-2279-0624; Griffin, Susan/0000-0003-2188-8400; Barber, Julie/0000-0001-5762-762X; Sculpher, Mark/0000-0003-3746-9913	MRC [MC_U105260792] Funding Source: UKRI; Medical Research Council [MC_U105260792] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alderman EL, 1997, JAMA-J AM MED ASSOC, V277, P715; Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; [Anonymous], CORONARY ANGIOGRAPHY; *BRIT MED ASS ROYA, 2004, BRIT NAT FORM; Brook R H, 1986, Int J Technol Assess Health Care, V2, P53; Bucher HC, 2000, BMJ-BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73; CAMPEAU L, 1976, CIRCULATION, V54, P522, DOI 10.1161/circ.54.3.947585; Claude J, 2004, EUR HEART J, V25, P2195, DOI 10.1016/j.ehj.2004.09.013; Dolan P, 1995, SOCIAL TARIFF EUROQO; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Hemingway H, 2006, JAMA-J AM MED ASSOC, V295, P1404, DOI 10.1001/jama.295.12.1404; Hemingway H, 2001, NEW ENGL J MED, V344, P645, DOI 10.1056/NEJM200103013440906; Hemingway H, 1999, J PUBLIC HEALTH MED, V21, P421, DOI 10.1093/pubmed/21.4.421; Hill R, 2004, HEALTH TECHNOL ASSES, V8, P1; Hlatky MA, 2004, CIRCULATION, V110, P1960, DOI 10.1161/01.CIR.0000143379.26342.5C; *HOSP EP STAT, 1998, MAIN OP SUMM; Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065; JOHANNESSON M, 1993, J HEALTH ECON, V12, P459, DOI 10.1016/0167-6296(93)90005-Y; Kaiser C, 2005, LANCET, V366, P921, DOI 10.1016/S0140-6736(05)67221-2; KIND P, 1999, 172 U YORK CTR HLTH; Kind P, 1996, QUALITY LIFE PHARMAC; KRAVITZ RL, 1995, JAMA-J AM MED ASSOC, V274, P632, DOI 10.1001/jama.274.8.632; KRUMHOLZ HM, 2005, CIRCULATION, V111, P3078; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; National Institute for Clinical Excellence, 2004, GUID METH TECHN APPR; NETTEN A, 2004, UNIT COSTS HLTH SOCI; PARSONNET V, 1989, CIRCULATION, V79, P3; POCOCK SJ, 1995, LANCET, V346, P1184, DOI 10.1016/S0140-6736(95)92897-9; Raftery J, 2001, BRIT MED J, V323, P1300, DOI 10.1136/bmj.323.7324.1300; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Sculpher MJ, 2002, EUR HEART J, V23, P1291, DOI 10.1053/euhj.2001.3075; Shekelle PG, 1998, NEW ENGL J MED, V338, P1888, DOI 10.1056/NEJM199806253382607; Togni M, 2004, EUR HEART J, V25, P1208, DOI 10.1016/j.ehj.2004.04.024; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Willan AR, 2004, HEALTH ECON, V13, P461, DOI 10.1002/hec.843; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	37	71	73	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2007	334	7594					624	628		10.1136/bmj.39129.442164.55	http://dx.doi.org/10.1136/bmj.39129.442164.55			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	152DC	17339236	Green Published, Bronze			2022-12-28	WOS:000245340000036
J	Baughman, RH				Baughman, Ray H.			Alan G. MacDiarmid (1927-2007)	SCIENCE			English	Biographical-Item									Univ Texas, Nanotech Inst, Dallas, TX 75080 USA	University of Texas System; University of Texas Dallas	Baughman, RH (corresponding author), Univ Texas, Nanotech Inst, Dallas, TX 75080 USA.	ray.baughman@utdallas.edu	Baughman, Ray/A-8628-2018	Baughman, Ray/0000-0001-5845-5137					0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1678	1678		10.1126/science.1141133	http://dx.doi.org/10.1126/science.1141133			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379798				2022-12-28	WOS:000245106900028
J	Coleman, P				Coleman, Piers			Frontier at your fingertips	NATURE			English	Editorial Material									Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Coleman, P (corresponding author), Rutgers State Univ, Dept Phys & Astron, 136 Frelinghuysen Rd, Piscataway, NJ 08854 USA.							ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Coleman P, 2005, NATURE, V433, P226, DOI 10.1038/nature03279; Laughlin R.B., 2005, DIFFERENT UNIVERSE	3	11	11	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2007	446	7134					379	379		10.1038/446379a	http://dx.doi.org/10.1038/446379a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17377567	Bronze, Green Submitted			2022-12-28	WOS:000245079500022
J	Jin, Y; Mailloux, CM; Gowan, K; Riccardi, SL; LaBerge, G; Bennett, DC; Fain, PR; Spritz, RA				Jin, Ying; Mailloux, Christina M.; Gowan, Katherine; Riccardi, Sheri L.; LaBerge, Greggory; Bennett, Dorothy C.; Fain, Pamela R.; Spritz, Richard A.			NALP1 in vitiligo-associated multiple autoimmune disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLD AUTOINFLAMMATORY SYNDROME; SUSCEPTIBILITY LOCI; GENE; EPIDEMIOLOGY; MUTATIONS; FAMILY; ONSET; SLEV1; HLA	Background: Autoimmune and autoinflammatory diseases involve interactions between genetic risk factors and environmental triggers. We searched for a gene on chromosome 17p13 that contributes to a group of epidemiologically associated autoimmune and autoinflammatory diseases. The group includes various combinations of generalized vitiligo, autoimmune thyroid disease, latent autoimmune diabetes in adults, rheumatoid arthritis, psoriasis, pernicious anemia, systemic lupus erythematosus, and Addison's disease. Methods: We tested 177 single-nucleotide polymorphisms (SNPs) spanning the 17p13 linkage peak for association with disease and identified a strong candidate gene. We then sequenced DNA in and around the gene to identify additional SNPs. We carried out a second round of tests of association using some of these additional SNPs, thus elucidating the association with disease in the gene and its extended promoter region in fine detail. Results: Association analyses resulted in our identifying as a candidate gene NALP1, which encodes NACHT leucine-rich-repeat protein 1, a regulator of the innate immune system. Fine-scale association mapping with the use of DNA from affected families and additional SNPs in and around NALP1 showed an association of specific variants with vitiligo alone, with an extended autoimmune and autoinflammatory disease phenotype, or with both. Conditional logistic-regression analysis of NALP1 SNPs indicated that at least two variants contribute independently to the risk of disease. Conclusions: DNA sequence variants in the NALP1 region are associated with the risk of several epidemiologically associated autoimmune and autoinflammatory diseases, implicating the innate immune system in the pathogenesis of these disorders.	Univ Colorado Denver, Human Med Genet Program, Aurora, CO 80045 USA; Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA; Hlth Sci Ctr, Aurora, CO USA; Univ London, St Georges, Div Basic Med Sci, London, England	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; St Georges University London; University of London	Spritz, RA (corresponding author), Univ Colorado Denver, Human Med Genet Program, POB 6511,Mailstop 8300, Aurora, CO 80045 USA.	richard.spritz@uchsc.edu	Bennett, Dorothy C/C-2418-2008	Bennett, Dorothy C/0000-0002-3639-7527	NIAID NIH HHS [AI46374] Funding Source: Medline; NIAMS NIH HHS [AR45584] Funding Source: Medline; NIDDK NIH HHS [DK57538] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI046374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057538] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brand Oliver, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009981; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Gregersen PK, 2006, NAT REV GENET, V7, P917, DOI 10.1038/nrg1944; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Hlaing T, 2001, J BIOL CHEM, V276, P9230, DOI 10.1074/jbc.M009853200; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Johansson CM, 2004, HUM GENET, V115, P230, DOI 10.1007/s00439-004-1145-3; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; KUMMER JA, IN PRESS J HISTOCHEM; Laberge G, 2005, PIGM CELL RES, V18, P300, DOI 10.1111/j.1600-0749.2005.00242.x; Liu F, 2004, CELL SIGNAL, V16, P1013, DOI 10.1016/j.cellsig.2004.02.006; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Nath SK, 2001, AM J HUM GENET, V69, P1401, DOI 10.1086/324470; NIH (National Institutes of Health), 2005, PROGR AUT DIS RES; Nordlund JJ, 2006, PIGMENTARY SYSTEM, P551, DOI DOI 10.1002/9780470987100.CH30.; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Petrilli V, 2005, CURR BIOL, V15, pR581, DOI 10.1016/j.cub.2005.07.049; Schug J., 1997, CBILTR19971001V00 U; Spritz RA, 2004, AM J HUM GENET, V74, P188, DOI 10.1086/381134; Stack JH, 2005, J IMMUNOL, V175, P2630, DOI 10.4049/jimmunol.175.4.2630; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tu CX, 2003, J DERMATOL SCI, V31, P73, DOI 10.1016/S0923-1811(02)00151-2; Walsh SJ, 2000, AM J PUBLIC HEALTH, V90, P1463, DOI 10.2105/AJPH.90.9.1463	38	459	483	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1216	1225		10.1056/NEJMoa061592	http://dx.doi.org/10.1056/NEJMoa061592			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377159	Green Accepted, Bronze			2022-12-28	WOS:000245101900006
J	Hadley, J				Hadley, Jack			Insurance coverage, medical care use, and short-term health changes following an unintentional injury or the onset of a chronic condition	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SELF-RATED HEALTH; PREMIUM INCREASES; MORTALITY; DECLINE; ADULTS; RISK; TRAUMA; OLDER	Context Given the large and increasing number of uninsured US individuals, identifying the health consequences of being uninsured has assumed increased importance. Objective To compare medical care use and short-term health changes among US uninsured individuals and insured nonelderly individuals following a health shock caused by either an unintentional injury or the onset of a chronic condition. Design, Setting, and Participants Multivariate logistic regression analysis of longitudinal data from Medical Expenditure Panel Surveys (1997-2004) limited to nonelderly individuals whose insurance status was established for 2 months prior to 1 or more unintentional injuries ( 20 783 cases among 15 866 individuals) and onset of 1 or more chronic conditions ( 10 485 cases among 7954 individuals). Main Outcome Measures Self-reported medical care use and change in short-term general health status following the health shock. Results After experiencing a health shock, uninsured individuals were less likely to obtain any medical care ( unintentional injury [UI] group: 78.8% uninsured vs 88.7% insured [ adjusted odds ratio {AOR}, 0.47; 95% confidence interval {CI}, 0.43-0.51]; new chronic condition [NCC] group: 81.7% uninsured vs 91.5% insured [ AOR, 0.45; 95% CI, 0.40-0.50]) and more likely not to have received any recommended follow-up care ( UI group: 19.3% uninsured vs 9.2% insured [ AOR, 2.59; 95% CI, 2.15-3.11]; NCC group: 9.4% uninsured vs 4.4% insured [ AOR, 1.65; 95% CI, 1.32-2.06]). Based on the AORs, uninsured individuals with UIs had fewer outpatient visits (6.1% uninsured vs 9.0% insured; AOR, 0.71 [ 95% CI, 0.63-0.80]), office-based visits (41.8% uninsured vs 57.3% insured; AOR, 0.59 [ 95% CI, 0.56-0.62]), and prescription medicines (35.5% uninsured vs 35.6% insured; AOR, 0.71 [ 95% CI, 0.67-0.75]). Uninsured individuals with an NCC had fewer office-based visits (58.9% uninsured vs 68.3% insured; AOR, 0.77 [ 95% CI, 0.72-0.82]) and prescription medicines (52.7% uninsured vs 61.7% insured; AOR, 0.66 [ 95% CI, 0.57-0.76]). Higher proportions of uninsured individuals reported a decrease in health status ( classified as much worse) approximately 3.5 months after the health shock ( UI group: 9.8% uninsured vs 6.7% insured; AOR, 0.86 [ 95% CI, 0.75-0.98]; NCC group: 12.3% uninsured vs 10.1% insured; AOR, 0.74 [ 95% CI, 0.68-0.80]). Uninsured individuals with UIs were more likely to report not being fully recovered and no longer receiving treatment. At approximately 7 months after the health shock, uninsured individuals with NCCs still reported worse health status. Conclusions Among individuals who experienced a health shock caused by an unintentional injury or a new chronic condition, uninsured individuals reported receiving less medical care and poorer short-term changes in health than those with insurance.	Urban Inst, Washington, DC 20037 USA	Urban Institute	Hadley, J (corresponding author), Urban Inst, 2100 M St NW, Washington, DC 20037 USA.	jhadley@ui.urban.org	Shadmi, Efrat/A-3954-2016					*AG HEALTHC RES QU, DET INF MED EXP PAN; *AG HEALTHC RES QU, MED EXP PAN SURV HC; [Anonymous], MEPS HC RESP RAT PAN; Baker DW, 2006, MED CARE, V44, P277, DOI 10.1097/01.mlr.0000199696.41480.45; Baker DW, 2002, MED CARE, V40, P1126, DOI 10.1097/00005650-200211000-00013; Baker DW, 2001, NEW ENGL J MED, V345, P1106, DOI 10.1056/NEJMsa002887; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; Diehr P, 2001, J AM GERIATR SOC, V49, P36, DOI 10.1046/j.1532-5415.2001.49007.x; Dor A, 2006, HEALTH SERV RES, V41, P759, DOI 10.1111/j.1475-6773.2006.00513.x; Doyle JJ, 2005, REV ECON STAT, V87, P256, DOI 10.1162/0034653053970348; ENGLE RF, 1983, ECONOMETRICA, V51, P277, DOI 10.2307/1911990; ERICSON P, 1995, 7 NAT CTR HLTH STAT; *FAM US, 2001, GETT LESS CAR UN CHR; FRANKS P, 1993, JAMA-J AM MED ASSOC, V270, P737, DOI 10.1001/jama.270.6.737; Gabel J, 2005, HEALTH AFFAIR, V24, P1273, DOI 10.1377/hlthaff.24.5.1273; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; Hadley J, 2006, HEALTH SERV RES, V41, P429, DOI 10.1111/j.1475-6773.2005.00491.x; Hadley J, 2006, MED CARE RES REV, V63, P447, DOI 10.1177/1077558706288841; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; *I MED, 2002, CAR COV; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; KREIDER B, 2006, INF POL HLTH CAR COS; LEVY H, 2005, HLTH POLICY UNINSURE; LICHTENBERG FR, 2002, FRONTIERS HLTH POLIC, V5; McWilliams JM, 2004, HEALTH AFFAIR, V23, P223, DOI 10.1377/hlthaff.23.4.223; McWilliams JM, 2003, JAMA-J AM MED ASSOC, V290, P757, DOI 10.1001/jama.290.6.757; NEWHOUSE J, 1993, FREE ALL RAND HLTH I; Schoen C, 1998, J URBAN HEALTH, V75, P30, DOI 10.1007/BF02344923; Schoen C, 2000, HEALTH SERV RES, V35, P187; SORLIE PD, 1994, ARCH INTERN MED, V154, P2409, DOI 10.1001/archinte.154.21.2409; STAGNITTI M, 2000, MED CARE TREATMENT C; *STATACORP, BIN COUNT LTD DEP VA; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; 2003, MED CARE RES REV S, V60, pS3	34	142	142	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2007	297	10					1073	1084		10.1001/jama.297.10.1073	http://dx.doi.org/10.1001/jama.297.10.1073			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	145KZ	17356028				2022-12-28	WOS:000244865200021
J	Holden, C				Holden, Constance			Stem cells - Data on adult stem cells questioned	SCIENCE			English	News Item																			0	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1207	1207		10.1126/science.315.5816.1207a	http://dx.doi.org/10.1126/science.315.5816.1207a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332385				2022-12-28	WOS:000244564700007
J	Stillman, RJ; Burns, RB				Stillman, Robert J.; Burns, Risa B.			A 47-year-old woman with fertility problems who desires a multiple pregnancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SINGLE-EMBRYO-TRANSFER; IN-VITRO FERTILIZATION; ASSISTED REPRODUCTIVE TECHNOLOGY; COST-EFFECTIVENESS ANALYSIS; TWIN PREGNANCY; RELEVANT STANDARD; INTRAUTERINE INSEMINATION; BLASTOCYST TRANSFER; OVARIAN RESPONSE; IVF	Mrs Z is a 47-year-old woman with long-standing infertility who is about to undergo in vitro fertilization (IVF) using donor oocytes from an anonymous donor. She has already undergone an IVF cycle with her own oocytes and an IVF cycle using donor oocytes from a known donor without a successful pregnancy. Mrs Z has been advised by her infertility physician to consider the transfer of a single embryo, but she does not wish to decrease her likelihood of conception, and, after her long and expensive infertility saga, wishes to conceive twins. The science of IVF has evolved significantly in the last several years, increasing the likelihood of successful pregnancy and reducing the need to transfer more than 1 embryo with its inherent risks of multiple pregnancy. The state of the science and why patients may continue to want multiple embryos transferred, including costs and lack of insurance coverage for infertility treatments, are discussed.	Shady Grove Fertil Reprod Sci Ctr, Washington, DC USA; Georgetown Univ, Sch Med, Washington, DC USA	Georgetown University	Stillman, RJ (corresponding author), Shady Grove Fertil Ctr, 15001 Shady Grove Rd, Rockville, MD 20850 USA.	robert.stillman@Integramed.com						Adamson D, 2004, FERTIL STERIL, V81, P517, DOI 10.1016/j.fertnstert.2003.09.041; Adashi Eli Y, 2003, Reprod Biomed Online, V7, P515; Alper MM, 2004, FERTIL STERIL, V81, P514, DOI 10.1016/j.fertnstert.2003.08.039; *AM SOC REPR MED, PROT YOUR FERT; American Society for Reproductive Medicine, 1999, GUID NUMB EMBR TRANS; American Society for Reproductive Medicine. Practice Committee Opinion, 1998, GUID NUMB EMBR TRANS; Barlow DH, 2005, HUM REPROD, V20, P1, DOI 10.1093/humrep/deh649; Bavister BD, 1997, HUM REPROD, V12, P1607; Bhattacharya S, 2004, HUM REPROD, V19, P1939, DOI 10.1093/humrep/deh379; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Bush MC, 2003, CLIN PERINATOL, V30, P623, DOI 10.1016/S0095-5108(03)00055-1; CALLAHAN TL, 1994, NEW ENGL J MED, V331, P244, DOI 10.1056/NEJM199407283310407; *CDCP, 2003 ASS REPR TECHN; Coetsier T, 2001, HUM REPROD, V16, P790; Criniti A, 2005, FERTIL STERIL, V84, P1613, DOI 10.1016/j.fertnstert.2005.06.035; Crosignani PG, 2000, HUM REPROD, V15, P1856; D'Alton M, 2004, FERTIL STERIL, V81, P523, DOI 10.1016/j.fertnstert.2003.10.022; De Neubourg D, 2006, HUM REPROD, V21, P843, DOI 10.1093/humrep/dei425; De Sutter P, 2002, HUM REPROD, V17, P2891, DOI 10.1093/humrep/17.11.2891; Dhont M, 1999, AM J OBSTET GYNECOL, V181, P688, DOI 10.1016/S0002-9378(99)70514-4; Dickey RP, 2005, HUM REPROD, V20, P2978, DOI 10.1093/humrep/dei144; Edi-Osagie E, 2003, HUM REPROD, V18, P1828, DOI 10.1093/humrep/deg334; EichenlaubRitter U, 1996, ENVIRON MOL MUTAGEN, V28, P211, DOI 10.1002/(SICI)1098-2280(1996)28:3<211::AID-EM6>3.0.CO;2-G; El-Toukhy T, 2006, AM J OBSTET GYNECOL, V194, P322, DOI 10.1016/j.ajog.2005.05.018; Ellison MA, 2003, FERTIL STERIL, V80, P405, DOI 10.1016/S0015-0282(03)00659-9; Ethics Committee of the American Society for Reproductive Medicine, 2004, Fertil Steril, V82 Suppl 1, pS249; Faber K, 1997, HUM REPROD, V12, P1614; Fauser BC, 2005, HUM REPROD UPDATE, V11, P437, DOI 10.1093/humupd/dmi026; Fiddelers AAA, 2006, HUM REPROD, V21, P2090, DOI 10.1093/humrep/del112; Flisser E, 2006, FERTIL STERIL, V85, P555, DOI 10.1016/j.fertnstert.2005.08.063; Gardner DK, 2004, FERTIL STERIL, V81, P551, DOI 10.1016/j.fertnstert.2003.07.023; Gardner DK, 2003, PLACENTA, V24, pS5, DOI 10.1016/S0143-4004(03)00136-X; Gerris J, 2004, HUM REPROD, V19, P917, DOI 10.1093/humrep/deh188; Gerris J, 2002, HUM REPROD, V17, P2626, DOI 10.1093/humrep/17.10.2626; Gerris J, 1999, HUM REPROD, V14, P2581, DOI 10.1093/humrep/14.10.2581; Glazebrook C, 2004, FERTIL STERIL, V81, P505, DOI 10.1016/j.fertnstert.2003.10.020; GLEICHER N, 1995, HUM REPROD, V10, P1079, DOI 10.1093/oxfordjournals.humrep.a136098; Gleicher N, 2006, HUM REPROD, V21, P1337, DOI 10.1093/humrep/del026; Goldfarb J, 1996, FERTIL STERIL, V65, P815, DOI 10.1016/S0015-0282(16)58220-X; Grobman WA, 2001, AM J OBSTET GYNECOL, V185, P920, DOI 10.1067/mob.2001.117305; Henman M, 2005, FERTIL STERIL, V84, P1620, DOI 10.1016/j.fertnstert.2005.05.064; Hunault CC, 2002, FERTIL STERIL, V77, P725, DOI 10.1016/S0015-0282(01)03243-5; Jain T, 2004, NEW ENGL J MED, V350, P1639, DOI 10.1056/NEJMsa032073; Jain T, 2003, FERTIL STERIL, V80, P27, DOI 10.1016/S0015-0282(03)00576-4; Kjellberg AT, 2006, HUM REPROD, V21, P210, DOI 10.1093/humrep/dei298; Lukassen HGM, 2005, HUM REPROD, V20, P702, DOI 10.1093/humrep/deh672; Martikainen H, 2004, HUM REPROD, V19, P1364, DOI 10.1093/humrep/deh197; Martikainen H, 2001, HUM REPROD, V16, P1900, DOI 10.1093/humrep/16.9.1900; Murray S, 2004, HUM REPROD, V19, P911, DOI 10.1093/humrep/deh176; Neuber E, 2003, HUM REPROD, V18, P1307, DOI 10.1093/humrep/deg269; Ng EHY, 2005, HUM REPROD, V20, P1647, DOI 10.1093/humrep/deh833; Nosarka S, 2005, GYNECOL OBSTET INVES, V60, P67, DOI 10.1159/000084546; Ombelet W, 2005, HUM REPROD UPDATE, V11, P3, DOI 10.1093/humupd/dmh048; Pandian Z, 2005, HUM REPROD, V20, P2681, DOI 10.1093/humrep/dei153; Papanikolaou EG, 2006, NEW ENGL J MED, V354, P1139, DOI 10.1056/NEJMoa053524; Pinborg A, 2004, BMJ-BRIT MED J, V329, P311, DOI 10.1136/bmj.38156.715694.3A; Pinborg A, 2003, HUM REPROD, V18, P621, DOI 10.1093/humrep/deg145; Reynolds MA, 2006, HUM REPROD, V21, P694, DOI 10.1093/humrep/dei363; Reynolds MA, 2003, FERTIL STERIL, V80, P16, DOI 10.1016/S0015-0282(03)00572-7; Ryan GL, 2004, FERTIL STERIL, V81, P526, DOI 10.1016/j.fertnstert.2003.10.021; Saldeen P, 2005, HUM REPROD, V20, P4, DOI 10.1093/humrep/deh610; Schieve LA, 2006, NEW ENGL J MED, V354, P1190, DOI 10.1056/NEJMe058321; Schieve LA, 2004, HUM REPROD, V19, P778, DOI 10.1093/humrep/deh160; Seif MMW, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001894.pub3; *SOC ASS REPR TECH, 2006, FERTIL STERIL, V86, pS51; Society for Assisted Reproductive Technology, CLIN SUMM REP; Soules MR, 2003, FERTIL STERIL, V80, P295, DOI 10.1016/S0015-0282(03)00667-8; Stachecki JJ, 2004, REPROD BIOMED ONLINE, V9, P152, DOI 10.1016/S1472-6483(10)62124-4; Strandell A, 2000, HUM REPROD, V15, P2520, DOI 10.1093/humrep/15.12.2520; Tarlatzis BC, 2003, HUM REPROD UPDATE, V9, P61, DOI 10.1093/humupd/dmg007; Templeton A, 1998, NEW ENGL J MED, V339, P573, DOI 10.1056/NEJM199808273390901; Thurin A, 2004, NEW ENGL J MED, V351, P2392, DOI 10.1056/NEJMoa041032; Thurin A, 2005, HUM REPROD, V20, P1876, DOI 10.1093/humrep/deh872; Tiitinen A, 2003, HUM REPROD, V18, P1449, DOI 10.1093/humrep/deg301; Tiitinen A, 2004, HUM REPROD, V19, P2439, DOI 10.1093/humrep/deh446; van Montfoort APA, 2005, HUM REPROD, V20, P433, DOI 10.1093/humrep/deh619; van Montfoort APA, 2006, HUM REPROD, V21, P338, DOI 10.1093/humrep/dei359; van Rumste MME, 2006, HUM REPROD, V21, P701, DOI 10.1093/humrep/dei365; van Wely M, 2006, HUM REPROD, V21, P2736, DOI 10.1093/humrep/del249; Veleva Z, 2006, HUM REPROD, V21, P2098, DOI 10.1093/humrep/del137; Wolner-Hanssen P, 1998, HUM REPROD, V13, P88, DOI 10.1093/humrep/13.1.88	81	9	9	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2007	297	8					858	867		10.1001/jama.297.8.858	http://dx.doi.org/10.1001/jama.297.8.858			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140DS	17327527				2022-12-28	WOS:000244485000028
J	Sleigh, AC				Sleigh, Adrian C.			Health-system reforms to control tuberculosis in China	LANCET			English	Editorial Material									Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia	Australian National University	Sleigh, AC (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	adrian.sleigh@anu.edu.au	sleigh, adrian/J-4540-2019	sleigh, adrian/0000-0001-8443-7864				Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P123; Chen XY, 2004, LANCET, V364, P417; Jackson S, 2005, CHINA QUART, V181, P137, DOI 10.1017/S0305741005000081; Jackson S, 2006, INT J TUBERC LUNG D, V10, P1104; Jackson S, 2006, Population Dynamics and Infectious Diseases in Asia, P231, DOI 10.1142/9789812773395_0012; Kelly D, 2006, Population Dynamics and Infectious Diseases in Asia, P389, DOI 10.1142/9789812773395_0020; SUN X, 2007, CATASTROPHIC PAYMENT; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Zhang LX, 2006, INT J TUBERC LUNG D, V10, P959; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	10	10	11	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2007	369	9562					626	627		10.1016/S0140-6736(07)60292-X	http://dx.doi.org/10.1016/S0140-6736(07)60292-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	141RO	17321296	Green Published, Bronze			2022-12-28	WOS:000244596600008
J	Kawahara, Y; Zinshteyn, B; Sethupathy, P; Iizasa, H; Hatzigeorgiou, AG; Nishikura, K				Kawahara, Yukio; Zinshteyn, Boris; Sethupathy, Praveen; Iizasa, Hisashi; Hatzigeorgiou, Artemis G.; Nishikura, Kazuko			Redirection of silencing targets by adenosine-to-inosine editing of miRNAs	SCIENCE			English	Article							RNA; MICRORNA; BIOGENESIS; GENE; DEAMINASES; MUTATION; ADAR1	Primary transcripts of certain microRNA ( miRNA) genes are subject to RNA editing that converts adenosine to inosine. However, the importance of miRNA editing remains largely undetermined. Here we report that tissue-specific adenosine-to-inosine editing of miR-376 cluster transcripts leads to predominant expression of edited miR-376 isoform RNAs. One highly edited site is positioned in the middle of the 5'-proximal half "seed" region critical for the hybridization of miRNAs to targets. We provide evidence that the edited miR-376 RNA silences specifically a different set of genes. Repression of phosphoribosyl pyrophosphate synthetase 1, a target of the edited miR-376 RNA and an enzyme involved in the uric-acid synthesis pathway, contributes to tight and tissue-specific regulation of uric-acid levels, revealing a previously unknown role for RNA editing in miRNA-mediated gene silencing.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Engn & Appl Sci, Dept Comp & Informat Sci, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; University of Pennsylvania	Kawahara, Y (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	ykawahara@wistar.org; kazuko@wistar.org	Hatzigeorgiou, Artemis/Z-1976-2019; Iizasa, Hisashi/A-9821-2012	Zinshteyn, Boris/0000-0003-0103-3501	NCI NIH HHS [P01 CA072765, P01 CA072765-050002] Funding Source: Medline; NHLBI NIH HHS [R01 HL070045, R01 HL070045-04] Funding Source: Medline; NIGMS NIH HHS [R01 GM040536, R01 GM040536-16] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA072765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040536] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed M, 1999, J BIOL CHEM, V274, P7482, DOI 10.1074/jbc.274.11.7482; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Reenan RA, 2001, TRENDS GENET, V17, P53, DOI 10.1016/S0168-9525(00)02169-7; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	19	581	620	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2007	315	5815					1137	1140		10.1126/science.1138050	http://dx.doi.org/10.1126/science.1138050			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17322061	Green Accepted			2022-12-28	WOS:000244387600040
J	Uemura, S; Dorywalska, M; Lee, TH; Kim, HD; Puglisi, JD; Chu, S				Uemura, Sotaro; Dorywalska, Magdalena; Lee, Tae-Hee; Kim, Harold D.; Puglisi, Joseph D.; Chu, Steven			Peptide bond formation destabilizes Shine-Dalgarno interaction on the ribosome	NATURE			English	Article							TRANSFER-RNA; MESSENGER-RNA; A-SITES; P-SITES; TRANSLOCATION; SPECTROSCOPY; TRANSLATION; ELONGATION	The ribosome is a molecular machine that translates the genetic code contained in the messenger RNA into an amino acid sequence through repetitive cycles of transfer RNA selection, peptide bond formation and translocation(1-3). Here we demonstrate an optical tweezer assay to measure the rupture force between a single ribosome complex and mRNA. The rupture force was compared between ribosome complexes assembled on an mRNA with and without a strong Shine-Dalgarno (SD) sequence - a sequence found just upstream of the coding region of bacterial mRNAs, involved in translation initiation(4,5). The removal of the SD sequence significantly reduced the rupture force in complexes carrying an aminoacyl tRNA, Phe-tRNA(Phe), in the A site, indicating that the SD interactions contribute significantly to the stability of the ribosomal complex on the mRNA before peptide bond formation. In contrast, the presence of a peptidyl tRNA analogue, N-acetyl-Phe-tRNA(Phe), in the A site, which mimicked the post-peptidyl transfer state, weakened the rupture force as compared to the complex with Phe-tRNA(Phe), and the resultant force was the same for both the SD-containing and SD-deficient mRNAs. These results suggest that formation of the first peptide bond destabilizes the SD interaction, resulting in the weakening of the force with which the ribosome grips an mRNA. This might be an important requirement to facilitate movement of the ribosome along mRNA during the first translocation step.	Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA	Stanford University; Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Puglisi, JD (corresponding author), Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA.	puglisi@stanford.edu; schu@lbl.gov	Lee, Tae-Hee/A-1266-2010					Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; CALOGERO RA, 1988, P NATL ACAD SCI USA, V85, P6427, DOI 10.1073/pnas.85.17.6427; Dorywalska M, 2005, NUCLEIC ACIDS RES, V33, P182, DOI 10.1093/nar/gki151; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Fredrick K, 2002, MOL CELL, V9, P1125, DOI 10.1016/S1097-2765(02)00523-3; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; Katunin VI, 2002, BIOCHEMISTRY-US, V41, P12806, DOI 10.1021/bi0264871; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; NOLLER HF, 1984, ANNU REV BIOCHEM, V53, P119, DOI 10.1146/annurev.bi.53.070184.001003; Semenkov YP, 2000, NAT STRUCT BIOL, V7, P1027; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; van Dijk MA, 2004, J PHYS CHEM B, V108, P6479, DOI 10.1021/jp049805+; Wintermeyer W, 2004, BIOCHEM SOC T, V32, P733, DOI 10.1042/BST0320733; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	16	82	83	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2007	446	7134					454	457		10.1038/nature05625	http://dx.doi.org/10.1038/nature05625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17377584				2022-12-28	WOS:000245079500043
J	Ross, JS; Lackner, JE; Lurie, P; Gross, CP; Wolfe, S; Krumholz, HM				Ross, Joseph S.; Lackner, Josh E.; Lurie, Peter; Gross, Cary P.; Wolfe, Sidney; Krumholz, Harlan M.			Pharmaceutical company payments to physicians - Early experiences with disclosure laws in Vermont and Minnesota	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACADEMIC MEDICAL-CENTERS; INDUSTRY; DRUG; HOUSESTAFF	Context Recent legislation in 5 states and the District of Columbia mandated state disclosure of payments made to physicians by pharmaceutical companies. In 2 of these states, Vermont and Minnesota, payment disclosures are publicly available. Objectives To determine the accessibility and quality of the data available in Vermont and Minnesota and to describe the prevalence and magnitude of disclosed payments. Design and Setting Cross-sectional analysis of publicly available data from July 1, 2002, through June 30, 2004, in Vermont and from January 1, 2002, through December 31, 2004, in Minnesota. Main Outcome Measures Accessibility and quality of disclosure data and the number, value, and type of payments of $100 or more to physicians. Results Access to payment data required extensive negotiation with the Office of the Vermont Attorney General and manual photocopying of individual disclosure forms at Minnesota's State Board of Pharmacy. In Vermont, 61% of payments were not released to the public because pharmaceutical companies designated them as trade secrets and 75% of publicly disclosed payments were missing information necessary to identify the recipient. In Minnesota, 25% of companies reported in each of the 3 years. In Vermont, among 12 227 payments totaling $2.18 million publicly disclosed, there were 2416 payments of $100 or more to physicians; total, $1.01 million; median payment, $177 (range, $100-$20 000). In Minnesota, among 6946 payments totaling $30.96 million publicly disclosed, there were 6238 payments of $100 or more to physicians; total, $22.39 million; median payment, $1000 (range, $100-$922239). Physician-specific analyses were possible only in Minnesota, identifying 2388 distinct physicians who received payment of $100 or more; median number of payments received, 1 (range, 1-88) and the median amount received, $1000 (range, $100-$1178203). Conclusions The Vermont and Minnesota laws requiring disclosure of payments do not provide easy access to payment information for the public and are of limited quality once accessed. However, substantial numbers of payments of $100 or more were made to physicians by pharmaceutical companies.	Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY 10029 USA; James J Peters VA Med Ctr, Ctr Geriatr Res Educ & Clin, Bronx, NY USA; Publ Citizen, Hlth Res Grp, Washington, DC USA; Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Med, Gen Internal Med Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adv, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Icahn School of Medicine at Mount Sinai; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Yale University; Yale University; Yale University; Yale University; Yale University	Ross, JS (corresponding author), Mt Sinai Sch Med, Dept Geriatr & Adult Dev, 1 Gustave L Levy Pl,POB 1070, New York, NY 10029 USA.	joseph.ross@mssm.edu	, Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320				*AM MED ASS, OP E8 061 GIFTS PHYS; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; *CAN MED ASS, 2001, CANADIAN MED ASS J, V164, P1339; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; Coyle SL, 2002, ANN INTERN MED, V136, P396, DOI 10.7326/0003-4819-136-5-200203050-00014; Kassirer JP, 2004, TAKE AM COMPLICITY B; LURIE N, 1990, J GEN INTERN MED, V5, P240, DOI 10.1007/BF02600542; *MINN BOARD MED PR, 2006, HLTH PROF DAT; *NAT C STAT LEG, 2006, MARK DIR CONS ADV DT; *NAT C STAT LEG, 2006, 2006 PRESCR DRUG STA; PEAY MY, 1988, SOC SCI MED, V26, P1183, DOI 10.1016/0277-9536(88)90149-9; *PHARM RES MAN AM, 2004, PHRMA COD INT HEALTH; RANDALL T, 1991, JAMA-J AM MED ASSOC, V265, P440, DOI 10.1001/jama.265.4.440; *STAT VERM OFF ATT, 2004, PHARM MARK DISCL; Steinman MA, 2001, AM J MED, V110, P551, DOI 10.1016/S0002-9343(01)00660-X; *VERM DEP HLTH AG, 2006, DOCF DOWNL DAT; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373	17	62	62	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2007	297	11					1216	1223		10.1001/jama.297.11.1216	http://dx.doi.org/10.1001/jama.297.11.1216			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	147XO	17374816				2022-12-28	WOS:000245039300025
J	Christensen, K; Murray, JC				Christensen, Kaare; Murray, Jeffrey C.			Focus on research: What genome-wide association studies can do for medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ So Denmark, Odense, Denmark; Univ Iowa, Iowa City, IA USA	University of Southern Denmark; University of Iowa	Christensen, K (corresponding author), Univ So Denmark, Odense, Denmark.		Christensen, Kaare/C-2360-2009	Christensen, Kaare/0000-0002-5429-5292				SLADEK R, IN PRESS NATURE	1	110	117	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2007	356	11					1094	1097		10.1056/NEJMp068126	http://dx.doi.org/10.1056/NEJMp068126			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	145PO	17360987				2022-12-28	WOS:000244877200002
J	Mandal, L; Martinez-Agosto, JA; Evans, CJ; Hartenstein, V; Banerjee, U				Mandal, Lolitika; Martinez-Agosto, Julian A.; Evans, Cory J.; Hartenstein, Volker; Banerjee, Utpal			A Hedgehog- and Antennapedia-dependent niche maintains Drosophila haematopoietic precursors	NATURE			English	Article							STEM-CELL NICHE; LYMPH-GLAND; MEIS1; BLOOD; AORTA	The Drosophila melanogaster lymph gland is a haematopoietic organ(1-3) in which pluripotent blood cell progenitors proliferate and mature into differentiated haemocytes. Previous work(4) has defined three domains, the medullary zone, the cortical zone and the posterior signalling centre (PSC), within the developing third-instar lymph gland. The medullary zone is populated by a core of undifferentiated, slowly cycling progenitor cells, whereas mature haemocytes comprising plasmatocytes, crystal cells and lamellocytes are peripherally located in the cortical zone. The PSC comprises a third region that was first defined as a small group of cells expressing the Notch ligand Serrate(5). Here we show that the PSC is specified early in the embryo by the homeotic gene Antennapedia (Antp) and expresses the signalling molecule Hedgehog. In the absence of the PSC or the Hedgehog signal, the precursor population of the medullary zone is lost because cells differentiate prematurely. We conclude that the PSC functions as a haematopoietic niche that is essential for the maintenance of blood cell precursors in Drosophila. Identification of this system allows the opportunity for genetic manipulation and direct in vivo imaging of a haematopoietic niche interacting with blood precursors.	Univ Calif Los Angeles, Inst Mol Biol, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Mattel Childrens Hosp, Dept Pediat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Banerjee, U (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu	Martinez-Agosto, Julian A/I-9435-2019	Martinez-Agosto, Julian A/0000-0001-6776-6949; MANDAL, LOLITIKA/0000-0002-7711-6090	NHLBI NIH HHS [K08 HL087026-01, L40 HL090710-02, K08 HL087026, L40 HL090710] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL087026] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABBOTT MK, 1986, GENETICS, V114, P919; Abramovich C, 2005, CURR OPIN HEMATOL, V12, P210, DOI 10.1097/01.moh.0000160737.52349.aa; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Casares F, 2001, SCIENCE, V293, P1477, DOI 10.1126/science.1062542; Chuang PT, 2000, CURR OPIN GENET DEV, V10, P515, DOI 10.1016/S0959-437X(00)00121-0; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; El Shatoury H. H., 1955, Roux Archiv fuer Entwicklungsmechanik Organismen, V147, P489, DOI 10.1007/BF00576000; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Kieusseian A, 2006, BLOOD, V107, P492, DOI 10.1182/blood-2005-02-0529; Kimble Judith, 2005, WormBook, P1; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Lo PCH, 2002, DEV BIOL, V251, P307, DOI 10.1006/dbio.2002.0839; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Mandal L, 2004, NAT GENET, V36, P1019, DOI 10.1038/ng1404; Rizki T.M., 1978, P397; Ryan KM, 2005, MECH DEVELOP, V122, P1023, DOI 10.1016/j.mod.2005.04.007; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schnabel CA, 2000, ONCOGENE, V19, P608, DOI 10.1038/sj.onc.1203371; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099	30	214	220	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2007	446	7133					320	324		10.1038/nature05585	http://dx.doi.org/10.1038/nature05585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361183	Green Accepted			2022-12-28	WOS:000244892900046
J	Eva, KW				Eva, Kevin W.			What the educators are saying - Putting the cart before the horse: testing to improve learning	BRITISH MEDICAL JOURNAL			English	Editorial Material									McMaster Univ, Dept Clin Epidemiol & Biostat, Program Educ Res & Dev, Hamilton, ON L8N 3Z5, Canada	McMaster University	Eva, KW (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Program Educ Res & Dev, Hamilton, ON L8N 3Z5, Canada.	evakw@mcmaster.ca							0	7	7	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2007	334	7592					535	535		10.1136/bmj.38993.466678.BE	http://dx.doi.org/10.1136/bmj.38993.466678.BE			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148VV	17347242	Green Published			2022-12-28	WOS:000245106400048
J	Donahue, SP				Donahue, Sean P.			Pediatric strabismus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LATERAL GENICULATE-NUCLEUS; STEREOACUITY OUTCOMES; SURGICAL ALIGNMENT; STRIATE CORTEX; RISK-FACTORS; SURGERY; AMBLYOPIA; PERFORATION; AGE; STEREOPSIS		Vanderbilt Childrens Hosp, Tennessee Lions Eye Ctr, Nashville, TN USA; Vanderbilt Univ, Med Ctr, Dept Ophthalmol, Nashville, TN USA; Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Donahue, SP (corresponding author), Vanderbilt Eye Inst, 1211 21st Ave S,104 Med Arts Bldg, Nashville, TN 37212 USA.							*AM AC OPHTH, 2001, COMPL THER ASS VIS T; *AM ASS PED OPHTH, 2004, POL STAT GLASS; *AM ASS PED OPHTH, 2004, POL STAT AMBL MED CO; *AM ASS PED OPHTH, 2004, POL STAT GLASS MED N; *AM ASS PED OPHTH, 2004, POL STAT AD STRAB SU; Archer SM, 2005, J AAPOS, V9, P148, DOI 10.1016/j.jaapos.2004.12.006; ARCHER SM, 1989, OPHTHALMOLOGY, V96, P133; Arthur B W, 1989, J Pediatr Ophthalmol Strabismus, V26, P224; Atkinson J, 1996, EYE, V10, P189, DOI 10.1038/eye.1996.46; Awad AH, 2000, J AAPOS, V4, P150, DOI 10.1016/S1091-8531(00)70004-8; BANKES JLK, 1983, ARCH DIS CHILD, V58, P766, DOI 10.1136/adc.58.10.766; Biglan AW, 1996, J PEDIATR OPHTHALMOL, V33, P79; Birch E, 1998, J AAPOS, V2, P325, DOI 10.1016/S1091-8531(98)90026-X; Birch EE, 2005, INVEST OPHTH VIS SCI, V46, P526, DOI 10.1167/iovs.04-0618; Birch EE, 2004, J AAPOS, V8, P146, DOI 10.1016/j.jaapos.2003.10.003; Birch EE, 2003, J AAPOS, V7, P369, DOI 10.1016/j.jaapos.2003.08.003; Birch EE, 2000, J AAPOS, V4, P10, DOI 10.1016/S1091-8531(00)90005-3; Coats DK, 2000, OPHTHALMOLOGY, V107, P402, DOI 10.1016/S0161-6420(99)00035-4; CONNETT JE, 1990, ARCH OPHTHALMOL-CHIC, V108, P1248; Dang Y, 2004, J AAPOS, V8, P325, DOI 10.1016/j.jaapos.2004.03.003; DOBSON V, 1989, INVEST OPHTH VIS SCI, V30, P1146; Ells AL, 2003, OPHTHALMOLOGY, V110, P2113, DOI 10.1016/S0161-6420(03)00831-5; Fawcett SL, 2005, INVEST OPHTH VIS SCI, V46, P521, DOI 10.1167/iovs.04-0175; Fawcett SL, 2004, AM J OPHTHALMOL, V138, P931, DOI 10.1016/j.ajo.2004.07.030; Glaser SR, 2002, ARCH OPHTHALMOL-CHIC, V120, P268; HILES DA, 1980, ARCH OPHTHALMOL-CHIC, V98, P697; Holmes JM, 2006, LANCET, V367, P1343, DOI 10.1016/S0140-6736(06)68581-4; Holmes JM, 2004, J AAPOS, V8, P420, DOI 10.1016/j.jaapas.2004.07.007; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Hunter DG, 2001, J AAPOS, V5, P352, DOI 10.1067/mpa.2001.120175; Ing MR, 1995, OPHTHALMOLOGY, V102, P2041, DOI 10.1016/S0161-6420(95)30756-7; KEECH RV, 1995, J PEDIATR OPHTHALMOL, V32, P89; Kushner BJ, 2005, ARCH OPHTHALMOL-CHIC, V123, P100, DOI 10.1001/archopht.123.1.100; KUSHNER BJ, 1994, ARCH OPHTHALMOL-CHIC, V112, P639, DOI 10.1001/archopht.1994.01090170083027; NIXON RB, 1985, AM J OPHTHALMOL, V100, P798, DOI 10.1016/S0002-9394(14)73370-7; Noel LP, 1997, J PEDIAT OPHTH STRAB, V34, P115; Parks M M, 1969, Trans Am Ophthalmol Soc, V67, P609; Paysse EA, 2001, J AAPOS, V5, P361, DOI 10.1067/mpa.2001.119243; Pediat Eye Dis Investigator Grp, 2003, ARCH OPHTHALMOL-CHIC, V121, P603; Quah SA, 2004, INVEST OPHTH VIS SCI, V45, P1817, DOI 10.1167/iovs.03-0945; Raab EL, 1984, J PEDIATR OPHTHALMOL, V21, P64; Recchia FM, 2000, ARCH OPHTHALMOL-CHIC, V118, P939; Repka MS, 2004, OPHTHALMOLOGY, V111, P2076, DOI 10.1016/j.ophtha.2004.04.032; SATTERFIELD D, 1993, ARCH OPHTHALMOL-CHIC, V111, P1100, DOI 10.1001/archopht.1993.01090080096024; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; Scheiman MM, 2005, ARCH OPHTHALMOL-CHIC, V123, P437; SIMON JW, 1992, J PEDIATR OPHTHALMOL, V29, P273; von Noorden G K, 1978, Invest Ophthalmol Vis Sci, V17, P762; VONNOORDEN GK, 1981, INVEST OPHTH VIS SCI, V21, P142; VONNOORDEN GK, 1983, INVEST OPHTH VIS SCI, V24, P788; VONNOORDEN GK, 1992, INVEST OPHTH VIS SCI, V33, P2729; VONNOORDEN GK, 1999, T OPHTHAL SOC UK, V99, P442; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; Wortham E 5th, 1989, J Pediatr Ophthalmol Strabismus, V26, P109; Wu C, 2006, AM J OPHTHALMOL, V141, P175, DOI 10.1016/j.ajo.2005.07.060	56	35	36	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2007	356	10					1040	1047		10.1056/NEJMcp051888	http://dx.doi.org/10.1056/NEJMcp051888			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143DC	17347457				2022-12-28	WOS:000244699200008
J	Hollenstein, K; Frei, DC; Locher, KP				Hollenstein, Kaspar; Frei, Dominik C.; Locher, Kaspar P.			Structure of an ABC transporter in complex with its binding protein	NATURE			English	Article							ATP-BINDING; AZOTOBACTER-VINELANDII; CASSETTE TRANSPORTER; MOLYBDATE TRANSPORT; MALTOSE TRANSPORT; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; P-GLYCOPROTEIN; MECHANISM; HYDROLYSIS	ATP-binding cassette (ABC) transporter proteins carry diverse substrates across cell membranes(1). Whereas clinically relevant ABC exporters are implicated in various diseases or cause multidrug resistance of cancer cells(2,3), bacterial ABC importers are essential for the uptake of nutrients(4), including rare elements such as molybdenum. A detailed understanding of their mechanisms requires direct visualization at high resolution and in distinct conformations. Our recent structure of the multidrug ABC exporter Sav1866 has revealed an outward-facing conformation of the transmembrane domains coupled to a closed conformation of the nucleotide-binding domains, reflecting the ATP-bound state(5). Here we present the 3.1 angstrom crystal structure of a putative molybdate transporter (ModB(2)C(2)) from Archaeoglobus fulgidus in complex with its binding protein ( ModA). Twelve transmembrane helices of the ModB subunits provide an inward-facing conformation, with a closed gate near the external membrane boundary. The ATP-hydrolysing ModC subunits reveal a nucleotide-free, open conformation, whereas the attached binding protein aligns the substrate-binding cleft with the entrance to the presumed translocation pathway. Structural comparison of ModB(2)C(2)A with Sav1866 suggests a common alternating access and release mechanism, with binding of ATP promoting an outward-facing conformation and dissociation of the hydrolysis products promoting an inward-facing conformation.	ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Locher, KP (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	kaspar.locher@mol.biol.ethz.ch		Hollenstein, Kaspar/0000-0001-7606-4105				Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Davidson AL, 2002, J BACTERIOL, V184, P1225, DOI 10.1128/JB.184.5.1225-1233.2002; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Holland I. B., 2003, ABC PROTEINS BACTERI; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hu YL, 1997, NAT STRUCT BIOL, V4, P703, DOI 10.1038/nsb0997-703; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Lawson DM, 1998, STRUCTURE, V6, P1529, DOI 10.1016/S0969-2126(98)00151-8; Liu CE, 1999, J BIOL CHEM, V274, P739, DOI 10.1074/jbc.274.2.739; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 2005, J MEMBRANE BIOL, V206, P173, DOI 10.1007/s00232-005-0792-1; Mannering DE, 2001, J BIOL CHEM, V276, P12362, DOI 10.1074/jbc.M011686200; MOUNCEY NJ, 1995, J BACTERIOL, V177, P5294, DOI 10.1128/jb.177.18.5294-5302.1995; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Nikaido H, 1998, METHOD ENZYMOL, V292, P3; Patzlaff JS, 2003, J BIOL CHEM, V278, P29546, DOI 10.1074/jbc.M304796200; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; PROSSNITZ E, 1991, J BIOL CHEM, V266, P9673; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RECH S, 1995, J BACTERIOL, V177, P1023, DOI 10.1128/jb.177.4.1023-1029.1995; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; Sebulsky MT, 2003, J BIOL CHEM, V278, P49890, DOI 10.1074/jbc.M305073200; Self WT, 2001, RES MICROBIOL, V152, P311, DOI 10.1016/S0923-2508(01)01202-5; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2	30	378	396	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					213	216		10.1038/nature05626	http://dx.doi.org/10.1038/nature05626			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17322901				2022-12-28	WOS:000244718100046
J	Fontana, L; Klein, S				Fontana, Luigi; Klein, Samuel			Aging, adiposity, and calorie restriction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FOLLOW-UP REPORT; BODY-MASS INDEX; DIETARY RESTRICTION; RHESUS-MONKEYS; OXIDATIVE STRESS; GENE-EXPRESSION; CARDIOVASCULAR-DISEASE; FOOD RESTRICTION; ENERGY-INTAKE; LIFE-SPAN	Context Excessive calorie intake and subsequent obesity increases the risk of developing chronic disease and decreases life expectancy. In rodent models, calorie restriction with adequate nutrient intake decreases the risk of developing chronic disease and extends maximum life span. Objective To evaluate the physiological and clinical implications of calorie restriction with adequate nutrient intake. Evidence Acquisition Search of PubMed (1966-December 2006) using terms encompassing various aspects of calorie restriction, dietary restriction, aging, longevity, life span, adiposity, and obesity; hand search of journals that focus on obesity, geriatrics, or aging; and search of reference lists of pertinent research and review articles and books. Reviewed reports ( both basic science and clinical) included epidemiologic studies, case-control studies, and randomized controlled trials, with quality of data assessed by taking into account publication in a peer-reviewed journal, number of animals or individuals studied, objectivity of measurements, and techniques used to minimize bias. Evidence Synthesis It is not known whether calorie restriction extends maximum life span or life expectancy in lean humans. However, calorie restriction in adult men and women causes many of the same metabolic adaptations that occur in calorie-restricted rodents and monkeys, including decreased metabolic, hormonal, and inflammatory risk factors for diabetes, cardiovascular disease, and possibly cancer. Excessive calorie restriction causes malnutrition and has adverse clinical effects. Conclusions Calorie restriction in adult men and women causes beneficial metabolic, hormonal, and functional changes, but the precise amount of calorie intake or body fat mass associated with optimal health and maximum longevity in humans is not known. In addition, it is possible that even moderate calorie restriction may be harmful in specific patient populations, such as lean persons who have minimal amounts of body fat.	Washington Univ, Sch Med, Div Geriatr & Nutr Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Human Nutr, St Louis, MO 63110 USA; Ist Super Sanita, Div Food Sci Human Nutr & Hlth, I-00161 Rome, Italy	Washington University (WUSTL); Washington University (WUSTL); Istituto Superiore di Sanita (ISS)	Fontana, L (corresponding author), Washington Univ, Sch Med, Div Geriatr & Nutr Sci, 4566 Scott Ave,Campus Box 8113, St Louis, MO 63110 USA.	lfontana@im.wustl.edu	Fontana, Luigi/K-4773-2013	Fontana, Luigi/0000-0001-8500-5537	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Basso N, 2005, REGUL PEPTIDES, V128, P247, DOI 10.1016/j.regpep.2004.12.027; Basu R, 2003, DIABETES, V52, P1738, DOI 10.2337/diabetes.52.7.1738; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Blanc S, 2003, J CLIN ENDOCR METAB, V88, P16, DOI 10.1210/jc.2002-020405; BOLMAN RJ, 1999, J GERONTOL A-BIOL, V54, pB283; BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; CEFALU WT, 1995, J GERONTOL A-BIOL, V50, pB337, DOI 10.1093/gerona/50A.6.B337; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Christou NV, 2004, ANN SURG, V240, P416, DOI 10.1097/01.sla.0000137343.63376.19; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; COLES LS, 2002, J ANTI-AGING MED, V5, P231; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; DAVIS LJ, 1994, ARCH GERONTOL GERIAT, V19, P295, DOI 10.1016/0167-4943(94)00575-3; Demetrius L, 2006, ANN NY ACAD SCI, V1067, P66, DOI 10.1196/annals.1354.010; Dhahbi JM, 2005, PHYSIOL GENOMICS, V23, P343, DOI 10.1152/physiolgenomics.00069.2005; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; ERSHLER WB, 1993, LYMPHOKINE CYTOK RES, V12, P225; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Eyre H, 2004, CA-CANCER J CLIN, V54, P190, DOI 10.3322/canjclin.54.4.190; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Fontana L, 2006, J CLIN ENDOCR METAB, V91, P3232, DOI 10.1210/jc.2006-0328; Forster MJ, 2000, J GERONTOL A-BIOL, V55, pB522, DOI 10.1093/gerona/55.11.B522; Frye EB, 1998, J BIOL CHEM, V273, P18714, DOI 10.1074/jbc.273.30.18714; Gafni A, 1997, J AM GERIATR SOC, V45, P871, DOI 10.1111/j.1532-5415.1997.tb01518.x; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Genuth S, 2003, DIABETES CARE, V26, P3160; Gilchrest BA, 1997, FASEB J, V11, P322, DOI 10.1096/fasebj.11.5.9141498; GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397; Gresl TA, 2001, AM J PHYSIOL-ENDOC M, V281, pE757, DOI 10.1152/ajpendo.2001.281.4.E757; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Guo ZM, 2002, MECH AGEING DEV, V123, P1121, DOI 10.1016/S0047-6374(02)00008-8; Han ES, 2001, J GERONTOL A-BIOL, V56, pB391, DOI 10.1093/gerona/56.9.B391; Harper JM, 2006, AGING CELL, V5, P441, DOI 10.1111/j.1474-9726.2006.00236.x; HARRISON DE, 1984, P NATL ACAD SCI-BIOL, V81, P1835, DOI 10.1073/pnas.81.6.1835; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; HENRY CJK, 1990, EUR J CLIN NUTR, V44, P329; HERLIHY JT, 1990, MECH AGEING DEV, V53, P9, DOI 10.1016/0047-6374(90)90030-J; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Higami Y, 2003, FASEB J, V17, P415, DOI 10.1096/fj.03-0678fje; HINDHEDE M, 1921, JAMA-J AM MED ASSOC, V74, P381; Holloszy JO, 1997, J APPL PHYSIOL, V82, P399, DOI 10.1152/jappl.1997.82.2.399; HOLLOSZY JO, 1985, J APPL PHYSIOL, V59, P826, DOI 10.1152/jappl.1985.59.3.826; Holloszy JO., 2000, MAYO CLIN P S, V75, pS3, DOI DOI 10.1016/S0025-6196(19)30634-2; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; INGRAM DK, 1990, J GERONTOL, V45, pB148, DOI 10.1093/geronj/45.5.B148; Johnson TE, 2006, EXP GERONTOL, V41, P1243, DOI 10.1016/j.exger.2006.09.006; Jolly CA, 2004, J NUTR, V134, P1853, DOI 10.1093/jn/134.8.1853; KAGAWA Y, 1978, PREV MED, V7, P205, DOI 10.1016/0091-7435(78)90246-3; KEMNITZ JW, 1994, AM J PHYSIOL, V266, pE540, DOI 10.1152/ajpendo.1994.266.4.E540; KEYS A, 1950, BIOL HUMAN STARVATIO, V2, P1133; Kim MJ, 1997, J NUTR, V127, P2293, DOI 10.1093/jn/127.12.2293; Klein S, 2002, GASTROENTEROLOGY, V123, P882, DOI 10.1053/gast.2002.35514; Klein S, 2004, NEW ENGL J MED, V350, P2549, DOI 10.1056/NEJMoa033179; Klein S., 2004, CECIL TXB MED, P1315; Kloting N, 2005, EXP GERONTOL, V40, P878, DOI 10.1016/j.exger.2005.07.004; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; LANDSBERG L, 1981, NUTR FACTORS MODULAT, P155; Lane MA, 1999, TOXICOL SCI, V52, P41, DOI 10.1093/toxsci/52.suppl_1.41; Lane MA, 1996, P NATL ACAD SCI USA, V93, P4159, DOI 10.1073/pnas.93.9.4159; Larson-Meyer DE, 2006, DIABETES CARE, V29, P1337, DOI 10.2337/dc05-2565; Leeuwenburgh C, 1997, ARCH BIOCHEM BIOPHYS, V346, P74, DOI 10.1006/abbi.1997.0297; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Looker AC, 1997, J BONE MINER RES, V12, P1761, DOI 10.1359/jbmr.1997.12.11.1761; Maglich JM, 2004, J BIOL CHEM, V279, P19832, DOI 10.1074/jbc.M313601200; Martin B, 2006, AGEING RES REV, V5, P332, DOI 10.1016/j.arr.2006.04.002; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Matsuzaki J, 2001, J NUTR, V131, P2139, DOI 10.1093/jn/131.8.2139; Mattson MP, 2007, NEUROMOL MED, V9, P17, DOI 10.1385/NMM:9:1:17; Mattson MP, 2005, ANNU REV NUTR, V25, P237, DOI 10.1146/annurev.nutr.25.050304.092526; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Messaoudi I, 2006, P NATL ACAD SCI USA, V103, P19448, DOI 10.1073/pnas.0606661103; Meyer TE, 2006, J AM COLL CARDIOL, V47, P398, DOI 10.1016/j.jacc.2005.08.069; Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142; *NIH, 1998, OBES RES S2, V6, pS51, DOI DOI 10.1001/JAMA.2012.39; O'Keefe JH, 2004, J AM COLL CARDIOL, V43, P2142, DOI 10.1016/j.jacc.2004.03.046; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; OSTER MH, 1995, J CLIN INVEST, V95, P2258, DOI 10.1172/JCI117916; Park SK, 2005, CARDIOVASC RES, V66, P205, DOI 10.1016/j.cardiores.2005.01.005; Phelan JP, 2006, BIOGERONTOLOGY, V7, P161, DOI 10.1007/s10522-006-9005-2; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Pratley RE, 1998, P NUTR SOC, V57, P175, DOI 10.1079/PNS19980029; Racette SB, 2006, J GERONTOL A-BIOL, V61, P943, DOI 10.1093/gerona/61.9.943; Ramsey JJ, 2000, EXP GERONTOL, V35, P1131, DOI 10.1016/S0531-5565(00)00166-2; Redman LM, 2007, J CLIN ENDOCR METAB, V92, P865, DOI 10.1210/jc.2006-2184; Riley J, 2001, RISING LIFE EXPECTAN; Roth GS, 2002, HORM METAB RES, V34, P378, DOI 10.1055/s-2002-33469; Roubenoff R, 2000, ANN NY ACAD SCI, V904, P553; SABATINO F, 1991, J GERONTOL, V46, pB171, DOI 10.1093/geronj/46.5.B171; SCHMIDT CD, 1973, AM REV RESPIR DIS, V108, P933; Seals DR, 2000, J PHYSIOL-LONDON, V528, P407, DOI 10.1111/j.1469-7793.2000.00407.x; SEIDELL JC, 1988, EUR J CLIN NUTR, V42, P805; Sell DR, 2003, J GERONTOL A-BIOL, V58, P508; SHIMOKAWA I, 1993, J GERONTOL, V48, pB27, DOI 10.1093/geronj/48.1.B27; SJOSTROM L, INT C OB SEPT 7 2006; Smith RG, 2005, ENDOCR REV, V26, P203, DOI 10.1210/er.2002-0017; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9; Spaulding CC, 1997, MECH AGEING DEV, V93, P87, DOI 10.1016/S0047-6374(96)01824-6; Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; STRAUS DS, 1994, FASEB J, V8, P6, DOI 10.1096/fasebj.8.1.8299891; STROM A, 1951, LANCET, V260, P126, DOI 10.1016/S0140-6736(51)91210-X; Taffet GE, 1997, J GERONTOL A-BIOL, V52, pB285, DOI 10.1093/gerona/52A.6.B285; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Urbanski HF, 2004, ANN NY ACAD SCI, V1019, P443, DOI 10.1196/annals.1297.081; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; Verzijl N, 2000, BIOCHEM J, V350, P381, DOI 10.1042/0264-6021:3500381; Villareal DT, 2006, ARCH INTERN MED, V166, P2502, DOI 10.1001/archinte.166.22.2502; Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923; Walford RL, 2002, J GERONTOL A-BIOL, V57, pB211, DOI 10.1093/gerona/57.6.B211; Wan RQ, 2004, AM J PHYSIOL-HEART C, V287, pH1186, DOI 10.1152/ajpheart.00932.2003; WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854; Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407; Weindruch R., 1988, RETARDATION AGING DI; Weiss EP, 2007, J APPL PHYSIOL, V102, P634, DOI 10.1152/japplphysiol.00853.2006; Weiss EP, 2006, AM J CLIN NUTR, V84, P1033; WERAARCHAKUL N, 1989, EXP CELL RES, V181, P197, DOI 10.1016/0014-4827(89)90193-6; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; Yager J, 2005, NEW ENGL J MED, V353, P1481, DOI 10.1056/NEJMcp050187; Yin L, 2001, PHOTODERMATOL PHOTO, V17, P178, DOI 10.1034/j.1600-0781.2001.170407.x; Zainal TA, 2000, FASEB J, V14, P1825, DOI 10.1096/fj.99-0881com	138	363	367	1	69	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2007	297	9					986	994		10.1001/jama.297.9.986	http://dx.doi.org/10.1001/jama.297.9.986			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143CP	17341713				2022-12-28	WOS:000244697900028
J	Bukowski, R; Szalewicz, K; Groenenboom, GC; van der Avoird, A				Bukowski, Robert; Szalewicz, Krzysztof; Groenenboom, Gerrit C.; van der Avoird, Ad			Predictions of the properties of water from first principles	SCIENCE			English	Article							POTENTIAL-ENERGY SURFACE; TRANSFERABLE INTERACTION MODELS; INITIO 3-BODY INTERACTIONS; HYDROGEN-BOND NETWORK; LIQUID WATER; SPECTROSCOPIC DETERMINATION; MOLECULAR-DYNAMICS; DIPOLE-MOMENT; DIMER; ENERGETICS	A force field for water has been developed entirely from first principles, without any fitting to experimental data. It contains both pairwise and many-body interactions. This force field predicts the properties of the water dimer and of liquid water in excellent agreement with experiments, a previously elusive objective. Precise knowledge of the intermolecular interactions in water will facilitate a better understanding of this ubiquitous substance.	Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA; Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands	University of Delaware; Radboud University Nijmegen	Bukowski, R (corresponding author), Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA.		Groenenboom, Gerrit C/F-9692-2015; Groenenboom, Gerrit/S-8138-2019	Groenenboom, Gerrit/0000-0002-0920-3707				Allesch M, 2004, J CHEM PHYS, V120, P5192, DOI 10.1063/1.1647529; Bukowski R, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2220040; Burnham CJ, 2002, J CHEM PHYS, V116, P5115, DOI 10.1063/1.1447904; Burnham CJ, 2002, J CHEM PHYS, V116, P1500, DOI 10.1063/1.1423942; de la Pena LH, 2004, J CHEM PHYS, V121, P5992, DOI 10.1063/1.1783871; Fanourgakis GS, 2006, J PHYS CHEM A, V110, P4100, DOI 10.1021/jp056477k; Fellers RS, 1999, J CHEM PHYS, V110, P6306, DOI 10.1063/1.478535; Fellers RS, 1999, SCIENCE, V284, P945, DOI 10.1126/science.284.5416.945; Goldman N, 2005, PHILOS T R SOC A, V363, P493, DOI 10.1098/rsta.2004.1504; Goldman N, 2002, J CHEM PHYS, V116, P10148, DOI 10.1063/1.1476932; Gregory JK, 1997, SCIENCE, V275, P814, DOI 10.1126/science.275.5301.814; Groenenboom GC, 2000, J CHEM PHYS, V113, P6702, DOI 10.1063/1.1311290; Harvey AH, 2004, J PHYS CHEM REF DATA, V33, P369, DOI 10.1063/1.1587731; JORGENSEN WL, 1982, J CHEM PHYS, V77, P4156, DOI 10.1063/1.444325; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keutsch FN, 2003, MOL PHYS, V101, P3477, DOI 10.1080/00268970310001636486; Keutsch FN, 2003, J CHEM PHYS, V119, P8927, DOI 10.1063/1.1614774; KUWAJIMA S, 1990, J PHYS CHEM-US, V94, P460, DOI 10.1021/j100364a080; Laage D, 2006, SCIENCE, V311, P832, DOI 10.1126/science.1122154; Leforestier C, 2002, J CHEM PHYS, V117, P8710, DOI 10.1063/1.1514977; Liu K, 1996, SCIENCE, V271, P929, DOI 10.1126/science.271.5251.929; Mas EM, 2000, J CHEM PHYS, V113, P6687, DOI 10.1063/1.1311289; Mas EM, 2003, J CHEM PHYS, V118, P4404, DOI 10.1063/1.1542872; Mas EM, 2003, J CHEM PHYS, V118, P4386, DOI 10.1063/1.1542871; MILIOT C, 1992, MOL PHYS, V77, P439; MILLS R, 1973, J PHYS CHEM-US, V77, P685, DOI 10.1021/j100624a025; Nilsson A, 2005, SCIENCE, V308, p793A, DOI 10.1126/science.1108864; Sharma M, 2003, INT J QUANTUM CHEM, V95, P821, DOI 10.1002/qua.10633; Smith JD, 2005, SCIENCE, V308, p793B, DOI 10.1126/science.1108945; Smith JD, 2004, SCIENCE, V306, P851, DOI 10.1126/science.1102560; Soper AK, 2000, CHEM PHYS, V258, P121, DOI 10.1016/S0301-0104(00)00179-8; Szalewicz K., 2006, LECT SERIES COMPUTER, V6, P482; Tschumper GS, 2002, J CHEM PHYS, V116, P690, DOI 10.1063/1.1408302; VandeVondele J, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1828433; Wernet P, 2004, SCIENCE, V304, P995, DOI 10.1126/science.1096205	35	347	351	3	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1249	1252		10.1126/science.1136371	http://dx.doi.org/10.1126/science.1136371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332406				2022-12-28	WOS:000244564700042
J	Painter, HJ; Morrisey, JM; Mather, MW; Vaidya, AB				Painter, Heather J.; Morrisey, Joanne M.; Mather, Michael W.; Vaidya, Akhil B.			Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum	NATURE			English	Article							CRYPTOSPORIDIUM-PARVUM; MALARIA PARASITES; GENOME SEQUENCE; GENE-TRANSFER; EVOLUTION; DIHYDROOROTATE; BIOSYNTHESIS; ATOVAQUONE; INHIBITORS; YEASTS	The origin of all mitochondria can be traced to the symbiotic arrangement that resulted in the emergence of eukaryotes in a world that was exclusively populated by prokaryotes(1-3). This arrangement, however, has been in continuous genetic flux: the varying degrees of gene loss and transfer from the mitochondrial genome in different eukaryotic lineages seem to signify an ongoing 'conflict' between the host and the symbiont. Eukaryotic parasites belonging to the phylum Apicomplexa provide an excellent example to support this view. These organisms contain the smallest mitochondrial genomes known(4,5), with an organization that differs among various genera; one genus, Cryptosporidium, seems to have lost the entire mitochondrial genome(6,7). Here we show that erythrocytic stages of the human malaria parasite Plasmodium falciparum seem to maintain an active mitochondrial electron transport chain to serve just one metabolic function: regeneration of ubiquinone required as the electron acceptor for dihydroorotate dehydrogenase, an essential enzyme for pyrimidine biosynthesis. Transgenic P. falciparum parasites expressing Saccharomyces cerevisiae dihydroorotate dehydrogenase, which does not require ubiquinone as an electron acceptor(8), were completely resistant to inhibitors of mitochondrial electron transport. Maintenance of mitochondrial membrane potential, however, was essential in these parasites, as indicated by their hypersensitivity to proguanil, a drug that collapsed the membrane potential in the presence of electron transport inhibitors. Thus, acquisition of just one enzyme can render mitochondrial electron transport nonessential in erythrocytic stages of P. falciparum.	Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Mol Parasitol, Philadelphia, PA 19129 USA	Drexel University	Vaidya, AB (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Mol Parasitol, Philadelphia, PA 19129 USA.	avaidya@drexelmed.edu		Mather, Michael/0000-0002-1062-0137	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028398] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI028398] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Allen RJW, 2004, J BIOL CHEM, V279, P11264, DOI 10.1074/jbc.M311110200; Baldwin J, 2005, J BIOL CHEM, V280, P21847, DOI 10.1074/jbc.M501100200; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; FRY M, 1990, COMP BIOCHEM PHYS B, V96, P775, DOI 10.1016/0305-0491(90)90230-Q; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Giraud MF, 1997, EUR J BIOCHEM, V245, P813, DOI 10.1111/j.1432-1033.1997.00813.x; Gojkovic Z, 2004, MOL GENET GENOMICS, V271, P387, DOI 10.1007/s00438-004-0995-7; GUTTERIDGE WE, 1979, BIOCHIM BIOPHYS ACTA, V582, P390, DOI 10.1016/0304-4165(79)90131-4; Keithly JS, 2005, J EUKARYOT MICROBIOL, V52, P132, DOI 10.1111/j.1550-7408.2005.04-3317.x; LANE N, 2005, POWER SEX SUICIDE MI; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; Nicholls D., 2002, BIOENERGETICS, V3; O'Donnell RA, 2002, EMBO J, V21, P1231, DOI 10.1093/emboj/21.5.1231; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Srivastava IK, 1999, ANTIMICROB AGENTS CH, V43, P1334, DOI 10.1128/AAC.43.6.1334; Striepen B, 2004, P NATL ACAD SCI USA, V101, P3154, DOI 10.1073/pnas.0304686101; VAIDYA AB, 1987, MOL BIOCHEM PARASIT, V22, P249, DOI 10.1016/0166-6851(87)90056-9; VAIDYA AB, 1989, MOL BIOCHEM PARASIT, V35, P97, DOI 10.1016/0166-6851(89)90112-6; Vaidya AB, 2005, CURR TOP MICROBIOL, V295, P233; VAIDYA AB, 1993, MOL BIOCHEM PARASIT, V58, P33, DOI 10.1016/0166-6851(93)90088-F; Vaidya AB, 2000, DRUG RESIST UPDATE, V3, P283, DOI 10.1054/drup.2000.0157; Vaidya Akhil B., 1998, P355; van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440; Wilson RJM, 1997, MICROBIOL MOL BIOL R, V61, P1; Wilson RJM, 2002, J MOL BIOL, V319, P257, DOI 10.1016/S0022-2836(02)00303-0; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977	30	347	355	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2007	446	7131					88	91		10.1038/nature05572	http://dx.doi.org/10.1038/nature05572			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330044				2022-12-28	WOS:000244525600043
J	Daemen, J; Wenaweser, P; Tsuchida, K; Abrecht, L; Sophia, V; Morger, C; Kukreja, N; Juni, P; Sianos, G; Hellige, G; Domburg, RT; Hess, OM; Boersma, E; Meier, B; Windecker, S; Serruys, PW				Daemen, Joost; Wenaweser, Peter; Tsuchida, Keiichi; Abrecht, Linda; Sophia, Vaina; Morger, Cyrill; Kukreja, Neville; Jueni, Peter; Sianos, Georgios; Hellige, Gerrit; van Domburg, Ron T.; Hess, Otto M.; Boersma, Eric; Meier, Bernhard; Windecker, Stephan; Serruys, Patrick W.			Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study	LANCET			English	Article							BARE-METAL STENT; HOSPITAL RESEARCH REGISTRY; LATE ANGIOGRAPHIC STENT; ARTERY-DISEASE; DIABETIC-PATIENTS; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; CIGARETTE-SMOKING; STANDARD STENT; REAL-WORLD	Background Stent thrombosis is a safety concern associated with use of drug-eluting stents. Little is known about occurrence of stent thrombosis more than 1 year after implantation of such stents. Methods Between April, 2002, and Dec, 2005, 8146 patients underwent percutaneous coronary intervention with sirolimus-eluting stents (SES; n=3823) or paclitaxel-eluting stents (PES; n=4323) at two academic hospitals. We assessed data from this group to ascertain the incidence, time course, and correlates of stent thrombosis, and the differences between early (0-30 days) and late (>30 days) stent thrombosis and between SES and PES. Findings Angiographically documented stent thrombosis occurred in 152 patients (incidence density 1.3 per 100 person-years; cumulative incidence at 3 years 2.9%). Early stent thrombosis was noted in 91 (60%) patients, and late stent thrombosis in 61 (40%) patients. Late stent thrombosis occurred steadily at a constant rate of 0.6% per year up to 3 years after stent implantation. incidence of early stent thrombosis was similar for SES (1.1%) and PES (1.3%), but late stent thrombosis was more frequent with PES (1.8%) than with SES (1.4%; p=0.031). At the time of stent thrombosis, dual antiplatelet therapy was being taken by 87% (early) and 23% (late) of patients (p<0.0001). Independent predictors of overall stent thrombosis were acute coronary syndrome at presentation (hazard ratio 2.28, 95% CI 1.29-4.03) and diabetes (2.03, 1.07-3.83). Interpretation Late stent thrombosis was encountered steadily with no evidence of diminution up to 3 years of follow-up. Early and late stent thrombosis were observed with SES and with PES. Acute coronary syndrome at presentation and diabetes were independent predictors of stent thrombosis.	Erasmus MC, Dept Cardiol, Thoraxctr, NL-3015 GD Rotterdam, Netherlands; Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; Univ Bern, Div Epidemiol & Biostat, Dept Social & Prevent Med, Bern, Switzerland	Erasmus University Rotterdam; Erasmus MC; University of Bern; University Hospital of Bern; University of Bern	Serruys, PW (corresponding author), Erasmus MC, Dept Cardiol, Thoraxctr, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.	p.w.j.c.serruys@erasmusmc.nl	Juni, Peter/Q-8700-2016; Wenaweser, Peter/AAN-7009-2021	Juni, Peter/0000-0002-5985-0670; 				Aronson D, 1996, J AM COLL CARDIOL, V27, P528, DOI 10.1016/0735-1097(95)00496-3; BARBASH GI, 1993, CIRCULATION, V87, P53, DOI 10.1161/01.CIR.87.1.53; Bavry AA, 2005, J AM COLL CARDIOL, V45, P941, DOI 10.1016/j.jacc.2004.11.064; Blais L, 1996, AM J EPIDEMIOL, V144, P1161; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44; Glynn RJ, 1996, BMJ-BRIT MED J, V312, P364; Granados JAT, 1997, J CLIN EPIDEMIOL, V50, P891, DOI 10.1016/S0895-4356(97)00105-4; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1827, DOI 10.1016/j.jacc.2005.07.056; Hofma SH, 2006, EUR HEART J, V27, P166, DOI 10.1093/eurheartj/ehi571; Honda Y, 2003, CIRCULATION, V108, P2, DOI 10.1161/01.CIR.0000075929.79964.D8; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kaiser C, 2005, LANCET, V366, P921, DOI 10.1016/S0140-6736(05)67221-2; Kaluza GL, 2000, J AM COLL CARDIOL, V35, P1288, DOI 10.1016/S0735-1097(00)00521-0; Kotani J, 2006, J AM COLL CARDIOL, V47, P2108, DOI 10.1016/j.jacc.2005.11.092; Kuchulakanti PK, 2006, CIRCULATION, V113, P1108, DOI 10.1161/CIRCULATIONAHA.105.600155; Lee CH, 2006, HEART, V92, P551, DOI 10.1136/hrt.2005.073619; Lemos PA, 2004, CIRCULATION, V109, P190, DOI 10.1161/01.CIR.0000109138.84579.FA; Lemos PA, 2003, J AM COLL CARDIOL, V41, P2093, DOI 10.1016/S0735-1097(03)00429-7; LEON M, 2006, J AM COLL CARDIOL SB, V47; Levin AD, 2004, P NATL ACAD SCI USA, V101, P9463, DOI 10.1073/pnas.0400918101; Lincoff AM, 2003, CIRCULATION, V107, P1556, DOI 10.1161/01.CIR.0000055653.52489.E9; Lincoff AM, 1999, NEW ENGL J MED, V341, P319, DOI 10.1056/NEJM199907293410503; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Moreno R, 2005, J AM COLL CARDIOL, V45, P954, DOI 10.1016/j.jacc.2004.11.065; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071; Niles NW, 2001, J AM COLL CARDIOL, V37, P1008, DOI 10.1016/S0735-1097(00)01205-5; Nilsen DWT, 2006, INT J CARDIOL, V109, P398, DOI 10.1016/j.ijcard.2005.05.029; Ong ATL, 2005, J AM COLL CARDIOL, V45, P2088, DOI 10.1016/j.jacc.2005.02.086; Ong ATL, 2005, J AM COLL CARDIOL, V45, P947, DOI 10.1016/j.jacc.2004.09.079; Ong ATL, 2005, J AM COLL CARDIOL, V45, P1135, DOI 10.1016/j.jacc.2005.01.008; Park DW, 2006, AM J CARDIOL, V98, P352, DOI 10.1016/j.amjcard.2006.02.039; Perimenis P, 2005, EXPERT OPIN PHARMACO, V6, P1, DOI 10.1517/14656566.6.1.1; Rodriguez Alfredo E, 2006, EuroIntervention, V2, P53; Rogers Campbell D K, 2005, Rev Cardiovasc Med, V6 Suppl 1, pS3; Roiron C, 2006, HEART, V92, P641, DOI 10.1136/hrt.2005.061622; Sabate M, 2005, CIRCULATION, V112, P2175, DOI 10.1161/CIRCULATIONAHA.105.562421; STONE G, 2006, INDEPENDENT PHYS LED; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Togni M, 2005, J AM COLL CARDIOL, V46, P231, DOI 10.1016/j.jacc.2005.01.062; Urban P, 2006, CIRCULATION, V113, P1434, DOI 10.1161/CIRCULATIONAHA.104.532242; Violaris AG, 2000, HEART, V84, P299, DOI 10.1136/heart.84.3.299; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Wenaweser P, 2005, J AM COLL CARDIOL, V45, P1748, DOI 10.1016/j.jacc.2005.01.058; Wenaweser P, 2005, EUR HEART J, V26, P1180, DOI 10.1093/eurheartj/ehi135; West NEJ, 2004, CIRCULATION, V109, P867, DOI 10.1161/01.CIR.0000116750.63158.94; Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175; ZEIHER AM, 1995, CIRCULATION, V92, P1094, DOI 10.1161/01.CIR.92.5.1094	56	1373	1457	2	78	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2007	369	9562					667	678		10.1016/S0140-6736(07)60314-6	http://dx.doi.org/10.1016/S0140-6736(07)60314-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141RO	17321312				2022-12-28	WOS:000244596600028
J	Hesketh, T				Hesketh, Therese			HIV/AIDS in China: the numbers problem	LANCET			English	Editorial Material									Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England	University of London; University College London	Hesketh, T (corresponding author), Inst Child Hlth, Ctr Int Child Hlth, 30 Guilford St, London WC1N 1EH, England.	t.hesketh@ich.ucl.ac.uk		Hesketh, Therese/0000-0002-7564-9221				*AM ENT I, 2002, CAN AS AV AIDS TYPH; *AS DIV, 2003, HUMAN RIGHTS WATCH, V15, P1; BATES G, 2004, CSIS HIV AIDS DEL CH; *ELD GAT, 2002, HIV AIDS CHIN TIT PE; Hesketh T, 2003, AIDS, V17, P1574, DOI [10.1097/00002030-200307040-00024, 10.1097/01.aids.0000076266.76134.23]; HONG L, 2001, MOD PREV MED, V28, P68; *NAT INT COUNC, 2002, 200204D ICA NAT INT; QU S, 2002, 14 INT AIDS C BARC S; Ruger JP, 2005, QJM-INT J MED, V98, P299, DOI 10.1093/qjmed/hci042; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; *WHO JOINT UN PROG, 2006, UPD HIV AIDS EP RESP; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; CHINA AIDS INFO	13	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2007	369	9562					621	623		10.1016/S0140-6736(07)60290-6	http://dx.doi.org/10.1016/S0140-6736(07)60290-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	141RO	17321294				2022-12-28	WOS:000244596600006
J	Taylor, PA; Margot, JL; Vokrouhlicky, D; Scheeres, DJ; Pravec, P; Lowry, SC; Fitzsimmons, A; Nolan, MC; Ostro, SJ; Benner, LAM; Giorgini, JD; Magri, C				Taylor, Patrick A.; Margot, Jean-Luc; Vokrouhlicky, David; Scheeres, Daniel J.; Pravec, Petr; Lowry, Stephen C.; Fitzsimmons, Alan; Nolan, Michael C.; Ostro, Steven J.; Benner, Lance A. M.; Giorgini, Jon D.; Magri, Christopher			Spin rate of asteroid (54509) 2000 PH5 increasing due to the YORP effect	SCIENCE			English	Article								Radar and optical observations reveal that the continuous increase in the spin rate of near-Earth asteroid (54509) 2000 PH5 can be attributed to the Yarkovsky-O'Keefe-Radzievskii-Paddack (YORP) effect, a torque due to sunlight. The change in spin rate is in reasonable agreement with theoretical predictions for the YORP acceleration of a body with the radar-determined size, shape, and spin state of 2000 PH5. The detection of asteroid spin-up supports the YORP effect as an explanation for the anomalous distribution of spin rates for asteroids under 10 kilometers in diameter and as a binary formation mechanism.	Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Charles Univ Prague, Inst Astron, CR-18000 Prague 8, Czech Republic; Univ Michigan, Dept Aerosp Engn, Ann Arbor, MI 48109 USA; Acad Sci Czech Republic, Astron Inst, CZ-25165 Ondrejov, Czech Republic; Queens Univ Belfast, Sch Math & Phys, Belfast BT7 1NN, Antrim, North Ireland; Arecibo Observ, Arecibo, PR 00612 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Maine, Farmington, ME USA	Cornell University; Charles University Prague; University of Michigan System; University of Michigan; Czech Academy of Sciences; Astronomical Institute of the Czech Academy of Sciences; Queens University Belfast; National Aeronautics & Space Administration (NASA); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Maine System; University of Maine Farmington; University of Maine Orono	Taylor, PA (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	ptaylor@astro.cornell.edu; jlm@astro.cornell.edu	Nolan, Michael C/H-4980-2012; Pravec, Petr/G-9037-2014; Pravec, Petr/AAE-2695-2019; Vokrouhlický, David/Q-4359-2017; Margot, Jean-Luc/A-6154-2012	Nolan, Michael C/0000-0001-8316-0680; Pravec, Petr/0000-0001-8434-9776; Vokrouhlický, David/0000-0002-6034-5452; Margot, Jean-Luc/0000-0001-9798-1797; SCHEERES, DANIEL/0000-0003-0558-3842; Taylor, Patrick/0000-0002-2493-943X; Lowry, Stephen/0000-0002-5605-4329				Asphaug E, 1996, ICARUS, V121, P225, DOI 10.1006/icar.1996.0083; Bottke W.F., 1994, HAZARDS DUE COMETS A, P337; Bottke W. F., 2002, ASTEROIDS, P395; Bottke WF, 1996, NATURE, V381, P51, DOI 10.1038/381051a0; Brasser R, 2004, ICARUS, V171, P102, DOI 10.1016/j.icarus.2004.04.019; Capek D, 2004, ICARUS, V172, P526, DOI 10.1016/j.icarus.2004.07.003; Gladman BJ, 1997, SCIENCE, V277, P197, DOI 10.1126/science.277.5323.197; HUDSON RS, 1993, REMOTE SENSING REV, V8, P195, DOI DOI 10.1080/02757259309532195; Lowry SC, 2007, SCIENCE, V316, P272, DOI 10.1126/science.1139040; Margot JL, 2002, SCIENCE, V296, P1445, DOI 10.1126/science.1072094; MARGOT JL, 2003, AAS DIV DYN ASTR M, V34; MARGOT JL, 2003, B AM ASTRON SOC, V35, P960; MUELLER M, 2006, IAU GEN ASS ABSTR, P95; OSTRO SJ, 1993, REV MOD PHYS, V65, pS123; Pravec P, 2000, ICARUS, V148, P12, DOI 10.1006/icar.2000.6482; Richardson DC, 1998, ICARUS, V134, P47, DOI 10.1006/icar.1998.5954; Rubincam DP, 2000, ICARUS, V148, P2, DOI 10.1006/icar.2000.6485; Scheeres DJ, 2007, ICARUS, V188, P430, DOI 10.1016/j.icarus.2006.12.015; Sharma I, 2005, MON NOT R ASTRON SOC, V359, P79, DOI 10.1111/j.1365-2966.2005.08864.x; Stokes GH, 2000, ICARUS, V148, P21, DOI 10.1006/icar.2000.6493; Wiegert P, 2002, AM GEOPH UN FALL M 2; [No title captured]	22	137	140	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					274	277		10.1126/science.1139038	http://dx.doi.org/10.1126/science.1139038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17347415				2022-12-28	WOS:000245654500050
J	Suel, GM; Kulkarni, RP; Dworkin, J; Garcia-Ojalvo, J; Elowitz, MB				Sueel, Guerol M.; Kulkarni, Rajan P.; Dworkin, Jonathan; Garcia-Ojalvo, Jordi; Elowitz, Michael B.			Tunability and noise dependence in differentiation dynamics	SCIENCE			English	Article							COMPETENCE TRANSCRIPTION FACTOR; SUBTILIS K-STATE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; GENETIC COMPETENCE; COMK; EXPRESSION; NETWORKS; BISTABILITY; BACTERIA	The dynamic process of differentiation depends on the architecture, quantitative parameters, and noise of underlying genetic circuits. However, it remains unclear how these elements combine to control cellular behavior. We analyzed the probabilistic and transient differentiation of Bacillus subtilis cells into the state of competence. A few key parameters independently tuned the frequency of initiation and the duration of competence episodes and allowed the circuit to access different dynamic regimes, including oscillation. Altering circuit architecture showed that the duration of competence events can be made more precise. We used an experimental method to reduce global cellular noise and showed that noise levels are correlated with frequency of differentiation events. Together, the data reveal a noise-dependent circuit that is remarkably resilient and tunable in terms of its dynamic behavior.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Texas, Green Ctr Div Syst Biol, SW Med Ctr, Dallas, TX 75390 USA; Univ Texas, Dept Pharmacol, SW Med Ctr, Dallas, TX 75390 USA; CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; Univ Politecn Catalunya, Dept Fis & Engn Nucl, E-08222 Terrassa, Spain	California Institute of Technology; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; California Institute of Technology; Columbia University; Universitat Politecnica de Catalunya	Elowitz, MB (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	melowitz@caltech.edu	Garcia-Ojalvo, Jordi/A-4574-2009	Garcia-Ojalvo, Jordi/0000-0002-3716-7520	NIGMS NIH HHS [GM079771, GM068763] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763, R01GM079771] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alon U., 2006, MATH COMPUTATIONAL B, V10; [Anonymous], [No title captured]; Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grossman AD, 1995, ANNU REV GENET, V29, P477, DOI 10.1146/annurev.ge.29.120195.002401; HAHN J, 1994, J BACTERIOL, V176, P5753, DOI 10.1128/JB.176.18.5753-5761.1994; Hoa TT, 2002, MOL MICROBIOL, V43, P15, DOI 10.1046/j.1365-2958.2002.02727.x; ISHINO F, 1989, J BACTERIOL, V171, P5523, DOI 10.1128/jb.171.10.5523-5530.1989; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Maki N, 2000, J BACTERIOL, V182, P4337, DOI 10.1128/JB.182.15.4337-4342.2000; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Ogura M, 1999, MOL MICROBIOL, V32, P799, DOI 10.1046/j.1365-2958.1999.01399.x; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; TETART F, 1992, MOL MICROBIOL, V6, P621, DOI 10.1111/j.1365-2958.1992.tb01509.x; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Turgay K, 1998, EMBO J, V17, P6730; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455	23	350	364	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1716	1719		10.1126/science.1137455	http://dx.doi.org/10.1126/science.1137455			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379809				2022-12-28	WOS:000245106900041
J	Stone, MD; Mihalusova, M; O'Connor, CM; Prathapam, R; Collins, K; Zhuang, XW				Stone, Michael D.; Mihalusova, Mariana; O'Connor, Catherine M.; Prathapam, Ramadevi; Collins, Kathleen; Zhuang, Xiaowei			Stepwise protein-mediated RNA folding directs assembly of telomerase ribonucleoprotein	NATURE			English	Article							STEM-LOOP IV; REVERSE-TRANSCRIPTASE; ENERGY-TRANSFER; HOLOENZYME; SUBUNIT; PROCESSIVITY; COMPONENT; DISEASE	Telomerase is an essential cellular ribonucleoprotein (RNP) that solves the end replication problem and maintains chromosome stability by adding telomeric DNA to the termini of linear chromosomes(1-3). Genetic mutations that abrogate the normal assembly of telomerase RNP cause human disease(4). It is therefore of fundamental and medical importance to decipher cellular strategies for telomerase biogenesis, which will require new insights into how specific interactions occur in a precise order along the RNP assembly pathway. Here we use a single-molecule approach to dissect the individual assembly steps of telomerase. Direct observation of complex formation in real time revealed two sequential steps of protein-induced RNA folding, establishing a hierarchical RNP assembly mechanism: interaction with the telomerase holoenzyme protein p65 induces structural rearrangement of telomerase RNA, which in turn directs the binding of the telomerase reverse transcriptase to form the functional ternary complex. This hierarchical assembly process is facilitated by an evolutionarily conserved structural motif within the RNA. These results identify the RNA folding pathway during telomerase biogenesis and define the mechanism of action for an essential telomerase holoenzyme protein.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Zhuang, XW (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054198, R01GM068518] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM068518-05, R01 GM068518-01A2, R01 GM054198, R01 GM068518] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adilakshmi T, 2005, J MOL BIOL, V351, P508, DOI 10.1016/j.jmb.2005.06.020; Aigner S, 2003, BIOCHEMISTRY-US, V42, P5736, DOI 10.1021/bi034121y; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Chen Y, 2006, EMBO J, V25, P3156, DOI 10.1038/sj.emboj.7601195; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; Cunningham DD, 2005, MOL CELL BIOL, V25, P4442, DOI 10.1128/MCB.25.11.4442-4454.2005; Greider Carol W., 2004, Cell, VS116, pS83, DOI 10.1016/S0092-8674(04)00053-4; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Harrington L, 2003, CANCER LETT, V194, P139, DOI 10.1016/S0304-3835(02)00701-2; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Lai CK, 2003, MOL CELL, V11, P1673, DOI 10.1016/S1097-2765(03)00232-6; Mason DX, 2003, MOL CELL BIOL, V23, P5606, DOI 10.1128/MCB.23.16.5606-5613.2003; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Moore MJ, 2000, METHOD ENZYMOL, V317, P109; O'Connor CM, 2005, J BIOL CHEM, V280, P17533, DOI 10.1074/jbc.M501211200; Prathapam R, 2005, NAT STRUCT MOL BIOL, V12, P252, DOI 10.1038/nsmb900; Richards RJ, 2006, RNA, V12, P1475, DOI 10.1261/rna.112306; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; Sperger JM, 2001, BIOCHEMISTRY-US, V40, P7005, DOI 10.1021/bi0103359; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Witkin KL, 2004, GENE DEV, V18, P1107, DOI 10.1101/gad.1201704; Wong JMY, 2003, LANCET, V362, P983, DOI 10.1016/S0140-6736(03)14369-3; Ye AJ, 2002, INT J SYST EVOL MICR, V52, P2297, DOI 10.1099/00207713-52-6-2297; Zhuang XW, 2005, ANNU REV BIOPH BIOM, V34, P399, DOI 10.1146/annurev.biophys.34.040204.144641	26	147	150	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2007	446	7134					458	461		10.1038/nature05600	http://dx.doi.org/10.1038/nature05600			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17322903	Green Accepted			2022-12-28	WOS:000245079500044
J	[Anonymous]				[Anonymous]			Tuberculosis and HIV in India	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		INDIA TB, 2006, 2006 RNTCP STATUS RE; Khatri GR, 2002, NEW ENGL J MED, V347, P1420, DOI 10.1056/NEJMsa020098; Reid A, 2006, LANCET INFECT DIS, V6, P483, DOI 10.1016/S1473-3099(06)70549-7; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102; World Health Organization, 2006, WHOHTMTB2006362	5	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1198	1199						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148UP	17377155				2022-12-28	WOS:000245101900002
J	Bhatnagar, S				Bhatnagar, Shinjini			Effects of zinc supplementation on child mortality	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES; POOLED ANALYSIS; DIARRHEA; PNEUMONIA		All India Inst Med Sci, Ctr Diarrhoeal Dis & Nutr Res, Dept Pediat, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Bhatnagar, S (corresponding author), All India Inst Med Sci, Ctr Diarrhoeal Dis & Nutr Res, Dept Pediat, New Delhi 110029, India.	shinjini_bhatnagar@rediffmail.com		bhatnagar, shinjini/0000-0003-1703-5296				Baqui AH, 2004, J HEALTH POPUL NUTR, V22, P440; Baqui AH, 2002, BRIT MED J, V325, P1059, DOI 10.1136/bmj.325.7372.1059; Bhandari N, 2005, J PEDIATR GASTR NUTR, V41, P685, DOI 10.1097/01.mpg.0000182799.69675.92; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Bhutta ZA, 2000, AM J CLIN NUTR, V72, P1516; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Brooks WA, 2005, LANCET, V366, P999, DOI 10.1016/S0140-6736(05)67109-7; Caulfi eld L. E., 2004, COMP QUANTIFICATION; Lira PIC, 1998, AM J CLIN NUTR, V68, p418S, DOI 10.1093/ajcn/68.2.418S; Sazawal S, 2001, PEDIATRICS, V108, P1280, DOI 10.1542/peds.108.6.1280; Sazawal S, 2007, LANCET, V369, P927, DOI 10.1016/S0140-6736(07)60452-8; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; Van Zweeden AB, 2001, BRIT MED J, V322, P1, DOI DOI 10.1136/BMJ.322.7277.1.PUBMED:11141128	13	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2007	369	9565					885	886		10.1016/S0140-6736(07)60423-1	http://dx.doi.org/10.1016/S0140-6736(07)60423-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148BQ	17368132				2022-12-28	WOS:000245049900006
J	Gleyzes, S; Kuhr, S; Guerlin, C; Bernu, J; Deleglise, S; Hoff, UB; Brune, M; Raimond, JM; Haroche, S				Gleyzes, Sebastien; Kuhr, Stefan; Guerlin, Christine; Bernu, Julien; Deleglise, Samuel; Hoff, Ulrich Busk; Brune, Michel; Raimond, Jean-Michel; Haroche, Serge			Quantum jumps of light recording the birth and death of a photon in a cavity	NATURE			English	Article							NONDEMOLITION MEASUREMENTS; STATES; FIELD; ATOM; NUMBERS	A microscopic quantum system under continuous observation exhibits at random times sudden jumps between its states. The detection of this quantum feature requires a quantum non-demolition (QND) measurement(1-3) repeated many times during the system's evolution. Whereas quantum jumps of trapped massive particles ( electrons, ions or molecules(4-8)) have been observed, this has proved more challenging for light quanta. Standard photodetectors absorb light and are thus unable to detect the same photon twice. It is therefore necessary to use a transparent counter that can 'see' photons without destroying them(3). Moreover, the light needs to be stored for durations much longer than the QND detection time. Here we report an experiment in which we fulfil these challenging conditions and observe quantum jumps in the photon number. Microwave photons are stored in a superconducting cavity for times up to half a second, and are repeatedly probed by a stream of non-absorbing atoms. An atom interferometer measures the atomic dipole phase shift induced by the non-resonant cavity field, so that the final atom state reveals directly the presence of a single photon in the cavity. Sequences of hundreds of atoms, highly correlated in the same state, are interrupted by sudden state switchings. These telegraphic signals record the birth, life and death of individual photons. Applying a similar QND procedure to mesoscopic fields with tens of photons should open new perspectives for the exploration of the quantum-to-classical boundary(9,10).	Ecole Normale Super, Dept Phys, Lab Kastler Brossel, F-75231 Paris 05, France; Coll France, F-75231 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France	Brune, M (corresponding author), Ecole Normale Super, Dept Phys, Lab Kastler Brossel, 24 Rue Lhomond, F-75231 Paris 05, France.	brune@lkb.ens.fr	Hoff, Ulrich Busk/H-9764-2018; Kuhr, Stefan/ABC-8654-2020; gleyzes, sebastien/AAA-7078-2022; Kuhr, Stefan/F-7296-2011; Deléglise, Samuel X/B-1599-2015	Hoff, Ulrich Busk/0000-0002-7122-8577; Kuhr, Stefan/0000-0001-8386-5357; Kuhr, Stefan/0000-0001-8386-5357; Deléglise, Samuel X/0000-0002-8680-5170; RAIMOND, Jean-Michel/0000-0002-4289-3455				BASCHE T, 1995, NATURE, V373, P132, DOI 10.1038/373132a0; BENSON O, 1994, PHYS REV LETT, V72, P3506, DOI 10.1103/PhysRevLett.72.3506; BERGQUIST JC, 1986, PHYS REV LETT, V57, P1699, DOI 10.1103/PhysRevLett.57.1699; Bertet P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.200402; BRAGINSKY VB, 1992, QUANTUM MEASUREMENT, pCH4; BRUNE M, 1990, PHYS REV LETT, V65, P976, DOI 10.1103/PhysRevLett.65.976; BRUNE M, 1992, PHYS REV A, V45, P5193, DOI 10.1103/PhysRevA.45.5193; Buzek V., 1995, PROG OPTICS, V34, P1, DOI DOI 10.1016/S0079-6638(08)70324-X; Carmichael H, 1993, OPEN SYSTEMS APPROAC; Davidovich L, 1996, PHYS REV A, V53, P1295, DOI 10.1103/PhysRevA.53.1295; Grangier P, 1998, NATURE, V396, P537, DOI 10.1038/25059; HAROCHE S, 1992, J PHYS II, V2, P659, DOI 10.1051/jp2:1992157; KUHR S, 2006, ULTRASHIGH FINESSE F; Lutterbach LG, 1997, PHYS REV LETT, V78, P2547, DOI 10.1103/PhysRevLett.78.2547; NAGOURNEY W, 1986, PHYS REV LETT, V56, P2797, DOI 10.1103/PhysRevLett.56.2797; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Nogues G, 1999, NATURE, V400, P239, DOI 10.1038/22275; Peil S, 1999, PHYS REV LETT, V83, P1287, DOI 10.1103/PhysRevLett.83.1287; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; SAUTER T, 1986, PHYS REV LETT, V57, P1696, DOI 10.1103/PhysRevLett.57.1696; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Schuster DI, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.123602; [No title captured]	23	364	372	1	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					297	300		10.1038/nature05589	http://dx.doi.org/10.1038/nature05589			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361178	Green Submitted			2022-12-28	WOS:000244892900040
J	Myles, PS; Power, I				Myles, Paul S.; Power, Ian			Clinical update: postoperative analgesia	LANCET			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ACUTE PAIN SERVICES; RANDOMIZED-TRIALS; NATIONAL-SURVEY; INHIBITORS; ANESTHESIA; SURGERY; NAUSEA		Alfred Hosp, Dept Anaesthesia & Perioperat Med, Melbourne, Vic 3004, Australia; Monash Univ, Melbourne, Vic 3004, Australia; Univ Edinburgh, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland	Florey Institute of Neuroscience & Mental Health; Monash University; University of Edinburgh	Myles, PS (corresponding author), Alfred Hosp, Dept Anaesthesia & Perioperat Med, Melbourne, Vic 3004, Australia.	p.myles@alfred.org.au	Myles, Paul/AAU-9524-2020	Myles, Paul/0000-0002-3324-5456				Apfelbaum JL, 2003, ANESTH ANALG, V97, P534, DOI 10.1213/01.ANE.0000068822.10113.9E; *AUSTR NZ COLL AN, 2005, AC PAIN MAN SCI EV; Bodian CA, 2001, ANESTHESIOLOGY, V95, P1356, DOI 10.1097/00000542-200112000-00013; BRUSTER S, 1994, BRIT MED J, V309, P1542, DOI 10.1136/bmj.309.6968.1542; Elia N, 2005, ANESTHESIOLOGY, V103, P1296, DOI 10.1097/00000542-200512000-00025; Gan TJ, 2003, ANESTH ANALG, V97, P62, DOI 10.1213/01.ANE.0000068580.00245.95; Harmer M, 1998, ANAESTHESIA, V53, P424, DOI 10.1046/j.1365-2044.1998.00368.x; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Lynch M, 2001, Adv Nurse Pract, V9, P28; McQuay H, 2003, EUR J ANAESTH, V20, P19; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; *PROSPECT, PROC SPEC POST PAIN; Rawal N, 1998, EUR J ANAESTH, V15, P354, DOI 10.1097/00003643-199805000-00019; Remy C, 2006, CURR OPIN ANESTHESIO, V19, P562, DOI 10.1097/01.aco.0000245285.30282.70; Rigg JRA, 2002, LANCET, V359, P1276, DOI 10.1016/S0140-6736(02)08266-1; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; van den Bosch JE, 2006, ANESTHESIOLOGY, V104, P1033, DOI 10.1097/00000542-200605000-00020; Werner MU, 2002, ANESTH ANALG, V95, P1361, DOI 10.1097/00000539-200211000-00049	18	33	34	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2007	369	9564					810	812		10.1016/S0140-6736(07)60388-2	http://dx.doi.org/10.1016/S0140-6736(07)60388-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144JC	17350437				2022-12-28	WOS:000244791300011
J	Kamerow, D				Kamerow, Douglas			Killing me softly - Can the prevention of suffering justify the involvement of doctors in capital punishment?	BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@bmj.com		Kamerow, Douglas/0000-0001-7000-9957					0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 3	2007	334	7591					454	454		10.1136/bmj.39135.671817.59	http://dx.doi.org/10.1136/bmj.39135.671817.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144NB	17332584	Green Published			2022-12-28	WOS:000244802000030
J	Miller, NL; Lingeman, JE				Miller, Nicole L.; Lingeman, James E.			Management of kidney stones	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SHOCK-WAVE LITHOTRIPSY; UPPER URINARY-TRACT; PRIMARY ENDOSCOPIC MANAGEMENT; URETERAL STONES; PERCUTANEOUS NEPHROSTOLITHOTOMY; STAGHORN CALCULI; RANDOMIZED-TRIAL; RISK-FACTORS; SUCCESS RATE; TAMSULOSIN		Indiana Univ, Sch Med, Methodist Hosp, Inst Kidney Stone Dis, Indianapolis, IN 46202 USA; Int Kidney Stone Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Lingeman, JE (corresponding author), Indiana Univ, Sch Med, Methodist Hosp, Inst Kidney Stone Dis, Indianapolis, IN 46202 USA.	jlingeman@clarian.org						Albala DM, 2001, J UROLOGY, V166, P2072, DOI 10.1016/S0022-5347(05)65508-5; BERNSTEIN MJ, 1988, JAMA-J AM MED ASSOC, V260, P977; Biri H, 1999, J ENDOUROL, V13, P77, DOI 10.1089/end.1999.13.77; Borghi L, 1996, J UROLOGY, V155, P839, DOI 10.1016/S0022-5347(01)66321-3; Borghi L, 2002, NEW ENGL J MED, V346, P77, DOI 10.1056/NEJMoa010369; Brater D. Craig, 1999, American Journal of Medicine, V107, p65S; Chandhoke PS, 2002, J UROLOGY, V168, P937, DOI 10.1016/S0022-5347(05)64546-6; Davenport K, 2005, BJU INT, V95, P297, DOI 10.1111/j.1464-410X.2005.05286.x; Dellabella M, 2005, J UROLOGY, V174, P167, DOI 10.1097/01.ju.0000161600.54732.86; DYER RB, 1989, SHOCK WAVE LITHOTRIP, V2, P203; Eskelinen M, 1998, EUR UROL, V34, P467, DOI 10.1159/000019785; Grasso M, 1999, J UROLOGY, V162, P1904, DOI 10.1016/S0022-5347(05)68065-2; Grasso M, 1998, J UROLOGY, V160, P346, DOI 10.1016/S0022-5347(01)62892-1; GRASSO M, 1995, UROLOGY, V45, P372, DOI 10.1016/S0090-4295(99)80003-X; GRASSO M, 1995, UROLOGY, V45, P363, DOI 10.1016/S0090-4295(99)80002-8; Gravina GL, 2005, UROLOGY, V66, P24, DOI 10.1016/j.urology.2005.01.013; Holdgate A, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004137.PUB2; Hollingsworth JM, 2006, LANCET, V368, P1171, DOI 10.1016/S0140-6736(06)69474-9; KERBL K, 1994, J UROLOGY, V151, P686, DOI 10.1016/S0022-5347(17)35048-6; KNAPP PM, 1988, J UROLOGY, V139, P700, DOI 10.1016/S0022-5347(17)42604-8; KOSTAKOPOULOS A, 1995, UROL INT, V55, P21, DOI 10.1159/000282741; Krambeck AE, 2006, J UROLOGY, V175, P1742, DOI 10.1016/S0022-5347(05)00989-4; Kuo RL, 2002, J ENDOUROL, V16, P229, DOI 10.1089/089277902753752188; Kupeli B, 2004, UROLOGY, V64, P1111, DOI 10.1016/j.urology.2004.07.020; LAM HS, 1992, J UROLOGY, V148, P1058, DOI 10.1016/S0022-5347(17)36816-7; LAM HS, 1992, J UROLOGY, V147, P1219, DOI 10.1016/S0022-5347(17)37522-5; Larkin GL, 1999, AM J EMERG MED, V17, P6, DOI 10.1016/S0735-6757(99)90003-7; LINGEMAN JE, 1988, UROL CLIN N AM, V15, P507; LINGEMAN JE, 1987, J UROLOGY, V138, P485, DOI 10.1016/S0022-5347(17)43236-8; LINGEMAN JE, 1990, JAMA-J AM MED ASSOC, V263, P1789, DOI 10.1001/jama.263.13.1789; McAteer J A, 2005, Minerva Urol Nefrol, V57, P271; Miller OF, 1998, UROLOGY, V52, P982, DOI 10.1016/S0090-4295(98)00368-9; Miller OF, 1999, J UROLOGY, V162, P688, DOI 10.1097/00005392-199909010-00014; MILLER OF, 1999, J UROL 1, V162, P90; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; Pace KT, 2000, J UROLOGY, V164, P1905, DOI 10.1016/S0022-5347(05)66914-5; PARDALIDIS NP, 1994, J ENDOUROL, V8, P321, DOI 10.1089/end.1994.8.321; Parks JH, 2004, KIDNEY INT, V66, P777, DOI 10.1111/j.1523-1755.2004.00803.x; Parks JH, 2002, J UROLOGY, V167, P1607, DOI 10.1016/S0022-5347(05)65163-4; Pearle MS, 2005, J UROLOGY, V173, P2005, DOI 10.1097/01.ju.0000158458.51706.56; Pearle MS, 1998, J UROLOGY, V160, P1260, DOI 10.1016/S0022-5347(01)62511-4; Peschel R, 1999, J UROLOGY, V162, P1909, DOI 10.1016/S0022-5347(05)68066-4; Preminger GM, 2005, J UROLOGY, V173, P1991, DOI 10.1097/01.ju.0000161171.67806.2a; Ramakumar S, 2000, UROL CLIN N AM, V27, P617, DOI 10.1016/S0094-0143(05)70111-7; Resim S, 2005, UROLOGY, V66, P945, DOI 10.1016/j.urology.2005.05.029; RUBIN JI, 1987, RADIOLOGY, V162, P21, DOI 10.1148/radiology.162.1.3786764; Segura JW, 1997, J UROLOGY, V158, P1915, DOI 10.1016/S0022-5347(01)64173-9; Shokeir AA, 2000, UROLOGY, V55, P344, DOI 10.1016/S0090-4295(99)00475-6; SUTHERLAND JW, 1985, MINER ELECTROL METAB, V11, P267; Tawfiek ER, 1999, UROLOGY, V53, P25, DOI 10.1016/S0090-4295(98)00462-2; Teichman JMH, 2004, NEW ENGL J MED, V350, P684, DOI 10.1056/NEJMcp030813; Toth C, 2001, J ENDOUROL, V15, P285, DOI 10.1089/089277901750161791; Trinchieri A, 1999, J UROLOGY, V162, P27, DOI 10.1097/00005392-199907000-00007; Vieweg J, 1998, J UROLOGY, V160, P679, DOI 10.1016/S0022-5347(01)62754-X; Watterson JD, 2002, J UROLOGY, V168, P442, DOI 10.1016/S0022-5347(05)64654-X; Willis LR, 2005, J ENDOUROL, V19, P90, DOI 10.1089/end.2005.19.90; Willis LR, 1999, J AM SOC NEPHROL, V10, P1753; Yilmaz E, 2005, J UROLOGY, V173, P2010, DOI 10.1097/01.ju.0000158453.60029.0a	58	177	194	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2007	334	7591					468	472B		10.1136/bmj.39113.480185.80	http://dx.doi.org/10.1136/bmj.39113.480185.80			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144NB	17332586	Green Published			2022-12-28	WOS:000244802000034
J	Pendry, JB				Pendry, J. B.			Negative refraction for electrons?	SCIENCE			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2AZ, England	Imperial College London	Pendry, JB (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Prince Consort Rd, London SW7 2AZ, England.	j.pendry@imperial.ac.uk		Pendry, John/0000-0001-5145-5441				Cheianov VV, 2007, SCIENCE, V315, P1252, DOI 10.1126/science.1138020; Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Grbic A, 2003, APPL PHYS LETT, V82, P1815, DOI 10.1063/1.1561167; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699	6	28	30	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1226	1227		10.1126/science.1140178	http://dx.doi.org/10.1126/science.1140178			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332397				2022-12-28	WOS:000244564700032
J	Nenci, A; Becker, C; Wullaert, A; Gareus, R; van Loo, G; Danese, S; Huth, M; Nikolaev, A; Neufert, C; Madison, B; Gumucio, D; Neurath, MF; Pasparakis, M				Nenci, Arianna; Becker, Christoph; Wullaert, Andy; Gareus, Ralph; van Loo, Geert; Danese, Silvio; Huth, Marion; Nikolaev, Alexei; Neufert, Clemens; Madison, Blair; Gumucio, Deborah; Neurath, Markus F.; Pasparakis, Manolis			Epithelial NEMO links innate immunity to chronic intestinal inflammation	NATURE			English	Article							NF-KAPPA-B; DEFICIENT MICE; CANCER DEVELOPMENT; COLON-CANCER; DISEASE; GAMMA; ACTIVATION; EXPRESSION; DELETION; COLITIS	Deregulation of intestinal immune responses seems to have a principal function in the pathogenesis of inflammatory bowel disease(1-4). The gut epithelium is critically involved in the maintenance of intestinal immune homeostasis-acting as a physical barrier separating luminal bacteria and immune cells, and also expressing antimicrobial peptides(3,5,6). However, the molecular mechanisms that control this function of gut epithelial cells are poorly understood. Here we show that the transcription factor NF kappa B, a master regulator of pro-inflammatory responses(7,8), functions in gut epithelial cells to control epithelial integrity and the interaction between the mucosal immune system and gut microflora. Intestinal epithelial-cell-specific inhibition of NF-kappa B through conditional ablation of NEMO ( also called I kappa B kinase-gamma ( IKK gamma)) or both IKK1 ( IKK alpha) and IKK2 ( IKK beta)-IKK subunits essential for NF-kappa B activation(7-9)-spontaneously caused severe chronic intestinal inflammation in mice. NF-kappa B deficiency led to apoptosis of colonic epithelial cells, impaired expression of antimicrobial peptides and translocation of bacteria into the mucosa. Concurrently, this epithelial defect triggered a chronic inflammatory response in the colon, initially dominated by innate immune cells but later also involving T lymphocytes. Deficiency of the gene encoding the adaptor protein MyD88 prevented the development of intestinal inflammation, demonstrating that Toll-like receptor activation by intestinal bacteria is essential for disease pathogenesis in this mouse model. Furthermore, NEMO deficiency sensitized epithelial cells to tumour-necrosis factor ( TNF)-induced apoptosis, whereas TNF receptor-1 inactivation inhibited intestinal inflammation, demonstrating that TNF receptor-1 signalling is crucial for disease induction. These findings demonstrate that a primary NF-kappa B signalling defect in intestinal epithelial cells disrupts immune homeostasis in the gastrointestinal tract, causing an inflammatory-bowel-disease-like phenotype. Our results identify NF-kappa B signalling in the gut epithelium as a critical regulator of epithelial integrity and intestinal immune homeostasis, and have important implications for understanding the mechanisms controlling the pathogenesis of human inflammatory bowel disease.	Univ Cologne, Inst Genet, D-50674 Cologne, Germany; EMBL, Mouse Biol Unit, I-00016 Monterotondo, Italy; Johannes Gutenberg Univ Mainz, Dept Med, Lab Clin Immunol 1, D-55131 Mainz, Germany; IRCCS Gastroenterol, Ist Clin Humanitas, Div Gastroenterol, I-20089 Milan, Italy; Univ Michigan, Dept Cell & Dev Biol, Ctr Organogenesis, Ann Arbor, MI 48109 USA	University of Cologne; European Molecular Biology Laboratory (EMBL); Johannes Gutenberg University of Mainz; IRCCS Humanitas Research Hospital; University of Michigan System; University of Michigan	Pasparakis, M (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47, D-50674 Cologne, Germany.	pasparakis@uni-koeln.de	Danese, Silvio/ABH-9571-2020; , van Loo Geert/AAD-1220-2019; Becker, Christoph/L-2996-2016; Pasparakis, Manolis/H-9292-2017; Wullaert, Andy/D-2975-2018; Pasparakis, Manolis/N-4350-2019; Eckhardt, Erik/G-1567-2010; Becker, Christoph/A-6694-2008; van Loo, Geert/C-1505-2009; Wullaert, Andy/R-1924-2019	Danese, Silvio/0000-0001-7341-1351; , van Loo Geert/0000-0002-8427-4775; Pasparakis, Manolis/0000-0002-9870-0966; Wullaert, Andy/0000-0001-5012-654X; Pasparakis, Manolis/0000-0002-9870-0966; Becker, Christoph/0000-0002-1388-1041; Wullaert, Andy/0000-0001-5012-654X				Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Darmoul D, 1996, AM J PHYSIOL-GASTR L, V271, pG68, DOI 10.1152/ajpgi.1996.271.1.G68; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; GAREUS R, IN PRESS NATURE CELL; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Lan JG, 2005, WORLD J GASTROENTERO, V11, P3375, DOI 10.3748/wjg.v11.i22.3375; Li QT, 2000, GENE DEV, V14, P1729; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Rudolph D, 2000, GENE DEV, V14, P854; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Wehkamp J, 2005, NAT CLIN PRACT GASTR, V2, P406, DOI 10.1038/ncpgasthep0265	29	794	828	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					557	561		10.1038/nature05698	http://dx.doi.org/10.1038/nature05698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17361131	Green Published			2022-12-28	WOS:000245242900053
J	Littman, DR; Singh, H				Littman, Dan R.; Singh, Harinder			Asymmetry and immune memory	SCIENCE			English	Editorial Material							CELL-DIVISION; IMMUNOLOGICAL SYNAPSE; T-CELLS; DROSOPHILA; DIFFERENTIATION; ACTIVATION		NYU, Howard Hughes Med Inst, Skirball Inst Biomol Med, New York, NY 10016 USA; Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; New York University; Howard Hughes Medical Institute; University of Chicago	Littman, DR (corresponding author), NYU, Howard Hughes Med Inst, Skirball Inst Biomol Med, 550 1st Ave, New York, NY 10016 USA.	littman@saturn.med.nyu.edu; hsingh@uchicago.edu						Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cullinan P, 2002, IMMUNOL REV, V189, P111, DOI 10.1034/j.1600-065X.2002.18910.x; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Fuerstenberg S, 1998, INT J DEV BIOL, V42, P379; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Kaech SM, 2003, SCIENCE, V300, P263, DOI 10.1126/science.1084511; Kalia V, 2006, CURR OPIN IMMUNOL, V18, P255, DOI 10.1016/j.coi.2006.03.020; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016	13	8	8	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1673	1674		10.1126/science.1141184	http://dx.doi.org/10.1126/science.1141184			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379796				2022-12-28	WOS:000245106900025
J	Rey, E; Boulet, LP				Rey, Evelyne; Boulet, Louis-Philippe			Pregnancy plus - Asthma in pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EXACERBATIONS; SEVERITY; THERAPY		Univ Montreal, CHU St Justine, Fac Med, Dept Med, Montreal, PQ H3T 1C5, Canada; Univ Montreal, CHU St Justine, Fac Med, Dept Obstet & Gynaecol, Montreal, PQ H3T 1C5, Canada; Univ Laval, Hop Laval, Inst Cardiol & Pneumol, Ste Foy, PQ G1V 4G5, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Laval University	Rey, E (corresponding author), Univ Montreal, CHU St Justine, Fac Med, Dept Med, 3175 Cote Ste Catherine, Montreal, PQ H3T 1C5, Canada.	evelyne_rey@ssss.gouv.qc.ca						[Anonymous], 2005, J ALLERGY CLIN IMMUN, V115, P34, DOI 10.1016/j.jaci.2004.10.023; Bracken MB, 2003, OBSTET GYNECOL, V102, P739, DOI 10.1016/S0029-7844(03)00621-5; Dombrowski MP, 2004, OBSTET GYNECOL, V103, P5, DOI 10.1097/01.AOG.0000103994.75162.16; Gluck JC, 2005, AM J OBSTET GYNECOL, V192, P369, DOI 10.1016/j.ajog.2004.07.056; Murphy VE, 2006, THORAX, V61, P169, DOI 10.1136/thx.2005.049718; Murphy VE, 2005, OBSTET GYNECOL, V106, P1046, DOI 10.1097/01.AOG.0000185281.21716.02; Murphy VE, 2005, EUR RESPIR J, V25, P731, DOI 10.1183/09031936.05.00085704; Schatz M, 2004, J ALLERGY CLIN IMMUN, V113, P1040, DOI 10.1016/j.jaci.2004.03.017; Schatz M, 2003, J ALLERGY CLIN IMMUN, V112, P283, DOI 10.1067/mai.2003.1516	9	33	33	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2007	334	7593					582	585		10.1136/bmj.39112.717674.BE	http://dx.doi.org/10.1136/bmj.39112.717674.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AP	17363831	Green Published			2022-12-28	WOS:000245404400038
J	Kastan, MB				Kastan, Michael B.			Wild-type p53: Tumors can't stand it	CELL			English	Review							TUMORIGENESIS; RESTORATION; APOPTOSIS; CANCER	Most malignant tumors disrupt the p53 signaling pathway in order to grow and survive. Although many genes in addition to p53 are mutated in tumors, recent studies by Ventura et al. (2007) and Xue et al. (2007) suggest that restoring p53 function alone is sufficient to cause regression of several different tumor types in mice and thus might represent a potent therapeutic strategy to treat certain human cancers. Martins et al. (2006) also demonstrate that restoration of p53 activity results in tumor regression but add the sobering caveat that tumors may be able to quickly generate resistance by finding other ways to disrupt the p53 pathway.	St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kastan, MB (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	michael.kastan@stjude.org						Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Roth JA, 2006, EXPERT OPIN BIOL TH, V6, P55, DOI 10.1517/14712598.6.1.55; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	16	122	127	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					837	840		10.1016/j.cell.2007.02.022	http://dx.doi.org/10.1016/j.cell.2007.02.022			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350571	Bronze			2022-12-28	WOS:000245073400009
J	Svitkina, T				Svitkina, Tatyana			N-WASP generates a buzz at membranes on the move	CELL			English	Editorial Material							ENA/VASP PROTEINS; ACTIN POLYMERIZATION; BARBED END; FILAMENT; MOTILITY	The fast-growing ends of actin filaments push against membranes to create cell-surface protrusions and to propel the movement of membrane vesicles. Co et al. (2007) now show that the neural Wiskott-Aldrich syndrome protein (N-WASP) mediates dynamic attachment between membranes and the growing ends of actin filaments to sustain membrane movement.	Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Svitkina, T (corresponding author), Univ Penn, Dept Biol, 415 S Univ Ave, Philadelphia, PA 19104 USA.	svitkina@sas.upenn.edu						Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Chereau D, 2006, J STRUCT BIOL, V155, P195, DOI 10.1016/j.jsb.2006.01.012; Dickinson RB, 2004, BIOPHYS J, V87, P2838, DOI 10.1529/biophysj.104.045211; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Pollard TD, 2003, CELL, V113, P549, DOI 10.1016/S0092-8674(03)00357-X; Zigmond SH, 2004, CURR TOP DEV BIOL, V63, P145, DOI 10.1016/S0070-2153(04)63005-5	9	6	6	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					828	830		10.1016/j.cell.2007.02.028	http://dx.doi.org/10.1016/j.cell.2007.02.028			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350569	Bronze			2022-12-28	WOS:000245073400007
J	Morrish, TA; Garcia-Perez, JL; Stamato, TD; Taccioli, GE; Sekiguchi, J; Moran, JV				Morrish, Tammy A.; Garcia-Perez, Jose Luis; Stamato, Thomas D.; Taccioli, Guillermo E.; Sekiguchi, JoAnn; Moran, John V.			Endonuclease-independent LINE-1 retrotransposition at mammalian telomeres	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; CULTURED HUMAN-CELLS; CATALYTIC SUBUNIT; DNA-REPAIR; SCID MOUSE; CHROMOSOMES; MECHANISM; MUTATION; FUSIONS; PKCS	Long interspersed element-1 (LINE-1 or L1) elements are abundant, non-long-terminal-repeat (non-LTR) retrotransposons that comprise 17% of human DNA(1). The average human genome contains similar to 80-100 retrotransposition- competent L1s (ref. 2), and they mobilize by a process that uses both the L1 endonuclease and reverse transcriptase, termed target-site primed reverse transcription(3-5). We have previously reported an efficient, endonuclease-independent L1 retrotransposition pathway (ENi) in certain Chinese hamster ovary (CHO) cell lines that are defective in the non-homologous end-joining (NHEJ) pathway of DNA double-strand-break repair(6). Here we have characterized ENi retrotransposition events generated in V3 CHO cells, which are deficient in DNA-dependent protein kinase catalytic subunit (DNA-PKcs) activity and have both dysfunctional telomeres and an NHEJ defect. Notably, similar to 30% of ENi retrotransposition events insert in an orientation-specific manner adjacent to a perfect telomere repeat (5'-TTAGGG-3'). Similar insertions were not detected among ENi retrotransposition events generated in controls or in XR-1 CHO cells deficient for XRCC4, an NHEJ factor that is required for DNA ligation but has no known function in telomere maintenance. Furthermore, transient expression of a dominant-negative allele of human TRF2 ( also called TERF2) in XRCC4-deficient XR-1 cells, which disrupts telomere capping, enables telomere-associated ENi retrotransposition events. These data indicate that L1s containing a disabled endonuclease can use dysfunctional telomeres as an integration substrate. The findings highlight similarities between the mechanism of ENi retrotransposition and the action of telomerase, because both processes can use a 3' OH for priming reverse transcription at either internal DNA lesions or chromosome ends(7,8). Thus, we propose that ENi retrotransposition is an ancestral mechanism of RNA-mediated DNA repair associated with non-LTR retrotransposons that may have been used before the acquisition of an endonuclease domain.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Lankenau Inst Med Res, Wynnewood, PA 19096 USA; Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Lankenau Medical Center; Lankenau Institute for Medical Research; Boston University	Moran, JV (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	morrisht@jhmi.edu; moranj@umich.edu		Morrish, Tammy/0000-0002-6725-0253; Garcia-Perez, Jose Luis/0000-0002-8132-9849; Sekiguchi, JoAnn/0000-0002-7178-4258				Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Beamish HJ, 2000, NUCLEIC ACIDS RES, V28, P1506, DOI 10.1093/nar/28.7.1506; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Faravelli M, 2002, GENE, V283, P11, DOI 10.1016/S0378-1119(01)00877-0; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Gilley D, 2001, P NATL ACAD SCI USA, V98, P15084, DOI 10.1073/pnas.261574698; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; Hao LY, 2004, J BIOL CHEM, V279, P45148, DOI 10.1074/jbc.M403924200; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Pardue ML, 2003, ANNU REV GENET, V37, P485, DOI 10.1146/annurev.genet.38.072902.093115; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; WHITMORE GF, 1989, INT J RADIAT BIOL, V56, P657, DOI 10.1080/09553008914551881	30	125	130	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					208	212		10.1038/nature05560	http://dx.doi.org/10.1038/nature05560			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344853	Green Published			2022-12-28	WOS:000244718100045
J	Menzies, D; Pai, M; Comstock, G				Menzies, Dick; Pai, Madhukar; Comstock, George			Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD INTERFERON-GAMMA; ENZYME-LINKED IMMUNOSPOT; HEALTH-CARE WORKERS; CELL-BASED ASSAY; CULTURE FILTRATE PROTEIN-10; MYCOBACTERIUM-TUBERCULOSIS; WHOLE-BLOOD; SKIN-TEST; HIV-1-INFECTED ADULTS; ANTIGENS ESAT-6	Background: Until recently, the tuberculin skin test was the only test for detecting latent tuberculosis (TB) infection, but 2 ex vivo interferon-gamma release assays (IGRAs) are now commercially licensed. Purpose: To estimate sensitivity, specificity, and reproducibility of IGRAs (commercial or research versions of QuantiFERON [QFT] and Elispot) for diagnosing latent TB infection in healthy and immune-suppressed persons. Data Sources: The authors searched MEDLINE and reviewed citations of all original articles and reviews for studies published in English. Study Selection: Studies had evaluated IGRAs using Mycobacterium tuberculosis-specific antigens (RD1 antigens) and overnight (16- to 24-h) incubation times. Reference standards had to be clearly defined without knowledge of test results. Data Extraction and Quality Assessment: Specific criteria for quality assessment were developed for sensitivity, specificity, and reproducibility. Data Synthesis: When newly diagnosed active TB was used as a surrogate for latent TB infection, sensitivity of all tests was suboptimal, although it was higher with Elispot. No test distinguishes active TB from latent TB. Sensitivity of the tuberculin skin test and IGRAs was similar in persons who were categorized into clinical gradients of exposure. Pooled specificity was 97.7% (95% CI, 96% to 99%) and 92.5% (CI, 86% to 99%) for QFT and for Elispot, respectively. Both assays were more specific than the tuberculin skin test in samples vaccinated with bacille Calmette-Guerin. Elispot was more sensitive than the tuberculin skin test in 3 studies of immune-compromised samples. Discordant tuberculin skin test and IGRA reactions were frequent and largely unexplained, although some may be related to varied definitions of positive test results. Reversion of IGRA results from positive to negative was common in 2 studies in which it was assessed. Limitations: Most studies used cross-sectional designs with the inherent limitation of no gold standard for latent TB infection, and most involved small samples with a widely varying likelihood of true-positive and false-positive test results. There is insufficient evidence on IGRA performance in children, immune-compromised persons, and the elderly. Conclusions: New IGRAs show considerable promise and have excellent specificity. Additional studies are needed to better define their performance in high-risk populations and in serial testing. Longitudinal studies are needed to define the predictive value of IGRAs.	McGill Univ, Montreal, PQ, Canada; Johns Hopkins Univ, Baltimore, MD USA	McGill University; Johns Hopkins University	Menzies, D (corresponding author), Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, 3650 St Urbain,Room K1-24, Montreal, PQ H2X 2P4, Canada.	dick.menzies@mcgill.ca	Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020	Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X				Aiken AM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-66; AN Q, 1995, J CLIN MICROBIOL, V33, P860, DOI 10.1128/JCM.33.4.860-867.1995; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Arend SM, 2002, J INFECT DIS, V186, P1797, DOI 10.1086/345760; BATTERSHILL JH, 1980, CHEST, V77, P188, DOI 10.1378/chest.77.2.188; BEARMAN JE, 1964, AM REV RESPIR DIS, V90, P913; Brock I, 2001, INT J TUBERC LUNG D, V5, P462; Brock I, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-56; Brock L, 2004, AM J RESP CRIT CARE, V170, P65, DOI 10.1164/rccm.200402-232OC; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; CHAPARAS SD, 1985, AM REV RESPIR DIS, V132, P175; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; COMSTOCK GW, 1974, AM REV RESPIR DIS, V110, P572; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Dewan PK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-47; Dewan PK, 2007, CLIN INFECT DIS, V44, P69, DOI 10.1086/509928; Diel R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-77; DOGRA S, 2006, J INFECTION, DOI DOI 10.1016/J.INF.2006.04.007; EDWARDS LB, 1969, AM REV RESPIR DIS, V99, P1; ERDTMANN FJ, 1974, JAMA-J AM MED ASSOC, V228, P479, DOI 10.1001/jama.228.4.479; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; FALK A, 1978, CHEST, V73, P44, DOI 10.1378/chest.73.1.44; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Ferrara G, 2005, AM J RESP CRIT CARE, V172, P631, DOI 10.1164/rccm.200502-196OC; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; FURCOLOW ML, 1967, AM REV RESPIR DIS, V96, P1009; Goletti D, 2006, CLIN MICROBIOL INFEC, V12, P544, DOI 10.1111/j.1469-0691.2006.01391.x; GRZYBOWSKI STEFAN, 1965, CAN J PUBLIC HEALTH, V56, P181; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Hawken MP, 1997, AIDS, V11, P875, DOI 10.1097/00002030-199707000-00006; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; HOLDEN M, 1971, NEW ENGL J MED, V285, P1506, DOI 10.1056/NEJM197112302852704; HOWARD WL, 1970, CHEST, V57, P530, DOI 10.1378/chest.57.6.530; Johnson PDR, 1999, CLIN DIAGN LAB IMMUN, V6, P934, DOI 10.1128/CDLI.6.6.934-937.1999; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; KARDJITO T, 1981, TUBERCLE, V62, P31, DOI 10.1016/0041-3879(81)90032-5; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lee JY, 2006, EUR RESPIR J, V28, P24, DOI 10.1183/09031936.06.00016906; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Mahomed H, 2006, INT J TUBERC LUNG D, V10, P310; MANTOUX MC, 1912, PRESSE MED, V20, P146; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Meier T, 2005, EUR J CLIN MICROBIOL, V24, P529, DOI 10.1007/s10096-005-1377-8; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Nakaoka H, 2006, EMERG INFECT DIS, V12, P1383, DOI 10.3201/eid1209.051606; Nicol MP, 2005, CLIN INFECT DIS, V40, P1301, DOI 10.1086/429245; NOLAN CM, 1988, AM REV RESPIR DIS, V137, P805, DOI 10.1164/ajrccm/137.4.805; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; PAI M, 2007, IN PRESS INFECTION; Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7; Pai M, 2006, INT J TUBERC LUNG D, V10, P942; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; PALMER CE, 1968, J AMER MED ASSOC, V205, P167, DOI 10.1001/jama.205.3.167; PASSALENT L, 2006, CLIN J AM SOC NEPHRO, P1; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; PEREZSTABLE EJ, 1985, AM J PUBLIC HEALTH, V75, P1341, DOI 10.2105/AJPH.75.11.1341; Piana F, 2006, EUR RESPIR J, V28, P31, DOI 10.1183/09031936.06.00110205; Porsa E, 2006, CLIN VACCINE IMMUNOL, V13, P53, DOI 10.1128/CVI.13.1.53-58.2006; Pouchot J, 1997, ANN INTERN MED, V126, P210, DOI 10.7326/0003-4819-126-3-199702010-00005; Ravn P, 2004, SCAND J INFECT DIS, V36, P499, DOI 10.1080/00365540410015222; Richeldi L, 2004, AM J RESP CRIT CARE, V170, P288, DOI 10.1164/rccm.200403-307OC; Richeldi L, 2004, ANN INTERN MED, V140, P709, DOI 10.7326/0003-4819-140-9-200405040-00010; *ROY COLL PHYS, 2006, TUB NAT CLIN GUID DI; Scholvinck E, 2004, J CLIN MICROBIOL, V42, P829, DOI 10.1128/JCM.42.2.829-831.2004; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Shams H, 2005, AM J RESP CRIT CARE, V172, P1161, DOI 10.1164/rccm.200505-748OC; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; STEAD WW, 1987, ANN INTERN MED, V107, P837, DOI 10.7326/0003-4819-107-6-837; Styblo K., 1985, B INT UNION TUBERC, V60, P117; Taggart EW, 2006, AM J CLIN PATHOL, V125, P467, DOI [10.1309/LTETF72AHG94KGUY, 10.1309/LTET-F72A-HG94-KGUY]; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Tsiouris SJ, 2006, INT J TUBERC LUNG D, V10, P939; *WHO, 1963, WHO STAND TUB TEST G; *WHO, 2005, GLOB BCG VACC COV 20; *WHO, 1995, LEPROSY REV, V66, P270; *WHO, 1955, B WORLD HEALTH ORGAN, V22, P63; Wilkinson KA, 2006, J INFECT DIS, V193, P354, DOI 10.1086/499311; Wood R, 2000, J ACQ IMMUN DEF SYND, V23, P75; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zellweger JP, 2005, INT J TUBERC LUNG D, V9, P1242	87	788	843	2	59	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2007	146	5					340	354		10.7326/0003-4819-146-5-200703060-00006	http://dx.doi.org/10.7326/0003-4819-146-5-200703060-00006			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144XK	17339619				2022-12-28	WOS:000244829600003
J	Balzarini, J; Van Damme, L				Balzarini, Jan; Van Damme, Lut			Microbicide drug candidates to prevent HIV infection	LANCET			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; SODIUM LAURYL SULFATE; ENVELOPE GLYCOPROTEIN GP120; CELLULOSE-ACETATE PHTHALATE; PHASE-I SAFETY; CYANOVIRIN-N; TOPICAL MICROBICIDES; SEXUAL TRANSMISSION; DENDRITIC CELLS; HERPES-SIMPLEX	25 years after the first HIV/AIDS cases emerged in 1981, the disease continues to spread worldwide, with about 15 000 new infections every day. Although highly active antiretroviral therapy (HAART) has greatly reduced the rate of HIV infection, and the spread of the epidemic, this effect has largely been seen in developed countries. More than 90% of HIV-infected people live in developing countries, most of whom do not have access to this treatment. The development of efficient, widely available, and low-cost microbicides (gels and creams can be applied topically before sex) to prevent sexually transmitted HIV infections should be given high priority. We review different categories of microbicide drugs and lead compounds, their mechanism of action, current status of development, and progress in phase III trials.	Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; CONRAD, Arlington, VA USA	KU Leuven	Balzarini, J (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium.	jan.balzarini@rega.kuleuven.be						Amaral E, 2006, CONTRACEPTION, V73, P542, DOI 10.1016/j.contraception.2005.12.006; Anderson RA, 2002, J ANDROL, V23, P426; AURELIAN L, 1992, CLIN VIROLOGY MANUAL, P473; BABA M, 1990, ANTIMICROB AGENTS CH, V34, P134, DOI 10.1128/AAC.34.1.134; Ballagh SA, 2002, CONTRACEPTION, V66, P369, DOI 10.1016/S0010-7824(02)00433-X; Balzarini J, 1998, AIDS, V12, P1129, DOI 10.1097/00002030-199810000-00004; Balzarini J, 2004, ANTIMICROB AGENTS CH, V48, P3858, DOI 10.1128/AAC.48.10.3858-3870.2004; Balzarini J, 2005, J BIOL CHEM, V280, P41005, DOI 10.1074/jbc.M508801200; BALZARINI J, 2006, 19 INT C ANT RES PUE; Balzarini O, 2005, LANCET INFECT DIS, V5, P726, DOI 10.1016/S1473-3099(05)70271-1; Baron S, 2000, ANTIVIR RES, V48, P71, DOI 10.1016/S0166-3542(00)00126-1; Bax R, 2002, CONTRACEPTION, V66, P365, DOI 10.1016/S0010-7824(02)00389-X; Bestman-Smith J, 2001, ANTIMICROB AGENTS CH, V45, P2229, DOI 10.1128/AAC.45.8.2229-2237.2001; Boadi T, 2005, AIDS, V19, P1587, DOI 10.1097/01.aids.0000186020.24426.62; Bolmstedt AJ, 2001, MOL PHARMACOL, V59, P949, DOI 10.1124/mol.59.5.949; Borkow G, 1997, J VIROL, V71, P3023, DOI 10.1128/JVI.71.4.3023-3030.1997; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; BRAUNSTEIN S, 2004, ACCEPTABILITY CARRAG; Burleigh L, 2006, J VIROL, V80, P2949, DOI 10.1128/JVI.80.6.2949-2957.2006; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; CARAWAY J, 2004, ORG IMPLEMENTING MUL; Chang TLY, 2003, P NATL ACAD SCI USA, V100, P11672, DOI 10.1073/pnas.1934747100; Christensen ND, 2001, ANTIMICROB AGENTS CH, V45, P3427, DOI 10.1128/AAC.45.12.3427-3432.2001; COPLAN P, 2004, METHODS ESTIMATE HIV; D'Cruz OJ, 2006, J ANTIMICROB CHEMOTH, V57, P411, DOI 10.1093/jac/dki464; Dhawan D, 2006, J INFECT DIS, V193, P36, DOI 10.1086/499163; Di Fabio S, 2003, AIDS, V17, P1597, DOI 10.1097/00002030-200307250-00003; El-Sadr WM, 2006, AIDS, V20, P1109, DOI 10.1097/01.aids.0000226950.72223.5f; Elias CJ, 1997, CONTRACEPTION, V56, P387, DOI 10.1016/S0010-7824(97)00176-5; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Fletcher P, 2005, J VIROL, V79, P11179, DOI 10.1128/JVI.79.17.11179-11186.2005; FROHLICH J, 2004, PREPARING RES NAIVE; FROHLICH J, 2004, ESTABLISHING APPROPR; GALLAHER WR, 1995, AIDS RES HUM RETROV, V11, P191, DOI 10.1089/aid.1995.11.191; Geijtenbeek TB, 2000, CELL, V100, P491; GIAIMINIETTI L, 2004, PARTICIPANT RETENTIO; Giomarelli B, 2002, AIDS, V16, P1351, DOI 10.1097/00002030-200207050-00006; GIOMARELLI B, 2004, MUCOSAL DELIVERY MIC; GOVINDEN R, 2004, SUCCESSFUL STRATEGIE; HARMAN S, 2004, TMC120 BLOCKS HIV 1; Hillier SL, 1998, AIDS RES HUM RETROV, V14, pS17; Hillier SL, 2005, JAIDS-J ACQ IMM DEF, V39, P1, DOI 10.1097/01.qai.0000159671.25950.74; Ho HT, 2006, J VIROL, V80, P4017, DOI 10.1128/JVI.80.8.4017-4025.2006; HOLMES W, 2004, SEX HEALTH, V33, P73; Hong PWP, 2002, J VIROL, V76, P12855, DOI 10.1128/JVI.76.24.12855-12865.2002; Hossain MM, 2006, J VIROL, V80, P4440, DOI 10.1128/JVI.80.9.4440-4446.2006; Howett MK, 2005, CURR PHARM DESIGN, V11, P3731, DOI 10.2174/138161205774580633; Howett MK, 1999, ANTIMICROB AGENTS CH, V43, P314, DOI 10.1128/AAC.43.2.314; *INT AID SOC, STAT ANN 2 PHAS 2 TR; Kawamura T, 2000, J EXP MED, V192, P1491, DOI 10.1084/jem.192.10.1491; Kawamura T, 2003, P NATL ACAD SCI USA, V100, P8401, DOI 10.1073/pnas.1432450100; Kazmierski W, 2003, BIOORGAN MED CHEM, V11, P2663, DOI 10.1016/S0968-0896(03)00161-5; Keller MJ, 2006, J INFECT DIS, V193, P27, DOI 10.1086/498533; KILMARX PH, 2006, IN PRESS J ACQU 0914; Lacey CJN, 2006, AIDS, V20, P1027, DOI 10.1097/01.aids.0000222075.83490.ca; LACKMANSMITH C, 2006, 13 C RETR OPP INF FE; Lagenaur LA, 2005, P NATL ACAD SCI USA, V102, P12294, DOI 10.1073/pnas.0505960102; Lekkerkerker AN, 2006, CURR HIV RES, V4, P169, DOI 10.2174/157016206776055020; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; LEWIS MG, 2001, 8 C RETR OPP INF CHI; Lin G, 2003, J VIROL, V77, P1337, DOI 10.1128/JVI.77.2.1337-1346.2003; Lu H, 2006, AIDS RES HUM RETROV, V22, P411, DOI 10.1089/aid.2006.22.411; Malcolm RK, 2005, J ANTIMICROB CHEMOTH, V56, P954, DOI 10.1093/jac/dki326; Malonza IM, 2005, AIDS, V19, P2157, DOI 10.1097/01.aids.0000194797.59046.8f; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; MASLANKOWSKI L, 2004, RETENTION IS EVERYBO; Mauck C, 2001, CONTRACEPTION, V64, P383, DOI 10.1016/S0010-7824(01)00271-2; Mayer KH, 2006, AIDS, V20, P543, DOI 10.1097/01.aids.0000210608.70762.c3; Mayer KH, 2003, AIDS, V17, P321, DOI 10.1097/00002030-200302140-00005; Mills Edward, 2005, HIV AIDS Policy Law Rev, V10, P31; MIREMBE BG, 2004, STRATEGIES RECRUITME; Mori T, 2001, ANTIMICROB AGENTS CH, V45, P664, DOI 10.1128/AAC.45.3.664-672.2001; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Neurath AR, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-27; Neurath AR, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-6; Neurath AR, 2001, BMC INFECT DIS, V1, DOI 10.1186/1471-2334-1-17; Nguyen DG, 2003, EUR J IMMUNOL, V33, P483, DOI 10.1002/immu.200310024; NUNN A, 2004, PROVING EFFICACY MIC; O'Hara BM, 2002, CURR OPIN PHARMACOL, V2, P523, DOI 10.1016/S1471-4892(02)00196-0; OBERG B, 2004, MIV150 POTENT HIV1 I; Olmsted SS, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-79; Otten RA, 2005, J INFECT DIS, V191, P164, DOI 10.1086/426452; Page-Shafer K, 2005, LANCET, V366, P1499, DOI 10.1016/S0140-6736(05)67146-2; Patterson BK, 1998, AM J PATHOL, V153, P481, DOI 10.1016/S0002-9440(10)65591-5; Pauwels R, 1996, J ACQ IMMUN DEF SYND, V11, P211, DOI 10.1097/00042560-199603010-00001; Perotti ME, 2003, BIOL REPROD, V69, P933, DOI 10.1095/biolreprod.102.014555; Pierson TC, 2003, IMMUNOL LETT, V85, P113, DOI 10.1016/S0165-2478(02)00235-3; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Piret J, 2000, J CLIN MICROBIOL, V38, P110; Poignard P, 2001, ANNU REV IMMUNOL, V19, P253, DOI 10.1146/annurev.immunol.19.1.253; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Princen K, 2005, CYTOKINE GROWTH F R, V16, P659, DOI 10.1016/j.cytogfr.2005.05.009; RAMJEE G, 2004, PROVISION CARE HIV P; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Rao S, 2005, P NATL ACAD SCI USA, V102, P11993, DOI 10.1073/pnas.0504881102; Ratterree M, 2005, AIDS, V19, P1595, DOI 10.1097/01.aids.0000185990.16477.47; Reeves JD, 2005, DRUGS, V65, P1747, DOI 10.2165/00003495-200565130-00002; Reimann KA, 2002, AIDS RES HUM RETROV, V18, P747, DOI 10.1089/08892220260139486; Roberton AM, 2005, J CLIN MICROBIOL, V43, P5504, DOI 10.1128/JCM.43.11.5504-5508.2005; Roy S, 2001, ANTIMICROB AGENTS CH, V45, P1671, DOI 10.1128/AAC.45.6.1671-1681.2001; Rusconi S, 1996, ANTIMICROB AGENTS CH, V40, P234, DOI 10.1128/AAC.40.1.234; Rusconi S, 2000, J VIROL, V74, P9328, DOI 10.1128/JVI.74.19.9328-9332.2000; Schaeffer DJ, 2000, ECOTOX ENVIRON SAFE, V45, P208, DOI 10.1006/eesa.1999.1862; Schneider SE, 2005, J PEPT SCI, V11, P744, DOI 10.1002/psc.703; Scholand SJ, 2005, CURR PHARM DESIGN, V11, P3747, DOI 10.2174/138161205774580688; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Schwebke JR, 2005, J INFECT DIS, V192, P1315, DOI 10.1086/462430; Scordi-Bello IA, 2005, ANTIMICROB AGENTS CH, V49, P3607, DOI 10.1128/AAC.49.9.3607-3615.2005; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Simoes JA, 2002, ANTIMICROB AGENTS CH, V46, P2692, DOI 10.1128/AAC.46.8.2692-2695.2002; Singh JA, 2005, PLOS MED, V2, P824, DOI 10.1371/journal.pmed.0020234; Soriano V, 2004, AIDS, V18, P1, DOI 10.1097/00002030-200401020-00001; STEVENS G, 2004, PREPARATION EFFICACY; Torre VS, 2000, J VIROL, V74, P4868, DOI 10.1128/JVI.74.10.4868-4876.2000; Trkola A, 2001, J VIROL, V75, P579, DOI 10.1128/JVI.75.2.579-588.2001; Trussell J, 2005, CONTRACEPTION, V72, P408, DOI 10.1016/j.contraception.2005.06.063; Tsai CC, 2003, AIDS RES HUM RETROV, V19, P535, DOI 10.1089/088922203322230897; Tsai CC, 2004, AIDS RES HUM RETROV, V20, P11, DOI 10.1089/088922204322749459; Turpin JA, 2002, EXPERT OPIN INV DRUG, V11, P1077, DOI 10.1517/13543784.11.8.1077; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Van Damme L, 2004, TROP MED INT HEALTH, V9, P1290, DOI 10.1111/j.1365-3156.2004.01338.x; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Herrewege Y, 2004, ANTIMICROB AGENTS CH, V48, P337, DOI 10.1128/AAC.48.1.337-339.2004; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; Veazey RS, 2003, J INFECT DIS, V187, P769, DOI 10.1086/368386; Vermeire K, 2005, J ANTIMICROB CHEMOTH, V56, P270, DOI 10.1093/jac/dki208; Wainberg M., 2004, PROSPECT RT INHIBITO; Wallace A, 2004, SEX TRANSM DIS, V31, P465, DOI 10.1097/01.olq.0000135986.35216.ba; Wang T, 2003, J MED CHEM, V46, P4236, DOI 10.1021/jm034082o; WOOLFSON AD, 2006, AM J DRUG DELIV, V4, P7; Wyrick PB, 1997, ANTIMICROB AGENTS CH, V41, P1335, DOI 10.1128/AAC.41.6.1335; Zacharopoulos VR, 1997, CLIN DIAGN LAB IMMUN, V4, P465, DOI 10.1128/CDLI.4.4.465-468.1997; Zussman A, 2003, AIDS, V17, P653, DOI 10.1097/00002030-200303280-00002; Zwick MB, 2001, J VIROL, V75, P12198, DOI 10.1128/JVI.75.24.12198-12208.2001	135	171	180	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2007	369	9563					787	797		10.1016/S0140-6736(07)60202-5	http://dx.doi.org/10.1016/S0140-6736(07)60202-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143MP	17336656	Green Accepted			2022-12-28	WOS:000244726700036
J	Houze, RA; Chen, SS; Smull, BF; Lee, WC; Bell, MM				Houze, Robert A., Jr.; Chen, Shuyi S.; Smull, Bradley F.; Lee, Wen-Chau; Bell, Michael M.			Hurricane intensity and eyewall replacement	SCIENCE			English	Article							AIRBORNE; EVOLUTION	Observations made during the historic 2005 hurricane season document a case of "eyewall replacement." Clouds outside the hurricane eyewall coalesce to form a new eyewall at a greater radius from the storm center, and the old eyewall dies. The winds in the new eyewall are initially weaker than those in the original eyewall, but as the new eyewall contracts, the storm reintensifies. Understanding this replacement mechanism is vital to forecasting variations in hurricane intensity. Processes in the "moat" region between the new and old eyewall have been particularly unclear. Aircraft data now show that the moat becomes dynamically similar to the eye and thus is converted into a region inimical to survival of the inner eyewall. We suggest that targeting aircraft to key parts of the storm to gain crucial input to high-resolution numerical models can lead to improvements in forecasting hurricane intensity.	Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; Natl Ctr Atmospher Res, Earth Observing Lab, Boulder, CO 80307 USA	University of Washington; University of Washington Seattle; University of Miami; National Center Atmospheric Research (NCAR) - USA	Houze, RA (corresponding author), Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA.	houze@atmos.washington.edu	Bell, Michael/B-1144-2009	Bell, Michael/0000-0002-0496-331X				Aberson SD, 2006, B AM METEOROL SOC, V87, P1039, DOI 10.1175/BAMS-87-8-1039; BARNES GM, 1983, J ATMOS SCI, V40, P2125, DOI 10.1175/1520-0469(1983)040<2125:MACSOA>2.0.CO;2; CHEN SS, IN PRESS B AM METEOR; Dodge P, 1999, MON WEATHER REV, V127, P987, DOI 10.1175/1520-0493(1999)127<0987:TKSOAH>2.0.CO;2; Emanuel KA, 1997, J ATMOS SCI, V54, P1014, DOI 10.1175/1520-0469(1997)054<1014:SAOHIC>2.0.CO;2; Hildebrand PH, 1996, B AM METEOROL SOC, V77, P213, DOI 10.1175/1520-0477(1996)077<0213:TEADWR>2.0.CO;2; Houze RA, 2006, B AM METEOROL SOC, V87, P1503, DOI 10.1175/BAMS-87-11-1503; Jorgensen DP, 1996, METEOROL ATMOS PHYS, V59, P83, DOI 10.1007/BF01032002; Kossin JP, 2000, J ATMOS SCI, V57, P3893, DOI 10.1175/1520-0469(2001)058<3893:UIBAHS>2.0.CO;2; MARKS FD, 1984, B AM METEOROL SOC, V65, P569, DOI 10.1175/1520-0477(1984)065<0569:ADROIH>2.0.CO;2; Montgomery MT, 2006, B AM METEOROL SOC, V87, P1335, DOI 10.1175/BAMS-87-10-1335; Montgomery MT, 1997, Q J ROY METEOR SOC, V123, P435, DOI 10.1002/qj.49712353810; ORITT D, 2006, 207 C HURR TROP MET; Persing J, 2003, J ATMOS SCI, V60, P2349, DOI 10.1175/1520-0469(2003)060<2349:HS>2.0.CO;2; Reasor PD, 2000, MON WEATHER REV, V128, P1653, DOI 10.1175/1520-0493(2000)128<1653:LWSAEO>2.0.CO;2; Ritchie EA, 2003, HURRICANE: COPING WITH DISASTER, P249; Saffir HS, 2003, HURRICANE: COPING WITH DISASTER, P155; SHAPIRO LJ, 1982, J ATMOS SCI, V39, P378, DOI 10.1175/1520-0469(1982)039<0378:TROBHT>2.0.CO;2; Sheets RC, 2003, HURRICANE: COPING WITH DISASTER, P63; SIMPSON RH, 1964, SCI AM, V211, P27, DOI 10.1038/scientificamerican1264-27; Willoughby HE, 1998, MON WEATHER REV, V126, P3053, DOI 10.1175/1520-0493(1998)126<3053:TCET>2.0.CO;2; WILLOUGHBY HE, 1985, B AM METEOROL SOC, V66, P505, DOI 10.1175/1520-0477(1985)066<0505:PSASC>2.0.CO;2; WILLOUGHBY HE, 1982, J ATMOS SCI, V39, P395, DOI 10.1175/1520-0469(1982)039<0395:CEWSWM>2.0.CO;2	23	223	234	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1235	1239		10.1126/science.1135650	http://dx.doi.org/10.1126/science.1135650			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332404				2022-12-28	WOS:000244564700039
J	Meyer, JC; Geim, AK; Katsnelson, MI; Novoselov, KS; Booth, TJ; Roth, S				Meyer, Jannik C.; Geim, A. K.; Katsnelson, M. I.; Novoselov, K. S.; Booth, T. J.; Roth, S.			The structure of suspended graphene sheets	NATURE			English	Article							CARBON NANOTUBES; CRYSTALLINE; GROWTH	The recent discovery of graphene has sparked much interest, thus far focused on the peculiar electronic structure of this material, in which charge carriers mimic massless relativistic particles(1-3). However, the physical structure of graphene - a single layer of carbon atoms densely packed in a honeycomb crystal lattice - is also puzzling. On the one hand, graphene appears to be a strictly two-dimensional material, exhibiting such a high crystal quality that electrons can travel submicrometre distances without scattering. On the other hand, perfect two-dimensional crystals cannot exist in the free state, according to both theory and experiment(4-9). This incompatibility can be avoided by arguing that all the graphene structures studied so far were an integral part of larger three-dimensional structures, either supported by a bulk substrate or embedded in a three-dimensional matrix(1-3,9-12). Here we report on individual graphene sheets freely suspended on a microfabricated scaffold in vacuum or air. These membranes are only one atom thick, yet they still display long-range crystalline order. However, our studies by transmission electron microscopy also reveal that these suspended graphene sheets are not perfectly flat: they exhibit intrinsic microscopic roughening such that the surface normal varies by several degrees and out-of-plane deformations reach 1 nm. The atomically thin single-crystal membranes offer ample scope for fundamental research and new technologies, whereas the observed corrugations in the third dimension may provide subtle reasons for the stability of two-dimensional crystals(13-15).	Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; Univ Manchester, Manchester Ctr Mesosci & Nanotechnol, Manchester M13 9PL, Lancs, England; Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands	Max Planck Society; University of Manchester; Radboud University Nijmegen	Meyer, JC (corresponding author), Max Planck Inst Solid State Res, Heisenbergstr 1, D-70569 Stuttgart, Germany.	email@jannikmeyer.de; geim@man.ac.uk	Meyer, Jannik C/H-8541-2012; Katsnelson, Mikhail I./D-4359-2012; Geim, Andre K/J-7888-2012; Novoselov, Kostya S/G-9581-2014; Booth, Timothy J/A-5847-2012	Meyer, Jannik C/0000-0003-4023-0778; Geim, Andre K/0000-0003-2861-8331; Novoselov, Kostya S/0000-0003-4972-5371; Booth, Timothy J/0000-0002-9784-989X; hai yan, he/0000-0003-0366-6185	Engineering and Physical Sciences Research Council [EP/C511875/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Affleck I, 2004, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2004/10/P10003; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Born M., 1954, DYNAMICAL THEORY CRY; Buseck P., 1988, HIGH RESOLUTION TRAN; DOYLE PA, 1968, ACTA CRYSTALL A-CRYS, VA 24, P390, DOI 10.1107/S0567739468000756; Evans JW, 2006, SURF SCI REP, V61, P1, DOI 10.1016/j.surfrep.2005.08.004; Horiuchi S, 2003, JPN J APPL PHYS 2, V42, pL1073, DOI 10.1143/JJAP.42.L1073; Huang JY, 2006, NATURE, V439, P281, DOI 10.1038/439281a; LANDAU LD, 2007, PHYS Z SOWJETUNION, V11, P26; LEDOUSSAL P, 1992, PHYS REV LETT, V69, P1209, DOI 10.1103/PhysRevLett.69.1209; MERMIN ND, 1968, PHYS REV, V176, P250, DOI 10.1103/PhysRev.176.250; MERMIN ND, 1966, PHYS REV LETT, V17, P1133, DOI 10.1103/PhysRevLett.17.1133; Morozov SV, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.016801; NELSON DR, 1987, J PHYS-PARIS, V48, P1085, DOI 10.1051/jphys:019870048070108500; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Ohta T, 2006, SCIENCE, V313, P951, DOI 10.1126/science.1130681; Peierls R. E., 1935, ANN I H POINCARE, V5, P177; Peierls RE., 1934, HELV PHYS ACTA, V7, P81, DOI DOI 10.5169/SEALS-110415; Peng LM, 1999, MICRON, V30, P625, DOI 10.1016/S0968-4328(99)00033-5; Spence J.C.H., 2003, HIGH RESOLUTION ELEC, V3rd; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; VENABLES JA, 1984, REP PROG PHYS, V47, P399, DOI 10.1088/0034-4885/47/4/002; Yu MF, 2000, PHYS REV LETT, V84, P5552, DOI 10.1103/PhysRevLett.84.5552; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhao QZ, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144105; ZINKEALLMANG M, 1992, SURF SCI REP, V16, P377, DOI 10.1016/0167-5729(92)90006-W	29	4051	4244	55	2982	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					60	63		10.1038/nature05545	http://dx.doi.org/10.1038/nature05545			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330039	Green Submitted			2022-12-28	WOS:000244525600036
J	Zimetbaum, P				Zimetbaum, Peter			Clinical therapeutics: Amiodarone for atrial fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RHYTHM MANAGEMENT AFFIRM; ANTIARRHYTHMIC-DRUGS; RECURRENCE; INITIATION; ONSET; EFFICACY; THERAPY; EVENTS		Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Zimetbaum, P (corresponding author), Beth Israel Deaconess Med Ctr, Div Cardiol, 185 Pilgrim Rd, Boston, MA 02215 USA.	pzimetba@bidmc.harvard.edu						AHMAD S, 1995, ARCH INTERN MED, V155, P1106, DOI 10.1001/archinte.155.10.1106; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Chung MK, 2005, J AM COLL CARDIOL, V46, P1891, DOI 10.1016/j.jacc.2005.07.040; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Goldschlager N, 2000, ARCH INTERN MED, V160, P1741, DOI 10.1001/archinte.160.12.1741; Greene HL, 2003, J AM COLL CARDIOL, V42, P20, DOI 10.1016/S0735-1097(03)00559-X; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hauser TH, 2004, AM J CARDIOL, V93, P1173, DOI 10.1016/j.amjcard.2004.01.051; Hauser TH, 2003, AM J CARDIOL, V91, P1437, DOI 10.1016/S0002-9149(03)00395-3; Ito S, 2000, NEW ENGL J MED, V343, P118, DOI 10.1056/NEJM200007133430208; Kaufman ES, 2004, J AM COLL CARDIOL, V44, P1276, DOI 10.1016/j.jacc.2004.06.052; Kochiadakis GE, 1999, AM J CARDIOL, V83, P58, DOI 10.1016/S0002-9149(98)00783-8; Madrid AH, 2002, CIRCULATION, V106, P331, DOI 10.1161/01.CIR.0000022665.18619.83; Mitchell LB, 2005, JAMA-J AM MED ASSOC, V294, P3093, DOI 10.1001/jama.294.24.3093; MITCHELL LB, 1989, CIRCULATION, V80, P34, DOI 10.1161/01.CIR.80.1.34; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Olshansky B, 2005, AM J CARDIOL, V95, P404, DOI 10.1016/j.amjcard.2004.09.044; Pearce EN, 2003, NEW ENGL J MED, V348, P2646, DOI 10.1056/NEJMra021194; PEARCE EN, 2003, NEW ENGL J MED, V349, P620, DOI DOI 10.1056/NEJMRA02119412826640; Reynolds MR, 2006, AM HEART J, V152, P1097, DOI 10.1016/j.ahj.2006.08.011; Roden M, 2000, HEART, V84, P339, DOI 10.1136/heart.84.3.339; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; Sanyal Arun J, 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Shinagawa K, 2003, CIRCULATION, V107, P1440, DOI 10.1161/01.CIR.0000055316.35552.74; Singh BN, 2005, NEW ENGL J MED, V352, P1861, DOI 10.1056/NEJMoa041705; SINGH SN, 1995, NEW ENGL J MED, V333, P77, DOI 10.1056/NEJM199507133330201; Steinberg JS, 2004, CIRCULATION, V109, P1973, DOI 10.1161/01.CIR.0000118472.77237.FA; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Zimetbaum P, 2003, AM J CARDIOL, V91, P81, DOI 10.1016/S0002-9149(02)03004-7	32	143	153	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2007	356	9					935	941		10.1056/NEJMct065916	http://dx.doi.org/10.1056/NEJMct065916			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140HV	17329700				2022-12-28	WOS:000244496400008
J	Schnurr, PP; Friedman, MJ; Engel, CC; Foa, EB; Shea, MT; Chow, BK; Resick, PA; Thurston, V; Orsillo, SM; Haug, R; Turner, C; Bernardy, N				Schnurr, Paula P.; Friedman, Matthew J.; Engel, Charles C.; Foa, Edna B.; Shea, M. Tracie; Chow, Bruce K.; Resick, Patricia A.; Thurston, Veronica; Orsillo, Susan M.; Haug, Rodney; Turner, Carole; Bernardy, Nancy			Cognitive behavioral therapy for posttraumatic stress disorder in women - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROLONGED EXPOSURE; PROCESSING THERAPY; CLINICAL-TRIALS; VETERANS; PTSD; PSYCHOTHERAPY; PREVALENCE; SEVERITY; SYMPTOMS; ASSAULT	Context The prevalence of posttraumatic stress disorder ( PTSD) is elevated among women who have served in the military, but no prior study has evaluated treatment for PTSD in this population. Prior research suggests that cognitive behavioral therapy is a particularly effective treatment for PTSD. Objective To compare prolonged exposure, a type of cognitive behavioral therapy, with present-centered therapy, a supportive intervention, for the treatment of PTSD. Design, Setting, and Participants A randomized controlled trial of female veterans (n= 277) and active-duty personnel ( n= 7) with PTSD recruited from 9 VA medical centers, 2 VA readjustment counseling centers, and 1 military hospital from August 2002 through October 2005. Intervention Participants were randomly assigned to receive prolonged exposure ( n= 141) or present-centered therapy ( n= 143), delivered according to standard protocols in 10 weekly 90-minute sessions. Main Outcome Measures Posttraumatic stress disorder symptom severity was the primary outcome. Comorbid symptoms, functioning, and quality of life were secondary outcomes. Blinded assessors collected data before and after treatment and at 3- and 6-month follow-up. Results Women who received prolonged exposure experienced greater reduction of PTSD symptoms relative to women who received present-centered therapy ( effect size, 0.27; P=. 03). The prolonged exposure group was more likely than the present-centered therapy group to no longer meet PTSD diagnostic criteria (41.0% vs 27.8%; odds ratio, 1.80; 95% confidence interval, 1.10-2.96; P=. 01) and achieve total remission (15.2% vs 6.9%; odds ratio, 2.43; 95% confidence interval, 1.10-5.37; P=. 01). Effects were consistent over time in longitudinal analyses, although in cross-sectional analyses most differences occurred immediately after treatment. Conclusions Prolonged exposure is an effective treatment for PTSD in female veterans and active- duty military personnel. It is feasible to implement prolonged exposure across a range of clinical settings.	Vet Affairs Med Ctr, Natl Ctr PTSD 116D, White River Jct, VT 05009 USA; Dartmouth Med Sch, Lebanon, NH USA; Walter Reed Army Med Ctr, Washington, DC 20307 USA; Uniformed Serv Univ Hlth Sci, Washington, DC USA; VA Off Women Vet Hlth, Washington, DC USA; Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; Brown Univ, Med Ctr, Providence, RI 02912 USA; Vet Affairs Med Ctr, Providence, RI USA; VA Cooperat Studies Program, Menlo Pk, CA USA; Boston Univ, Sch Med, VA Natl Ctr PTSD, Boston, MA 02118 USA; Suffolk Univ, Boston, MA 02114 USA; VA Readjustment Counseling Ctr, Cheyenne, WY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Dartmouth College; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; University of Pennsylvania; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Boston University; Suffolk University	Schnurr, PP (corresponding author), Vet Affairs Med Ctr, Natl Ctr PTSD 116D, 215 N Main St, White River Jct, VT 05009 USA.	Paula.Schnurr@Dartmouth.edu		Orsillo, Susan/0000-0003-3871-3690; Shea, Tracie/0000-0002-0579-6699; Engel, Charles/0000-0002-9232-3389				[Anonymous], NATL COMORBIDITY SUR; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Bryant RA, 2003, J CONSULT CLIN PSYCH, V71, P706, DOI 10.1037/0022-006X.71.4.706; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Ehlers A, 2005, BEHAV RES THER, V43, P413, DOI 10.1016/j.brat.2004.03.006; Foa E.B., 1998, TREATING TRAUMA RAPE; FOA EB, 1991, J CONSULT CLIN PSYCH, V59, P715, DOI 10.1037/0022-006X.59.5.715; Foa EB, 1999, J CONSULT CLIN PSYCH, V67, P194, DOI 10.1037/0022-006X.67.2.194; Foa EB, 2005, J CONSULT CLIN PSYCH, V73, P953, DOI 10.1037/0022-006X.73.5.953; FONTANA A, 1997, WOMEN STRESS EVALUAT; FONTANA A, 2002, WOMEN STRESS, V2; Frisch M.B., 1992, PSYCHOL ASSESS, V4, P92, DOI [10.1037/1040-3590.4.1.92, DOI 10.1037/1040-3590.4.1.92]; Fullerton CS, 2004, AM J PSYCHIAT, V161, P1370, DOI 10.1176/appi.ajp.161.8.1370; Glynn SM, 1999, J CONSULT CLIN PSYCH, V67, P243, DOI 10.1037/0022-006X.67.2.243; Greenberg PE, 1999, J CLIN PSYCHIAT, V60, P427, DOI 10.4088/JCP.v60n0702; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hourani LL, 1999, MIL MED, V164, P174, DOI 10.1093/milmed/164.3.174; KEANE TM, 1989, BEHAV THER, V20, P245, DOI 10.1016/S0005-7894(89)80072-3; KELLER MB, 1987, ARCH GEN PSYCHIAT, V44, P540; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kulka R.A., 1990, TRAUMA VIETNAM WAR G; Magruder KM, 2004, J TRAUMA STRESS, V17, P293, DOI 10.1023/B:JOTS.0000038477.47249.c8; Marks I, 1998, ARCH GEN PSYCHIAT, V55, P317, DOI 10.1001/archpsyc.55.4.317; McDonagh A, 2005, J CONSULT CLIN PSYCH, V73, P515, DOI 10.1037/0022-006X.73.3.515; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Rosen CS, 2004, J TRAUMA STRESS, V17, P213, DOI 10.1023/B:JOTS.0000029264.23878.53; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rothbaum BO, 2006, J TRAUMA STRESS, V19, P625, DOI 10.1002/jts.20170; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Schnurr PP, 2005, CONTEMP CLIN TRIALS, V26, P626, DOI 10.1016/j.cct.2005.09.001; Schnurr PP, 2003, ARCH GEN PSYCHIAT, V60, P481, DOI 10.1001/archpsyc.60.5.481; Skinner KM, 2000, J INTERPERS VIOLENCE, V15, P291, DOI 10.1177/088626000015003005; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Spitzer RL, 1995, STRUCTURED CLIN INTE; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; *VA, 2003, MAN POSTTR STRESS; Van Etten ML, 1998, CLIN PSYCHOL PSYCHOT, V5, P126, DOI 10.1002/(SICI)1099-0879(199809)5:3<126::AID-CPP153>3.3.CO;2-8; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; WEATHERS FW, 1993, P 9 ANN M INT SOC TR, P8; WOLFINGER R, 1993, J STAT COMPUT SIM, V48, P233, DOI 10.1080/00949659308811554	45	618	623	2	71	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2007	297	8					820	830		10.1001/jama.297.8.820	http://dx.doi.org/10.1001/jama.297.8.820			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	140DS	17327524	Bronze			2022-12-28	WOS:000244485000025
J	Saha, S; Bastiaenen, R; Hayward, M; McEwan, JR				Saha, Sagar; Bastiaenen, Rachel; Hayward, Martin; McEwan, Jean R.			An undiagnosed bicuspid aortic valve can result in severe left ventricular failure	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFECTIVE ENDOCARDITIS; SURGICAL PATHOLOGY; STENOSIS; FREQUENCY; GUIDELINES		Heart Hosp, London W1G 8PH, England	University College London Hospitals NHS Foundation Trust	McEwan, JR (corresponding author), Heart Hosp, London W1G 8PH, England.	j.mcewan@ucl.ac.uk		Bastiaenen, Rachel/0000-0002-5018-8035				BEPPU S, 1993, AM J CARDIOL, V71, P322, DOI 10.1016/0002-9149(93)90799-I; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Espinal M, 2000, AM HEART J, V139, P1071, DOI 10.1067/mhj.2000.103843; Fedak Paul W M, 2005, Expert Rev Cardiovasc Ther, V3, P295, DOI 10.1586/14779072.3.2.295; Horstkotte D, 2004, EUR HEART J, V25, P267, DOI 10.1016/j.ehj.2003.11.008; Huntington K, 1997, J AM COLL CARDIOL, V30, P1809, DOI 10.1016/S0735-1097(97)00372-0; Lamas CC, 2000, CLIN INFECT DIS, V30, P336, DOI 10.1086/313646; Newby DE, 2006, HEART, V92, P729, DOI 10.1136/hrt.2005.066852; Nistri S, 2005, AM J CARDIOL, V96, P718, DOI 10.1016/j.amjcard.2005.04.051; OLSON LJ, 1984, MAYO CLIN PROC, V59, P835, DOI 10.1016/S0025-6196(12)65618-3; Roberts WC, 2005, CIRCULATION, V111, P920, DOI 10.1161/01.CIR.0000155623.48408.C5; ROBERTS WC, 1970, AM J CARDIOL, V26, P72, DOI 10.1016/0002-9149(70)90761-7; SUBRAMANIAN R, 1984, MAYO CLIN PROC, V59, P683, DOI 10.1016/S0025-6196(12)62057-6; Ward C, 2000, HEART, V83, P81, DOI 10.1136/heart.83.1.81	14	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2007	334	7590					420	422		10.1136/bmj.39065.624815.80	http://dx.doi.org/10.1136/bmj.39065.624815.80			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	142MQ	17322259	Green Published, Green Submitted			2022-12-28	WOS:000244654400036
J	Suzuki, K; Okuno, T; Yamamoto, M; Pasterkamp, RJ; Takegahara, N; Takamatsu, H; Kitao, T; Takagi, J; Rennert, PD; Kolodkin, AL; Kumanogoh, A; Kikutani, H				Suzuki, Kazuhiro; Okuno, Tatsusada; Yamamoto, Midori; Pasterkamp, R. Jeroen; Takegahara, Noriko; Takamatsu, Hyota; Kitao, Tomoe; Takagi, Junichi; Rennert, Paul D.; Kolodkin, Alex L.; Kumanogoh, Atsushi; Kikutani, Hitoshi			Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha 1 beta 1 integrin	NATURE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COLLAGEN-BINDING INTEGRINS; EXPRESSION; FAMILY; HYPERSENSITIVITY; ALPHA(1)BETA(1); TRANSMEMBRANE; ARTHRITIS; ADHESION; COLITIS	Semaphorins are axon guidance factors that assist growing axons in finding appropriate targets and forming synapses(1). Emerging evidence suggests that semaphorins are involved not only in embryonic development but also in immune responses(2). Semaphorin 7A (Sema7A; also known as CD108)(3,4), which is a glycosylphosphatidylinositol-anchored semaphorin, promotes axon outgrowth through beta 1-integrin receptors and contributes to the formation of the lateral olfactory tract(5). Although Sema7A has been shown to stimulate human monocytes(6), its function as a negative regulator of T-cell responses has also been reported(7). Thus, the precise function of Sema7A in the immune system remains unclear. Here we show that Sema7A, which is expressed on activated T cells, stimulates cytokine production in monocytes and macrophages through alpha 1 beta 1 integrin ( also known as very late antigen-1) as a component of the immunological synapse, and is critical for the effector phase of the inflammatory immune response. Sema7A-deficient (Sema7a(-/-)) mice are defective in cell-mediated immune responses such as contact hypersensitivity and experimental autoimmune encephalomyelitis. Although antigen-specific and cytokine-producing effector T cells can develop and migrate into antigen-challenged sites in Sema7a(-/-) mice, Sema7a(-/-) T cells fail to induce contact hypersensitivity even when directly injected into the antigen-challenged sites. Thus, the interaction between Sema7A and alpha 1 beta 1 integrin is crucial at the site of inflammation. These findings not only identify a function of Sema7A as an effector molecule in T-cell-mediated inflammation, but also reveal a mechanism of integrin-mediated immune regulation.	JST, Dept Mol Immunol, Suita, Osaka 5650871, Japan; JST, CREST Program, Suita, Osaka 5650871, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Immunopathol, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka 5650871, Japan; Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Pharmacol & Anat, NL-3584 CG Utrecht, Netherlands; Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, Suita, Osaka 5650871, Japan; Biogen Idec Inc, Cambridge, MA 01746 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Osaka University; Osaka University; Utrecht University; Utrecht University Medical Center; Osaka University; Biogen; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Kumanogoh, A (corresponding author), JST, Dept Mol Immunol, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	kumanogo@ragtime.biken.osaka-u.ac.jp; kikutani@ragtime.biken.osaka-u.ac.jp	Takegahara, Noriko/AAP-1694-2021; Kumanogoh, Atsushi/C-7354-2009; Kikutani, Hitoshi/C-9525-2009; Suzuki, Kazuhiro/B-3886-2012; Kitao, Tomoe/AHE-0728-2022	Kitao, Tomoe/0000-0003-1366-4861; Suzuki, Kazuhiro/0000-0002-9081-538X; Pasterkamp, Jeroen/0000-0003-1631-6440				Andreasen SO, 2003, J IMMUNOL, V171, P2804, DOI 10.4049/jimmunol.171.6.2804; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Ben-Horin S, 2004, CLIN IMMUNOL, V113, P119, DOI 10.1016/j.clim.2004.06.007; Czopik AK, 2006, IMMUNITY, V24, P591, DOI 10.1016/j.immuni.2006.03.013; de Fougerolles AR, 2000, J CLIN INVEST, V105, P721, DOI 10.1172/JCI7911; Fiorucci S, 2002, IMMUNITY, V17, P769, DOI 10.1016/S1074-7613(02)00476-4; Gardner H, 1996, DEV BIOL, V175, P301, DOI 10.1006/dbio.1996.0116; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; Holmes S, 2002, SCAND J IMMUNOL, V56, P270, DOI 10.1046/j.1365-3083.2002.01129.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Krieglstein CF, 2002, J CLIN INVEST, V110, P1773, DOI 10.1172/JCI200215256; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Lange C, 1998, GENOMICS, V51, P340, DOI 10.1006/geno.1998.5256; McInnes IB, 1997, NAT MED, V3, P189, DOI 10.1038/nm0297-189; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; RICHES DWH, 1991, J BIOL CHEM, V266, P24785; Riminton DS, 1998, J EXP MED, V187, P1517, DOI 10.1084/jem.187.9.1517; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Xu XM, 1998, J BIOL CHEM, V273, P22428, DOI 10.1074/jbc.273.35.22428	27	197	211	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					680	684		10.1038/nature05652	http://dx.doi.org/10.1038/nature05652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17377534				2022-12-28	WOS:000245438300043
J	Anandakrishnan, S; Catania, GA; Alley, RB; Horgan, HJ				Anandakrishnan, Sridhar; Catania, Ginny A.; Alley, Richard B.; Horgan, Huw J.			Discovery of till deposition at the grounding line of Whillans Ice Stream	SCIENCE			English	Article							PLEISTOCENE-HOLOCENE RETREAT; ROSS SEA; SHEET SYSTEM; EROSION	We report on the discovery of a grounding-line sedimentary wedge ("till delta") deposited by Whillans Ice Stream, West Antarctica. Our observation is that grounding-line deposition serves to thicken the ice and stabilize the position of the grounding line. The ice thickness at the grounding line is greater than that of floating ice in hydrostatic equilibrium. Thus, the grounding line will tend to remain in the same location despite changes in sea level ( until sea level rises enough to overcome the excess thickness that is due to the wedge). Further, our observation demonstrates the occurrence of rapid subglacial erosion, sediment transport by distributed subglacial till deformation, and grounding-line sedimentation, which have important implications for ice dynamics, numerical modeling of ice flow, and interpretation of the sedimentation record.	Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Univ Texas, Inst Geophys, Austin, TX 78758 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; University of Texas Austin	Anandakrishnan, S (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	sak@essc.psu.edu	Catania, Ginny/B-9787-2008; Horgan, Huw/I-5847-2019	Catania, Ginny/0000-0002-7561-5902; Horgan, Huw/0000-0002-4836-0078				Alley RB, 2000, GEOL SOC SPEC PUBL, V176, P171, DOI 10.1144/GSL.SP.2000.176.01.13; Alley RB, 2007, SCIENCE, V315, P1838, DOI 10.1126/science.1138396; BLANKENSHIP DD, 1989, ANN GLACIOL, V12, P200; Bogorodsky VV., 1985, RADIOGLACIOLOGY, DOI 10.1007/978-94-009-5275-1; Christoffersen P, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000363; Clark PU, 1998, PALEOCEANOGRAPHY, V13, P1, DOI 10.1029/97PA02660; Conway H, 1999, SCIENCE, V286, P280, DOI 10.1126/science.286.5438.280; Domack EW, 1999, GEOL SOC AM BULL, V111, P1517, DOI 10.1130/0016-7606(1999)111<1517:LPHROT>2.3.CO;2; Engelhardt H, 1998, J GLACIOL, V44, P223; Hallet B, 1996, GLOBAL PLANET CHANGE, V12, P213, DOI 10.1016/0921-8181(95)00021-6; Holland DM, 2003, ANTARCT SCI, V15, P13, DOI 10.1017/S0954102003001019; Horgan HJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027091; Iverson NR, 1998, J GLACIOL, V44, P634, DOI 10.3189/S0022143000002136; Kamb B., 2001, ANTARCT RES SER, V77, DOI DOI 10.1029/AR077P0157; MEIER MF, 1987, J GEOPHYS RES-SOLID, V92, P9051, DOI 10.1029/JB092iB09p09051; Mosola AB, 2006, QUATERNARY SCI REV, V25, P2177, DOI 10.1016/j.quascirev.2005.12.013; Murray T, 2000, J GEOPHYS RES-SOL EA, V105, P13491, DOI 10.1029/2000JB900066; PETERS IE, 2006, J GEOPHYS RES, V111; SEN PN, 1981, GEOPHYSICS, V46, P781, DOI 10.1190/1.1441215; SHABTAIE S, 1987, J GEOPHYS RES-SOLID, V92, P1311, DOI 10.1029/JB092iB02p01311; Sheriff R. E., 1995, EXPLORATION SEISMOLO; Shipp S, 1999, GEOL SOC AM BULL, V111, P1486, DOI 10.1130/0016-7606(1999)111<1486:LPHROT>2.3.CO;2; Tucker P.M, 1973, PITFALLS SEISMIC INT; [No title captured]	24	118	118	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1835	1838		10.1126/science.1138393	http://dx.doi.org/10.1126/science.1138393			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17332378				2022-12-28	WOS:000245280100040
J	Sahdev, A				Sahdev, A.			Imaging the endometrium in postmenopausal bleeding	BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; SONOGRAPHY; CARCINOMA; TAMOXIFEN; WOMEN		St Bartholomews Hosp, Dept Radiol, London EC1A 7BE, England	University of London; Queen Mary University London	Sahdev, A (corresponding author), St Bartholomews Hosp, Dept Radiol, London EC1A 7BE, England.	anju.Sahdev@bartsandthelondon.nhs.uk						Ciatto S, 2003, BRIT J CANCER, V88, P1175, DOI 10.1038/sj.bjc.6600894; Fishman A, 2000, EUR J GYNAECOL ONCOL, V21, P128; Gerber B, 2000, J CLIN ONCOL, V18, P3464, DOI 10.1200/JCO.2000.18.20.3464; HULKA CA, 1994, RADIOLOGY, V191, P755, DOI 10.1148/radiology.191.3.8184058; Manfredi R, 2004, RADIOLOGY, V231, P372, DOI 10.1148/radiol.2312021184; *NHS EX, 1999, GUID COMM CANC SERV; *SIGN, 2002, INV POST MEN BLEED	7	4	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 24	2007	334	7594					635	636		10.1136/bmj.39126.628924.BE	http://dx.doi.org/10.1136/bmj.39126.628924.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	152DC	17379910	Green Published			2022-12-28	WOS:000245340000038
J	Kawasaki, S; Kawasaki, T				Kawasaki, Shingo; Kawasaki, Tatsuya			Evolution of a thoracic aortic aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Matsushita Mem Hosp, Moriguchi, Osaka 5708540, Japan		Kawasaki, S (corresponding author), Matsushita Mem Hosp, Moriguchi, Osaka 5708540, Japan.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1251	1251		10.1056/NEJMicm060473	http://dx.doi.org/10.1056/NEJMicm060473			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377163				2022-12-28	WOS:000245101900010
J	Williams, G				Williams, Gareth			Should we ditch impact factors? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Bristol, Fac Med & Dent, Bristol BS2 8DZ, Avon, England	University of Bristol	Williams, G (corresponding author), Univ Bristol, Fac Med & Dent, Bristol BS2 8DZ, Avon, England.	gareth.williams@bris.ac.uk		hobbs, richard/0000-0001-7976-7172					0	34	35	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 17	2007	334	7593					568	568		10.1136/bmj.39146.549225.BE	http://dx.doi.org/10.1136/bmj.39146.549225.BE			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AP	17363827	Green Published			2022-12-28	WOS:000245404400032
J	Steinbrook, R				Steinbrook, Robert			HIV in India - A complex epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HIV/AIDS					rsteinbrook@attglobal.net						Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Dandona L, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-31; Kumar R, 2006, LANCET, V367, P1164, DOI 10.1016/S0140-6736(06)68435-3; O'Neil J, 2004, SOC SCI MED, V59, P851, DOI 10.1016/j.socscimed.2003.11.032; SIMOES EAF, 1987, INDIAN J MED RES, V85, P335	5	83	85	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2007	356	11					1089	1093		10.1056/NEJMp078009	http://dx.doi.org/10.1056/NEJMp078009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	145PO	17360986	Bronze			2022-12-28	WOS:000244877200001
J	Dube, C; Rostom, A; Lewin, G; Tsertsvadze, A; Barrowman, N; Code, C; Sampson, M; Moher, D				Dube, Catherine; Rostom, Alaa; Lewin, Gabriela; Tsertsvadze, Alexander; Barrowman, Nicholas; Code, Catherine; Sampson, Margaret; Moher, David			The use of aspirin for primary prevention of colorectal cancer: A systematic review prepared for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LOW-DOSE ASPIRIN; LONG-TERM USE; REDUCED RISK; GASTROINTESTINAL COMPLICATIONS; BLEEDING COMPLICATIONS; CARDIOVASCULAR EVENTS; METAANALYSIS; COLON; STATISTICS	Background: Aspirin for prevention of colorectal cancer is controversial. Purpose: To examine the benefits and harms of aspirin chemoprevention. Data Sources: MEDLINE, 1966 to December 2006; EMBASE, 1980 to April 2005; CENTRAL, Cochrane Collaboration's registry of clinical trials; Cochrane Database of Systematic Reviews. Study Selection: Two independent reviewers conducted multilevel screening to identify randomized, controlled trials (RCTs), case-control studies, and cohort studies of aspirin chemoprophylaxis. For harms, systematic reviews were sought. Data Extraction: In duplicate, data were abstracted and checked and quality was assessed. Data Synthesis: Regular use of aspirin reduced the incidence of colonic adenomas in RCTs (relative risk [RR], 0.82 [95% CI, 0.7 to 0.95]), case-control studies (RR, 0.87 [CI, 0.77 to 0.98]), and cohort studies (RR, 0.72 [CI, 0.61 to 0.85]). In cohort studies, regular use of aspirin was associated with RR reductions of 22% for incidence of colorectal cancer. Two RCTs of low-dose aspirin failed to show a protective effect. Data for colorectal cancer mortality were limited. Benefits from chemoprevention were more evident when aspirin was used at a high dose and for periods longer than 10 years. Aspirin use was associated with a dose-related increase in incidence of gastrointestinal complications. Limitations: Important clinical and methodological heterogeneity in the definitions of regular use, dose, and duration of use of aspirin necessitated careful grouping for analysis. Conclusions: Aspirin appears to be effective at reducing the incidence of colonic adenoma and colorectal cancer, especially if used in high doses for more than 10 years. However, the possible harms of such a practice require careful consideration. Further evaluation of the cost-effectiveness of chemoprevention compared with, and in combination with, a screening strategy is required.	Univ Calgary, Med Clin, Div Gastroenterol, Calgary, AB T2N 4N1, Canada; Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON, Canada; Carleton Univ, Ottawa, ON K1S 5B6, Canada	University of Calgary; University of Ottawa; Children's Hospital of Eastern Ontario; Carleton University	Rostom, A (corresponding author), Univ Calgary, Med Clin, Div Gastroenterol, 3330 Hosp Dr NW,G176, Calgary, AB T2N 4N1, Canada.	arostom@ucalgary.ca	Barrowman, Nick/AAL-3166-2020	Barrowman, Nick/0000-0002-4704-9595; Sampson, Margaret/0000-0003-2550-9893; Moher, David/0000-0003-2434-4206				ASANO TK, 2004, COCHRANE DATABASE SY; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Bartolucci AA, 2006, AM J CARDIOL, V98, P746, DOI 10.1016/j.amjcard.2006.04.012; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Breuer-Katschinski B, 2000, DIGESTION, V61, P129, DOI 10.1159/000007745; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P162; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P193; Chan AT, 2004, ANN INTERN MED, V140, P157, DOI 10.7326/0003-4819-140-3-200402030-00006; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; Coogan PF, 2000, CANCER CAUSE CONTROL, V11, P249, DOI 10.1023/A:1008931708716; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Friedman GD, 1998, PHARMACOEPIDEM DR S, V7, P99, DOI 10.1002/(SICI)1099-1557(199803/04)7:2<99::AID-PDS320>3.0.CO;2-0; Friis S, 2003, BRIT J CANCER, V88, P684, DOI 10.1038/sj.bjc.6600760; GANN PH, 1993, JNCI-J NATL CANCER I, V85, P1220, DOI 10.1093/jnci/85.15.1220; Gibbs Winter J, 2004, Cardiol Rev, V12, P327, DOI 10.1097/01.crd.0000128731.70567.0e; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; GREENBERG ER, 1993, JNCI-J NATL CANCER I, V85, P912, DOI 10.1093/jnci/85.11.912; Hart RG, 2000, ARCH NEUROL-CHICAGO, V57, P326, DOI 10.1001/archneur.57.3.326; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; He J, 1998, JAMA-J AM MED ASSOC, V280, P1930, DOI 10.1001/jama.280.22.1930; Henry D, 1996, BRIT MED J, V312, P1563, DOI 10.1136/bmj.312.7046.1563; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Juarranz M, 2002, EUR J CANCER PREV, V11, P465, DOI 10.1097/00008469-200210000-00009; Kahn HS, 1998, J GEN INTERN MED, V13, P303, DOI 10.1046/j.1525-1497.1998.00095.x; Kune GA, 2007, INT J EPIDEMIOL, V36, P951, DOI 10.1093/ije/dym193; LaVecchia C, 1997, BRIT J CANCER, V76, P675, DOI 10.1038/bjc.1997.444; LIP GY, 2004, COCHRANE DATABASE SY; LOGAN RFA, 1993, BRIT MED J, V307, P285, DOI 10.1136/bmj.307.6899.285; Main C, 2004, HEALTH TECHNOL ASSES, V8, P1; Morimoto LM, 2002, CANCER EPIDEM BIOMAR, V11, P1012; PAGANINIHILL A, 1995, PREV MED, V24, P113, DOI 10.1006/pmed.1995.1020; *POL PREV STUD GRO, 2003, CANC CAUS CONTR, V14, P403; Reese S, 2001, JAMA-J AM MED ASSOC, V285, P1570; Reeves MJ, 1996, CANCER EPIDEM BIOMAR, V5, P955; RODERICK PJ, 1993, BRIT J CLIN PHARMACO, V35, P219, DOI 10.1111/j.1365-2125.1993.tb05689.x; Rodriguez LAG, 2000, EPIDEMIOLOGY, V11, P376, DOI 10.1097/00001648-200007000-00003; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; Rodriguez LAG, 2001, BRIT J CLIN PHARMACO, V52, P563, DOI 10.1046/j.0306-5251.2001.01476.x; Rosenberg L, 1998, CANCER-AM CANCER SOC, V82, P2326, DOI 10.1002/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q; Rostom A, 2002, COCHRANE DATABASE SY; ROSTOM A, 2006, USE ASPIRIN NSAIDS P; ROSTOM A, 2004, GASTRODUODENAL ULCER; Sandler RS, 1998, GASTROENTEROLOGY, V114, P441, DOI 10.1016/S0016-5085(98)70526-8; SCHREINEMACHERS DM, 1994, EPIDEMIOLOGY, V5, P138, DOI 10.1097/00001648-199403000-00003; Seeff LC, 2004, CANCER-AM CANCER SOC, V100, P2093, DOI 10.1002/cncr.20276; Serebruany VL, 2005, AM J CARDIOL, V95, P1218, DOI 10.1016/j.amjcard.2005.01.049; Serebruany VL, 2004, AM J HEMATOL, V75, P40, DOI 10.1002/ajh.10451; Slattery ML, 2004, CANCER EPIDEM BIOMAR, V13, P538; Sturmer T, 1998, ANN INTERN MED, V128, P713, DOI 10.7326/0003-4819-128-9-199805010-00003; SUH O, 1993, CANCER-AM CANCER SOC, V72, P1171, DOI 10.1002/1097-0142(19930815)72:4<1171::AID-CNCR2820720407>3.0.CO;2-D; Thiis-Evensen E, 1999, SCAND J GASTROENTERO, V34, P414; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; Tramer MR, 2000, PAIN, V85, P169, DOI 10.1016/S0304-3959(99)00267-5; Wang WH, 2003, JNCI-J NATL CANCER I, V95, P1784, DOI 10.1093/jnci/djg106; Weisman SM, 2002, ARCH INTERN MED, V162, P2197, DOI 10.1001/archinte.162.19.2197	61	257	263	1	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2007	146	5					365	375		10.7326/0003-4819-146-5-200703060-00009	http://dx.doi.org/10.7326/0003-4819-146-5-200703060-00009			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144XK	17339622				2022-12-28	WOS:000244829600006
J	Rocco, B; Djavan, B				Rocco, Bernardo; Djavan, Bob			Robotic prostatectomy: facts or fiction?	LANCET			English	Editorial Material							LAPAROSCOPIC RADICAL PROSTATECTOMY; OUTCOMES; CANCER		European Inst Oncol, Dept Urol, I-20141 Milan, Italy; Univ Vienna, Dept Urol, Vienna, Austria	IRCCS European Institute of Oncology (IEO); University of Vienna	Rocco, B (corresponding author), European Inst Oncol, Dept Urol, I-20141 Milan, Italy.	bernardo.rocco@ieo.it	Rocco, Bernardo/R-4041-2016	Rocco, Bernardo/0000-0002-9135-0035				Ahlering TE, 2004, UROLOGY, V63, P819, DOI 10.1016/j.urology.2004.01.038; Ahlering TE, 2003, J UROLOGY, V170, P1738, DOI 10.1097/01.ju.0000092881.24608.5e; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Burgess SV, 2006, J ENDOUROL, V20, P827, DOI 10.1089/end.2006.20.827; Descazeaud A, 2007, EUR UROL, V51, P9, DOI 10.1016/j.eururo.2006.10.007; Ficarra V, 2007, EUR UROL, V51, P45, DOI 10.1016/j.eururo.2006.06.017; Han M, 2004, J UROLOGY, V171, P23, DOI 10.1097/01.ju.0000098604.09395.27; Lepor Herbert, 2005, Rev Urol, V7 Suppl 2, pS11; Lotan Y, 2004, J UROLOGY, V172, P1431, DOI 10.1097/01.ju.0000139714.09832.47; Menon M, 2005, UROLOGY, V66, P101, DOI 10.1016/j.urology.2005.06.008; Menon M, 2007, EUR UROL, V51, P648, DOI 10.1016/j.eururo.2006.10.055; Penson DF, 2005, J UROLOGY, V173, P1701, DOI 10.1097/01.ju.0000154637.38262.3a; Rassweiler J, 2006, EUR UROL, V49, P612, DOI 10.1016/j.eururo.2005.12.054; Smith JA, 2005, J CLIN ONCOL, V23, P8170, DOI 10.1200/JCO.2005.03.1963; Tewari Ashutosh, 2003, Rev Urol, V5 Suppl 6, pS33; *UK OFF NAT STAT, CANC INC MORT UK 200; *US NAT CANC I, SURV EP END RES CAND	17	14	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2007	369	9563					723	724		10.1016/S0140-6736(07)60336-5	http://dx.doi.org/10.1016/S0140-6736(07)60336-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143MP	17336632				2022-12-28	WOS:000244726700008
J	Smellie, WSA; Heald, A				Smellie, W. Stuart A.; Heald, A.			Cases in primary care laboratory medicine - Hyponatraemia and hypernatraemia: pitfalls in testing	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SECRETION		Gen Hosp, Clin Lab, Bishop Auckland DL14 6AD, England; Gen Hosp, Dept Med, Bishop Auckland, England		Smellie, WSA (corresponding author), Gen Hosp, Clin Lab, Bishop Auckland DL14 6AD, England.	info@smellie.com						Hawkins RC, 2003, CLIN CHIM ACTA, V337, P169, DOI 10.1016/j.cccn.2003.08.001; Jones RP, 1997, CLIN INVESTIGATION S, P196; KAMOI K, 1993, J CLIN ENDOCR METAB, V77, P1584, DOI 10.1210/jc.77.6.1584; Kugler JP, 2000, AM FAM PHYSICIAN, V61, P3623; Lang T, 2002, ANN CLIN BIOCHEM, V39, P66, DOI 10.1258/0004563021901586; Milionis HJ, 2002, CAN MED ASSOC J, V166, P1056; ORAHILLY S, 1985, BRIT MED J, V290, P1803, DOI 10.1136/bmj.290.6484.1803; Penney MSodiu, 1995, CLIN BIOCH METABOLIC, P25; Reynolds RM, 2006, BMJ-BRIT MED J, V332, P702, DOI 10.1136/bmj.332.7543.702; SMELLIE WSA, 2006, J CLIN PATHOL   1215; 2005, HYPERNATRAEMIA	11	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2007	334	7591					473	476		10.1136/bmj.39098.744560.47	http://dx.doi.org/10.1136/bmj.39098.744560.47			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144NB	17332587	Green Published			2022-12-28	WOS:000244802000035
J	Coombes, R				Coombes, Rebecca			Medicine and the media - Having the last laugh at big pharma - How campaigners are creating humorous videos to hit back at the drug industry	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmjgroup.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 24	2007	334	7590					396	397		10.1136/bmj.39133.480880.59	http://dx.doi.org/10.1136/bmj.39133.480880.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	142MQ	17322252	Green Published			2022-12-28	WOS:000244654400025
J	Yang, PK; Kuroda, MI				Yang, Pok Kwan; Kuroda, Mitzi I.			Noncoding RNAs and intranuclear positioning in monoallelic gene expression	CELL			English	Review							IMPRINTING CONTROL REGION; INACTIVE X-CHROMOSOME; REPRESSIVE HISTONE METHYLATION; INTERGENIC TRANSCRIPTION; ANTISENSE TRANSCRIPTION; CHROMATIN CONFORMATION; PROMOTER DETERMINES; EPIGENETIC DYNAMICS; DOSAGE COMPENSATION; XIST TRANSCRIPTION		Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Partners Ctr Genet & Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Harvard University; Harvard Medical School	Kuroda, MI (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	mkuroda@genetics.med.harvard.edu						Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Brannan CI, 1999, CURR OPIN GENET DEV, V9, P164, DOI 10.1016/S0959-437X(99)80025-2; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Capelson M, 2004, BIOL CELL, V96, P617, DOI 10.1016/j.biolcel.2004.06.004; Carninci P, 2006, TRENDS GENET, V22, P501, DOI 10.1016/j.tig.2006.07.003; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chen JJ, 2005, TRENDS GENET, V21, P326, DOI 10.1016/j.tig.2005.04.006; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Chevillard C, 2002, J IMMUNOL, V168, P5659, DOI 10.4049/jimmunol.168.11.5659; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Coombes C, 2003, MOL CELL BIOL, V23, P5475, DOI 10.1128/MCB.23.16.5475-5488.2003; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Fang J, 2004, J BIOL CHEM, V279, P52812, DOI 10.1074/jbc.C400493200; Ficz G, 2005, DEVELOPMENT, V132, P3963, DOI 10.1242/dev.01950; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Frith MC, 2005, EUR J HUM GENET, V13, P894, DOI 10.1038/sj.ejhg.5201459; Goldmit M, 2004, IMMUNOL REV, V200, P197, DOI 10.1111/j.0105-2896.2004.00158.x; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Ischia R, 1997, J BIOL CHEM, V272, P11657; Johnson K, 2005, MOL IMMUNOL, V42, P749, DOI 10.1016/j.molimm.2004.06.039; Johnson K, 2004, NAT IMMUNOL, V5, P853, DOI 10.1038/ni1099; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Jones BK, 1998, GENE DEV, V12, P2200, DOI 10.1101/gad.12.14.2200; Kalantry S, 2006, NAT CELL BIOL, V8, P195, DOI 10.1038/ncb1351; Kalantry S, 2006, PLOS GENET, V2, P656, DOI 10.1371/journal.pgen.0020066; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kanduri C, 2006, EMBO J, V25, P2096, DOI 10.1038/sj.emboj.7601090; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kelsey G, 1999, GENOMICS, V62, P129, DOI 10.1006/geno.1999.6022; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; Leighton PA, 1996, BIOL REPROD, V54, P273, DOI 10.1095/biolreprod54.2.273; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Lewis A, 2006, DEVELOPMENT, V133, P4203, DOI 10.1242/dev.02612; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Liu J, 2000, MOL CELL BIOL, V20, P5808, DOI 10.1128/MCB.20.16.5808-5817.2000; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Mahy NL, 2002, J CELL BIOL, V159, P753, DOI 10.1083/jcb.200207115; Mahy NL, 2002, J CELL BIOL, V157, P579, DOI 10.1083/jcb.200111071; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Mann JR, 2000, CRIT REV EUKAR GENE, V10, P241; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Navarro P, 2005, GENE DEV, V19, P1474, DOI 10.1101/gad.341105; Navarro P, 2006, GENE DEV, V20, P2787, DOI 10.1101/gad.389006; O'Neill LP, 2003, HUM MOL GENET, V12, P1783, DOI 10.1093/hmg/ddg193; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Ogawa Y, 2002, CYTOGENET GENOME RES, V99, P59, DOI 10.1159/000071575; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Parada LA, 2004, EXP CELL RES, V296, P64, DOI 10.1016/j.yexcr.2004.03.013; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2004, COLD SPRING HARB SYM, V69, P29, DOI 10.1101/sqb.2004.69.29; Sado T, 2005, DEV CELL, V9, P159, DOI 10.1016/j.devcel.2005.05.015; Sado T, 2001, DEVELOPMENT, V128, P1275; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Smith RJ, 2004, CYTOGENET GENOME RES, V105, P335, DOI 10.1159/000078206; Soares LMM, 2006, EMBO J, V25, P923, DOI 10.1038/sj.emboj.7601023; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Terryn N, 2000, TRENDS PLANT SCI, V5, P394, DOI 10.1016/S1360-1385(00)01696-4; Thakur N, 2004, MOL CELL BIOL, V24, P7855, DOI 10.1128/MCB.24.18.7855-7862.2004; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tycko B, 2002, NATURE, V417, P913, DOI 10.1038/417913a; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Williamson CM, 2006, NAT GENET, V38, P350, DOI 10.1038/ng1731; Williamson CM, 2004, NAT GENET, V36, P894, DOI 10.1038/ng1398; Wroe SF, 2000, P NATL ACAD SCI USA, V97, P3342, DOI 10.1073/pnas.050015397; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Yamasaki Y, 2005, HUM MOL GENET, V14, P2511, DOI 10.1093/hmg/ddi255; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zwart R, 2001, GENE DEV, V15, P2361, DOI 10.1101/gad.206201	104	86	99	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2007	128	4					777	786		10.1016/j.cell.2007.01.032	http://dx.doi.org/10.1016/j.cell.2007.01.032			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148TX	17320513	Bronze			2022-12-28	WOS:000245098600018
J	Sebat, J; Lakshmi, B; Malhotra, D; Troge, J; Lese-Martin, C; Walsh, T; Yamrom, B; Yoon, S; Krasnitz, A; Kendall, J; Leotta, A; Pai, D; Zhang, R; Lee, YH; Hicks, J; Spence, SJ; Lee, AT; Puura, K; Lehtimaki, T; Ledbetter, D; Gregersen, PK; Bregman, J; Sutcliffe, JS; Jobanputra, V; Chung, W; Warburton, D; King, MC; Skuse, D; Geschwind, DH; Gilliam, TC; Ye, K; Wigler, M				Sebat, Jonathan; Lakshmi, B.; Malhotra, Dheeraj; Troge, Jennifer; Lese-Martin, Christa; Walsh, Tom; Yamrom, Boris; Yoon, Seungtai; Krasnitz, Alex; Kendall, Jude; Leotta, Anthony; Pai, Deepa; Zhang, Ray; Lee, Yoon-Ha; Hicks, James; Spence, Sarah J.; Lee, Annette T.; Puura, Kaija; Lehtimaeki, Terho; Ledbetter, David; Gregersen, Peter K.; Bregman, Joel; Sutcliffe, James S.; Jobanputra, Vaidehi; Chung, Wendy; Warburton, Dorothy; King, Mary-Claire; Skuse, David; Geschwind, Daniel H.; Gilliam, T. Conrad; Ye, Kenny; Wigler, Michael			Strong association of de novo copy number mutations with autism	SCIENCE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; COMMON FRAGILE SITES; DELETION; GENE	We tested the hypothesis that de novo copy number variation (CNV) is associated with autism spectrum disorders (ASDs). We performed comparative genomic hybridization (CGH) on the genomic DNA of patients and unaffected subjects to detect copy number variants not present in their respective parents. Candidate genomic regions were validated by higher-resolution CGH, paternity testing, cytogenetics, fluorescence in situ hybridization, and microsatellite genotyping. Confirmed de novo CNVs were significantly associated with autism ( P = 0.0005). Such CNVs were identified in 12 out of 118 (10%) of patients with sporadic autism, in 2 out of 77 (3%) of patients with an affected first-degree relative, and in 2 out of 196 (1%) of controls. Most de novo CNVs were smaller than microscopic resolution. Affected genomic regions were highly heterogeneous and included mutations of single genes. These findings establish de novo germline mutation as a more significant risk factor for ASD than previously recognized.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; Univ Washington, Dept Med & Genome Sci, Seattle, WA 98195 USA; NIMH, Pediat & Neurodev Psychiat Branch, NIH, Bethesda, MD 20892 USA; N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA; Univ Tampere, Sch Med, Dept Child Psychiat, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Dept Clin Chem, FIN-33521 Tampere, Finland; N Shore Long Isl Jewish Hlth Syst, Fay J Lindner Ctr Autism & Dev Disorders, Bethpage, NY 11714 USA; Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10027 USA; Columbia Univ, Dept Pediat, New York, NY 10027 USA; UCL, Inst Child Hlth, Behav & Brain Sci Unit, London WC1N 1EH, England; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet,Interdept Program Neurosci, Los Angeles, CA 90095 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA	Cold Spring Harbor Laboratory; Emory University; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Northwell Health; Tampere University; Tampere University; Tampere University Hospital; Northwell Health; Vanderbilt University; Columbia University; Columbia University; University of London; University College London; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Chicago; Yeshiva University; Albert Einstein College of Medicine	Wigler, M (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	sebat@cshl.edu; wigler@cshl.edu	Sutcliffe, James S/C-1348-2012; Puura, Kaija/ADG-7880-2022; Ye, Kenny/U-2341-2019; Lehtimäki, Terho/AAD-1094-2022; Ye, Kenny/GSM-7731-2022; Warfield, Simon/B-3352-2009	Sutcliffe, James S/0000-0001-5200-6007; Ye, Kenny/0000-0002-1466-855X; Lehtimäki, Terho/0000-0002-2555-4427; Warfield, Simon/0000-0002-7659-3880; King, Mary-Claire/0000-0001-9426-1743; Wigler, Michael/0000-0003-4396-1971; Sebat, Jonathan/0000-0002-9087-526X; Walsh, Tom/0000-0002-8875-0310	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547, R01MH076431, R01MH061009] Funding Source: NIH RePORTER; NIMH NIH HHS [MH076431, MH64547, R01 MH064547, R01 MH061009, R01 MH076431-01, MH61009, R01 MH076431] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bhalla K, 2004, J HUM GENET, V49, P308, DOI 10.1007/s10038-004-0145-4; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; *EUR CONS TUB SCLE, 1993, CELL, V75, P130; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; Ghaziuddin M, 1999, J AUTISM DEV DISORD, V29, P259, DOI 10.1023/A:1023088207468; GOSPE SM, 1989, NEUROLOGY, V39, P1277, DOI 10.1212/WNL.39.10.1277; Huebner K, 2001, NAT REV CANCER, V1, P214, DOI 10.1038/35106058; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Igarashi T, 2001, J AM SOC NEPHROL, V12, P713, DOI 10.1681/ASN.V124713; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klauck SM, 2006, EUR J HUM GENET, V14, P714, DOI 10.1038/sj.ejhg.5201610; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Manning MA, 2004, PEDIATRICS, V114, P451, DOI 10.1542/peds.114.2.451; ORYE E, 1971, LANCET, V2, P1376; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Smith DI, 2006, CANCER LETT, V232, P48, DOI 10.1016/j.canlet.2005.06.049; Veenstra-VanderWeele J, 2004, MOL PSYCHIATR, V9, P819, DOI 10.1038/sj.mp.4001505; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757	30	1954	2143	27	403	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					445	449		10.1126/science.1138659	http://dx.doi.org/10.1126/science.1138659			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17363630	Green Accepted			2022-12-28	WOS:000245813400056
J	Huikeshoven, M; Koster, PHL; de Borgie, CAJM; Beek, JF; van Gemert, MJC; van der Horst, CMAM				Huikeshoven, Menno; Koster, Petra H. L.; de Borgie, Corianne A. J. M.; Beek, Johan F.; van Gemert, Martin J. C.; van der Horst, Chantal M. A. M.			Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EFFICACY	Background: Although pulsed-dye-laser therapy is currently the gold standard for the treatment of port-wine stains, few objective data are available on its long-term efficacy. Using objective color measurements, we performed a 10-year follow-up of a previously conducted prospective clinical study of the treatment of port-wine stains with a pulsed-dye laser. Methods: We invited the patients to undergo repeated color measurements performed by the same procedures as in the previous study. The results at long-term follow-up were compared with color measurements obtained before treatment and after completion of an average of five laser treatments of the complete port-wine stain. A questionnaire was used to investigate patients' satisfaction with the treatment and their perception of long-term changes in the stain. Results: Of the 89 patients from whom color measurements were obtained in the previous study, 51 were included in this study. The patients had received a median of seven additional treatment sessions since the last color measurement, which had been made after an average of five treatments. The median length of follow-up was 9.5 years. On average, the stain when measured at follow-up was significantly darker than it was when measured after the last of the initial five laser treatments (P=0.001), but it was still significantly lighter than it was when measured before treatment (P<0.001). Fifty-nine percent of patients were satisfied with the overall treatment result. Six percent of patients reported that the stain had become lighter since their last treatment, 59% that it was unchanged, and 35% that it had become darker. Conclusions: Using objective color measurements, we observed significant redarkening of port-wine stains at long-term follow-up after pulsed-dye-laser therapy. Patients should be informed about the possibility of redarkening before beginning treatment.	Univ Amsterdam, Acad Med Ctr, Dept Plast Reconstruct & Hand Surg, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Ctr Laser, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Huikeshoven, M (corresponding author), Univ Amsterdam, Acad Med Ctr G4 226, Dept Plast Reconstruct & Hand Surg, Meibergdreeef 9, NL-1105 AZ Amsterdam, Netherlands.	m.huikeshoven@amc.uva.nl		van der Horst, chantal/0000-0002-4937-3786				BARSKY SH, 1980, J INVEST DERMATOL, V74, P154, DOI 10.1111/1523-1747.ep12535052; BRAINARD DH, 1995, HDB OPTICS, V1; Breugem CC, 2005, PLAST RECONSTR SURG, V115, P578, DOI 10.1097/01.PRS.0000150150.69479.70; Hansen K, 2003, DERMATOL SURG, V29, P49, DOI 10.1046/j.1524-4725.2003.29010.x; Heger M, 2005, THROMB HAEMOSTASIS, V93, P242, DOI 10.1160/TH04-05-0291; Ho WS, 2002, LASER SURG MED, V30, P44, DOI 10.1002/lsm.10003; Koster PHL, 1998, PLAST RECONSTR SURG, V102, P1210, DOI 10.1097/00006534-199809040-00047; Michel S, 2000, BRIT J DERMATOL, V143, P1230, DOI 10.1046/j.1365-2133.2000.03893.x; MORK NJ, 1998, J EUR ACAD DERMATOL, V11, pS142; Orten SS, 1996, ARCH OTOLARYNGOL, V122, P1174; Ozluer SM, 2001, CLIN EXP DERMATOL, V26, P37, DOI 10.1046/j.1365-2230.2001.00756.x; ROSEN S, 1987, J AM ACAD DERMATOL, V17, P164, DOI 10.1016/S0190-9622(87)70186-8; TAN OT, 1989, NEW ENGL J MED, V320, P416, DOI 10.1056/NEJM198902163200702; TAN OT, 1992, MANAGEMENT TREATMENT, P83; Troilius A, 2000, DERMATOL SURG, V26, P190, DOI 10.1046/j.1524-4725.2000.09204.x; van der Horst CMAM, 1998, NEW ENGL J MED, V338, P1028, DOI 10.1056/NEJM199804093381504	16	92	98	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1235	1240		10.1056/NEJMoa064329	http://dx.doi.org/10.1056/NEJMoa064329			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377161				2022-12-28	WOS:000245101900008
J	Meyer, JR; Kassen, R				Meyer, Justin R.; Kassen, Rees			The effects of competition and predation on diversification in a model adaptive radiation	NATURE			English	Article							PROMOTES DIVERGENCE; EVOLUTION; DIVERSITY; PREY	Much of life's diversity is thought to have arisen through successive rounds of adaptive radiation - the rapid diversification of a lineage into a range of ecologically and phenotypically distinct species(1-3). Both resource competition and predation have been suggested as mechanisms driving this process(4,5), although the former is better studied than the latter(6,7). Here we show experimentally how predation by a protist, Tetrahymena thermophila, affects diversification in a model adaptive radiation of the bacterial prey, Pseudomonas fluorescens. We estimate the frequency-dependent fitness functions of competing niche-specialist prey in the presence and absence of predation, and use these to test hypotheses about the extent ( measured as the number of new genotypes) and rate of diversification. Competition and predation independently generated diversifying selection that we show is capable of driving prey diversification to similar extents but at different rates, diversification being markedly delayed in the presence of predators. The cause of this delay stems from weaker diversifying selection due to the reduction in prey density caused by predation. Our results suggest that predation may play an under-appreciated role in driving adaptive radiations.	Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Ctr Adv Res Environm Genom, Ottawa, ON K1N 6N5, Canada	University of Ottawa; University of Ottawa	Meyer, JR (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada.	justin.raymond.meyer@gmail.com						BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Bohannan BJM, 1999, AM NAT, V153, P73, DOI 10.1086/303151; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; CLARKE B, 1988, FREQUENCY DEPENDENT; Fryer G, 1972, CICHLID FISHES GREAT; Goymer P, 2006, GENETICS, V173, P515, DOI 10.1534/genetics.106.055863; Grant PR, 1998, EVOLUTION ISLANDS; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; Jablonski D, 1996, ECOLOGY, V77, P1367, DOI 10.2307/2265534; Jablonski D, 1999, SCIENCE, V284, P2114, DOI 10.1126/science.284.5423.2114; Kassen R, 2004, NATURE, V431, P984, DOI 10.1038/nature02923; Lack D., 1947, DARWINS FINCHES; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; MacLean RC, 2004, P NATL ACAD SCI USA, V101, P8072, DOI 10.1073/pnas.0307195101; Nosil P, 2006, P NATL ACAD SCI USA, V103, P9090, DOI 10.1073/pnas.0601575103; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rundle HD, 2003, P NATL ACAD SCI USA, V100, P14943, DOI 10.1073/pnas.2036360100; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schrag SJ, 1996, AM NAT, V148, P348, DOI 10.1086/285929; SEPKOSKI JJ, 1984, PALEOBIOLOGY, V10, P246, DOI 10.1017/S0094837300008186; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Travisano M, 2000, AM NAT, V156, pS35, DOI 10.1086/303414; Vamosi SM, 2005, CAN J ZOOL, V83, P894, DOI 10.1139/Z05-063; VANVALEN L, 1974, J THEOR BIOL, V44, P19, DOI 10.1016/S0022-5193(74)80026-3; WALKER TD, 1984, AM NAT, V124, P887, DOI 10.1086/284322; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337	30	152	153	2	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					432	435		10.1038/nature05599	http://dx.doi.org/10.1038/nature05599			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17377581				2022-12-28	WOS:000245079500038
J	White, C				White, Christopher			Intermittent claudication	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERIPHERAL ARTERIAL-DISEASE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROSPECTIVE RANDOMIZED-TRIAL; EXCIMER-LASER ANGIOPLASTY; LOWER-EXTREMITY; ENDOVASCULAR BRACHYTHERAPY; BALLOON ANGIOPLASTY; MEDICAL-TREATMENT; LONG; PREVALENCE		Ochsner Med Ctr, Dept Cardiol, New Orleans, LA 70121 USA	Ochsner Health System	White, C (corresponding author), Ochsner Med Ctr, Dept Cardiol, 1514 Jefferson Hwy, New Orleans, LA 70121 USA.	cwhite@ochsner.org	White, Christopher J/J-6686-2012	White, Christopher J/0000-0001-8618-7539				Aquino R, 2001, J VASC SURG, V34, P962, DOI 10.1067/mva.2001.119749; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bendermacher BLW, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005263.pub2; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clark TWI, 2001, J VASC INTERV RADIOL, V12, P923, DOI 10.1016/S1051-0443(07)61570-X; Dawson DL, 2000, AM J MED, V109, P523, DOI 10.1016/S0002-9343(00)00569-6; de Vries SO, 2002, RADIOLOGY, V222, P25, DOI 10.1148/radiol.2221001743; Diehm N, 2005, J ENDOVASC THER, V12, P723, DOI 10.1583/05-1583MR.1; Duda SH, 2005, J VASC INTERV RADIOL, V16, P331, DOI 10.1097/01.RVI.0000151260.74519.CA; Feinglass J, 2000, J VASC SURG, V31, P93, DOI 10.1016/S0741-5214(00)70071-1; *FOOD DRUG ADM, P040037 PMA FOOD DRU; GARDNER AW, 1995, JAMA-J AM MED ASSOC, V274, P975, DOI 10.1001/jama.274.12.975; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gradinscak DJ, 2004, AM J ROENTGENOL, V183, P377, DOI 10.2214/ajr.183.2.1830377; Hankey GJ, 2006, JAMA-J AM MED ASSOC, V295, P547, DOI 10.1001/jama.295.5.547; Hiatt WR, 2001, NEW ENGL J MED, V344, P1608, DOI 10.1056/NEJM200105243442108; Hirsch AT, 2006, J AM COLL CARDIOL, V47, P1239, DOI 10.1016/j.jacc.2005.10.009; Holm J, 1991, Eur J Vasc Surg, V5, P517, DOI 10.1016/S0950-821X(05)80338-X; KANNEL WB, 1970, CIRCULATION, V41, P875, DOI 10.1161/01.CIR.41.5.875; Laird JR, 2006, J ENDOVASC THER, V13, P52, DOI 10.1583/05-1755.1; Lederman RJ, 2002, LANCET, V359, P2053, DOI 10.1016/S0140-6736(02)08937-7; LENG G, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD000990; LUNDGREN F, 1989, ANN SURG, V209, P346, DOI 10.1097/00000658-198903000-00016; McDermott MM, 2001, J GEN INTERN MED, V16, P384, DOI 10.1046/j.1525-1497.2001.016006384.x; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; Muluk SC, 2001, J VASC SURG, V33, P251, DOI 10.1067/mva.2001.112210; Muradin GSR, 2001, RADIOLOGY, V221, P137, DOI 10.1148/radiol.2211010039; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Ouwendijk R, 2005, RADIOLOGY, V236, P1094, DOI 10.1148/radiol.2363041140; Pasternak RC, 2004, CIRCULATION, V109, P2605, DOI 10.1161/01.CIR.0000128518.26834.93; Perkins JMT, 1996, EUR J VASC ENDOVASC, V11, P409, DOI 10.1016/S1078-5884(96)80171-7; Scheinert D, 2005, J AM COLL CARDIOL, V45, P312, DOI 10.1016/j.jacc.2004.11.026; Scheinert D, 2001, J ENDOVASC THER, V8, P156, DOI 10.1583/1545-1550(2001)008<0156:ELAROL>2.0.CO;2; Schillinger M, 2006, NEW ENGL J MED, V354, P1879, DOI 10.1056/NEJMoa051303; Schmieder FA, 2001, AM J CARDIOL, V87, p3D; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Singh H, 2002, J VASC INTERV RADIOL, V13, P1, DOI 10.1016/S1051-0443(07)60001-3; Spronk S, 2005, RADIOLOGY, V235, P833, DOI 10.1148/radiol.2353040457; Strandness D Eugene Jr, 2002, Vasc Endovascular Surg, V36, P83, DOI 10.1177/153857440203600202; Suri R, 2006, CATHETER CARDIO INTE, V67, P417, DOI 10.1002/ccd.20634; Therasse E, 2005, CIRCULATION, V111, P3310, DOI 10.1161/CIRCULATIONAHA.104.502179; Visona A, 1998, ANGIOLOGY, V49, P91, DOI 10.1177/000331979804900201; Vroegindeweij D, 1997, CARDIOVASC INTER RAD, V20, P420, DOI 10.1007/s002709900186; Whyman MR, 1997, J VASC SURG, V26, P551, DOI 10.1016/S0741-5214(97)70052-1; WILSON SE, 1989, J VASC SURG, V9, P1, DOI 10.1067/mva.1989.vs0090001; Wissgott C, 2004, ACTA RADIOL, V45, P23, DOI 10.1080/02841850410000746; Wolfram RM, 2006, RADIOLOGY, V239, P610, DOI 10.1148/radiol.2392051233; Wolfram RM, 2005, RADIOLOGY, V236, P338, DOI 10.1148/radiol.2361040084; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zeller T, 2004, J VASC INTERV RADIOL, V15, P1391, DOI 10.1097/01.RVI.0000138060.05915.9D	50	79	84	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1241	1250		10.1056/NEJMcp064483	http://dx.doi.org/10.1056/NEJMcp064483			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377162				2022-12-28	WOS:000245101900009
J	Brown, H				Brown, Hannah			How impact factors changed medical publishing - and science	BRITISH MEDICAL JOURNAL			English	Editorial Material												Hannah@two-cultures.com							0	89	92	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 17	2007	334	7593					561	564		10.1136/bmj.39142.454086.AD	http://dx.doi.org/10.1136/bmj.39142.454086.AD			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AP	17363824	Green Published			2022-12-28	WOS:000245404400029
J	Donner, T; Ritter, S; Bourdel, T; Ottl, A; Kohl, M; Esslinger, T				Donner, T.; Ritter, S.; Bourdel, T.; Oettl, A.; Koehl, M.; Esslinger, T.			Critical behavior of a trapped interacting Bose gas	SCIENCE			English	Article							TONKS-GIRARDEAU GAS; SPATIAL COHERENCE; PHASE-TRANSITION; 2ND SOUND; SUPERFLUID; TEMPERATURE; DENSITY	The phase transition of Bose-Einstein condensation was studied in the critical regime, where fluctuations extend far beyond the length scale of thermal de Broglie waves. We used matter-wave interference to measure the correlation length of these critical fluctuations as a function of temperature. Observations of the diverging behavior of the correlation length above the critical temperature enabled us to determine the critical exponent of the correlation length for a trapped, weakly interacting Bose gas to be nu = 0.67 +/- 0.13. This measurement has direct implications for the understanding of second-order phase transitions.	ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Cambridge	Kohl, M (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	koehl@phys.ethz.ch	Ritter, Stephan/F-1579-2010; Donner, Tobias/A-2845-2011; Kohl, Michael/C-6114-2009; Esslinger, Tilman/M-9022-2016	Ritter, Stephan/0000-0001-9002-7407; Donner, Tobias/0000-0001-7016-587X; Kohl, Michael/0000-0003-4055-713X; Esslinger, Tilman/0000-0002-8333-107X				ADRIAANS MJ, 1994, PHYSICA B, V194, P733, DOI 10.1016/0921-4526(94)90696-3; [Anonymous], 1987, STAT MECH; Arnold P, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.120401; Arnold P, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.053609; Baym G, 1999, PHYS REV LETT, V83, P1703, DOI 10.1103/PhysRevLett.83.1703; Bloch I, 2000, NATURE, V403, P166, DOI 10.1038/35003132; Bourdel T, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.043602; Burovski E, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.132502; Campostrini M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.214503; Damle K, 1996, EUROPHYS LETT, V36, P7, DOI 10.1209/epl/i1996-00179-4; Giorgini S, 1996, PHYS REV A, V54, pR4633, DOI 10.1103/PhysRevA.54.R4633; GOLDNER LS, 1993, J LOW TEMP PHYS, V93, P131, DOI 10.1007/BF00682285; Hadzibabic Z, 2006, NATURE, V441, P1118, DOI 10.1038/nature04851; JOSEPHSON BD, 1966, PHYS LETT, V21, P608, DOI 10.1016/0031-9163(66)90088-6; Kashurnikov VA, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.120402; Kibble T., 1976, QUANTUM FIELD THEORY, V9, P1387; Kinoshita T, 2004, SCIENCE, V305, P1125, DOI 10.1126/science.1100700; Lipa JA, 2000, PHYS REV LETT, V84, P4894, DOI 10.1103/PhysRevLett.84.4894; Lipa JA, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.174518; Naraschewski M, 1999, PHYS REV A, V59, P4595, DOI 10.1103/PhysRevA.59.4595; Niu Q, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.053604; Ottl A, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2216907; Onsager L, 1944, PHYS REV, V65, P117, DOI 10.1103/PhysRev.65.117; Paredes B, 2004, NATURE, V429, P277, DOI 10.1038/nature02530; Prokof'ev N, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.053625; Stoferle T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.130403	26	144	146	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1556	1558		10.1126/science.1138807	http://dx.doi.org/10.1126/science.1138807			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363669	Green Submitted			2022-12-28	WOS:000244934800046
J	Gunawardane, LS; Saito, K; Nishida, KM; Miyoshi, K; Kawamura, Y; Nagami, T; Siomi, H; Siomi, MC				Gunawardane, Lalith S.; Saito, Kuniaki; Nishida, Kazumichi M.; Miyoshi, Keita; Kawamura, Yoshinori; Nagami, Tomoko; Siomi, Haruhiko; Siomi, Mikiko C.			A slicer-mediated mechanism for repeat-associated siRNA 5 ' end formation in Drosophila	SCIENCE			English	Article							RNA INTERFERENCE; ARGONAUTE; GERMLINE; PIWI	In Drosophila, repeat-associated small interfering RNAs (rasiRNAs) are produced in the germ line by a Dicer-independent pathway and function through the PIWI subfamily of Argonautes to ensure silencing of retrotransposons. We sequenced small RNAs associated with the PIWI subfamily member AGO3. Although other members of PIWI, Aubergine (Aub) and Piwi, associated with rasiRNAs derived mainly from the antisense strand of retrotransposons, AGO3-associated rasiRNAs arose mainly from the sense strand. Aub- and Piwi-associated rasiRNAs showed a strong preference for uracil at their 5' ends, and AGO3-associated rasiRNAs showed a strong preference for adenine at nucleotide 10. Comparisons between AGO3- and Aub- associated rasiRNAs revealed pairs of rasiRNAs showing complementarities in their first 10 nucleotides. Aub and AGO3 exhibited Slicer activity in vitro. These data support a model in which formation of a 5' terminus within rasiRNA precursors is guided by rasiRNAs originating from transcripts of the other strand in concert with the Slicer activity of PIWI.	Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan	Tokushima University	Siomi, MC (corresponding author), Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan.	siomi@genome.tokushima-u.ac.jp	Siomi, Haruhiko/A-7020-2015; Saito, Kuniaki/A-6967-2015	Siomi, Haruhiko/0000-0001-8690-3822; Saito, Kuniaki/0000-0001-8233-9283				Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Harris AN, 2001, DEVELOPMENT, V128, P2823; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; Kavi HH, 2005, FEBS LETT, V579, P5940, DOI 10.1016/j.febslet.2005.08.069; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vagin Vasily V, 2004, RNA Biol, V1, P54; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680	20	844	886	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1587	1590		10.1126/science.1140494	http://dx.doi.org/10.1126/science.1140494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17322028				2022-12-28	WOS:000244934800056
J	Mishchenko, MI; Geogdzhayev, IV; Rossow, WB; Cairns, B; Carlson, BE; Lacis, AA; Liu, L; Travis, LD				Mishchenko, Michael I.; Geogdzhayev, Igor V.; Rossow, William B.; Cairns, Brian; Carlson, Barbara E.; Lacis, Andrew A.; Liu, Li; Travis, Larry D.			Long-term satellite record reveals likely recent aerosol trend	SCIENCE			English	Article							SOLAR-RADIATION; SURFACE; CLIMATE; SPACE		NASA, Goddard Inst Space Studies, New York, NY 10025 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Mishchenko, MI (corresponding author), NASA, Goddard Inst Space Studies, 2880 Broadway, New York, NY 10025 USA.	mmishchenko@giss.nasa.gov	Rossow, William B/F-3138-2015; Lacis, Andrew/GVT-2947-2022; Mishchenko, Michael I/D-4426-2012; Carlson, Barbara E/D-8319-2012; Lacis, Andrew A/D-4658-2012	Mishchenko, Michael/0000-0001-5252-7777; Cairns, Brian/0000-0002-1980-1022; Carlson, Barbara/0000-0002-5635-9552				Geogdzhayev IV, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006170; Hansen J, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001143; Liu L, 2004, J QUANT SPECTROSC RA, V88, P97, DOI 10.1016/j.jqsrt.2004.03.031; Mishchenko MI, 2004, J QUANT SPECTROSC RA, V88, P149, DOI 10.1016/j.jqsrt.2004.03.030; Pinker RT, 2005, SCIENCE, V308, P850, DOI 10.1126/science.1103159; Rossow WB, 1999, B AM METEOROL SOC, V80, P2261, DOI 10.1175/1520-0477(1999)080<2261:AIUCFI>2.0.CO;2; Smirnov A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026051; Streets DG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026471; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215; Zhang YC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004457	10	168	174	4	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1543	1543		10.1126/science.1136709	http://dx.doi.org/10.1126/science.1136709			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363666				2022-12-28	WOS:000244934800042
J	Lupski, JR				Lupski, James R.			Structural variation in the human genome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COPY-NUMBER		Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.							Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731	5	89	94	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2007	356	11					1169	1171		10.1056/NEJMcibr067658	http://dx.doi.org/10.1056/NEJMcibr067658			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	145PO	17360997				2022-12-28	WOS:000244877200013
J	Agari, D; Koide, R; Kashiyama, T; Yoshida, H; Naito, R; Bandoh, M				Agari, Dai; Koide, Reiji; Kashiyama, Tetsuya; Yoshida, Hiroshi; Naito, Rie; Bandoh, Mitsuaki			Neurosarcoidosis: a treatable cause of vestibular dysfunction	LANCET			English	Editorial Material							MANIFESTATIONS; SARCOIDOSIS		Tokyo Metropolitan Neurol Hosp, Dept Neurol, Tokyo 1830042, Japan; Tokyo Metropolitan Neurol Hosp, Dept Neuroophthalmol, Tokyo 1830042, Japan; Tokyo Metropolitan Neurol Hosp, Dept Otoneurol, Tokyo 1830042, Japan; Tokyo Metropolitan Fuchu Gen Hosp, Dept Emergency Med, Tokyo, Japan	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute for Neuroscience	Koide, R (corresponding author), Tokyo Metropolitan Neurol Hosp, Dept Neurol, 2-6-1 Musashidai, Tokyo 1830042, Japan.	reiji@tmnh.fuchu.tokyo.jp						Colvin IB, 2006, LARYNGOSCOPE, V116, P75, DOI 10.1097/01.mlg.0000184580.52723.9f; HYBELS RL, 1976, LARYNGOSCOPE, V86, P1873, DOI 10.1002/lary.5540861214; STERN BJ, 1985, ARCH NEUROL-CHICAGO, V42, P909, DOI 10.1001/archneur.1985.04060080095022; vonBrevern M, 1997, ANN NEUROL, V42, P117, DOI 10.1002/ana.410420119	4	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2007	369	9564					878	878		10.1016/S0140-6736(07)60417-6	http://dx.doi.org/10.1016/S0140-6736(07)60417-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144JC	17350459				2022-12-28	WOS:000244791300038
J	Bhutta, ZA				Bhutta, Zulfiqar A.			Tracking inequity: assessments of poverty-related outcomes	LANCET			English	Editorial Material							CHILD-MORTALITY; HEALTH		Aga Khan Univ, Dept Paediat & Child Hlth, Karachi 74800, Pakistan	Aga Khan University	Bhutta, ZA (corresponding author), Aga Khan Univ, Dept Paediat & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu						[Anonymous], 1999, DEV FREEDOM; Bhutta Z A, 2001, Indian Pediatr, V38, P127; Bhutta ZA, 2006, PLOS MED, V3, P163, DOI 10.1371/journal.pmed.0030103; Brockerhoff M, 2000, B WORLD HEALTH ORGAN, V78, P30; DEOLALIKAR AB, 2003, POVERTY GROWTH ROLE; GWATKIN DR, 2005, REACHING POOR HLTH P; Hoff K., 2004, 3351 WORLD BANK; HUMPHREYS NA, 1885, VITAL STAT MEMORIAL, P166; Marmot M, 2006, LANCET, V368, P2081, DOI 10.1016/S0140-6736(06)69746-8; Office of Mgmt. & Budget, 2003, COMPL PROGR GUID PHA, p[1, 14]; Townsend P, 1992, INEQUALITIES HLTH BL; Vapattanawong P, 2007, LANCET, V369, P850, DOI 10.1016/S0140-6736(07)60413-9; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0	13	0	0	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2007	369	9564					804	806		10.1016/S0140-6736(07)60384-5	http://dx.doi.org/10.1016/S0140-6736(07)60384-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144JC	17350432				2022-12-28	WOS:000244791300006
J	Potok, RM; Rau, IG; Shtrikman, H; Oreg, Y; Goldhaber-Gordon, D				Potok, R. M.; Rau, I. G.; Shtrikman, Hadas; Oreg, Yuval; Goldhaber-Gordon, D.			Observation of the two-channel Kondo effect	NATURE			English	Article							SINGLE-ELECTRON TRANSISTOR; 2-LEVEL TUNNELING SYSTEMS; ANDERSON MODEL; RENORMALIZATION-GROUP; CONDUCTANCE; METALS; IMPURITIES; TRANSPORT; POINT; STATE	Some of the most intriguing problems in solid-state physics arise when the motion of one electron dramatically affects the motion of surrounding electrons. Traditionally, such highly correlated electron systems have been studied mainly in materials with complex transition metal chemistry(1,2). Over the past decade, researchers have learned to confine one or a few electrons within a nanometre-scale semiconductor 'artificial atom', and to understand and control this simple system in detail(3). Here we combine artificial atoms to create a highly correlated electron system within a nano-engineered semiconductor structure(4). We tune the system in situ through a quantum phase transition between two distinct states, each a version of the Kondo state(5), in which a bound electron interacts with surrounding mobile electrons. The boundary between these competing Kondo states is a quantum critical point - namely, the exotic and previously elusive two-channel Kondo state(6,7), in which electrons in two reservoirs are entangled through their interaction with a single localized spin.	Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Weizmann Inst Sci, Dept Condensed Matter Phys, IL-96100 Rehovot, Israel	Stanford University; Stanford University; Harvard University; Weizmann Institute of Science	Goldhaber-Gordon, D (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	goldhaber-gordon@stanford.edu		Goldhaber-Gordon, David/0000-0001-8549-0560				AFFLECK I, 1993, PHYS REV B, V48, P7297, DOI 10.1103/PhysRevB.48.7297; BESNUS MJ, 1988, J MAGN MAGN MATER, V76-7, P471, DOI 10.1016/0304-8853(88)90458-1; Cichorek T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.236603; COSTI TA, 1994, J PHYS-CONDENS MAT, V6, P2519, DOI 10.1088/0953-8984/6/13/013; COX DL, 1987, PHYS REV LETT, V59, P1240, DOI 10.1103/PhysRevLett.59.1240; Cox DL, 1998, ADV PHYS, V47, P599, DOI 10.1080/000187398243500; Florens S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.216601; GLAZMAN LI, 1988, JETP LETT+, V47, P452; Goldhaber-Gordon D, 1998, NATURE, V391, P156, DOI 10.1038/34373; Goldhaber-Gordon D, 1998, PHYS REV LETT, V81, P5225, DOI 10.1103/PhysRevLett.81.5225; Gores J, 2000, PHYS REV B, V62, P2188, DOI 10.1103/PhysRevB.62.2188; GROBIS M, 2006, KONDO EFFECT MESOSCO; HALDANE FDM, 1978, PHYS REV LETT, V40, P416, DOI 10.1103/PhysRevLett.40.416; HANSON R, 2006, SPINS FEW ELECT QUAN; HETTLER MH, 1994, PHYS REV LETT, V73, P1967, DOI 10.1103/PhysRevLett.73.1967; KONDO J, 1964, PROG THEOR PHYS, V32, P37, DOI 10.1143/PTP.32.37; Le Hur K, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.045326; Lebanon E, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.155301; Majumdar K, 1998, PHYS REV B, V57, P2991, DOI 10.1103/PhysRevB.57.2991; NOZIERES P, 1980, J PHYS-PARIS, V41, P193, DOI 10.1051/jphys:01980004103019300; Oreg Y, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.136602; OREG Y, IN PRESS SPRINGER SE; Pruschke T, 1995, ADV PHYS, V44, P187, DOI 10.1080/00018739500101526; Pustilnik M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.115316; RALPH DC, 1992, PHYS REV LETT, V69, P2118, DOI 10.1103/PhysRevLett.69.2118; RALPH DC, 1994, PHYS REV LETT, V72, P1064, DOI 10.1103/PhysRevLett.72.1064; SEAMAN CL, 1991, PHYS REV LETT, V67, P2882, DOI 10.1103/PhysRevLett.67.2882; von Delft J, 1999, ANN PHYS-NEW YORK, V273, P175, DOI 10.1006/aphy.1998.5897; WILSON KG, 1975, REV MOD PHYS, V47, P773, DOI 10.1103/RevModPhys.47.773; ZAWADOWSKI A, 1980, PHYS REV LETT, V45, P211, DOI 10.1103/PhysRevLett.45.211	30	271	272	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					167	171		10.1038/nature05556	http://dx.doi.org/10.1038/nature05556			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344849	Green Submitted			2022-12-28	WOS:000244718100036
J	Smith, C				Smith, Caitlin			Tools for drug discovery - Tools of the trade	NATURE			English	Editorial Material																			0	32	34	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					219	224		10.1038/446219a	http://dx.doi.org/10.1038/446219a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344855	Bronze			2022-12-28	WOS:000244718100047
J	Greenspan, SL; Bone, HG; Ettinger, MP; Hanley, DA; Lindsay, R; Zanchetta, JR; Blosch, CM; Mathisen, AL; Morris, SA; Marriott, TB				Greenspan, Susan L.; Bone, Henry G.; Ettinger, Mark P.; Hanley, David A.; Lindsay, Robert; Zanchetta, Jose R.; Blosch, Consuelo M.; Mathisen, Annette L.; Morris, Stephen A.; Marriott, Thomas B.		Treatment of Osteoporosis with Par	Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							PLACEBO-CONTROLLED TRIALS; PARATHYROID-HORMONE 1-34; ACTIVE-CONTROL TRIALS; TRABECULAR BONE; RISK; ALENDRONATE; IMPROVES; HIP; ARCHITECTURE; RISEDRONATE	Background: Recombinant human parathyroid hormone (1-84) (PTH) increases bone mass and strength and improves bone quality by stimulating new bone formation. Objective: To determine the safety of PTH and its effect on the incidence of vertebral fractures in postmenopausal women with osteoporosis. Design: 18-month, randomized, double-blind, placebo-controlled, parallel-group study. Setting: 168 centers in 9 countries Patients: 2532 postmenopausal women with low bone mineral density at the hip or lumbar spine. Interventions: Women received 100 mu g of recombinant human PTH or placebo daily by subcutaneous injection. All received calcium, 700 mg/d, and vitamin D-3, 400 U/d. Measurements: New or worsened vertebral fractures (primary outcome) and changes in bone mineral density and safety (secondary outcomes). Results: 67.2% of patients who received at least 1 dose of the study drug completed the study. Parathyroid hormone reduced the risk for new or worsened vertebral fractures, but in sensitivity analyses, the magnitude of the reduction was changed with assumptions about fracture incidence in patients who did not complete the study (relative risk assuming no fractures, 0.42 [95% CI, 0.24 to 0.72] [P = 0.001]; relative risk assuming fracture incidence observed in all patients who completed the trial, 0.60 [CI, 0.36 to 1.00] [P = 0.05]; relative risk assuming fracture incidence observed in the placebo group, 0.62 [CI, 0.37 to 1.04] [P = 0.07]). Compared with placebo, mean bone mineral density increased at the spine by 6.9% (CI, 6.4% to 7.4%) and at the hip by 2.1% (CI, 1.7% to 2.5%) but decreased at the forearm in the PTH-treated group. Parathyroid hormone treatment increased the percentage of participants with hypercalciuria, hypercalcemia, and nausea by 24% (CI, 20% to 27%), 23% (CI, 21% to 26%), and 14% (CI, 11% to 16%), respectively, compared with placebo. Limitations: Baseline serum PTH and vitamin D levels were not measured. Many patients discontinued the trial prematurely. Conclusions: Parathyroid hormone (1-84) reduced the overall risk for new or worsened vertebral fracture in postmenopausal women with osteoporosis. Hypercalciuria, hypercalcemia, and nausea were more common in women who took the drug. Although the magnitude of the reduction was sensitive to assumptions about fracture incidence in patients who did not complete the study, the findings suggest that PTH provides an alternative therapeutic option for fracture prevention.	Univ Pittsburgh, Osteoporosis Prevent & Treatment Ctr, Pittsburgh, PA 15213 USA; Michigan Bone & Mineral Clin, Detroit, MI USA; Radiant Res Ctr S Florida, Stuart, FL USA; Reg Osteoporosis Ctr, Stuart, FL USA; Univ Calgary, Hlth Sci Ctr, Calgary, AB, Canada; Helen Hayes Hosp, Reg Bone Ctr, W Haverstraw, NY USA; Inst Invest Metab, Buenos Aires, DF, Argentina; NPS Pharmaceut Inc, Parsippany, NJ USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba	Greenspan, SL (corresponding author), Univ Pittsburgh, Osteoporosis Prevent & Treatment Ctr, Kaufmann Med Bldg,Suite 1110,3471 5th Ave, Pittsburgh, PA 15213 USA.				NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NIA NIH HHS [P30 AG024827] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; [Anonymous], 2000, NIH Consens Statement, V17, P1; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Black DM, 1999, J BONE MINER RES, V14, P821, DOI 10.1359/jbmr.1999.14.5.821; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Bogado CE, 2005, J BONE MINER RES, V20, pS22; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Dempster DW, 2005, J BONE MINER RES, V20, pS98; Dobnig H, 2005, J CLIN ENDOCR METAB, V90, P3970, DOI 10.1210/jc.2003-1703; Ellenberg SS, 2000, ANN INTERN MED, V133, P464, DOI 10.7326/0003-4819-133-6-200009190-00015; Ensrud KE, 2000, J AM GERIATR SOC, V48, P241, DOI 10.1111/j.1532-5415.2000.tb02641.x; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Gold DT, 1998, ENDOCRIN METAB CLIN, V27, P485, DOI 10.1016/S0889-8529(05)70018-9; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Hodsman AB, 2003, J CLIN ENDOCR METAB, V88, P5212, DOI 10.1210/jc.2003-030768; *INT C HARM, 1995, FED REG, V60; Ismail AA, 2001, OSTEOPOROSIS INT, V12, P85, DOI 10.1007/s001980170138; Jiang YB, 2003, J BONE MINER RES, V18, P1932, DOI 10.1359/jbmr.2003.18.11.1932; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Lang TF, 1997, BONE, V21, P101, DOI 10.1016/S8756-3282(97)00072-0; Lang TF, 1999, J COMPUT ASSIST TOMO, V23, P130, DOI 10.1097/00004728-199901000-00027; Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001/jama.285.3.320; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Recker RR, 2004, J BONE MINER RES, V19, pS97; RECKER RR, 2003, PRIMER METAB BONE DI, V31, P213; REEVE J, 2003, PRIMER METAB BONE DI, V31, P344; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; Rosenblatt M, 2003, J BONE MINER RES, V18, P1142, DOI 10.1359/jbmr.2003.18.6.1142; Smith SY, 2000, J BONE MINER RES, V15, pS442; Tannenbaum C, 2002, J CLIN ENDOCR METAB, V87, P4431, DOI 10.1210/jc.2002-020275; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; Zanchetta JR, 2003, J BONE MINER RES, V18, P539, DOI 10.1359/jbmr.2003.18.3.539	33	343	357	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2007	146	5					326	339		10.7326/0003-4819-146-5-200703060-00005	http://dx.doi.org/10.7326/0003-4819-146-5-200703060-00005			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144XK	17339618				2022-12-28	WOS:000244829600002
J	Boots, M; Mealor, M				Boots, Michael; Mealor, Michael			Local interactions select for lower pathogen infectivity	SCIENCE			English	Article							INDIAN MEAL MOTH; PLODIA-INTERPUNCTELLA; GRANULOSIS-VIRUS; EVOLUTION; VIRULENCE; TRANSMISSION; POPULATION; COOPERATION; DYNAMICS	Theory suggests that the current rapid increase in connectivity and consequential changes in the structure of human, agricultural, and wildlife populations may select for parasite strains with higher infectivity. We carried out a test of this spatial theory by experimentally altering individual host movement rates in a model host/pathogen system by altering the viscosity of their environment. In our microevolutionary selection experiments, the infectivity of the virus was, as predicted by the theory, reduced in the most viscous populations. We therefore provide empirical support for the theory that population structure affects the evolution of infectious organisms.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Boots, M (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	m.boots@sheffield.ac.uk			Natural Environment Research Council [NE/A503439/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Boots M, 1999, P ROY SOC B-BIOL SCI, V266, P1933, DOI 10.1098/rspb.1999.0869; Boots M, 2000, ECOL LETT, V3, P181; BOOTS M, 1993, FUNCT ECOL, V7, P528, DOI 10.2307/2390128; Boots M, 2004, SCIENCE, V303, P842, DOI 10.1126/science.1088542; Boots M, 1998, ECOL ENTOMOL, V23, P118, DOI 10.1046/j.1365-2311.1998.00115.x; BREMERMANN HJ, 1989, J MATH BIOL, V27, P179, DOI 10.1007/BF00276102; DIECKMANN U, 2002, ADAPTIVE DYNAMICS IN; Dieckmann U., 2000, GEOMETRY ECOLOGICAL; Ebert D, 1996, PARASITOL TODAY, V12, P96, DOI 10.1016/0169-4758(96)80668-5; EWALD PW, 1993, SCI AM, V268, P86, DOI 10.1038/scientificamerican0493-86; EWALD PW, 1991, EPIDEMIOL INFECT, V106, P83, DOI 10.1017/S0950268800056478; Ewald PW, 1994, EVOLUTION INFECT DIS; FERRIERE R, 1995, P ROY SOC B-BIOL SCI, V259, P77, DOI 10.1098/rspb.1995.0012; Ferriere R, 1996, AM NAT, V147, P692, DOI 10.1086/285875; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Haraguchi Y, 2000, J THEOR BIOL, V203, P85, DOI 10.1006/jtbi.1999.1065; JOHN DT, 1994, J PARASITOL, V80, P149, DOI 10.2307/3283359; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708; MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075; RAND DA, 1995, P ROY SOC B-BIOL SCI, V259, P55, DOI 10.1098/rspb.1995.0009; SAIT SM, 1994, J ANIM ECOL, V63, P861, DOI 10.2307/5263; SAIT SM, 1994, J ANIM ECOL, V63, P541, DOI 10.2307/5220; van Baalen M, 1998, J THEOR BIOL, V193, P631, DOI 10.1006/jtbi.1998.0730	24	146	148	4	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1284	1286		10.1126/science.1137126	http://dx.doi.org/10.1126/science.1137126			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332415				2022-12-28	WOS:000244564700052
J	Mani, A; Radhakrishnan, J; Wang, H; Mani, A; Mani, MA; Nelson-Williams, C; Carew, KS; Mane, S; Najmabadi, H; Wu, D; Lifton, RP				Mani, Arya; Radhakrishnan, Jayaram; Wang, He; Mani, Alaleh; Mani, Mohammad-Ali; Nelson-Williams, Carol; Carew, Khary S.; Mane, Shrikant; Najmabadi, Hossein; Wu, Dan; Lifton, Richard P.			LRP6 mutation in a family with early coronary disease and metabolic risk factors	SCIENCE			English	Article							RECEPTOR-RELATED PROTEIN-5; HEART-DISEASE; DENSITY; GENE; MORTALITY	Coronary artery disease ( CAD) is the leading cause of death worldwide and is commonly caused by a constellation of risk factors called the metabolic syndrome. We characterized a family with autosomal dominant early CAD, features of the metabolic syndrome (hyperlipidemia, hypertension, and diabetes), and osteoporosis. These traits showed genetic linkage to a short segment of chromosome 12p, in which we identified a missense mutation in LRP6, which encodes a co-receptor in the Wnt signaling pathway. The mutation, which substitutes cysteine for arginine at a highly conserved residue of an epidermal growth factor-like domain, impairs Wnt signaling in vitro. These results link a single gene defect in Wnt signaling to CAD and multiple cardiovascular risk factors.	Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06510 USA; Howard Hughes Med Inst, Dept Genet & Mol Biophys, New Haven, CT 06510 USA; Howard Hughes Med Inst, Dept Biochem, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; Amirkabir Univ Technol, Dept Mat Sci, Tehran 15875 4413, Iran; Azad Univ Tehran, Dept Human Sci, Tehran 13185 786, Iran; Social Welf & Rehab Sci Univ, Ctr Gene Res, Tehran 19875 383, Iran	Howard Hughes Medical Institute; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Yale University; Amirkabir University of Technology; Islamic Azad University	Mani, A (corresponding author), Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06510 USA.	arya.mani@yale.edu; richard.lifton@yale.edu	Najmabadi, Hossein/P-8182-2017	Najmabadi, Hossein/0000-0002-6084-7778	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD041481] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL055007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK068229] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL55007] Funding Source: Medline; NIAMS NIH HHS [R01 AR051476, R01 AR051476-03, R01 AR051476-04, R01 AR051476-02, R01 AR051476-01A1] Funding Source: Medline; NICHD NIH HHS [K08 HD041481-01, K08 HD041481] Funding Source: Medline; NIDDK NIH HHS [P01DK68229] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Johansson J, 2002, J INTERN MED, V252, P551, DOI 10.1046/j.1365-2796.2002.01068.x; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Magoori K, 2003, J BIOL CHEM, V278, P11331, DOI 10.1074/jbc.M211987200; Mansfield TA, 1997, NAT GENET, V16, P202, DOI 10.1038/ng0697-202; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Marcovitz PA, 2005, AM J CARDIOL, V96, P1059, DOI 10.1016/j.amjcard.2005.06.034; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; Poulsen P, 2001, DIABETOLOGIA, V44, P537, DOI 10.1007/s001250051659; SCHILDKRAUT JM, 1989, AM J CARDIOL, V64, P555, DOI 10.1016/0002-9149(89)90477-3; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; ZAVARONI I, 1991, DIABETES METAB, V17, P109	26	452	518	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1278	1282		10.1126/science.1136370	http://dx.doi.org/10.1126/science.1136370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332414	Green Accepted			2022-12-28	WOS:000244564700050
J	Sokolov, S; Scheuer, T; Catterall, WA				Sokolov, Stanislav; Scheuer, Todd; Catterall, William A.			Gating pore current in an inherited ion channelopathy	NATURE			English	Article							HYPOKALEMIC PERIODIC PARALYSIS; SODIUM-CHANNEL; VOLTAGE-SENSOR; SKELETAL-MUSCLE; ENHANCED INACTIVATION; FUNCTIONAL EXPRESSION; MUTATIONS; BRAIN; PERSPECTIVE; MODELS	Ion channelopathies are inherited diseases in which alterations in control of ion conductance through the central pore of ion channels impair cell function, leading to periodic paralysis, cardiac arrhythmia, renal failure, epilepsy, migraine and ataxia(1). Here we show that, in contrast with this well-established paradigm, three mutations in gating-charge-carrying arginine residues in an S4 segment that cause hypokalaemic periodic paralysis(2) induce a hyperpolarization- activated cationic leak through the voltage sensor of the skeletal muscle Na(V)1.4 channel. This 'gating pore current' is active at the resting membrane potential and closed by depolarizations that activate the voltage sensor. It has similar permeability to Na+, K+ and Cs+, but the organic monovalent cations tetraethylammonium and N-methyl-D-glucamine are much less permeant. The inorganic divalent cations Ba2+, Ca2+ and Zn2+ are not detectably permeant and block the gating pore at millimolar concentrations. Our results reveal gating pore current in naturally occurring disease mutations of an ion channel and show a clear correlation between mutations that cause gating pore current and hypokalaemic periodic paralysis. This gain-of-function gating pore current would contribute in an important way to the dominantly inherited membrane depolarization, action potential failure, flaccid paralysis and cytopathology that are characteristic of hypokalaemic periodic paralysis. A survey of other ion channelopathies reveals numerous examples of mutations that would be expected to cause gating pore current, raising the possibility of a broader impact of gating pore current in ion channelopathies.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@u.washington.edu						ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; BARCHI RL, 1983, J NEUROCHEM, V36, P1377; Bendahhou S, 2001, ANN NEUROL, V50, P417, DOI 10.1002/ana.1144; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bulman DE, 1999, NEUROLOGY, V53, P1932, DOI 10.1212/WNL.53.9.1932; Cannon SC, 2006, ANNU REV NEUROSCI, V29, P387, DOI 10.1146/annurev.neuro.29.051605.112815; CATTERALL WA, 1986, TRENDS NEUROSCI, V9, P7, DOI 10.1016/0166-2236(86)90004-4; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; Horn R, 2002, J GEN PHYSIOL, V120, P449, DOI 10.1085/jgp.20028658; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; Jurkat-Rott K, 2000, P NATL ACAD SCI USA, V97, P9549, DOI 10.1073/pnas.97.17.9549; Kuzmenkin A, 2002, BRAIN, V125, P835, DOI 10.1093/brain/awf071; Sokolov S, 2005, NEURON, V47, P183, DOI 10.1016/j.neuron.2005.06.012; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Struyk AF, 2000, J NEUROSCI, V20, P8610; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; Venance SL, 2006, BRAIN, V129, P8, DOI 10.1093/brain/awh639; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103	24	210	215	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					76	78		10.1038/nature05598	http://dx.doi.org/10.1038/nature05598			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330043				2022-12-28	WOS:000244525600040
J	Morgan, M; Palmer, J				Morgan, Marina; Palmer, John			Dog bites	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CAPNOCYTOPHAGA-CANIMORSUS; INJURIES; INFECTIONS; WOUNDS; ANTIBIOTICS; EXPERIENCE; MANAGEMENT; ARTHRITIS; PROTOCOL; BITTEN		Royal Devon & Exeter Fdn Trust, Dept Plast & Reconstruct Surg, Exeter EX2 5AD, Devon, England		Morgan, M (corresponding author), Royal Devon & Exeter Fdn Trust, Old Pathol Lab, Exeter EX2 5AD, Devon, England.	marina.morgan@rdeft.nhs.uk						BRAKENBURY PH, 1989, ARCH EMERG MED, V6, P251; CALLAHAM M, 1988, ANN EMERG MED, V17, P1321, DOI 10.1016/S0196-0644(88)80359-7; CHAPMAN S, 2000, BRIT MED J, V320, P512; COLE RP, 1991, BRIT MED J, V303, P467; CUMMINGS P, 1994, ANN EMERG MED, V23, P535, DOI 10.1016/S0196-0644(94)70073-7; De Keuster T, 2006, VET J, V172, P482, DOI 10.1016/j.tvjl.2005.04.024; DIRE DJ, 1994, ACAD EMERG MED, V3, P258; GERSHMAN KA, 1994, PEDIATRICS, V93, P913; GOLDSTEIN EJC, 1993, ANTIMICROB AGENTS CH, V37, P1150, DOI 10.1128/AAC.37.5.1150; Gomes CRISTIANO M., 2000, J Urol, V165, P80; GRIEGO RD, 1995, J AM ACAD DERMATOL, V33, P1019, DOI 10.1016/0190-9622(95)90296-1; Holm M, 2000, SCAND J INFECT DIS, V32, P181, DOI 10.1080/003655400750045303; KULLBERG BJ, 1991, MEDICINE, V70, P287, DOI 10.1097/00005792-199109000-00001; LEVIN JM, 1990, ANN EMERG MED, V19, P1458, DOI 10.1016/S0196-0644(05)82621-6; Mcheik JN, 2000, J PEDIATR SURG, V35, P580, DOI 10.1053/jpsu.2000.0350580; Moore F, 1997, BRIT MED J, V314, P88, DOI 10.1136/bmj.314.7074.88; MORGAN JP, 1995, J ORAL MAXIL SURG, V53, P435, DOI 10.1016/0278-2391(95)90720-3; MORGAN M, 1994, J CLIN PATHOL, V47, P681, DOI 10.1136/jcp.47.7.681-c; PALMER J, 1983, BRIT J PLAST SURG, V36, P315; Pounder D, 2005, BMJ-BRIT MED J, V331, P469, DOI 10.1136/bmj.331.7515.469; Presutti J, 2001, AM FAM PHYSICIAN, V63, P1567; RAFFI F, 1987, SCAND J INFECT DIS, V19, P385, DOI 10.3109/00365548709021670; Rohrich RJ, 1999, PLAST RECONSTR SURG, V103, P2067, DOI 10.1097/00006534-199906000-00045; ROSENTHAL DU, 1994, K9S CAUSE CHAOS EXAM, P11279; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; Sacks JJ, 1996, PEDIATRICS, V97, P891; Saconato H., 2001, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001738, DOI 10.1002/14651858.CD001738]; SHEWELL PC, 1991, BRIT MED J, V303, P1512, DOI 10.1136/bmj.303.6816.1512; Smith MR, 2003, EMERG MED J, V20, P253, DOI 10.1136/emj.20.3.253; SPAGNUOLO PJ, 1978, AM J MED SCI, V275, P359, DOI 10.1097/00000441-197805000-00014; SPIEGEL JD, 1988, J HAND SURG-AM, V13A, P254, DOI 10.1016/S0363-5023(88)80060-1; TALAN DA, 1989, J CLIN MICROBIOL, V27, P78, DOI 10.1128/JCM.27.1.78-81.1989; Talan DA, 1999, NEW ENGL J MED, V340, P85, DOI 10.1056/NEJM199901143400202; THOMAS HF, 1990, J ROY SOC HEALTH, V110, P173, DOI 10.1177/146642409011000508; WEBER DJ, 1984, MEDICINE, V63, P133, DOI 10.1097/00005792-198405000-00001; WIGGINS ME, 1980, ANN EMERG MED, V9, P410; Wolff KD, 1998, J ORAL MAXIL SURG, V56, P838, DOI 10.1016/S0278-2391(98)90009-X; ZOOK EG, 1980, J TRAUMA, V20, P243, DOI 10.1097/00005373-198003000-00010; MANAGEMENT ANIMAL BI	39	127	132	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2007	334	7590					413	417		10.1136/bmj.39105.659919.BE	http://dx.doi.org/10.1136/bmj.39105.659919.BE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	142MQ	17322257	Green Published			2022-12-28	WOS:000244654400034
J	Brotherton, SE; Etzel, SI				Brotherton, Sarah E.; Etzel, Sylvia I.			Graduate Medical Education, 2005-2006	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Amer Med Assoc, Div Grad Med Educ, Chicago, IL 60610 USA	American Medical Association	Brotherton, SE (corresponding author), Amer Med Assoc, Div Grad Med Educ, 515 N State St, Chicago, IL 60610 USA.								0	50	50	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2006	296	9					1154	1169		10.1001/jama.296.9.1154	http://dx.doi.org/10.1001/jama.296.9.1154			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	081DW	17370353				2022-12-28	WOS:000240298400020
J	Lezec, HJ; Dionne, JA; Atwater, HA				Lezec, Henri J.; Dionne, Jennifer A.; Atwater, Harry A.			Negative refraction at visible frequencies	SCIENCE			English	Article							INDEX	Nanofabricated photonic materials offer opportunities for crafting the propagation and dispersion of light in matter. We demonstrate an experimental realization of a two-dimensional negative-index material in the blue-green region of the visible spectrum, substantiated by direct geometric visualization of negative refraction. Negative indices were achieved with the use of an ultrathin Au-Si3N4-Ag waveguide sustaining a surface plasmon polariton mode with antiparallel group and phase velocities. All-angle negative refraction was observed at the interface between this bimetal waveguide and a conventional Ag-Si3N4-Ag slot waveguide. The results may enable the development of practical negative-index optical designs in the visible regime.	CALTECH, Thomas J Watson Lab Appl Phys, Pasadena, CA 91125 USA; CNRS, F-75794 Paris 16, France	California Institute of Technology; Centre National de la Recherche Scientifique (CNRS)	Lezec, HJ (corresponding author), CALTECH, Thomas J Watson Lab Appl Phys, Pasadena, CA 91125 USA.	lezec@caltech.edu	Atwater, Harry A/H-2823-2014	Atwater, Harry A/0000-0001-9435-0201				Alu A, 2006, J OPT SOC AM B, V23, P571, DOI 10.1364/JOSAB.23.000571; Dionne JA, 2006, NANO LETT, V6, P1928, DOI 10.1021/nl0610477; Dionne JA, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.035407; Dionne JA, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.075405; Dolling G, 2006, SCIENCE, V312, P892, DOI 10.1126/science.1126021; Dolling G, 2007, OPT LETT, V32, P551, DOI 10.1364/OL.32.000551; Dolling G, 2007, OPT LETT, V32, P53, DOI 10.1364/OL.32.000053; Houck AA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.137401; Kim KY, 2006, OPT EXPRESS, V14, P320, DOI 10.1364/OPEX.14.000320; Pendry JB, 1996, PHYS REV LETT, V76, P4773, DOI 10.1103/PhysRevLett.76.4773; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Ramakrishna SA, 2005, REP PROG PHYS, V68, P449, DOI 10.1088/0034-4885/68/2/R06; Shalaev VM, 2007, NAT PHOTONICS, V1, P41, DOI 10.1038/nphoton.2006.49; Shalaev VM, 2005, OPT LETT, V30, P3356, DOI 10.1364/OL.30.003356; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Shin Hocheol, 2006, Phys Rev Lett, V96, P073907, DOI 10.1103/PhysRevLett.96.073907; Shvets G, 2003, PHYSICA B, V338, P338, DOI 10.1016/j.physb.2003.08.016; Shvets G, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.035109; Smith DR, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.195104; Soukoulis CM, 2007, SCIENCE, V315, P47, DOI 10.1126/science.1136481; Soukoulis CM, 2006, ADV MATER, V18, P1941, DOI 10.1002/adma.200600106; Tournois P, 1997, OPT COMMUN, V137, P41, DOI 10.1016/S0030-4018(96)00767-5; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; Zhang S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.137404	25	492	512	2	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					430	432		10.1126/science.1139266	http://dx.doi.org/10.1126/science.1139266			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17379773				2022-12-28	WOS:000245813400051
J	Aziz, O; Rao, C; Panesar, SS; Jones, C; Morris, S; Darzi, A; Athanasiou, T				Aziz, Omer; Rao, Christopher; Panesar, Sukhmeet Singh; Jones, Catherine; Morris, Stephen; Darzi, Ara; Athanasiou, Thanos			Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRANSLUMINAL CORONARY ANGIOPLASTY; RANDOMIZED CONTROLLED-TRIALS; HIGH-GRADE STENOSIS; MYOCARDIAL-INFARCTION; SURGERY; MIDCAB; DISEASE; INTERVENTION; MORTALITY; STENT	Objective To compare outcomes between minimally invasive left internal thoracic artery bypass and percutaneous coronary artery stenting as primary interventions for isolated lesions of the left anterior descending artery. Design Meta-analysis of randomised and non-randomised comparative peer reviewed publications. Data sources Embase, Medline, Cochrane, Google Scholar, and Health Technology Assessment databases (1966-2005). Review methods Studies comparing the two procedures as the primary intervention for isolated left anterior descending artery stenosis were identified and the following extracted: study design, population characteristics, severity of coronary artery disease, cardiovascular risk factors, and outcomes of interest. Results 12 studies (1952 patients) reporting results from eight groups were included: one was a retrospective design, one prospective non-randomised, and six prospective randomised. Meta-analysis of randomised trials showed a higher rate of recurrence of angina (odds ratio 2.62, 95% confidence interval 1.32 to 5.21), incidence of major adverse coronary and cerebral events (2.86, 1.62 to 5.08), and need for repeat revascularisation (4.63, 2.52 to 8.51) with percutaneous stenting. No significant difference was found in myocardial infarction, stroke, or mortality at maximum follow-up between interventions. Conclusions Minimally invasive left internal thoracic artery bypass for isolated lesions of the left anterior descending artery resulted in fewer complications in the mid-term compared with percutaneous transluminal coronary artery stenting.	St Marys Hosp, Imperial Coll London, Dept Biosurg & Surg Technol, London W2 1NY, England; Imperial Coll London, Tanaka Business Sch, London, England	Imperial College London; Imperial College London	Athanasiou, T (corresponding author), St Marys Hosp, Imperial Coll London, Dept Biosurg & Surg Technol, Praed St, London W2 1NY, England.	tathan5253@aol.com	Rao, Christopher/G-5330-2010	Morris, Stephen/0000-0002-5828-3563; Aziz, Omer/0000-0002-3765-2702; Rao, Christopher/0000-0003-3244-3888				Boodhwani M, 2006, EUR J CARDIO-THORAC, V29, P65, DOI 10.1016/j.ejcts.2005.07.020; Casula Roberto, 2004, Expert Rev Cardiovasc Ther, V2, P589, DOI 10.1586/14779072.2.4.589; Cisowski M, 2002, ANN THORAC SURG, V74, pS1334; Cisowski M, 2002, EUR J CARDIO-THORAC, V22, P261, DOI 10.1016/S1010-7940(02)00262-2; Cisowski M, 2004, KARDIOL POL, V61, P262; Cisowski Marek, 2004, Kardiol Pol, V61, P253; Clarke M, 2001, COCHRANE REV HDB 4 1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diegeler A, 2002, NEW ENGL J MED, V347, P561, DOI 10.1056/NEJMoa013563; Drenth DJ, 2004, EUR J CARDIO-THORAC, V25, P567, DOI 10.1016/j.ejcts.2004.01.015; Drenth DJ, 2002, J THORAC CARDIOV SUR, V124, P130, DOI 10.1067/mtc.2002.122525; Drenth DJ, 2002, J AM COLL CARDIOL, V40, P1955, DOI 10.1016/S0735-1097(02)02536-6; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EGGER M, 1995, BRIT MED J, V311, P753, DOI 10.1136/bmj.311.7007.753c; Goy JJ, 2000, MAYO CLIN PROC, V75, P1116, DOI 10.4065/75.11.1116; Hong SJ, 2005, CATHETER CARDIO INTE, V64, P75, DOI 10.1002/ccd.20238; Iakovou I, 2002, AM J CARDIOL, V90, P885, DOI 10.1016/S0002-9149(02)02715-7; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P1089, DOI 10.1001/jama.279.14.1089; Kim JW, 2005, INT J CARDIOL, V99, P437, DOI 10.1016/j.ijcard.2004.08.045; MANTEL N, 1959, J NATL CANCER I, V22, P719; Meads C, 2000, Health Technol Assess, V4, P1; Moher D, 2000, ONKOLOGIE, V23, P597, DOI 10.1159/000055014; Niinami H, 2001, ANN THORAC SURG, V72, pS1041, DOI 10.1016/S0003-4975(01)02945-9; Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282; O'Keefe JH, 1999, CIRCULATION, V100, P114; Opie LH, 2006, LANCET, V367, P69, DOI 10.1016/S0140-6736(06)67927-0; Poyen V, 2003, J CARDIOVASC SURG, V44, P307; Rao C, 2007, BMJ-BRIT MED J, V334, P621, DOI 10.1136/bmj.39112.480023.BE; Reeves BC, 2004, HEALTH TECHNOL ASSES, V8, P1; Shirai K, 2004, AM J CARDIOL, V93, P959, DOI 10.1016/j.amjcard.2003.12.048; Smith SC, 2001, CIRCULATION, V103, P3019, DOI 10.1161/01.CIR.103.24.3019; Versaci F, 2004, HEART, V90, P672, DOI 10.1136/hrt.2003.020826; Villareal RP, 2002, TEX HEART I J, V29, P3; Yock CA, 2003, AM J MED, V115, P382, DOI 10.1016/S0002-9343(03)00296-1; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	35	85	91	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2007	334	7594					617	621		10.1136/bmj.39106.476215.BE	http://dx.doi.org/10.1136/bmj.39106.476215.BE			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	152DC	17337458	Green Published, Bronze			2022-12-28	WOS:000245340000034
J	Eshelby, K				Eshelby, Kate			Dying for a drink	BRITISH MEDICAL JOURNAL			English	Article												kate@kateeshelby.com						*UN, HUM DEV REP 2006 SCA	1	9	9	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 24	2007	334	7594					610	612		10.1136/bmj.39150.398009.BEimages	http://dx.doi.org/10.1136/bmj.39150.398009.BEimages			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	152DC	17379906	Green Published			2022-12-28	WOS:000245340000031
J	Modlin, JF				Modlin, John F.			Focus on research: Enterovirus deja vu	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dartmouth Coll Sch Med, Dept Pediat, Lebanon, NH 03766 USA	Dartmouth College	Modlin, JF (corresponding author), Dartmouth Coll Sch Med, Dept Pediat, Lebanon, NH 03766 USA.							Paul JR, 1971, HIST POLIOMYELITIS; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304	2	23	25	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1204	1205		10.1056/NEJMp078016	http://dx.doi.org/10.1056/NEJMp078016			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377157				2022-12-28	WOS:000245101900004
J	Van Spall, HGC; Toren, A; Kiss, A; Fowler, RA				Van Spall, Harriette G. C.; Toren, Andrew; Kiss, Alex; Fowler, Robert A.			Eligibility criteria of randomized controlled trials published in high-impact general medical journals - A systematic sampling review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CLINICAL-TRIALS; USERS GUIDES; OLDER PERSONS; WOMEN; HEART; ATTITUDES; THERAPY; CANCER; REPRESENTATION; PUBLICATION	Context Selective eligibility criteria of randomized controlled trials (RCTs) are vital to trial feasibility and internal validity. However, the exclusion of certain patient populations may lead to impaired generalizability of results. Objective To determine the nature and extent of exclusion criteria among RCTs published in major medical journals and the contribution of exclusion criteria to the representation of certain patient populations. Data Sources and Study Selection The MEDLINE database was searched for RCTs published between 1994 and 2006 in certain general medical journals with a high impact factor. Of 4827 articles, 283 were selected using a series technique. Data Extraction Trial characteristics and the details regarding exclusions were extracted independently. All exclusion criteria were graded independently and in duplicate as either strongly justified, potentially justified, or poorly justified according to previously developed and pilot-tested guidelines. Data Synthesis Common medical conditions formed the basis for exclusion in 81.3% of trials. Patients were excluded due to age in 72.1% of all trials (60.1% in pediatric populations and 38.5% in older adults). Individuals receiving commonly prescribed medications were excluded in 54.1% of trials. Conditions related to female sex were grounds for exclusion in 39.2% of trials. Of all exclusion criteria, only 47.2% were graded as strongly justified in the context of the specific RCT. Exclusion criteria were not reported in 12.0% of trials. Multivariable analyses revealed independent associations between the total number of exclusion criteria and drug intervention trials (risk ratio, 1.35; 95% confidence interval, 1.11-1.65; P = .003) and between the total number of exclusion criteria and multicenter trials (risk ratio, 1.26; 95% confidence interval, 1.06-1.52; P = .009). Industry-sponsored trials were more likely to exclude individuals due to concomitant medication use, medical comorbidities, and age. Drug intervention trials were more likely to exclude individuals due to concomitant medication use, medical comorbidities, female sex, and socioeconomic status. Among such trials, justification for exclusions related to concomitant medication use and comorbidities were more likely to be poorly justified. Conclusions The RCTs published in major medical journals do not always clearly report exclusion criteria. Women, children, the elderly, and those with common medical conditions are frequently excluded from RCTs. Trials with multiple centers and those involving drug interventions are most likely to have extensive exclusions. Such exclusions may impair the generalizability of RCT results. These findings highlight a need for careful consideration and transparent reporting and justification of exclusion criteria in clinical trials.	Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Div Cardiol, Toronto, ON, Canada; Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; Univ Ottawa, Dept Ophthalmol, Ottawa, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Ottawa	Fowler, RA (corresponding author), Sunnybrook Med Ctr, Room D478,2075 Bayview Ave, Toronto, ON M5N 3M5, Canada.	rob.fowler@sunnybrook.ca		Toren, Andrew/0000-0003-0734-5653				Bartlett C, 2003, HEART, V89, P327, DOI 10.1136/heart.89.3.327; Benjamin DK, 2006, JAMA-J AM MED ASSOC, V296, P1266, DOI 10.1001/jama.296.10.1266; Bijker N, 2002, BRIT J CANCER, V87, P615, DOI 10.1038/sj.bjc.6600514; Blumer JL, 1999, PEDIATRICS, V104, P598; BRIGGS GG, 1998, DRUGS PREGNANCY LACT; Britton A, 1999, J Health Serv Res Policy, V4, P112; Caldwell PHY, 2004, LANCET, V364, P803, DOI 10.1016/S0140-6736(04)16942-0; CASSILETH BR, 1982, JAMA-J AM MED ASSOC, V248, P968, DOI 10.1001/jama.248.8.968; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Corrie P, 2003, BMJ-BRIT MED J, V327, P320, DOI 10.1136/bmj.327.7410.320; DAVIS S, 1985, CANCER-AM CANCER SOC, V56, P1710, DOI 10.1002/1097-0142(19851001)56:7<1710::AID-CNCR2820560741>3.0.CO;2-T; DOUGLAS PS, 1986, CIRCULATION, V74, P917, DOI 10.1161/01.CIR.74.5.917; EGGER M, 2001, SYSTEMATIC REV HLTH, P429; Flack JM, 2000, CURR MED RES OPIN, V16, P66, DOI 10.1185/030079900542867; Food and Drug Administration, 1994, FED REGISTER, V59, P64240; Fossa SD, 2002, ACTA ONCOL, V41, P131, DOI 10.1080/028418602753669490; Fuks A, 1998, J CLIN EPIDEMIOL, V51, P69, DOI 10.1016/S0895-4356(97)00240-0; GARFIELD E, 1986, ANN INTERN MED, V105, P313, DOI 10.7326/0003-4819-105-2-313; Guyatt GH, 1999, JAMA-J AM MED ASSOC, V281, P1836, DOI 10.1001/jama.281.19.1836; GUYATT GH, 1994, JAMA-J AM MED ASSOC, V271, P59, DOI 10.1001/jama.271.1.59; GUYATT GH, 1993, JAMA-J AM MED ASSOC, V270, P2598, DOI 10.1001/jama.270.21.2598; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Hall W. Dallas, 1999, Ethnicity and Disease, V9, P333; HARRELL FE, 1985, CANCER TREAT REP, V69, P1071; Harris DJ, 2000, NEW ENGL J MED, V343, P475, DOI 10.1056/NEJM200008173430706; Heiat A, 2002, ARCH INTERN MED, V162, P1682, DOI 10.1001/archinte.162.15.1682; HULLEY SB, 2001, DESIGNING CLIN RES, P25; International Committee of Medical Journal Editors, UN REQ MAN SUBM BIOM; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5; MANSOUR EG, 1994, CANCER, V74, P2672, DOI 10.1002/1097-0142(19941101)74:9+<2672::AID-CNCR2820741815>3.0.CO;2-X; Masoudi FA, 2003, AM HEART J, V146, P250, DOI 10.1016/S0002-8703(03)00189-3; Matsui D, 2003, CAN MED ASSOC J, V169, P1033; *MEDC HLTH SOL, 2000, DRUG TREND REP; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Moore TJ, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e53; National Institutes of Health, NIH POL GUID INCL CH; National Institutes of Health, 1994, FED REGISTER, V59, P1408; *NIH, 1987, NIH GUID GRANTS CONT; *NIH, 1990, NIH GUID GRANTS CONT; Rathore SS, 2003, BRIT MED J, V327, P763, DOI 10.1136/bmj.327.7418.763; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; SCHAIN WS, 1994, CANCER, V74, P2666, DOI 10.1002/1097-0142(19941101)74:9+<2666::AID-CNCR2820741814>3.0.CO;2-P; Schmidt B, 1999, J PEDIATR-US, V134, P151, DOI 10.1016/S0022-3476(99)70428-2; Schneider LS, 1997, J AM GERIATR SOC, V45, P923, DOI 10.1111/j.1532-5415.1997.tb02960.x; Sokka T, 2003, J RHEUMATOL, V30, P1138; Steinbrook R, 2002, NEW ENGL J MED, V347, P1462, DOI 10.1056/NEJMhpr021646; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; TAYLOR KM, 1984, NEW ENGL J MED, V310, P1363, DOI 10.1056/NEJM198405243102106; *THOMS CORP, IS WEB KNOWL; *US FOOD DRUG ADM, 2001, PED EXCL PROV JAN 20; *US FOOD DRUG ADM, 1994, EX SUMM FDA REG PROD; VIST GE, 2001, OUTCOMES PATIENTS WH; Wilson JT, 1999, PEDIATRICS, V104, P585	56	645	651	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2007	297	11					1233	1240		10.1001/jama.297.11.1233	http://dx.doi.org/10.1001/jama.297.11.1233			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	147XO	17374817				2022-12-28	WOS:000245039300027
J	Bhattacharya, T; Daniels, M; Heckerman, D; Foley, B; Frahm, N; Kadie, C; Carlson, J; Yusim, K; McMahon, B; Gaschen, B; Mallal, S; Mullins, JI; Nickle, DC; Herbeck, J; Rousseau, C; Learn, GH; Miura, T; Brander, C; Walker, B; Korber, B				Bhattacharya, Tanmoy; Daniels, Marcus; Heckerman, David; Foley, Brian; Frahm, Nicole; Kadie, Carl; Carlson, Jonathan; Yusim, Karina; McMahon, Ben; Gaschen, Brian; Mallal, Simon; Mullins, James I.; Nickle, David C.; Herbeck, Joshua; Rousseau, Christine; Learn, Gerald H.; Miura, Toshiyuki; Brander, Christian; Walker, Bruce; Korber, Bette			Founder effects in the assessment of HIV polymorphisms and HLA allele associations	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ESCAPE; RESPONSES; CTL; EPITOPES; FITNESS; GAG; MUTATIONS; DIVERSITY; VARIANTS	Escape from T cell-mediated immune responses affects the ongoing evolution of rapidly evolving viruses such as HIV. By applying statistical approaches that account for phylogenetic relationships among viral sequences, we show that viral lineage effects rather than immune escape often explain apparent human leukocyte antigen (HLA)-mediated immune-escape mutations defined by older analysis methods. Phylogenetically informed methods identified immune-susceptible locations with greatly improved accuracy, and the associations we identified with these methods were experimentally validated. This approach has practical implications for understanding the impact of host immunity on pathogen evolution and for defining relevant variants for inclusion in vaccine antigens.	Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Santa Fe Inst, Santa Fe, NM 87501 USA; Microsoft Corp, Res, Machine Learning & Appl Stat Grp, Redmond, WA 98052 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Partners AIDS Res Ctr, Boston, MA 02129 USA; Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA, Australia; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute; Microsoft; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Washington; University of Washington Seattle; Royal Perth Hospital; University of Western Australia; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Korber, B (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	btk@lanl.gov	Learn, Jerry/E-3356-2012; Learn, Gerald H/B-6934-2011; Nickle, David/ABF-2727-2020; Mallal, Simon Alexander/HDM-9561-2022; Bhattacharya, Tanmoy/J-8956-2013; Foley, Brian T/N-4527-2018	Learn, Gerald H/0000-0003-0434-7733; Mallal, Simon Alexander/0000-0002-7036-1309; Bhattacharya, Tanmoy/0000-0002-1060-652X; Foley, Brian T/0000-0002-1086-0296; Korber, Bette/0000-0002-2026-5757; Mcmahon, Benjamin/0000-0002-8226-1276; Brander, Christian/0000-0002-0548-5778; Walker, Bruce/0000-0002-8506-6740	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, P01AI057005] Funding Source: NIH RePORTER; NIAID NIH HHS [AI57005, AI27757] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Altfeld M, 2001, J IMMUNOL, V167, P2743, DOI 10.4049/jimmunol.167.5.2743; Ammaranond P, 2005, AIDS RES HUM RETROV, V21, P395, DOI 10.1089/aid.2005.21.395; Corbet S, 2003, J GEN VIROL, V84, P2409, DOI 10.1099/vir.0.19152-0; De Groot AS, 2003, VACCINE, V21, P4486, DOI 10.1016/S0264-410X(03)00390-6; FRAHM N, 2005, HIV MOL IMMUNOLOGY, P3; Friedrich TC, 2004, J VIROL, V78, P2581, DOI 10.1128/JVI.78.5.2581-2585.2004; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; MARSH S, 2000, HLA FACTSBOOK, P99; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Mehra N, 2001, TISSUE ANTIGENS, V57, P502, DOI 10.1034/j.1399-0039.2001.057006502.x; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Peyerl FW, 2004, J VIROL, V78, P13901, DOI 10.1128/JVI.78.24.13901-13910.2004; Rodriguez William R, 2004, J Transl Med, V2, P15, DOI 10.1186/1479-5876-2-15; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Wells RS, 1997, IMMUNOGENETICS, V46, P173, DOI 10.1007/s002510050259; Yu XG, 2002, AIDS, V16, P321, DOI 10.1097/00002030-200202150-00002; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002	20	204	214	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1583	1586		10.1126/science.1131528	http://dx.doi.org/10.1126/science.1131528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363674				2022-12-28	WOS:000244934800055
J	Weir, JT; Schluter, D				Weir, Jason T.; Schluter, Dolph			The latitudinal gradient in recent speciation and extinction rates of birds and mammals	SCIENCE			English	Article							NEW-WORLD BIRDS; DIVERSITY GRADIENT; DIVERSIFICATION; EVOLUTION; BIODIVERSITY; PATTERNS	Although the tropics harbor greater numbers of species than do temperate zones, it is not known whether the rates of speciation and extinction also follow a latitudinal gradient. By sampling birds and mammals, we found that the distribution of the evolutionary ages of sister species-pairs of species in which each is the other's closest relative-adheres to a latitudinal gradient. The time to divergence for sister species is shorter at high latitudes and longer in the tropics. Birth-death models fitting these data estimate that the highest recent speciation and extinction rates occur at high latitudes and decline toward the tropics. These results conflict with the prevailing view that links high tropical diversity to elevated tropical speciation rates. Instead, our findings suggest that faster turnover at high latitudes contributes to the latitudinal diversity gradient.	Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Weir, JT (corresponding author), Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada.	weir@zoology.ubc.ca	Weir, Jason/A-2920-2009	Schluter, Dolph/0000-0003-1683-7836				[Anonymous], 1878, TROPICAL NATURE OTHE; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Bohm M, 2005, BIOL J LINN SOC, V85, P235, DOI 10.1111/j.1095-8312.2005.00488.x; Buzas MA, 2002, P NATL ACAD SCI USA, V99, P7841, DOI 10.1073/pnas.122241499; Cardillo M, 2005, ECOLOGY, V86, P2278, DOI 10.1890/05-0112; Cardillo M, 1999, P ROY SOC B-BIOL SCI, V266, P1221, DOI 10.1098/rspb.1999.0766; Crame JA, 2002, PALEOBIOLOGY, V28, P184; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Hawkins BA, 2006, J BIOGEOGR, V33, P770, DOI 10.1111/j.1365-2699.2006.01452.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; HONEYCUTT RL, 1995, J MOL EVOL, V40, P260, DOI 10.1007/BF00163231; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; KENDALL DG, 1948, ANN MATH STAT, V19, P1, DOI 10.1214/aoms/1177730285; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Ricklefs RE, 2006, ECOLOGY, V87, P2468, DOI 10.1890/0012-9658(2006)87[2468:GVITDR]2.0.CO;2; Ricklefs Robert E., 2005, P16; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Weir JT, 2006, EVOLUTION, V60, P842; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; Yule G. V., 1924, Philosophical Transactions of the Royal Society London B, V213, P21	23	395	408	3	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2007	315	5818					1574	1576		10.1126/science.1135590	http://dx.doi.org/10.1126/science.1135590			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363673				2022-12-28	WOS:000244934800052
J	Ravelli, A; Martini, A				Ravelli, Angelo; Martini, Alberto			Juvenile idiopathic arthritis	LANCET			English	Review							MACROPHAGE ACTIVATION SYNDROME; MIGRATION INHIBITORY FACTOR; REGULATORY T-CELLS; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; CLINICAL-TRIAL; RADIOGRAPHIC PROGRESSION; ILAR CLASSIFICATION; JOINT INVOLVEMENT; SELECT CATEGORIES	Juvenile idiopathic arthritis is a broad term that describes a clinically heterogeneous group of arthritides of unknown cause, which begin before 16 years of age. This term encompasses several disease categories, each of which has distinct methods of presentation, clinical signs, and symptoms, and, in some cases, genetic background. The cause of disease is still poorly understood but seems to be related to both genetic and environmental factors, which result in the heterogeneity of the illness. Although none of the available drugs has a curative potential, prognosis has greatly improved as a result of substantial progresses in disease management. The most important new development has been the introduction of drugs such as anticytokine agents, which constitute a valuable treatment option for patients who are resistant to conventional antirheumatic agents. Further insights into the disease pathogenesis and treatment will be provided by the continuous advances in understanding of the mechanisms connected to the immune response and inflammatory process, and by the development of new drugs that are able to inhibit selectively single molecules or pathways.	Ist Giannina Gaslini, I-16147 Genoa, Italy; Univ Genoa, Dept Paediat, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa	Ravelli, A (corresponding author), Ist Giannina Gaslini, Largo G Gaslini 5, I-16147 Genoa, Italy.	angeloravelli@ospedale-gaslini.ge.it	RAVELLI, ANGELO/J-8161-2016; Kasapcopur, Ozgur/A-8888-2018	RAVELLI, ANGELO/0000-0001-9658-0385; Kasapcopur, Ozgur/0000-0002-1125-7720				AGGARWAL A, 1994, RHEUMATOL INT, V14, P53, DOI 10.1007/BF00300247; Al-Matar MJ, 2002, ARTHRITIS RHEUM-US, V46, P2708, DOI 10.1002/art.10544; Albani S, 2006, ARTHRITIS RHEUM, V54, P19, DOI 10.1002/art.21520; Ansell B M, 1987, Scand J Rheumatol Suppl, V66, P47; Arguedas O, 1998, J RHEUMATOL, V25, P1844; Armbrust W, 2004, RHEUMATOLOGY, V43, P527, DOI 10.1093/rheumatology/keh074; Bechtold S, 2003, J PEDIATR-US, V143, P512, DOI 10.1067/S0022-3476(03)00390-1; Bianchi ML, 2000, ARTHRITIS RHEUM-US, V43, P1960, DOI 10.1002/1529-0131(200009)43:9<1960::AID-ANR6>3.0.CO;2-J; Burgos-Vargas R, 2002, J RHEUMATOL, V29, P869; Burgos-Vargas R, 2002, RHEUM DIS CLIN N AM, V28, P531, DOI 10.1016/S0889-857X(02)00033-9; Burgos-Vargas R, 2002, ANN RHEUM DIS, V61, P941, DOI 10.1136/ard.61.10.941; CABRAL DA, 1992, J RHEUMATOL, V19, P1282; CASSIDY JT, 2005, TXB PEDIAT RHEUMATOL; Cazzola M, 1996, BLOOD, V87, P4824, DOI 10.1182/blood.V87.11.4824.bloodjournal87114824; CLEMENS LE, 1983, ANN RHEUM DIS, V42, P431, DOI 10.1136/ard.42.4.431; De Benedetti F, 2003, ARTHRITIS RHEUM, V48, P1398, DOI 10.1002/art.10882; De Benedetti F, 1998, J RHEUMATOL, V25, P203; De Benedetti Fabrizio, 1997, Current Opinion in Rheumatology, V9, P428, DOI 10.1097/00002281-199709000-00009; de Benedetti F, 2005, ARTHRITIS RHEUM-US, V52, P687, DOI 10.1002/art.20946; de Kleer IM, 2004, ANN RHEUM DIS, V63, P1318, DOI 10.1136/ard.2003.017798; de Kleer IM, 2004, J IMMUNOL, V172, P6435, DOI 10.4049/jimmunol.172.10.6435; de Kleer IM, 2003, ARTHRITIS RHEUM, V48, P2001, DOI 10.1002/art.11174; DeBenedetti F, 1997, J CLIN INVEST, V99, P643, DOI 10.1172/JCI119207; DEBENEDETTI F, 1994, J CLIN INVEST, V93, P2114, DOI 10.1172/JCI117206; DEBENEDETTI F, 1991, ARTHRITIS RHEUM, V34, P1158, DOI 10.1002/art.1780340912; Dekker L, 2004, CLIN EXP RHEUMATOL, V22, P252; Donn R, 2004, ARTHRITIS RHEUM-US, V50, P1604, DOI 10.1002/art.20178; Fantini F, 2001, J RHEUMATOL, V28, P456; Felici E, 2005, J RHEUMATOL, V32, P1805; Ferucci ED, 2005, ARTHRITIS RHEUM-US, V52, P239, DOI 10.1002/art.20773; Firestein GS, 2005, KELLEYS TXB RHEUMATO, P996; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Gattorno M, 2005, CLIN EXP RHEUMATOL, V23, P133; Gattorno M, 2005, ARTHRITIS RES THER, V7, pR256, DOI 10.1186/ar1485; Gattorno M, 2004, RHEUMATOLOGY, V43, P1091, DOI 10.1093/rheumatology/keh250; Gattorno M, 2002, J RHEUMATOL, V29, P1774; GIANNINI EH, 1992, NEW ENGL J MED, V326, P1043, DOI 10.1056/NEJM199204163261602; Glass DN, 1999, ARTHRITIS RHEUM-US, V42, P2261, DOI 10.1002/1529-0131(199911)42:11<2261::AID-ANR1>3.0.CO;2-P; Gregorio A, 2007, RHEUMATOLOGY, V46, P308, DOI 10.1093/rheumatology/kel225; Grom AA, 2004, ARTHRITIS RHEUM, V50, P689, DOI 10.1002/art.20198; Guillaume S, 2000, ARTHRITIS RHEUM, V43, P1858, DOI 10.1002/1529-0131(200008)43:8<1858::AID-ANR23>3.0.CO;2-A; Hafner R, 1996, Curr Opin Rheumatol, V8, P467; Hartman C, 2004, J RHEUMATOL, V31, P981; Hashkes PJ, 2005, JAMA-J AM MED ASSOC, V294, P1671, DOI 10.1001/jama.294.13.1671; Henrickson M, 2004, J RHEUMATOL, V31, P2055; Hinks A, 2005, ARTHRITIS RHEUM-US, V52, P1694, DOI 10.1002/art.21049; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Horneff G, 2004, ANN RHEUM DIS, V63, P1638, DOI 10.1136/ard.2003.014886; Hunt PG, 1997, J RHEUMATOL, V24, P2230; Ilowite NT, 2002, PEDIATRICS, V109, P109, DOI 10.1542/peds.109.1.109; Janka Gritta, 2005, Hematology Am Soc Hematol Educ Program, P82; Kamphuis S, 2005, LANCET, V366, P50, DOI 10.1016/S0140-6736(05)66827-4; Kim TH, 2005, CURR OPIN RHEUMATOL, V17, P400, DOI 10.1097/01.bor.0000163447.44037.c4; Kimura Y, 2005, J RHEUMATOL, V32, P935; LEAK AM, 1981, ANN RHEUM DIS, V40, P229, DOI 10.1136/ard.40.3.229; Lehman TJA, 2004, J PEDIATR-US, V145, P856, DOI 10.1016/j.jpeds.2004.08.020; Liem JJ, 2003, CLIN EXP RHEUMATOL, V21, P663; Lien G, 2003, ARTHRITIS RHEUM-US, V48, P2214, DOI 10.1002/art.11097; Lien G, 2005, ARTHRITIS RHEUM-US, V52, P833, DOI 10.1002/art.20963; Lomater C, 2000, J RHEUMATOL, V27, P491; Lovell DJ, 2006, ARTHRITIS RHEUM, V54, P2235, DOI 10.1002/art.21956; Lovell DJ, 2006, ARTHRITIS RHEUM, V54, P1987, DOI 10.1002/art.21885; Lovell DJ, 2000, NEW ENGL J MED, V342, P763, DOI 10.1056/NEJM200003163421103; Maeno N, 2002, ARTHRITIS RHEUM, V46, P2539, DOI 10.1002/art.10389; Magni-Manzoni S, 2003, ARTHRITIS RHEUM-US, V48, P3509, DOI 10.1002/art.11337; Malleson Peter N., 1997, Current Opinion in Rheumatology, V9, P291, DOI 10.1097/00002281-199707000-00003; Manners PJ, 1996, PEDIATRICS, V98, P84; Marini JC, 2003, NEW ENGL J MED, V349, P423, DOI 10.1056/NEJMp038103; Martini A, 2003, J RHEUMATOL, V30, P1900; MARTINI A, 1994, LANCET, V344, P1052, DOI 10.1016/S0140-6736(94)91710-8; Massa M, 2002, ARTHRITIS RHEUM, V46, P2721, DOI 10.1002/art.10564; Meazza C, 2002, ARTHRITIS RHEUM, V46, P232, DOI 10.1002/1529-0131(200201)46:1<232::AID-ART10059>3.0.CO;2-B; Mouy R, 1996, J PEDIATR-US, V129, P750, DOI 10.1016/S0022-3476(96)70160-9; Murray KJ, 1996, J RHEUMATOL, V23, P2116; Murray KJ, 1998, J RHEUMATOL, V25, P1388; Oen K, 2002, BEST PRACT RES CL RH, V16, P347, DOI 10.1053/berh.2002.0233; Oen K, 2002, J RHEUMATOL, V29, P1989; Ogilvie EM, 2003, ARTHRITIS RHEUM-US, V48, P3202, DOI 10.1002/art.11300; OSTROV BE, 2004, PEDIAT RHEUMATOL ONL, V2, P114; Pascual V, 2005, J EXP MED, V201, P1479, DOI 10.1084/jem.20050473; Petty RE, 2004, J RHEUMATOL, V31, P390; Petty RE, 2003, AM J OPHTHALMOL, V135, P879, DOI 10.1016/S0002-9394(03)00104-1; PETTY RE, 1994, CLIN EXP RHEUMATOL, V12, pS55; Petty RE, 2001, J RHEUMATOL, V28, P927; Prahalad S, 2004, CURR OPIN RHEUMATOL, V16, P588, DOI 10.1097/01.bor.0000134407.48586.b0; Prieur A.-M., 1994, REV RHUM ENGL ED, V61, P385; Quartier P, 2003, ARTHRITIS RHEUM, V48, P1093, DOI 10.1002/art.10885; Ravelli A, 2005, J PEDIATR-US, V146, P598, DOI 10.1016/j.jpeds.2004.12.016; Ravelli A, 2002, CURR OPIN RHEUMATOL, V14, P548, DOI 10.1097/00002281-200209000-00012; Ravelli A, 1996, J PEDIATR-US, V128, P275, DOI 10.1016/S0022-3476(96)70408-0; Ravelli A, 1999, CLIN EXP RHEUMATOL, V17, P625; Ravelli A, 2000, J RHEUMATOL, V27, P1830; Ravelli A, 2004, CLIN EXP RHEUMATOL, V22, P271; Ravelli A, 2003, CLIN EXP RHEUMATOL, V21, pS89; Ravelli A, 2005, ARTHRITIS RHEUM, V52, P826, DOI 10.1002/art.20945; Reiff A, 2006, J RHEUMATOL, V33, P985; Reiff A, 2001, ARTHRITIS RHEUM, V44, P1411, DOI 10.1002/1529-0131(200106)44:6<1411::AID-ART235>3.0.CO;2-O; Richards JC, 2005, CLIN EXP OPHTHALMOL, V33, P461, DOI 10.1111/j.1442-9071.2005.01062.x; Rosen P, 2003, CLIN EXP RHEUMATOL, V21, P650; Rosenberg AM, 2002, CURR OPIN RHEUMATOL, V14, P542, DOI 10.1097/00002281-200209000-00011; Rossi F, 2006, ARTHRIT RHEUM-ARTHR, V55, P717, DOI 10.1002/art.22246; Ruperto N, 2006, ANN RHEUM DIS, V65, P56; Ruperto N, 2005, ANN RHEUM DIS, V64, P1101, DOI 10.1136/ard.2004.030221; Ruperto N, 2005, ARTHRITIS RHEUM-US, V52, P563, DOI 10.1002/art.20860; Ruperto N, 2004, CURR OPIN RHEUMATOL, V16, P566, DOI 10.1097/01.bor.0000130286.54383.ea; Ruperto N, 2004, ARTHRITIS RHEUM-US, V50, P2191, DOI 10.1002/art.20288; RUPERTO N, 2005, CLIN EXP RHEUMAT S37, V23, P67; Ruprecht CR, 2005, J EXP MED, V201, P1793, DOI 10.1084/jem.20050085; Saha MT, 2004, J RHEUMATOL, V31, P1413; Sailer M, 1997, J RHEUMATOL, V24, P586; Saurenmann RK, 2006, RHEUMATOLOGY, V45, P982, DOI 10.1093/rheumatology/kel030; Sawhney S, 2001, ARCH DIS CHILD, V85, P421, DOI 10.1136/adc.85.5.421; Schmeling H, 2005, RHEUMATOLOGY, V44, P1008, DOI 10.1093/rheumatology/keh658; Scola MP, 2001, ARTHRITIS RHEUM-US, V44, P794, DOI 10.1002/1529-0131(200104)44:4<794::AID-ANR135>3.0.CO;2-7; Silverman E, 2005, NEW ENGL J MED, V352, P1655, DOI 10.1056/NEJMoa041810; Simon D, 2001, J Pediatr Endocrinol Metab, V14 Suppl 6, P1483; Simon D, 2002, J RHEUMATOL, V29, P1296; Singh-Grewal D, 2006, ARTHRITIS RHEUM-US, V54, P1595, DOI 10.1002/art.21774; Smith JA, 2005, ARTHRIT RHEUM-ARTHR, V53, P18, DOI 10.1002/art.20904; STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659, DOI 10.1001/jama.1949.02900430001001; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; Szer IS, 2006, ARTHRITIS CHILDREN A; Thompson SD, 2004, ARTHRITIS RHEUM-US, V50, P2920, DOI 10.1002/art.20425; Thomson W, 2002, ARTHRITIS RES, V4, P302, DOI 10.1186/ar591; Thomson W, 2002, RHEUMATOLOGY, V41, P1183, DOI 10.1093/rheumatology/41.10.1183; Tse SML, 2005, ARTHRITIS RHEUM, V52, P2103, DOI 10.1002/art.21121; Tsitsami E, 2003, ARTHRIT RHEUM-ARTHR, V49, P488, DOI 10.1002/art.11191; van Rossum MAJ, 2005, ARTHRITIS RHEUM, V52, P2865, DOI 10.1002/art.21247; van Rossum MAJ, 1998, ARTHRITIS RHEUM, V41, P808, DOI 10.1002/1529-0131(199805)41:5<808::AID-ART6>3.0.CO;2-T; Viola S, 2005, ARTHRITIS RHEUM-US, V52, P2092, DOI 10.1002/art.21119; Wallace CA, 2006, BEST PRACT RES CL RH, V20, P279, DOI 10.1016/j.berh.2005.11.008; Wallace CA, 2005, ARTHRITIS RHEUM-US, V52, P3554, DOI 10.1002/art.21389; Wallace CA, 2004, J RHEUMATOL, V31, P2290; Wallace CA, 1998, ARTHRITIS RHEUM-US, V41, P381, DOI 10.1002/1529-0131(199803)41:3<381::AID-ART2>3.0.CO;2-3; Wedderburn LR, 2000, ARTHRITIS RHEUM-US, V43, P765, DOI 10.1002/1529-0131(200004)43:4<765::AID-ANR7>3.0.CO;2-B; Yokota S, 2005, ARTHRITIS RHEUM, V52, P818, DOI 10.1002/art.20944	137	992	1079	0	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2007	369	9563					767	778		10.1016/S0140-6736(07)60363-8	http://dx.doi.org/10.1016/S0140-6736(07)60363-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143MP	17336654				2022-12-28	WOS:000244726700034
J	Shann, F				Shann, Frank			Suckling and sugar reduce pain in babies	LANCET			English	Editorial Material							ORALLY-ADMINISTERED GLUCOSE; RANDOMIZED CONTROLLED-TRIAL; SUCROSE ANALGESIA; NEONATAL PAIN; INFANTS; NEWBORNS; YOUNGER; RELIEF; AGE		Royal Childrens Hosp, Intens Care Unit, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne	Shann, F (corresponding author), Royal Childrens Hosp, Intens Care Unit, Flemington Rd, Parkville, Vic 3052, Australia.	frank.shann@rch.org.au	Shann, Frank/C-9510-2011					ANAND KJS, 1992, NEW ENGL J MED, V326, P1, DOI 10.1056/NEJM199201023260101; ANAND KJS, 1987, NEW ENGL J MED, V317, P1321, DOI 10.1056/NEJM198711193172105; Bilgen H, 2001, J PAIN, V2, P301, DOI 10.1054/jpai.2001.23140; Bucher HU, 2000, EARLY HUM DEV, V59, P51, DOI 10.1016/S0378-3782(00)00085-2; Carbajal R, 1999, BRIT MED J, V319, P1393, DOI 10.1136/bmj.319.7222.1393; Carbajal R, 2003, BMJ-BRIT MED J, V326, P13, DOI 10.1136/bmj.326.7379.13; Eriksson M, 2004, ACTA PAEDIATR, V93, P246, DOI 10.1080/08035250310008041; Gradin M, 2005, PEDIATRICS, V115, P1004, DOI 10.1542/peds.2004-1189; Gradin M, 2004, EARLY HUM DEV, V77, P57, DOI 10.1016/j.earlhumdev.2004.01.003; Guala A, 2001, Minerva Pediatr, V53, P271; Isik U, 2000, J PAIN, V1, P275, DOI 10.1054/jpai.2000.8919; Johnston CC, 2002, PEDIATRICS, V110, P523, DOI 10.1542/peds.110.3.523; Lewindon PJ, 1998, ARCH DIS CHILD, V78, P453, DOI 10.1136/adc.78.5.453; Lidow MS, 2002, PAIN, V99, P377, DOI 10.1016/S0304-3959(02)00258-0; Rogers AJ, 2006, ACAD EMERG MED, V13, P617, DOI 10.1197/j.aem.2006.01.026; Shah PS, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004950.PUB2; STEVENS B, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001069.P1B2; WILLIS DM, 1977, PEDIATRICS, V60, P535	18	9	9	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2007	369	9563					721	723		10.1016/S0140-6736(07)60335-3	http://dx.doi.org/10.1016/S0140-6736(07)60335-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143MP	17336631				2022-12-28	WOS:000244726700007
J	Ecker, JL; Frigoletto, FD				Ecker, Jeffrey L.; Frigoletto, Fredric D., Jr.			Cesarean delivery and the risk-benefit calculus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SECTION		Harvard Univ, Sch Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Ecker, JL (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Duncan CJ, 1937, NEW ENGL J MED, V216, P1, DOI 10.1056/NEJM193701072160101; Greene MF, 2001, NEW ENGL J MED, V345, P54, DOI 10.1056/NEJM200107053450108; HAMILTON BE, 2006, BIRTHS PRELIMINARY D; LOCALIO AR, 1993, JAMA-J AM MED ASSOC, V269, P366, DOI 10.1001/jama.269.3.366; Rouse DJ, 1996, JAMA-J AM MED ASSOC, V276, P1480, DOI 10.1001/jama.276.18.1480	5	119	128	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2007	356	9					885	888		10.1056/NEJMp068290	http://dx.doi.org/10.1056/NEJMp068290			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	140HV	17329693				2022-12-28	WOS:000244496400001
J	Warkentin, TE				Warkentin, Theodore E.			Focus on research: Drug-induced immune-mediated thrombocytopenia - from purpura to thrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada	McMaster University	Warkentin, TE (corresponding author), McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada.							ACKROYD JF, 1949, CLIN SCI, V7, P249; Aster RH, 2006, J THROMB HAEMOST, V4, P678, DOI 10.1111/j.1538-7836.2006.01829.x; RHODES GR, 1973, SURG GYNECOL OBSTET, V136, P409; Tinmouth AT, 2006, TRANSFUS MED REV, V20, P294, DOI 10.1016/j.tmrv.2006.05.008; WARKENTIN TE, 2005, HEMATOLOGY BASIC PRI, P2305	5	67	71	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2007	356	9					891	893		10.1056/NEJMp068309	http://dx.doi.org/10.1056/NEJMp068309			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140HV	17329695				2022-12-28	WOS:000244496400003
J	Adams, K; Jones, D				Adams, Kate; Jones, David			Should the NHS curb spending on translation services?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Broadwater Farm Estate, London N17 6BF, England			kateadams@doctors.org.uk							0	19	19	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 24	2007	334	7590					398	399		10.1136/bmj.39126.572431.47	http://dx.doi.org/10.1136/bmj.39126.572431.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	142MQ	17322254	Green Published			2022-12-28	WOS:000244654400026
J	Klein, Y; Efrati, E; Sharon, E				Klein, Yael; Efrati, Efi; Sharon, Eran			Shaping of elastic sheets by prescription of non-Euclidean metrics	SCIENCE			English	Article							THIN-FILMS; GELS; PLATES; EDGES	The connection between a surface's metric and its Gaussian curvature ( Gauss theorem) provides the base for a shaping principle of locally growing or shrinking elastic sheets. We constructed thin gel sheets that undergo laterally nonuniform shrinkage. This differential shrinkage prescribes non-Euclidean metrics on the sheets. To minimize their elastic energy, the free sheets form three-dimensional structures that follow the imposed metric. We show how both large-scale buckling and multiscale wrinkling structures appeared, depending on the nature of possible embeddings of the prescribed metrics. We further suggest guidelines for how to generate each type of feature.	Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Sharon, E (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.	erans@vms.huji.ac.il						Audoly B, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.086105; BenAmar M, 1997, P ROY SOC A-MATH PHY, V453, P729, DOI 10.1098/rspa.1997.0041; Boudaoud A, 2000, NATURE, V407, P718, DOI 10.1038/35037535; Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; Cerda E, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.074302; Cerda E, 2002, NATURE, V419, P579, DOI 10.1038/419579b; EFIRNENKO K, 2005, NAT MATER, V4, P293; FOPPEL A, 2007, VORLESUNGEN TECHNISC; HIROKAWA Y, 1984, J CHEM PHYS, V81, P6379, DOI 10.1063/1.447548; HU ZB, 1995, SCIENCE, V269, P525, DOI 10.1126/science.269.5223.525; Kataoka K, 1998, J AM CHEM SOC, V120, P12694, DOI 10.1021/ja982975d; Kramer EM, 1997, PHYS REV LETT, V78, P1303, DOI 10.1103/PhysRevLett.78.1303; Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496; Lobkovsky AE, 1997, PHYS REV E, V55, P1577, DOI 10.1103/PhysRevE.55.1577; Marder M, 2006, J STAT PHYS, V125, P1069, DOI 10.1007/s10955-006-9087-x; Marder M, 2003, EUROPHYS LETT, V62, P498, DOI 10.1209/epl/i2003-00334-5; Mora T, 2006, EUR PHYS J E, V20, P119, DOI 10.1140/epje/i2005-10124-5; ONeill B., 1966, ELEMENTARY DIFFERENT; Philippova OE, 1997, MACROMOLECULES, V30, P8278, DOI 10.1021/ma970957v; Pomeau Y, 1997, CR ACAD SCI II B, V325, P181, DOI 10.1016/S1251-8069(97)88276-0; POZNYAK EG, 1996, AM MATH SOC TRANSL 2, V176, P151; Roman B, 1999, EUROPHYS LETT, V46, P602, DOI 10.1209/epl/i1999-00306-3; ROZENDORN R, 1992, ENCY MATH SCI GEOMET, V48, P89; Sharon E, 2002, NATURE, V419, P579, DOI 10.1038/419579a; SPIVAK M., 1979, COMPREHENSIVE INTRO, VI; Spivak M., 1979, COMPREHENSIVE INTRO, VIII; TANAKA T, 1978, PHYS REV LETT, V40, P820, DOI 10.1103/PhysRevLett.40.820; Thompson D. W., 1917, GROWTH FORM; Yu YL, 2004, PURE APPL CHEM, V76, P1467, DOI 10.1351/pac200476071467	29	462	476	2	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1116	1120		10.1126/science.1135994	http://dx.doi.org/10.1126/science.1135994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17322058				2022-12-28	WOS:000244387600034
J	Koenigs, M; Young, L; Adolphs, R; Tranel, D; Cushman, F; Hauser, M; Damasio, A				Koenigs, Michael; Young, Liane; Adolphs, Ralph; Tranel, Daniel; Cushman, Fiery; Hauser, Marc; Damasio, Antonio			Damage to the prefrontal cortex increases utilitarian moral judgements	NATURE			English	Article							NETWORKS; EMOTION; FMRI	The psychological and neurobiological processes underlying moral judgement have been the focus of many recent empirical studies(1-11). Of central interest is whether emotions play a causal role in moral judgement, and, in parallel, how emotion-related areas of the brain contribute to moral judgement. Here we show that six patients with focal bilateral damage to the ventromedial prefrontal cortex (VMPC), a brain region necessary for the normal generation of emotions and, in particular, social emotions(12-14), produce an abnormally 'utilitarian' pattern of judgements on moral dilemmas that pit compelling considerations of aggregate welfare against highly emotionally aversive behaviours ( for example, having to sacrifice one person's life to save a number of other lives)(7,8). In contrast, the VMPC patients' judgements were normal in other classes of moral dilemmas. These findings indicate that, for a selective set of moral dilemmas, the VMPC is critical for normal judgements of right and wrong. The findings support a necessary role for emotion in the generation of those judgements.	Univ Iowa Hosp & Clin, Dept Neurol, Iowa City, IA 52242 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA; Univ So Calif, Dornsife Ctr Cognit Neuroimaging, Los Angeles, CA 90089 USA	University of Iowa; Harvard University; California Institute of Technology; California Institute of Technology; University of Southern California; University of Southern California	Adolphs, R (corresponding author), Univ Iowa Hosp & Clin, Dept Neurol, Iowa City, IA 52242 USA.	radolphs@hss.caltech.edu	Damasio, Antonio/AAD-1342-2019	Cushman, Fiery/0000-0002-6929-9982; Koenigs, Michael/0000-0002-5799-4881; Tranel, Daniel/0000-0002-1338-1389	NIDA NIH HHS [R01 DA022549-02, R01 DA022549] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022549] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anderson S. W., 1993, IOWA RATING SCALES P; Anderson SW, 2006, J INT NEUROPSYCH SOC, V12, P224, DOI 10.1017/S1355617706060346; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Beer JS, 2003, J PERS SOC PSYCHOL, V85, P594, DOI 10.1037/0022-3514.85.4.594; BLAIR RJR, 1995, COGNITION, V57, P1, DOI 10.1016/0010-0277(95)00676-P; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Cushman F, 2006, PSYCHOL SCI, V17, P1082, DOI 10.1111/j.1467-9280.2006.01834.x; Damasio A.R., 2005, DESCARTES ERROR EMOT; Damasio A.R., 2003, LOOKING SPINOZA JOY; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; Frank RJ, 1997, NEUROIMAGE, V5, P13, DOI 10.1006/nimg.1996.0250; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Hauser M.D., 2006, MORAL MINDS; Hauser M, 2007, MIND LANG, V22, P1, DOI 10.1111/j.1468-0017.2006.00297.x; Heekeren HR, 2003, NEUROREPORT, V14, P1215, DOI 10.1097/00001756-200307010-00005; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Kohlberg L., 1981, ESSAYS MORAL DEV, V1; Luo QA, 2006, NEUROIMAGE, V30, P1449, DOI 10.1016/j.neuroimage.2005.11.005; Mendez MF, 2005, COGN BEHAV NEUROL, V18, P193, DOI 10.1097/01.wnn.0000191292.17964.bb; MIKHAIL JM, 2000, THESIS CORNELL U; Moll J, 2002, NEUROIMAGE, V16, P696, DOI 10.1006/nimg.2002.1118; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Valdesolo P, 2006, PSYCHOL SCI, V17, P476, DOI 10.1111/j.1467-9280.2006.01731.x; Wheatley T, 2005, PSYCHOL SCI, V16, P780, DOI 10.1111/j.1467-9280.2005.01614.x	29	959	993	14	293	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2007	446	7138					908	911		10.1038/nature05631	http://dx.doi.org/10.1038/nature05631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158IR	17377536	Green Accepted, Green Published			2022-12-28	WOS:000245785700041
J	Lowry, SC; Fitzsimmons, A; Pravec, P; Vokrouhlicky, D; Boehnhardt, H; Taylor, PA; Margot, JL; Galad, A; Irwin, M; Irwin, J; Kusnirak, P				Lowry, Stephen C.; Fitzsimmons, Alan; Pravec, Petr; Vokrouhlicky, David; Boehnhardt, Hermann; Taylor, Patrick A.; Margot, Jean-Luc; Galad, Adrian; Irwin, Mike; Irwin, Jonathan; Kusnirak, Peter			Direct detection of the asteroidal YORP effect	SCIENCE			English	Article							YARKOVSKY	The Yarkovsky-O'Keefe-Radzievskii-Paddack (YORP) effect is believed to alter the spin states of small bodies in the solar system. However, evidence for the effect has so far been indirect. We report precise optical photometric observations of a small near-Earth asteroid, ( 54509) 2000 PH5, acquired over 4 years. We found that the asteroid has been continuously increasing its rotation rate omega over this period by d omega/dt = 2.0 (+/- 0.2) x 10(-4) degrees per day squared. We simulated the asteroid's close Earth approaches from 2001 to 2005, showing that gravitational torques cannot explain the observed spin rate increase. Dynamical simulations suggest that 2000 PH5 may reach a rotation period of similar to 20 seconds toward the end of its expected lifetime.	Queens Univ Belfast, Sch Math & Phys, Belfast BT7 1NN, Antrim, North Ireland; Acad Sci Czech Republic, Inst Astron, CZ-25165 Ondrejov, Czech Republic; Charles Univ Prague, Inst Astron, CR-18000 Prague 8, Czech Republic; Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Fac Math Phys & Informat, Dept Astron Phys Earth & Meteorol, Bratislava 84248, Slovakia; Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England	Queens University Belfast; Czech Academy of Sciences; Astronomical Institute of the Czech Academy of Sciences; Charles University Prague; Max Planck Society; Cornell University; Comenius University Bratislava; University of Cambridge	Lowry, SC (corresponding author), Queens Univ Belfast, Sch Math & Phys, Belfast BT7 1NN, Antrim, North Ireland.	s.c.lowry@qub.ac.uk	Vokrouhlický, David/Q-4359-2017; Pravec, Petr/AAE-2695-2019; Galad, Adrian/G-9011-2014; Pravec, Petr/G-9037-2014; Margot, Jean-Luc/A-6154-2012	Vokrouhlický, David/0000-0002-6034-5452; Pravec, Petr/0000-0001-8434-9776; Galad, Adrian/0000-0002-5971-1136; Margot, Jean-Luc/0000-0001-9798-1797; Taylor, Patrick/0000-0002-2493-943X; Lowry, Stephen/0000-0002-5605-4329	Science and Technology Facilities Council [PP/E003303/1] Funding Source: researchfish; STFC [PP/E003303/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Bottke W. F., 2002, ASTEROIDS, P395; Bottke WF, 2006, ANNU REV EARTH PL SC, V34, P157, DOI 10.1146/annurev.earth.34.031405.125154; Capek D, 2004, ICARUS, V172, P526, DOI 10.1016/j.icarus.2004.07.003; Chesley SR, 2003, SCIENCE, V302, P1739, DOI 10.1126/science.1091452; Morbidelli A, 2003, ICARUS, V163, P120, DOI 10.1016/S0019-1035(03)00047-2; Pravec P., 2002, ASTEROIDS 3, P113; Rubincam DP, 2000, ICARUS, V148, P2, DOI 10.1006/icar.2000.6485; Slivan SM, 2002, NATURE, V419, P49, DOI 10.1038/nature00993; Taylor PA, 2007, SCIENCE, V316, P274, DOI 10.1126/science.1139038; Taylor R.C., 1979, ASTEROIDS EDITORS, P480; Vokrouhlicky D, 2006, ICARUS, V182, P118, DOI 10.1016/j.icarus.2005.12.010; Vokrouhlicky D, 2004, ASTRON ASTROPHYS, V414, pL21, DOI 10.1051/0004-6361:20031739; Vokrouhlicky D, 2003, NATURE, V425, P147, DOI 10.1038/nature01948; Vokrouhlicky D, 2002, ICARUS, V159, P449, DOI 10.1006/icar.2002.6918; WHITELEY RJ, 2002, P ACM, P473	15	128	132	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					272	274		10.1126/science.1139040	http://dx.doi.org/10.1126/science.1139040			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17347414	Green Published			2022-12-28	WOS:000245654500049
J	Alley, RB; Anandakrishnan, S; Dupont, TK; Parizek, BR; Pollard, D				Alley, Richard B.; Anandakrishnan, Sridhar; Dupont, Todd K.; Parizek, Byron R.; Pollard, David			Effect of sedimentation on ice-sheet grounding-line stability	SCIENCE			English	Article							RETREAT; INITIATION; SEA	Sedimentation filling space beneath ice shelves helps to stabilize ice sheets against grounding-line retreat in response to a rise in relative sea level of at least several meters. Recent Antarctic changes thus cannot be attributed to sea-level rise, strengthening earlier interpretations that warming has driven ice-sheet mass loss. Large sea-level rise, such as the approximate to 100-meter rise at the end of the last ice age, may overwhelm the stabilizing feedback from sedimentation, but smaller sea-level changes are unlikely to have synchronized the behavior of ice sheets in the past.	Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; Univ Illinois, Dept Earth & Environm Sci, Chicago, IL 60607 USA; Coll New Jersey, Dept Phys, Ewing, NJ 08628 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; College of New Jersey	Alley, RB (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	rba6@psu.edu			Directorate For Geosciences [0809106] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [0917509] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Adkins JF, 2002, SCIENCE, V298, P1769, DOI 10.1126/science.1076252; Alley RB, 2006, GEOMORPHOLOGY, V75, P76, DOI 10.1016/j.geomorph.2004.01.011; Anandakrishnan S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016329; Anandakrishnan S, 2007, SCIENCE, V315, P1835, DOI 10.1126/science.1138393; Anderson JB, 2002, QUATERNARY SCI REV, V21, P49, DOI 10.1016/S0277-3791(01)00083-X; Clarke GKC, 2005, ANNU REV EARTH PL SC, V33, P247, DOI 10.1146/annurev.earth.33.092203.122621; Conway H, 1999, SCIENCE, V286, P280, DOI 10.1126/science.286.5438.280; Dowdeswell JA, 2002, MAR GEOL, V188, P3, DOI 10.1016/S0025-3227(02)00272-4; Dupont TK, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025665; Dupont TK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022024; Elliot M, 1998, PALEOCEANOGRAPHY, V13, P433, DOI 10.1029/98PA01792; Hollin J. T., 1962, J GLACIOL, V4, P173, DOI DOI 10.1017/S0022143000027386; Horgan HJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027091; Huybrechts P, 2002, QUATERNARY SCI REV, V21, P203, DOI 10.1016/S0277-3791(01)00082-8; Kamb B., 2001, ANTARCT RES SER, V77, DOI DOI 10.1029/AR077P0157; MEIER MF, 1987, J GEOPHYS RES-SOLID, V92, P9051, DOI 10.1029/JB092iB09p09051; Mosola AB, 2006, QUATERNARY SCI REV, V25, P2177, DOI 10.1016/j.quascirev.2005.12.013; Parizek BR, 2004, GLOBAL PLANET CHANGE, V42, P265, DOI 10.1016/j.gloplacha.2003.09.005; PENCK A, 1928, SITZUNGSBER PREUS PM, V6, P76; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Rooney S. T., 1991, GEOLOGICAL EVOLUTION, P261; Scambos TA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020670; Scott RF, 1905, GEOGR J, V25, P353, DOI 10.2307/1776136; Weertman J., 1974, J GLACIOL, V13, P3, DOI [DOI 10.3189/S0022143000023327, 10.3189/S0022143000023327]; Wellner JS, 2006, GEOMORPHOLOGY, V75, P157, DOI 10.1016/j.geomorph.2005.05.015	25	150	150	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1838	1841		10.1126/science.1138396	http://dx.doi.org/10.1126/science.1138396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17332377				2022-12-28	WOS:000245280100041
J	Jung, J; Bonini, N				Jung, Joonil; Bonini, Nancy			CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease	SCIENCE			English	Article							MACHADO-JOSEPH-DISEASE; CAG REPEATS; DNA-REPAIR; POLYGLUTAMINE DISEASE; GENETIC INSTABILITY; LENGTH; TRANSCRIPTION; MECHANISMS; HUNTINGTIN; EXPANSION	Although expansion of trinucleotide repeats accounts for over 30 human diseases, mechanisms of repeat instability remain poorly understood. We show that a Drosophila model for the CAG/polyglutamine (polyQ) disease spinocerebellar ataxia type 3 recapitulates key features of human CAG-repeat instability, including large repeat changes and strong expansion bias. Instability is dramatically enhanced by transcription and modulated by nuclear excision repair and a regulator of DNA repair adenosine 3',5'- monophosphate (cAMP) response element-binding protein (CREB)-binding protein-a histone acetyltransferase (HAT) whose decreased activity contributes to polyQ disease. Pharmacological treatment to normalize acetylation suppressed instability. Thus, toxic consequences of pathogenic polyQ protein may include enhancing repeat instability.	Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Bonini, N (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu						Bodai L, 2003, CURR MED CHEM, V10, P2577, DOI 10.2174/0929867033456530; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Hasan S, 2002, J MOL MED, V80, P463, DOI 10.1007/s00109-002-0341-7; Jackson SM, 2005, GENE, V347, P35, DOI 10.1016/j.gene.2004.12.008; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kaytor MD, 1997, HUM MOL GENET, V6, P2135, DOI 10.1093/hmg/6.12.2135; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Lin YF, 2006, NAT STRUCT MOL BIOL, V13, P179, DOI 10.1038/nsmb1042; Maciel P, 1999, EUR J HUM GENET, V7, P147, DOI 10.1038/sj.ejhg.5200264; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Marx J, 2005, SCIENCE, V310, P43, DOI 10.1126/science.310.5745.43; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Sato T, 1999, HUM MOL GENET, V8, P99, DOI 10.1093/hmg/8.1.99; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Takiyama Y, 1997, HUM MOL GENET, V6, P1063, DOI 10.1093/hmg/6.7.1063; Tanaka F, 1999, AM J HUM GENET, V65, P966, DOI 10.1086/302578; Taylor JP, 2003, GENE DEV, V17, P1463, DOI 10.1101/gad.1087503; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Zhang Y, 2002, HUM MOL GENET, V11, P791, DOI 10.1093/hmg/11.7.791	30	110	110	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1857	1859		10.1126/science.1139517	http://dx.doi.org/10.1126/science.1139517			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17332375				2022-12-28	WOS:000245280100047
J	Smolyaninov, II; Hung, YJ; Davis, CC				Smolyaninov, Igor I.; Hung, Yu-Ju; Davis, Christopher C.			Magnifying superlens in the visible frequency range	SCIENCE			English	Article								We demonstrate a magnifying superlens that can be integrated into a conventional far-field optical microscope. Our design is based on a multilayer photonic metamaterial consisting of alternating layers of positive and negative refractive index, as originally proposed by Narimanov and Engheta. We achieved a resolution on the order of 70 nanometers. The use of such a magnifying superlens should find numerous applications in imaging.	Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Smolyaninov, II (corresponding author), Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA.	smoly@eng.umd.edu		Smolyaninov, Igor/0000-0003-3522-6731				Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Jacob Z, 2006, OPT EXPRESS, V14, P8247, DOI 10.1364/OE.14.008247; LEONHARDT U, 2006, SCIENCE         0524, DOI DOI 10.1126/SCIENCE.1126493; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Liu ZW, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2188378; Melville DOS, 2005, OPT EXPRESS, V13, P2127, DOI 10.1364/OPEX.13.002127; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; PENDRY JB, 2006, SCIENCE         0524, DOI DOI 10.1126/SCIENCE.1125907; Salandrino A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075103; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Smolyaninov II, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.057401; Zayats AV, 2005, PHYS REP, V408, P131, DOI 10.1016/j.physrep.2004.11.001	13	627	645	6	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1699	1701		10.1126/science.1138746	http://dx.doi.org/10.1126/science.1138746			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379804	Green Submitted			2022-12-28	WOS:000245106900035
J	Ginsburg, PB; Berenson, RA				Ginsburg, Paul B.; Berenson, Robert A.			Revising Medicare's physician fee schedule - Much activity, little change	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Studying Hlth Syst Change, Washington, DC USA; Urban Inst, Washington, DC 20037 USA	Urban Institute	Ginsburg, PB (corresponding author), Ctr Studying Hlth Syst Change, Washington, DC USA.							Berenson RA, 2007, HEALTH AFFAIR, V26, pW31, DOI 10.1377/hlthaff.26.1.w31; Berenson RA, 2006, HEALTH AFFAIR, V25, pW337, DOI 10.1377/hlthaff.25.w337; Bodenheimer T, 2007, ANN INTERN MED, V146, P301, DOI 10.7326/0003-4819-146-4-200702200-00011; Ginsburg PB, 2005, HEALTH AFFAIR, V24, pW5376, DOI 10.1377/hlthaff.W5.376; HACKBARTH GM, 2006, COMMUNICATION   0817	5	33	33	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1201	1203		10.1056/NEJMp068272	http://dx.doi.org/10.1056/NEJMp068272			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377156				2022-12-28	WOS:000245101900003
J	Harper, S; Lynch, J; Burris, S; Smith, GD				Harper, Sam; Lynch, John; Burris, Scott; Smith, George Davey			Trends in the black-white life expectancy gap in the United States, 1983-2003	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; MORTALITY; HIV; DECLINE; RACE; ADOLESCENTS; 1990S; CARE	Context Since the early 1980s, the black-white gap in life expectancy at birth increased sharply and subsequently declined, but the causes of these changes have not been investigated. Objective To determine the contribution of specific age groups and causes of death contributing to the changes in the black-white life expectancy gap from 1983-2003. Design and Setting US vital statistics data from the US National Vital Statistics System, maintained by the National Center for Health Statistics. Standard life table techniques were used to decompose the change in the black-white life expectancy gap by combining absolute changes in age-specific mortality with relative changes in the distribution of causes of death. Main Outcome Measure The gap in life expectancy at birth between blacks and whites. Results Among females, the black-white life expectancy gap increased 0.5 years in the period 1983-1993, primarily due to increased mortality from human immunodeficiency virus (HIV) (0.4 years) and slower declines in heart disease (0.1 years), which were somewhat offset by relative improvements in stroke (-0.1 years). The gap among males increased by 2 years in the period 1983-1993, principally because of adverse changes in HIV (1.1 years), homicide (0.5 years), and heart disease (0.3 years). Between 1993 and 2003, the female gap decreased by 1 year (from 5.59 to 4.54 years). Half of the total narrowing of the gap among females was due to relative mortality improvement among blacks in heart disease (-0.2 years), homicide (-0.2 years), and unintentional injuries (-0.1 years). The decline in the life expectancy gap was larger among males, declining by 25% (from 8.44 to 6.33 years). Nearly all of the 2.1-year decline among males was due to relative mortality improvement among blacks at ages 15 to 49 years (-2.0 years). Three causes of death accounted for 71% of the narrowing of the gap among males (homicide [-0.6 years], HIV [-0.6 years], and unintentional injuries [-0.3 years]), and lack of improvement in heart disease at older ages kept the gap from narrowing further. Conclusions After widening during the late 1980s, the black-white life expectancy gap has declined because of relative mortality improvements in homicide, HIV, unintentional injuries, and, among females, heart disease. Further narrowing of the gap will require concerted efforts in public health and health care to address the major causes of the remaining gap from cardiovascular diseases, homicide, HIV, and infant mortality.	McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; Temple Univ, Sch Law, Philadelphia, PA 19122 USA; Univ Bristol, Dept Social Med, Bristol, Avon, England	McGill University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Bristol	Harper, S (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave W Room 17B, Montreal, PQ H3A 1A2, Canada.	sam.harper@mcgill.ca	Davey Smith, George/A-7407-2013; Harper, Sam/A-3406-2008; Lynch, John W/A-4797-2008	Davey Smith, George/0000-0002-1407-8314; Harper, Sam/0000-0002-2767-1053; Lynch, John W/0000-0003-2781-7902; Burris, Scott/0000-0002-6013-5842				ANDERSON RN, 2005, NATL VITAL STAT REPO, V17; ARIAS E, 2006, NATL VITAL STAT REPO, V14; Arriaga E. E., 1989, DIFFERENTIAL MORTALI, P105; ARRIAGA EE, 1984, DEMOGRAPHY, V21, P83, DOI 10.2307/2061029; Blumstein A, 2000, ANNU REV PUBL HEALTH, V21, P505, DOI 10.1146/annurev.publhealth.21.1.505; Blumstein A, 2006, ANNU REV LAW SOC SCI, V2, P125, DOI 10.1146/annurev.lawsocsci.2.081805.110011; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P333; Compton WM, 2006, DRUG ALCOHOL DEPEN, V81, P103, DOI 10.1016/j.drugalcdep.2005.05.009; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; Cutler DM, 2007, HEALTH AFFAIR, V26, P97, DOI 10.1377/hlthaff.26.1.97; Davey Smith G., 2003, HLTH INEQUALITIES LI; DUGGAN MG, 2005, ESTIMATING IMPACT ME; Easterlin RA, 2000, CAMBRIDGE EC HIST US, V3, P505; Edelman PB., 2006, RECONNECTING DISADVA; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; ELO IT, 2004, DEMOGR RES, P255; Fingerhut LA, 1998, PUBLIC HEALTH REP, V113, P218; Gebo KA, 2005, JAIDS-J ACQ IMM DEF, V38, P96, DOI 10.1097/00126334-200501010-00017; Geiger H.J., 2003, UNEQUAL TREATMENT CO, P417, DOI DOI 10.1046/J.1525-1497.1999.00293.X; Gortmaker SL, 2001, NEW ENGL J MED, V345, P1522, DOI 10.1056/NEJMoa011157; Haines MR, 2003, HIST METHOD, V36, P157, DOI 10.1080/01615440309604818; Klein Herbert S., 2004, POPULATION HIST US; KOCHANEK KD, 1994, AM J PUBLIC HEALTH, V84, P938, DOI 10.2105/AJPH.84.6.938; LaFree G, 1999, ANNU REV SOCIOL, V25, P145, DOI 10.1146/annurev.soc.25.1.145; Levitt SD, 2004, J ECON PERSPECT, V18, P163, DOI 10.1257/089533004773563485; LIAO Y, 1995, PUBLIC HEALTH REP, V110, P572; MANTON KG, 1987, MILBANK Q, V65, P129, DOI 10.2307/3349954; MARTIN JA, 2005, NATL VITAL STAT REPO, V2; MATHEWS TJ, 2005, NATL VITAL STAT REPO, V20; MINCY RB, 2006, BLACK MALES LEFT BEH; MININO AM, 2006, NATL VITAL STAT REPO, V19; MININO AM, 2006, NATL VITAL STAT REPO, V10; Mueller MR, 2006, AM J PREV MED, V30, P423, DOI 10.1016/j.amepre.2005.12.011; *NCI SURV RES PROG, US MORT DAT; *NCI SURV RES PROG, 2006, SEER STT VERS 6 2 4; Ousey GC, 2004, J RES CRIME DELINQ, V41, P352, DOI 10.1177/0022427803262059; Palacio H, 2002, PUBLIC HEALTH REP, V117, P233, DOI 10.1016/S0033-3549(04)50158-9; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Paulozzi LJ, 2006, J SAFETY RES, V37, P277, DOI 10.1016/j.jsr.2006.02.004; Preston S., 2000, DEMOGRAPHY MEASURING; Rosen AB, 2007, HEALTH AFFAIR, V26, P111, DOI 10.1377/hlthaff.26.1.111; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; SEMPOS C, 1988, AM J PUBLIC HEALTH, V78, P1422, DOI 10.2105/AJPH.78.11.1422; STOLL MA, 2004, AFRICAN AM COLOR LIN; *SUBST AB MENT HLT, 2003, DHHS PUBL; Troesken Werner., 2004, WATER RACE DIS; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; WODAK A, 2004, EFFECTIVENESS STERIL; World Health Organization, 1992, INT STAT CLASS DIS 1	51	197	197	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2007	297	11					1224	1232		10.1001/jama.297.11.1224	http://dx.doi.org/10.1001/jama.297.11.1224			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	147XO	17369405	Bronze			2022-12-28	WOS:000245039300026
J	Smits, M; Dippel, DWJ; Steyerberg, EW; de Haan, GG; Dekker, HM; Vos, PE; Kool, DR; Nederkoorn, PJ; Hofman, PAM; Twijnstra, A; Tanghe, HLJ; Hunink, MGM				Smits, Marion; Dippel, Diederik W. J.; Steyerberg, Ewout W.; de Haan, Gijs G.; Dekker, Helena M.; Vos, Pieter E.; Kool, Digna R.; Nederkoorn, Paul J.; Hofman, Paul A. M.; Twijnstra, Albert; Tanghe, Herve L. J.; Hunink, M. G. Myriam			Predicting intracranial traumatic findings on computed tomography in patients with minor head injury: The CHIP prediction rule	ANNALS OF INTERNAL MEDICINE			English	Article							LOGISTIC-REGRESSION ANALYSIS; NEW-ORLEANS CRITERIA; MILD; VALIDATION; GUIDELINES; MODELS; MANAGEMENT; IMPUTATION; DIAGNOSIS; PROPOSAL	Background: Prediction rules for patients with minor head injury suggest that the use of computed tomography (CT) may be limited to certain patients at risk for intracranial complications. These rules apply only to patients with a history of loss of consciousness, which is frequently absent. Objective: To develop a prediction rule for the use of CT in patients with minor head injury, regardless of the presence or absence of a history of loss of consciousness. Design: Prospective, observational study. Setting: 4 university hospitals in the Netherlands that participated in the CT in Head Injury Patients (CHIP) study. Patients: Consecutive adult patients with minor head injury ( 16 years of age) with a Glasgow Coma Scale (GCS) score of 13 to 14 or with a GCS score of 15 and at least 1 risk factor. Measurements: Outcomes were any intracranial traumatic CT finding and neurosurgical intervention. The authors performed logistic regression analysis by using variables from existing prediction rules and guidelines, with internal validation by using bootstrapping. Results: 3181 patients were included (February 2002 to August 2004): 243 (7.6%) had intracranial traumatic CT findings and 17 (0.5%) underwent neurosurgical intervention. A detailed prediction rule was developed from which a simple rule was derived. Sensitivity of both rules was 100% for neurosurgical interventions, with an associated specificity of 23% to 30%. For intracranial traumatic CT findings, sensitivity and specificity were 94% to 96% and 25% to 32%, respectively. Potential CT reduction by implementing the prediction rule was 23% to 30%. Internal validation showed slight optimism for the model's performance. Limitation: External validation of the prediction model will be required. Conclusion: The authors propose the highly sensitive CHIP prediction rule for the selective use of CT in patients with minor head injury with or without loss of consciousness.	Erasmus MC Univ Med Ctr, Dept Epidemiol & Biostat, NL-3000 CA Rotterdam, Netherlands; Univ Med Ctr Nijmegen St Radboud, Nijmegen, Netherlands; Acad Med Ctr, Amsterdam, Netherlands; Univ Hosp Maastricht, Maastricht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Maastricht University Medical Centre (MUMC)	Hunink, MGM (corresponding author), Erasmus MC Univ Med Ctr, Dept Epidemiol & Biostat, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.hunink@erasmusmc.nl	Vos, Pieter/A-6043-2012; Smits, Marion/E-4795-2011; Dippel, Diederik/AAJ-2192-2020; Dekker, H.M./L-4262-2015; Smits, Marion/AAB-3985-2019; Steyerberg, Ewout/C-1509-2018	Dippel, Diederik/0000-0002-9234-3515; Smits, Marion/0000-0001-5563-2871; Steyerberg, Ewout/0000-0002-7787-0122				BERRY CC, 1990, AM J ROENTGENOL, V154, P477, DOI 10.2214/ajr.154.3.2106207; Bossuyt PM, 2003, CLIN RADIOL, V58, P575, DOI 10.1016/S0009-9260(03)00258-7; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Dunning J, 2004, EMERG MED J, V21, P404, DOI 10.1136/emj.2004.014944; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; Geijerstam JL, 2005, EMERG MED J, V22, P103; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Haydel MJ, 2005, JAMA-J AM MED ASSOC, V294, P1551, DOI 10.1001/jama.294.12.1551; Hunink MGM, 2005, RADIOLOGY, V235, P375, DOI 10.1148/radiol.2352040727; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; KLINE R, 1998, PRINCIPLES PRACTICE, P74; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; Los RK, 2004, J AM MED INFORM ASSN, V11, P162, DOI 10.1197/jamia.M1375; Moons KGM, 2004, J CLIN EPIDEMIOL, V57, P1262, DOI 10.1016/j.jclinepi.2004.01.020; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; *NIH CLIN EXC, HEAD INJ TRIAG ASS I; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.3.CO;2-S; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; TWIJNSTRA A, GUIDELINES DIAGNOSIS; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	36	142	148	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2007	146	6					397	405		10.7326/0003-4819-146-6-200703200-00004	http://dx.doi.org/10.7326/0003-4819-146-6-200703200-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150CC	17371884				2022-12-28	WOS:000245192200001
J	Tunnicliffe, G; Raymond, N; Nowitz, M				Tunnicliffe, Georgia; Raymond, Nigel; Nowitz, Mike			An unexpected diagnosis after unstable angina	LANCET			English	Editorial Material							DISSECTING INTRAMURAL HEMATOMA; ESOPHAGUS		Wellington Hosp, Dept Med, Wellington 6011, New Zealand; Wellington Hosp, Dept Radiol, Wellington 6011, New Zealand		Tunnicliffe, G (corresponding author), Wellington Hosp, Dept Med, 32 Riddiford St, Wellington 6011, New Zealand.	georgiat@doctors.org.uk						CRIBLEZ D, 1992, SCHWEIZ MED WSCHR, V122, P416; Cullen SN, 1999, QJM-MON J ASSOC PHYS, V92, P123, DOI 10.1093/qjmed/92.2.123; Hennessy T P, 1970, J Ir Med Assoc, V63, P298; McGurk C, 2001, AGE AGEING, V30, P357, DOI 10.1093/ageing/30.4.357; McIntyre AS, 1998, QJM-MON J ASSOC PHYS, V91, P701, DOI 10.1093/qjmed/91.10.701	5	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 17	2007	369	9565					964	964		10.1016/S0140-6736(07)60455-3	http://dx.doi.org/10.1016/S0140-6736(07)60455-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148BQ	17368158				2022-12-28	WOS:000245049900037
J	Pelletier, F; Clutton-Brock, T; Pemberton, J; Tuljapurkar, S; Coulson, T				Pelletier, Fanie; Clutton-Brock, Tim; Pemberton, Josephine; Tuljapurkar, Shripad; Coulson, Tim			The evolutionary demography of ecological change: Linking trait variation and population growth	SCIENCE			English	Article							NATURAL-SELECTION; RAPID EVOLUTION; NEONATAL TRAITS; SOAY SHEEP; DENSITY; TIME	Population dynamics and evolutionary change are linked by the fundamental biological processes of birth and death. This means that population growth may correlate with the strength of selection, whereas evolutionary change can leave an ecological signature. We decompose population growth in an age-structured population into contributions from variation in a quantitative trait. We report that the distribution of body sizes within a population of Soay sheep can markedly influence population dynamics, accounting for up to one-fifth of observed population growth. Our results suggest that there is substantial opportunity for evolutionary dynamics to leave an ecological signature and visa versa.	Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Div Biol, Ascot SL5 7PY, Berks, England; Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, NERC, Ascot SL5 7PY, Berks, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Cambridge; University of Edinburgh; Stanford University	Coulson, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Div Biol, Silwood Pk, Ascot SL5 7PY, Berks, England.	t.coulson@imperial.ac.uk	Pemberton, Josephine M/F-3100-2010; Coulson, Tim/AAL-8148-2021	Coulson, Tim/0000-0001-9371-9003; Tuljapurkar, Shripad/0000-0001-5549-4245	NIA NIH HHS [P01 AG022500-04, P01 AG 22500, P01 AG022500] Funding Source: Medline; NERC [cpb010001] Funding Source: UKRI; Natural Environment Research Council [cpb010001, NER/A/S/2003/00461] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARNOLD SJ, 1984, EVOLUTION, V38, P709, DOI [10.2307/2408383, 10.1111/j.1558-5646.1984.tb00344.x]; BRODIE ED, 1995, TRENDS ECOL EVOL, V10, P313, DOI 10.1016/S0169-5347(00)89117-X; Catchpole EA, 2000, J R STAT SOC C-APPL, V49, P453, DOI 10.1111/1467-9876.00205; CLUTTONELROCK TH, 2004, SOAY SHEEP DYNAMICS; Coulson T, 2006, P ROY SOC B-BIOL SCI, V273, P547, DOI 10.1098/rspb.2005.3357; Coulson T, 2003, EVOLUTION, V57, P2879, DOI 10.1111/j.0014-3820.2003.tb01528.x; Falconer DS, 1996, INTRO QUANTITATIVE G; Fisher R.A., 1930, GENETICAL THEORY NAT; Forchhammer MC, 2001, J ANIM ECOL, V70, P721, DOI 10.1046/j.0021-8790.2001.00532.x; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hanski I, 2006, PLOS BIOL, V4, P719, DOI 10.1371/journal.pbio.0040129; JORGENSON JT, 1993, CAN J ZOOL, V71, P2509, DOI 10.1139/z93-344; LANDE R, 1982, ECOLOGY, V63, P607, DOI 10.2307/1936778; Overall ADJ, 2005, MOL ECOL, V14, P3383, DOI 10.1111/j.1365-294X.2005.02682.x; R Development Core Team, 2006, R LANG ENV STAT COMP; Saccheri I, 2006, TRENDS ECOL EVOL, V21, P341, DOI 10.1016/j.tree.2006.03.018; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; SLOBODKIN LAWRENCE B., 1961; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Wilson AJ, 2006, PLOS BIOL, V4, P1270, DOI 10.1371/journal.pbio.0040216; WILSON AJ, 2004, J EVOLUTION BIOL, DOI DOI 10.1007/S10682-006-9106-Z	22	185	185	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1571	1574		10.1126/science.1139024	http://dx.doi.org/10.1126/science.1139024			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363672				2022-12-28	WOS:000244934800051
J	Klaassen, PA				Klaassen, Perry A.			What makes a difference	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												drklaassen@coinsaccess.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2007	297	10					1039	1039		10.1001/jama.297.10.1039	http://dx.doi.org/10.1001/jama.297.10.1039			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	145KZ	17356018				2022-12-28	WOS:000244865200001
J	Griffin, A				Griffin, Anne			Kidneys on demand	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REGULATED SYSTEM; TRANSPLANTATION											Broumand Behrooz, 2005, Exp Clin Transplant, V3, P333; CECKA MJ, 2001, CLIN TRANSPLANTS 200; Daar AS, 2006, NAT CLIN PRACT NEPHR, V2, P600, DOI 10.1038/ncpneph0320; Ghods AJ, 2006, CLIN J AM SOC NEPHRO, V1, P1136, DOI 10.2215/CJN.00700206; Ghods Ahad J, 2004, Exp Clin Transplant, V2, P221; Ghods AJ, 2001, TRANSPL P, V33, P2626, DOI 10.1016/S0041-1345(01)02118-2; Haghighi AN, 2003, TRANSPL P, V35, P2584, DOI 10.1016/j.transproceed.2003.09.018; HAGHIGHI N, 2006, NAT CLIN PRACT NEPHR, DOI DOI 10.1038/NCPNEPH0364; JAVAAD Z, 2001, J UROLOGY, V166, P1790; JAVAAD Z, 2001, J UROLOGY, V165, P386; Jha V, 2006, NAT CLIN PRACT NEPHR, V2, P466, DOI 10.1038/ncpneph0268; Larijani B, 2006, AM J TRANSPLANT, V6, P1493, DOI 10.1111/j.1600-6143.2006.01327.x; PARVIZ K, 1999, NEPHROL DIAL TRANSPL, V14, P2621; World Health Organization, 2003, ETH ACC SAF TISS ORG; *WORLD MED ASS, 2006, STAT HUM ORG TISS DO; 2006, ECONOMIST       1116	16	38	38	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2007	334	7592					502	505		10.1136/bmj.39141.493148.94	http://dx.doi.org/10.1136/bmj.39141.493148.94			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148VV	17347232	Green Published			2022-12-28	WOS:000245106400033
J	Bao, ZH; Weatherspoon, MR; Shian, S; Cai, Y; Graham, PD; Allan, SM; Ahmad, G; Dickerson, MB; Church, BC; Kang, ZT; Abernathy, HW; Summers, CJ; Liu, ML; Sandhage, KH				Bao, Zhihao; Weatherspoon, Michael R.; Shian, Samuel; Cai, Ye; Graham, Phillip D.; Allan, Shawn M.; Ahmad, Gul; Dickerson, Matthew B.; Church, Benjamin C.; Kang, Zhitao; Abernathy, Harry W., III; Summers, Christopher J.; Liu, Meilin; Sandhage, Kenneth H.			Chemical reduction of three-dimensional silica micro-assemblies into microporous silicon replicas	NATURE			English	Article							POROUS SILICON; GAS SENSOR; VAPOR; EMISSION; DIOXIDE; WATER	The carbothermal reduction of silica into silicon requires the use of temperatures well above the silicon melting point (>= 2,000 degrees C)(1). Solid silicon has recently been generated directly from silica at much lower temperatures (<= 850 degrees C) via electrochemical reduction in molten salts(2,3). However, the silicon products of such electrochemical reduction did not retain the microscale morphology of the starting silica reactants(2,3). Here we demonstrate a low-temperature ( 650 degrees C) magnesiothermic reduction process for converting three-dimensional nanostructured silica micro-assemblies into microporous nanocrystalline silicon replicas. The intricate nanostructured silica microshells (frustules) of diatoms ( unicellular algae) were converted into co-continuous, nanocrystalline mixtures of silicon and magnesia by reaction with magnesium gas. Selective magnesia dissolution then yielded an interconnected network of silicon nanocrystals that retained the starting three-dimensional frustule morphology. The silicon replicas possessed a high specific surface area (>500 m(2) g(-1)), and contained a significant population of micropores (<= 20 angstrom). The silicon replicas were photoluminescent, and exhibited rapid changes in impedance upon exposure to gaseous nitric oxide ( suggesting a possible application in microscale gas sensing). This process enables the syntheses of microporous nanocrystalline silicon microassemblies with multifarious three-dimensional shapes inherited from biological(4-6) or synthetic silica templates(7-9) for sensor, electronic, optical or biomedical applications(10-13).	Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Sandhage, KH (corresponding author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.	ken.sandhage@mse.gatech.edu	Liu, Meilin/E-5782-2010; Shao, Zongping/AAY-8177-2020; Shian, Samuel/H-3168-2013; Ahmad, Gul/GZL-7770-2022	Liu, Meilin/0000-0002-6188-2372; Bao, Zhihao/0000-0002-8708-7510; Kang, Zhitao/0000-0001-6736-7809				Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Balagurov LA, 1996, J APPL PHYS, V79, P7143, DOI 10.1063/1.361484; BANERJEE HD, 1982, MATER SCI ENG, V52, P173, DOI 10.1016/0025-5416(82)90046-5; Baratto C, 2001, THIN SOLID FILMS, V391, P261, DOI 10.1016/S0040-6090(01)00992-0; Barin I., 1995, THERMOCHEMICAL DATA, P994; BARRET EP, 1951, J AM CHEM SOC, V73, P380; Bengtsson M, 2000, PHYS STATUS SOLIDI A, V182, P495, DOI 10.1002/1521-396X(200011)182:1<495::AID-PSSA495>3.0.CO;2-4; Blaaderen A, 1997, NATURE, V385, P321; Boarino L, 2000, MAT SCI ENG B-SOLID, V69, P210, DOI 10.1016/S0921-5107(99)00267-6; BOUVARD D, 1991, ACTA METALL MATER, V39, P3083, DOI 10.1016/0956-7151(91)90041-X; Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038; CULLIS AG, 1991, NATURE, V353, P335, DOI 10.1038/353335a0; Cullity B. D., 1978, ELEMENTS XRAY DIFFRA, P101; Fan HY, 2000, NATURE, V405, P56, DOI 10.1038/35011026; Gelloz B, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2001136; Hall SR, 2003, CHEM COMMUN, P2784, DOI 10.1039/b309877j; International Centre for Diffraction Data, POWD DIFFR FIL; Li XG, 2003, LANGMUIR, V19, P8490, DOI 10.1021/la034487b; Miron AS, 1999, J BIOTECHNOL, V70, P249; NAGAMORI M, 1986, METALL TRANS B, V17, P503, DOI 10.1007/BF02670216; Nohira T, 2003, NAT MATER, V2, P397, DOI 10.1038/nmat900; Round F. E, 2000, DIATOMS BIOL MORPHOL; Sandhage KH, 2002, ADV MATER, V14, P429, DOI 10.1002/1521-4095(20020318)14:6<429::AID-ADMA429>3.3.CO;2-3; SCHMID AM, 1981, CELL BIOL MONOGR, V8, P63; Seals L, 2002, J APPL PHYS, V91, P2519, DOI 10.1063/1.1436556; Shin HC, 2005, J POWER SOURCES, V139, P314, DOI 10.1016/j.jpowsour.2004.06.073; Watanabe K, 1996, SENSOR ACTUAT B-CHEM, V33, P194, DOI 10.1016/0925-4005(96)80097-9; WYNNYCKYJ JR, 1976, HIGH TEMP SCI, V8, P203; Yasuda K, 2005, J ELECTROCHEM SOC, V152, pD232, DOI 10.1149/1.2103947	29	632	680	17	738	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					172	175		10.1038/nature05570	http://dx.doi.org/10.1038/nature05570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344850				2022-12-28	WOS:000244718100037
J	Balague, F; Mannion, AF; Pellise, F; Cedraschi, C				Balague, Federico; Mannion, Anne F.; Pellise, Ferran; Cedraschi, Christine			Clinical update: low back pain	LANCET			English	Article							EUROPEAN GUIDELINES; PRIMARY-CARE; PREDICTION; MANAGEMENT; DISABILITY; DISORDERS		Cantonal Hosp, Dept Rheumatol Phys Med & Rehabil, CH-1708 Fribourg, Switzerland; Schulthess Klin, Spine Unit, Zurich, Switzerland; Hosp Univ Vall Hebron, Spine Unit, Barcelona, Spain; Univ Hosp Geneva, Ctr Multidisciplinary Pain, Serv Clin Pharmacol & Toxicol, Geneva, Switzerland; Univ Hosp Geneva, Ctr Multidisciplinary Pain, Div Gen Med Rehabil, Geneva, Switzerland	Schulthess Clinic; Hospital Universitari Vall d'Hebron; University of Geneva; University of Geneva	Balague, F (corresponding author), Cantonal Hosp, Dept Rheumatol Phys Med & Rehabil, CH-1708 Fribourg, Switzerland.	balaguef@hopcantfr.ch	Mannion, Anne F./AAN-5908-2020; Mannion, Anne F./C-6615-2009; Pellise, Ferran/D-4488-2016	Mannion, Anne F./0000-0002-1203-1096; Mannion, Anne F./0000-0002-1203-1096; Pellise, Ferran/0000-0002-0644-7757				Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Balague F, 2006, JOINT BONE SPINE, V73, P508, DOI 10.1016/j.jbspin.2006.01.005; Bombardier C, 2000, SPINE, V25, P3100, DOI 10.1097/00007632-200012150-00003; Brennan GP, 2006, SPINE, V31, P623, DOI 10.1097/01.brs.0000202807.72292.a8; Burton AK, 2006, EUR SPINE J, V15, pS136, DOI 10.1007/s00586-006-1070-3; Cassidy JD, 2005, SPINE, V30, P2817, DOI 10.1097/01.brs.0000190448.69091.53; Deyo RA, 1998, SPINE, V23, P2003, DOI 10.1097/00007632-199809150-00018; Dunn KM, 2006, PAIN, V126, P10, DOI 10.1016/j.pain.2006.06.005; Ferrer M, 2006, SPINE, V31, P1372, DOI 10.1097/01.brs.0000218477.53318.bc; Hicks GE, 2005, ARCH PHYS MED REHAB, V86, P1753, DOI 10.1016/j.apmr.2005.03.033; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Laerum E, 2006, J REHABIL MED, V38, P255, DOI 10.1080/16501970600613461; Mannion AF, 2005, EUR SPINE J, V14, P1014, DOI 10.1007/s00586-005-0911-9; Mannion AF, 2001, SPINE, V26, P920, DOI 10.1097/00007632-200104150-00015; Modic MT, 2005, RADIOLOGY, V237, P597, DOI 10.1148/radiol.2372041509; Ostelo RWJG, 2005, BEST PRACT RES CL RH, V19, P593, DOI 10.1016/j.berh.2005.03.003; van Tulder M, 2006, EUR SPINE J, V15, pS169, DOI 10.1007/s00586-006-1071-2; Von Korff M, 2000, SPINE, V25, P3140, DOI 10.1097/00007632-200012150-00009; Walsh TL, 2003, SPINE, V28, P607, DOI 10.1097/00007632-200303150-00017; Watkins E, 2006, MAYO CLIN PROC, V81, P167, DOI 10.4065/81.2.167	20	87	88	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 3	2007	369	9563					726	728		10.1016/S0140-6736(07)60340-7	http://dx.doi.org/10.1016/S0140-6736(07)60340-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143MP	17336636				2022-12-28	WOS:000244726700012
J	Morris, SC; Caron, JB				Morris, Simon Conway; Caron, Jean-Bernard			Halwaxiids and the early evolution of the lophotrochozoans	SCIENCE			English	Article							WIWAXIA-CORRUGATA MATTHEW; BURGESS SHALE; FOSSIL; MOLLUSKS; MICRINA; WALCOTT; YUNNAN; CHINA	Halkieriids and wiwaxiids are cosmopolitan sclerite-bearing metazoans from the Lower and Middle Cambrian. Although they have similar scleritomes, their phylogenetic position is contested. A new scleritomous fossil from the Burgess Shale has the prominent anterior shell of the halkieriids but also bears wiwaxiid-like sclerites. This new fossil defines the monophyletic halwaxiids and indicates that they have a key place in early lophotrochozoan history.	Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada	University of Cambridge; Royal Ontario Museum	Morris, SC (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	sc113@esc.cam.ac.uk; jcaron@rom.ca		Caron, Jean-Bernard/0000-0002-1670-5502				Aris-Brosou S, 2003, MOL BIOL EVOL, V20, P1947, DOI 10.1093/molbev/msg226; Bengtson S, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P101; BENGTSON S, 1992, LETHAIA, V25, P401, DOI 10.1111/j.1502-3931.1992.tb01644.x; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Budd GE, 1998, LETHAIA, V31, P197, DOI 10.1111/j.1502-3931.1998.tb00508.x; BUTTERFIELD NJ, 1990, PALEOBIOLOGY, V16, P287, DOI 10.1017/S0094837300010009; Caron JB, 2006, PALAIOS, V21, P451, DOI 10.2110/palo.2003.P05-070R; Caron JB, 2006, NATURE, V442, P159, DOI 10.1038/nature04894; Conway Morris S., 1995, N JB GEOL PALAONTOL, V195, P319; DURHAM JW, 1974, J PALEONTOL, V48, P750; Eibye-Jacobsen D, 2004, LETHAIA, V37, P317, DOI 10.1080/00241160410002027; Giribet G, 2006, P NATL ACAD SCI USA, V103, P7723, DOI 10.1073/pnas.0602578103; Gould S. J., 1989, WONDERFUL LIFE BURGE; JELL PA, 1981, ALCHERINGA, V5, P85, DOI 10.1080/03115518108565423; Li GX, 2004, J PALEONTOL, V78, P900, DOI 10.1666/0022-3360(2004)078<0900:TAMTFT>2.0.CO;2; MORRIS SC, 1995, PHILOS T ROY SOC B, V347, P305, DOI 10.1098/rstb.1995.0029; MORRIS SC, 1985, PHILOS T R SOC B, V307, P507, DOI 10.1098/rstb.1985.0005; Morris SC, 2006, PHILOS T R SOC B, V361, P1069, DOI 10.1098/rstb.2006.1846; Qian Y., 1989, FOSS STRAT, V24, P156; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Shu DG, 2004, NATURE, V430, P422, DOI 10.1038/nature02648; Siegmund H, 1997, LETHAIA, V30, P285; Vinther J, 2005, ZOOL SCR, V34, P81, DOI 10.1111/j.1463-6409.2005.00177.x; Williams A, 2002, PALAEONTOLOGY, V45, P845, DOI 10.1111/1475-4983.00264	25	89	94	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1255	1258		10.1126/science.1137187	http://dx.doi.org/10.1126/science.1137187			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332408				2022-12-28	WOS:000244564700044
J	Heersche, HB; Jarillo-Herrero, P; Oostinga, JB; Vandersypen, LMK; Morpurgo, AF				Heersche, Hubert B.; Jarillo-Herrero, Pablo; Oostinga, Jeroen B.; Vandersypen, Lieven M. K.; Morpurgo, Alberto F.			Bipolar supercurrent in graphene	NATURE			English	Article								Graphene - a recently discovered form of graphite only one atomic layer thick(1) - constitutes a new model system in condensed matter physics, because it is the first material in which charge carriers behave as massless chiral relativistic particles. The anomalous quantization of the Hall conductance(2,3), which is now understood theoretically(4,5), is one of the experimental signatures of the peculiar transport properties of relativistic electrons in graphene. Other unusual phenomena, like the finite conductivity of order 4e(2)/h ( where e is the electron charge and h is Planck's constant) at the charge neutrality ( or Dirac) point(2), have come as a surprise and remain to be explained(5-13). Here we experimentally study the Josephson effect(14) in mesoscopic junctions consisting of a graphene layer contacted by two closely spaced superconducting electrodes(15). The charge density in the graphene layer can be controlled by means of a gate electrode. We observe a supercurrent that, depending on the gate voltage, is carried by either electrons in the conduction band or by holes in the valence band. More importantly, we find that not only the normal state conductance of graphene is finite, but also a finite supercurrent can flow at zero charge density. Our observations shed light on the special role of time reversal symmetry in graphene, and demonstrate phase coherent electronic transport at the Dirac point.	Delft Univ Technol, Kavli Inst nanosci, NL-2600 GA Delft, Netherlands	Delft University of Technology	Heersche, HB (corresponding author), Delft Univ Technol, Kavli Inst nanosci, POB 5046, NL-2600 GA Delft, Netherlands.	h.b.heersche@tudelft.nl; P.D.Jarillo-Herrero@tudelft.nl	Oostinga, Jeroen/N-1933-2015; Jarillo-Herrero, Pablo/E-3755-2013	Oostinga, Jeroen/0000-0002-7522-6077; Jarillo-Herrero, Pablo/0000-0001-8217-8213				Aleiner IL, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.236801; Altland A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.236802; Barone A., 1982, PHYS APPL JOSEPHSON; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Datta S., 1997, ELECT TRANSPORT MESO; DEGENNES PG, 1964, REV MOD PHYS, V36, P225, DOI 10.1103/RevModPhys.36.225; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; FRADKIN E, 1986, PHYS REV B, V33, P3263, DOI 10.1103/PhysRevB.33.3263; Gusynin VP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146801; Jarillo-Herrero P, 2006, NATURE, V439, P953, DOI 10.1038/nature04550; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; JOYEZ P, 1994, PHYS REV LETT, V72, P2458, DOI 10.1103/PhysRevLett.72.2458; Katsnelson MI, 2006, EUR PHYS J B, V51, P157, DOI [10.1140/epjb/e2006-00203-1, 10.1140/epjb/e200S-00203-1]; LEE PA, 1985, PHYS REV LETT, V55, P1622, DOI 10.1103/PhysRevLett.55.1622; LIKHAREV KK, 1979, REV MOD PHYS, V51, P101, DOI 10.1103/RevModPhys.51.101; LUDWIG AWW, 1994, PHYS REV B, V50, P7526, DOI 10.1103/PhysRevB.50.7526; McCann E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.146805; Morozov SV, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.016801; Morpurgo AF, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.196804; NERSESYAN AA, 1994, PHYS REV LETT, V72, P2628, DOI 10.1103/PhysRevLett.72.2628; NOMURA K, 2006, QUANTUM TRANSPORT MA; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; OCTAVIO M, 1983, PHYS REV B, V27, P6739, DOI 10.1103/PhysRevB.27.6739; Peres NMR, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125411; Suzuura H, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.266603; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; Titov M, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.041401; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	30	1028	1057	7	423	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					56	59		10.1038/nature05555	http://dx.doi.org/10.1038/nature05555			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330038	Green Submitted			2022-12-28	WOS:000244525600035
J	Metzl, JM				Metzl, Jonathan M.			If direct-to-consumer advertisements come to Europe: lessons from the USA	LANCET			English	Article; Proceedings Paper	Meeting on Medicalisation in the 21st Century	JUN, 2005	New York, NY				ANTIDEPRESSANTS		Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; Univ Michigan, Womens Studies Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Metzl, JM (corresponding author), Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.	jmetzl@umich.edu			NICHD NIH HHS [K12HD001438] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001438] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aikin K. J., 2003, DIRECT TO CONSUMER A; Alexander-Banys Bambi, 2002, J Pediatr Health Care, V16, P49, DOI 10.1016/S0891-5245(02)96294-2; ANGELL M, 2004, TRUTH DRUG CO THEY D, P83; AUTON F, 2004, INT J ADVER, V23, P1; Hollon MF, 2005, JAMA-J AM MED ASSOC, V293, P2030, DOI 10.1001/jama.293.16.2030; HONE F, 2004, PHARM EXEC, V24, P96; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Metzl JM, 2004, SOC SCI MED, V58, P577, DOI 10.1016/S0277-9536(03)00369-1; Metzl Jonathan, 2003, PROZAC COUCH PRESCRI; Weissman JS, 2003, HEALTH AFFAIR, V22, pW82, DOI 10.1377/hlthaff.w3.82	10	12	13	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 24	2007	369	9562					704	706		10.1016/S0140-6736(07)60321-3	http://dx.doi.org/10.1016/S0140-6736(07)60321-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	141RO	17321319				2022-12-28	WOS:000244596600035
J	Greene, CH; Pershing, AJ				Greene, Charles H.; Pershing, Andrew J.			Climate drives sea change	SCIENCE			English	Editorial Material							MAINE; GULF; VARIABILITY		Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14853 USA; Univ Maine, Portland, ME 04101 USA; Gulf Maine Res Inst, Portland, ME 04101 USA	Cornell University; University of Maine System; University of Maine Orono; Gulf of Maine Research Institute	Greene, CH (corresponding author), Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14853 USA.	chg2@cornell.edu						Belkin IM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019334; Durbin EG, 2003, MAR ECOL PROG SER, V254, P81, DOI 10.3354/meps254081; Frank KT, 2006, ECOL LETT, V9, P1096, DOI 10.1111/j.1461-0248.2006.00961.x; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Hakkinen S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015243; Lindsay RW, 2005, J CLIMATE, V18, P4879, DOI 10.1175/JCLI3587.1; Morison J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026826; Mountain DG, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001044; Pershing AJ, 2005, ICES J MAR SCI, V62, P1511, DOI 10.1016/j.icesjms.2005.04.025; Smith PC, 2001, DEEP-SEA RES PT II, V48, P37, DOI 10.1016/S0967-0645(00)00081-3; Steele M, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002009; Vilhalmsson Hjalmar, 2005, P691; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2	13	187	200	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1084	1085		10.1126/science.1136495	http://dx.doi.org/10.1126/science.1136495			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	138UA	17322049				2022-12-28	WOS:000244387600023
J	Misteli, T				Misteli, Tom			Beyond the sequence: Cellular organization of genome function	CELL			English	Review							DOUBLE-STRAND BREAKS; CHROMATIN DOMAINS; CHROMOSOME TERRITORIES; SPATIAL-ORGANIZATION; GENE DENSITY; NUCLEAR ARCHITECTURE; DYNAMIC EQUILIBRIUM; SELF-ORGANIZATION; PROTEIN DYNAMICS; ACTIVE CHROMATIN		NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov			NATIONAL CANCER INSTITUTE [Z01BC010309, ZIABC010309] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Agresti A, 2005, MOL CELL, V18, P109, DOI 10.1016/j.molcel.2005.03.005; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Bickmore WA, 2002, CHROMOSOME RES, V10, P707, DOI 10.1023/A:1021589031769; Blanton J, 2003, GENE DEV, V17, P664, DOI 10.1101/gad.1052003; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Boutanaev AM, 2005, MOL CELL BIOL, V25, P8379, DOI 10.1128/MCB.25.18.8379-8386.2005; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Bressan DA, 2004, J CELL BIOL, V164, P361, DOI 10.1083/jcb.200311063; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Brown JM, 2006, J CELL BIOL, V172, P177, DOI 10.1083/jcb.200507073; Byrd K, 2003, J CELL BIOL, V162, P565, DOI 10.1083/jcb.200305013; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Carrero G, 2006, J THEOR BIOL, V239, P298, DOI 10.1016/j.jtbi.2005.07.019; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chakalova L, 2005, NAT REV GENET, V6, P669, DOI 10.1038/nrg1673; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Cheutin T, 2004, MOL CELL BIOL, V24, P3157, DOI 10.1128/MCB.24.8.3157-3167.2004; Chubb JR, 2003, CELL, V112, P403, DOI 10.1016/S0092-8674(03)00078-3; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Cook PR, 2002, NAT GENET, V32, P347, DOI 10.1038/ng1102-347; Cornforth MN, 2002, J CELL BIOL, V159, P237, DOI 10.1083/jcb.200206009; Cremer M, 2003, J CELL BIOL, V162, P809, DOI 10.1083/jcb.200304096; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; D'Anjou H, 2004, NUCLEIC ACIDS RES, V32, P6136, DOI 10.1093/nar/gkh952; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Elbi C, 2002, MOL BIOL CELL, V13, P2001, DOI 10.1091/mboc.13.6.mk0602002001; Essers J, 2006, CURR OPIN CELL BIOL, V18, P240, DOI 10.1016/j.ceb.2006.03.004; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Fraser P, 2006, CURR OPIN GENET DEV, V16, P490, DOI 10.1016/j.gde.2006.08.002; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Gorisch SM, 2005, J CELL SCI, V118, P5825, DOI 10.1242/jcs.02689; Gorski S, 2005, J CELL SCI, V118, P4083, DOI 10.1242/jcs.02596; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; Hager GL, 2002, CURR OPIN GENET DEV, V12, P137, DOI 10.1016/S0959-437X(02)00278-2; Hancock R, 2004, J STRUCT BIOL, V146, P281, DOI 10.1016/j.jsb.2003.12.008; Hernandez-Verdun D, 2002, J CELL SCI, V115, P2265; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; KARPEN GH, 1988, GENE DEV, V2, P1745, DOI 10.1101/gad.2.12b.1745; Kim SH, 2004, CYTOGENET GENOME RES, V105, P292, DOI 10.1159/000078201; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Labrador M, 2002, CELL, V111, P151, DOI 10.1016/S0092-8674(02)01004-8; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Lukasova E, 1997, HUM GENET, V100, P525, DOI 10.1007/s004390050547; Marenduzzo D, 2006, BIOPHYS J, V90, P3712, DOI 10.1529/biophysj.105.077685; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101; McNairn AJ, 2005, EXP CELL RES, V308, P345, DOI 10.1016/j.yexcr.2005.05.009; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; MEABURN KJ, 2006, CANC BIOL       1026, DOI DOI 10.1016/J.SEM-CANCER.2006.10.008; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Misteli T, 2005, BIOESSAYS, V27, P477, DOI 10.1002/bies.20226; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Neves H, 1999, BLOOD, V93, P1197, DOI 10.1182/blood.V93.4.1197.404k33_1197_1207; Noma KI, 2006, CELL, V125, P859, DOI 10.1016/j.cell.2006.04.028; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; Parada LA, 2002, TRENDS CELL BIOL, V12, P425, DOI 10.1016/S0962-8924(02)02351-6; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Politi A, 2005, MOL CELL, V19, P679, DOI 10.1016/j.molcel.2005.06.036; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Raska I, 2006, CURR OPIN CELL BIOL, V18, P325, DOI 10.1016/j.ceb.2006.04.008; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P4537, DOI 10.1073/pnas.0400678101; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Schneider DA, 2004, P NATL ACAD SCI USA, V101, P15112, DOI 10.1073/pnas.0406746101; Shopland LS, 2006, J CELL BIOL, V174, P27, DOI 10.1083/jcb.200603083; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Soula H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-228; Spann TP, 1997, J CELL BIOL, V136, P1201, DOI 10.1083/jcb.136.6.1201; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Therizols P, 2006, J CELL BIOL, V172, P189, DOI 10.1083/jcb.200505159; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; van Driel R, 2003, J CELL SCI, V116, P4067, DOI 10.1242/jcs.00779; Vecerova J, 2004, MOL BIOL CELL, V15, P4904, DOI 10.1091/mbc.E04-07-0645; Verschure PJ, 2003, EMBO REP, V4, P861, DOI 10.1038/sj.embor.embor922; Volpi EV, 2000, J CELL SCI, V113, P1565; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Weil MR, 2004, GENOME RES, V14, P1374, DOI 10.1101/gr.1396104; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Williams RRE, 2002, EXP CELL RES, V272, P163, DOI 10.1006/excr.2001.5400; Woodcock CL, 2006, CURR OPIN STRUC BIOL, V16, P213, DOI 10.1016/j.sbi.2006.02.005; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107	120	842	862	4	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2007	128	4					787	800		10.1016/j.cell.2007.01.028	http://dx.doi.org/10.1016/j.cell.2007.01.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148TX	17320514	Bronze			2022-12-28	WOS:000245098600019
J	Thomas, RJ; Krehbiel, PR; Rison, W; Edens, HE; Aulich, GD; Winn, WP; McNutt, SR; Tytgat, G; Clark, E				Thomas, R. J.; Krehbiel, P. R.; Rison, W.; Edens, H. E.; Aulich, G. D.; Winn, W. P.; McNutt, S. R.; Tytgat, G.; Clark, E.			Electrical activity during the 2006 Mount St. Augustine volcanic eruptions	SCIENCE			English	Article							CLOUDS; CRATER		New Mexico Inst Min & Technol, Langmuir Lab, Socorro, NM 87801 USA; Univ Alaska, Alaska Volcano Observ, Fairbanks, AK 99775 USA	New Mexico Institute of Mining Technology; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks	Thomas, RJ (corresponding author), New Mexico Inst Min & Technol, Langmuir Lab, Socorro, NM 87801 USA.	thomas@nmt.edu		Edens, Harald/0000-0003-4444-6971				ANDERSON R, 1965, SCIENCE, V148, P1179, DOI 10.1126/science.148.3674.1179; Behnke SA, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005312; BROOK M, 1974, J GEOPHYS RES, V79, P472, DOI 10.1029/JC079i003p00472; HOBLITT RP, 1994, J VOLCANOL GEOTH RES, V62, P499, DOI 10.1016/0377-0273(94)90049-3; McNutt SR, 2000, J VOLCANOL GEOTH RES, V102, P45, DOI 10.1016/S0377-0273(00)00181-5; Power J., 2006, EOS, V87, P373, DOI DOI 10.1029/2006EO370002; Thomas RJ, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004549; Vogfjord K.S., 2005, EOS T AGU, V86, P245, DOI [10.1029/2005EO260001, DOI 10.1029/2005E0260001, DOI 10.1029/2005EO260001]; WILLIAMS ER, 2004, EOS S, V85	9	63	64	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2007	315	5815					1097	1097		10.1126/science.1136091	http://dx.doi.org/10.1126/science.1136091			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17322054				2022-12-28	WOS:000244387600028
J	Koshino, M; Tanaka, T; Solin, N; Suenaga, K; Isobe, H; Nakamura, E				Koshino, Masanori; Tanaka, Takatsugu; Solin, Niclas; Suenaga, Kazutomo; Isobe, Hiroyuki; Nakamura, Eiichi			Imaging of single organic molecules in motion	SCIENCE			English	Article									Japan Sci & Technol Agcy, ERATO, Nakamura Funct Carbon Cluster Project, Bunkyo Ku, Tokyo 1130033, Japan; Natl Inst Adv Ind Sci & Technol, Res Ctr Adv Carbon Mat, Tsukuba, Ibaraki 3058565, Japan; Univ Tokyo, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; JST, Precursory Res Embryon Sci & Technol PRESTO, Bunkyo Ku, Tokyo 1130033, Japan	Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; Japan Science & Technology Agency (JST)	Suenaga, K (corresponding author), Japan Sci & Technol Agcy, ERATO, Nakamura Funct Carbon Cluster Project, Bunkyo Ku, Tokyo 1130033, Japan.	suenaga-kazu@aist.go.jp; isobe@mail.tains.tohoku.ac.jp; nakamura@chem.s.u-tokyo.ac.jp	Solin, Niclas/L-6639-2015; Koshino, Masanori/M-8237-2018; Suenaga, Kazu/E-2339-2014	Solin, Niclas/0000-0002-0915-2575; Isobe, Hiroyuki/0000-0001-8907-0694; Koshino, Masanori/0000-0002-5474-1475; Suenaga, Kazu/0000-0002-6107-1123				Egerton RF, 2004, MICRON, V35, P399, DOI 10.1016/j.micron.2004.02.003; HURTLEY SM, 2003, SCIENCE, V300; Liu Z, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088304; SMITH RM, 2005, UNDERSTANDING MASS S; Zheng JR, 2006, SCIENCE, V313, P1951, DOI 10.1126/science.1132178	5	198	198	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					853	853		10.1126/science.1138690	http://dx.doi.org/10.1126/science.1138690			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17322029				2022-12-28	WOS:000246369800028
J	Liu, ZW; Lee, H; Xiong, Y; Sun, C; Zhang, X				Liu, Zhaowei; Lee, Hyesog; Xiong, Yi; Sun, Cheng; Zhang, Xiang			Far-field optical hyperlens magnifying sub-diffraction-limited objects	SCIENCE			English	Article									Univ Calif Berkeley, NSF, Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA	National Science Foundation (NSF); University of California System; University of California Berkeley	Zhang, X (corresponding author), Univ Calif Berkeley, NSF, Nanoscale Sci & Engn Ctr, 5130 Etcheverry Hall, Berkeley, CA 94720 USA.	xiang@berkeley.edu	Sun, Cheng/A-8111-2010; Sun, Cheng/B-7609-2009; Liu, Zhaowei/A-8521-2010; Zhang, Xiang/F-6905-2011; Liu, Zhaowei/N-9936-2019	Sun, Cheng/0000-0002-2744-0896; Liu, Zhaowei/0000-0002-5732-8109; Zhang, Xiang/0000-0002-3272-894X				Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Govyadinov AA, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155108; Jacob Z, 2006, OPT EXPRESS, V14, P8247, DOI 10.1364/OE.14.008247; Melville DOS, 2005, OPT EXPRESS, V13, P2127, DOI 10.1364/OPEX.13.002127; Pendry JB, 2002, J PHYS-CONDENS MAT, V14, P8463, DOI 10.1088/0953-8984/14/36/306; Pendry JB, 2003, OPT EXPRESS, V11, P755, DOI 10.1364/OE.11.000755; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Salandrino A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075103; Smith DR, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.077405; Taubner T, 2006, SCIENCE, V313, P1595, DOI 10.1126/science.1131025; Wood B, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.115116	11	1749	1797	15	485	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1686	1686		10.1126/science.1137368	http://dx.doi.org/10.1126/science.1137368			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379801				2022-12-28	WOS:000245106900031
J	Wilson, JF				Wilson, Jennifer Fisher			Lessons for health care could be found abroad	ANNALS OF INTERNAL MEDICINE			English	News Item							INFORMATION-TECHNOLOGY; COUNTRIES; SYSTEMS; COSTS					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Anderson GF, 2006, HEALTH AFFAIR, V25, P819, DOI 10.1377/hlthaff.25.3.819; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; SCHOEN C, 2005, HLTH AFF; Schoen C, 2006, HEALTH AFFAIR, V25, pW555, DOI 10.1377/hlthaff.25.w555	6	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2007	146	6					473	476		10.7326/0003-4819-146-6-200703200-00027	http://dx.doi.org/10.7326/0003-4819-146-6-200703200-00027			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150CC	17371900				2022-12-28	WOS:000245192200017
J	Benazzi, F				Benazzi, Franco			Bipolar disorder - focus on bipolar II disorder and mixed depression	LANCET			English	Review							TREATMENT ENHANCEMENT PROGRAM; FAMILY-HISTORY VALIDATION; WEEKLY SYMPTOMATIC STATUS; PLACEBO-CONTROLLED TRIAL; AGE-OF-ONSET; DSM-IV; UNIPOLAR DEPRESSION; DOUBLE-BLIND; HYPOMANIC SYMPTOMS; BORDERLINE PERSONALITY	Bipolar II disorder (recurrent depressive and hypomanic episodes) and related disorders (united in the bipolar spectrum) are understudied, despite a prevalence of about 5% in the community and about 50% in depressed outpatients. The apparent increase in prevalence of the bipolar spectrum is related to several changes in diagnostic criteria, including improved probing for history of hypomania (focused more on overactivity than on mood change), lower minimum duration of hypomania, and inclusion of unipolar depressions with bipolar signs (eg, family history of bipolar disorder, mixed depression). Prevalence of mixed depression, a combination of depression and manic or hypomanic symptoms, is high in patients with bipolar disorders. Controlled studies are needed to investigate treatment of mixed depression; antidepressants can worsen manic and hypomanic symptoms, and mood stabilising agents might be necessary.	Hecker Psychiat Res Ctr, Forli, Italy; Univ Calif San Diego, Collaborating Ctr, San Diego, CA 92103 USA; Univ Szeged, Dept Psychiat, Szeged, Hungary; Natl Hlth Serv, Dept Psychiat, Forli, Italy	University of California System; University of California San Diego; Szeged University	Benazzi, F (corresponding author), Via Pozzeto 17, I-48015 Cervia, RA, Italy.	francobenazzi@fbenazzi.it						Akiskal HS, 2006, J AFFECT DISORDERS, V96, P197, DOI 10.1016/j.jad.2006.05.015; Akiskal HS, 2006, J AFFECT DISORDERS, V92, P45, DOI 10.1016/j.jad.2005.12.035; Akiskal HS, 2003, J AFFECT DISORDERS, V73, P7, DOI 10.1016/S0165-0327(02)00318-X; Akiskal HS, 2005, BIPOLAR DISORD, V7, P456, DOI 10.1111/j.1399-5618.2005.00242.x; Akiskal HS, 2005, J CLIN PSYCHIAT, V66, P914, DOI 10.4088/JCP.v66n0715; Akiskal HS, 2005, J AFFECT DISORDERS, V85, P245, DOI 10.1016/j.jad.2004.12.004; Akiskal HS, 2004, ACTA PSYCHIAT SCAND, V110, P401, DOI 10.1111/j.1600-0447.2004.00461.x; Akiskal HS, 2003, J AFFECT DISORDERS, V73, P113, DOI 10.1016/S0165-0327(02)00330-0; Akiskal HS, 2003, J AFFECT DISORDERS, V73, P49, DOI 10.1016/S0165-0327(02)00320-8; AKISKAL HS, 1995, ARCH GEN PSYCHIAT, V52, P114; Altshuler L, 2003, AM J PSYCHIAT, V160, P1252, DOI 10.1176/appi.ajp.160.7.1252; Altshuler LL, 2006, AM J PSYCHIAT, V163, P313, DOI 10.1176/appi.ajp.163.2.313; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Angst J, 1998, J AFFECT DISORDERS, V50, P143, DOI 10.1016/S0165-0327(98)00142-6; Angst J, 2005, J AFFECT DISORDERS, V88, P217, DOI 10.1016/j.jad.2005.05.011; Angst J, 2003, J AFFECT DISORDERS, V73, P133, DOI 10.1016/S0165-0327(02)00322-1; Angst J, 2005, BIPOLAR DISORD, V7, P4, DOI 10.1111/j.1399-5618.2005.00210.x; Angst J, 2005, J AFFECT DISORDERS, V84, P149, DOI 10.1016/S0165-0327(03)00195-2; ANGST J, 1985, PSYCHOPATHOLOGY, V18, P140, DOI 10.1159/000284227; Axelson D, 2006, ARCH GEN PSYCHIAT, V63, P1139, DOI 10.1001/archpsyc.63.10.1139; Balazs J, 2006, J AFFECT DISORDERS, V91, P133, DOI 10.1016/j.jad.2005.12.049; Baldessarini RJ, 2006, ARCH GEN PSYCHIAT, V63, P246, DOI 10.1001/archpsyc.63.3.246; Baldessarini RJ, 2002, HARVARD REV PSYCHIAT, V10, P59, DOI 10.1080/10673220216208; BAUER MS, 1991, ARCH GEN PSYCHIAT, V48, P807; Bauer MS, 2006, J CLIN PSYCHIAT, V67, P48, DOI 10.4088/JCP.v67n0108; Bauer MS, 2005, BRIT J PSYCHIAT, V187, P87, DOI 10.1192/bjp.187.1.87; Benazzi F, 2000, EUR ARCH PSY CLIN N, V250, P249, DOI 10.1007/s004060070014; Benazzi F, 2003, WORLD J BIOL PSYCHIA, V4, P166, DOI 10.1080/15622970310029914; Benazzi F, 2006, EUR PSYCHIAT, V21, P274, DOI 10.1016/j.eurpsy.2006.02.003; Benazzi F, 2006, CURR OPIN PSYCHIATR, V19, P1, DOI 10.1097/01.yco.0000194145.03895.bc; Benazzi F, 2006, PROG NEURO-PSYCHOPH, V30, P68, DOI 10.1016/j.pnpbp.2005.06.010; Benazzi F, 2005, COMPR PSYCHIAT, V46, P399, DOI 10.1016/j.comppsych.2005.02.002; Benazzi F, 2005, PSYCHIAT CLIN NEUROS, V59, P570, DOI 10.1111/j.1440-1819.2005.01416.x; Benazzi F, 2005, COMPR PSYCHIAT, V46, P159, DOI 10.1016/j.comppsych.2004.07.034; Benazzi F, 2005, PSYCHOTHER PSYCHOSOM, V74, P61, DOI 10.1159/000082029; Benazzi F, 2004, PROG NEURO-PSYCHOPH, V28, P1279, DOI 10.1016/j.pnpbp.2004.06.018; Benazzi F, 2004, COMPR PSYCHIAT, V45, P441, DOI 10.1016/j.comppsych.2004.07.004; Benazzi F, 2004, PSYCHIAT RES, V127, P247, DOI 10.1016/j.psychres.2003.07.006; Benazzi F, 2004, BIPOLAR DISORD, V6, P440, DOI 10.1111/j.1399-5618.2004.00125.x; Benazzi F, 1999, J AFFECT DISORDERS, V54, P249, DOI 10.1016/S0165-0327(99)00083-X; Benazzi F, 2004, COMPR PSYCHIAT, V45, P77, DOI 10.1016/j.comppsych.2003.12.003; Benazzi F, 2003, PROG NEURO-PSYCHOPH, V27, P985, DOI 10.1016/S0278-5846(03)00158-1; Benazzi F, 2003, CURR OPIN PSYCHIATR, V16, pS71, DOI 10.1097/00001504-200304002-00011; Benazzi F, 2003, J AFFECT DISORDERS, V73, P33, DOI 10.1016/S0165-0327(02)00327-0; Benazzi F, 2003, COMPR PSYCHIAT, V44, P21, DOI 10.1053/comp.2003.50000; Benazzi F, 2002, PROG NEURO-PSYCHOPH, V26, P1105, DOI 10.1016/S0278-5846(02)00244-0; Benazzi F, 1997, J AFFECT DISORDERS, V43, P163, DOI 10.1016/S0165-0327(96)01421-8; Benazzi F, 1997, J AFFECT DISORDERS, V46, P73, DOI 10.1016/S0165-0327(97)00082-7; BENAZZI F, 2005, BIPOLAR DISORDERS MI, P131, DOI DOI 10.1017/CBO9780511544019.007; BENAZZI F, IN PRESS ANN CLIN PS; BENAZZI F, IN PRESS WORLD J BIO; BENAZZI F, 2006, PSYCHIAT TIMES, V9, P26; Benazzi F, 2007, EUR PSYCHIAT, V22, P99, DOI 10.1016/j.eurpsy.2006.06.003; Benazzi F, 2007, PROG NEURO-PSYCHOPH, V31, P97, DOI 10.1016/j.pnpbp.2006.08.003; Benazzi F, 2007, PSYCHOTHER PSYCHOSOM, V76, P70, DOI 10.1159/000097965; Benazzi F, 2006, J AFFECT DISORDERS, V96, P183, DOI 10.1016/j.jad.2004.04.005; Benazzi F, 2006, J AFFECT DISORDERS, V96, P189, DOI 10.1016/j.jad.2004.04.006; Benazzi F, 2007, PSYCHOPATHOLOGY, V40, P54, DOI 10.1159/000096513; Benazzi F, 2006, AM J PSYCHIAT, V163, P1644, DOI 10.1176/appi.ajp.163.9.1644; Benazzi F, 2006, PROG NEURO-PSYCHOPH, V30, P1043, DOI 10.1016/j.pnpbp.2006.03.037; Biondi M, 2005, J AFFECT DISORDERS, V84, P133, DOI 10.1016/S0165-0327(02)00103-9; Birmaher B, 2006, ARCH GEN PSYCHIAT, V63, P175, DOI 10.1001/archpsyc.63.2.175; Bottlender R, 2004, J AFFECT DISORDERS, V78, P149, DOI 10.1016/S0165-0327(02)00265-3; Brown EB, 2006, J CLIN PSYCHIAT, V67, P1025, DOI 10.4088/JCP.v67n0703; Calabrese JR, 2003, J CLIN PSYCHIAT, V64, P1013, DOI 10.4088/JCP.v64n0906; Calabrese JR, 2005, AM J PSYCHIAT, V162, P1351, DOI 10.1176/appi.ajp.162.7.1351; Calabrese JR, 2000, J CLIN PSYCHIAT, V61, P841, DOI 10.4088/JCP.v61n1106; Cassano GB, 2004, AM J PSYCHIAT, V161, P1264, DOI 10.1176/appi.ajp.161.7.1264; Cassano GB, 2002, PSYCHIAT CLIN N AM, V25, P699, DOI 10.1016/S0193-953X(02)00025-4; Cassidy F, 1998, ARCH GEN PSYCHIAT, V55, P27, DOI 10.1001/archpsyc.55.1.27; Chun BJDH, 2004, BIPOLAR DISORD, V6, P32, DOI 10.1046/j.1399-5618.2003.00084.x; Coppen A, 2000, J CLIN PSYCHIAT, V61, P52; CORYELL W, 1995, AM J PSYCHIAT, V152, P385; DeBattista C, 2005, J CLIN PSYCHOPHARM, V25, P476, DOI 10.1097/01.jcp.0000177552.21338.b0; Dikeos DG, 2006, BRIT J PSYCHIAT, V189, P346, DOI 10.1192/bjp.bp.105.017251; Dilsaver SC, 1999, AM J PSYCHIAT, V156, P426; Dilsaver SC, 2005, PSYCHOPATHOLOGY, V38, P268, DOI 10.1159/000088443; Duffy A, 2000, J CLIN PSYCHIAT, V61, P630, DOI 10.4088/JCP.v61n0906; El-Mallakh RS, 2006, BIPOLAR DEPRESSION, P167; Faedda GL, 2004, BIPOLAR DISORD, V6, P305, DOI 10.1111/j.1399-5618.2004.00128.x; First M. B., 1997, STRUCTURED CLIN INTE; Frank E, 2005, ARCH GEN PSYCHIAT, V62, P996, DOI 10.1001/archpsyc.62.9.996; FRYE MA, 2006, AM PSYCH ASS ANN M; Geller B, 2006, ARCH GEN PSYCHIAT, V63, P1130, DOI 10.1001/archpsyc.63.10.1130; GERSHON ES, 1982, ARCH GEN PSYCHIAT, V39, P1157; Ghaemi SN, 2007, PSYCHOTHER PSYCHOSOM, V76, P65, DOI 10.1159/000097964; Ghaemi SN, 2003, BIPOLAR DISORD, V5, P421, DOI 10.1046/j.1399-5618.2003.00074.x; Ghaemi SN, 2002, CAN J PSYCHIAT, V47, P125, DOI 10.1177/070674370204700202; GHAEMI SN, 2006, S NEW VIST TREATM RE; Gijsman HJ, 2004, AM J PSYCHIAT, V161, P1537, DOI 10.1176/appi.ajp.161.9.1537; Goldberg JF, 2004, NEUROPSYCHOPHARMACOL, V29, pS144; Goldberg JF, 2001, AM J PSYCHIAT, V158, P1265, DOI 10.1176/appi.ajp.158.8.1265; Goodwin F, 1990, MANIC DEPRESSIVE ILL; Goodwin GM, 2004, J CLIN PSYCHIAT, V65, P432; Gyulai L, 2003, NEUROPSYCHOPHARMACOL, V28, P1374, DOI 10.1038/sj.npp.1300190; Hantouche EG, 2003, J AFFECT DISORDERS, V73, P39, DOI 10.1016/S0165-0327(02)00319-1; Hantouche EG, 1998, J AFFECT DISORDERS, V50, P163, DOI 10.1016/S0165-0327(98)00112-8; Hawton K, 2005, J CLIN PSYCHIAT, V66, P693, DOI 10.4088/JCP.v66n0604; HEUN R, 1993, ACTA PSYCHIAT SCAND, V87, P279, DOI 10.1111/j.1600-0447.1993.tb03372.x; Houston JP, 2006, J CLIN PSYCHIAT, V67, P1246, DOI 10.4088/JCP.v67n0811; Joyce PR, 2004, COMPR PSYCHIAT, V45, P168, DOI 10.1016/j.comppsych.2004.02.005; Judd LL, 2003, J AFFECT DISORDERS, V73, P123, DOI 10.1016/S0165-0327(02)00332-4; Judd LL, 2002, ARCH GEN PSYCHIAT, V59, P530, DOI 10.1001/archpsyc.59.6.530; Judd LL, 2003, ARCH GEN PSYCHIAT, V60, P261, DOI 10.1001/archpsyc.60.3.261; Kendell R, 2003, AM J PSYCHIAT, V160, P4, DOI 10.1176/appi.ajp.160.1.4; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koukopoulos A, 2003, J AFFECT DISORDERS, V73, P199, DOI 10.1016/S0165-0327(02)00326-9; Koukopoulos A., 2005, BIPOLAR DISORD, P157; Koukopoulos A, 2006, BIPOLAR PSYCHOPHARMACOTHERAPY: CARING FOR THE PATIENT, P169, DOI 10.1002/0470017953.ch10; Krabbendam L, 2004, PSYCHOL MED, V34, P1177, DOI 10.1017/S0033291703001892; Kraepelin E., 1921, MANIC DEPRESSIVE INS; Lam DH, 2003, ARCH GEN PSYCHIAT, V60, P145, DOI 10.1001/archpsyc.60.2.145; Leverich GS, 2006, AM J PSYCHIAT, V163, P232, DOI 10.1176/appi.ajp.163.2.232; MacKinnon DF, 2005, BIPOLAR DISORD, V7, P441, DOI 10.1111/j.1399-5618.2005.00236.x; Maj M, 2003, AM J PSYCHIAT, V160, P2134, DOI 10.1176/appi.ajp.160.12.2134; Maj M, 2006, J CLIN PSYCHIAT, V67, P712, DOI 10.4088/JCP.v67n0504; Mammen OK, 2004, J CLIN PSYCHIAT, V65, P627; Mantere O, 2004, BIPOLAR DISORD, V6, P395, DOI 10.1111/j.1399-5618.2004.00140.x; MCMAHON FJ, 1994, AM J PSYCHIAT, V151, P210; Mitchell PB, 2004, BIPOLAR DISORD, V6, P530, DOI 10.1111/j.1399-5618.2004.00137.x; Moller HJ, 2006, EUR ARCH PSY CLIN N, V256, P1, DOI 10.1007/s00406-005-0591-9; Perlis RH, 2006, AM J PSYCHIAT, V163, P217, DOI 10.1176/appi.ajp.163.2.217; Perugi G, 2003, J AFFECT DISORDERS, V73, P87, DOI 10.1016/S0165-0327(02)00329-4; Perugi G, 2001, J AFFECT DISORDERS, V67, P105, DOI 10.1016/S0165-0327(01)00443-8; Post RM, 2003, BIPOLAR DISORD, V5, P396, DOI 10.1046/j.1399-5618.2003.00065.x; Regeer EJ, 2006, PSYCHOL MED, V36, P619, DOI 10.1017/S0033291705006823; ROBINS E, 1970, AM J PSYCHIAT, V126, P983, DOI 10.1176/ajp.126.7.983; Rybakowski JK, 2005, J AFFECT DISORDERS, V84, P141, DOI 10.1016/j.jad.2004.01.005; SACHS GS, 2005, ADV TREATMENT BIPOLA, P57; Sato T, 2005, J AFFECT DISORDERS, V84, P187, DOI 10.1016/S0165-0327(02)00172-6; Sato T, 2004, J AFFECT DISORDERS, V81, P103, DOI 10.1016/S0165-0327(03)00159-9; Sato T, 2003, ACTA PSYCHIAT SCAND, V107, P268, DOI 10.1034/j.1600-0447.2003.00051.x; SEDLER MJ, 1983, AM J PSYCHIAT, V140, P1127; Serretti A, 2005, J AFFECT DISORDERS, V84, P159, DOI 10.1016/j.jad.2003.09.011; Simpson SG, 2002, ARCH GEN PSYCHIAT, V59, P736, DOI 10.1001/archpsyc.59.8.736; Smith DJ, 2005, J AFFECT DISORDERS, V84, P167, DOI 10.1016/j.jad.2004.02.005; Suppes T, 2005, ARCH GEN PSYCHIAT, V62, P1089, DOI 10.1001/archpsyc.62.10.1089; Swann AC, 2001, J AFFECT DISORDERS, V67, P123, DOI 10.1016/S0165-0327(01)00447-5; Thase ME, 2006, J CLIN PSYCHOPHARM, V26, P600, DOI 10.1097/01.jcp.0000248603.76231.b7; Tohen M, 2004, BRIT J PSYCHIAT, V184, P337, DOI 10.1192/bjp.184.4.337; Tohen M, 2003, ARCH GEN PSYCHIAT, V60, P1079, DOI 10.1001/archpsyc.60.11.1079; Tohen M, 2003, AM J PSYCHIAT, V160, P1263, DOI 10.1176/appi.ajp.160.7.1263; *US FDA, LAB CHANG REQ LETT A; VIETA E, 2005, BIPOLAR DISORDERS MI, P88; Winokur G., 1996, NATURAL HIST MANIA D; World Health Organisation, 1993, ICD 10 CLASSIFICATIO; Yatham LN, 2005, J CLIN PSYCHIAT, V66, P13; ZORNBERG GL, 1993, J CLIN PSYCHOPHARM, V13, P397	148	180	185	3	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2007	369	9565					935	945		10.1016/S0140-6736(07)60453-X	http://dx.doi.org/10.1016/S0140-6736(07)60453-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148BQ	17368155				2022-12-28	WOS:000245049900034
J	Smith, GCS; Fleming, KM; White, IR				Smith, Gordon C. S.; Fleming, Kate M.; White, Ian R.			Birth order of twins and risk of perinatal death related to delivery in England, Northern Ireland, and Wales, 1994-2003: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							2ND TWIN; MORBIDITY; MORTALITY; MODE; OUTCOMES; WEIGHT; FETAL; TERM	Objective To determine the effect of birth order on the risk of perinatal death in twin pregnancies. Design Retrospective cohort study. Setting England, Northern Ireland, and Wales, 1994-2003. Participants 1377 twin pregnancies with one intrapartum stillbirth or neonatal death from causes other than congenital abnormality and one surviving infant. Main outcome measures The risk of perinatal death in the first and second twin estimated with conditional logistic regression. Results There was no association between birth order and, the risk of death overall (odds ratio 1.0, 95% confidence interval 0.9 to 1.1). However, there was a highly significant interaction with gestational age (P < 0.001). There was no association between birth order and the risk of death among infants born before 36 weeks' gestation but there was an increased risk of death among second twins born at term (2.3, 1.7 to 3.2, P < 0.001), which was stronger for deaths caused by intrapartum anoxia or trauma (3.4, 2.2 to 5.3). Among term births, there was a trend (P=0.1) towards a greater risk of the second twin dying from anoxia among those delivered vaginally (4.1, 1.8 to 9.5) compared with those delivered by caesarean section (1.8, 0.9 to 3.6). Conclusions In this cohort, compared with first twins, second twins born at term were at increased risk of perinatal death related to delivery. Vaginally delivered second twins had a fourfold risk of death caused by intrapartum anoxia.	Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Cambridge CB2 2QQ, England; Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 2SR, England	University of Cambridge; MRC Biostatistics Unit; University of Cambridge	Smith, GCS (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Box223, Cambridge CB2 2QQ, England.	gcss2@cam.ac.uk	Fleming, Kate M/A-6475-2010; Smith, Gordon/A-8070-2008	Fleming, Kate M/0000-0002-6572-5016; Smith, Gordon/0000-0003-2124-0997; White, Ian/0000-0002-6718-7661	Medical Research Council [MC_U105260558] Funding Source: Medline; MRC [MC_U105260558] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Armson BA, 2006, OBSTET GYNECOL, V108, P556, DOI 10.1097/01.AOG.0000227747.37184.0a; Cahill AG, 2006, AM J OBSTET GYNECOL, V194, P909, DOI 10.1016/j.ajog.2006.02.031; GOODMAN SN, 1994, ANN INTERN MED, V121, P200, DOI 10.7326/0003-4819-121-3-199408010-00008; Hartley RS, 2005, J MATERN-FETAL NEO M, V17, P375, DOI 10.1080/147670505000132484; HEY EN, 1986, BRIT J OBSTET GYNAEC, V93, P1213, DOI 10.1111/j.1471-0528.1986.tb07854.x; Lydon-Rochelle MT, 2005, AM J PUBLIC HEALTH, V95, P1948, DOI 10.2105/AJPH.2004.044305; Sheay W, 2004, OBSTET GYNECOL, V103, P63, DOI 10.1097/01.AOG.0000101291.14773.F0; Smith GCS, 2005, BJOG-INT J OBSTET GY, V112, P1139, DOI 10.1111/j.1471-0528.2005.00631.x; Smith GCS, 2005, AM J OBSTET GYNECOL, V192, P17, DOI 10.1016/j.ajog.2004.08.014; Smith GCS, 2002, BRIT MED J, V325, P1004, DOI 10.1136/bmj.325.7371.1004; Thorngren-Jerneck K, 2001, OBSTET GYNECOL, V98, P65, DOI 10.1016/S0029-7844(01)01370-9; Yang Q, 2006, J PERINATOL, V26, P3, DOI 10.1038/sj.jp.7211408; Yang QY, 2006, AM J PERINAT, V23, P381, DOI 10.1055/s-2006-951286; Yang QY, 2005, AM J OBSTET GYNECOL, V192, P840, DOI 10.1016/j.ajog.2004.09.132	14	85	89	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2007	334	7593					576	578A		10.1136/bmj.39118.483819.55	http://dx.doi.org/10.1136/bmj.39118.483819.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AP	17337456	Green Published, Bronze			2022-12-28	WOS:000245404400036
J	Walker, N; Bryce, J; Black, RE				Walker, Neff; Bryce, Jennifer; Black, Robert E.			Health Statistics 3 - Interpreting health statistics for policymaking: the story behind the headlines	LANCET			English	Article							GLOBAL BURDEN; MORTALITY; CHILDREN; HIV; DEATHS; AIDS; TUBERCULOSIS; MALNUTRITION; COUNTRIES; HIV/AIDS	Politicians, policymakers, and public-health professionals make complex decisions on the basis of estimates of disease burden from different sources, many of which are "marketed" by skilled advocates. To help people who rely on such statistics make more informed decisions, we explain how health estimates are developed, and offer basic guidance on how to assess and interpret them. We describe the different levels of estimates used to quantify disease burden and its correlates; understanding how closely linked a type of statistic is to disease and death rates is crucial in designing health policies and programmes. We also suggest questions that people using such statistics should ask and offer tips to help separate advocacy from evidence-based positions. Global health agencies have a key role in communicating robust estimates of disease, as do policymakers at national and subnational levels where key public-health decisions are made. A common framework and standardised methods, building on the work of Child Health Epidemiology Reference Group (CHERG) and others, are urgently needed.	UNICEF, Div Policy & Planning, New York, NY 10017 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	UNICEF; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Walker, N (corresponding author), UNICEF, Div Policy & Planning, New York, NY 10017 USA.	pneffwalker@yahoo.com		Black, Robert/0000-0001-9926-7984				AbouZahr C, 2007, LANCET, V369, P1039, DOI 10.1016/S0140-6736(07)60463-2; [Anonymous], 2001, ROAD MAP IMPL UN MIL; Bchir A, 2006, LANCET, V367, P190, DOI 10.1016/S0140-6736(06)68011-2; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; BLACK RE, 1991, ACTA PAEDIATR SCAND, P133; BOERMA T, 2000, LANCET, V369, P779; BRADSHER K, 2004, NY TIMES        1130; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Fishman SM, 2004, COMP QUANTIFICATION, P39; Gordon B., 2004, INHERITING WORLD ATL; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Grassly NC, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010637; Haddad L, 2003, WORLD BANK ECON REV, V17, P107, DOI 10.1093/wber/lhg012; Hill K, 2001, B WORLD HEALTH ORGAN, V79, P182; Hodes R, 2002, AIDS, V16, P1, DOI 10.1097/00002030-200201040-00001; Hunt JM, 2002, J NUTR, V132, p794S, DOI 10.1093/jn/132.4.794S; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; KOLATA G, 2004, NY TIMES        1124; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2004, LANCET, V364, P399, DOI 10.1016/S0140-6736(04)16783-4; Milman A, 2005, J NUTR, V135, P1415, DOI 10.1093/jn/135.6.1415; Morgan M, 2006, SEX TRANSM INFECT, V82, pIII71, DOI 10.1136/sti.2006.021097; Morris SS, 2003, INT J EPIDEMIOL, V32, P1041, DOI 10.1093/ije/dyg241; MURRAY CLJ, 2000, LANCET, V369, P862; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; OPS OMS, 2003, INT STAT CLASS DIS R, V1, P157; OSTERHOLM M, INCR HLTH RISKS OUR; PELLETIER DL, 1993, AM J PUBLIC HEALTH, V83, P1130, DOI 10.2105/AJPH.83.8.1130; Pisani E, 2003, BRIT MED J, V326, P1384, DOI 10.1136/bmj.326.7403.1384; Rochefort D.A., 1994, POLITICS PROBLEM DEF; Roe E, 1994, NARRATIVE POLICY ANA; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; Sachdev HPS, 2005, PUBLIC HEALTH NUTR, V8, P117, DOI 10.1079/PHN2004677; Sachs JD, 2005, NEW ENGL J MED, V352, P115, DOI 10.1056/NEJMp048319; Schellenberg JRMA, 2001, LANCET, V357, P1241, DOI 10.1016/S0140-6736(00)04404-4; Schwartlander B, 1999, AIDS, V13, P2445, DOI 10.1097/00002030-199912030-00017; Stein CE, 2003, J INFECT DIS, V187, pS8, DOI 10.1086/368114; *TASK FORC CHILD S, GAINS MAD PAST 20 YE; *UNAIDS, 2004, UNAIDS GLOB REP HIV; *UNAIDS, 1998, UNAIDS GLOB REP HIV; *UNAIDS, 2002, UNAIDS GLOB REP HIV; *UNICEF, 2003, GLOB LEAD INT COMM P; *US CDCP NAT CTR H, 2004, QUES ANSW TB; Walker N, 2004, LANCET, V363, P2180, DOI 10.1016/S0140-6736(04)16511-2; Walker N, 2003, AIDS, V17, P2215, DOI 10.1097/00002030-200310170-00010; *WHO, 2003, WHO STOP TB IN TB AD; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; 2005, BBC NEWS        1122; 2002, WASHINGTON POST 1001	55	36	36	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2007	369	9565					956	963		10.1016/S0140-6736(07)60454-1	http://dx.doi.org/10.1016/S0140-6736(07)60454-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148BQ	17368157				2022-12-28	WOS:000245049900036
J	Campbell, M; Cleland, J; Ezeh, A; Prata, N				Campbell, Martha; Cleland, John; Ezeh, Alex; Prata, Ndola			Public health - Return of the population growth factor	SCIENCE			English	Editorial Material									Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; London Sch Hyg & Trop Med, London WC1 3DP, England; African Populat & Hlth Res Ctr, Nairobi, Kenya	University of California System; University of California Berkeley; University of London; London School of Hygiene & Tropical Medicine; African Population & Health Research Centre	Campbell, M (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	campbell@berkeley.edu	Cleland, John G./AAZ-4185-2020; Ezeh, Alex/AAN-8646-2020	Cleland, John G./0000-0002-1471-7016; Ezeh, Alex/0000-0002-1309-4697				BATES J, 2000, IMPLICATIONS HLTH SE; Campbell M, 2006, STUD FAMILY PLANN, V37, P87, DOI 10.1111/j.1728-4465.2006.00088.x; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Collumbien M., 2004, COMP QUANTIFICATION, P1255; GRAHAMSMITH F, 1994, POPULATION COMPLEX R; POTTS M, 1990, LANCET, V336, P1293, DOI 10.1016/0140-6736(90)92972-K; POTTS M, 1990, LANCET, V336, P1227, DOI 10.1016/0140-6736(90)92843-7; Reynolds HW, 2005, SEX TRANSM INFECT, V81, P184, DOI 10.1136/sti.2004.012013; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; Shelton JD, 2001, BRIT MED J, V323, P139, DOI 10.1136/bmj.323.7305.139; SPEIDEL JJ, 2005, POPULATION DONOR LAN; *UN EC SOC AFF, 2005, WORLD POP PROSP 2004, P34; WESTOFF CF, IN PRESS NEW ESTIMAT	13	53	53	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2007	315	5818					1501	1502		10.1126/science.1140057	http://dx.doi.org/10.1126/science.1140057			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146LB	17363647				2022-12-28	WOS:000244934800023
J	Luo, ZX; Chen, PJ; Li, G; Chen, M				Luo, Zhe-Xi; Chen, Peiji; Li, Gang; Chen, Meng			A new eutriconodont mammal and evolutionary development in early mammals	NATURE			English	Article							OSSIFIED MECKELS CARTILAGE; MIDDLE-EAR; MESOZOIC MAMMALS; HOX GENES; ORIGIN; DIVERSIFICATION; CONSTRAINTS; PHYLOGENY; SKELETON; CHINA	Detachment of the three tiny middle ear bones from the reptilian mandible is an important innovation of modern mammals. Here we describe a Mesozoic eutriconodont nested within crown mammals that clearly illustrates this transition: the middle ear bones are connected to the mandible via an ossified Meckel's cartilage. The connected ear and jaw structure is similar to the embryonic pattern in modern monotremes (egg-laying mammals) and placental mammals, but is a paedomorphic feature retained in the adult, unlike in monotreme and placental adults. This suggests that reversal to (or retention of) this premammalian ancestral condition is correlated with different developmental timing (heterochrony) in eutriconodonts. This new eutriconodont adds to the evidence of homoplasy of vertebral characters in the thoraco-lumbar transition and unfused lumbar ribs among early mammals. This is similar to the effect of homeobox gene patterning of vertebrae in modern mammals, making it plausible to extrapolate the effects of Hox gene patterning to account for homoplastic evolution of vertebral characters in early mammals.	Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA; Nanjing Univ, Dept Earth Sci, Nanjing 210093, Peoples R China; Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Strat, Nanjing 210008, Peoples R China	Nanjing University; Chinese Academy of Sciences	Luo, ZX (corresponding author), Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA.	luoz@carnegiemnh.org	Luo, Zhe-XI/AAU-2263-2021					ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; ALLIN EF, 1975, J MORPHOL, V147, P403, DOI 10.1002/jmor.1051470404; BEVER GS, 2005, SCIENCE, V309, pA1492, DOI DOI 10.1126/SCIENCE.1112248; Burke AC, 2001, AM ZOOL, V41, P687, DOI 10.1668/0003-1569(2001)041[0687:HGAASI]2.0.CO;2; Crompton AW, 1993, MAMMAL PHYLOGENY, V1, P30, DOI DOI 10.1007/978-1-4613-9249-1; FLEISCHER G, 1973, Saeugetierkundliche Mitteilungen, V21, P131; Galis F, 1999, J EXP ZOOL, V285, P19, DOI 10.1002/(SICI)1097-010X(19990415)285:1<19::AID-JEZ3>3.0.CO;2-Z; Gaupp E., 1913, ARCH ANATOMIE ENTWIC, P1; Hu Yaoming, 2002, Journal of Vertebrate Paleontology, V22, p67A; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; Jenkins F. A. Jr., 1970, Breviora, V352, P1; Jenkins F.A. Jr, 1988, Journal of Vertebrate Paleontology, V8, P1; JENKINS FA, 1976, PHILOS T ROY SOC B, V273, P387, DOI 10.1098/rstb.1976.0022; Jenkins Jr F. A., 1971, PEABODY MUS NAT HIST, V36, P1; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Ji Q, 1999, NATURE, V398, P326; Ji Q., 2004, MESOZOIC JEHOL BIOTA; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; Kielan-Jaworowska Zofia, 1994, Fossils and Strata, V36, P1; KIELANJAWOROWSK.Z, 2004, MAMMALS AGE DINOSAUR; KRAUSE D W, 1983, Bulletin of the Museum of Comparative Zoology, V150, P199; Krebs B., 1991, Berliner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V133, P1; Li CK, 2003, CHINESE SCI BULL, V48, P1129, DOI 10.1360/02wd0134; Li G, 2006, NATURE, V439, P195, DOI 10.1038/nature04168; Luo Zhe-Xi, 2005, Journal of Mammalian Evolution, V12, P337, DOI 10.1007/s10914-005-6958-x; Luo ZX, 2005, SCIENCE, V308, P103, DOI 10.1126/science.1108875; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Luo ZX, 2001, SCIENCE, V292, P1535, DOI 10.1126/science.1058476; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; MAIER W, 1990, NETH J ZOOL, V40, P55, DOI 10.1163/156854289X00183; MAIER W, 1993, MAMMAL PHYLOGENY, V1, P165; Martin T, 2005, ZOOL J LINN SOC-LOND, V145, P219, DOI 10.1111/j.1096-3642.2005.00187.x; Martin T, 2005, SCIENCE, V307, P861, DOI 10.1126/science.1107202; Meng J, 2003, ZOOL J LINN SOC-LOND, V138, P431, DOI 10.1046/j.1096-3642.2003.00064.x; Narita Y, 2005, J EXP ZOOL PART B, V304B, P91, DOI 10.1002/jez.b.21029; Rich TH, 2005, SCIENCE, V307, P910, DOI 10.1126/science.1105717; Rougier G.W., 1993, THESIS U NACL BUENOS; Rowe T, 1996, SCIENCE, V273, P651, DOI 10.1126/science.273.5275.651; Sanchez-Villagra MR, 2002, J MORPHOL, V251, P219, DOI 10.1002/jmor.1085; Sues Hans-Dieter, 2006, P114; Szalay F. S., 1994, EVOLUTIONARY HIST MA; Wang YQ, 2001, SCIENCE, V294, P357, DOI 10.1126/science.1063830; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Zeller U., 1989, ABHANDLUNGEN SENCKEN, V545, P1; Zeller U., 1993, MAMMAL PHYLOGENY, P95; Zhang FC, 2004, CAN J EARTH SCI, V41, P1097, DOI 10.1139/E04-055; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	50	129	141	3	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					288	293		10.1038/nature05627	http://dx.doi.org/10.1038/nature05627			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361176				2022-12-28	WOS:000244892900038
J	Pham, HH; Schrag, D; O'Malley, AS; Wu, BN; Bach, PB				Pham, Hoangmai H.; Schrag, Deborah; O'Malley, Ann S.; Wu, Beny; Bach, Peter B.			Care patterns in Medicare and their implications for pay for performance	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERPERSONAL CONTINUITY; PHYSICIANS	BACKGROUND: Two assumptions underpin the implementation of pay for performance in Medicare: that with the use of claims data, patients can be assigned to a physician or to a practice that will have primary responsibility for their care, and that a meaningful fraction of the care physicians deliver is for patients for whom they have primary responsibility. METHODS: We analyzed Medicare claims from 2000 through 2002 for 1.79 million fee-for-service beneficiaries treated by 8604 respondents to the Community Tracking Study Physician Survey in 2000 and 2001. In separate analyses, we assigned each patient to the physician or primary care physician with whom the patient had had the most visits. We determined the number of physicians and practices seen annually, the percentage of care received from the assigned physician or practice, the stability of assignments over time, and the percentage of physicians' Medicare patients who were their assigned patients. RESULTS: Beneficiaries saw a median of two primary care physicians and five specialists working in four different practices. A median of 35% of beneficiaries' visits each year were with their assigned physicians; for 33% of beneficiaries, the assigned physician changed from one year to another. On the basis of all visits to any physician, a primary care physician's assigned patients accounted for a median of 39% of the physician's Medicare patients and 62% of Medicare visits. For medical specialists, the respective percentages were 6% and 10%. On the basis of visits to primary care physicians only, 79% of beneficiaries could be assigned to a physician, and a median of 31% of beneficiaries' visits were with that assigned primary care physician. CONCLUSIONS: In fee-for-service Medicare, the dispersion of patients' care among multiple physicians will limit the effectiveness of pay-for-performance initiatives that rely on a single retrospective method of assigning responsibility for patient care.	Ctr Studying Hlth Syst Change, Washington, DC 20024 USA; Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, New York, NY 10021 USA; Social & Sci Syst, Silver Spring, MD USA	Memorial Sloan Kettering Cancer Center; Social & Scientific Systems	Pham, HH (corresponding author), Ctr Studying Hlth Syst Change, 600 Maryland Ave SW,Suite 550, Washington, DC 20024 USA.	mpham@hschange.org		Schrag, Deborah/0000-0002-4334-5717	NIA NIH HHS [R01 AG025687-01A1] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG025687] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; *CTR MED MED SERV, 2005, MED PAY PERF P4P IN; *CTR MED MED SERV, NAT PROV ID NPI STAN; *CTR MED MED SERV, PHYS FEE SCHED REL V; *CTR MED MED SERV, 2006, CURR PROC TERM CPT; *CTR STUD HLTH SYS, 2003, PHYS SURV METH REP 2, V38; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; Institute of Medicine, 2006, REW PROV PERF AL INC; Institute of Medicine, 2006, PERF MEAS ACC IMPR; *LEAPFR GROUP, BRIDG EXC MEAS PROV; National Center for Health Statistics, 1999, INT CLASS DIS; Pham HH, 2005, JAMA-J AM MED ASSOC, V294, P473, DOI 10.1001/jama.294.4.473; Pope GC, 2002, PHYS GROUP PRACTICE; *RES DAT ASS CTR, 2003, MED PHYS ID UPINS PI; Rosenblatt RA, 1998, JAMA-J AM MED ASSOC, V279, P1364, DOI 10.1001/jama.279.17.1364; *SAS I, 2004, SAS SOFTW REL 9 1 3; Saultz John W, 2003, Ann Fam Med, V1, P134, DOI 10.1370/afm.23; Saultz JW, 2005, ANN FAM MED, V3, P159, DOI 10.1370/afm.285; Saultz JW, 2004, ANN FAM MED, V2, P445, DOI 10.1370/afm.91; Shah BV, 1996, SUDAAN USERS MANUAL; Starfield B, 1998, PRIMARY CARE BALANCI; WEINER JP, 1995, JAMA-J AM MED ASSOC, V273, P1503, DOI 10.1001/jama.273.19.1503; [No title captured]	25	377	379	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2007	356	11					1130	1139		10.1056/NEJMsa063979	http://dx.doi.org/10.1056/NEJMsa063979			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	145PO	17360991				2022-12-28	WOS:000244877200006
J	Shelly, DR; Beroza, GC; Ide, S				Shelly, David R.; Beroza, Gregory C.; Ide, Satoshi			Non-volcanic tremor and low-frequency earthquake swarms	NATURE			English	Article							CASCADIA SUBDUCTION ZONE; EPISODIC TREMOR; FORESHOCK SEQUENCES; SOUTHWEST JAPAN; SHORT-TERM; SLIP; EVENTS; FAULT	Non-volcanic tremor is a weak, extended duration seismic signal observed episodically on some major faults, often in conjunction with slow slip events(1-4). Such tremor may hold the key to understanding fundamental processes at the deep roots of faults, and could signal times of accelerated slip and hence increased seismic hazard. The mechanism underlying the generation of tremor and its relationship to aseismic slip are, however, as yet unresolved. Here we demonstrate that tremor beneath Shikoku, Japan, can be explained as a swarm of small, low-frequency earthquakes, each of which occurs as shear faulting on the subduction-zone plate interface. This suggests that tremor and slow slip are different manifestations of a single process.	Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan	Stanford University; University of Tokyo	Shelly, DR (corresponding author), Stanford Univ, Dept Geophys, 397 Panama Mall, Stanford, CA 94305 USA.	dshelly@pangea.stanford.edu	IDE, SATOSHI/G-4887-2014	IDE, SATOSHI/0000-0003-0063-548X; Shelly, David/0000-0003-2783-5158				ANDO M, 1982, PHYS EARTH PLANET IN, V28, P320, DOI 10.1016/0031-9201(82)90089-9; Dodge DA, 1996, J GEOPHYS RES-SOL EA, V101, P22371, DOI 10.1029/96JB02269; Dragert H, 2004, EARTH PLANETS SPACE, V56, P1143, DOI 10.1186/BF03353333; Gibbons SJ, 2006, GEOPHYS J INT, V165, P149, DOI 10.1111/j.1365-246X.2006.02865.x; Hirose H, 2005, EARTH PLANETS SPACE, V57, P961, DOI 10.1186/BF03351875; IDE S, 2007, GEOPHYS RES LETT, V34; Kao H, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003727; Kao H, 2005, NATURE, V436, P841, DOI 10.1038/nature03903; Katsumata A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015981; McGuire JJ, 2005, NATURE, V434, P457, DOI 10.1038/nature03377; Nadeau RM, 2005, SCIENCE, V307, P389, DOI 10.1126/science.1107142; Obara K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020848; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Shelly DR, 2006, NATURE, V442, P188, DOI 10.1038/nature04931; Vidale JE, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004034	16	649	670	4	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					305	307		10.1038/nature05666	http://dx.doi.org/10.1038/nature05666			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361180				2022-12-28	WOS:000244892900042
J	Opal, SM				Opal, Steven M.			Can we RESOLVE the treatment of sepsis?	LANCET			English	Editorial Material							ACTIVATED PROTEIN-C; ANTITHROMBIN		Brown Univ, Mem Hosp Rhode Isl, Sch Med, Dept Med, Pawtucket, RI 02860 USA	Brown University	Opal, SM (corresponding author), Brown Univ, Mem Hosp Rhode Isl, Sch Med, Dept Med, Pawtucket, RI 02860 USA.	Steven_Opal@brown.edu						Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; de Backer D, 2006, CRIT CARE MED, V34, P1918, DOI 10.1097/01.CCM.0000220498.48773.3C; Dhainaut JF, 2004, J THROMB HAEMOST, V2, P1924, DOI 10.1111/j.1538-7836.2004.00955.x; GOLDSTEIN B, 2005, PEDIAT CRIT CRE MED, V6, P2; Hoffmann JN, 2004, CRIT CARE MED, V32, P1011, DOI 10.1097/01.CCM.0000120058.88975.42; Hoffmann JN, 2006, CURR OPIN CRIT CARE, V12, P426, DOI 10.1097/01.ccx.0000244121.54495.f7; Kienast J, 2006, J THROMB HAEMOST, V4, P90, DOI 10.1111/j.1538-7836.2005.01697.x; Nadel S, 2007, LANCET, V369, P836, DOI 10.1016/S0140-6736(07)60411-5	9	14	16	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2007	369	9564					803	804		10.1016/S0140-6736(07)60383-3	http://dx.doi.org/10.1016/S0140-6736(07)60383-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144JC	17350431				2022-12-28	WOS:000244791300005
J	Broecker, WS				Broecker, Wallace S.			Climate change - CO2 arithmetic	SCIENCE			English	Editorial Material									Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	Broecker, WS (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	broecker@ldeo.columbia.edu						Lackner KS, 1999, P 24 ANN TECHN C COA	1	67	69	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1371	1371		10.1126/science.1139585	http://dx.doi.org/10.1126/science.1139585			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143UP	17347428				2022-12-28	WOS:000244752200017
J	Tang, RH; Han, SC; Zheng, HL; Cook, CW; Choi, CS; Woerner, TE; Jackson, RB; Pei, ZM				Tang, Ru-Hang; Han, Shengcheng; Zheng, Hailei; Cook, Charles W.; Choi, Christopher S.; Woerner, Todd E.; Jackson, Robert B.; Pei, Zhen-Ming			Coupling diurnal cytosolic Ca2+ oscillations to the CAS-IP3 pathway in Arabidopsis	SCIENCE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE; CALCIUM; DYNAMICS; PHYSIOLOGY	Various signaling pathways rely on changes in cytosolic calcium ion concentration ([Ca2+](i)). In plants, resting [Ca2+](i) oscillates diurnally. We show that in Arabidopsis thaliana, [Ca2+](i) oscillations are synchronized to extracellular Ca2+ concentration ([Ca2+](o)) oscillations largely through the Ca2+- sensing receptor CAS. CAS regulates concentrations of inositol 1,4,5- trisphosphate (IP3), which in turn directs release of Ca2+ from internal stores. The oscillating amplitudes of [Ca2+](o) and [Ca2+](i) are controlled by soil Ca2+ concentrations and transpiration rates. The phase and period of oscillations are likely determined by stomatal conductance. Thus, the internal concentration of Ca2+ in plant cells is constantly being actively revised.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Xiamen Univ, Dept Biol, Xiamen 361005, Fujian, Peoples R China; Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361005, Fujian, Peoples R China; Duke Univ, Dept Chem, Durham, NC 27708 USA	Duke University; Xiamen University; Xiamen University; Duke University	Pei, ZM (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	zpei@duke.edu	Zheng, Hai-Lei/G-3432-2010	Zheng, Hai-Lei/0000-0001-8588-1529; Jackson, Robert/0000-0001-8846-7147; Han, Shengcheng/0000-0002-4039-7589; Tang, Ruhang/0000-0003-4918-3525; Pei, Zhen-Ming/0000-0003-1473-696X				Bartlett PJ, 2005, J BIOL CHEM, V280, P21837, DOI 10.1074/jbc.M411843200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Colwell CS, 2000, EUR J NEUROSCI, V12, P571, DOI 10.1046/j.1460-9568.2000.00939.x; Dodd AN, 2005, TRENDS PLANT SCI, V10, P15, DOI 10.1016/j.tplants.2004.12.001; Gao DJ, 2004, PLANT PHYSIOL, V134, P898, DOI 10.1104/pp.103.032508; Han SC, 2003, NATURE, V425, P196, DOI 10.1038/nature01932; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Hetherington AM, 2004, ANNU REV PLANT BIOL, V55, P401, DOI 10.1146/annurev.arplant.55.031903.141624; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Love J, 2004, PLANT CELL, V16, P956, DOI 10.1105/tpc.020214; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; McLaughlin SB, 1999, NEW PHYTOL, V142, P373, DOI 10.1046/j.1469-8137.1999.00420.x; Meijer HJG, 2003, ANNU REV PLANT BIOL, V54, P265, DOI 10.1146/annurev.arplant.54.031902.134748; Mueller-Roeber B, 2002, PLANT PHYSIOL, V130, P22, DOI 10.1104/pp.004770; Nash MS, 2001, NATURE, V413, P381, DOI 10.1038/35096643; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Webb AAR, 2003, NEW PHYTOL, V160, P281, DOI 10.1046/j.1469-8137.2003.00895.x; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164	26	120	137	5	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1423	1426		10.1126/science.1134457	http://dx.doi.org/10.1126/science.1134457			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347443				2022-12-28	WOS:000244752200037
J	Torres-Rosell, J; De Piccoli, G; Cordon-Preciado, V; Farmer, S; Jamuz, A; Machin, F; Pasero, P; Lisby, M; Haber, JE; Aragon, L				Torres-Rosell, Jordi; De Piccoli, Giacomo; Cordon-Preciado, Violeta; Farmer, Sarah; Jamuz, Adam; Machin, Felix; Pasero, Philippe; Lisby, Michael; Haber, James E.; Aragon, Luis			Anaphase onset before complete DNA replication with intact checkpoint responses	SCIENCE			English	Article							COMMON FRAGILE SITE; S-PHASE; BUDDING YEAST; ACTIVATION; ORIGINS; DAMAGE; GENES	Cellular checkpoints prevent mitosis in the presence of stalled replication forks. Whether checkpoints also ensure the completion of DNA replication before mitosis is unknown. Here, we show that in yeast smc5-smc6 mutants, which are related to cohesin and condensin, replication is delayed, most significantly at natural replication-impeding loci like the ribosomal DNA gene cluster. In the absence of Smc5-Smc6, chromosome nondisjunction occurs as a consequence of mitotic entry with unfinished replication despite intact checkpoint responses. Eliminating processes that obstruct replication fork progression restores the temporal uncoupling between replication and segregation in smc5-smc6 mutants. We propose that the completion of replication is not under the surveillance of known checkpoints.	Imperial Coll London, Fac Med, Ctr Clin Sci, MRC,Cell Cycle Grp, London W12 0NN, England; Inst Human Genet, CNRS, Unite Propre Rech 1142, F-34396 Montpellier, France; Univ Copenhagen, Inst Mol Biol & Physiol, Dept Genet, DK-1353 Copenhagen, Denmark; Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02454 USA	Imperial College London; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Copenhagen; Brandeis University	Aragon, L (corresponding author), Imperial Coll London, Fac Med, Ctr Clin Sci, MRC,Cell Cycle Grp, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	luis.aragon@csc.mrc.ac.uk	Pasero, Philippe/O-2340-2018; Machín, Félix/K-6569-2017; Torres-Rosell, Jordi/A-4213-2010; Lisby, Michael/K-9814-2014	Pasero, Philippe/0000-0001-5891-0822; Machín, Félix/0000-0003-4559-7798; Torres-Rosell, Jordi/0000-0003-1308-6926; Lisby, Michael/0000-0002-4830-5247; Haber, James/0000-0002-1878-0610	MRC [MC_U120074328] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061766, R01GM020056, R37GM020056] Funding Source: NIH RePORTER; Medical Research Council [MC_U120074328] Funding Source: Medline; NIGMS NIH HHS [R01 GM061766, GM 20056, R01 GM061766-08, R01 GM061766-07] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; Hellman A, 2000, MOL CELL BIOL, V20, P4420, DOI 10.1128/MCB.20.12.4420-4427.2000; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; LINSKENS MHK, 1988, MOL CELL BIOL, V8, P4927, DOI 10.1128/MCB.8.11.4927; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P3962, DOI 10.1073/pnas.88.9.3962; Palakodeti A, 2004, GENE CHROMOSOME CANC, V39, P71, DOI 10.1002/gcc.10290; Pasero P, 2002, GENE DEV, V16, P2479, DOI 10.1101/gad.232902; Pasero P, 1999, GENE DEV, V13, P2159, DOI 10.1101/gad.13.16.2159; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Weinert T, 1998, CURR OPIN GENET DEV, V8, P185, DOI 10.1016/S0959-437X(98)80140-8; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	21	103	105	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1411	1415		10.1126/science.1134025	http://dx.doi.org/10.1126/science.1134025			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347440				2022-12-28	WOS:000244752200034
J	Weinert, T				Weinert, Ted			What a cell should know (but may not)	SCIENCE			English	Editorial Material							REPLICATION; CHECKPOINT; SEGREGATION; SMC5/6; GENOME		Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona	Weinert, T (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	tweinert@email.arizona.edu						Ampatzidou E, 2006, MOL CELL BIOL, V26, P9387, DOI 10.1128/MCB.01335-06; Arlt MF, 2003, CYTOGENET GENOME RES, V100, P92, DOI 10.1159/000072843; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Miyabe I, 2006, MOL CELL BIOL, V26, P343, DOI 10.1128/MCB.26.1.343-353.2006; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Torres-Rosell J, 2007, SCIENCE, V315, P1411, DOI 10.1126/science.1134025; TOYN JH, 1995, MOL CELL BIOL, V15, P5312; van Brabant AJ, 2001, MOL CELL, V7, P705, DOI 10.1016/S1097-2765(01)00216-7	15	6	6	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1374	1375		10.1126/science.1140759	http://dx.doi.org/10.1126/science.1140759			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347431				2022-12-28	WOS:000244752200020
J	Hanto, DW				Hanto, Douglas W.			Ethical challenges posed by the solicitation of deceased and living organ donors	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DONATION; KIDNEY		Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Hanto, DW (corresponding author), 110 Francis St,7th Fl, Boston, MA 01742 USA.	dhanto@bidmc.harvard.edu	Hanto, Douglas/AAZ-5390-2021	Hanto, Douglas/0000-0003-4088-3568				*A SOC TRANSPL, 2004, AST POS INT BAS PAT; Abecassis M, 2000, JAMA-J AM MED ASSOC, V284, P2919; Adams PL, 2002, TRANSPLANTATION, V74, P582, DOI 10.1097/00007890-200208270-00030; *AM SOC TRANSPL SU, 2006, STAT DIR DON SOL DON; Ankeny RA, 2001, CAMB Q HEALTHC ETHIC, V10, P387, DOI 10.1017/S096318010100408X; BROUSSARD C, 2003, NY TIMES        1126, pD1; Caplan A, 2004, HASTINGS CENT REP, V34, P8; DAVIS R, 2004, USA TODAY       1025; Delmonico FL, 2006, AM J TRANSPLANT, V6, P37, DOI 10.1111/j.1600-6143.2005.01163.x; HOPPER L, 2004, HOUSTON CHRONIC 0814, pB1; Ingelfinger JR, 2005, NEW ENGL J MED, V353, P447, DOI 10.1056/NEJMp058156; Jacobs CL, 2004, AM J TRANSPLANT, V4, P1110, DOI 10.1111/j.1600-6143.2004.00478.x; KLUGE EHW, 1989, HASTINGS CENT REP, V19, P10, DOI 10.2307/3562635; Murphy TF, 2006, CAMB Q HEALTHC ETHIC, V15, P50; Ross LF, 2002, PERSPECT BIOL MED, V45, P329, DOI 10.1353/pbm.2002.0055; SATEL S, 2005, NY TIMES        1122; Spital A, 2003, TRANSPLANTATION, V76, P1252, DOI 10.1097/01.TP.0000087852.74220.9A; Steinbrook R, 2005, NEW ENGL J MED, V353, P441, DOI 10.1056/NEJMp058151; Truog RD, 2005, NEW ENGL J MED, V353, P444, DOI 10.1056/NEJMp058155; Truog Robert D, 2005, Med Ethics (Burlingt Mass), V12, P5; *UN NETW ORG SHAR, 2004, OPTN UNOS BOARD OPP; Wright L, 2006, SEMIN DIALYSIS, V19, P5, DOI 10.1111/j.1525-139X.2006.00110.x; 2005, PEW INTERNET AM LIFE	23	31	31	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2007	356	10					1062	1066		10.1056/NEJMsb062319	http://dx.doi.org/10.1056/NEJMsb062319			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143DC	17347461				2022-12-28	WOS:000244699200013
J	Bach, PB; Jett, JR; Pastorino, U; Tockman, MS; Swensen, SJ; Begg, CB				Bach, Peter B.; Jett, James R.; Pastorino, Ugo; Tockman, Melvyn S.; Swensen, Stephen J.; Begg, Colin B.			Computed tomography screening and lung cancer outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLORECTAL-CANCER; MORTALITY; CT; NODULES; OVERDIAGNOSIS; COLONOSCOPY; CARCINOMA; RESECTION; SURVIVAL; PROJECT	Context Current and former smokers are currently being screened for lung cancer with computed tomography (CT), although there are limited data on the effect screening has on lung cancer outcomes. Randomized controlled trials assessing CT screening are currently under way. Objective To assess whether screening may increase the frequency of lung cancer diagnosis and lung cancer resection or may reduce the risk of a diagnosis of advanced lung cancer or death from lung cancer. Design, Setting, and Participants Longitudinal analysis of 3246 asymptomatic current or former smokers screened for lung cancer beginning in 1998 either at 1 of 2 academic medical centers in the United States or an academic medical center in Italy with follow-up for a median of 3.9 years. Intervention Annual CT scans with comprehensive evaluation and treatment of detected nodules. Main Outcome Measures Comparison of predicted with observed number of new lung cancer cases, lung cancer resections, advanced lung cancer cases, and deaths from lung cancer. Results There were 144 individuals diagnosed with lung cancer compared with 44.5 expected cases ( relative risk [RR], 3.2; 95% confidence interval [CI], 2.7-3.8; P <. 001). There were 109 individuals who had a lung resection compared with 10.9 expected cases ( RR, 10.0; 95% CI, 8.2-11.9; P <. 001). There was no evidence of a decline in the number of diagnoses of advanced lung cancers ( 42 individuals compared with 33.4 expected cases) or deaths from lung cancer ( 38 deaths due to lung cancer observed and 38.8 expected; RR, 1.0; 95% CI, 0.7- 1.3; P=. 90). Conclusions Screening for lung cancer with low-dose CT may increase the rate of lung cancer diagnosis and treatment, but may not meaningfully reduce the risk of advanced lung cancer or death from lung cancer. Until more conclusive data are available, asymptomatic individuals should not be screened outside of clinical research studies that have a reasonable likelihood of further clarifying the potential benefits and risks.	Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; Mayo Clin, Dept Radiol, Rochester, MN USA; Mayo Clin, Div Pulm Med & Oncol, Rochester, MN USA; Ist Tumori, Div Thorac Surg, Milan, Italy; H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Prevent & Control, Tampa, FL USA	Memorial Sloan Kettering Cancer Center; Mayo Clinic; Mayo Clinic; H Lee Moffitt Cancer Center & Research Institute	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Box 221, New York, NY 10021 USA.		Pastorino, Ugo/C-2712-2017; Peng, Bo/A-6920-2009	Pastorino, Ugo/0000-0001-9974-7902; Peng, Bo/0000-0001-8225-2284	NATIONAL CANCER INSTITUTE [K22CA094973, R01CA079935] Funding Source: NIH RePORTER; NCI NIH HHS [UO1CA94973, R01CA79935] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bach PB, 2004, CHEST, V126, P1742, DOI 10.1378/chest.126.6.1742; Bach PB, 2003, CHEST, V123, p72S, DOI 10.1378/chest.123.1_suppl.72S; Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; BACH PB, 2005, CHEST           0318; BACH PB, 2000, J NATL CANCER I, V95, P470; Cronin KA, 2006, JNCI-J NATL CANCER I, V98, P637, DOI 10.1093/jnci/djj163; Dammas S, 2001, LUNG CANCER, V33, P11, DOI 10.1016/S0169-5002(01)00190-8; FONTANA RS, 1986, J OCCUP ENVIRON MED, V28, P746, DOI 10.1097/00043764-198608000-00038; Gibson L, 1997, J Med Screen, V4, P44; GOLDBERG KB, 2002, NCI LUNG CANC SCREEN; HAKAMA M, 1985, BRIT J CANCER, V52, P669, DOI 10.1038/bjc.1985.241; Harpole DH, 1999, J THORAC CARDIOV SUR, V117, P969, DOI 10.1016/S0022-5223(99)70378-8; Henschke CI, 2004, RADIOLOGY, V231, P164, DOI 10.1148/radiol.2311030634; Henschke CI, 2001, ONCOLOGIST, V6, P147, DOI 10.1634/theoncologist.6-2-147; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; KJELLGREN O, 1986, GYNECOL OBSTET INVES, V22, P57, DOI 10.1159/000298892; KUBIK A, 1986, CANCER-AM CANCER SOC, V57, P2427, DOI 10.1002/1097-0142(19860615)57:12<2427::AID-CNCR2820571230>3.0.CO;2-M; Kubik AK, 2000, CANCER, V89, P2363, DOI 10.1002/1097-0142(20001201)89:11+<2363::AID-CNCR9>3.0.CO;2-W; LANGE P, 1990, THORAX, V45, P579, DOI 10.1136/thx.45.8.579; Lee TH, 2002, NEW ENGL J MED, V346, P529, DOI 10.1056/NEJM200202143460715; LEVIN ML, 1982, RECENT RES CANCER, V82, P138; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lindell RM, 2007, RADIOLOGY, V242, P555, DOI 10.1148/radiol.2422052090; Mannino DM, 2003, ARCH INTERN MED, V163, P1475, DOI 10.1001/archinte.163.12.1475; Marcus PM, 2000, J NATL CANCER I, V92, P1308, DOI 10.1093/jnci/92.16.1308; Melamed MR, 2000, CANCER, V89, P2356, DOI 10.1002/1097-0142(20001201)89:11+<2356::AID-CNCR8>3.3.CO;2-Q; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Pastorino U, 2003, LANCET, V362, P593, DOI 10.1016/S0140-6736(03)14188-8; Pinsky PF, 2005, CANCER-AM CANCER SOC, V103, P157, DOI 10.1002/cncr.20746; Schilling FH, 2002, NEW ENGL J MED, V346, P1047, DOI 10.1056/NEJMoa012277; Silvestri GA, 1998, CHEST, V114, P675, DOI 10.1378/chest.114.3.675; Sone S, 1998, LANCET, V351, P1242, DOI 10.1016/S0140-6736(97)08229-9; Stephan F, 2000, CHEST, V118, P1263, DOI 10.1378/chest.118.5.1263; STITIK FP, 1978, RADIOL CLIN N AM, V16, P347; Swensen SJ, 2003, RADIOLOGY, V226, P756, DOI 10.1148/radiol.2263020036; Swensen SJ, 2002, AM J RESP CRIT CARE, V165, P508, DOI 10.1164/ajrccm.165.4.2107006; Thiis-Evensen E, 1999, SCAND J GASTROENTERO, V34, P414; TOCKMAN MS, 2003, 10 INT C LUNG CANC A; *WHO, 2002, NUMB RAT REG DEATHS, V92, P1280; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Woods WG, 2002, NEW ENGL J MED, V346, P1041, DOI 10.1056/NEJMoa012387; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251; Yankelevitz DF, 2003, CANCER, V97, P1271, DOI 10.1002/cncr.11185; Zhukov TA, 2003, LUNG CANCER, V40, P267, DOI 10.1016/S0169-5002(03)00082-5; FOCUS LUNG CANC SCRE	46	428	447	1	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2007	297	9					953	961		10.1001/jama.297.9.953	http://dx.doi.org/10.1001/jama.297.9.953			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143CP	17341709				2022-12-28	WOS:000244697900024
J	Nallamothu, BK; Rogers, MAM; Chernew, ME; Krumholz, HM; Eagle, KA; Birkmeyer, JD				Nallamothu, Brahmajee K.; Rogers, Mary A. M.; Chernew, Michael E.; Krumholz, Harlan M.; Eagle, Kim A.; Birkmeyer, John D.			Opening of specialty cardiac hospitals and use of coronary revascularization in medicare beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED-TRIALS; METAANALYSIS; PHYSICIANS; OWNERSHIP; THERAPY; DISEASE	Context Although proponents argue that specialty cardiac hospitals provide high-quality cost-efficient care, strong financial incentives for physicians at these facilities could result in greater procedure utilization. Objective To determine whether the opening of cardiac hospitals was associated with increasing population-based rates of coronary revascularization. Design, Setting, and Patients In a study of Medicare beneficiaries from 1995 through 2003, we calculated annual population-based rates for total revascularization ( coronary artery bypass graft [CABG] plus percutaneous coronary intervention [PCI]), CABG, and PCI. Hospital referral regions (HRRs) were used to categorize health care markets into those where ( 1) cardiac hospitals opened (n= 13), ( 2) new cardiac programs opened at general hospitals ( n= 142), and ( 3) no new programs opened ( n= 151). Main Outcome Measures Rates of change in total revascularization, CABG, and PCI using multivariable linear regression models with generalized estimating equations. Results Overall, rates of change for total revascularization were higher in HRRs after cardiac hospitals opened when compared with HRRs where new cardiac programs opened at general hospitals and HRRs with no new programs ( P M. 001 for both comparisons). Four years after their opening, the relative increase in adjusted rates was more than 2-fold higher in HRRs where cardiac hospitals opened (19.2% [95% confidence interval {CI}, 6.1%- 32.2%], P <. 001) when compared with HRRs where new cardiac programs opened at general hospitals (6.5% [ 95% CI, 3.2%-9.9%], P <. 001) and HRRs with no new programs (7.4% [ 95% CI, 3.2%- 11.5%], P <. 001). These findings were consistent when rates for CABG and PCI were considered separately. For PCI, this growth appeared largely driven by increased utilization among patients without acute myocardial infarction ( 42.1% [ 95% CI, 21.4%-62.9%], P <. 001). Conclusion The opening of a cardiac hospital within an HRR is associated with increasing population-based rates of coronary revascularization in Medicare beneficiaries.	Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; VA Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA; Harvard Univ, Sch Med, Dept Internal Med, Boston, MA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School	Nallamothu, BK (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	bnal-lamo@umich.edu	, Harlan/AAI-2875-2020	Rogers, Mary/0000-0001-5519-3223	AHRQ HHS [1R01HS015571-01A1] Funding Source: Medline; NCRR NIH HHS [K12 RR017607-01] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS015571] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR017607] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Casalino LP, 2003, HEALTH AFFAIR, V22, P56, DOI 10.1377/hlthaff.22.6.56; Cram P, 2005, NEW ENGL J MED, V352, P1454, DOI 10.1056/NEJMsa042325; DEVERS KJ, 2003, SPECIALTY HOSP FOCUS; Dobson Allen, 2003, Am Heart Hosp J, V1, P21, DOI 10.1111/j.1541-9215.2003.02100.x; Dupont W. D., 2002, STAT MODELING BIOMED, P356; *GEN ACC OFF, 2003, SPEC HOSP INF NAT MA; *GEN ACC OFF, 2006, GEN HOSP OP CLIN CHA; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Herzlinger RE, 2004, CIRCULATION, V109, P2376, DOI 10.1161/01.CIR.0000130782.33860.E0; HILLMAN BJ, 1990, NEW ENGL J MED, V323, P1604, DOI 10.1056/NEJM199012063232306; Iglehart JK, 2005, NEW ENGL J MED, V352, P78, DOI 10.1056/NEJMhpr043631; Iglehart JK, 2005, NEW ENGL J MED, V352, P1405, DOI 10.1056/NEJMp058037; IGLEHART JK, 1990, NEW ENGL J MED, V322, P1682, DOI 10.1056/NEJM199006073222327; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P260; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Stensland J, 2006, HEALTH AFFAIR, V25, P119, DOI 10.1377/hlthaff.25.1.119; Voelker R, 2003, JAMA-J AM MED ASSOC, V289, P409, DOI 10.1001/jama.289.4.409; Wennberg D.E, 1999, DARTMOUTH ATLAS CARD; 2004, FED REG, V69, P16084; 2003, ANN SURVEY HOSP DATA	24	80	80	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2007	297	9					962	968		10.1001/jama.297.9.962	http://dx.doi.org/10.1001/jama.297.9.962			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143CP	17341710	Bronze			2022-12-28	WOS:000244697900025
J	Boerma, T; Abou-Zahr, C				Boerma, Ties; Abou-Zahr, Carla			Health statistics are no longer boring!	LANCET			English	Editorial Material									WHO, CH-1211 Geneva, Switzerland; Hlth Metr Network, Geneva, Switzerland	World Health Organization	Boerma, T (corresponding author), WHO, CH-1211 Geneva, Switzerland.	boermat@who.int						Barron P, 2006, DISTRICT HLTH BAROME; Bevan G, 2006, BMJ-BRIT MED J, V332, P419, DOI 10.1136/bmj.332.7538.419; Boerma JT, 2007, LANCET, V369, P779, DOI 10.1016/S0140-6736(07)60364-X; Health Canada, 2006, HLTH CAN FED REP COM; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; SCHOEN C, 2006, NATL SCORECARD US HL	6	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2007	369	9563					718	719		10.1016/S0140-6736(07)60333-X	http://dx.doi.org/10.1016/S0140-6736(07)60333-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143MP	17336629				2022-12-28	WOS:000244726700005
J	Ghezzi, I; Ruggles, C				Ghezzi, Ivan; Ruggles, Clive			Chankillo: A 2300-year-old solar observatory in coastal Peru	SCIENCE			English	Article							RADIOCARBON CALIBRATION	The Thirteen Towers of Chankillo run north to south along a low ridge within a fourth-century B. C. E. ceremonial complex in north coastal Peru. From evident observing points within the adjacent buildings to the west and east, they formed an artificial toothed horizon that spanned-almost exactly-the annual rising and setting arcs of the Sun. The Chankillo towers thus provide evidence of early solar horizon observations and of the existence of sophisticated Sun cults, preceding the Sun pillars of Incaic Cusco by almost two millennia.	Inst Nacl Cultura, Lima 41, Peru; Pontificia Univ Catolica Peru, Lima 32, Peru; Yale Univ, New Haven, CT 06511 USA; Univ Leicester, Sch Archaeol & Ancient Hist, Leicester LE1 7RH, Leics, England	Pontificia Universidad Catolica del Peru; Yale University; University of Leicester	Ghezzi, I (corresponding author), Inst Nacl Cultura, Ave Javier Prado Este 2465, Lima 41, Peru.	ighezzi@yahoo.com	Ghezzi, Ivan/ABC-1026-2021	Ghezzi, Ivan/0000-0002-7006-307X				AVENI A, 1986, T AM PHILOS SOC, V76, P1, DOI 10.2307/1006457; Aveni AF, 2003, LAT AM ANTIQ, V14, P159, DOI 10.2307/3557593; AVENI AF, 2001, SKYWATCHERS, P40; AVENI AF, 2001, SKYWATCHERS, P55; AVENI AF, 1997, STAIRWAYS STARS, P147; Aveni Anthony F., 1989, WORLD ARCHAEOASTRONO, P441; Aylesworth Grant, 2004, ARCHAEOASTRONOMY, V18, P34; BASSI M, 1988, CURR ANTHROPOL, V29, P619, DOI 10.1086/203682; Bauer B., 2001, RITUAL PILGRIMAGE AN; Bauer B.S., 1998, SACRED LANDSCAPE INC; Bauer Brian S., 1995, ASTRONOMY EMPIRE ANC; BAUER BS, 1995, ASTRONOMY EMPIRE ANC, P67; BAUER BS, 1995, ASTRONOMY EMPIRE ANC, P94; Dearborn DSP, 1998, LAT AM ANTIQ, V9, P240, DOI 10.2307/971730; GHEZZI I, 2004, PROYECTO ARQUEOLOGIC; Ghezzi I, 2006, ANDEAN ARCHAEOLOGY III: NORTH AND SOUTH, P67, DOI 10.1007/0-387-28940-2_4; Hoskin M., 2001, TOMBS TEMPLES THEIR; McCluskey S, 1977, J HIST ASTRON, V8, P174; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; Ramsey CB, 2001, RADIOCARBON, V43, P355; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; Ruggles C. L. N., 1997, ARCHAEOASTRONOMY, V28, pS45; Ruggles Clive, 2005, ANCIENT ASTRONOMY EN; Ruggles Clive, 2005, ARCHAEOLOGY KEY CONC, P11; RUGGLES CLN, 1999, ASTRONOMY PREHISTORI, P91; RUGGLES CLN, 1999, ASTRONOMY PREHISTORI, pR9; Sprajc Ivan, 2001, ORIENTACIONES ASTRON; TOPIC JR, 1997, ARQUEOLOGIA ANTROPOL, P567; ZIOLKOWSKI MS, 1989, BRIT ARCHAEOLOGICAL, V479; Zuidema R.T, 1964, INT ARCH ETHNOGRAP S, VL; [No title captured]	31	34	35	3	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1239	1243		10.1126/science.1136415	http://dx.doi.org/10.1126/science.1136415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332405				2022-12-28	WOS:000244564700040
J	Shea, K				Shea, Katriona			How the wood moves	SCIENCE			English	Editorial Material							DISPERSAL		Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; Penn State Univ, Intercoll Grad Degree Program Ecol, Mueller Lab 208, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Shea, K (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.	k-shea@psu.edu	Shea, Katriona/B-7954-2008	Shea, Katriona/0000-0002-7607-8248				Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; Garcia C, 2005, MOL ECOL, V14, P1821, DOI 10.1111/j.1365-294X.2005.02542.x; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; SHAKESPEARE W, 1969, MACBETH; Sugden A, 2006, SCIENCE, V313, P775, DOI 10.1126/science.313.5788.775; Tolkien J.R.R., 1966, 2 TOWERS BEING 2 PAR, V2nd; Wyndham J., 1951, DOUBLEDAY	8	12	13	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1231	1232		10.1126/science.1136096	http://dx.doi.org/10.1126/science.1136096			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332401				2022-12-28	WOS:000244564700036
J	Landon, BE; Hicks, LS; O'Malley, AJ; Lieu, TA; Keegan, T; McNeil, BJ; Guadagnoli, E				Landon, Bruce E.; Hicks, LeRoi S.; O'Malley, A. James; Lieu, Tracy A.; Keegan, Thomas; McNeil, Barbara J.; Guadagnoli, Edward			Improving the management of chronic disease at community health centers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN-HEART-ASSOCIATION; QUALITY-IMPROVEMENT; ASTHMA CARE; OUTCOMES; GUIDELINES; DISPARITIES; COMMITTEE; TRENDS; IMPACT; MODEL	BACKGROUND: The Health Disparities Collaboratives of the Health Resources and Services Administration (HRSA) were designed to improve care in community health centers, where many patients from ethnic and racial minority groups and uninsured patients receive treatment. METHODS: We performed a controlled preintervention and postintervention study of community health centers participating in quality-improvement collaboratives (the Health Disparities Collaboratives sponsored by the HRSA) for the care of patients with diabetes, asthma, or hypertension. We enrolled 9658 patients at 44 intervention centers that had participated in the collaboratives and 20 centers that had not participated (external control centers). Each intervention center also served as an internal control for another condition. Quality measures were abstracted from medical records at each health center. We created overall quality scores by standardizing and averaging the scores from all of the applicable measures. Changes in quality were evaluated with the use of hierarchical regression models that controlled for patient characteristics. RESULTS: Overall, the intervention centers had considerably greater improvement than the external and internal control centers in the composite measures of quality for the care of patients with asthma and diabetes, but not for those with hypertension. As compared with the external control centers, the intervention centers had significant improvements in the measures of prevention and screening, including a 21% increase in foot examinations for patients with diabetes, and in disease treatment and monitoring, including a 14% increase in the use of antiinflammatory medication for asthma and a 16% increase in the assessment of glycated hemoglobin. There was no improvement, however, in any of the intermediate outcomes assessed (urgent care or hospitalization for asthma, control of glycated hemoglobin levels for diabetes, and control of blood pressure for hypertension). CONCLUSIONS: The Health Disparities Collaboratives significantly improved the processes of care for two of the three conditions studied. There was no improvement in the clinical outcomes studied.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; Harvard Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Landon, BE (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	landon@hcp.med.harvard.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U01HS013653] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AHRQ, 2005, AHRQ NAT HEALTHC DIS; *AHRQ, 2005, AHRQ NAT HEALTHC QUA; *AM DIAB ASS, 2006, STAND MED CAR DIAB; ASCH S, DOES PARTICIPATION C; BERWICK DM, 1989, NEW ENGL J MED, V320, P53, DOI 10.1056/NEJM198901053200110; Chin MH, 2004, DIABETES CARE, V27, P2099; Chin MH, 2004, DIABETES CARE, V27, P2, DOI 10.2337/diacare.27.1.2; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Davidoff F, 2005, QUAL SAF HEALTH CARE, V14, P319, DOI 10.1136/qshc.2005.014787; *DHHS, 2000, OBJ IMPR HLTH HLTH P; Dievler A, 1998, MED CARE RES REV, V55, P405, DOI 10.1177/107755879805500402; Ferlie EB, 2001, MILBANK Q, V79, P281, DOI 10.1111/1468-0009.00206; Fleming BB, 2002, DIABETES CARE, V25, P249; Fleming BB, 2001, DIABETES CARE, V24, P1815, DOI 10.2337/diacare.24.10.1815; Gustafson DH, 2003, HEALTH SERV RES, V38, P751, DOI 10.1111/1475-6773.00143; Homer CJ, 2005, ARCH PEDIAT ADOL MED, V159, P464, DOI 10.1001/archpedi.159.5.464; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jha AK, 2005, NEW ENGL J MED, V353, P683, DOI 10.1056/NEJMsa050672; Kilo C M, 1998, Qual Manag Health Care, V6, P1; Landon BE, 2004, ANN INTERN MED, V140, P887, DOI 10.7326/0003-4819-140-11-200406010-00010; LETHBRIDGECEJKU M, 2005, VITAL HLTH STAT, V10; Mangione-Smith R, 2005, AMBUL PEDIATR, V5, P75, DOI 10.1367/A04-106R.1; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Mittman BS, 2004, ANN INTERN MED, V140, P897, DOI 10.7326/0003-4819-140-11-200406010-00011; *NAT ASS COMM HLTH, 2005, SAF NET EDG; *NAT COMM QUAL ASS, 2003, QUAL COMP 2003; Ovretveit J, 2002, QUAL SAF HEALTH CARE, V11, P345, DOI 10.1136/qhc.11.4.345; Schonlau M, 2005, ANN FAM MED, V3, P200, DOI 10.1370/afm.269; SHORTELL SM, 1995, HEALTH SERV RES, V30, P377; Smedley B.D, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Smith SC, 2001, J AM COLL CARDIOL, V38, P1581, DOI 10.1016/S0735-1097(01)01682-5; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Wagner E H, 1998, Eff Clin Pract, V1, P2; Williams Seymour G, 2003, MMWR Recomm Rep, V52, P1; Wilson Tim, 2003, Jt Comm J Qual Saf, V29, P85	36	208	211	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2007	356	9					921	934		10.1056/NEJMsa062860	http://dx.doi.org/10.1056/NEJMsa062860			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	140HV	17329699	Bronze			2022-12-28	WOS:000244496400007
J	Safdar, N; Kaul, DR; Saint, S				Safdar, Nasia; Kaul, Daniel R.; Saint, Sanjay			Clinical problem-solving: Into the woods	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NOCARDIA INFECTION; SULFAMETHOXAZOLE; TRIMETHOPRIM; EXPERIENCE		Univ Wisconsin, Sch Med, Dept Med, Div Infect Dis, Madison, WI 53792 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; Vet Affairs Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA	University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan	Safdar, N (corresponding author), Univ Wisconsin, Sch Med, Dept Med, Div Infect Dis, H4-572 Clin Sci Ctr,600 Highland Ave, Madison, WI 53792 USA.	ns2@medicine.wisc.edu	Saint, Sanjay/AAF-5126-2019					BEAMAN BL, 1976, J INFECT DIS, V134, P286, DOI 10.1093/infdis/134.3.286; BEAMAN BL, 1994, CLIN MICROBIOL REV, V7, P213, DOI 10.1128/CMR.7.2.213-264.1994; Elstein AS, 1978, MED PROBLEM SOLVING; GEORGHIOU PR, 1992, MED J AUSTRALIA, V156, P692, DOI 10.5694/j.1326-5377.1992.tb121509.x; Kontoyiannis DP, 2000, CLIN INFECT DIS, V31, P617, DOI 10.1086/313941; Lederman ER, 2004, MEDICINE, V83, P300, DOI 10.1097/01.md.0000141100.30871.39; Lerner PI, 1996, CLIN INFECT DIS, V22, P891, DOI 10.1093/clinids/22.6.891; MADERAZO EG, 1974, AM J MED, V57, P671, DOI 10.1016/0002-9343(74)90022-9; Moylett EH, 2003, CLIN INFECT DIS, V36, P313, DOI 10.1086/345907; Saubolle MA, 2003, J CLIN MICROBIOL, V41, P4497, DOI 10.1128/JCM.41.10.4497-4501.2003; Saubolle MA., 2002, CLIN LAB MED, P1201; SCHMIDT HG, 1992, ACAD MED, V67, P287; SCHMIDT HG, 1990, ACAD MED, V65, P611, DOI 10.1097/00001888-199010000-00001; SMEGO RA, 1983, ARCH INTERN MED, V143, P711, DOI 10.1001/archinte.143.4.711; Threlkeld S C, 1997, Curr Clin Top Infect Dis, V17, P1; Torres HA, 2002, MEDICINE, V81, P388, DOI 10.1097/00005792-200209000-00004	16	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2007	356	9					943	947		10.1056/NEJMcps054496	http://dx.doi.org/10.1056/NEJMcps054496			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140HV	17329702				2022-12-28	WOS:000244496400011
J	Lerosey, G; De Rosny, J; Tourin, A; Fink, M				Lerosey, Geoffroy; De Rosny, Julien; Tourin, Arnaud; Fink, Mathias			Focusing beyond the diffraction limit with far-field time reversal	SCIENCE			English	Article							MICROSCOPY; SUPERLENS; REFRACTION; CAVITY; INDEX	We present an approach for subwavelength focusing of microwaves using both a time-reversal mirror placed in the far field and a random distribution of scatterers placed in the near field of the focusing point. The far-field time-reversal mirror is used to build the time-reversed wave field, which interacts with the random medium to regenerate not only the propagating waves but also the evanescent waves required to refocus below the diffraction limit. Focal spots as small as one-thirtieth of a wavelength are described. We present one example of an application to telecommunications, which shows enhancement of the information transmission rate by a factor of 3.	Univ Paris 07, Ecole Super Phys & Chim Ind, Lab Ondes & Acoust, CNRS,UMR 7587, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Universite Paris Cite	Fink, M (corresponding author), Univ Paris 07, Ecole Super Phys & Chim Ind, Lab Ondes & Acoust, CNRS,UMR 7587, 10 Rue Vauquelin, F-75005 Paris, France.	mathias.fink@espci.fr	刘, 奇/AAF-2601-2021; Fink, Mathias/M-9437-2016	Fink, Mathias/0000-0002-8494-7562; Lerosey, Geoffroy/0000-0002-7087-5377; Tourin, Arnaud/0000-0002-4692-7333				BETZIG E, 1992, SCIENCE, V257, P189, DOI 10.1126/science.257.5067.189; Carminati R, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.012712; CASSEREAU D, 1992, IEEE T ULTRASON FERR, V39, P579, DOI 10.1109/58.156176; de Rosny J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.124301; Draeger C, 1997, PHYS REV LETT, V79, P407, DOI 10.1103/PhysRevLett.79.407; Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Fink M, 1997, PHYS TODAY, V50, P34, DOI 10.1063/1.881692; Henty BE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.243904; Jacob Z, 2006, OPT EXPRESS, V14, P8247, DOI 10.1364/OE.14.008247; Lerosey G, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2194009; Lerosey G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.193904; Melville DOS, 2005, OPT EXPRESS, V13, P2127, DOI 10.1364/OPEX.13.002127; Moustakas AL, 2000, SCIENCE, V287, P287, DOI 10.1126/science.287.5451.287; NICOROVICI NA, 1994, PHYS REV B, V49, P8479, DOI 10.1103/PhysRevB.49.8479; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; Smith DR, 2005, SCIENCE, V308, P502, DOI 10.1126/science.1110900; Taubner T, 2006, SCIENCE, V313, P1595, DOI 10.1126/science.1131025; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; Wiltshire MCK, 2001, SCIENCE, V291, P849, DOI 10.1126/science.291.5505.849; ZENHAUSERN F, 1995, SCIENCE, V269, P1083, DOI 10.1126/science.269.5227.1083	22	497	537	10	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1120	1122		10.1126/science.1134824	http://dx.doi.org/10.1126/science.1134824			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17322059				2022-12-28	WOS:000244387600035
J	Zaratiegui, M; Irvine, DV; Martienssen, RA				Zaratiegui, Mikel; Irvine, Danielle V.; Martienssen, Robert A.			Noncoding RNAs and gene silencing	CELL			English	Review							DIRECTED DNA METHYLATION; SMALL INTERFERING RNAS; TRANSPOSABLE ELEMENTS; UNPAIRED DNA; GENOME REARRANGEMENT; LYSINE-9 METHYLATION; HISTONE METHYLATION; EPIGENETIC CONTROL; TANDEM REPEATS; POL-IV		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu		Zaratiegui, Mikel/0000-0002-0342-0268	NIGMS NIH HHS [R01 GM076396-04, R01 GM076396, R01-GM067014] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076396, R01GM067014] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Bean CJ, 2004, NAT GENET, V36, P100, DOI 10.1038/ng1283; Bestor TH, 2004, COLD SPRING HARB SYM, V69, P381, DOI 10.1101/sqb.2004.69.381; Bouzinba-Segard H, 2006, P NATL ACAD SCI USA, V103, P8709, DOI 10.1073/pnas.0508006103; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Buhler M, 2005, MOL CELL, V18, P307, DOI 10.1016/j.molcel.2005.03.030; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Ciaudo C, 2006, PLOS GENET, V2, P874, DOI 10.1371/journal.pgen.0020094; Costa Y, 2006, HUM MOL GENET, V15, P2324, DOI 10.1093/hmg/ddl158; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Dawe RK, 2003, PLANT CELL, V15, P297, DOI 10.1105/tpc.150230; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Deshpande G, 2006, GENETICS, V174, P1287, DOI 10.1534/genetics.106.062414; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Ekwall K, 2004, CHROMOSOME RES, V12, P535, DOI 10.1023/B:CHRO.0000036584.40567.e5; Fischer A, 2006, J PLANT PHYSIOL, V163, P358, DOI 10.1016/j.jplph.2005.10.015; Flaherty SM, 1997, P NATL ACAD SCI USA, V94, P11893, DOI 10.1073/pnas.94.22.11893; Freitag M, 2004, SCIENCE, V304, P1939, DOI 10.1126/science.1099709; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Furuno M, 2006, PLOS GENET, V2, P537, DOI 10.1371/journal.pgen.0020037; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jia ST, 2004, CELL, V119, P469, DOI 10.1016/j.cell.2004.10.020; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Kavi HH, 2005, FEBS LETT, V579, P5940, DOI 10.1016/j.febslet.2005.08.069; Khaitovich P, 2006, PLOS GENET, V2, P1590, DOI 10.1371/journal.pgen.0020171; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kim HS, 2004, J BIOL CHEM, V279, P42850, DOI 10.1074/jbc.M407259200; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee DW, 2004, GENETICS, V167, P131, DOI 10.1534/genetics.167.1.131; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Liu YF, 2004, P NATL ACAD SCI USA, V101, P1679, DOI 10.1073/pnas.0305421101; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Maine EM, 2005, CURR BIOL, V15, P1972, DOI 10.1016/j.cub.2005.09.049; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Martienssen R, 2004, COLD SPRING HARB SYM, V69, P371, DOI 10.1101/sqb.2004.69.371; Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005; Martienssen Rob, 2003, P129; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; May BP, 2005, PLOS GENET, V1, P705, DOI 10.1371/journal.pgen.0010079; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Melquist S, 2004, GENETICS, V166, P437, DOI 10.1534/genetics.166.1.437; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nakayashiki H, 2005, FEBS LETT, V579, P5950, DOI 10.1016/j.febslet.2005.08.016; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Quesada V, 2005, INT J DEV BIOL, V49, P773, DOI 10.1387/ijdb.051995vq; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Reiss D, 2004, MOL GENET GENOMICS, V272, P336, DOI 10.1007/s00438-004-1061-1; Robert V, 2001, GENETICS, V158, P701; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Sado T, 2006, DEVELOPMENT, V133, P4925, DOI 10.1242/dev.02670; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Scheid OM, 2002, P NATL ACAD SCI USA, V99, P13659, DOI 10.1073/pnas.202380499; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schramke V, 2005, NATURE, V435, P1275, DOI 10.1038/nature03652; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Shiu PKT, 2002, GENETICS, V161, P1483; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Slotkin RK, 2005, NAT GENET, V37, P641, DOI 10.1038/ng1576; Song JJ, 2006, CURR OPIN STRUC BIOL, V16, P5, DOI 10.1016/j.sbi.2006.01.010; Sun XP, 2003, GENOME RES, V13, P182, DOI 10.1101/gr.681703; Sung S, 2005, ANNU REV PLANT BIOL, V56, P491, DOI 10.1146/annurev.arplant.56.032604.144307; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; Timmons JA, 2006, BIOCHEM SOC T, V34, P1148, DOI 10.1042/BST0341148; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Tran RK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r90; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Ungerer MC, 2006, CURR BIOL, V16, pR872, DOI 10.1016/j.cub.2006.09.020; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; Vaughn MW, 2005, MOL CELL, V17, P754, DOI 10.1016/j.molcel.2005.03.003; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wassenegger M, 2005, CELL, V122, P13, DOI 10.1016/j.cell.2005.06.034; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Weinberg MS, 2006, RNA, V12, P256, DOI 10.1261/rna.2235106; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	130	304	336	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2007	128	4					763	776		10.1016/j.cell.2007.02.016	http://dx.doi.org/10.1016/j.cell.2007.02.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148TX	17320512	Green Accepted, Bronze			2022-12-28	WOS:000245098600017
J	Seal, A; Kerac, M				Seal, Andrew; Kerac, Marko			Operational implications of using 2006 World Health Organization growth standards in nutrition programmes: secondary data analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To assess the implications of adopting the World Health Organization 2006 growth standards in combination with current diagnostic criteria in emergency and non-emergency child feeding programmes. Design Secondary analysis of data from three standardised nutrition surveys (n=2555) for prevalence of acute malnutrition, using weight for height z score (<-2 and <-3) and percentage of the median (< 80% and < 70%) cut-offs for moderate and severe acute malnutrition from the National Center for Health Statistics/WHO growth reference (NCHS reference) and the new WHO 2006 growth standards (WHO standards). Setting Refugee camps in Algeria, Kenya, and Bangladesh. Population Children aged 6-59 months. Results Important differences exist in the weight for height cut-offs used for defining acute malnutrition obtained from the WHO standards and NCHS reference data. These vary according to a child's height and according to whether z score or percentage of the median cut-offs are used. If applied and used according to current practice in nutrition programmes, the WHO standards will result in a higher measured prevalence of severe acute malnutrition during surveys but, paradoxically, a decrease in the admission of children to emergency feeding programmes and earlier discharge of recovering patients. The expected impact on case fatality rates of applying the new standards in conjunction with current diagnostic criteria is unknown. Conclusions A full assessment of the appropriate use of the new WHO standards in the diagnosis of acute malnutrition is urgently needed. This should be completed before the standards are adopted by organisations that run nutrition programmes targeting acute malnutrition.	Inst Child Hlth, Ctr Int Hlth & Dev, London WC1N 1EH, England; Coll Med, Blantyre, Malawi; Valid Int, London, England	University of London; University College London; University of Malawi	Seal, A (corresponding author), Inst Child Hlth, Ctr Int Hlth & Dev, 30 Guilford St, London WC1N 1EH, England.	a.seat@ich.ucl.ac.uk	Seal, Andrew/C-8550-2014; Kerac, Marko/GQR-1136-2022; Kerac, Marko/G-1777-2010	Seal, Andrew/0000-0003-3656-4054; Kerac, Marko/0000-0002-3745-7317				[Anonymous], 2004, SPHER PROJ HUM CHART; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; DIBLEY MJ, 1987, AM J CLIN NUTR, V46, P736, DOI 10.1093/ajcn/46.5.736; Newcombe RG, 1998, STAT MED, V17, P2635, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2635::AID-SIM954>3.0.CO;2-C; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; *UN HIGH COMM REF, 2001, NW KEN ANTHR MICR NU; *UN HIGH COMM REF, 2003, REP NUTR SURV INV UN; *UN SYST STAND COM, 2006, 8 UN SYST STAND COMM; W.H.O, 1983, MEAS CHANG NUTR STAT; *WHO, WHO ANTHR 2005 SOFTW; WHO, WHO CHILD GROWTH STA; World Bank, 2006, REP NUTR CENTR DEV; *WORLD FOOD PROGR, FAST FOOD WFPS EM RE; *WORLD FOOD PROGR, 2002, ALG ANTHR MICR NUTR; World Health Organization, 2000, MAN NUTR MAJ EM	15	43	45	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2007	334	7596					733	735		10.1136/bmj.39101.664109.AE	http://dx.doi.org/10.1136/bmj.39101.664109.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AO	17322275	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000245763300030
J	Edwards, RT; Ceilleachair, A; Bywater, T; Hughes, DA; Hutchings, J				Edwards, Rhiannon T.; Ceilleachair, Alan; Bywater, Tracey; Hughes, Dyfrig A.; Hutchings, Judy			Parenting programme for parents of children at risk of developing conduct disorder: cost effectiveness analysis	BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP; ECONOMIC EVALUATIONS; ANTISOCIAL CHILDREN; INTERVENTIONS	Objective To investigate the cost effectiveness of a parenting programme. Design An incremental cost effectiveness analysis alongside a pragmatic randomised controlled trial of the effectiveness of a group parenting programme delivered through Sure Start in the community. Setting Sure Start areas in north and mid Wales. Participants Parents of 116 children aged 36-59 months (87% of the clinical sample) at risk of developing conduct disorders defined by scoring over the clinical cut off on the Eyberg child behaviour inventory). Children were identified by health visitors and recruited by the research team. Intervention The Webster-Stratton Incredible Years basic parenting programme or a six month waiting list control. Main outcome measure Incremental cost per unit of improvement on the intensity score of the Eyberg child behaviour inventory. Results The bootstrapped incremental cost effectiveness ratio point estimate was 73 pound (E109, $142) per one point improvement on the intensity score (95% confidence interval 42 pound to 140) pound. It would cost 5486 pound (E8190, $10 666) to bring the child with the highest intensity score to below the clinical cut-off point and 1344 pound (E2006, $2618) to bring the average child in the intervention group within the non-clinical limits on the intensity score (below 127). For a ceiling ratio of 100 pound (E149, $194) per point increase in intensity score, there is an 83.9% chance of the intervention being cost effective. The mean cost per child attending the parenting group was 1934 pound (E2887, $3760) for eight children and 1289 pound (E1924, $2506) for 12 children, including initial costs and materials for training group leaders. When we categorised the sample into relatively mild, moderate, and severe behaviour groups based on intensity scores at baseline the intervention seemed more cost effective in those with the highest risk of developing conduct disorder. Conclusion This parenting programme improves child behaviour as measured by the intensity scores of the Eyberg child behaviour inventory at a relatively low cost and was cost effective compared with the waiting list control. This parenting programme involves modest costs and demonstrates strong clinical effect, suggesting it would represent good value for money for public spending.	Univ Wales, Inst Med & Social Care Res, Ctr Econ & Policy Hlth, Bangor LL57 1UT, Gwynedd, Wales; Univ Wales, Sch Psychol, Bangor, Gwynedd, Wales	Bangor University; Bangor University	Edwards, RT (corresponding author), Univ Wales, Inst Med & Social Care Res, Ctr Econ & Policy Hlth, Bangor LL57 1UT, Gwynedd, Wales.	r.t.edwards@bangor.ac.uk	Hughes, Dyfrig/H-5252-2012	Hughes, Dyfrig/0000-0001-8247-7459; hutchings, judy/0000-0003-2562-8104				[Anonymous], 1999, CLIN CHILD PSYCHOL P, DOI DOI 10.1177/1359104599004004003; Beecham J., 2001, MEASURING MENTAL HLT; Briggs AH, 1999, BRIT MED J, V319, P635, DOI 10.1136/bmj.319.7210.635; CHRISTENSEN A, 1980, BEHAV THER, V11, P208, DOI 10.1016/S0005-7894(80)80021-9; Eyberg SM, 1980, J CLIN CHILD PSYCHOL, V9, P27; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; GARDNER FEM, 1987, J ABNORM CHILD PSYCH, V15, P283, DOI 10.1007/BF00916355; Godfrey C, 2005, BMJ-BRIT MED J, V331, P544; Hutchings J, 2004, BEHAV COGN PSYCHOTH, V32, P15, DOI 10.1017/S1352465804001018; Hutchings J, 2007, BMJ-BRIT MED J, V334, P678, DOI 10.1136/bmj.39126.620799.55; KAZDIN AE, 1989, ADV BEHAV RES THER, V11, P1, DOI 10.1016/0146-6402(89)90025-8; Kazdin AE, 2006, EVID-BASED MENT HEAL, V9, P8, DOI 10.1136/ebmh.9.1.8; LOEBER R, 1990, CLIN PSYCHOL REV, V10, P1, DOI 10.1016/0272-7358(90)90105-J; Muntz Rachel, 2004, J Ment Health Policy Econ, V7, P177; National Institute for Health and Clinical Excellence, 2006, PAR TRAIN ED PROGR M; NETTEN A, 2004, UNIT COSTS HLTH SOCI; *NHS, NHS REF COSTS 2004; NHS Health Advisory Service, 1995, CHILD AD MENT HLTH S; Office for National Statistics, 1999, MENT HLTH CHILDR AD; OFFORD DR, 1989, J AM ACAD CHILD ADOL, V28, P850; Robins LN, 1990, STRAIGHT DEVIOUS PAT; Romeo R, 2005, J CHILD PSYCHOL PSYC, V46, P919, DOI 10.1111/j.1469-7610.2005.00407.x; Scott S, 2001, BRIT MED J, V323, P191, DOI 10.1136/bmj.323.7306.191; Thompson R., 1996, J CHILD FAM STUD, V5, P415, DOI [DOI 10.1007/BF02233863, 10.1007/BF02233863]; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Webster-Stratton C, 1998, HDB PARENT TRAINING; WHO, 2012, ICD 10 CLASS MENT BE	27	107	107	0	23	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 31	2007	334	7595					682	685		10.1136/bmj.39126.699421.55	http://dx.doi.org/10.1136/bmj.39126.699421.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	154ON	17350965	Bronze, Green Published			2022-12-28	WOS:000245517100035
J	Stobbart, L; Murtagh, MJ; Rapley, T; Ford, GA; Louw, SJ; Rodgers, H				Stobbart, L.; Murtagh, M. J.; Rapley, T.; Ford, G. A.; Louw, S. J.; Rodgers, H.			"We saw human guinea pigs explode"	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Newcastle, Dept Hlth Res Capac Dev, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Royal Victoria Infirm, Stroke Res Grp, Inst Ageing & Hlth, Clin Res Facil, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Freeman Rd Hosp, Newcastle upon Tyne Hosp NHS Fdn Trust, Dept Hen Internal Med, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Murtagh, MJ (corresponding author), Univ Newcastle, Dept Hlth Res Capac Dev, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	m.j.murtagh@newcastle.ac.uk	Ford, Gary/AAY-6405-2020; Ford, Gary A/A-6353-2012	Ford, Gary/0000-0001-8719-4968; 	Department of Health [RDA/01/05/091] Funding Source: Medline	Department of Health			0	7	8	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 17	2007	334	7593					566	567		10.1136/bmj.39150.488264.47	http://dx.doi.org/10.1136/bmj.39150.488264.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AP	17363826	Green Published			2022-12-28	WOS:000245404400031
J	Franck, L; Colquhoun, D				Franck, Linda; Colquhoun, David			Demand for complementary and alternative medicine is high despite limited evidence.	BRITISH MEDICAL JOURNAL			English	Article									UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Colquhoun, D (corresponding author), UCL, Dept Pharmacol, Mortimer St, London WC1E 6BT, England.	d.colquhoun@ucl.ac.uk	Colquhoun, David/C-1664-2008	Colquhoun, David/0000-0002-4263-017X					0	12	12	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2007	334	7592					507	507						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148VV	17347234				2022-12-28	WOS:000245106400035
J	Prall, OWJ; Menon, MK; Solloway, MJ; Watanabe, Y; Zaffran, S; Bajolle, F; Biben, C; McBride, JJ; Robertson, BR; Chaulet, H; Stennard, FA; Wise, N; Schaft, D; Wolstein, O; Furtado, MB; Shiratori, H; Chien, KR; Hamada, H; Black, BL; Saga, Y; Robertson, EJ; Buckingham, ME; Harvey, RP				Prall, Owen W. J.; Menon, Mary K.; Solloway, Mark J.; Watanabe, Yusuke; Zaffran, Stephane; Bajolle, Fanny; Biben, Christine; McBride, Jim J.; Robertson, Bronwyn R.; Chaulet, Herve; Stennard, Fiona A.; Wise, Natalie; Schaft, Daniel; Wolstein, Orit; Furtado, Milena B.; Shiratori, Hidetaka; Chien, Kenneth R.; Hamada, Hiroshi; Black, Brian L.; Saga, Yumiko; Robertson, Elizabeth J.; Buckingham, Margaret E.; Harvey, Richard P.			An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation	CELL			English	Article							HOMEOBOX GENE NKX2-5; TRANSCRIPTION FACTOR NKX2-5; OUTFLOW TRACT; ASYMMETRIC EXPRESSION; SIGNALING PATHWAY; EMBRYOS LACKING; FIELD; MUTATIONS; CELLS; DISEASE	During heart development the second heart field (SHF) provides progenitor cells for most cardiomyocytes and expresses the homeodomain factor Nkx2-5. We now show that feedback repression of Bmp2/Smad1 signaling by Nkx2-5 critically regulates SHF proliferation and outflow tract (OFT) morphology. In the cardiac fields of Nkx2-5 mutants, genes controlling cardiac specification (including Bmp2) and maintenance of the progenitor state were upregulated, leading initially to progenitor overspecification, but subsequently to failed SHF proliferation and OFT truncation. In Smad1 mutants, SHF proliferation and deployment to the OFT were increased, while Smad1 deletion in Nkx2-5 mutants rescued SHF proliferation and OFT development. In Nkx2-5 hyponnorphic mice, which recapitulate human congenital heart disease (CHD), OFT anomalies were also rescued by Smad1 deletion. Our findings demonstrate that Nkx2-5 orchestrates the transition between periods of cardiac induction, progenitor proliferation, and OFT morphogenesis via a Smadl dependent negative feedback loop, which may be a frequent molecular target in CHD.	Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia; Univ New S Wales, Fac Life Sci, Kensington, NSW 2053, Australia; Univ New S Wales, Fac Med, Kensington, NSW 2053, Australia; Inst Pasteur, Dept Dev Biol, CNRS, URA 2578, Paris, France; Garvan Inst Med Res, Sydney, NSW 2010, Australia; Univ New S Wales, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW, Australia; Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Natl Inst Genet, Div Mammalian Dev, Mishima, Shizuoka 4118540, Japan; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of New South Wales Sydney; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Garvan Institute of Medical Research; University of New South Wales Sydney; Osaka University; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Oxford; Wellcome Centre for Human Genetics	Harvey, RP (corresponding author), Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia.	r.harvey@victorchang.unsw.edu.au	Zaffran, Stéphane/S-7454-2019; Zaffran, Stéphane/I-2955-2016; Hamada, Hiroshi/N-6374-2015	Zaffran, Stéphane/0000-0002-0811-418X; Zaffran, Stéphane/0000-0002-0811-418X; Hamada, Hiroshi/0000-0002-7196-5948; Black, Brian/0000-0002-6664-8913; Harvey, Richard/0000-0002-9950-9792	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD047858] Funding Source: NIH RePORTER; NICHD NIH HHS [R21 HD047858-01, R21 HD047858, HD 047858] Funding Source: Medline; Wellcome Trust [059312] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission)		Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elliott DA, 2003, J AM COLL CARDIOL, V41, P2072, DOI 10.1016/S0735-1097(03)00420-0; Elliott DA, 2006, DEVELOPMENT, V133, P1311, DOI 10.1242/dev.02305; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Hu TH, 2004, DEVELOPMENT, V131, P5491, DOI 10.1242/dev.01399; Jay PY, 2004, J CLIN INVEST, V113, P1130, DOI 10.1172/JCI200419846; Kelly RG, 1997, DEV BIOL, V187, P183, DOI 10.1006/dbio.1997.8577; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kelly RG, 2005, TRENDS CARDIOVAS MED, V15, P51, DOI 10.1016/j.tcm.2005.02.001; Liberatore CM, 2002, DEV BIOL, V244, P243, DOI 10.1006/dbio.2002.0604; Lien CL, 2002, DEV BIOL, V244, P257, DOI 10.1006/dbio.2002.0603; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; McElhinney DB, 2003, J AM COLL CARDIOL, V42, P1650, DOI 10.1016/j.jacc.2003.05.004; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Ross RS, 1996, DEVELOPMENT, V122, P1799; Saga Y, 1999, DEVELOPMENT, V126, P3437; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Shiratori H, 2001, MOL CELL, V7, P137, DOI 10.1016/S1097-2765(01)00162-9; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Tanaka M, 2001, MOL CELL BIOL, V21, P4391, DOI 10.1128/MCB.21.13.4391-4398.2001; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Vitelli F, 2002, DEVELOPMENT, V129, P4605; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Ward C, 2005, DEV BIOL, V284, P72, DOI 10.1016/j.ydbio.2005.05.003; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Yelbuz TM, 2002, CIRCULATION, V106, P504, DOI 10.1161/01.CIR.0000023044.44974.8A; Zaffran S, 2004, CIRC RES, V95, P261, DOI 10.1161/01.RES.0000136815.73623.BE; Zhang WJ, 2002, J BIOL CHEM, V277, P45435, DOI 10.1074/jbc.M208056200	41	381	399	1	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					947	959		10.1016/j.cell.2007.01.042	http://dx.doi.org/10.1016/j.cell.2007.01.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350578	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000245073400018
J	Garner, EC; Campbell, CS; Weibel, DB; Mullins, RD				Garner, Ethan C.; Campbell, Christopher S.; Weibel, Douglas B.; Mullins, R. Dyche			Reconstitution of DNA segregation driven by assembly of a prokaryotic actin homolog	SCIENCE			English	Article							DYNAMIC INSTABILITY; PLASMID; MREB	Multiple unrelated polymer systems have evolved to partition DNA molecules between daughter cells at division. To better understand polymer-driven DNA segregation, we reconstituted the three-component segregation system of the R1 plasmid from purified components. We found that the ParR/parC complex can construct a simple bipolar spindle by binding the ends of ParM filaments, inhibiting dynamic instability, and acting as a ratchet permitting incorporation of new monomers and riding on the elongating filament ends. Under steady-state conditions, the dynamic instability of unattached ParM filaments provides the energy required to drive DNA segregation.	Univ Calif San Francisco, UCB Nanomed Dev Ctr, San Francisco, CA 94158 USA; Marine Biol Lab, Physiol Course, Woods Hole, MA 02543 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of California System; University of California San Francisco; Marine Biological Laboratory - Woods Hole; University of Wisconsin System; University of Wisconsin Madison	Mullins, RD (corresponding author), Univ Calif San Francisco, UCB Nanomed Dev Ctr, San Francisco, CA 94158 USA.	dyche@mullinslab.ucsf.edu	Garner, Ethan/J-4025-2014	Garner, Ethan/0000-0003-0141-3555; Campbell, Christopher/0000-0002-3927-344X	NIGMS NIH HHS [R01GM61010, R01 GM061010-07, R01 GM061010, R01GM675287] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061010] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; GERDES K, 1986, J MOL BIOL, V190, P269, DOI 10.1016/0022-2836(86)90001-X; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; INOUE S, 1967, J GEN PHYSIOL, V50, P259, DOI 10.1085/jgp.50.6.259; Kruse T, 2006, GENE DEV, V20, P113, DOI 10.1101/gad.366606; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; MORITZ M, 1995, J CELL BIOL, V130, P1149, DOI 10.1083/jcb.130.5.1149; Theriot JA, 2000, TRAFFIC, V1, P19, DOI 10.1034/j.1600-0854.2000.010104.x; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5	15	169	172	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1270	1274		10.1126/science.1138527	http://dx.doi.org/10.1126/science.1138527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332412	Green Accepted			2022-12-28	WOS:000244564700048
J	Duster, T				Duster, Troy			Medicalisation of race	LANCET			English	Article; Proceedings Paper	Meeting on Medicalisation in the 21st Century	JUN, 2005	New York, NY				BLACKS		NYU, New York, NY 10003 USA	New York University	Duster, T (corresponding author), NYU, New York, NY 10003 USA.	troy.duster@nyu.edu						COHN JN, 1993, CIRCULATION, V87, P1; Cooper RS, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-2; Duster T, 2005, SCIENCE, V307, P1050, DOI 10.1126/science.1110303; *FOOD DRUG ADM, 2005, FDA APPR BIDIL HEART; Kahn J, 2005, NAT GENET, V37, P655, DOI 10.1038/ng0705-655; Kahn Jonathan, 2004, Yale J Health Policy Law Ethics, V4, P1; KLAG MJ, 1991, JAMA-J AM MED ASSOC, V265, P599, DOI 10.1001/jama.265.5.599; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; ZAMISAK N, 2005, WALL STR J      0504, P1; 2001, FINANCIAL TIMES 0309, P16; 2005, PR NEWSWIRE US  0111	11	35	35	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2007	369	9562					702	704		10.1016/S0140-6736(07)60320-1	http://dx.doi.org/10.1016/S0140-6736(07)60320-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	141RO	17321318				2022-12-28	WOS:000244596600034
J	Kahl, BC; Peters, G				Kahl, Barbara C.; Peters, Georg			Mayhem in the lung	SCIENCE			English	Editorial Material							RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; NECROTIZING PNEUMONIA; INFECTIONS; EMERGENCE; DISEASE; CLONE		Univ Munster, Inst Med Microbiol, D-49149 Munster, Germany	University of Munster	Kahl, BC (corresponding author), Univ Munster, Inst Med Microbiol, Domagkstr 10, D-49149 Munster, Germany.	georg.peters@uni-muenster.de		Kahl, Barbara/0000-0001-5155-3383				Adem PV, 2005, NEW ENGL J MED, V353, P1245, DOI 10.1056/NEJMoa044194; de Bentzmann S, 2004, J INFECT DIS, V190, P1506, DOI 10.1086/424521; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Vojtov N, 2002, P NATL ACAD SCI USA, V99, P10102, DOI 10.1073/pnas.152152499; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506	14	11	12	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1082	1083		10.1126/science.1139628	http://dx.doi.org/10.1126/science.1139628			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	138UA	17322047				2022-12-28	WOS:000244387600021
J	Galburt, EA; Grill, SW; Wiedmann, A; Lubkowska, L; Choy, J; Nogales, E; Kashlev, M; Bustamante, C				Galburt, Eric A.; Grill, Stephan W.; Wiedmann, Anna; Lubkowska, Lucyna; Choy, Jason; Nogales, Eva; Kashlev, Mikhail; Bustamante, Carlos			Backtracking determines the force sensitivity of RNAP II in a factor-dependent manner	NATURE			English	Article							ELONGATION-FACTOR TFIIS; POLYMERASE-II; TRANSCRIPT-CLEAVAGE; ARREST; DNA; MECHANISM; RESOLUTION; COMPLEXES; MOLECULES; BACTERIAL	RNA polymerase II ( RNAP II) is responsible for transcribing all messenger RNAs in eukaryotic cells during a highly regulated process that is conserved from yeast to human 1, and that serves as a central control point for cellular function. Here we investigate the transcription dynamics of single RNAP II molecules from Saccharomyces cerevisiae against force and in the presence and absence of TFIIS, a transcription elongation factor known to increase transcription through nucleosomal barriers(2\). Using a single-molecule dual-trap optical-tweezers assay combined with a novel method to enrich for active complexes, we found that the response of RNAP II to a hindering force is entirely determined by enzyme backtracking(3-6). Surprisingly, RNAP II molecules ceased to transcribe and were unable to recover from backtracks at a force of 7.5 +/- 2 pN, only one-third of the force determined for Escherichia coli RNAP(7,8). We show that backtrack pause durations follow a t(-3/2) power law, implying that during backtracking RNAP II diffuses in discrete base-pair steps, and indicating that backtracks may account for most of RNAP II pauses. Significantly, addition of TFIIS rescued backtracked enzymes and allowed transcription to proceed up to a force of 16.9 +/- 3.4 pN. Taken together, these results describe a regulatory mechanism of transcription elongation in eukaryotes by which transcription factors modify the mechanical performance of RNAP II, allowing it to operate against higher loads.	Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; NCI, Ctr Canc Res, Frederick, MD 21702 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bustamante, C (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu	Grill, Stephan/D-9427-2012	Galburt, Eric/0000-0003-4314-3215; Bustamante, Carlos/0000-0002-2970-0073				Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; Borukhov S, 2005, MOL MICROBIOL, V55, P1315, DOI 10.1111/j.1365-2958.2004.04481.x; BUSTAMANTE C, 1994, SCIENCE, V265, P1600; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2003, METHOD ENZYMOL, V370, P138; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; Li PTX, 2006, BIOPHYS J, V90, P250, DOI 10.1529/biophysj.105.068049; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Palangat M, 2005, P NATL ACAD SCI USA, V102, P15036, DOI 10.1073/pnas.0409405102; REINES D, 1993, P NATL ACAD SCI USA, V90, P1917, DOI 10.1073/pnas.90.5.1917; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653	28	214	221	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					820	823		10.1038/nature05701	http://dx.doi.org/10.1038/nature05701			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17361130				2022-12-28	WOS:000245626800046
J	Ono, M; Yaguchi, H; Ohkura, N; Kitabayashi, I; Nagamura, Y; Nomura, T; Miyachi, Y; Tsukada, T; Sakaguchi, S				Ono, Masahiro; Yaguchi, Hiroko; Ohkura, Naganari; Kitabayashi, Issay; Nagamura, Yuko; Nomura, Takashi; Miyachi, Yoshiki; Tsukada, Toshihiko; Sakaguchi, Shimon			Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1	NATURE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; TRANSCRIPTION FACTOR FOXP3; RUNX1 BINDING-SITE; INTERLEUKIN-2 GENE; LEUKEMIA; DIFFERENTIATION; SUSCEPTIBILITY; HEMATOPOIESIS; COOPERATION; ACTIVATION	Naturally arising CD25(+)CD4(+) regulatory T cells (T-R cells) are engaged in the maintenance of immunological self-tolerance and immune homeostasis by suppressing aberrant or excessive immune responses, such as autoimmune disease and allergy(1-3). T-R cells specifically express the transcription factor Foxp3, a key regulator of T-R-cell development and function. Ectopic expression of Foxp3 in conventional T cells is indeed sufficient to confer suppressive activity, repress the production of cytokines such as interleukin-2 (IL-2) and interferon-gamma (IFN-gamma), and upregulate T-R-cell-associated molecules such as CD25, cytotoxic T-lymphocyte-associated antigen-4, and glucocorticoid-induced TNF-receptor-family-related protein(4-7). However, the method by which Foxp3 controls these molecular events has yet to be explained. Here we show that the transcription factor AML1 ( acute myeloid leukaemia 1)/Runx1 (Runt-related transcription factor 1), which is crucially required for normal haematopoiesis including thymic T-cell development(8-11), activates IL-2 and IFN-gamma gene expression in conventional CD4(+) T cells through binding to their respective promoters. In natural T-R cells, Foxp3 interacts physically with AML1. Several lines of evidence support a model in which the interaction suppresses IL-2 and IFN-gamma production, upregulates T-R-cell-associated molecules, and exerts suppressive activity. This transcriptional control of T-R-cell function by an interaction between Foxp3 and AML1 can be exploited to control physiological and pathological T-cell-mediated immune responses.	Kyoto Univ, Grad Sch Med, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan; Natl Canc Ctr, Res Inst, Div Mol Oncol, Chuo Ku, Tokyo 1040045, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan; Natl Canc Ctr, Res Inst, Tumor Endocrinol Project, Chuo Ku, Tokyo 1040045, Japan	Kyoto University; Kyoto University; National Cancer Center - Japan; Japan Science & Technology Agency (JST); National Cancer Center - Japan	Sakaguchi, S (corresponding author), Kyoto Univ, Grad Sch Med, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan.	shimon@frontier.kyoto-u.ac.jp	Sakaguchi, Shimon/C-9535-2009; Ono, Masahiro/H-2378-2011; Kitabayashi, Issay/G-2204-2017	Ono, Masahiro/0000-0002-9284-7326; Kitabayashi, Issay/0000-0002-8409-0407				Brenner O, 2004, P NATL ACAD SCI USA, V101, P16016, DOI 10.1073/pnas.0407180101; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Kanno Y, 1998, MOL CELL BIOL, V18, P4252, DOI 10.1128/MCB.18.7.4252; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; NOVAK TJ, 1990, NUCLEIC ACIDS RES, V18, P4523, DOI 10.1093/nar/18.15.4523; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Ono M, 2006, J IMMUNOL, V176, P4748, DOI 10.4049/jimmunol.176.8.4748; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165	28	494	523	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					685	689		10.1038/nature05673	http://dx.doi.org/10.1038/nature05673			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17377532				2022-12-28	WOS:000245438300044
J	Hardie, DG				Hardie, D. Grahame			Balancing cellular energy	SCIENCE			English	Editorial Material							ACTIVATED PROTEIN-KINASE; AMP		Univ Dundee, Div Mol Physiol, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Hardie, DG (corresponding author), Univ Dundee, Div Mol Physiol, Coll Life Sci, Dundee DD1 5EH, Scotland.	d.g.hardie@dundee.ac.uk	Hardie, David/Z-1979-2019	Hardie, Grahame/0000-0002-8373-7379				Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Burwinkel B, 2005, AM J HUM GENET, V76, P1034, DOI 10.1086/430840; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Scott JW, 2007, EMBO J, V26, P806, DOI 10.1038/sj.emboj.7601542; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031	11	34	37	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1671	1672		10.1126/science.1140737	http://dx.doi.org/10.1126/science.1140737			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379794				2022-12-28	WOS:000245106900023
J	Jacobs, GH; Williams, GA; Cahill, H; Nathans, J				Jacobs, Gerald H.; Williams, Gary A.; Cahill, Hugh; Nathans, Jeremy			Emergence of novel color vision in mice engineered to express a human cone photopigment	SCIENCE			English	Article							PRIMATE; COEXPRESSION; RECEPTORS; RESPONSES; EVOLUTION; RETINA; MOUSE	Changes in the genes encoding sensory receptor proteins are an essential step in the evolution of new sensory capacities. In primates, trichromatic color vision evolved after changes in X chromosome-linked photopigment genes. To model this process, we studied knock-in mice that expressed a human long-wavelength-sensitive (L) cone photopigment in the form of an X-linked polymorphism. Behavioral tests demonstrated that heterozygous females, whose retinas contained both native mouse pigments and human L pigment, showed enhanced long-wavelength sensitivity and acquired a new capacity for chromatic discrimination. An inherent plasticity in the mammalian visual system thus permits the emergence of a new dimension of sensory experience based solely on gene-driven changes in receptor organization.	Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA; Johns Hopkins Med Sch, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Med Sch, Dept Ophthalmol, Baltimore, MD 21205 USA; Johns Hopkins Med Sch, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Med Sch, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Jacobs, GH (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	jacobs@psych.ucsb.edu		Nathans, Jeremy/0000-0001-8106-5460	NEI NIH HHS [EY002052] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002052] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALPERN M, 1953, J PHYSL, V335, P655; Boycott B, 1999, INVEST OPHTH VIS SCI, V40, P1313; Brainard DH, 2000, J OPT SOC AM A, V17, P607, DOI 10.1364/JOSAA.17.000607; Dacey DM, 1999, PROG RETIN EYE RES, V18, P737, DOI 10.1016/S1350-9462(98)00013-5; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hofer H, 2005, J NEUROSCI, V25, P9669, DOI 10.1523/JNEUROSCI.2414-05.2005; Hunt DM, 1998, VISION RES, V38, P3299, DOI 10.1016/S0042-6989(97)00443-4; Jacobs GH, 2004, VISION RES, V44, P1615, DOI 10.1016/j.visres.2004.01.016; Jacobs GH, 1996, J OPT SOC AM A, V13, P641, DOI 10.1364/JOSAA.13.000641; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Jacobs GH, 1999, J NEUROSCI, V19, P3258; Jacobs GH, 1996, P NATL ACAD SCI USA, V93, P577, DOI 10.1073/pnas.93.2.577; JACOBS GH, 1987, P NATL ACAD SCI USA, V84, P2545, DOI 10.1073/pnas.84.8.2545; Lee Barry B, 2004, Clin Exp Optom, V87, P239; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Migeon BR, 2002, CYTOGENET GENOME RES, V99, P8, DOI 10.1159/000071568; MOLLON JD, 1989, J EXP BIOL, V146, P21; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; Onishi A, 2005, ZOOL SCI, V22, P1145, DOI 10.2108/zsj.22.1145; Sagdullaev BT, 2005, VISUAL NEUROSCI, V22, P649, DOI 10.1017/S0952523805225142; Smallwood PM, 2003, P NATL ACAD SCI USA, V100, P11706, DOI 10.1073/pnas.1934712100; Smallwood PM, 2002, P NATL ACAD SCI USA, V99, P1008, DOI 10.1073/pnas.022629799; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	27	143	149	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1723	1725		10.1126/science.1138838	http://dx.doi.org/10.1126/science.1138838			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379811				2022-12-28	WOS:000245106900043
J	Biskup, C; Kusch, J; Schulz, E; Nache, V; Schwede, F; Lehmann, F; Hagen, V; Benndorf, K				Biskup, Christoph; Kusch, Jana; Schulz, Eckhard; Nache, Vasilica; Schwede, Frank; Lehmann, Frank; Hagen, Volker; Benndorf, Klaus			Relating ligand binding to activation gating in CNGA2 channels	NATURE			English	Article							NUCLEOTIDE-GATED CHANNEL; FUNCTIONAL EXPRESSION; STRUCTURAL BASIS; MECHANISM; EFFICACY; STOICHIOMETRY	Cyclic nucleotide-gated (CNG) ion channels mediate sensory signal transduction in photoreceptors and olfactory cells. Structurally, CNG channels are heterotetramers composed of either two or three homologue subunits(1-4). Although it is well established that activation is a cooperative process of these subunits(5), it remains unknown whether the cooperativity is generated by the ligand binding, the gating, or both, and how the subunits interact. In this study, the action of homotetrameric olfactory-type CNGA2 channels(6) was studied in inside-out membrane patches by simultaneously determining channel activation and ligand binding, using the fluorescent cGMP analogue 8-DY547-cGMP as the ligand. At concentrations of 8-DY547-cGMP <1 mu M, steady-state binding was larger than steady-state activation, whereas at higher concentrations it was smaller, generating a crossover of the steady-state relationships. Global analysis of these relationships together with multiple activation time courses following cGMP jumps(7) showed that four ligands bind to the channels and that there is significant interaction between the binding sites. Among the binding steps, the second is most critical for channel opening: its association constant is three orders of magnitude smaller than the others and it triggers a switch from a mostly closed to a maximally open state. These results contribute to unravelling the role of the subunits in the cooperative mechanism of CNGA2 channel activation and could be of general relevance for the action of other ion channels and receptors.	Univ Jena, Inst Physiol 2, D-07740 Jena, Germany; Fachhsch Schmalkalden, Fachbereich Elektrotech, D-98574 Schmalkalden, Germany; BIOLOG Life Sci Inst, D-28199 Bremen, Germany; Dyomics GmbH, D-07745 Jena, Germany; Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	Friedrich Schiller University of Jena; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Benndorf, K (corresponding author), Univ Jena, Inst Physiol 2, D-07740 Jena, Germany.	klaus.benndorf@mti.uni-jena.de	Horstmann, Britta/C-2154-2008; Kusch, Jana/ABC-9738-2020	Kusch, Jana/0000-0001-7206-8133; Benndorf, Klaus/0000-0002-0707-4083				Beato M, 2004, J NEUROSCI, V24, P895, DOI 10.1523/JNEUROSCI.4420-03.2004; Bonigk W, 1999, J NEUROSCI, V19, P5332; Bradley J, 2004, NAT NEUROSCI, V7, P705, DOI 10.1038/nn1266; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Colquhoun D, 2006, BRIT J PHARMACOL, V147, pS17, DOI 10.1038/sj.bjp.0706502; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Edsall J. T., 1958, BIOPHYSICAL CHEM; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Li J, 1999, MOL PHARMACOL, V55, P883; Li J, 1997, Q REV BIOPHYS, V30, P177, DOI 10.1017/S0033583597003326; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Liu J, 2000, NEURON, V28, P899, DOI 10.1016/S0896-6273(00)00162-8; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nache V, 2005, J PHYSIOL-LONDON, V569, P91, DOI 10.1113/jphysiol.2005.092304; PICONES A, 1995, J PHYSIOL-LONDON, V485, P699, DOI 10.1113/jphysiol.1995.sp020763; Ruiz M, 1999, J GEN PHYSIOL, V113, P873, DOI 10.1085/jgp.113.6.873; Ruiz M, 1997, NATURE, V389, P389, DOI 10.1038/38744; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Trudeau MC, 2004, J GEN PHYSIOL, V124, P211, DOI 10.1085/jgp.200409101; Wyman J, 1990, BINDING LINKAGE FUNC; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zheng Jie, 2003, Sci STKE, V2003, pPL7, DOI 10.1126/stke.2003.176.pl7; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201	30	90	91	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					440	443		10.1038/nature05596	http://dx.doi.org/10.1038/nature05596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17322905				2022-12-28	WOS:000245079500040
J	Eshaghian, S; Kaul, S; Amin, S; Shah, PK; Diamond, GA				Eshaghian, Shervin; Kaul, Sanjay; Amin, Sameer; Shah, Prediman K.; Diamond, George A.			Role of clopidogrel in managing atherothrombotic cardiovascular disease	ANNALS OF INTERNAL MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ST-SEGMENT ELEVATION; ACUTE MYOCARDIAL-INFARCTION; ELUTING STENT IMPLANTATION; PLACEBO-CONTROLLED TRIAL; ASSOCIATION TASK-FORCE; LONG-TERM OUTCOMES; FIBRINOLYTIC THERAPY; PLATELET REACTIVITY; AMERICAN-COLLEGE	Aspirin is the most widely used antiplatelet agent for preventing and treating vascular events. The thienopyridine derivatives, ticlopidine and clopidogrel, are a suitable alternative in patients who are intolerant to aspirin, and clopiclogrel exhibits better tolerability than ticlopidine. The available evidence from randomized trials indicates that dual therapy with clopidogrel and aspirin is modestly but significantly more effective than aspirin in preventing serious vascular events. It is also associated with a favorable benefit-risk profile in patients at high risk (especially in acute coronary syndromes and after stenting). In patients at low risk (stable cardiovascular disease), however, the bleeding risk of dual therapy exceeds its potential benefit. The dose and duration of pretreatment before stenting, the optimal duration of treatment after drug-eluting stent implantation, concurrent administration of platelet glycoprotein IIb/IIIa inhibitors, and the exact mechanism and clinical relevance of clopiclogrel resistance are unclear.	Univ Calif Los Angeles, Div Cardiol, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kaul, S (corresponding author), Univ Calif Los Angeles, Div Cardiol, Cedars Sinai Med Ctr, Room 5536,S Tower,8700 Beverly Blvd, Los Angeles, CA 90048 USA.	kaul@cshs.org						*AM COLL CARD, 2004, J AM COLL CARDIOL, V44, P671; *AM COLL CARD AM H, 2006, J AM COLL CARDIOL, V47, P216; *BASKET LATE INV, 2006, J AM COLL CARDIOL, V48, P2584; Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; Bertrand ME, 2000, CIRCULATION, V102, P624, DOI 10.1161/01.CIR.102.6.624; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bhatt DL, 2002, J AM COLL CARDIOL, V39, P9, DOI 10.1016/S0735-1097(01)01713-2; Braunwald E, 2002, CIRCULATION, V106, P1893, DOI 10.1161/01.CIR.0000037106.76139.53; Casella Gianni, 2003, Ital Heart J, V4, P677; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; *CLOP UNST ANG PRE, 2004, CIRCULATION, V110, P1202; Diamond GA, 2004, J AM COLL CARDIOL, V43, P1929, DOI 10.1016/j.jacc.2004.01.035; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Fisher LD, 2001, AM HEART J, V141, P26, DOI 10.1067/mhj.2001.111262; Gachet C, 2001, THROMB HAEMOSTASIS, V86, P222; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1827, DOI 10.1016/j.jacc.2005.07.056; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; *ISAR REACT STUD I, 2004, J AM COLL CARDIOL, V44, P2133; Kapetanakis EI, 2006, CIRCULATION, V113, P1667, DOI 10.1161/CIRCULATIONAHA.105.571828; Kastrati A, 2006, JAMA-J AM MED ASSOC, V295, P1531, DOI 10.1001/jama.295.13.joc60034; Kastrati A, 2004, NEW ENGL J MED, V350, P232, DOI 10.1056/NEJMoa031859; Kuchulakanti PK, 2006, CIRCULATION, V113, P1108, DOI 10.1161/CIRCULATIONAHA.105.600155; Lange RA, 2005, NEW ENGL J MED, V352, P1248, DOI 10.1056/NEJMe058050; Matetzky S, 2004, CIRCULATION, V109, P3171, DOI 10.1161/01.CIR.0000130846.46168.03; Mehilli J, 2004, CIRCULATION, V110, P3627, DOI 10.1161/01.CIR.0000148956.93631.4D; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Mueller C, 2003, J AM COLL CARDIOL, V41, P969, DOI 10.1016/S0735-1097(02)02974-1; Muller C, 2000, CIRCULATION, V101, P590, DOI 10.1161/01.CIR.101.6.590; Purkayastha S, 2006, HEART, V92, P531, DOI 10.1136/hrt.2004.058396; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Taniuchi M, 2001, CIRCULATION, V104, P539, DOI 10.1161/hc3001.093435; *TRUE STUD INV, 2006, INT J CARDIOL, V108, P406; Tsai TT, 2006, CIRCULATION, V114, pE362, DOI 10.1161/CIRCULATIONAHA.106.630210; *US FDA, FDA APPR NEW MED US; van der Heijden DJ, 2004, J AM COLL CARDIOL, V44, P20, DOI 10.1016/j.jacc.2004.02.056; Wang TH, 2006, EUR HEART J, V27, P647, DOI 10.1093/eurheartj/ehi684; Wenaweser P, 2005, EUR HEART J, V26, P1180, DOI 10.1093/eurheartj/ehi135; WENAWESER P, 2006, EUR SOC CARD SCI C 2; Wolak A, 2005, INT J CARDIOL, V103, P293, DOI 10.1016/j.ijcard.2004.08.061; Yusuf S, 2001, NEW ENGL J MED, V345, P494	48	32	38	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2007	146	6					434	441		10.7326/0003-4819-146-6-200703200-00008	http://dx.doi.org/10.7326/0003-4819-146-6-200703200-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150CC	17371888				2022-12-28	WOS:000245192200005
J	Collman, JP; Devaraj, NK; Decreau, RA; Yang, Y; Yan, YL; Ebina, W; Eberspacher, TA; Chidsey, CED				Collman, James P.; Devaraj, Neal K.; Decreau, Richard A.; Yang, Ying; Yan, Yi-Long; Ebina, Wataru; Eberspacher, Todd A.; Chidsey, Christopher E. D.			A cytochrome c oxidase model catalyzes oxygen to water reduction under rate-limiting electron flux	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; GOLD ELECTRODES; DIOXYGEN REDUCTION; TERMINAL ALKYNES; SITE; O-2; SURFACES; ANALOGS; BINDING; METALLOPORPHYRINS	We studied the selectivity of a functional model of cytochrome c oxidase's active site that mimics the coordination environment and relative locations of Fe-a3, Cu-B, and Tyr(244). To control electron flux, we covalently attached this model and analogs lacking copper and phenol onto self-assembled monolayer-coated gold electrodes. When the electron transfer rate was made rate limiting, both copper and phenol were required to enhance selective reduction of oxygen to water. This finding supports the hypothesis that, during steady-state turnover, the primary role of these redox centers is to rapidly provide all the electrons needed to reduce oxygen by four electrons, thus preventing the release of toxic partially reduced oxygen species.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Collman, JP (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	jpc@stanford.edu; chidsey@stanford.edu	DECREAU, Richard/I-4568-2012; Devaraj, Neal/B-4712-2014	DECREAU, Richard/0000-0003-4205-0092; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM017880, R37GM017880] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-17880-35, R01 GM017880, R01 GM017880-35] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alleman KS, 1996, J PHYS CHEM-US, V100, P17050, DOI 10.1021/jp962193b; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; Boulatov R, 2002, J AM CHEM SOC, V124, P11923, DOI 10.1021/ja026179q; Brunori M, 2005, J INORG BIOCHEM, V99, P324, DOI 10.1016/j.jinorgbio.2004.10.011; Cha SK, 2004, B KOREAN CHEM SOC, V25, P786; CHAZOTTE B, 1989, J BIOL CHEM, V264, P4978; CHIDSEY CED, 1991, SCIENCE, V251, P919, DOI 10.1126/science.251.4996.919; Collman JP, 2004, J ORG CHEM, V69, P3546, DOI 10.1021/jo0499625; Collman JP, 2006, LANGMUIR, V22, P2457, DOI 10.1021/la052947q; Collman JP, 2005, INORG CHEM, V44, P9628, DOI 10.1021/ic0516717; Collman JP, 2004, LANGMUIR, V20, P1051, DOI 10.1021/la0362977; Collman JP, 2002, INORG CHEM, V41, P2282, DOI 10.1021/ic011191p; Collman JP, 2002, ANGEW CHEM INT EDIT, V41, P3487, DOI 10.1002/1521-3773(20020916)41:18<3487::AID-ANIE3487>3.0.CO;2-Y; Collman JP, 1997, SCIENCE, V275, P949, DOI 10.1126/science.275.5302.949; COLLMAN JP, 1994, J AM CHEM SOC, V116, P9783, DOI 10.1021/ja00100a067; Collman JP, 1999, J AM CHEM SOC, V121, P1387, DOI 10.1021/ja983351a; Creager S, 1999, J AM CHEM SOC, V121, P1059, DOI 10.1021/ja983204c; CREAGER SE, 1993, LANGMUIR, V9, P2330, DOI 10.1021/la00033a014; Das TK, 1998, BIOCHEMISTRY-US, V37, P14471, DOI 10.1021/bi981500w; Degefa TH, 2004, J ELECTROANAL CHEM, V574, P49, DOI 10.1016/j.jelechem.2004.07.026; Devaraj NK, 2006, J PHYS CHEM B, V110, P15955, DOI 10.1021/jp057416p; FINKLEA HO, 1992, J AM CHEM SOC, V114, P3173, DOI 10.1021/ja00035a001; GUPTE SS, 1988, J BIOL CHEM, V263, P5248; Haas AS, 2001, J PHYS CHEM B, V105, P11351, DOI 10.1021/jp011834m; HUTCHISON JE, 1993, LANGMUIR, V9, P3277, DOI 10.1021/la00035a084; KATZ E, 1994, J ELECTROANAL CHEM, V368, P87, DOI 10.1016/0022-0728(93)03039-R; Lee JK, 2004, LANGMUIR, V20, P3844, DOI 10.1021/la049748b; MOGI T, 1995, FEBS LETT, V370, P259; Morgan JE, 2001, BIOCHEMISTRY-US, V40, P6882, DOI 10.1021/bi010246w; Offord DA, 1998, J AM CHEM SOC, V120, P4478, DOI 10.1021/ja973528l; Pfitzner U, 1998, J BIOENERG BIOMEMBR, V30, P89, DOI 10.1023/A:1020515713103; Proshlyakov DA, 2000, SCIENCE, V290, P1588, DOI 10.1126/science.290.5496.1588; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; SAWYER DT, 1981, ACCOUNTS CHEM RES, V14, P393, DOI 10.1021/ar00072a005; Shikama K, 1998, CHEM REV, V98, P1357, DOI 10.1021/cr970042e; Sigal GB, 1997, LANGMUIR, V13, P2749, DOI 10.1021/la961024f; Sigman JA, 2000, J AM CHEM SOC, V122, P8192, DOI 10.1021/ja0015343; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; ZAK J, 1993, LANGMUIR, V9, P2772, DOI 10.1021/la00035a006; Zou SZ, 2002, LANGMUIR, V18, P3241, DOI 10.1021/la011444r	41	412	414	5	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1565	1568		10.1126/science.1135844	http://dx.doi.org/10.1126/science.1135844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363671	Green Accepted			2022-12-28	WOS:000244934800049
J	Rodriguez-Trelles, F; Rodriguez, MA				Rodriguez-Trelles, Francisco; Rodriguez, Miguel Angel			Comment on "Global genetic change tracks global climate warming in Drosophila subobscura"	SCIENCE			English	Editorial Material							INVERSION POLYMORPHISM; POPULATIONS		Univ Santiago de Compostela, Hosp Clin Univ, Grp Med Xeriom, Santiago 15706, Spain; Univ Alcala De Henares, Dept Ecol, Madrid 28871, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Universidad de Alcala	Rodriguez-Trelles, F (corresponding author), Univ Santiago de Compostela, Hosp Clin Univ, Grp Med Xeriom, Santiago 15706, Spain.	ftrelles@usc.es	Rodriguez, Miguel A/A-3409-2011; Rodriguez-Trelles, Francisco/E-7666-2016	Rodriguez, Miguel A/0000-0002-4082-2995; Rodriguez-Trelles, Francisco/0000-0001-6279-3630				Balanya J, 2004, J ZOOL SYST EVOL RES, V42, P191, DOI 10.1111/j.1439-0469.2004.00274.x; Balanya J, 2006, SCIENCE, V313, P1773, DOI 10.1126/science.1131002; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Dobzhansky T, 1943, GENETICS, V28, P162; Hoffmann AA, 2004, TRENDS ECOL EVOL, V19, P482, DOI 10.1016/j.tree.2004.06.013; KRINBAS CB, 1992, DROSOPHILA INVERSION; Levitan M, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-4; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Rodriguez-Trelles F, 1998, EVOL ECOL, V12, P829, DOI 10.1023/A:1006546616462; RodriguezTrelles F, 1996, GENETICS, V142, P179; RODRIGUEZTRELLES F, 1998, CONSERV ECOL, V2	12	12	12	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1497	1497		10.1126/science.1136298	http://dx.doi.org/10.1126/science.1136298			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363646	Green Submitted			2022-12-28	WOS:000244934800019
J	DuBard, CA; Massing, MW				DuBard, C. Annette; Massing, Mark W.			Trends in emergency Medicaid expenditures for recent and undocumented immigrants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SAFETY NET PROVIDERS; HEALTH-INSURANCE; UNITED-STATES; PREGNANCY OUTCOMES; CITIZENSHIP STATUS; BIRTH OUTCOMES; FOREIGN-BORN; PRIMARY-CARE; ACCESS; US	Context Undocumented immigrants and legal immigrants who have been in the United States less than 5 years are excluded from Medicaid eligibility, with the exception of limited coverage for emergency conditions ( Emergency Medicaid). New immigrant population growth has been rapid in recent years, but little is known about use of health services by this group or the conditions for which Emergency Medicaid coverage has been applied. Objective To describe Emergency Medicaid use by recent and undocumented immigrants including patient characteristics, diagnoses, and recent spending trends in North Carolina, a state with a rapidly increasing population of undocumented immigrants. Design, Setting, and Patients Descriptive analysis of North Carolina Medicaid administrative data for all claims reimbursed under Emergency Medicaid eligibility criteria 2001 through 2004 in North Carolina, a state with high immigration from Mexico and Latin America. Patients are recent and undocumented immigrants who meet categorical and income criteria for Medicaid coverage, but are excluded from full coverage due to legal status. Main Outcome Measures Patient characteristics, hospitalizations, diagnoses, and Medicaid spending for emergency care. Results A total of 48 391 individuals received services reimbursed under Emergency Medicaid during the 4-year period of this study. The patient population was 99% undocumented, 93% Hispanic, 95% female, and 89% in the 18- to 40-year age group. Total spending increased by 28% from 2001 through 2004, with more rapid spending increases among elderly (98%) and disabled (82%) patients. In 2004, childbirth and complications of pregnancy accounted for 82% of spending and 91% of hospitalizations. Injury, renal failure, gastrointestinal disease, and cardiovascular conditions were also prevalent. Conclusions Childbirth and complications of pregnancy account for the majority of Emergency Medicaid spending for undocumented immigrants in North Carolina. Spending for elderly and disabled patients, however, is increasing at a faster rate. Among nonpregnant immigrants, injuries, other acute emergencies, and severe complications of chronic disease are major contributors to Emergency Medicaid use.	Univ N Carolina, Sch Med, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA; N Carolina Dept Hlth & Human Serv, Div Med Assistance, Raleigh, NC USA; Carolinas Ctr Med Excellence, Cary, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	DuBard, CA (corresponding author), Univ N Carolina, Sch Med, Cecil G Sheps Ctr Hlth Serv Res, CB 7590, Chapel Hill, NC 27599 USA.	adubard@schsr.unc.edu	Schiaffino, Melody K/E-9629-2011					[Anonymous], CLIN CLASSIFICATIONS; Berk M L, 2001, J Immigr Health, V3, P151; Berk ML, 2000, HEALTH AFFAIR, V19, P51, DOI 10.1377/hlthaff.19.4.51; Blewett LA, 2004, J RURAL HEALTH, V20, P237, DOI 10.1111/j.1748-0361.2004.tb00034.x; Brown R, 2000, RACIAL ETHNIC DISPAR; Buescher Paul A, 2003, N C Med J, V64, P97; CAPPS R, 2002, DISPERSAL IMMIGRANTS; Carr DD, 2006, PROF CASE MANAG, V11, P195; Carrasquillo O, 2000, AM J PUBLIC HEALTH, V90, P917, DOI 10.2105/AJPH.90.6.917; Carrasquillo O, 2004, PREV MED, V39, P943, DOI 10.1016/j.ypmed.2004.03.033; Carrasquillo O, 2003, AM J PUBLIC HEALTH, V93, P1680, DOI 10.2105/AJPH.93.10.1680; Castel LD, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-1; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P1091; Coritsidis GN, 2004, AM J KIDNEY DIS, V43, P424, DOI 10.1053/j.ajkd.2003.11.004; Cunningham P, 2006, HLTH COVERAGE ACCESS; Echeverria SE, 2006, MED CARE, V44, P788, DOI 10.1097/01.mlr.0000215863.24214.41; Epstein AJ, 2001, HEALTH SERV RES, V36, P405; FIX M, 2002, 0203 URB I; Forna F, 2003, INT J GYNECOL OBSTET, V83, P257, DOI 10.1016/S0020-7292(03)00307-2; FREMSTAD S, 2004, COVERING NEW AM REV; *GAO, 2004, GAO04472; Goel MS, 2003, J GEN INTERN MED, V18, P1028, DOI 10.1111/j.1525-1497.2003.20807.x; Goldman DP, 2005, HEALTH AFFAIR, V24, P1640, DOI 10.1377/hlthaff.24.6.1640; Guendelman S, 2001, HEALTH AFFAIR, V20, P257, DOI 10.1377/hlthaff.20.1.257; Hadley J, 2004, HEALTH SERV RES, V39, P1527, DOI 10.1111/j.1475-6773.2004.00302.x; Horwitz SM, 2005, ACAD EMERG MED, V12, P647, DOI 10.1197/j.aem.2005.02.015; JAPSEN B, 2006, CHICAGO TRIBUNE 1022, P1; *KAIS COMM MED UN, GROWTH UN AM OUTP FE; *KAIS COMM MED UN, 2004, HLTH INS COV AM; *KAIS COMM MED UN, ROL EMPL SPONS HLTH; Ku L, 2001, HEALTH AFFAIR, V20, P247, DOI 10.1377/hlthaff.20.1.247; Ku L., 2003, RACE ETHNICITY IMMIG; Lu MC, 2000, AM J OBSTET GYNECOL, V182, P233, DOI 10.1016/S0002-9378(00)70518-7; Mohanty SA, 2005, AM J PUBLIC HEALTH, V95, P1431, DOI 10.2105/AJPH.2004.044602; *N CAR DEP HLTH HU, FAM CHILDR MED MA 33; *N CAR DIV MED ASS, MED STAT; *NAT IMM LAW CTR, 2006, UPD PAG GUID IMM EL; Passel JS, 2005, ESTIMATES SIZE CHARA; Reed MM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-100; Rosenberg TJ, 2005, J NATL MED ASSOC, V97, P550; SCHUR C, RUNNING PLACE JOB CH; Singh GK, 1996, AM J PUBLIC HEALTH, V86, P837, DOI 10.2105/AJPH.86.6.837; Starfield B, 2004, PEDIATRICS, V113, P1493; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; Wingate MS, 2006, SOC SCI MED, V62, P491, DOI 10.1016/j.socscimed.2005.06.015	45	95	95	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2007	297	10					1085	1092		10.1001/jama.297.10.1085	http://dx.doi.org/10.1001/jama.297.10.1085			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	145KZ	17356029	Bronze			2022-12-28	WOS:000244865200022
J	Kendall, M; Harris, F; Boyd, K; Sheikh, A; Murray, SA; Brown, D; Mallinson, I; Kearney, N; Worth, A				Kendall, Marilyn; Harris, Fiona; Boyd, Kirsty; Sheikh, Aziz; Murray, Scott A.; Brown, Duncan; Mallinson, Ian; Kearney, Nora; Worth, Allison			Key challenges and ways forward in researching the "good death": qualitative in-depth interview and focus group study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARE; CANCER; VIEWS; NEED	Objective To understand key challenges in researching end of life issues and identify ways of overcoming these. Design Qualitative study involving in-depth interviews with researchers and focus groups with people affected by cancer. Participants An international sample of 32 researchers; seven patients with experience of cancer; and four carers in south east Scotland. Results Researchers highlighted the difficulty of defining, the end of life, overprotective gatekeeping by ethics committees and clinical staff, the need to factor in high attrition rates associated with deterioration or death, and managing the emotions of participants and research staff. People affected by cancer and researchers suggested that many people nearing the end of life do want to be offered the chance to participate in research, provided it is conducted sensitively. Although such research can be demanding, most researchers believed it to be no more problematic than many other areas of research and that the challenges identified can be overcome. Conclusions The continuing taboos around death and dying act as barriers to the commissioning and conduct of end of life research. Some people facing death, however, may want to participate in research and should be allowed to do so. Ethics committees and clinical staff must balance understandable concern about non-maleficence with the right of people with advanced illness to participate in research. Despite the inherent difficulties, end of life research can be conducted with ethical and methodological rigour. Adequate psychological support must be provided for participants, researchers, and transcribers.	Univ Edinburgh, Primary Palliat Care Res Grp, Div Community Hlth Sci, Gen Practice Sect, Edinburgh EH8 9DX, Midlothian, Scotland; St Columbas Hosp, Edinburgh EH5 3RW, Midlothian, Scotland; Univ Stirling, Canc Care Res Ctr, Dept Nursing & Midwifery, Stirling FK9 4LA, Scotland	University of Edinburgh; University of Edinburgh; University of Stirling	Kendall, M (corresponding author), Univ Edinburgh, Primary Palliat Care Res Grp, Div Community Hlth Sci, Gen Practice Sect, Edinburgh EH8 9DX, Midlothian, Scotland.	Marilyn.Kendall@ed.ac.uk	Sheikh, Aziz/D-2818-2009; Harris, Fiona/B-5633-2008	Sheikh, Aziz/0000-0001-7022-3056; Harris, Fiona/0000-0003-3258-5624; Boyd, Kirsty/0000-0002-5526-1078				Addington-Hall J, 2002, EUR J CANCER CARE, V11, P220, DOI 10.1046/j.1365-2354.2002.00343.x; *ASS SOC ANTHR, ETH GUID GOOD RES PR; Beaver K., 1999, INT J PALLIAT NURS, V5, P13, DOI [10.12968/ijpn.1999.5.1.9926, DOI 10.12968/IJPN.1999.5.1.9926]; Bowling A, 2000, BRIT MED J, V320, P1205; *BRIT SOC ASS, STAT ETH PRACT; Clark J, 2003, BRIT MED J, V327, P174, DOI 10.1136/bmj.327.7408.174; Cook AM, 2002, PALLIATIVE MED, V16, P163, DOI 10.1191/0269216302pm551xx; Entwistle V, 2002, EUR J CANCER CARE, V11, P232, DOI 10.1046/j.1365-2354.2002.00344.x; Gray RE, 2003, QUAL INQ, V9, P254, DOI 10.1177/1077800402250957; Gray Ross, 2000, Health Expect, V3, P137, DOI 10.1046/j.1369-6513.2000.00071.x; Harris FM, 2005, WHAT ARE BEST WAYS S; Krishnasamy M, 2000, PALLIATIVE MED, V14, P410, DOI 10.1191/026921600701536246; Lawton J, 2001, QUAL HEALTH RES, V11, P693, DOI 10.1177/104973201129119389; Lee R.M., 1993, DOING RES SENSITIVE; Riley J, 2005, LANCET, V365, P735; Rose K, 1998, QUAL HEALTH RES, V8, P556, DOI 10.1177/104973239800800409; ROWLING L, 1999, MORTALITY, V14, P167; Seale C, 1998, CONSTRUCTING DEATH S; Seamark DA, 2000, PALLIATIVE MED, V14, P55, DOI 10.1191/026921600674088597; Seymour J, 2002, EUR J CANCER CARE, V11, P215, DOI 10.1046/j.1365-2354.2002.00342.x; Seymour J, 2005, INT J PALLIAT NURS, V11, P240, DOI 10.12968/ijpn.2005.11.5.240; Woods S, 2000, NURS ETHICS, V7, P314, DOI 10.1191/096973300676700359	22	80	80	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2007	334	7592					521	524		10.1136/bmj.39097.582639.55	http://dx.doi.org/10.1136/bmj.39097.582639.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148VV	17329313	Bronze, Green Published			2022-12-28	WOS:000245106400042
J	Mito, Y; Henikoff, JG; Henikoff, S				Mito, Yoshiko; Henikoff, Jorja G.; Henikoff, Steven			Histone replacement marks the boundaries of cis-regulatory domains	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; BITHORAX COMPLEX; GENE-EXPRESSION; CHROMATIN; PROTEINS; H3.3; DISPLACEMENT; TRANSCRIPTION; MAINTENANCE; PATTERNS	Cellular memory is maintained at homeotic genes by cis-regulatory elements whose mechanism of action is unknown. We have examined chromatin at Drosophila homeotic gene clusters by measuring, at high resolution, levels of histone replacement and nucleosome occupancy. Homeotic gene clusters display conspicuous peaks of histone replacement at boundaries of cis-regulatory domains superimposed over broad regions of low replacement. Peaks of histone replacement closely correspond to nuclease-hypersensitive sites, binding sites for Polycomb and trithorax group proteins, and sites of nucleosome depletion. Our results suggest the existence of a continuous process that disrupts nucleosomes and maintains accessibility of cis-regulatory elements.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Washington, Cell & Mol Biol Program, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave, Seattle, WA 98109 USA.	steveh@fhcrc.org		Henikoff, Steven/0000-0002-7621-8685				Barges S, 2000, DEVELOPMENT, V127, P779; BISISIC D, 2006, EMBO J, V25, P798; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Brock HW, 2005, DEV DYNAM, V232, P633, DOI 10.1002/dvdy.20298; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Ficz G, 2005, DEVELOPMENT, V132, P3963, DOI 10.1242/dev.01950; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jin C, 2006, P NATL ACAD SCI USA, V103, P574, DOI 10.1073/pnas.0509974103; KARCH F, 1994, NUCLEIC ACIDS RES, V22, P3138, DOI 10.1093/nar/22.15.3138; Leibovitch BA, 2002, MOL CELL BIOL, V22, P6148, DOI 10.1128/MCB.22.17.6148-6157.2002; Maeda RK, 2006, DEVELOPMENT, V133, P1413, DOI 10.1242/dev.02323; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mohd-Sarip A, 2006, MOL CELL, V24, P91, DOI 10.1016/j.molcel.2006.08.007; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Platero JS, 1998, J CELL BIOL, V140, P1297; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Schwartz YB, 2005, MOL CELL BIOL, V25, P432, DOI 10.1128/MCB.25.1.432-439.2005; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Sun FL, 2004, MOL CELL BIOL, V24, P8210, DOI 10.1128/MCB.24.18.8210-8220.2004; Wirbelauer C, 2005, GENE DEV, V19, P1761, DOI 10.1101/gad.347705; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706	25	219	227	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1408	1411		10.1126/science.1134004	http://dx.doi.org/10.1126/science.1134004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347439				2022-12-28	WOS:000244752200033
J	Ramirez, AP				Ramirez, Arthur P.			Oxide electronics emerge	SCIENCE			English	Editorial Material							ZNO; MODULATION		Alcatel Lucent, Bell Labs, Murray Hill, NJ 07974 USA	Alcatel-Lucent; AT&T	Ramirez, AP (corresponding author), Alcatel Lucent, Bell Labs, 600 Mt Ave, Murray Hill, NJ 07974 USA.	apr@bell-labs.com	Ramirez, Arthur/HGD-6619-2022					ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Arden W, 2006, MAT SCI ENG B-SOLID, V134, P104, DOI 10.1016/j.mseb.2006.07.004; Cho A. Y., 1975, Progress in Solid State Chemistry, V10, P157, DOI 10.1016/0079-6786(75)90005-9; LAUGHLIN RB, 1981, PHYS REV B, V23, P5632, DOI 10.1103/PhysRevB.23.5632; Laughlin RB, 2000, P NATL ACAD SCI USA, V97, P28, DOI 10.1073/pnas.97.1.28; Look DC, 1999, PHYS REV LETT, V82, P2552, DOI 10.1103/PhysRevLett.82.2552; Look DC, 2001, MAT SCI ENG B-SOLID, V80, P383, DOI 10.1016/S0921-5107(00)00604-8; Minne SC, 1995, APPL PHYS LETT, V67, P3918, DOI 10.1063/1.115317; Novoselov KS, 2007, SCIENCE, V315, P1379, DOI 10.1126/science.1137201; Ohtomo A, 2002, NATURE, V419, P378, DOI 10.1038/nature00977; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Tsukazaki A, 2007, SCIENCE, V315, P1388, DOI 10.1126/science.1137430; Tsukazaki A, 2005, NAT MATER, V4, P42, DOI 10.1038/nmat1284; Vanheusden K, 1996, J APPL PHYS, V79, P7983, DOI 10.1063/1.362349; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Zhou C, 1997, APPL PHYS LETT, V70, P598, DOI 10.1063/1.118285	17	118	120	1	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1377	1378		10.1126/science.1138578	http://dx.doi.org/10.1126/science.1138578			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347433				2022-12-28	WOS:000244752200022
J							US Preventive Services Task Force	Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: US preventive services task force recommendation statement	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-DOSE ASPIRIN; LONG-TERM USE; REDUCED RISK; NATION; METAANALYSIS; ADENOMAS	This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendation and supporting scientific evidence on routine use of aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer. The complete information on which this statement is based, including evidence tables and references, is available in the accompanying articles in this issue and on the USPSTF Web site (www.preventiveservices.ahrq.gov). The USPSTF is redesigning its recommendation statement in response to feedback from primary care clinicians. The USPSTF plans to release, later in 2007, a new, updated recommendation statement that is easier to read and incorporates advances in USPSTF methodology. The recommendation statement below is an interim version that combines existing language and elements with a new format. Although the definitions of grades remain the same, other elements have been revised.	Acgy Healthcare Res & Qual, US Prevent Serv Task Force, Rockville, MD USA		Acgy Healthcare Res & Qual, US Prevent Serv Task Force, Rockville, MD USA.							*AM CANC SOC, 2005, MAJ STUD DEB ASP VIT; Chan AT, 2004, ANN INTERN MED, V140, P157, DOI 10.7326/0003-4819-140-3-200402030-00006; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Edwards JE, 2004, PAIN, V111, P286, DOI 10.1016/j.pain.2004.07.004; Friedman GD, 1998, PHARMACOEPIDEM DR S, V7, P99, DOI 10.1002/(SICI)1099-1557(199803/04)7:2<99::AID-PDS320>3.0.CO;2-0; GANN PH, 1993, JNCI-J NATL CANCER I, V85, P1220, DOI 10.1093/jnci/85.15.1220; Griffin MR, 2000, AM J EPIDEMIOL, V151, P488; Hauret KG, 2004, AM J EPIDEMIOL, V159, P983, DOI 10.1093/aje/kwh130; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; He J, 1998, JAMA-J AM MED ASSOC, V280, P1930, DOI 10.1001/jama.280.22.1930; Howe HL, 2001, J NATL CANCER I, V93, P824, DOI 10.1093/jnci/93.11.824; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; JOHNSON AG, 1994, ANN INTERN MED, V121, P289, DOI 10.7326/0003-4819-121-4-199408150-00011; Kune GA, 2007, INT J EPIDEMIOL, V36, P951, DOI 10.1093/ije/dym193; Lipworth Loren, 2004, Am J Ther, V11, P156, DOI 10.1097/00045391-200405000-00002; LOGAN RFA, 1993, BRIT MED J, V307, P285, DOI 10.1136/bmj.307.6899.285; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Morimoto LM, 2002, CANCER EPIDEM BIOMAR, V11, P1012; Ofman JJ, 2002, J RHEUMATOL, V29, P804; Peleg II, 1996, DIGEST DIS SCI, V41, P1319, DOI 10.1007/BF02088554; Reeves MJ, 1996, CANCER EPIDEM BIOMAR, V5, P955; RODERICK PJ, 1993, BRIT J CLIN PHARMACO, V35, P219, DOI 10.1111/j.1365-2125.1993.tb05689.x; Rodriguez LAG, 2000, EPIDEMIOLOGY, V11, P376, DOI 10.1097/00001648-200007000-00003; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; Rosenberg L, 1998, CANCER-AM CANCER SOC, V82, P2326, DOI 10.1002/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q; Smalley W, 1999, ARCH INTERN MED, V159, P161, DOI 10.1001/archinte.159.2.161; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; *US DEP HHS, 2005, SEER CANC STAT REV; Weir HK, 2003, JNCI-J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X	33	106	112	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2007	146	5					361	364		10.7326/0003-4819-146-5-200703060-00008	http://dx.doi.org/10.7326/0003-4819-146-5-200703060-00008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144XK	17339621				2022-12-28	WOS:000244829600005
J	Di Giorgio, A; Sofa, L; Ridolfini, MP; Alfieri, S; Doglietto, GB				Di Giorgio, Andrea; Sofa, Luigi; Ridolfini, Marco Pericoli; Alfieri, Sergio; Doglietto, Giovanni Battista			Pneumatosis cystoides intestinalis	LANCET			English	Editorial Material									Univ Cattolica Sacro Cuore, Sch Med, Dept Surg Sci, I-00168 Rome, Italy; Univ Cattolica Sacro Cuore, Sch Med, A Gemelli Univ Hosp, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Di Giorgio, A (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Dept Surg Sci, I-00168 Rome, Italy.	andrea.digiorgio@rm.unicatt.it	Alfieri, Sergio/AAB-2102-2019	Di Giorgio, Andrea/0000-0003-3981-1145; Alfieri, Sergio/0000-0002-7813-4426					0	5	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2007	369	9563					766	766		10.1016/S0140-6736(07)60362-6	http://dx.doi.org/10.1016/S0140-6736(07)60362-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143MP	17336653	Bronze			2022-12-28	WOS:000244726700033
J	Ratcliff, A; Siswantoro, H; Kenangalem, E; Maristela, R; Wuwung, RM; Laihad, F; Ebsworth, EP; Anstey, NM; Tjitra, E; Price, RN				Ratcliff, A.; Siswantoro, H.; Kenangalem, E.; Maristela, R.; Wuwung, R. M.; Laihad, F.; Ebsworth, E. P.; Anstey, N. M.; Tjitra, E.; Price, R. N.			Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison	LANCET			English	Article							UNCOMPLICATED PLASMODIUM-FALCIPARUM; DIHYDROARTEMISININ-PIPERAQUINE; SULFADOXINE-PYRIMETHAMINE; ARTEMETHER-LUMEFANTRINE; CHLOROQUINE; PHARMACOKINETICS; EFFICACY; MEFLOQUINE; CHILDREN; FAILURE	Background The burden of Plasmodium vivax infections has been underappreciated, especially in southeast Asia where chloroquine resistant strains have emerged. Our aim was to compare the safety and efficacy of dihydroartemisinin-piperaquine with that of artemether-lumefantrine in patients with uncomplicated malaria caused by multidrug-resistant P falciparum and P vivax. Methods 774 patients in southern Papua, Indonesia, with slide-confirmed malaria were randomly assigned to receive either artemether-lumefantrine or dihydroartemisinin-piperaquine and followed up for at least 42 days. The primary endpoint was the overall cumulative risk of parasitological failure at day 42 with a modified intention-to-treat analysis. This trial is registered with ClinicalTrials.gov, trial number 00157833. Findings Of the 754 evaluable patients enrolled, 466 had infections with P falciparum, 175 with P vivax, and 113 with a mixture of both species. The overall risk of failure at day 42 was 43% (95% CI 38-48) for artemether-lumefantrine and 19% (14-23) for dihydroartemisinin-piperaquine (hazard ratio=3.0, 95% CI 2.2-4. 1, p<0.0001). After correcting for reinfections, the risk of recrudescence of P falciparum was 4.4% (2.6-6.2) with no difference between regimens. Recurrence of vivax occurred in 38% (33-44) of patients given artemether-lumefantrine compared with 10% (6.9-14.0) given dihydroartemisinin-piperaquine (p<0.0001). At the end of the study, patients receiving dihydroartemisinin-piperaquine were 2.0 times (1.2-3.6) less likely to be anaemic and 6.6 times (2.8-16) less likely to carry vivax gametocytes than were those given artemether-lumefantrine. Interpretation Both dihydroartemisinin-piperaquine and artemether-lumefantrine were safe and effective for the treatment of multidrug-resistant uncomplicated malaria. However, dihydroartemisinin-piperaquine provided greater post-treatment prophylaxis than did artemether-lumefantrine, reducing P falciparum reinfections and P vivax recurrences, the clinical public-health importance of which should not be ignored.	Menzies Sch Hlth Res, Int Hlth Programme, Darwin, NT 0811, Australia; Charles Darwin Univ, Darwin, NT, Australia; Natl Inst Hlth Res & Dev, Minist Hlth, Jakarta, Indonesia; NIHRD, MSHR, Malaria Res Programme, Timika, Indonesia; Dist Minist Hlth, Timika, Papua, Indonesia; PT Freeport, Publ Hlth & Malaria Control Dept, Tembagapura, Papua, Indonesia; Int SOS, Tembagapura, Papua, Indonesia; Directorate Gen Ctr Dis Control & Environm Hlth, Minist Hlth, Jakarta, Indonesia; John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Vaccinol & Trop Med, Oxford OX3 9DU, England	Charles Darwin University; Menzies School of Health Research; Charles Darwin University; Ministry of Health - Indonesia; National Institute of Health Research & Development - Indonesia; National Institute of Health Research & Development (NIHRD); Ministry of Health - Indonesia; International SOS; Ministry of Health - Indonesia; University of Oxford	Price, RN (corresponding author), Menzies Sch Hlth Res, Int Hlth Programme, POB 41096, Darwin, NT 0811, Australia.	rnp@menzies.edu.au		Price, Richard/0000-0003-2000-2874	Wellcome Trust [GR071614MA, 071614] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ashley EA, 2004, J INFECT DIS, V190, P1773, DOI 10.1086/425015; Baird JK, 2003, TRENDS PARASITOL, V19, P115, DOI 10.1016/S1471-4922(03)00005-9; Baird JK, 1997, AM J TROP MED HYG, V56, P621, DOI 10.4269/ajtmh.1997.56.621; BAIRD JK, 1991, AM J TROP MED HYG, V44, P547, DOI 10.4269/ajtmh.1991.44.547; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Brockman A, 1999, AM J TROP MED HYG, V60, P14, DOI 10.4269/ajtmh.1999.60.14; CLYDE DF, 1977, AM J TROP MED HYG, V26, P562, DOI 10.4269/ajtmh.1977.26.562; Denis MB, 2002, CLIN INFECT DIS, V35, P1469, DOI 10.1086/344647; Dua VK, 1996, TROP MED INT HEALTH, V1, P816; Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000; Hien TT, 2004, LANCET, V363, P18, DOI 10.1016/S0140-6736(03)15163-X; Hung TY, 2004, BRIT J CLIN PHARMACO, V57, P253, DOI 10.1111/j.1365-2125.2003.02004.x; LEE V H, 1980, Southeast Asian Journal of Tropical Medicine and Public Health, V11, P341; Maguire JD, 2006, CLIN INFECT DIS, V42, P1067, DOI 10.1086/501357; MYATPHONEKYAW, 1993, T ROY SOC TROP MED H, V87, P687, DOI 10.1016/0035-9203(93)90294-Z; Piola P, 2005, LANCET, V365, P1467, DOI 10.1016/S0140-6736(05)66416-1; Pribadi Wita, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P228; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Ratcliff A, 2007, T ROY SOC TROP MED H, V101, P351, DOI 10.1016/j.trstmh.2006.06.008; RIECKMANN KH, 1989, LANCET, V2, P1183, DOI 10.1016/S0140-6736(89)91792-3; Roshammar D, 2006, EUR J CLIN PHARMACOL, V62, P335, DOI 10.1007/s00228-005-0084-9; Sim IK, 2005, ANTIMICROB AGENTS CH, V49, P2407, DOI 10.1128/AAC.49.6.2407-2411.2005; Smithuis F, 2006, LANCET, V367, P2075, DOI 10.1016/S0140-6736(06)68931-9; Soto J, 2001, AM J TROP MED HYG, V65, P90, DOI 10.4269/ajtmh.2001.65.90; Stepniewska K, 2004, ANTIMICROB AGENTS CH, V48, P4271, DOI 10.1128/AAC.48.11.4271-4280.2004; Sumawinata IW, 2003, AM J TROP MED HYG, V68, P416, DOI 10.4269/ajtmh.2003.68.416; Tarning J, 2005, ANTIMICROB AGENTS CH, V49, P5127, DOI 10.1128/AAC.49.12.5127-5128.2005; Tjitra E, 2002, T ROY SOC TROP MED H, V96, P434, DOI 10.1016/S0035-9203(02)90385-8; Tjitra E, 2002, ANTIMICROB AGENTS CH, V46, P3947, DOI 10.1128/AAC.46.12.3947-3953.2002; van Vugt M, 2000, T ROY SOC TROP MED H, V94, P545, DOI 10.1016/S0035-9203(00)90082-8; Watkins WM, 2005, AM J TROP MED HYG, V72, P163, DOI 10.4269/ajtmh.2005.72.163; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; White NJ, 2002, TRENDS PARASITOL, V18, P458, DOI 10.1016/S1471-4922(02)02373-5; WHO, 2003, ASS MON ANT DRUG EFF	34	209	214	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2007	369	9563					757	765		10.1016/S0140-6736(07)60160-3	http://dx.doi.org/10.1016/S0140-6736(07)60160-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143MP	17336652	Green Accepted			2022-12-28	WOS:000244726700032
J	Toon, OB; Robock, A; Turco, RP; Bardeen, C; Oman, L; Stenchikov, GL				Toon, Owen B.; Robock, Alan; Turco, Richard P.; Bardeen, Charles; Oman, Luke; Stenchikov, Georgiy L.			Nuclear war - Consequences of regional-scale nuclear conflicts	SCIENCE			English	Editorial Material									Univ Colorado, Dept Atmospher & Ocean Sci, Boulder, CO 80309 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ 08903 USA; Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Rutgers State University New Brunswick; University of California System; University of California Los Angeles; Johns Hopkins University	Toon, OB (corresponding author), Univ Colorado, Dept Atmospher & Ocean Sci, Boulder, CO 80309 USA.	toon@lasp.colorado.edu; robock@envsci.rutgers.edu	Georgiy, Stenchikov/J-8569-2013; Stenchikov, Georgiy/AAA-4371-2022; Oman, Luke D/C-2778-2009; Robock, Alan/B-6385-2016	Oman, Luke D/0000-0002-5487-2598; Robock, Alan/0000-0002-6319-5656				ALBRIGHT D, 1997, PLUTONIUM HIGHLY ENR, P502; DRELL SD, 2003, GRAVEST DANGER NUCL; Gibson James N., 1996, NUCL WEAPONS US; HARWELL MA, 1989, SCOPE, V28; Kothari Smitha, OUT NUCL SHADOW, P137; LAVOY PR, 2003, STRATEGIC INSIGHTS, V2; *NAT AC SCI, 2005, MON NUCL WEAP NUCL E; Oman L, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027665; PITTOCK AB, 1989, SCOPE, V28; Robock A., 2006, ATMOS CHEM PHYS, V6, P11817; SHULTZ GP, 2007, WALL STREET J   0104, pA15; TOON OB, 2006, ATMOS PHYS CHEM DISC, V6, P11745	12	37	40	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1224	1225		10.1126/science.1137747	http://dx.doi.org/10.1126/science.1137747			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	141FR	17332396				2022-12-28	WOS:000244564700031
J	Wang, LD; Liu, JJ; Chin, DP				Wang, Longde; Liu, Jianjun; Chin, Daniel P.			Progress in tuberculosis control and the evolving public-health system in China	LANCET			English	Article								China has the world's second largest tuberculosis epidemic, but progress in tuberculosis control was slow during the 1990s. Detection of tuberculosis had stagnated at around 30% of the estimated total of new cases, and multidrug-resistant tuberculosis was a major problem. These signs of inadequate tuberculosis control can be linked to a malfunctioning health system. The spread of severe acute respiratory syndrome (SARS) in 2003, brought to light substantial weaknesses in the country's public-health system. After the SARS epidemic was brought under control, the government increased its commitment and leadership to tackle public-health problems and, among other efforts, increased public-health funding, revised laws that concerned the control of infectious diseases, implemented the world's largest internet-based disease reporting system, and started a programme to rebuild local public-health facilities. These measures contributed to acceleration in efforts to control tuberculosis. By 2005, the detection of cases of tuberculosis had increased to 80% of the estimated total new cases, permitting China to achieve the 2005 global tuberculosis control targets. At the same time, specific efforts to improve tuberculosis control also contributed to strengthening of the public-health system. We examine how the strengthening of a disease control programme and the public-health system worked together to achieve a desired health outcome.	Minist Hlth, Beijing, Peoples R China; Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; WHO, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; World Health Organization	Chin, DP (corresponding author), Room 401,23 Dongzhimenwai Dajie, Beijing 100600, Peoples R China.	chind@chn.wpro.who.int						Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Cai J, 2003, MODEL TUBERCULOSIS C; China National Health Development Research Center, 2020, CHIN NAT HLTH ACC RE; *DEV RES CTR PROJ, 2005, CHINA DEV REV, V7, P1; LEI H, 2005, CHINA DEV REV, V7, P81; Ma J. Q., 2006, DIS SURVEILLANCE, V21, P1; *MIN HLTH PUBL INF, 2005, MIN HLTH REP STAT NA; *MIN PUBL HLTH PEO, 1990, NAT RAND SURV EP TUB; Ministry of Health of the People's Republic of China, 2002, REP NAT RAND SURV EP; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; *STAT COUNC PEOPL, 200175 GEN OFF STAT, P75; *STAT COUNC PEOPL, CHIN AIDS PREV CONTR; *STAT COUNC PEOPL, 2003, CHIN PREV MED S, V4, P1; *STOP TB PARTN, 2 STOP TB PARTN FOR; *UN HLTH PARTN GRO, 2005, HLTH SIT ASS PEOPL R; *UN STAT DIV, MILL IND DAT; WEN J, 10 NAT PEOPL C CHIN; *WHO, 2000, WHOCDSTB2000278 IUAT; *WHO, 2004, WHOHTMTB2004343 IUAT; *WHO REG COMM W PA, WPRRC51R4 WHO REG CO; *WHO STOP TB PARTN, 2006, WHOHTMSTB200635; *WHO UNAIDS MIN HL, 2006, 2005 UPD HIV AIDS EP; World Health Organization, 2006, WHOHTMTB2006362; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877; GEN OFFICE MINISTRY	25	184	194	3	27	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2007	369	9562					691	696		10.1016/S0140-6736(07)60316-X	http://dx.doi.org/10.1016/S0140-6736(07)60316-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141RO	17321314	Bronze, Green Published			2022-12-28	WOS:000244596600030
J	Evans, MJ; von Hahn, T; Tscherne, DM; Syder, AJ; Panis, M; Wolk, B; Hatziioannou, T; McKeating, JA; Bieniasz, PD; Rice, CM				Evans, Matthew J.; von Hahn, Thomas; Tscherne, Donna M.; Syder, Andrew J.; Panis, Maryline; Woelk, Benno; Hatziioannou, Theodora; McKeating, Jane A.; Bieniasz, Paul D.; Rice, Charles M.			Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry	NATURE			English	Article							TIGHT JUNCTIONS; CELL ENTRY; LIVER-TRANSPLANTATION; CHOLESTATIC HEPATITIS; VIRAL-INFECTION; RECEPTOR; GLYCOPROTEINS; REPLICATION; CD81; TETRASPANIN	Hepatitis C virus (HCV) is a leading cause of cirrhosis and liver cancer worldwide. A better understanding of the viral life cycle, including the mechanisms of entry into host cells, is needed to identify novel therapeutic targets. Although HCV entry requires the CD81 co-receptor, and other host molecules have been implicated, at least one factor critical to this process remains unknown (reviewed in refs 1 - 3). Using an iterative expression cloning approach we identified claudin-1 (CLDN1), a tight junction component that is highly expressed in the liver(4), as essential for HCV entry. CLDN1 is required for HCV infection of human hepatoma cell lines and is the first factor to confer susceptibility to HCV when ectopically expressed in non-hepatic cells. Discrete residues within the first extracellular loop (EL1) of CLDN1, but not protein interaction motifs in intracellular domains, are critical for HCV entry. Moreover, antibodies directed against an epitope inserted in the CLDN1 EL1 block HCV infection. The kinetics of this inhibition indicate that CLDN1 acts late in the entry process, after virus binding and interaction with the HCV co-receptor CD81. With CLDN1 we have identified a novel key factor for HCV entry and a new target for antiviral drug development.	Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10021 USA; Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA	Rockefeller University; Rockefeller University	Rice, CM (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, 1230 York Ave, New York, NY 10021 USA.	ricec@mail.rockefeller.edu		Evans, Matthew/0000-0002-4991-3877; McKeating, Jane/0000-0002-7229-5886	Medical Research Council [G0801976, G0400802] Funding Source: Medline; MRC [G0400802] Funding Source: UKRI; Medical Research Council [G9818340B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Barth H, 2006, HEPATOLOGY, V44, P527, DOI 10.1002/hep.21321; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Bartosch B, 2006, VIROLOGY, V348, P1, DOI 10.1016/j.virol.2005.12.027; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Borlak J, 2005, ONCOGENE, V24, P1809, DOI 10.1038/sj.onc.1208196; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Doughty AL, 1998, LIVER TRANSPLANT SUR, V4, P15, DOI 10.1002/lt.500040102; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Heiskala M, 2001, TRAFFIC, V2, P92, DOI 10.1034/j.1600-0854.2001.020203.x; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Kato T, 2005, J VIROL, V79, P592, DOI 10.1128/JVI.79.1.592-596.2005; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; McKeating JA, 2004, J VIROL, V78, P8496, DOI 10.1128/JVI.78.16.8496-8505.2004; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Schluger LK, 1996, HEPATOLOGY, V23, P971, DOI 10.1002/hep.510230505; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; Tiwari-Woodruff SK, 2001, J CELL BIOL, V153, P295, DOI 10.1083/jcb.153.2.295; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004	29	927	1001	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					801	805		10.1038/nature05654	http://dx.doi.org/10.1038/nature05654			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17325668				2022-12-28	WOS:000245626800042
J	Norton, DA; Didham, RK				Norton, David A.; Didham, Raphael K.			Comment on "Why are there so many species of herbivorous insects in tropical rainforests?"	SCIENCE			English	Editorial Material							HOST-SPECIFICITY; SPECIALIZATION; MISTLETOES; RICHNESS	Novotny et al. (Reports, 25 August 2006, p. 1115) argued that higher herbivore diversity in tropical forests results from greater phylogenetic diversity of host plants, not from higher host specificity. However, if host specificity is related to host abundance, differences in relative host abundance between tropical and temperate regions may limit any general conclusion that herbivore diversity scales directly with host-plant diversity.	Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; Univ Canterbury, Sch Forestry, Christchurch 1, New Zealand	University of Canterbury; University of Canterbury	Didham, RK (corresponding author), Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 1, New Zealand.	raphael.didham@canterbury.ac.nz	Didham, Raphael K/B-5953-2011; Norton, David/D-6978-2011					BEAVER RA, 1979, NATURE, V281, P139, DOI 10.1038/281139a0; DIXON AFG, 1987, AM NAT, V129, P580, DOI 10.1086/284659; HAWKINS BA, 1992, AM NAT, V139, P58, DOI 10.1086/285313; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Janz N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-4; JANZEN DH, 1981, ECOLOGY, V62, P532, DOI 10.2307/1937717; Kelly CK, 1999, P NATL ACAD SCI USA, V96, P8013, DOI 10.1073/pnas.96.14.8013; Norton DA, 1998, TRENDS ECOL EVOL, V13, P101, DOI 10.1016/S0169-5347(97)01243-3; Norton DA, 1999, FUNCT ECOL, V13, P552, DOI 10.1046/j.1365-2435.1999.00347.x; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Thompson JD., 1994, COEVOLUTIONARY PROCE; Vazquez DP, 2005, J ANIM ECOL, V74, P946, DOI 10.1111/j.1365-2656.2005.00992.x	13	4	4	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1666	1666		10.1126/science.1137249	http://dx.doi.org/10.1126/science.1137249			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379792	Green Submitted			2022-12-28	WOS:000245106900018
J	Chang, L; Huang, L; Gau, SS; Wu, Y; Hsia, S; Fan, T; Lin, K; Huang, Y; Lu, C; Lin, T				Chang, Luan-Yin; Huang, Li-Min; Gau, Susan Shur-Fen; Wu, Yu-Yu; Hsia, Shao-Hsuan; Fan, Tsui-Yen; Lin, Kuang-Lin; Huang, Yhu-Chering; Lu, Chun-Yi; Lin, Tzou-Yien			Neurodevelopment and cognition in children after enterovirus 71 infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLUENZAE MENINGITIS; BACTERIAL-MENINGITIS; MOUTH-DISEASE; EPIDEMIC; OUTBREAK; TAIWAN; OUTCOMES; ENCEPHALOMYELITIS; ENCEPHALITIS; MANAGEMENT	Background: Enterovirus 71 is a common cause of hand, foot, and mouth disease and encephalitis in Asia and elsewhere. The long-term neurologic and psychiatric effects of this viral infection on the central nervous system (CNS) are not well understood. Methods: We conducted long-term follow-up of 142 children after enterovirus 71 infection with CNS involvement - 61 who had aseptic meningitis, 53 who had severe CNS involvement, and 28 who had cardiopulmonary failure after CNS involvement. At a median follow-up of 2.9 years (range, 1.0 to 7.4) after infection, the children received physical and neurologic examinations. We administered the Denver Developmental Screening Test (DDST II) to children 6 years of age or younger and the Wechsler intelligence test to children 4 years of age or older. Results: Nine of the 16 patients with a poliomyelitis-like syndrome (56%) and 1 of the 5 patients with encephalomyelitis (20%) had sequelae involving limb weakness and atrophy. Eighteen of the 28 patients with cardiopulmonary failure after CNS involvement (64%) had limb weakness and atrophy, 17 (61%) required tube feeding, and 16 (57%) required ventilator support. Among patients who underwent DDST II assessment, delayed neurodevelopment was found in only 1 of 20 patients (5%) with severe CNS involvement and in 21 of 28 patients (75%) with cardiopulmonary failure (P<0.001 for the overall comparison). Children with cardiopulmonary failure after CNS involvement scored lower on intelligence tests than did children with CNS involvement alone (P=0.003). Conclusions: Enterovirus 71 infection with CNS involvement and cardiopulmonary failure may be associated with neurologic sequelae, delayed neurodevelopment, and reduced cognitive functioning. Children with CNS involvement without cardiopulmonary failure did well on neurodevelopment tests. (ClinicalTrials. gov number, NCT00172393.)	Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, Taipei, Taiwan; Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Psychiat, Taipei, Taiwan; Chang Gung Univ, Chang Gung Childrens Hosp, Dept Child Psychiat, Tao Yuan, Taiwan; Chang Gung Univ, Chang Gung Childrens Hosp, Dept Pediat, Tao Yuan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chang, L (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, 7 Chung Shan S Rd, Taipei, Taiwan.	ly7077@tpts6.seed.net.tw	Gau, Susan Shur-Fen/P-4726-2017	Gau, Susan Shur-Fen/0000-0002-2718-8221; LU, CHUN-YI/0000-0002-5240-2808; CHANG, LUAN-YIN/0000-0003-2632-1956; HUANG, LI-MIN/0000-0002-9291-260X				ALLEN SR, 1995, J CLIN PSYCHOL, V51, P648, DOI 10.1002/1097-4679(199509)51:5<648::AID-JCLP2270510510>3.0.CO;2-R; BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; Baruah H C, 2002, Indian Pediatr, V39, P1143; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang LY, 2004, PEDIATR INFECT DIS J, V23, P327, DOI 10.1097/00006454-200404000-00010; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Dolin R, 1999, NEW ENGL J MED, V341, P984, DOI 10.1056/NEJM199909233411309; EMMETT M, 1980, AUST PAEDIATR J, V16, P90; FRANKENBURG WK, 1992, PEDIATRICS, V89, P91; GRIMWOOD K, 1995, PEDIATRICS, V95, P646; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsueh C, 2000, MODERN PATHOL, V13, P1200, DOI 10.1038/modpathol.3880222; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Kari K, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-8; Lahat E, 1999, ARCH DIS CHILD, V80, P69, DOI 10.1136/adc.80.1.69; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Mekan Sabeen F., 2005, JPMA Journal of the Pakistan Medical Association, V55, P146; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Shen WC, 1999, AM J NEURORADIOL, V20, P1889; SHINDAROV LM, 1979, J HYG EPID MICROB IM, V23, P284; Taylor HG, 2000, NEUROPSYCHOLOGY, V14, P509, DOI 10.1037/0894-4105.14.4.509; Wong KT, 2000, NEUROPATH APPL NEURO, V26, P313, DOI 10.1046/j.1365-2990.2000.00256.x	22	258	318	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1226	1234		10.1056/NEJMoa065954	http://dx.doi.org/10.1056/NEJMoa065954			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377160				2022-12-28	WOS:000245101900007
J	Hickenboth, CR; Moore, JS; White, SR; Sottos, NR; Baudry, J; Wilson, SR				Hickenboth, Charles R.; Moore, Jeffrey S.; White, Scott R.; Sottos, Nancy R.; Baudry, Jerome; Wilson, Scott R.			Biasing reaction pathways with mechanical force	NATURE			English	Article							DERIVATIVES; ACTIVATION; POLYMERS; BONDS	During the course of chemical reactions, reactant molecules need to surmount an energy barrier to allow their transformation into products. The energy needed for this process is usually provided by heat, light, pressure or electrical potential, which act either by changing the distribution of the reactants on their ground-state potential energy surface or by moving them onto an excited-state potential energy surface and thereby facilitate movement over the energy barrier. A fundamentally different way of initiating or accelerating a reaction is the use of force to deform reacting molecules along a specific direction of the reaction coordinate. Mechanical force has indeed been shown to activate covalent bonds in polymers, but the usual result is chain scission(1). Here we show that mechanically sensitive chemical groups make it possible to harness the mechanical forces generated when exposing polymer solutions to ultrasound 2, and that this allows us to accelerate rearrangement reactions and bias reaction pathways to yield products not obtainable from purely thermal or light-induced reactions. We find that when placed within long polymer strands, the trans and cis isomers of a 1,2-disubstituted benzocyclobutene undergo an ultrasound-induced electrocyclic ring opening in a formally conrotatory and formally disrotatory process, respectively, that yield identical products. This contrasts with reaction initiation by light or heat alone 3, in which case the isomers follow mutually exclusive pathways to different products. Mechanical forces associated with ultrasound can thus clearly alter the shape of potential energy surfaces 4 so that otherwise forbidden or slow processes proceed under mild conditions, with the directionally specific nature of mechanical forces providing a reaction control that is fundamentally different from that achieved by adjusting chemical or physical parameters. Because rearrangement in our system occurs before chain scission, the effect we describe might allow the development of materials that are activated by mechanical stress fields.	Univ Illinois, Sch Chem Sci, Urbana, IL 61801 USA; Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; Univ Illinois, Dept Aerosp Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Moore, JS (corresponding author), Univ Illinois, Sch Chem Sci, Urbana, IL 61801 USA.	jsmoore@uiuc.edu	; White, Scott/G-9667-2013	Moore, Jeffrey/0000-0001-5841-6269; White, Scott/0000-0002-0831-9097				[Anonymous], 1977, ADV POLYM SCI, DOI DOI 10.1007/3-540-07942-4_6; ARNOLD BJ, 1974, J CHEM SOC PERK T 1, P415, DOI 10.1039/p19740000415; Berkowski KL, 2005, MACROMOLECULES, V38, P8975, DOI 10.1021/ma051394n; Beyer MK, 2005, CHEM REV, V105, P2921, DOI 10.1021/cr030697h; Beyer MK, 2000, J CHEM PHYS, V112, P7307, DOI 10.1063/1.481330; Boffa LS, 1997, MACROMOLECULES, V30, P3494, DOI 10.1021/ma961805n; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; GRAESSLEY WW, 1980, POLYMER, V21, P258, DOI 10.1016/0032-3861(80)90266-9; Kersey FR, 2006, J AM CHEM SOC, V128, P3886, DOI 10.1021/ja058516b; NGUYEN TQ, 1992, ADV POLYM SCI, V100, P73; Price, 1990, ADV SONOCHEMISTRY, V1, P231; Reddy PY, 1998, SYNTHESIS-STUTTGART, P999; Rodd LE, 2005, J NON-NEWTON FLUID, V129, P1, DOI 10.1016/j.jnnfm.2005.04.006; Roth WR, 1996, LIEBIGS ANN, P409; SUSLICK KS, 1983, J AM CHEM SOC, V105, P5781, DOI 10.1021/ja00356a014; WOODWARD RB, 1969, ANGEW CHEM INT EDIT, V8, P781, DOI 10.1002/anie.196907811	16	585	604	5	290	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2007	446	7134					423	427		10.1038/nature05681	http://dx.doi.org/10.1038/nature05681			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	148MO	17377579				2022-12-28	WOS:000245079500036
J	Kales, SN; Soteriades, ES; Christophi, CA; Christiani, DC				Kales, Stefanos N.; Soteriades, Elpidoforos S.; Christophi, Costas A.; Christiani, David C.			Emergency duties and deaths from heart disease among firefighters in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; BODY-MASS INDEX; RISK-FACTORS; CARDIOVASCULAR-DISEASE; HEALTH; RESPONSES; FITNESS; PROFILE; TIME; ECG	Background: Heart disease causes 45% of the deaths that occur among U.S. firefighters while they are on duty. We examined duty-specific risks of death from coronary heart disease among on-duty U.S. firefighters from 1994 to 2004. Methods: We reviewed summaries provided by the Federal Emergency Management Agency of the deaths of all on-duty firefighters between 1994 and 2004, except for deaths associated with the September 11, 2001, terrorist attacks. Estimates of the proportions of time spent by firefighters each year performing various duties were obtained from a municipal fire department, from 17 large metropolitan fire departments, and from a national database. Odds ratios and 95% confidence intervals for death from coronary heart disease during specific duties were calculated from the ratios of the observed odds to the expected odds, with nonemergency duties as the reference category. Results: Deaths from coronary heart disease were associated with suppressing a fire (32.1% of all such deaths), responding to an alarm (13.4%), returning from an alarm (17.4%), engaging in physical training (12.5%), responding to nonfire emergencies (9.4%), and performing nonemergency duties (15.4%). As compared with the odds of death from coronary heart disease during nonemergency duties, the odds were 12.1 to 136 times as high during fire suppression, 2.8 to 14.1 times as high during alarm response, 2.2 to 10.5 times as high during alarm return, and 2.9 to 6.6 times as high during physical training. These odds were based on three estimates of the time that firefighters spend on their duties. Conclusions: Certain emergency firefighting duties were associated with a risk of death from coronary heart disease that was markedly higher than the risk associated with nonemergency duties. Fire suppression was associated with the highest risk, which was approximately 10 to 100 times as high as that for nonemergency duties.	Harvard Univ, Sch Med, Cambridge Hlth Alliance, Employee Hlth & Ind Med, Cambridge, MA 02139 USA; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA; Kindred Hosp NE, Ctr Occupat & Environm Med, Braintree, MA USA; Harvard Univ, Sch Publ Hlth, Cyprus Inst Inst Environm & Publ Hlth, Nicosia, Cyprus	Harvard University; Cambridge Health Alliance; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Kales, SN (corresponding author), Harvard Univ, Sch Med, Cambridge Hlth Alliance, Employee Hlth & Ind Med, Lee B Macht Bldg,Rm 427,1493 Cambridge St, Cambridge, MA 02139 USA.	skales@challiance.org			PHS HHS [T42/CCT122961-02] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Austin CC, 2001, AM J IND MED, V40, P683, DOI 10.1002/ajim.10023; BARNARD RJ, 1975, J OCCUP ENVIRON MED, V17, P247; Burgess JL, 2001, J OCCUP ENVIRON MED, V43, P467, DOI 10.1097/00043764-200105000-00007; Clark S, 2002, J OCCUP ENVIRON MED, V44, P940, DOI 10.1097/00043764-200210000-00013; Cohen, 1998, AM J CARDIOL, V81, P260; Cohen MC, 1997, AM J CARDIOL, V79, P1512, DOI 10.1016/S0002-9149(97)00181-1; Fahy RF., 2005, ANAL NFPA FIRE ANAL; Fisher Nicholas G, 2005, J R Nav Med Serv, V91, P112; FRANKE WD, 1994, J OCCUP ENVIRON MED, V36, P1127, DOI 10.1097/00043764-199410000-00016; Franklin BA, 1996, AM J CARDIOL, V77, P855, DOI 10.1016/S0002-9149(97)89181-3; FRIEL JK, 1992, AM J PUBLIC HEALTH, V82, P1175, DOI 10.2105/AJPH.82.8.1175-a; Glueck CJ, 1996, AM J IND MED, V30, P331, DOI 10.1002/ajim.4700300313; Guidotti TL, 1995, J OCCUP ENVIRON MED, V37, P1348, DOI 10.1097/00043764-199512000-00004; GUIDOTTI TL, 1992, INT ARCH OCC ENV HEA, V64, P1, DOI 10.1007/BF00625945; Haas NS, 2003, INT J OCCUP ENV HEAL, V9, P95, DOI 10.1179/oeh.2003.9.2.95; Holder JD, 2006, J OCCUP ENVIRON MED, V48, P1047, DOI 10.1097/01.jom.0000235909.31632.46; Ide CW, 2000, SCOT MED J, V45, P79, DOI 10.1177/003693300004500307; *INT ASS FIR FIGHT, PRES LEG; Johnstone MT, 1996, AM J HYPERTENS, V9, pS22, DOI 10.1016/0895-7061(95)00403-3; Kales SN, 1999, J OCCUP ENVIRON MED, V41, P589, DOI 10.1097/00043764-199907000-00007; Kales SN, 2000, J OCCUP ENVIRON MED, V42, P467, DOI 10.1097/00043764-200005000-00001; Kales Stefanos N, 2003, Environ Health, V2, P14, DOI 10.1186/1476-069X-2-14; KARTER MJ, 2001, US FIR DEP PROF 2000; KAWACHI I, 1995, CIRCULATION, V92, P3178, DOI 10.1161/01.CIR.92.11.3178; KUORINKA I, 1981, J OCCUP ENVIRON MED, V23, P762, DOI 10.1097/00043764-198111000-00010; LEMON PWR, 1977, J OCCUP ENVIRON MED, V19, P337; Maguire BJ, 2002, ANN EMERG MED, V40, P625, DOI 10.1067/mem.2002.128681; Melius J, 2001, OCCUP MED-STATE ART, V16, P101; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; *NAT FIR PROT ASS, FIR STAT; Roberts MA, 2002, J STRENGTH COND RES, V16, P271; Smith DL, 2001, ERGONOMICS, V44, P244, DOI 10.1080/00140130010000910; Soteriades ES, 2005, OBES RES, V13, P1756, DOI 10.1038/oby.2005.214; Soteriades ES, 2002, J OCCUP ENVIRON MED, V44, P840, DOI 10.1097/00043764-200209000-00006; Spencer FA, 1998, J AM COLL CARDIOL, V31, P1226, DOI 10.1016/S0735-1097(98)00098-9; Steenland K, 1996, AM J IND MED, V30, P495, DOI 10.1002/(SICI)1097-0274(199610)30:4<495::AID-AJIM16>3.3.CO;2-I; TriData Corporation, 2002, FIR FAT RETR STUD; *US FIR ADM, FIR FAT; Willich SN, 1998, EUR HEART J, V19, pC12	39	338	342	1	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1207	1215		10.1056/NEJMoa060357	http://dx.doi.org/10.1056/NEJMoa060357			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377158	Green Published, Bronze			2022-12-28	WOS:000245101900005
J	Laine, C; Goodman, SN; Griswold, ME; Sox, HC				Laine, Christine; Goodman, Steven N.; Griswold, Michael E.; Sox, Harold C.			Reproducible research: Moving toward research the public can really trust	ANNALS OF INTERNAL MEDICINE			English	Article							OF-INTEREST; EXPRESSION	A community of scientists arrives at the truth by independently verifying new observations. In this time-honored process, journals serve 2 principal functions: evaluative and editorial. In their evaluative function, they winnow out research that is unlikely to stand up to independent verification; this task is accomplished by peer review. In their editorial function, they try to ensure transparent (by which we mean clear, complete, and unambiguous) and objective descriptions of the research. Both the evaluative and editorial functions go largely unnoticed by the public-the former only draws public attention when a journal publishes fraudulent research. However, both play a critical role in the progress of science. This paper is about both functions. We describe the evaluative processes we use and announce a new policy to help the scientific community evaluate, and build upon, the research findings that we publish.	Amer Coll Physicians, Customer Serv, Philadelphia, PA 19106 USA	American College of Physicians	Laine, C (corresponding author), Amer Coll Physicians, Customer Serv, 190 N Independence Mall W, Philadelphia, PA 19106 USA.			Goodman, Steven/0000-0002-3872-5723				Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; BOSMAN J, 2006, NY TIMES        0213; Curfman GD, 2006, NEW ENGL J MED, V354, P1193, DOI 10.1056/NEJMe068054; Davidoff F, 2001, ANN INTERN MED, V135, P463, DOI 10.7326/0003-4819-135-6-200109180-00016; De Angelis CD, 2005, ANN INTERN MED, V143, P146, DOI 10.7326/0003-4819-143-2-200507190-00016; DeAngelis CD, 2006, JAMA-J AM MED ASSOC, V296, P654, DOI 10.1001/jama.296.6.654-a; Flanagin A, 2006, JAMA-J AM MED ASSOC, V296, P220, DOI 10.1001/jama.296.2.220; Fontanarosa PB, 2005, JAMA-J AM MED ASSOC, V294, P110, DOI 10.1001/jama.294.1.110; Garrel DR, 2006, ANN INTERN MED, V145, P473, DOI 10.7326/0003-4819-145-6-200609190-00019; GOODMAN SN, 1994, ANN INTERN MED, V121, P11, DOI 10.7326/0003-4819-121-1-199407010-00003; Horton R, 2006, LANCET, V367, P382, DOI 10.1016/S0140-6736(06)68119-1; Kennedy D, 2006, SCIENCE, V311, P36; Kennedy D, 2006, SCIENCE, V314, P1353, DOI 10.1126/science.1137840; Kurth T, 2006, JAMA-J AM MED ASSOC, V296, P653, DOI 10.1001/jama.296.6.653-b; LEE KP, EDITORIAL CHANGES MA; Moher D, 2001, ANN INTERN MED, V134, P657, DOI 10.7326/0003-4819-134-8-200104170-00011; Peng RD, 2006, AM J EPIDEMIOL, V163, P783, DOI 10.1093/aje/kwj093; Poehlman ET, 2005, ANN INTERN MED, V142, P798, DOI 10.7326/0003-4819-142-9-200505030-00116; Sox HC, 2005, ANN INTERN MED, V142, P798, DOI 10.7326/0003-4819-142-9-200505030-00115; Sylvestre MP, 2006, ANN INTERN MED, V145, P361, DOI 10.7326/0003-4819-145-5-200609050-00009	20	136	135	1	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2007	146	6					450	453		10.7326/0003-4819-146-6-200703200-00154	http://dx.doi.org/10.7326/0003-4819-146-6-200703200-00154			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150CC	17339612				2022-12-28	WOS:000245192200007
J	Stone, GW; White, HD; Ohman, EM; Bertrand, ME; Lincoff, AM; McLaurin, BT; Cox, DA; Pocock, SJ; Ware, JH; Feit, F; Colombo, A; Manoukian, SV; Lonsky, AJ; Mehran, R; Moses, JW				Stone, Gregg W.; White, Harvey D.; Ohman, E. Magnus; Bertrand, Michel E.; Lincoff, A. Michael; McLaurin, Brent T.; Cox, David A.; Pocock, Stuart J.; Ware, James H.; Feit, Frederick; Colombo, Antonio; Manoukian, Steven V.; Lonsky, Alexandra J.; Mehran, Roxana; Moses, Jeffrey W.		ACUITY trial investigators	Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial	LANCET			English	Article							GLYCOPROTEIN IIB/IIIA INHIBITION; CLINICAL-OUTCOMES; RECEPTOR INHIBITION; BLOOD-TRANSFUSION; TASK-FORCE; HEPARIN; ANGIOPLASTY; IMPACT; SAFETY; THROMBOLYSIS	Background The aim of this study was to assess anticoagulation with the direct thrombin inhibitor bivalirudin during percutaneous coronary intervention in individuals with moderate and high-risk acute coronary syndromes. Methods 13 819 individuals in the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial were prospectively randomly assigned to receive heparin (unfiractionated or enoxaparin) plus glycoprotein IIb/IIIa inhibitors, bivalirudin plus glycoprotein IIb/IIIa. inhibitors, or bivalirudin alone. Of these individuals, 7789 underwent percutaneous coronary intervention after angiography. The effect of the three regimens on the primary 30-day endpoints of composite ischaemia (death, myocardial infarction, or unplanned revascularisation for ischaemia), major bleeding, and net clinical outcomes (composite ischaemia or major bleeding) was assessed in this subgroup. Analyses were done by intention to treat. This trial is registered with ClinicalTrials.gov, with the number NCT00093158. Findings Of the individuals who underwent percutaneous coronary intervention, 2561 received heparin plus glycoprotein IIb/IIIa inhibitors, 2609 received bivalirudin plus glycoprotein IIb/IIIa inhibitors, and 2619 received bivalirudin alone. 26 (0.3%) individuals dropped out or were lost to follow-up. There was no significant difference in the proportion of individuals with composite ischaemia, major bleeding, or net clinical outcomes at 30 days between those who received bivalirudin plus glycoprotein IIb/IIIa. inhibitors and those who received heparin plus glycoprotein IIb/IIIa inhibitors (composite ischaemia: 243 [9%] patients vs 210 [8%] patients, p=0.16; major bleeding: 196 [8%] patients vs 174 [7%] patients, P=0.32; net clinical outcomes: 389 [15%] patients vs 341 [13%] patients, p=0.1). Rates of composite ischaemia were much the same in those who received bivalirudin alone and those who received heparin plus glycoprotein IIb/IIIa inhibitors (230 [9%] patients vs 210 [8%] patients, p=0.45); however, there were significantly fewer individuals who experienced major bleeding among those who received bivalirudin alone than among those who received heparin plus glycoprotein IIb/IIIa. inhibitors (92 [4%] patients vs 174 [7%] patients, p<0.0001, relative risk 0.52, 95% CI 0.40-0.66), resulting in a trend towards better 30-day net clinical outcomes (303 [12%] patients vs 341 [13%] patients, p=0.057; 0.87, 0.75-1.00). Interpretation Substitution of unfractionated heparin or enoxaparin with bivalirudin results in comparable clinical outcomes in patients with moderate and high-risk acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors in whom percutaneous coronary intervention is done. Anticoagulation with bivalitudin alone suppresses adverse ischaemic events to a similar extent as does heparin plus glycoprotein IIb/IIIa inhibitors, while significantly lowering the risk of major haemorrhagic complications.	Columbia Univ, Med Ctr, Cardiovasc Res Fdn, New York, NY 10022 USA; Auckland City Hosp, Auckland, New Zealand; Duke Univ, Med Ctr, Durham, NC USA; Hop Cardiol, F-59037 Lille, France; Cleveland Clin, Cleveland, OH 44106 USA; AnMed Hlth, Anderson, SC USA; Mid Carolina Cardiol, Charlotte, NC USA; London Sch Hyg & Trop Med, London WC1, England; Harvard Univ, Boston, MA 02115 USA; NYU, Sch Med, New York, NY USA; Osped San Raphael, Milan, Italy; Emory Univ, Sch Med, Atlanta, GA USA	Cardiovascular Research Foundation (CRF); Columbia University; Auckland City Hospital; Duke University; Universite de Lille - ISITE; CHU Lille; Cleveland Clinic Foundation; University of London; London School of Hygiene & Tropical Medicine; Harvard University; New York University; Emory University	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Cardiovasc Res Fdn, New York, NY 10022 USA.	gs2184@columbia.edu	Colombo, Antonio/N-2960-2015; Mehran, Roxana/ABF-4160-2021	Colombo, Antonio/0000-0002-2940-2455; 				Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Bertrand ME, 2002, EUR HEART J, V23, P1809, DOI 10.1053/euhj.2002.3385; Bittl JA, 2001, AM HEART J, V142, P952, DOI 10.1067/mhj.2001.119374; Blankenship JC, 2001, J AM COLL CARDIOL, V38, P653, DOI 10.1016/S0735-1097(01)01423-1; Boersma E, 1999, CIRCULATION, V100, P2045, DOI 10.1161/01.CIR.100.20.2045; Braunwald E, 2002, CIRCULATION, V106, P1893, DOI 10.1161/01.CIR.0000037106.76139.53; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Cohen DJ, 2004, J AM COLL CARDIOL, V44, P1792, DOI 10.1016/j.jacc.2004.05.085; Costantini CO, 2004, J AM COLL CARDIOL, V44, P305, DOI 10.1016/j.jacc.2004.03.058; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Gibson CM, 2006, J AM COLL CARDIOL, V47, P2364, DOI 10.1016/j.jacc.2005.12.077; Gibson CM, 2002, AM HEART J, V143, P106, DOI 10.1067/mhj.2002.119618; Gibson CM, 2002, AM HEART J, V144, P130, DOI 10.1067/mhj.2002.123142; Hernandez AV, 2006, AM HEART J, V151, P257, DOI 10.1016/j.ahj.2005.04.020; Kastrati A, 2006, JAMA-J AM MED ASSOC, V295, P1531, DOI 10.1001/jama.295.13.joc60034; Kinnaird TD, 2003, AM J CARDIOL, V92, P930, DOI 10.1016/S0002-9149(03)00972-X; Lansky A, 1999, TXB INTERVENTIONAL C, P725; LEFKOVITS J, 1994, CIRCULATION, V90, P1522, DOI 10.1161/01.CIR.90.3.1522; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; Mandelzweig L, 2006, EUR HEART J, V27, P2285, DOI 10.1093/eurheartj/ehl196; Moscucci M, 2003, EUR HEART J, V24, P1815, DOI 10.1016/S0195-668X(03)00485-8; PETERSON ED, 2006, TRANSCATHETER CA OCT; Rao SV, 2005, AM J CARDIOL, V96, P1200, DOI 10.1016/j.amjcard.2005.06.056; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Rothman MT, 2005, NAT CLIN PRACT CARD, V2, P465, DOI 10.1038/ncpcardio0311; Segev A, 2005, AM HEART J, V150, P690, DOI 10.1016/j.ahj.2004.11.012; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Singh M, 2001, AM J CARDIOL, V88, P1091, DOI 10.1016/S0002-9149(01)02040-9; Smith SC., ACC AHA SCAI 2005 GU ACC AHA SCAI 2005 GU; Stone Gregg W, 2004, J Invasive Cardiol, V16 Suppl G, P12; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Stone GW, 2004, AM HEART J, V148, P764, DOI 10.1016/j.ahj.2004.04.036; Tcheng JE, 2000, LANCET, V356, P2037; Topol E, 1998, NEW ENGL J MED, V339, P436; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; Urban P, 2006, CIRCULATION, V113, P1434, DOI 10.1161/CIRCULATIONAHA.104.532242; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; White HD, 2006, AM HEART J, V152, P1042, DOI 10.1016/j.ahj.2006.08.002	40	301	319	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2007	369	9565					907	919		10.1016/S0140-6736(07)60450-4	http://dx.doi.org/10.1016/S0140-6736(07)60450-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148BQ	17368152				2022-12-28	WOS:000245049900031
J	Thomas, L; Hayashi, M; Jiang, X; Moriya, R; Rettner, C; Parkin, S				Thomas, Luc; Hayashi, Masamitsu; Jiang, Xin; Moriya, Rai; Rettner, Charles; Parkin, Stuart			Resonant amplification of magnetic domain-wall motion by a train of current pulses	SCIENCE			English	Article							NANOWIRES	The current-induced motion of magnetic domain walls confined to nanostructures is of interest for applications in magnetoelectronic devices in which the domain wall serves as the logic gate or memory element. The injection of spin-polarized current below a threshold value through a domain wall confined to a pinning potential results in its precessional motion within the potential well. We show that by using a short train of current pulses, whose length and spacing are tuned to this precession frequency, the domain wall's oscillations can be resonantly amplified. This makes possible the motion of domain walls with much reduced currents, more than five times smaller than in the absence of resonant amplification.	IBM Corp, Almaden Res Ctr, San Jose, CA 95120 USA	International Business Machines (IBM)	Thomas, L (corresponding author), IBM Corp, Almaden Res Ctr, 650 Harry Rd, San Jose, CA 95120 USA.	lucthom@us.ibm.com; parkin@almaden.ibm.com	Hayashi, Masamitsu/N-8033-2019; Parkin, Stuart/D-2521-2012; Hayashi, Masamitsu/H-2809-2011; Moriya, Rai/P-1460-2016	Hayashi, Masamitsu/0000-0003-2134-2563; Parkin, Stuart/0000-0003-4702-6139; Hayashi, Masamitsu/0000-0003-2134-2563; Moriya, Rai/0000-0001-7471-7432				BARRIES SE, 2005, PHYS REV LETT, V95, P7204; Hayashi M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.207205; Klaui M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.026601; Klaui M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.106601; Lawrence MS, 2005, RNA, V11, P1173, DOI 10.1261/rna.2110905; Li Z, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.024417; Malozemoff A.P., 1979, MAGNETIC DOMAIN WALL; Parkin SSP, 2004, ( 2004- 2007) U. S. Patents, Patent No. [Patents 6,834,005, 6834005, 6,834,005]; Ravelosona D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.117203; Saitoh E, 2004, NATURE, V432, P203, DOI 10.1038/nature03009; Tatara G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.086601; Thiaville A, 2005, EUROPHYS LETT, V69, P990, DOI 10.1209/epl/i2004-10452-6; Thomas L, 2006, NATURE, V443, P197, DOI 10.1038/nature05093; Vernier N, 2004, EUROPHYS LETT, V65, P526, DOI 10.1209/epl/i2003-10112-5; Yamanouchi M, 2004, NATURE, V428, P539, DOI 10.1038/nature02441; Zhang S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.127204	17	125	129	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1553	1556		10.1126/science.1137662	http://dx.doi.org/10.1126/science.1137662			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363668				2022-12-28	WOS:000244934800045
J	Brown, ME; Barkume, KM; Ragozzine, D; Schaller, EL				Brown, Michael E.; Barkume, Kristina M.; Ragozzine, Darin; Schaller, Emily L.			A collisional family of icy objects in the Kuiper belt	NATURE			English	Article							PLANETARY COLLISIONS; SIZED OBJECT; 2003 EL61; IMPACT; SURFACE	The small bodies in the Solar System are thought to have been highly affected by collisions and erosion. In the asteroid belt, direct evidence of the effects of large collisions can be seen in the existence of separate families of asteroids - a family consists of many asteroids with similar orbits and, frequently, similar surface properties, with each family being the remnant of a single catastrophic impact(1). In the region beyond Neptune, in contrast, no collisionally created families have hitherto been found(2). The third largest known Kuiper belt object, 2003 EL61, however, is thought to have experienced a giant impact that created its multiple satellite system, stripped away much of an overlying ice mantle, and left it with a rapid rotation(3-5). Here we report the discovery of a family of Kuiper belt objects with surface properties and orbits that are nearly identical to those of 2003 EL61. This family appears to be fragments of the ejected ice mantle of 2003 EL61.	CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Brown, ME (corresponding author), CALTECH, Div Geol & Planetary Sci, Mail Code 150-21,1200 E Calif Blvd, Pasadena, CA 91125 USA.	mbrown@caltech.edu	Ragozzine, Darin/C-4926-2013	Brown, Michael E./0000-0002-8255-0545; Schaller, Emily/0000-0001-8967-5423				Agnor C, 2004, ASTROPHYS J, V613, pL157, DOI 10.1086/425158; Asphaug E, 2006, NATURE, V439, P155, DOI 10.1038/nature04311; Barkume KM, 2006, ASTROPHYS J, V640, pL87, DOI 10.1086/503159; Barucci MA, 2006, ASTRON ASTROPHYS, V455, P725, DOI 10.1051/0004-6361:20064951; BENDJOYA P, 2002, ASTEROIDS, V3, P613; Benz W, 1999, ICARUS, V142, P5, DOI 10.1006/icar.1999.6204; Brown ME, 2006, ASTROPHYS J, V639, pL43, DOI 10.1086/501524; Brown ME, 2005, ASTROPHYS J, V635, pL97, DOI 10.1086/499336; BROWN ME, IN PRESS ASTRON J; Canup RM, 2004, ICARUS, V168, P433, DOI 10.1016/j.icarus.2003.09.028; Canup RM, 2005, SCIENCE, V307, P546, DOI 10.1126/science.1106818; Chiang EI, 2002, ASTROPHYS J, V573, pL65, DOI 10.1086/342089; Farinella P., 2000, Protostars and planets 4, P1255; Hainaut OR, 2002, ASTRON ASTROPHYS, V389, P641, DOI 10.1051/0004-6361:20020431; Kuchner MJ, 2002, ASTRON J, V124, P1221, DOI 10.1086/341643; Licandro J, 2006, ASTRON ASTROPHYS, V445, pL35, DOI 10.1051/0004-6361:200500219; Nesvorny D, 2001, ICARUS, V150, P104, DOI 10.1006/icar.2000.6568; Nesvorny D, 2006, ICARUS, V183, P296, DOI 10.1016/j.icarus.2006.03.008; Rabinowitz DL, 2006, ASTROPHYS J, V639, P1238, DOI 10.1086/499575	20	150	151	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					294	296		10.1038/nature05619	http://dx.doi.org/10.1038/nature05619			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361177				2022-12-28	WOS:000244892900039
J	Fukushima, K; Sato, S; Yamazaki, M; Kaneko, A; Oofusa, H; Yahikozawa, H				Fukushima, Kazuhiro; Sato, Shunichi; Yamazaki, Masashi; Kaneko, Astuko; Oofusa, Hirokazu; Yahikozawa, Hiroyuki			Shock and stony hard ears	LANCET			English	Editorial Material									Nagano Red Cross Hosp, Dept Neurol, Nagano 3808582, Japan; Nagano Red Cross Hosp, Dept Internal Med, Nagano 3808582, Japan; Shinshu Univ, Sch Med, Dept Geriatr Endocrinol & Metab, Matsumoto, Nagano 3908621, Japan	Nagano Red Cross Hospital; Nagano Red Cross Hospital; Shinshu University	Yahikozawa, H (corresponding author), Nagano Red Cross Hosp, Dept Neurol, Nagano 3808582, Japan.	yahiko@nagano-med.jrc.or.jp							0	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2007	369	9564					856	856		10.1016/S0140-6736(07)60414-0	http://dx.doi.org/10.1016/S0140-6736(07)60414-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144JC	17350455				2022-12-28	WOS:000244791300034
J	Murray, CJL				Murray, Christopher J. L.			Health statistics 2 - Towards good practice for health statistics: lessons from the Millennium Development Goal health indicators	LANCET			English	Article							CORONARY-HEART-DISEASE; GLOBAL BURDEN; MORTALITY; DEATH; YEAR-2000; ACCURACY; CHILDREN	Health statistics are at the Centre of an increasing number of worldwide health controversies. Several factors are sharpening the tension between the supply and demand for high quality health information, and the health-related Millennium Development Goals (MDGs) provide a high-profile example. With thousands of indicators recommended but few measured well, the worldwide health community needs to focus its efforts on improving measurement of a small set of priority areas. Priority indicators should be selected on the basis of public-health significance and several dimensions of measurability. Health statistics can be divided into three types: crude, corrected, and predicted. Health statistics are necessary inputs to planning and strategic decision making, programme implementation, monitoring progress towards targets, and assessment of what works and what does not. Crude statistics that are biased have no role in any of these steps; corrected statistics are preferred. For strategic decision making, when corrected statistics are unavailable, predicted statistics can play an important part. For monitoring progress towards agreed targets and assessment of what works and what does not, however, predicted statistics should not be used. Perhaps the most effective method to decrease controversy over health statistics and to encourage better primary data collection and the development of better analytical methods is a strong commitment to provision of an explicit data audit trail. This initiative would make available the primary data, all post-data collection adjustments, models including covariates used for farcasting and forecasting, and necessary documentation to the public.	Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA; Harvard Univ, Initiat Global Hlth, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Murray, CJL (corresponding author), Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA.	christopher_murray@harvard.edu						[Anonymous], 2005, WORLD POP PROSP 2004; Boerma JT, 2007, LANCET, V369, P779, DOI 10.1016/S0140-6736(07)60364-X; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; *CTR PEAC DEV IN C, 2006, DAWN PAK CHANG FREED; ENGEL LW, 1980, AM J EPIDEMIOL, V111, P99, DOI 10.1093/oxfordjournals.aje.a112879; *EUR COMM, 2005, EU REP MILL DEV GOAL; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Gakidou EE, 2000, B WORLD HEALTH ORGAN, V78, P42; Gakidou Emmanuela, 2002, Int J Equity Health, V1, P3, DOI 10.1186/1475-9276-1-3; Gwatkin DR, 2005, LANCET, V365, P813, DOI 10.1016/S0140-6736(05)17992-6; *HEALTHC COMM, 2005, OUR PROGR ON YEAR AN; Hill K, 2005, DEMOGR RES, V13, P281, DOI 10.4054/DemRes.2005.13.12; *INT BANK REC DEV, 2004, GLOB MON REP 2004 PO; *INT FREED EXPR EX, 2006, UPD ALL 72 SUBM ITS; *IOM, 2000, PROT DAT PRIV HLTH S; KANTROWITZ B, 2006, NEWSWEEK        0228; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Murray C., 2003, HLTH SYSTEMS PERFORM, P115; Murray CJ, 2003, HLTH SYSTEMS PERFORM, P705; Murray CJL, 2006, CIRCULATION, V113, P2071, DOI 10.1161/CIRCULATIONAHA.105.595777; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; MURRAY CJL, 1996, LOBAL BURDEN DIS COM; NAIK G, 2004, WALL STREET J   0712; Razum O, 1999, TROP MED INT HEALTH, V4, P243, DOI 10.1046/j.1365-3156.1999.00399.x; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; Sobel D. L., 2006, FEDERAL I ACCESS PUB; STURCKE J, 2005, GUARDIAN UNLIMI 1101; *UN, 2006, MINN IND DAT; *UN POP DIV, 1989, QFIVE MICR PROGR CHI; *UN POP DIV, 1983, MAN X IND DEM EST; *UNAIDS, 2003, M UNAIDS WHO REF GRO; *UNAIDS WHO UNICEF, 2004, NAT AIDS PROGR GUID; Walker N, 2004, LANCET, V363, P2180, DOI 10.1016/S0140-6736(04)16511-2; *WHO, 1999, IND MON NATL DRUG P; *WHO, 2005, COMM DIS GLOB ATL; *WHO, HLTH METR NETW; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 2005, NAT AIDS PROGR GUID	40	82	84	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2007	369	9564					862	873		10.1016/S0140-6736(07)60415-2	http://dx.doi.org/10.1016/S0140-6736(07)60415-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144JC	17350457	hybrid, Green Published			2022-12-28	WOS:000244791300036
J	Campbell, NC; Murray, E; Darbyshire, J; Emery, J; Farmer, A; Griffiths, F; Guthrie, B; Lester, H; Wilson, P; Kinmonth, AL				Campbell, Neil C.; Murray, Elizabeth; Darbyshire, Janet; Emery, Jon; Farmer, Andrew; Griffiths, Frances; Guthrie, Bruce; Lester, Helen; Wilson, Phil; Kinmonth, Ann Louise			Designing and evaluating complex interventions to improve health care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERPRETING FAMILY HISTORIES; RANDOMIZED CONTROLLED-TRIAL; LIFE-STYLE CHANGES; COMPUTER SUPPORT; OVARIAN-CANCER; FRAMEWORK; BEHAVIOR; BREAST		Univ Aberdeen, Dept Gen Practice & Primary Care, Foresterhill Hlth Ctr, Aberdeen AB25 2AY, Scotland; UCL, Dept Primary Care & Populat Sci, E Hlth Unit, London N19 5LW, England; MRC, Clin Trials Unit, London NW1 2DA, England; Univ Western Australia, Sch Primary Aboriginal & Rural Hlth Care, Claremont, Australia; Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; Univ Warwick, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England; Univ Dundee, Tayside Ctr Gen Practice, Dundee DD2 4BF, Scotland; Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England; Univ Cambridge, Gen Practice & Primary Care Res Unit, Cambridge CB2 2SR, England	University of Aberdeen; University of London; University College London; Medical Research Council Clinical Trials Unit; University of Western Australia; University of Oxford; University of Warwick; University of Dundee; University of Manchester; University of Cambridge	Campbell, NC (corresponding author), Univ Aberdeen, Dept Gen Practice & Primary Care, Foresterhill Hlth Ctr, Aberdeen AB25 2AY, Scotland.	n.campbell@abdn.ac.uk	Guthrie, Bruce/HHM-9696-2022; Wilson, Philip/V-6519-2019	Wilson, Philip/0000-0002-4123-8248; Griffiths, Frances/0000-0002-4173-1438; Guthrie, Bruce/0000-0003-4191-4880; Murray, Elizabeth/0000-0002-8932-3695	MRC [MC_U122861386, G0200391] Funding Source: UKRI; Medical Research Council [G0200391, MC_U122861386] Funding Source: researchfish; National Institute for Health Research [CSA03/003] Funding Source: researchfish; Chief Scientist Office [CZF/2/16] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office		Armitage CJ, 2000, PSYCHOL HEALTH, V15, P173, DOI 10.1080/08870440008400299; BOADEN R, 2005, EVERCARE EVALUATION; Campbell M, 2000, J Health Serv Res Policy, V5, P12; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Cassell J, 2002, J Med Ethics, V28, P313, DOI 10.1136/jme.28.5.313; *DEP HLTH, 2000, NHS PLAN; Department of Health, 2003, FAST FORW PRIM CAR M; Eldridge Sandra, 2005, J Health Serv Res Policy, V10, P133, DOI 10.1258/1355819054338942; Emery J, 1999, FAM PRACT, V16, P426, DOI 10.1093/fampra/16.4.426; Emery J, 2000, BMJ-BRIT MED J, V321, P28, DOI 10.1136/bmj.321.7252.28; Emery J, 2005, ANN HUM BIOL, V32, P218, DOI 10.1080/03014460500074921; Emery J, 1999, BRIT MED J, V319, P32, DOI 10.1136/bmj.319.7201.32; England E, 2007, BRIT J GEN PRACT, V57, P204; Hardeman W, 2005, HEALTH EDUC RES, V20, P676, DOI 10.1093/her/cyh022; Hutt Ruth, 2005, J Health Serv Res Policy, V10, P194, DOI 10.1258/135581905774414286; Kane RL, 2003, J AM GERIATR SOC, V51, P1427, DOI 10.1046/j.1532-5415.2003.51461.x; Lester H, 2007, BRIT J GEN PRACT, V57, P196; Lester H, 2006, BRIT J GEN PRACT, V56, P244; Low N, 2002, INT J EPIDEMIOL, V31, P891, DOI 10.1093/ije/31.5.891; McNeill LH, 2006, SOC SCI MED, V63, P1011, DOI 10.1016/j.socscimed.2006.03.012; *MED RES COUNC, 2000, FRAM DEV EV RCTS COM; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; *OFF NAT STAT, 2000, KEY HLTH STAT GEN PR; Ornish D, 1998, JAMA-J AM MED ASSOC, V280, P2001, DOI 10.1001/jama.280.23.2001; ORNISH D, 1990, LANCET, V336, P129, DOI 10.1016/0140-6736(90)91656-U; Power R, 2004, HEALTH EDUC RES, V19, P570, DOI 10.1093/her/cyg073; PRIMATESTA T, 1998, HLTH SURVEY ENGLAND; Rowlands G, 2005, FAM PRACT, V22, P132, DOI 10.1093/fampra/cmh704; Senok A, 2005, J EPIDEMIOL COMMUN H, V59, P198, DOI 10.1136/jech.2004.021584	29	841	846	0	66	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2007	334	7591					455	459		10.1136/bmj.39108.379965.BE	http://dx.doi.org/10.1136/bmj.39108.379965.BE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144NB	17332585	Green Submitted, Green Published			2022-12-28	WOS:000244802000031
J	Mayor, S				Mayor, Susan			Fitting the drug to the patient	BRITISH MEDICAL JOURNAL			English	Editorial Material												susan@mayor.dircon.co.uk						Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540; *DEP HLTH, 2003, OUR INH OU FUT REAL	2	7	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 3	2007	334	7591					452	453		10.1136/bmj.39133.452315.AD	http://dx.doi.org/10.1136/bmj.39133.452315.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144NB	17332583	Green Published			2022-12-28	WOS:000244802000029
J	Konhauser, KO; Lalonde, SV; Amskold, L; Holland, HD				Konhauser, Kurt O.; Lalonde, Stefan V.; Amskold, Larry; Holland, Heinrich D.			Was there really an Archean phosphate crisis?	SCIENCE			English	Article							OCEAN		Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	University of Alberta; Harvard University	Konhauser, KO (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada.	kurtk@ualberta.ca	Lalonde, Stefan V/I-8879-2014	Lalonde, Stefan V/0000-0003-1318-2280; Konhauser, Kurt/0000-0001-7722-7068				Bjerrum CJ, 2002, NATURE, V417, P159, DOI 10.1038/417159a; Feely RA, 1998, GEOPHYS RES LETT, V25, P2253, DOI 10.1029/98GL01546; Holland HD., 1984, CHEM EVOLUTION ATMOS; Maliva RG, 2005, GEOL SOC AM BULL, V117, P835, DOI 10.1130/B25555.1; SCHWERTMANN U, 1982, CLAY MINER, V17, P471, DOI 10.1180/claymin.1982.017.4.10; SIGG L, 1981, COLLOID SURFACE, V2, P101, DOI 10.1016/0166-6622(81)80001-7; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375	7	131	138	4	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1234	1234		10.1126/science.1136328	http://dx.doi.org/10.1126/science.1136328			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332403				2022-12-28	WOS:000244564700038
J	Kripalani, S; LeFevre, F; Phillips, CO; Williams, MV; Basaviah, P; Baker, DW				Kripalani, Sunil; LeFevre, Frank; Phillips, Christopher O.; Williams, Mark V.; Basaviah, Preetha; Baker, David W.			Deficits in communication and information transfer between hospital-based and primary care physicians - Implications for patient safety and continuity of care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FOLLOW-UP SYSTEM; GENERAL-PRACTITIONERS; DISCHARGE SUMMARIES; ELDERLY PATIENTS; HEALTH-CARE; IMPROVING COMMUNICATION; COMMUNITY PHYSICIANS; EMERGENCY-DEPARTMENT; MEDICAL-RECORD; QUALITY	Context Delayed or inaccurate communication between hospital-based and primary care physicians at hospital discharge may negatively affect continuity of care and contribute to adverse events. Objectives To characterize the prevalence of deficits in communication and information transfer at hospital discharge and to identify interventions to improve this process. Data Sources MEDLINE ( through November 2006), Cochrane Database of Systematic Reviews, and hand search of article bibliographies. Study Selection Observational studies investigating communication and information transfer at hospital discharge (n= 55) and controlled studies evaluating the efficacy of interventions to improve information transfer ( n= 18). Data Extraction Data from observational studies were extracted on the availability, timeliness, content, and format of discharge communications, as well as primary care physician satisfaction. Results of interventions were summarized by their effect on timeliness, accuracy, completeness, and overall quality of the information transfer. Data Synthesis Direct communication between hospital physicians and primary care physicians occurred infrequently (3%-20%). The availability of a discharge summary at the first postdischarge visit was low (12%-34%) and remained poor at 4 weeks (51%-77%), affecting the quality of care in approximately 25% of follow-up visits and contributing to primary care physician dissatisfaction. Discharge summaries often lacked important information such as diagnostic test results ( missing from 33%-63%), treatment or hospital course (7%-22%), discharge medications (2%-40%), test results pending at discharge (65%), patient or family counseling (90%-92%), and follow-up plans (2%-43%). Several interventions, including computer-generated discharge summaries and using patients as couriers, shortened the delivery time of discharge communications. Use of standardized formats to highlight the most pertinent information improved the perceived quality of documents. Conclusions Deficits in communication and information transfer at hospital discharge are common and may adversely affect patient care. Interventions such as computer-generated summaries and standardized formats may facilitate more timely transfer of pertinent patient information to primary care physicians and make discharge summaries more consistently available during follow-up care.	Emory Univ, Sch Med, Div Gen Med, Dept Internal Med, Atlanta, GA 30303 USA; Northwestern Univ, Feinberg Sch Med, Inst Healthcare Studies, Chicago, IL 60611 USA; Northwestern Univ, Dept Med, Div Gen Med, Chicago, IL 60611 USA; Blue Cross & Blue Shield Assoc Technol Evaluat Ct, Chicago, IL USA; Cleveland Clin Fdn, Sect Hosp Med, Cleveland, OH 44195 USA; Stanford Univ, Sch Med, Dept Internal Med, Div Gen Med, Stanford, CA 94305 USA	Emory University; Northwestern University; Feinberg School of Medicine; Northwestern University; Cleveland Clinic Foundation; Stanford University	Kripalani, S (corresponding author), Emory Univ, Sch Med, Div Gen Med, Dept Internal Med, 49 Jesse Hill Jr SE, Atlanta, GA 30303 USA.	skripal@emory.edu		Williams, Mark V/0000-0001-6107-0457	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [T32PE010025] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR017643] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL077597] Funding Source: NIH RePORTER; NCRR NIH HHS [K12 RR017643] Funding Source: Medline; NHLBI NIH HHS [K23 HL077597] Funding Source: Medline; BHP HRSA HHS [2-T32-PE10025] Funding Source: Medline	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BHP HRSA HHS		ADAMS DCR, 1993, ANN ROY COLL SURG, V75, P96; Adhiyaman V, 2000, INT J CLIN PRACT, V54, P457; Al-Rashed SA, 2002, BRIT J CLIN PHARMACO, V54, P657, DOI 10.1046/j.1365-2125.2002.01707.x; ALPERS A, 2001, AM J MED, V11, pS5; Archbold RA, 1998, BRIT J GEN PRACT, V48, P1163; Auerbach AD, 2000, AM J MED, V109, P648, DOI 10.1016/S0002-9343(00)00597-0; BADO W, 1984, BRIT MED J, V288, P1813, DOI 10.1136/bmj.288.6433.1813; BALLA JI, 1994, MED J AUSTRALIA, V161, P656, DOI 10.5694/j.1326-5377.1994.tb126911.x; Bartlett R C, 1991, J Am Med Rec Assoc, V62, P32; Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; Bell CM, 2006, J GEN INTERN MED, V21, P17; Bertrand D, 1998, Int J Health Care Qual Assur Inc Leadersh Health Serv, V11, P90, DOI 10.1108/09526869810213019; Bolch Denise, 2005, Aust J Rural Health, V13, P91, DOI 10.1111/j.1440-1854.2005.00660.x; Bolton P, 1998, J Qual Clin Pract, V18, P241, DOI 10.1046/j.1440-1762.1998.00281.x; BOYLE CM, 1974, LANCET, V2, P466; Branger P J, 1991, Proc Annu Symp Comput Appl Med Care, P58; BRANGER PJ, 1992, BRIT MED J, V305, P1068, DOI 10.1136/bmj.305.6861.1068; CARTWRIGHT A, 1991, FAM PRACT, V8, P350, DOI 10.1093/fampra/8.4.350; CASTLEDEN WM, 1992, MED J AUSTRALIA, V157, P380, DOI 10.5694/j.1326-5377.1992.tb137245.x; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; CLEMENTS D, 1992, J ROY COLL PHYS LOND, V26, P169; Coleman EA, 2004, HEALTH SERV RES, V39, P1449, DOI 10.1111/j.1475-6773.2004.00298.x; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; COLLEDGE N R, 1992, Health Bulletin (Edinburgh), V50, P219; Crosswhite R, 1997, AM J MANAG CARE, V3, P473; CURRAN P, 1992, ULSTER MED J, V61, P56; de Cruppe W, 2002, GEN HOSP PSYCHIAT, V24, P343, DOI 10.1016/S0163-8343(02)00202-5; DEITELZWEIG S, 2005, SOC HOSP MED ANN M A; Delpierre C, 2004, INT J QUAL HEALTH C, V16, P407, DOI 10.1093/intqhc/mzh064; DEMLO LK, 1981, MED CARE, V19, P1030, DOI 10.1097/00005650-198110000-00005; Dover S B, 1984, Health Trends, V16, P48; Dunnion ME, 2005, J CLIN NURS, V14, P776, DOI 10.1111/j.1365-2702.2005.01129.x; FAIR JF, 1989, BRIT J HOSP MED, V42, P59; FLYER B, 1988, J MED EDUC, V63, P407; Foster DS, 2002, SCOT MED J, V47, DOI 10.1177/003693300204700402; GAMMON DA, 1980, MED J AUSTRALIA, V1, P663, DOI 10.5694/j.1326-5377.1980.tb135216.x; Goldman L, 2001, AM J MED, V111, P36, DOI 10.1016/S0002-9343(01)00968-8; Goldman RD, 2005, CLIN PEDIATR, V44, P305, DOI 10.1177/000992280504400404; HAIKIO JP, 1995, SCAND J PRIM HEALTH, V13, P287, DOI 10.3109/02813439508996777; Halasyamani L, 2006, J HOSP MED, V1, P354, DOI 10.1002/jhm.129; HARDING J, 1987, J ROY COLL GEN PRACT, V37, P494; Hersh W, 2004, JAMA-J AM MED ASSOC, V292, P2273, DOI 10.1001/jama.292.18.2273; Holyoake T I, 1990, Health Bull (Edinb), V48, P29; Howard D J, 1986, Health Trends, V18, P12; Isaac DR, 1997, MED J AUSTRALIA, V166, P9, DOI 10.5694/j.1326-5377.1997.tb138694.x; JANIK DS, 1978, J PEDIATR-US, V93, P519, DOI 10.1016/S0022-3476(78)81185-8; Jansen JO, 2003, EMERG MED J, V20, P256, DOI 10.1136/emj.20.3.256; JELOVSEK F, 1977, METHOD INFORM MED, V16, P199; Johnson PH, 1998, RESP MED, V92, P289, DOI 10.1016/S0954-6111(98)90111-1; *JOINT COMM ACCR H, JOINT COMM NAT PAT S; *JOINT COMM ACCR H, 2006, 610 IM JOINT COMM AC, P338; Jones JS, 1997, ACAD EMERG MED, V4, P1147, DOI 10.1111/j.1553-2712.1997.tb03698.x; KENDRICK AR, 1989, BRIT MED J, V298, P362, DOI 10.1136/bmj.298.6670.362-a; KENNY C, 1991, PUBLIC HEALTH, V105, P243, DOI 10.1016/S0033-3506(05)80114-3; King M H, 1991, West Engl Med J, V106, P40; KING MH, 1991, W ENGL MED J, V106, P55; Kljakovic Marjan, 2004, Inform Prim Care, V12, P227; Knight AM, 2003, J GEN INTERN MED, V18, P134; Kramer JM, 2004, J GEN INTERN MED, V19, P233; Kramer JM, 2004, J GEN INTERN MED, V19, P108; Lee RG, 2003, SOC SCI MED, V56, P449, DOI 10.1016/S0277-9536(02)00045-X; Liesenfeld B, 1996, INT J QUAL HEALTH C, V8, P537, DOI 10.1093/intqhc/8.6.537; LIPWORTH BJ, 1993, SCOT MED J, V38, P116, DOI 10.1177/003693309303800408; LISSAUER T, 1991, ARCH DIS CHILD-FETAL, V66, P433, DOI 10.1136/adc.66.4_Spec_No.433; LLEWELYN DEH, 1988, BRIT MED J, V297, P1504, DOI 10.1136/bmj.297.6662.1504; LLOYD BW, 1993, BRIT MED J, V306, P247, DOI 10.1136/bmj.306.6872.247; Lloyd J, 2000, Aust Health Rev, V23, P134; Lockwood E, 1970, Health Bull (Edinb), V28, P75; LONG A, 1974, BRIT MED J, V4, P456, DOI 10.1136/bmj.4.5942.456; MAGEEAN RJ, 1986, BRIT MED J, V293, P1283, DOI 10.1136/bmj.293.6557.1283; Mant A, 2002, MED J AUSTRALIA, V177, P32, DOI 10.5694/j.1326-5377.2002.tb04632.x; Mant A, 2001, MED J AUSTRALIA, V174, P277, DOI 10.5694/j.1326-5377.2001.tb143268.x; Marks MK, 1999, J PAEDIATR CHILD H, V35, P251, DOI 10.1046/j.1440-1754.1999.00350.x; Massy-Westropp Matthew, 2005, Aust Health Rev, V29, P12; Mathur R, 1997, SCOT MED J, V42, P19, DOI 10.1177/003693309704200108; McInnes E, 1999, FAM PRACT, V16, P289, DOI 10.1093/fampra/16.3.289; MEARA JR, 1992, J PUBLIC HEALTH MED, V14, P145; Moore C, 2006, J GEN INTERN MED, V21, P153; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; Munday A, 1997, BRIT J GEN PRACT, V47, P563; Myers JS, 2005, J GEN INTERN MED, V20, P165; NEWTON J, 1992, BRIT MED J, V304, P821, DOI 10.1136/bmj.304.6830.821; O'Neill KA, 2001, PEDIATR EMERG CARE, V17, P392, DOI 10.1097/00006565-200110000-00018; OETGEN WJ, 1982, MIL MED, V147, P1054, DOI 10.1093/milmed/147.12.1054; Pantilat SZ, 2002, DM-DIS MON, V48, P218, DOI 10.1016/S0011-5029(02)90029-5; Pantilat SZ, 2001, AM J MED, V111, P15, DOI 10.1016/S0002-9343(01)00964-0; Paterson JM, 1999, CAN FAM PHYSICIAN, V45, P2893; PENNEY TM, 1988, BRIT MED J, V297, P28, DOI 10.1136/bmj.297.6640.28-a; Philp I, 1988, Health Bull (Edinb), V46, P291; Pillai Anand, 2004, Inform Prim Care, V12, P67; Poon EG, 2004, ARCH INTERN MED, V164, P2223, DOI 10.1001/archinte.164.20.2223; Qvist P, 2004, INT J QUAL HEALTH C, V16, P141, DOI 10.1093/intqhc/mzh028; Rao P, 2005, AM J MED QUAL, V20, P337, DOI 10.1177/1062860605281078; Raval AN, 2003, CAN J CARDIOL, V19, P365; RAWAL J, 1993, BRIT MED J, V307, P1044, DOI 10.1136/bmj.307.6911.1044; Roy CL, 2005, ANN INTERN MED, V143, P121, DOI 10.7326/0003-4819-143-2-200507190-00011; Rutherford A, 2001, Aust Fam Physician, V30, P1101; SANDLER DA, 1989, BRIT MED J, V298, P870, DOI 10.1136/bmj.298.6677.870; SANDLER DA, 1987, BRIT MED J, V295, P1523, DOI 10.1136/bmj.295.6612.1523; SANDLER DA, 1989, BRIT MED J, V299, P1511, DOI 10.1136/bmj.299.6714.1511; Sexton J, 2000, J CLIN PHARM THER, V25, P385, DOI 10.1046/j.1365-2710.2000.00305.x; SMITH RP, 1989, OBSTET GYNECOL, V73, P803; *SOC HOSP MED, GROWTH HOSP MED NAT; Solis D H, 1982, J Am Med Rec Assoc, V53, P26; SOLOMON JK, 1995, J ROY COLL PHYS LOND, V29, P307; South J, 1972, J R Coll Gen Pract, V22, P28; Stalhammar J, 1998, SCAND J PRIM HEALTH, V16, P154; Sujansky WV, 1998, WESTERN J MED, V169, P176; Taylor DM, 1997, MED J AUSTRALIA, V167, P575, DOI 10.5694/j.1326-5377.1997.tb138902.x; TEMPLE J, 1988, PRACTITIONER, V232, P148; TULLOCH AJ, 1975, BRIT MED J, V4, P443, DOI 10.1136/bmj.4.5994.443; van Walraven C, 2004, J GEN INTERN MED, V19, P624, DOI 10.1111/j.1525-1497.2004.30082.x; van Walraven C, 2002, J GEN INTERN MED, V17, P186, DOI 10.1046/j.1525-1497.2002.10741.x; van Walraven C, 1998, CAN FAM PHYSICIAN, V44, P62; van Walraven C, 2001, J EVAL CLIN PRACT, V7, P289, DOI 10.1046/j.1365-2753.2001.00305.x; van Walraven C, 1999, AM J MED QUAL, V14, P160, DOI 10.1177/106286069901400403; van Walraven C, 2002, CAN FAM PHYSICIAN, V48, P737; van Walraven C, 1999, CAN MED ASSOC J, V160, P319; van Zyl LT, 2003, CAN J PSYCHIAT, V48, P555, DOI 10.1177/070674370304800807; VANDOMBURG RT, 1985, MED INFORM, V10, P259, DOI 10.3109/14639238509080303; VANWALRAVEN C, 1995, CAN MED ASSOC J, V152, P1437; Vinker S, 2004, BMC FAM PRACT, V5, P1; Wachter RM, 2001, AM J MED, V111, P40, DOI 10.1016/S0002-9343(01)00969-X; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487; Wachter RM, 1999, ANN INTERN MED, V130, P338, DOI 10.7326/0003-4819-130-4-199902161-00002; Wachter RM, 1996, NEW ENGL J MED, V335, P514, DOI 10.1056/NEJM199608153350713; WAGSTAFF R, 1994, BRIT J GEN PRACT, V44, P315; Wass AR, 1996, J ACCID EMERG MED, V13, P406; Weiner M, 2003, ANN INTERN MED, V139, P430, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00010; Weiner SJ, 2005, ANN INTERN MED, V142, P709, DOI 10.7326/0003-4819-142-8-200504190-00039; Wilkin T J, 1978, Health Bull (Edinb), V36, P16; WILLIAMS EI, 1990, BRIT MED J, V300, P159, DOI 10.1136/bmj.300.6718.159; Wilson S, 2001, J Qual Clin Pract, V21, P104, DOI 10.1046/j.1440-1762.2001.00430.x	134	1289	1303	4	140	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2007	297	8					831	841		10.1001/jama.297.8.831	http://dx.doi.org/10.1001/jama.297.8.831			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	140DS	17327525				2022-12-28	WOS:000244485000026
J	Scarsbrook, AF; Gleeson, FV				Scarsbrook, Andrew Frederick; Gleeson, Fergus Vincent			Investigating suspected pulmonary embolism in pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CT		Churchill Hosp, Oxford Radcliffe Hosp NHS Trust, Dept Radiol, Oxford OX3 7LJ, England; St James Univ Hosp, Leeds Teaching Hosp NHS Trust, Dept Radiol, Leeds LS9 7TF, W Yorkshire, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford; Saint James's University Hospital; University of Leeds	Gleeson, FV (corresponding author), Churchill Hosp, Oxford Radcliffe Hosp NHS Trust, Dept Radiol, Oxford OX3 7LJ, England.	fergus.gleeson@clinical-medicine.oxford.ac.uk	Scarsbrook, Andrew/I-1660-2019	Scarsbrook, Andrew/0000-0002-4243-032X				Allen C, 2006, RADIOLOGY, V240, P613, DOI 10.1148/radiol.2402051490; [Anonymous], 1998, Ann ICRP, V28, P1; Chan WS, 2002, ARCH INTERN MED, V162, P1170, DOI 10.1001/archinte.162.10.1170; Daftary A, 2005, AM J ROENTGENOL, V185, P132, DOI 10.2214/ajr.185.1.01850132; ICRP, 2003, ANN ICRP, P1, DOI [10.1016/S0146-6453(03)00024-1, DOI 10.1016/S0146-6453(03)00024-1, DOI 10.1016/S0146-6453(03)00021-6]; Nickoloff EL, 2001, AM J ROENTGENOL, V177, P285, DOI 10.2214/ajr.177.2.1770285; Parker MS, 2005, AM J ROENTGENOL, V185, P1228, DOI 10.2214/AJR.04.0770; Sharp C, 1998, DIAGNOSTIC MED EXPOS; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Webb JAW, 2005, EUR RADIOL, V15, P1234, DOI 10.1007/s00330-004-2583-y; Winer-Muram HT, 2002, RADIOLOGY, V224, P487, DOI 10.1148/radiol.2242011581	11	11	11	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2007	334	7590					418	419		10.1136/bmj.39071.617257.80	http://dx.doi.org/10.1136/bmj.39071.617257.80			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	142MQ	17322258	Green Published			2022-12-28	WOS:000244654400035
J	Dangl, JL				Dangl, Jeffery L.			Nibbling at the plant cell nucleus	SCIENCE			English	Editorial Material							RESISTANCE; PATHWAYS; PROTEINS; DEFENSE		Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dangl, JL (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu						Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Bieri S, 2004, PLANT CELL, V16, P3480, DOI 10.1105/tpc.104.026682; Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Heidel AJ, 2004, GENETICS, V168, P2197, DOI 10.1534/genetics.104.032193; Holt BF, 2002, DEV CELL, V2, P807, DOI 10.1016/S1534-5807(02)00174-0; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Zhang YL, 2003, PLANT CELL, V15, P2636, DOI 10.1105/tpc.015842	12	10	12	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2007	315	5815					1088	1089		10.1126/science.1138991	http://dx.doi.org/10.1126/science.1138991			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	138UA	17322052				2022-12-28	WOS:000244387600026
J	Morris, T; Podsiadlowski, P				Morris, Thomas; Podsiadlowski, Philipp			The triple-ring nebula around SN 1987A: Fingerprint of a binary merger	SCIENCE			English	Article							OUTER RINGS; MODEL; PROGENITOR; EMISSION; SN1987A; ORIGIN	Supernova 1987A, the first naked-eye supernova observed since Kepler's supernova in 1604, defies a number of theoretical expectations. Its anomalies have long been attributed to a merger between two massive stars that occurred some 20,000 years before the explosion, but so far there has been no conclusive proof that this merger took place. Here, we present three-dimensional hydrodynamical simulations of the mass ejection associated with such a merger and the subsequent evolution of the ejecta, and we show that this accurately reproduces the properties of the triple-ring nebula surrounding the supernova.	Univ Oxford, Dept Astrophys, Oxford OX1 3RH, England; Max Planck Inst Astrophys, D-85741 Garching, Germany	University of Oxford; Max Planck Society	Podsiadlowski, P (corresponding author), Univ Oxford, Dept Astrophys, Oxford OX1 3RH, England.	podsi@astro.ox.ac.uk						BURROWS CJ, 1995, ASTROPHYS J, V452, P680, DOI 10.1086/176339; CHEVALIER RA, 1989, ASTROPHYS J, V341, P867, DOI 10.1086/167545; CROTTS APS, 1991, NATURE, V350, P683, DOI 10.1038/350683a0; Heger A, 1998, ASTRON ASTROPHYS, V334, P210; HILLEBRANDT W, 1989, ASTRON ASTROPHYS, V219, pL3; Ivanova N, 2003, ESO ASTROPHY SYMP, P19, DOI 10.1007/10828549_3; LLOYD HM, 1995, MON NOT R ASTRON SOC, V273, pL19, DOI 10.1093/mnras/273.1.L19; LUNDQVIST P, 1991, ASTROPHYS J, V380, P575, DOI 10.1086/170615; Luo D., 1991, ASTROPHYS J, V379, P659, DOI [10.1086/170539, DOI 10.1086/170539]; MARTIN CL, 1995, ASTROPHYS J, V447, P378, DOI 10.1086/175881; McCray R, 1997, NATURE, V386, P438, DOI 10.1038/386438a0; Meyer F, 1997, MON NOT R ASTRON SOC, V285, pL11, DOI 10.1093/mnras/285.2.L11; Morris T, 2006, MON NOT R ASTRON SOC, V365, P2, DOI 10.1111/j.1365-2966.2005.09645.x; PODSIADLOWSKI P, 1991, NATURE, V354, P43, DOI 10.1038/354043a0; PODSIADLOWSKI P, 1992, PUBL ASTRON SOC PAC, V104, P717, DOI 10.1086/133043; SAIO H, 1988, ASTROPHYS J, V331, P388, DOI 10.1086/166565; SOKER N, IN PRESS ASTROPHYS J; Sonneborn G, 1997, ASTROPHYS J, V477, P848, DOI 10.1086/303720; Springel V, 2001, NEW ASTRON, V6, P79, DOI 10.1016/S1384-1076(01)00042-2; WAMPLER EJ, 1990, ASTROPHYS J, V362, pL13, DOI 10.1086/185836; XU J, 1995, ASTROPHYS J, V451, P806, DOI 10.1086/176267	26	98	98	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1103	1106		10.1126/science.1136351	http://dx.doi.org/10.1126/science.1136351			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17322055	Green Submitted			2022-12-28	WOS:000244387600030
J	Siripala, AD; Welch, MD				Siripala, Anosha D.; Welch, Matthew D.			SnapShot: Actin regulators II	CELL			English	Editorial Material														Siripala, Anosha/0000-0003-4073-9195	NIGMS NIH HHS [R01 GM059609, R01 GM059609-07] Funding Source: Medline; NIGMS NIH HHS [R01 GM059609-07, R01 GM059609] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059609] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	23	23	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					1014	1014		10.1016/j.cell.2007.02.021	http://dx.doi.org/10.1016/j.cell.2007.02.021			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350583	Bronze			2022-12-28	WOS:000245073400023
J	Gale, C; Davidson, O				Gale, Christopher; Davidson, Oliver			Generalised anxiety disorder	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DSM-IV; GENETIC EPIDEMIOLOGY; CO-MORBIDITY; COMORBIDITY; PREVALENCE; METAANALYSIS; DEPRESSION; EFFICACY		Univ Otago, Dunedin Sch Med, Dept Psychol Med, Dunedin, New Zealand; Otago Dist Hlth, Mental Hlth Serv, Dunedin, New Zealand; Psychol Associates, Dunedin, New Zealand	University of Otago	Gale, C (corresponding author), Univ Otago, Dunedin Sch Med, Dept Psychol Med, POB 913, Dunedin, New Zealand.	christopher.gate@stonebow.otago.ac.nz	Gale, Christopher Kennington/C-6513-2009; Stein, Dan/A-1752-2008	Gale, Christopher Kennington/0000-0001-8032-765X; Stein, Dan/0000-0001-7218-7810				Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P28; Brown ES, 2000, COMPR PSYCHIAT, V41, P19, DOI 10.1016/S0010-440X(00)90126-3; Bruce SE, 2005, AM J PSYCHIAT, V162, P1179, DOI 10.1176/appi.ajp.162.6.1179; Carter RM, 2001, DEPRESS ANXIETY, V13, P78, DOI 10.1002/da.1020; Conway KP, 2006, J CLIN PSYCHIAT, V67, P247, DOI 10.4088/JCP.v67n0211; GALE C, CLIN EVIDENCE; GAMMANS RE, 1992, NEUROPSYCHOBIOLOGY, V25, P193, DOI 10.1159/000118837; Gould RA, 1997, BEHAV THER, V28, P285, DOI 10.1016/S0005-7894(97)80048-2; Hawker DSJ, 2000, J CHILD PSYCHOL PSYC, V41, P441, DOI 10.1017/S0021963099005545; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Hunt C, 2002, PSYCHOL MED, V32, P649, DOI 10.1017/S0033291702005512; Kapczinski F., 2003, COCHRANE DB SYST REV, V2003, DOI [DOI 10.1002/14651858.CD003592, 10.1002/14651858.CD003592]; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lim L, 2005, SOC PSYCH PSYCH EPID, V40, P972, DOI 10.1007/s00127-005-0978-y; Middeldorp CM, 2005, PSYCHOL MED, V35, P611, DOI 10.1017/S003329170400412X; Mitte K, 2005, J CLIN PSYCHOPHARM, V25, P141, DOI 10.1097/01.jcp.0000155821.74832.f9; Pittler MH, 2000, J CLIN PSYCHOPHARM, V20, P84, DOI 10.1097/00004714-200002000-00014; Seivewright N, 2000, DEPRESS ANXIETY, V11, P105, DOI 10.1002/(SICI)1520-6394(2000)11:3<105::AID-DA4>3.3.CO;2-8; Slade T, 2001, SOC PSYCH PSYCH EPID, V36, P45, DOI 10.1007/s001270050289; Tyrer P, 2004, PSYCHOL MED, V34, P1385, DOI 10.1017/S0033291704002569; Westen D, 2001, J CONSULT CLIN PSYCH, V69, P875, DOI 10.1037//0022-006X.69.6.875	21	25	25	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2007	334	7593					579	581		10.1136/bmj.39133.559282.BE	http://dx.doi.org/10.1136/bmj.39133.559282.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AP	19450347	Green Published			2022-12-28	WOS:000245404400037
